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8THE RELATIONSHIPS BETWEEN THE PUBLICATIONS
Contributions to the Study of Dementia
The major focus of the work on dementia has been its epidemiology, including 
studies of prevalence, risk factors and mortality. The state of knowledge about the 
epidemiology of dementia, including the supplicant's own work, was reviewed in the 
book The Epidemiology of Alzheimer's Disease and Related Disorders (Publication 1, 
provided separately).
The literature on the prevalence of dementia is extensive and hard to integrate. 
Accordingly, the supplicant and his colleagues performed a meta-analysis of dementia 
prevalence studies which was the first ever application of meta-analysis to prevalence 
data (Publication 7). This publication showed that the prevalence rates varied between 
studies as a function of methodological differences. However, despite these 
differences, the underlying relationship between prevalence and age was consistent, 
with rates doubling every 5.1 years. An exponential model of the relationship between 
prevalence and age was proposed. Publications 8 and 9 used this exponential model to 
develop a method for calculating projected increases in the number of dementia cases in 
a population. Publication 8 developed the method and applied it to the situation of 
Australia and New Zealand. Publication 9 applied the method to UN population 
projections for 29 developed countries for the period 1980 to 2025. Publication 14 
gave a quantitative review of cross-national differences in the occurrence of 
Alzheimer's and vascular dementias. These differences were examined using incidence, 
prevalence, clinic and neuropathological studies. The analysis showed that Alzheimer's 
dementia is more common than vascular dementia in Great Britain, North America and, 
to a lesser degree, in Scandinavia. The more limited evidence from other Caucasian 
populations also supported a preponderance of Alzheimer's. By contrast, the evidence 
from Japan and China showed a predominance of vascular dementia. These cross­
national differences may give aetiological clues.
9Publications 31, 33 and 34 reported prevalence data from the Canberra 
community survey. Publication 31 reported the prevalence of dementia in Canberra 
using DSM-III-R and ICD-10 criteria. The prevalence was higher by DSM-III-R than 
by using ICD-10, showing that these criteria do not provide equivalent definitions of 
dementia. However, both criteria showed a similar rise in prevalence with age and no 
gender difference. These findings are consistent with the meta-analysis discussed 
earlier (Publication 7). Publication 34 applied the Canberra data to the estimation of 
dementia-free life expectancy in Australia. It was found that women can expect to have 
both more dementia-free years and more dementia-affected years than men. 
Publication 33 compared the Canberra data with an earlier survey in Hobart. Because 
these two surveys did not use the same methods for ascertaining dementia, a 
comparison was carried out using the Mini-Mental State Examination (MMSE) as a 
measure of cognitive impairment. The prevalence of cognitive impairment was 
considerately lower in Canberra than in Hobart. Various possible reasons for this 
difference were explored, but it was found to be entirely due to the higher level of 
education in Canberra. Because future elderly cohorts will be better educated, this 
finding may have implications for the future prevalence of cognitive impairment.
A series of publications was devoted to risk factors for Alzheimer's disease. 
Publications 13, 15, 23, 25 and 29 were derived from a case-control study of 
Alzheimer's disease. As reported in Publication 13, this study involved 170 cases of 
Alzheimer's disease and 170 matched controls. Informants of both cases and controls 
provided information on exposure to potential risk factors. Significant differences were 
found for family history of dementia and Down's syndrome, and underactivity as a 
behavioural trait. Several other risk factors proposed in the literature were not 
confirmed. Publication 15 presented an analysis of season of birth in this sample. This 
publication was written in reaction to a British report of a season of birth effect. If such 
an effect existed, then the months with increased risk should be reversed in a Southern 
hemisphere sample. However, no effect was found. Publication 23 sought to find out 
whether the pattern of risk factors might differ as a function of age of onset or for
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familial versus sporadic types. A number of such differences were found e.g. sporadic 
Alzheimer’s disease was associated with starvation and with head injury. Publication 
25 reported on the reliability of risk factor information in case-control studies of 
Alzheimer's disease. It compared data on agreement between controls and informants 
from four different studies and found it to be adequate. Publication 29 reported a study 
on familial risk for Alzheimer's disease using data derived from a follow-up of the case- 
control sample. The life-time risk for Alzheimer's disease was found to be higher in 
first-degree relatives of cases than in relatives of controls. No evidence was found to 
support suggestions that a familial form of Alzheimer's disease is more common in 
those with earlier onset, in those with prominent aphasia or apraxia, or that an 
Alzheimer gene is sex-linked. Furthermore, the risk curves did not reach an asymptote 
as implied by the theory that many cases are due to an autosomal dominant gene.
Publication 11 presented some cases of monozygotic twins discordant for 
Alzheimer's disease. Such twins are interesting because the discordance must be due to 
environmental factors. However, the analysis of differences in exposures in these twins 
did not yield any clear results.
Several case-control studies of Alzheimer's disease appeared at around the same 
time as the Australian study. To get a clearer picture of risk factors, a meeting was held 
under the sponsorship of the European Community with a view to pooling data from all 
available studies. The results of this collaborative pooling were published as a series of 
publications (16-22) in a special issue of the International Journal of Epidemiology. 
The results were quite extensive, but it could be said that the following risk factors were 
confirmed: family history of dementia, Down's syndrome and Parkinson's disease, 
history of head trauma, hypothyroidism and depression. Smoking, headaches and 
osteoarthritis emerged as protection factors.
The research on risk factors for Alzheimer’s disease has implications for 
prevention. These possibilities were explored for Publication 30 which dealt with 
prevention of dementia and Publication 27 on the role of dementia as a cause of 
disability.
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Another epidemiological theme has been dementia as a factor in mortality. 
Publication 12 used data from a community sample in Hobart to confirm that dementia 
is a major predictor of mortality. Publication 10 examined the feasibility of using death 
certificate data to explore regional differences in the occurrence of dementia. It was 
concluded that such data are not useful in this regard and that regional differences can 
easily arise as an artefact of death certification procedures.
The epidemiological study of dementia relies heavily on the use of standardized 
diagnostic criteria. Publication 2 presented a critique of the DSM-III criteria for 
dementia. This was written as a submission to the developers of DSM-III-R. Whether 
or not this submission had an influence is not known, but some changes were made to 
the criteria consistent with the suggestions. It is known, however, that the ideas did 
influence the later development of the ICD-10 criteria for dementia. Publication 6 
looked at the problems of applying criteria for the clinical diagnosis of Alzheimer's 
disease in field surveys. These criteria were produced for use in hospital settings and 
are difficult to apply in household surveys. Diagnostic criteria for dementia have been 
developed by committees of experts and do not necessarily have an empirical basis. 
Publication 26 explored the interrelationships between symptoms of dementia using 
principal components analysis of data from the Stockholm population survey. This 
analysis found factors of cognitive impairment, disturbed behaviour, cerebrovascular 
disease and depression. Cases of dementia were found to be high on the cognitive 
impairment factor. Cases of Alzheimer's dementia were higher on disturbed behaviour 
but low on cerebrovascular disease, while cases of vascular dementia showed the 
converse pattern. These findings give a better understanding of the clinical 
differentiation between Alzheimer's and vascular dementias. Publication 3 looked at 
the notion that there are two forms of Alzheimer's disease with different clinical 
features and argued that the evidence available on the issue was not adequate to support 
the distinction at present.
Research on dementia has tended to concentrate on cognitive impairments and 
neglected other clinical changes such as disturbances of behaviour. Publications 28 and
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32 dealt with disturbed behaviour and personality change as seen in community 
surveys. (This theme was also present in Publication 26). Publication 28 used data 
from the Stockholm study to show how behavioural disturbances vary over different 
stages of dementia. This study also found discrepancies between informants' reports 
and physicians' ratings of such disturbances. Publication 32 looked at personality 
changes as reported by informants in the Canberra study. A single dimension of 
personality change was found and scores on this were correlated with cognitive decline 
in the subject and with neurotic symptoms in the informant.
Publications 4 and 24 dealt with cognitive deficits in Alzheimer’s disease. 
Publication 4 was a review of the literature arguing that dementia affected "controlled" 
or "effortful" cognitive processes more than "automatic" ones. Publication 24 reported 
a study on cognitive deficits in early dementia. Two types of cognitive tests were used: 
those which in normal people are affected by scopolamine (the cholinergically-sensitive 
tests) and those which are not so affected (the cholinergically-insensitive tests). If the 
cognitive deficits in Alzheimer's disease are due to cholinergic deficiencies, than 
deficits should be specific to the cholinergically-sensitive tests. This was found to be 
true of mild cases, but not of moderate ones. This finding has implications for drug 
treatments for Alzheimer’s disease which attempt to enhance the cholinergic system.
Publications 5 and 35 dealt with the use of cholinergic enhancement therapies 
for Alzheimer's disease. Publication 5 was a meta-analysis of early studies on the 
subject and indicated that treatments which combine a precursor with an 
anticholinesterase were the most promising. Publication 35 reported the results of a 
long-term randomized trial using Tacrine (an anticholinesterase) in combination with 
lecithin (a precursor source). No effects on cognitive functioning were found over the 9 
months of the trial, but side effects were common.
Contributions to the Study of Age-Related Cognitive Deficits
A series of publications was devoted to the study of age-related cognitive 
deficits which fall short of these seen in dementia. All of these publications involved
community samples. Publications 36, 38, 39, 40 and 41 were derived from the 
Canberra study of the elderly and Publication 37 from the Stockholm study.
Publication 40 examined age trends and inter-individual variation in cognitive 
performance of persons aged 70+. Crystallized intelligence, fluid intelligence and 
memory were all found to decrease across age groups, but the decrease was greatest for 
fluid intelligence and least for crystallized intelligence. Although crystallized 
intelligence is generally thought to hold up well in old age, these findings indicate that 
it is lower in the very old. Publications 38 and 39 looked at factors which might 
mediate age-related cognitive deficits. Publication 39 explored the possibility that poor 
physical health might account for some of the age differences. However, age 
differences remained even after cognitive performance was adjusted for health effects. 
Publication 38 looked at whether neuroticism is related to cognitive performance in the 
elderly. Some small correlations were found which are consistent with the theory that 
chronic stress can affect brain ageing.
Publications 36 and 37 looked at subjective complaints of memory and other 
cognitive deficits in the elderly. Publication 36 found that such complaints are common 
but they have little validity, being uncorrelated with age and only weakly with cognitive 
test performance. Rather, cognitive complaints were correlated with anxiety, 
depression and neuroticism, indicating a negative evaluation of cognitive performance. 
Informants' reports of cognitive decline were found to have greater validity. 
Publication 37 looked at memory complaints in different stages of dementia. Mildly 
demented subjects were somewhat more likely to complain of poor memory, but more 
severely demented subjects were less likely to complain because of lack of insight. 
Depression was found to be better correlated with memory complaints than was 
dementia. Depressed subjects tended to underestimate their own memory, while 
moderate-severely demented subjects overestimated theirs. Again, informants' 
complaints of poor memory were found to be valid.
Publication 41 dealt with the validity of the proposed ICD-10 syndrome of Mild 
Cognitive Disorder. No evidence was found to support the validity of this syndrome.
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A major weakness was that the diagnostic criteria for the syndrome involve self- 
reported cognitive deficits. As shown in the publications described above, subjective 
complaints have little validity. Not surprisingly, cases of mild cognitive disorder were 
found to be higher on anxiety, depression and neuroticism.
Contributions to the Study of Depression in the Elderly
The publications on this topic focussed on the epidemiology of depression in the 
elderly and, in particular, on the relationship between depression and dementia in 
general population samples.
Publication 43 reported on a survey of depression in the Canberra community 
using DSM-III-R and ICD-10 diagnostic criteria. The prevalence of depression was 
found to be low overall, but higher for the ICD-10 criteria which incorporate milder 
states. Number of depressive symptoms was found to be correlated with neuroticism, 
poor physical health, disability and a history of previous depression.
Publication 42 was a review of the evidence on cognitive deficit in the depressed 
elderly, looking at the possible sources of the deficit and how it might differ from the 
cognitive deficit seen in dementia. Publications 44 and 46 used data from the 
Stockholm study to examine the relationships between depression and dementia. This 
publication looked at the possibility that depressive symptoms are not related to 
dementia in a uniform way. It was found that depressive symptoms cluster into two 
groups, labelled mood disturbance and motivation disturbance. The mood disturbance 
increased in mild dementia, then decreased in moderate and severe dementia, while the 
motivation disturbance systematically increased with dementia severity. Publication 46 
replicated this result in a larger population sample from the Stockholm study and 
sought to discover whether different factors are associated with mood and motivation 
disturbance. Women were found to have more mood disturbance, but men slightly 
more motivation disturbance. As cognitive function declined mood disturbance first 
increased but then decreased. By contrast, motivation disturbance continued to increase 
with greater cognitive impairment. Disability was related to both types of disturbance.
The distinction between mood and motivation disturbances helps make sense of the 
otherwise confusing literature on the relationship between dementia and depression.
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Publications 45 and 12 look at the outcome of depression in the elderly using 
data from community surveys. (Publication 12 also reported data on dementia and this 
was described earlier). Publication 45 used data from the Stockholm study and found 
that clinically depressed subjects often have a poor outcome. After 3 years, most of the 
non-demented cases of depression had not recovered, in contrast to the dementia cases 
who showed a higher mortality rate but less depression as their dementia progressed. 
Publication 12 examined depression as a predictor of mortality in the Hobart 
community survey. Depressed subjects were found to have a higher mortality. 
However, it appeared that physical illness could be associated with a drop in mood and 
this physical illness was the cause of the increased mortality.
Contributions to the Study of Neurotic Disorders
The term "neurotic disorder" is used to refer the closely interrelated 
psychological states involving anxiety and/or depression. Publications 51 and 56 were 
concerned with the dimensional structure of neurotic symptoms in community samples. 
Publication 51 used principal components analysis to examine the interrelationships 
among scales of neurotic symptoms and subjective well-being. The aim was to see 
whether subjective well-being and neurotic symptoms are opposite ends of the same 
continuum or are independent of each other as some have claimed. The two types of 
scales were found to load on different factors, although these factors were negatively 
correlated. Some differential correlates of the two factors were found, but these were 
not great. It was concluded that neurotic symptom scales and well-being scales do 
largely measure different ends of a single continuum, but well-being scales have an 
extraversion component not shared by neurotic symptom scales. Publication 56 used 
latent trait analysis to explore the dimensionality of symptoms within the neurotic 
domain. Two correlated dimensions of anxiety and depression were found and there 
was some evidence for a third dimension of sleep disturbance.
Publications 47 and 53 dealt specifically with depression as seen in community 
samples. Publication 47 reported a meta-analysis of published data on age and sex 
differences in depression. It is frequently claimed that females have a higher 
prevalence of depression than males. However, this meta-analysis found that the sex 
difference varied by age, being small in childhood and old age and greatest in the 
middle period of life. The pattern of differences was interpreted in terms of variation in 
sex roles across the life span. Publication 53 was a methodological review of studies on 
risk factors for depression. The publication pointed out that information on exposures 
is generally based on self-report of subjects. However, there is substantial evidence 
from laboratory studies of memory that depressed subjects have enhanced recall of 
emotionally negative material and reduced recall of positive material. This 
phenomenon could potentially bias reporting of exposures in risk factor studies.
Publications 48, 50 and 54 dealt with the personality trait of neuroticism which 
involves the predisposition to negative emotions and neurotic disorders. Publication 48 
reported a meta-analysis of published data on sex differences in neuroticism across the 
life span. It was found that females have higher mean scores on neuroticism measures 
at all ages. This has implications for the sex difference in depression (reported in 
Publication 47) because neuroticism is a major risk factor for depression. Publication 
54 reported data from the Canberra survey of the elderly on the relationship between 
personality and physical health. Neuroticism was related to subjective ratings of health 
but not to objective measures, implying that this personality trait affects the evaluation 
of health rather than physical functioning. Publication 50 reported a meta-analysis of 
psychotherapy outcome studies which had included a measure of neuroticism as a 
dependent variable. The aim was to see if psychological interventions might plausibly 
modify neuroticism which is a major risk factor for mental health problems. The meta­
analysis found that rational-emotive and related therapies had strong effects on 
neuroticism and there was some evidence that effects could be long lasting.
Publication 49 investigated measures of neurotic symptoms and personality in a 
longitudinal study of a community sample of adults. It has been observed in similar
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studies that symptom levels drop on re-test, even in general population samples where 
no mean change should be occurring over short periods. The publication explored the 
reasons for this "re-test artefact" which has potentially serious consequences for 
longitudinal studies. The artefact was unrelated to the time lag between testing 
occasions, but was confined to measures assessing negative self-characteristics and 
administered orally by an interviewer.
Publications 52 and 55 were written in response to the not infrequent claim of 
lay persons that surveys of sensitive mental health issues (like the wish to die) may 
have a negative effect on respondents. Both publications report data from community 
surveys on mental health in which respondents were asked at the end of the interview 
whether the questions made them feel anxious or depressed or intruded on their privacy. 
Publication 52 dealt with a survey of adults and publication 55 with a survey of the 
elderly. Negative reactions were found to be uncommon and to be outweighed by 
positive effects.
Contributions to the Assessment of Mental Disorders
Brief cognitive tests such as the Mini-Mental State Examination (MMSE) have 
come into wide use in the assessment of dementia. It has been frequently reported that 
scores on such tests are correlated with education. This correlation is often seen as a 
weakness of the tests and indicative of a bias against the less educated. However, a 
correlation with education may either reflect test bias or a real effect. Publications 58 
and 65 examined this issue using psychometric techniques for assessing test bias. 
Publication 58 looked at performance of the MMSE in a community sample in Hobart, 
while publication 65 did the same for a community sample in Stockholm. In both 
studies, test bias was assessed by seeing whether the MMSE had equal validity in more- 
and less-educated groups. In Hobart, the validity standard was a measure of disability, 
while in Stockholm both disability and clinical diagnosis of dementia were used as 
validity standards. In both samples, the MMSE was found to be correlated with
education, but there was no evidence of test bias, implying that the education difference 
is real.
A series of publications (57, 59, 60, 61, 63, 66, 67) was devoted to the 
development of a method for assessing cognitive decline using informant reports. 
Informant reports have advantages over cognitive tests in that they can assess cognitive 
change rather than current cognitive functioning and they are based on observations of 
everyday behaviour rather than an artificial test situation. Publication 57 reported an 
initial study exploring the feasibility of using informant reports for this purpose. 
Interviews were carried out with informants of a group of elderly people and a scale 
was constructed from items in this interview. A quite high correlation was found with 
MMSE score and low correlations with education and pre-morbid ability. These results 
showed the feasibility of the approach and led to the construction of a self-administered 
questionnaire: the Informant Questionnaire on Cognitive Decline in the Elderly
(IQCODE). Publication 59 described the IQCODE and reported on its psychometric 
properties, reliability and validity in a dementing sample. Publication 60 reported on 
the use of the IQCODE in a postal survey of the general community and gave further 
data on socio-demographic correlates, reliability, validity and norms. Publication 61 
reported on the validity of the IQCODE in a clinical sample using clinical diagnosis of 
dementia as the validity standard. The questionnaire was found to perform at least as 
well as the MMSE and to be uncontaminated by pre-morbid ability. Publication 63 
reported on the use of the IQCODE in a sample of very highly educated elderly 
compared to retired blue-collar workers. Again the IQCODE was found to be 
unaffected by premorbid ability and education, unlike the MMSE. Publication 66 
reported on the development of a short form of the IQCODE in which the original 26 
items were reduced to 16. Data from 4 studies were analyzed to discover the best 16 
items. In a validation study, the short IQCODE was found to perform as well as the full 
version. Publication 67 is a review of research carried out on the use of informants' 
reports to study cognitive changes in dementia, both with the IQCODE and other
related approaches. This publication also reported new data indicating that the 
IQCODE items are primarily measuring episodic memory performance.
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Publications 62, 64 and 68 were concerned with the development of a 
standardized psychiatric interview for elderly persons which can be administered by lay 
interviewers. This interview, called the Canberra Interview for the Elderly (CIE), was 
designed for use in epidemiological studies where it is often not possible to employ 
clinicians to assess a large sample. The CIE gathers information necessary for the 
diagnosis of dementia and depression and related conditions by DSM-III-R and ICD-10 
criteria. A computer program written in SPSS analyzes this information to arrive at the 
diagnoses. Publication 62 described the CIE and reported data on its test-retest 
reliability in a clinic sample. Publication 64 reported on the validity of the interview 
using clinicians' diagnoses as the validity standard. The CIE was used in the Canberra 
longitudinal study of the elderly, the results of which are reported in a number of 
publications described in other sections (see especially publications 31 and 43). 
Publication 68 introduces the Psychogeriatric Assessment Scales (PAS) which were 
derived from the CIE using principal components and latent trait analysis. These 
analyses were based on the Canberra community survey and substantially replicated the 
results of the principal components analysis reported earlier on data from the 
Stockholm study (Publication 26). The PAS assesses the clinical changes seen in 
dementia and depression along multiple dimensions rather than in terms of categorical 
diagnoses. There are three scales derived from an interview with the subject (Cognitive 
Impairment, Depression, Stroke) and three from an interview with an informant 
(Cognitive Decline, Behaviour Change, Stroke). The PAS is easy to administer and 
score and can be used by lay interviewers after brief training.
Contributions to the Evaluation of Health and Community Services
Publications 72 and 73 dealt with the services provided by GPs to elderly people 
suffering from dementia or depression. Publication 72 evaluated the accuracy of GPs at 
detecting these disorders in their patients. Detection of dementia was good, but
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detection of depression poor. Publication 73 reported results from a survey of GPs' 
knowledge about dementia and depression. It was found that their knowledge of 
symptoms and signs was limited and many did not know that Alzheimer's disease is the 
most common dementing disorder.
Publications 69, 71 and 74 dealt with the mental health consequences of caring 
for a dementing relative. Publication 74 reported data on the effects of being a carer 
using carers identified in a community survey. It was found that caring for a disabled 
elderly person was associated with higher levels of anxiety and depressive symptoms. 
However, caring for a physically disabled person was more stressful than caring for 
someone with dementia. Publications 69 and 71 looked at the effects on carers of 
particular types of services. Publication 69 reported a randomized controlled trial of 
entry to a special nursing home for dementia sufferers. This was found to produce 
substantial benefits to the mental health of carers and no ill-effects to the dementia 
sufferers themselves. Publication 71 looked at the effects of special dementia day care 
on carers. Only limited mental health benefits to carers were found, in contrast to the 
strong benefits of residential care.
Publications 70, 75 and 76 examined the distribution of mental health services in 
Australia. Publication 70 reported an analysis of private psychiatric services provided 
under Medicare. The use of services was found to be lowest in children and the elderly 
and highest in the middle period of life. Females received more services than males at 
all ages except in childhood. Publication 75 examined the distribution of Medicare 
psychiatric services by electorate. Great inequalities were found, with urban and high 
socio-economic electorates receiving a much higher rate of services. This pattern of 
service use does not correspond with epidemiological data on the distribution of mental 
disorders. Publication 76 used data from the National Health Survey to look at the 
characteristics of people who consulted psychologists. Again, the social distribution of 
consultation did not always match the known epidemiological pattern.
Methodological Contributions
Publications 78-80 dealt with methodological issues in the epidemiological 
study of dementia, in particular whether dementing diseases form the end point of a 
continuum in the population or whether they are categorically distinct diseases. 
Publication 78 was a consensus report from a workshop which discussed the issue. It 
was concluded that dementing diseases could be seen as end points of a continuum of 
ageing. Publication 79 discussed methodological problems in evaluating this issue. In 
particular, it showed that observations of unimodal or bimodal distributions in the 
population cannot readily distinguish the two positions. Publication 80 presented a 
statistical method for studying dementia as a continuum in community surveys.
Publication 77 is a discussion of methodological issues arising from the meta­
analysis of drug treatments for Alzheimer's disease reported in Publication 5. This 
meta-analysis revealed that published reports often do not present basic descriptive data 
such as means and standard deviations of effects. Authors also do not respond to 
written requests for this information.
Contributions to the Study of Reading Disability
The research on reading disability focussed on two issues. Firstly, what aspects 
of the reading process are primarily affected in reading disabled children and, secondly, 
what fundamental cognitive processes underlie the problem in learning to read.
Publications 81 and 87 were devoted to the first of these issues. Publication 81 
looked at the ability to read single words at a whole-word level and using grapheme- 
phoneme correspondence rules ("phonological recoding"). Reading disabled children 
were found to be deficient at using phonological recoding, but had the ability to process 
words wholistically. Publication 87 further examined the reading processes of disabled 
readers. Children had to either read words aloud ("word naming") or simply decide 
whether or not a string of letters constituted a real word ("lexical decision"). The times 
for naming the words or making the lexical decision were recorded. Unlike normal 
readers, the disabled readers were slower to name written words than to make lexical
decisions. Since naming a word involves phonological recoding and lexical decision 
does not, this finding was further evidence that disabled readers have a deficiency in 
this component of the reading process.
To find out more about the fundamental cognitive deficits which underlie 
reading disability, a longitudinal study was carried out on young children entering 
school. The aim of this study was to assess cognitive deficits before the children had 
formal reading instruction. Any cognitive deficits which predicted later reading 
disability could then not be an effect of the reading disability and were more likely to 
be causative. Publication 84 reported on the factors at school entry which predicted 
reading achievement at the end of two years at school. The strongest predictors of 
reading achievement were tasks tapping phonological processing skills, interdigital 
dexterity, and familiarity with the alphabetic code of English script. Publications 85 
and 86 reported specifically on the factors which differentiated disabled from normal 
readers. Publication 85 found that the disabled readers were poorer at school entry on 
tasks involving early literacy and phonological processing skills. This study also 
showed that, contrary to earlier claims, reading disabled children do not have a general 
language deficit. Publication 86 reported on behaviour problems in disabled readers. 
Children who have broad academic problems were found to have more behavioural 
problems at school entry, mainly involving attentional deficit. However, children with 
academic problems specifically in reading did not show early behaviour problems.
Publications 82 and 83 give literature reviews and theoretical integration. 
Publication 83 reviewed the literature on memory functioning in disabled readers and 
concluded that they have specific problems in memory for phonological information. 
Publication 82 linked together the literature on the nature of the reading deficit with the 
literature on the underlying cognitive deficit. It was argued that disabled readers often 
have a deficit in the ability to process phonological information. This deficit makes it 
harder for them to read unfamiliar words via phonological recoding. Although they can 
process words wholistically, disabled readers are less likely to learn to do so because 
phonological recoding acts as a self-teaching mechanism to help children learn to
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identify words as wholes. In short, most disabled readers have difficulty learning to 
read because they lack the ability to teach themselves words they have never seen 
before.
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NATURE AND EXTENT OF CONTRIBUTION TO THOSE PUBLICATIONS
WITH JOINT AUTHORSHIP
The supplicant's contribution to each publication with joint authorship is reported here 
using a scheme based on that proposed by Shapiro et al. (1994). This scheme involves 
reporting separately the contributions made to each of the following components of a 
publication: initial conception of the research, design of the research, collection of data, 
analysis and interpretation of data, and writing and revision of the publication. The 
contribution to each component is reported as major (2 stars), minor (1 star), little or no 
contribution (no stars), or not applicable (NA). The not applicable category applies in 
narrative review publications where, for example, there is no research design or collection 
of data.
Reference
Shapiro, D.W., Wenger, N.S. & Shapiro, M.F. (1994). The contributions of authors to 
multiauthored biomedical research papers. Journal of the American Medical Association. 
271,438-442.
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15 - * - * *
16 * * * * * * *
17 * * * - -
18 * * * - -
19 * * * - -
2 0 * * * - -
21 * * * - -
22 * * * - -
23 * * - * *
2 4 * * - - *
25 * * * - * *
26 * * * * - * * * *
28 - - - * * * *
29 * * * * - * *
31 * * * * * * * *
32 * * * * * *
33 * * * * * * * * *
34 - - * * *
35 * * - * *
36 * * * * * * * * *
37 - - - * * * *
38 * * * * * * * * *
39 * * * * * *
4 0 * * * * * *
41 * * * * * *
26
P u b l. N o . In itia l
C o n c e p tio n
D e s ig n D ata
C o lle c tio n
A n a ly s is  & 
In te rp re ta tio n
W rit in g  &  
R e v is io n
43 ** ** * ** *
4 4 - - - ** **
4 5 - - - ** **
4 6 - - - **
4 9 - - - ** **
51 - - - ** **
52 ** - - ** **
53 ** N A N A N A **
5 4 ** ** * ** **
55 ** ** * ** **
5 6 - * * - *
57 ** ** ** ** **
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6 4 ** ** - * *
65 ** - - ** **
68 ** ** * ** **
69 ** ** - ** **
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71 ** ** - ** **
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73 * ** . ** *
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Possible Improvements to the Diagnostic Criteria for 
Dementia in D S M -III
A. F. JORM and A. S. HENDERSON
The DSM-III diagnostic criteria for dementia can be criticised because thev treat 
“  f  a categorical rather than dimensional disorder, and thus ignore the 
problem of placing appropriate cutoffs. They are also too broad and may result in
diagnosticians6 Sreareo^sCf USe ° f vary'n9 interPretations of the criteria by different
S Ä Ä Ä S i  ° '/ercom,n9,hese problems are discussed and some
While investigation o f dememia has become a 
priority area, a requirement for all such research is 
us accurate clinical diagnosis; unfortunately, diag­
nostic criteria for this group of disorders are less well 
developed than for many others. A major advance 
was the publication of DSM-III (American Psychi­
atric Association, 1980), in which the diagnostic 
criteria for dementia provide greater specification 
and incorporate a range o f clinical insights not 
present in earlier diagnostic schemes (e.g. ICD-9 
World Health Organisation, 1978). Nevertheless,’ 
these criteria leave much to be desired. Given the
1 ° ' submissions on possible changes to 
vSM-111 which could be incorporated in DSM -IIIR  
(Spitzer, 1984), it is now particularly appropriate to 
discuss these weaknesses.
Overview of problems in implementing the criteria
The DSM -III criteria for dementia are set out in 
able I. Consider the steps a research worker or 
clinician has to go through to implement these 
criteria: for the former, these might be carried out in 
a torrnal manner, while for the clinician it would be 
done tacnly. Firstly, each of the criteria has to be 
translated into a set of specific questions to assess 
oss ot intellectual abilities, memory impairment 
and other higher functions. For criteria A  and B,’ 
DSM-111 provides no guidance as to the components 
vvithin these domains which should be tapped by 
these questions, although criteria C (l) and C(3) are 
better in this regard. Secondly, responses to the 
questions are weighted and summed to give a total 
score for each criterion. This is done largely 
implicitly by the clinician and more formally by the 
research worker. Presumably, more important 
questions would be given greater weight, but DSM- 
111 does not provide guidance on this. Thirdly a cut­
off on the score for each criterion needs’ to be 
adopted, to decide whether or not that criterion has
been met, i.e. a decision must be made as to how 
many errors on questions for loss o f intellectual 
abilities, memory impairment, or other higher 
functions are allowable before the particular 
criterion is regarded as being met. DSM -III does not 
specify these cut-offs, although it does specify a 
minimum number o f attributes for crite rion ’c. 
1 inally, once each criterion has been scored as beine 
met or not, D SM -III provides a clear algorithm for 
deciding whether or not a particular individual is 
demented.
It can be seen that the first three steps in imple­
menting the criteria provide considerable latitude 
tor individual interpretation, and are consequently 
sources o f unreliability in diagnosis. This situation is 
unsatisfactory, and its causes and possible remedies 
are considered below' in greater detail.
Categorical and dimensional conceptions of 
dementia
In producing a reliable operationalisation o f the 
DSM-III criteria for dementia, problems result 
because both the concept o f dememia itself and its 
component features are dimensional rather than 
categorical. W ith clearly continuous features like 
intellectual abilities and memory performance, as 
demonstrated by the distribution o f scores on such 
tests as the Wechsler Adult Intelligence Scale and 
the Wechsler Memory Scale, a cu t-o ff must be 
placed on a continuum, and unreliability will result 
if diagnosticians use varying cut-offs. Despite the 
dimensional nature o f the criteria, DSM -III leads to 
problems in this regard by imposing a dichotomy on 
them: e.g. memory is either impaired or it is not.
Dementia itself is a dimensional disorder. D istri­
butions ot scores on brief dementia scales like the 
Mini-Mental State (Folstein ei al, 1975), obtained 
from sizeable community samples o f the elderly, 
reveal a monotonic distribution, with a continuous
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Table I
Diagnostic criteria Jor dementia in DSM-III
A A loss of inielleclual abilities of sufficient severity to interfere with social or occupational functioning.
8 Memory impairment
C At least one of the following:
(1) impairment of abstract thinking, as manifested by concrete interpretation of proverbs, inability to find similarities and differences 
between related words, difficulty in defining words and concepts, and other similar tasks
(2) impaired judgment
(3) other disturbances of higher cortical function, such as aphasia (disorder of language due to brain dysfunction), apraxia (inability 
to carry out motor activities despite intact comprehension and motor function), agnosia (failure to recognise or identify objects 
despite intact sensory function), “ constructional difficulty" (e g., inability to copy three-dimensional figures, assemble blocks, 
or arrange sticks in specific designs)
(4) personality change, i.e., alteration or accentuation of premorbid traits
D. State of consciousness not clouded (i.e., does not meet the criteria for Delirium or Intoxication, although these may be superimposed).
E. Either (I) or (2):
(1) evidence from the history, physical examination, or laboratory tests, of a specific organic factor that is judged to be etiologically 
related to the disturbance
(2) in the absence of such evidence, an organic factor necessary for the development of the syndrome can be presumed if conditions 
other than Organic Mental Disorders have been reasonably excluded and if the behavioral change represents cognitive impairment 
in a variety of areas.
Note: From Diagnostic and Statistical Manual o f  Mental Disorders, Third Edition (pp. 111 - 112). by American Psychiatric Association,
1980, Washington, DC: APA. Copyright 1980 by APA Reprinted by permission.
tail of scores at the low end of the distribution and 
no hump to suggest the presence of a discrete 
disorder (Kay ei al, in press; Holzer el at, in press). 
Furthermore, senile dementia of the Alzheimer 
type, which is the most common form of dementia, 
appears to show continuous variation in its neuro- 
pathological features, which merge into the changes 
found in the normal aged (Tomlinson el al, 1970). 
Further support for the dimensional nature of 
dementia comes from surveys of the disorder in the 
general population, which have frequently distin­
guished between mild, moderate, and severe 
dementia (Henderson, 1983), suggesting some 
underlying dimension of severity. The implication 
of adopting a dimensional viewpoint for the 
development of diagnostic criteria is that different 
criteria for different levels of severity must be 
specified and, in particular, the problem of mild 
dementia must be squarely faced (Henderson & 
Huppert, 1984). This requirement applies particu­
larly for epidemiological research, where the profile 
of morbidity is quite different from clinical popula­
tions, with many more mild cases and fewer severe 
ones. The reliable diagnosis of mild dementia is 
technically demanding, but it is nevertheless 
essential for studies of the earlier manifestations of 
this group of disorders and of their natural history.
The problem of selecting items
Diagnostic criteria in psychiatry inevitably have to 
be translated into a set of questions which the 
diagnostician asks the patient or an informant, or
which he assesses in a mental state examination. 
With a clear set of criteria,’different diagnosticians 
should arrive at a rather similar set of questions. 
However, with the DSM-III dementia criteria, quite 
different implementations would be possible, all of 
which could justifiably claim to satisfy these 
criteria. Criteria A, 3, and C(2) are particularly 
open to varying interpretation, although the dis­
cussion preceding the criteria in DSM-III does 
provide some suggestions for suitable items. Thus, 
for criterion B, the discussion in DSM-III suggests 
how problems in new learning and in recall of 
material from the past can be assessed. However, 
the scope of the required memory deficit is not 
specified; e.g. whether short-term storage as well as 
long-term storage and retrieval should be deficient, 
and whether non-verbal as well as verbal memory 
should be impaired. Lawrence (1984) has set out 
the problems in assessing memory deficit, uncon­
founded by other cognitive functions such as 
attention and concentration. In the DSM-III 
criteria, evidence of subjective memory impairment 
would appear to be acceptable in meeting criterion 
B, despite the fact that there is little relationship 
between subjective memory problems and objec­
tively determined memory performance (Kahn el al, 
1975). Further elaboration of the intended meaning 
of these criteria, as is provided for criteria C(l) and 
C(3), would be a significant improvement.
Criterion A presents particular problems because 
it requires evidence of loss of intellectual abilities, 
rather than the current level. The assessment of 
intellectual loss, strictly speaking, requires measure-
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ment at two points some time apart, with these 
assessments indicating temporal decline. However, 
in actual practice, assessment at only one point in 
lime is generally possible, particularly in epidemio­
logical studies. With severe dementia, it may be 
obvious that a person who has achieved certain 
occupational and social skills in the past could not 
possibly have done so with his or her current low 
level o f intellectual abilities. W ith mild cases o f 
dementia, on the other hand, the determination o f 
intelllectual loss by assessment at one point in time is 
a d ifficu lt problem, and one for which D SM -llI 
does not give an answer. Nevertheless, there are 
techniques in the literature for the estimation o f 
premorbid intelligence which go some way towards 
providing a solution (Nelson & O ’Connell, 1978; 
Wilson el al, 1979). A similar problem applies to 
criterion C(4), which requires the assessment o f 
personality change. For ascertaining on cross- 
sectional evidence that deterioration has taken 
place, a carefully obtained history from an 
informant is most valuable; this applies to loss o f 
intellectual abilities, memory impairment, or a 
change in personality. D SM -III does not provide 
guidance on the place o f the informant for assess­
ment o f these, yet there is often no other way to 
determine if  deterioration has occurred, on the basis 
o f cross-sectional information.
Weighting of symptoms or signs
It seems intuitively likely that some symptoms or 
signs w ill be stronger indicators than others that a 
diagnostic criterion is fu lfilled. One feature on its 
own may be more indicative o f dementia than others 
or even combinations o f others. This is probably 
recognised in some way by the clinician during the 
diagnostic process, but it has so far not been 
formalised in the specification foT each criterion and 
its elements. There are various statistical procedures 
available for deriving appropriate weightings which 
are o f use to research workers, and their potential 
use is discussed below.
The problem of cut-offs
Once dementia is regarded as a dimensional rather 
than categorical concept, the issue arises o f placing 
cu t-o ff points on the dimension to define cases. The 
need for this is particularly apparent in epidemio­
logical surveys, where diagnostic criteria must be 
implemented as a specific procedure, rather than 
tacitly. This well illustrates the different require­
ments in research and clinical practice. In imple­
menting D S M -llI ’ s diagnostic criteria for dementia,
a research worker would want to derive scores for 
each criterion, and then place a precise quantitative 
cut-off to define whether that criterion has been 
met. For clinicians, on the other hand, such 
precision would probably be overly restrictive and 
unnecessary; instead, what would be required are 
some sort o f qualitative anchor points to define 
whether a particular level of dementia severity has 
been met. DSM-III does, in fact, use this latter 
approach for criterion A, where the degree of loss of 
intellectual abilities necessary for the criterion to be 
met is defined qualitatively in terms o f “ sufficient 
severity to interfere with social or occupational 
functioning” . However, no such anchor points are 
given for the other criteria o f dementia. Dementia 
scales by Reisbcrg el al (1982) and by Hughes el al 
(1982) are largely based on their use to define 
varying levels o f severity, and are good examples o f 
the usefulness of this approach, if  extended further.
Although the use o f qualitative anchor points is a 
valuable aid for ensuring that cut-offs for severity 
are consistent across criteria,- it does have weak­
nesses. Take, for example,"’The anchor point pro­
vided for criterion A. Whether intellectua1 loss will 
interfere with a person’s social and occupational 
functioning will vary greatly depending on that 
person’ s premobid intellectual abilities and the 
demands o f the social and occupational tasks he 
undertakes. A retired person o f high premorbid 
intelligence living in a stable social environment may 
suffer considerable intellectual loss without inter­
ference with social or occupational functioning. On 
the other hand, a person working in an intellectually 
demanding job involving considerable adjustment 
to change may be affected by relatively slight 
intellectual loss. Despite problems o f this sort, 
providing qualitative anchor points is a better 
alternative than ignoring the issue o f cut-offs 
altogether.
Problems with the algorithm
Once decisions have been made as to whether 
criteria have been met, DSM -III provides a clear 
algorithm for diagnosing dementia. Nevertheless, 
the precision of the algorithm should not blind us to 
its considerable problems.
In defining a case o f dementia, we are placing a 
cut-o ff on a latent dimension o f dementia, and 
calling all individuals above that point demented. 
Using the terminology of structural equation 
modelling (Jöreskog & Sorborn, 1978), the criteria 
for dementia can be regarded as a set o f manifest 
variables which we combine together in a specified
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way to give a measure of the latent variable of 
dementia which underlies them. However, with the 
algorithmic approach of DSM-III, cut-offs arc not 
placed on the latent dementia variable, but on the 
manifest variables which constitute the criteria. 
These dichotomised criteria are then fed into the 
algorithm.
This sort ol algorithmic approach is appropriate 
I or disorders for which the criteria are categorical in 
nature, but in converting dimensional variables into 
categories, as is done for DSM-III dementia, major 
problems could arise. Consider what might happen 
if the cut-off point on criterion A were placed fairly 
low, at a point appropriate for mild dementia. With 
criterion B, on the other hand, the cut-off might be 
placed high, at the severe end of the dementia 
dimension. It would turn out that virtually all 
individuals who meet criterion A would also satisfy 
criterion B, but many individuals who satisfy 
criterion B would not meet criterion A. Thus, 
criterion A w'ould have an overwhelming influence 
in deciding whether a particular individual is 
demented, whilst criterion B w'ould have virtually no 
influence, because a positive score on it is quite 
predictable from a positive score on A. In such a 
case of greatly varying cut-offs, only one criterion is 
really deciding who is demented and who is not. 
Whilst it is unlikely that this extreme situation 
would occur in actual practice, it is still necessary to 
ensure that cut-offs for each criterion are lined up at 
an equivalent point of severity. Unfortunately, 
DSM-III does nothing to ensure that diagnosticians 
will line up their criterion cut-offs, and incon­
sistencies could easily arise, particularly where the 
user has had limited clinical experience with the 
disorder.
The ultimate alternative to the present type of 
DSM-111 algorithm would be one in which scores on 
each ot the criteria are combined in some way and 
cut-offs for varying degrees of severity placed on the 
resulting single dimension. In this way, the problem 
of lining up cut-offs disappears, but some method 
of combining scores on the criteria must first be 
developed. If an objective measure of dementia 
existed, such as an index of severity based on neuro- 
pathological data, the appropriate way to weight 
each of the criterion scores, then sum them, would 
be derived from a logistic regression analysis. If no 
objective measure were available, then factor 
analysis of the criterion scores, or latent trait 
analysis of item scores would provide a weighted 
sum of them to index the latent dimension of 
dementia (c.f. Young, 1983).
For research workers who have developed a
particular set of questions to implement a set of 
diagnostic criteria, an approach of this sort would 
appear to be quite appropriate, but for clinicians it 
would be unnecessarily complex and constraining. 
For them, an improved algorithmic approach which 
took note of the problem of lining up cut-offs would 
be more appropriate, and in actual practice, such an 
approach need not result in widely differing diag­
nostic decisions. Rather, the research worker’s 
instrument would still be seen as a particular in­
stantiation of the general diagnostic criteria, 
provided that these criteria were used as the basis of 
initial item selection.
If the present DSM-III algorithm were to be 
improved, some attention would need to be given to 
the way in which the criteria are presently combined. 
In particular, criteria C, which requires “ at least one 
of the following” to be met, poses a problem. What 
DSM-III appears to be implying is that criterion A 
and B are always met in dementia, while C(l) to 
C(4), considered individually, are sometimes but not 
always met. If these criteria are-indeed each present 
in dementia with a probability' of less than 1, then it 
is at least possible for a case of dementia to meet 
none of them. However, DSM-111 leaves no place 
for the individual who fulfills all of the other criteria 
for dementia but none of C( 1) to C(4). It insists that 
in a case of dementia there is a probability of 1 that 
at least one of the four C criteria is met. An alterna­
tive would be to say that these criteria should be 
regarded as features which increase the diag­
nostician’s certainty that dementia is present, but 
are not necessary features of the disorder. In fact, 
they are probably best seen as features of particular 
diseases which manifest as dementia (e.g. Hunting­
ton’s disease, Alzheimer’s disease, senile dementia 
of the Alzheimer type, multi-infarct dementia) and 
worthy of note for that reason, rathe: than as 
features central to the global concept of dementia 
itself.
Broad vs. specific criteria
DSM-III presently provides fairly broad diagnostic 
criteria which the clinician or research worker has 
then to interpret and modify as a diagnostic 
instrument. For the research worker, this process 
can be made explicit, but for the clinician it involves 
decisions made in a tacit way. The ultimate means of 
reducing diagnostic unreliability due to varying 
operationalisations of the criteria is to make the 
criteria so specific that they themselves comprise a 
diagnostic instrument. The result w-ould be a set of 
criteria which would look like the Present Slate 
Examination with its associated algorithm (Wing ei
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o!, 1974), or the Diagnostic interview Schedule 
(Robins el at, 1981).
Although there would be advantages in having 
such a specific set of criteria, there are a number of 
reasons why DSM-I1I should specify its criteria at a 
reasonably general level. Firstly, any set of criteria 
must be useful to clinicians as well as research 
workers. A totally scripted examination for 
dementia with a rigorous scoring system would 
probably be unacceptable, and perhaps unnecessary 
in the context of clinical practice. Secondly, DSM- 
111’s diagnostic criteria for dementia must maintain, 
as far as possible, a universal relevance. A specific 
diagnostic instrument for dementia must necessarily 
contain cuIturally-specific content (e.g. knowing the 
date, one’s age, the Head of State, or being able to 
write) and would therefore lose this universal 
applicability. Thirdly, DSM-III is to a large degree a
document reflecting consensus between diag­
nosticians with different viewpoints, and if this is to 
be reached, it is much more likely to occur with 
broad diagnostic criteria than with very specific 
ones. DSM-IlTs criteria for dementia must there­
fore be fairly broad, but also need to be sufficiently 
specific to discourage unreliability.
Possible improvements to the criteria
Although we have been critical of the DSM-111 
criteria for dementia, we acknowlege their impor­
tance and the advance they represent. The aim of 
this paper has been to promote their improvement in 
two areas: (a) recognition of the dimensional rather 
than categorical nature of dementia and the con­
sequent need to incorporate anchor points for 
severity in the criteria; and (b) increased specifica-
Table II
Improved diagnostic criteria fo r dementia
A A loss of intellectual abilities which interferes with social or occupational functioning. This should be alfcssed by comparing current 
abilities with actual or estimated premorbtd abilities. Data gathered from an informant familiar with the individual in earlier life or 
demographic data reflecting previous functioning (occupation, educational achievement, income) are useful in this regard Where 
more formal testing is involved, intellectual abilities resistant to decline (e.g. word reading skill) may be used to estimate premorbid 
intelligence.
Mild dementia is characterised by inability to function independently at activities such as usual level in job, shopping, business and 
financial affairs, volunteer and social groups, where this was previously possible There is mild but definite impairment of function 
at home; more difficult chores and more complicated hobbies and interests are abandoned.
Moderate dementia is characterised by no pretence of independent function outside of the home. Wit hin the home, only simple chores 
are preserved. Interests are very restricted and poorly sustained.
Severe dementia is characterised by no pretence of independent function outside of the home and no significant function in the home 
outside of own room.
B Memory impairment, as manifested by problems in learning of new material, retrieval of previously learned material, and working 
memory function (short-term storage) The memory impairment applies to both verbal and non-verbal material. The memory 
problems should be objectively verifiable rather than be only subjective memory complaints.
Mild dementia is characterised by moderate memory loss, more marked for new learning; the defect interferes w ith everyday activities. 
Moderate dementia is characterised by severe memory loss. Only highly learned material is retained and new material is rapidly lost 
Severe dementia is characterised by severe memory loss with only fragments remaining
C The following are present in particular disorders which manifest as dementia Their presence may be used to increase diagnostic 
certainly or to aid differentia) diagnosis between particular types of dementia:
( 1) impairment of abstract thinking, as manifested by concrete interpretation of prov erbs, inability to find similarities and differences 
between related words, difficulty in defining words and concepts, and other similar tasks.
(2) impaired judgement as manifested by a general disregard for the conventional rules of social conduct which wa^ previously not 
present, e.g. coarse language, inappropriate jokes, neglect of personal appearance and hygiene.
(3) other disturbances of higher cortical function, such as aphasia (disorder of language due to brain dysfunction), apraxia (inability 
to carry out motor activities despite intact comprehension and motor function), agnosia (failure to recognise or identify objects 
despite intact sensory function), "constructional difficulty” (e.g inability to copy three-dimensional figures, assemble blocks, 
or arrange slicks in specific designs).
(4) personality change which may involve an alteration or accentuation of premorbid traits (increase in apathy and withdrawal, 
narrowing of range of interests, increase in slovenliness) or accentuations of compulsive, histrionic, impulsive or paranoid traits 
These changes can be assessed by informant interview.
D State of consciousness not clouded (i.e., does not meet the criteria for Delinum or Intoxication, although these may be superimposed)
E Either (1) or (2):
(1) evidence from the history , physical examination, or laboratory tests, of a specific organic factor that is judged to be aetiologically 
related to the disturbance.
(2) in the absence of such evidence, an organic factor necessary for the development of the sy ndrome can be presumed if conditions 
other than Organic Mental Disorder^ have been reasonably excluded and if the behavioural change represents cognitive impair 
ment in a variety of areas.
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tion o f criteria to reduce diagnostic unreliability due 
to widely varying interpretations. Accordingly, in 
Table II we propose improved criteria for dementia 
which build on the existing foundation of DSM-III 
and attempt to incorporate these requirements. The 
anchor points for mild, moderate, and severe 
dementia derive from the work of Hughes el al 
(1982). This proposal is not meant to be a final word 
on the subject, but a contribution to much-needed 
discussion o f the issues involved.
Finally, we note that while criteria of this general 
sort might be sufficient for clinical practice, 
research workers will need to produce more specific 
rules for their purposes. For research use, it would 
be best i f  cut-offs on the actual criteria were 
abandoned, and that these be assessed as continuous 
dimensions, thereby retaining more information. 
Also, the algorithmic approach o f combining scores
on the criteria to arrive at a diagnosis becomes less 
appropriate. Empirically derived weightings for 
these scores would be best obtained from factor 
analysis o f scores on the criteria or by latent trait 
analysis o f item scores. Cut-offs for levels o f 
severity would then be placed on the resulting latent 
variable o f dementia. Furthermore, as Finn (1982) 
has pointed out, cut-offs should be varied, depend­
ing on the purposes o f the investigator. An epi­
demiologist using a community sample w'ith a low 
prevalence o f dementia may need to use a different 
cut-off point for defining cases than a research 
worker dealing with a clinical sample in which the 
base rate for dementia is much higher.
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Subtypes of Alzheimer’s Dementia: a conceptual 
analysis and critical review
A. F. J O R M 1
From the NH and MRC Social Psychiatry Research Unit, The Australian National University,
Canberra, Australia
s y n o p s i s  Criteria necessary for establishing the existence of qualitatively-different subtypes of 
a disorder are proposed. A review is made of the existing literature on Alzheimer’s Dementia which 
proposes subtypes on the basis of either psychological or neuropathological data. It is concluded 
that, as yet, this research has not met the criteria for establishing qualitatively-different subtypes. 
However, Alzheimer’s Dementia does seem to show quantitative variability in a number of respects 
and this appears to be related to factors of aetiological significance. The possibility that this 
quantitative variability could provide the basis for subtyping is discussed.
INTRODUCTION
In current thinking, prc-senile Alzheimer’s 
Disease and senile dementia of the Alzheimer 
type are regarded by many as being the same 
disorder because they both involve the presence 
of neuritic plaques and neurofibrillary tangles 
(Constantinidis, 1978). This disorder will be 
referred to here as Alzheimer’s Dementia (AD). 
However, in recent years a number of authors 
have proposed that AD is not a unitary disorder 
and that subtypes may exist. This issue may be 
of importance in the disorder under discussion, 
because different therapies (e.g. replacement of 
different substances which are lacking) may be 
effective in one of the postulated varieties of AD 
and not in the other.
The issue of whether subtypes of various 
psychiatric disorders exist has a long history, and 
the debate has been particularly lengthy and 
heated in areas such as depression and schizo­
phrenia. Part of the problem in resolving such 
debates is that the criteria for successfully 
demonstrating the existence of a subtype have 
not been clearly elucidated. Therefore, while 
reviewing the evidence relevant to subtypes of
1 Address for correspondence: Dr A F. Jorm, NH and MRC 
Social Psychiatry Research Unit, The Australian National University. 
GPO Box 4, Canberra. ACT 2601, Australia.
AD, the present paper attempts to provide a 
conceptual analysis of what is meant by a 
subtype of a psychiatric disorder.
In considering the criteria for demonstrating 
subtypes, there is a need for a pictorial device to 
aid thinking. The method of structural equation 
modelling developed by Jöreskog (see Jöreskog 
& Sörbom, 1978) provides a diagrammatical 
representation which is very useful heuristically 
in this instance. In these diagrams, variables are 
represented by either circles or boxes and causal 
relationships between the variables are indicated 
by arrows. Two types of variable are dis­
tinguished. Latent variables are constructs (like 
AD, depression, or anxiety) which are not 
directly observable, but are indicated by manifest 
variables (like symptoms, signs, or scores on 
scales). Latent variables are represented by 
circles and manifest indicator variables by boxes. 
In many instances, several manifest variables 
will be used as indicators of a latent variable 
because no single manifest variable can validly 
and reliably capture a complex construct. Such 
is the case with all psychiatric disorders where a 
set of symptoms, signs or scores is required for 
diagnosis.
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F ig I A situation in which qualiiatively-diffcrent subtypes can be 
said to exist. Aeliological factors A, and A, are indicated by the 
manifest variables X , and Xt. respectively A, and A, both have a 
causative influence on the disorder B, which is indicated by the 
symptoms Y, and Yt. However, when A, is operating, there is also 
a deficit B, (indicated by symptoms Y, and Y,) which is additional 
to the core disorder fl. The combination of fi, and B, defines a 
qualitatively-different subtype to the core disorder alone (£,).
A CONCEPTUAL ANALYSIS OF
QUALITATIVELY-DIFFERENT
SUBTYPES
When people consider that a disorder has 
subtypes, they seem to be referring to a situation 
like that shown in Fig. 1. In this diagram, there 
are two aetiological factors (Ax and A2) which 
produce a disorder (B,). These aetiological 
factors are indicated by manifest variables X x 
and X2, while Bx is indicated by the symptoms 
Ft and Y2. However, the disorder also has a 
variant form in which B2 is present, and this is 
indicated by the additional symptoms F3 and F4. 
There are also arrows leading into the manifest 
variables and into Bx and ß2, indicating 
causative influences not explicitly represented in 
the model. As an example, if Bx were AD, then 
B2 might be an additional cognitive deficit which 
is not a necessary feature of the disorder, but 
occurs in certain cases. Note that the additional 
cognitive deficit is itself a latent variable (and 
hence represented by a circle) because it is not 
directly observable, but rather inferred from 
performance on a range of cognitive tasks (i.e. 
the manifest variables F3 and F4). Thus, if the 
specific cognitive deficient indicative of a subtype 
were aphasia, this could be measured by 
performance on a number of language tasks such 
as oral expression and auditory comprehension.
The cases of AD which had the additional 
cognitive deficit (ß,) would be those where the 
second aetiological factor (A2) was operating, 
and the presence of symptoms F3 and F4 
would indicate the involvement of this additional 
factor. Therapy and prognosis could well be 
influenced by whether the disorder was the 
standard type (ß,) or the variant type (ß ,-f ß 2). 
Subtypes of this kind will be referred to here as 
qualiiatively-different sublypes because there are 
qualitative differences in symptomatology be­
tween the standard and variant types.
To show convincingly that such a subtype 
exists, it is important to demonstrate that there 
is a causative influence from Bx to ß2, that is, 
from the core disorder to the additional deficit 
present in the subtype. When the arrow between 
ß, and ß2 is present, then the additional deficit, 
ß2 has a similar states to that of the symptoms 
F, and F2, in that it is an indicator of the core 
disorder ß2. Because it is an indicator of the 
disorder ß t, arrows flow from ß, to ß 2 just as 
they do from ß, to Yx and F2. Thus, as the 
disorder Bx becomes more severe, the additional 
deficit ß2 will also tend to become more severe 
in cases where it is present. However, ß 2 differs 
from Fj and F2 in that it is a construct indicated 
by its own symptoms, rather than a directly 
observable symptom itself. If the arrow between 
ß, and ß 2 were removed from Fig. 1, then the 
presence of ß 2 could not be regarded as indi­
cating a subtype (ß, + ß 2). Rather, it would be 
an independent disorder (ß2) which happened to 
share an aetiological factor (/12) in common with 
the disorder of interest (ß,). In this case, ß 2 might 
predate or postdate Bx by many years. Imagine, 
for example, that biological aging has a causative 
influence on both AD and deafness. In the terms 
of Fig. 1, A2 would be biological aging, Bx would 
be AD and ß 2 deafness However, AD and 
deafness are independent disorders, so there 
should be no arrow from Bx to ß 2. Furthermore, 
it would be inappropriate in such a case to 
postulate the existence of qualitatively-different 
subtypes of AD, one involving hearing-impaired 
cases and the other not.
There are a number of factors which can 
complicate the apparently simple situation of 
Fig. 1. First, for ß 2 to be the criterion for the 
existence of a useful subtype, there must be a 
strong relationship between A2 and ß 2 so that the 
subtypes are clearly related to aetiology With a
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weak relationship it might not be useful to posit 
a subtype because the implications for prevention, 
therapy, and prognosis would be weak.
A second complication is that B2 may be a 
continuous rather than a dichotomous variable. 
For example, rather than the variant subtype 
being indicated by some distinct signs or 
symptoms which are not part of the standard 
symptomatology of the disorder, it might be 
indicated by a shift on a continuous variable, 
such as some dimension of cognitive functioning. 
Whether or not we would be justified in positing 
a subtype would then depend on the distribution 
of this continuous variable. When A2 is a 
dichotomous variable (e.g. an autosomal domi­
nant gene), then the distribution of B2 will, in 
some instances, be bimodal. In fact, the existence 
of bimodality in the distribution of symptoms 
has often been regarded as the hallmark of 
subtypes by those investigating the issue with 
regard to depression (see Kendell, 1976, for a 
review). The ‘point of rarity’ between the two 
humps on the distribution can then be used as the 
dividing point between the two subtypes of the 
disorder. In such a case, severity of the optional 
symptom pattern B2 would indicate aetiology 
and hence be useful in guiding therapeutic and 
preventative measures. For instance, signs and 
symptoms of multi-infarct dementia have been 
found to have a bimodal distribution in samples 
of demented patients (Hachinski el al. 1975; 
Harrison el al. 1979), suggesting that it is a 
separate disorder from other types of dementia 
like AD.
However, as Fleiss (1972) and Everitt (1981) 
have pointed out, bimodality will result from the 
mixture of two normal distributions only when 
they are sufficiently separated from each other 
and when the size of one of the distributions is 
not substantially smaller than the other. If these 
conditions are not met, either a symmetrical 
unimodal distribution or a skewed unimodal 
distribution will result. In such cases, to speak of 
categorical subtypes would be inappropriate 
because, although the subtypes exist in a sense, 
they cannot be distinguished on the basis of 
symptomatology. Rather, as discussed later in 
this paper, a dimensional assessment of symp­
tomatology would be more useful.
It should be noted that bimodality, in itself, 
does not indicate the existence of meaningful 
subtypes, although it is a useful first stage in
F ig. 2. A situation in which bimodality in the distribution of 
symptoms would not be due to bimodality in the disorder they 
indicate. An aeuological factor A , (indicated by the manifest variable 
-F,) gives rise to a disorder fi, which is indicated by the symptoms F, 
and F,. However. F, and F, also indicate another latent variable, Bt. 
which is not an aeuological factor for B, but is dichotomous in nature. 
The distributions of F, an?rF t may be bimodal as a result of the 
dichotomous nature of B,. rather than because the disorder B, has 
a bimodal distribution
identifying them. Take, for example, the model 
represented in Fig. 2. In this model, the disorder 
Bx is influenced by only one aetiological factor 
A x. However, the indicators of the disorder, Yx 
and T2, are also indicators of another variable, 
B2. If B2 is dichotomous (e.g. gender, or a major 
cultural difference), then Yl and Y2 may have 
bimodal distributions without Bx itself being 
bimodal. To give a concrete example, imagine 
that AD manifests itself differently in males and 
females, even though the causative influence is 
the same for both sexes. Thus, the manifest 
variables would indicate not only AD (Bx), but 
also gender (B2). However, the bimodality in 
their distributions would be due to B2 rather than 
to Bx. Thus, it is necessary for the bimodality to 
result from some aetiological influence on the 
disorder if it is to indicate valid subtypes. A 
related point is that the presence or absence 
of bimodality in a manifest variable does not 
necessarily indicate its presence or absence in the 
latent variable of interest. It is possible to make 
bimodality appear or disappear in the distribution 
of a manifest variable by suitable monotonic 
transformations of the scale of measurement. 
The problem is that there is no natural metric tor 
measuring psychiatric disorders. However, if 
bimodality were to appear in a number of 
indicators of a disorder, it would be much less
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likely to be an artifact of the particular 
measurement scales used.
More recently, Kendell & Brockington (1980) 
have proposed an alternative method of establish­
ing discrete boundaries between disorders. This 
method would apply to qualitatively different 
subtypes where the optional features of the 
disorder are continuous. The method involves 
plotting the relationship between symptomato­
logy and a second variable such as outcome, sex 
ratio, or familial prevalence. In terms of the 
conventions adopted here, these variables might 
be indicators of Bx + B2 (symptomatology) and 
A2 (outcome, sex ratio, familial prevalence), and 
the real relationship of interest is that between 
the strength of the optional features of the 
disorder, ß2, and the aetiological factor, A2. 
Kendell & Brockington argue that this relation­
ship should be linear if there is no discontinuity 
in the disorder. However, the existence of a 
discontinuity should produce a non-linear rela­
tionship like that shown in Fig. 3. The advantage 
over simply looking for bimodality appears to be 
that both A2 and B2 are being studied in relation 
to one another, rather than B2 alone. As pointed 
out earlier, discontinuity in B2 alone does not 
indicate meaningful subtypes. Only when a 
discontinuity in B2 is related to an aetiological 
factor A2 is the possibility of a subtype 
meaningful.
Using this approach, Kendell & Brockington 
were unable to find evidence of a discontinuity 
between schizophrenic and affective psychoses, 
although such a relationship may have been 
masked by the considerable noise in their data.
Symptomatology
Eig 3. Example of a discontinuity in the relationship between 
symptomatology and outcome, indicating the possible existence of 
subtypes If there are no subtypes, symptomatology should have a 
linear relationship to treatment outcome However, if the ends of the 
combined symptomatology score represent subtypes there will be a 
discontinuity in the relationship with treatment outcome
Even allowing for the possibility that clearer data 
could , be collected, there are a number of 
problems with Kendell & Brockington’s pro­
posal. Most important, perhaps, is that even if 
the relationship between the latent variables B2 
and A2 were expected to be linear if no dis­
continuity existed, such would not necessarily be 
the case for manifest variables like outcome and 
symptomatology. The relationship might, for 
example, just as plausibly take a normal ogive 
form, in which it w'ould be rather like the 
discontinuous curve hypothesized by Kendell & 
Brockington. Their method also suffers from 
some of the same problems as the bimodality 
approach: namely, if the dichotomous aetio­
logical factor A2 has a small effect or if it consists 
of one large category and one small one, then 
clear discontinuity may be difficult to find.
A final problem wuhestablishingqualitatively- 
different subtypes applies particularly todisorders 
which have a marked developmental course. AD 
is a disorder of this kind because the later stages 
of the disorder may have some features which are 
qualitatively different from early stages. For 
example, some cognitive deficits (e.g. problems 
in learning new information) may be present in 
both early and late AD, while others (e.g. 
impoverishment of vocabulary) may be present 
only in severe dementia. In such cases, different 
stages of a developmental course could be 
mistaken for different subtypes of the same 
disorder. The only effective way to guard against 
this possibility is to follow any hypothesized 
qualitative subtypes longitudinally to see whether 
the features of the variant subtype eventually 
develop in the standard subtype. It is also 
because of the marked developmental course of 
disorders such as AD that prognosis cannot be 
used to validate subtypes in the same way as 
aetiology can. That is, to show that differing 
patterns of symptomatology are related to, say, 
survival time does not necessarily indicate that 
the patternsdefine meaningful subtypes. Research 
workers looking at subtypes typically take a 
cross-sectional slice of a longitudinal pattern. 
Thus, any group of patients will at any point of 
assessment be at varying points along a path 
from onset of dementia to death. The place on 
the path may well be related to qualitative 
differences in symptomatology, and it should 
not be surprising that these are related to indices 
of prognosis such as survival time.
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ARE THERE
QUALITATIVELY-DIFFERENT 
SUBTYPES OF AD?
Having proposed criteria required for demon­
strating a valid subtype, we may now appro­
priately turn to the existing research on the 
subject. This literature will be examined 
according to whether it attempts to divide AD 
into subtypes on the basis of psychological data 
or on the basis of neuropathological data.
Subtypes from psychological data
A study by McDonald (1969) has attempted to 
demonstrate qualitatively-different subtypes 
within senile dementia using psychological data. 
McDonald’s study consisted of two parts. In the 
first, he administered a battery of cognitive tests 
to a group of 51 senile dementia patients. 
Examining the distribution of test scores in this 
group, he observed that one test in particular had 
a distribution skewed towards severe impairment 
rather than intact function. This test purported 
to measure parietal function. McDonald then 
investigated the natural history of high and low 
scorers (low means more impaired) on the 
parietal test in a new sample of 57 senile dements. 
There were 31 low' scorers (2+ errors) and 26 
high scorers (0 or 1 error). The low scorers were 
younger in mean age (76 years) than the high 
scorers (83 years). However, at 6 months 
follow-up 26% of the low scorers were dead, 
compared with only 4% of the high scorers. Since 
it was the older high scoring group who had a 
longer life expectancy, McDonald argued that it 
was unlikely that they were simply in an early 
stage of the disorder. Rather, he argued for the 
existence of two types of senile dementia, one 
occurring in a younger age group and having a 
bad 6-month prognosis, and the other occurring 
in an older age group and having a better 
6-month prognosis. McDonald’s study seems to 
meet some of the criteria for demonstrating 
qualitatively-different subtypes, but the evidence 
he presents is far from adequate for establishing 
a convincing case. A major limitation is the lack 
of longitudinal data on the parietal test for the 
group with high scores. If this group were found 
to develop lower scores at a later stage in the 
disorder, then no qualitative difference in 
symptomatology between the hypothesized sub- 
types has been demonstrated. Furthermore,
whether the parietal test produces a true 
qualitative difference between the groups or 
whether the difference is quantitative but masked 
by a ceiling performance from many of the 
patients is unknown. Although the parietal 
scores were not shown to be related to an 
aetiological factor, they did at least relate to age 
in a counterintuitive manner, suggesting that 
there might be some aetiological factor (in 
addition to biological aging) which leads to this 
effect. Whether such an aetiological factor does 
lead to qualitative subtypes, as McDonald 
suggests, or simply to some continuous variation 
in rate of decline must remain uncertain.
Stronger evidence that variability in symp­
tomatology relates to an aetiological factor 
comes from studies by Folstein & Breitner 
(1981), Seltzer & Sherwin (1983), and Breitner & 
Folstein (1984), indicating that some cases of AD 
have language disturbance while others do not, 
and that the presence of language disturbance is 
related to the aetiological indicator of familial 
prevalence and to prognosis as measured by 
survival time. These studies will be examined 
individually.
Seltzer & Sherwin (1983) studied 65 patients 
with AD whom they divided into two groups: a 
group of 34 whose age of onset was < 65 years, 
and a group of 31 whose age of onset was 65 or 
greater. These groups were found to differ in a 
number of respects, particularly in the frequency 
of language disorders The patients with an early 
age of onset were more likely to show 
abnormalities of spontaneous speech, verbal 
comprehension, object naming and writing. In 
addition, the early onset group was found to 
contain a greater proportion of left-handers, 
while the late onset group more frequently had 
disorders of gait. The groups were also differen­
tiated with respect to life expectancy, with the 
early onset cases being less likely to reach the 
expected age. To explain these findings, Seltzer 
& Sherwin hypothesized that the early onset of 
AD is related to a genetic factor which leads to 
a heightened vulnerability of the left hemisphere 
and hence to language disturbance.
Folstein & Breitner’s (1981) study came to a 
similar conclusion, but with some direct evidence 
for the hypothesized genetic factor. Analysing 
items from the Mini-Mental State Examination, 
they noted that AD patients who were unable to 
write a sentence (agraphic) were more likely to
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have affected relatives. Following up this 
observation, Breitner & Folstein (1984) identified 
62 cases of AD and assessed them for agraphia, 
aphasia and apraxia. The association between 
agraphia and aphasia/apraxia was found to be 
very high, so cases were dichotomized according 
to the presence or absence of agraphia alone, 
because this dysfunction is simpler to assess. The 
sample was thus broken down into 39 agraphic 
AD patients and 15 non-agraphic, with 8 
non-agraphic cases being excluded because of the 
short duration of their dementia and the 
possibility that they might later develop agraphia. 
There were also 33 non-demented controls 
selected from the same institutions as the AD 
cases. Informants’ reports were used to assess the 
prevalence of AD in first-degree relatives aged 60 
or over. The prevalence of the disorder in these 
relatives was 10 5% for agraphic ADcases, 38%  
for non-agraphics, and 2-6% for non-demented 
controls. Estimating the cumulative incidence of 
dementia by the age of 90 for first-degree 
relatives, Breitner & Folstein arrived at a figure 
of just over 50% for agraphic cases, leading to 
the hypothesis that an autosomal dominant gene 
with an age-dependent penetrance is involved.
The analysis of AD given by Seltzer & Sherwin
(1983) , Folstein & Breitner (1981) and Breitner 
& Folstein (1984) appears to correspond to the 
general situation portrayed earlier in Fig. 1. To 
be specific, A2 is the genetic factor, Bx the core 
cognitive deficit of AD, and B2 the language 
disorder found in the early onset subtype. On the 
surface, they seem to have fulfilled the criteria for 
the existence of qualitative subtypes. However, 
there is an alternative interpretation of their data 
which must be considered. As pointed out 
earlier, it may be that such studies are comparing 
a group of patients in the early stages of the 
disorder with a group in the later stages. In other 
words, the AD patients without language 
disturbance might eventually develop such 
problems if followed longitudinally. The possi­
bility that the language disordered group is at a 
later stage of the disorder is supported by Seltzer 
& Sherwin’s (1983) finding that they had poorer 
survival and by data from Breitner & Folstein
(1984) showing that their agraphic AD patients 
had been in nursing homes for longer than the 
non-agraphic group. Constantinidis (1978) also 
found that AD cases without aphasia, apraxia 
and agnosia tended to have a later age of onset
and a shorter average survival period after the 
first appearance of amnesia. He suggested that 
they did not live long enough to develop 
problems of aphasia, apraxia and agnosia. 
Furthermore, Heyman (1984) has reported that 
the frequency or severity of language disorder in 
AD is closely related to the duration of the 
dementia. Whereas 43% of the AD patients he 
studied had language disorder initially, after a 
period of 3 years the figure had jumped to 75% . 
He also reported that the frequency of familial 
AD did not appear to be greater in the patients 
with language disorder than in those without, 
directly contradicting the central claim of 
Breitner & Folstein’s (1984) research.
A plausible alternative interpretation of the 
research using psychological data is that there is 
a single type of AD, but that the age of onset and 
the rate of decline^ary, depending on whether 
specific genetic influences are operating. When 
looked at cross-sectionally, late and early onset 
AD may appear to be qualitatively distinct, but 
only because the earlier onset cases are further 
advanced and are consequently more likely to 
show signs and symptoms characteristic of the 
later stages of the disorder.
Subtypes from neuropathological data
A number of authors have suggested that AD 
can be divided into two subtypes on the basis of 
neuropathological data. This view has been most 
fully articulated by Bondareff (1983) who has 
claimed that there are two distinct forms of AD 
which both involve plaques and neurofibrillary 
tangles but differ in other respects. He labelled 
these subtypes as AD-1 and AD-2. According to 
Bondareff, AD-1 usually begins in old age and 
has an insidious course, while AD-2 begins in 
middle age and runs a rapid course. Sum­
marizing the existing literature, Bondareff 
suggested that AD-1 and AD-2 also differ in 
terms of the extent to which there is parietal lobe 
involvement, motor signs, ventricular enlarge­
ment. neurofibrillary tangles, loss of locus 
coeruleus neurons, and loss of choline acetyl- 
transferase For all these features, AD-2 involves 
greater impairment than AD-1. Bondareff also 
suggested that AD-2 involves an extensive loss 
of nucleus basalis neurons, but left open the 
question of whether there is loss of these neurons 
in AD-I Subsequently. Wilcock & Esiri (1983)
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reported that AD-1 also involved a loss of 
nucleus basalis neurons.
Some of the specific studies whose authors 
have suggested the possibility of subtypes are 
reviewed next. The results of these studies largely 
formed the basis for BondarefT’s proposal for a 
distinction between AD-1 and AD-2.
A study by Hubbard & Anderson (1981) 
examined cerebral atrophy in 20 severely 
demented patients aged 64-92 years, as well as 
in normal elderly controls. They divided these 
patients into those dying before 80 years of age 
and those dying after. They found the younger 
group to have atrophy afifecting the whole 
cerebrum, while the older group usually had 
atrophy confined to the temporal lobes. Both 
groups had the plaques and tangles characteristic 
of AD. From these data, Hubbard & Anderson 
raised the possibility that there are two disorders 
rather than one, but did not commit themselves 
on the matter. Hubbard & Anderson’s caution 
is quite appropriate because, although they 
demonstrated variability within AD, they had no 
evidence of a dichotomy between the older and 
younger patients.
Bondareff el al. (19816) investigated loss of 
neurons in the locus coeruleus, which is the point 
of origin for noradrenergic projections to the 
cortex. They plotted a histogram of cell counts 
from this area and found that the 20 AD patients 
fell into two distinct groups. The distribution of 
cell loss in the sample was clearly bimodal, with 
zero frequency at the point of rarity between the 
two distributions. The group with greater cell 
loss was younger at death and had higher 
dementia scores during life. Because the younger 
group showed the greater deficit, Bondareff et al. 
(19816) concluded that there was a qualitative 
rather than a quantitative difference between the 
two groups. The extent to which the difference 
can be held to be qualitative is, however, 
doubtful. The older AD patients did show some 
loss of neurons, although far less than that of the 
younger ones. Furthermore, the point of rarity 
on the distribution of neuronal loss could well 
arise by chance with a sample of only 20 patients. 
Everitt (1981) has pointed out that bimodality 
can easily arise with small samples when it is not 
present in the population frequency curve. 
Therefore, it must be concluded that Bondareff 
et al. (19816) have established a quantitative 
variation within AD, but not distinct subtypes.
A laterstudy by Taghavim& Pillen (1983)also 
examined neuronal counts, but in the basal 
nucleus of Meynert which is a projection area for 
the cholinergic system. With 9 AD cases, they 
found that there was a negative relationship 
between age and neuronal loss: that is, the 
younger cases showed a greater loss from the 
basal nucleus of Meynert. Tagliavini & Pilleri 
claimed that their findings supported the view 
that early and late onset AD are distinct entities. 
However, the difference between early and late 
cases appeared to be purely quantitative. 
Tagliavini & Pilleri’s paper contains a graph of 
the relationship between percentage neuronal 
loss and age and this appears to be linear, 
without any hint of the sort of discontinuity that 
Kendell & Brockington (1980) say should exist 
between distinct subtypes. However, 9 cases is 
much too small ■&: sample to study such 
relationships reliably.
Rossor et al. (1981) also studied the cholinergic 
system in AD patients, but by examining the 
activity of the enzyme choline acetyltransferase 
(ChAT). They had 25 cases of AC) which they 
split into two groups around the median age (79 
years), and compared them with 26 normal 
controls. In both groups, ChAT activity was 
lower in all areas of the temporal cortex 
examined. However, in the frontal cortex only 
the younger AD group showed a reduction in 
ChAT activity in most areas. Rossor et al. were 
cautious in the interpretation of their results, 
noting that these findings could be explained 
either in terms of distinct subtypes or else by 
involvement of the frontal cortex only late in 
AD. Interestingly, they also reported a regression 
line predicting log ChAT activity from age. The 
points on which this line is based do not appear 
to indicate any discontinuity, but the sample size 
is too small and the data too noisy to be sure.
A study by Bird et al. (1983) has likewise 
shown variability in cholinergic dysfunction 
among cases of AD. They attempted to divide 
their 16 AD cases into subgroups, using a num­
ber of clinical and pathological criteria. Of these, 
age of onset and a history of myoclonus were 
related to decreased ChAT activity. Early-onset 
cases differed from age-matched controls in the 
frontal cortex, temporal cortex, hippocampus 
and cerebellum, while the late-onset cases 
differed from controls only in the hippocampus. 
Patients w'ith myoclonus (who tended to be
550 A. F. Jorm
younger as well) also had lower ChAl activity 
than those without. The authors concluded that 
AD is a heterogeneous disorder, although their 
study provided no evidence of any qualitative 
differences in ChAT activity between the cases 
investigated. They also suggested that the 
differences observed between early- and late- 
onset cases could not be due to the older AD 
patients dying earlier in the disease because there 
was no difference in the duration of the disorder 
between the two groups. However, if it is the case 
that late-onset cases have a slower course than 
early-onset cases, then they could indeed be 
dying earlier in the disease, despite no difference 
in its duration.
In a subsequent study, Rossor el al. (1984) 
studied the activity of a number of neurotrans­
mitter systems in AD. They examined the brains 
of 49 AD cases and 54 normal controls, this 
sample being an extension of that in their earlier 
study. Again, the AD patients were split at 79 
years into younger and older groups. The older 
group was found to have reduced cholinergic 
activity in the temporal lobe and hippocampus 
as well as reduced somatostatin in the temporal 
cortex. However, the younger group had a more 
widespread cholinergic deficit as well as de­
ficiencies of noradrenaline, GABA, and somato­
statin. Rossor ei al. concluded that the younger 
AD patients may form a distinct subtype of AD, 
but acknowledge that the older patients may 
simply be dying at an earlier stage of the disorder 
due to other diseases. Again, they presented 
regression lines predicting the logarithm of 
various neurochemical levels from age. However, 
only linear regressions are reported and the raw 
data points are not plotted to allow for detection 
of any discontinuities.
Taken together, the neuropathological data 
present a consistent picture. AD patients dying 
younger appear to have a more severe disorder 
than those dying at a later age. However, 
whether qualitatively-different subtypes exist, as 
Bondareff (1983) has argued, is debatable. A 
number of points need to be made ir. relation to 
his argument. First, all these studies, like those 
using psychological data, were cross-sectional. 
Given that neuropathological data can be 
collected only after death, it is not possible, as 
it is with psychological data, to follow up 
hypothesized subtypes to see whether they are 
simply different stages of the same disorder. A
number of investigators have indeed raised the 
possibility that the older AD cases may be dying 
earlier in the course of the disorder because of 
greater susceptibility to other illnesses. Although 
it is not possible to follow these late-onset cases 
to see whether they develop more severe and 
broadly based neuropathological deficits, it 
would, in principle, be possible to study the 
neuropathology of early-onset AD earlier in the 
disorder to see whether it is then like the terminal 
stages of late-onset AD. Cases in which 
early-onset AD patients die in the early stages of 
their disorder from other causes must exist. An 
alternative approach, which is probably more 
feasible, is to use brain imaging techniques for 
the longitudinal monitoring of hypothesized 
subtypes of AD. Although computed tomo­
graphic measures of ventricular size and cortical 
atrophy can play a useful role in the diagnosis of 
dementia (Damasio ei al. 1983), the most 
valuable data for the investigation of possible 
subtypes come from studies of regional changes 
in tissue density. Bondareff ei al. (1981a) have 
found density changes in the temporal and 
frontal lobes consistent with the neuropatho­
logical changes observed in autopsy studies. 
Furthermore, Naguib & Levy (1982a, b) have 
found some indication that lower brain density 
in the parietal region is predictive of poor 
prognosis, consistent with McDonald's (1969) 
earlier neuropsychological observations. Posi­
tron emission tomography also appears to be a 
promising technique for investigation of subtypes 
Benson et al. (1983) and Chase ei al. (1984) have 
found this technique to be sensitive to regional 
differences in cortical dysfunction, as measured 
by the amount of metabolic reduction. Longi­
tudinal monitoring of early- and late-onset AD 
with both these brain imaging techniques would 
be most valuable.
The second point that needs to be made is that, 
although there appears to be a quantitative 
difference in severity, this in itself cannot be 
taken as indicating subtypes (a similar point has 
been made by Wiicock & Esiri, 1983). The basic 
difference between early- and late-onset cases ot 
AD may be in the rate of decline rather than any 
qualitative difference in their neuropathology 
However, even with quantitative differences, it is 
still possible to conceive of meaningful subtypes 
of a disorder This possibility is examined next
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F ig 4 A situiyion in which quantilalively-different subtypes could 
exist. Aeliological factors A, and A, are indicated by the manifest 
variables X, and X,, respectively. These have a causative influence on 
the disorder B,, which is indicated by the symptoms Y,. Y, and >'s 
Where A , or At is a dichotomous variable then the distribution of B, 
may be bimodal. in which case quantitatively-difTerent subtypes could 
be said to exist
A CONCEPTUAL ANALYSIS OF 
QUANTITATIVELY-DIFFERENT 
SUBTYPES
Fig. 4 illustrates a situation in which subtypes of 
a purely quantitative sort could exist. In this 
situation there are two aetiological factors (/l, 
and A 2) producing a single disorder (ß,). The 
degree of the disorder is indicated by three 
manifest variables E,„ Y2 and K3, while the 
aetiological factors are indicated by manifest 
variables X x and X 2. As a particular example of 
the general case, ß, might be AD and E,, Y2 and 
E3 particular symptoms of AD. Then A x might 
be biological age, which is indicated by chrono­
logical age (T t), and A 2 might be a genetic 
influence indicated by a familial incidence of the 
disorder (X2). Put in simple terms, the model 
would then say that AD occurs as a function of 
biological aging but is also influenced by specific 
genes. Flowever, which causative influences 
are operating in a particular case could not oe 
assessed by looking at the symptomatology of 
the disorder, because the effects of both 
aetiological factors are identical -  i.e. they 
increase ß,. Generally speaking, then, when this 
sort of situation prevails it would not be 
meaningful to talk about subtypes of AD. even 
though some individuals will have the disorder 
because they are high on variable A }, others 
because they are high on A.,, and still
others because they are high on both variables. 
The severity of the disorder in itself would 
generally provide no clear guide as to which 
situation prevailed in the individual case, 
although probabilistically speaking the more 
severe cases would tend to be those in which both 
A, and A 2 exerted an effect. The only exception 
would be where one of the causative influences, 
say A 2, was a dichotomous variable such as an 
autosomal dominant gene, rather than a con­
tinuous variable such as a polygenic influence. 
When A2 is a dichotomous variable then the 
distribution of ß, will, in some instances, be 
bimodal.
This kind of subtype is, of course, a weak 
variety and probably does not correspond to 
what is normally regarded as a subtype. 
However, the evidence with regard to subtypes 
of AD which has been reviewed so far would 
appear to indicate the! if there are subtypes of 
AD they could possibly be of this kind. This 
possibility is discussed next.
ARE THERE
QUANTITATIVELY-DIFFERENT 
SUBTYPES OF AD?
To demons! rate quantita lively-different subtypes 
of AD, we would need to examine the 
distribution of the slope of decline. Decline 
would have to be studied using either cognitive 
tests or brain imaging. Longitudinal studies 
taking measures of cognitive dysfunction or 
regional brain dysfunction at several time points 
using a large sample would be necessary. 
These measures would be used to infer the latent 
variable of dementia, and the slope of the latent 
variable over time for each case could then be 
estimated. The distribution of the slopes would 
be the critical data for determining whether 
quantitatively-different subtypes exist. If a point 
of rarity in the distribution of slopes was found, 
then the first step in demonstrating the existence 
of subtypes would have been achieved. The 
second step would be to show that the position 
of cases at each side of the point of rarity was 
related to an aetiological factor. A genetic factor 
would be the most plausible aetiological candi­
date, since the presence of a genetic factor in 
early-onset cases has received support trom 
family studies of AD (Heston et al 1981. 
Hevman et al 1983) As vet, no data have
552 A . F Jorm
appeared in the literature which would allow' for 
a test of the existence of quantitatively-different 
subtypes.
If a point of rarity were not found in the 
distribution of the slope of decline, there would 
be two possible reasons. First, there could indeed 
be a dichotomous aetiological factor which gives 
rise to subtypes, but these cannot be reliably 
distinguished on the basis of a quantitative 
cut-off. Unless another means could be found to 
detect the presence or absence of the dichotomous 
aetiological factor, it would not be meaningful to 
conceptualize variability in the disorder in terms 
of categorical subtypes. The second possibility is 
that variability in the disorder is not due to a 
dichotomous influence, in which case the notion 
of subtypes is also inappropriate. In such 
situations, the most appropriate way of con­
ceptualizing variability in AD would be by 
means of a dimensional system, in which the 
severity of dementia would be one dimension and 
the slope of decline another. Bondareff’s (1983) 
AD-I group would then correspond to cases 
high on severity but low on slope of decline, 
while the AD-2 group would be high on both the 
severity and slope dimensions. However, the use 
of terms like AD-1 and AD-2 would be merely 
a linguistic convenience (in the same way that it 
is convenient to talk of people as bright or dull, 
introverted or extraverted), without any impli­
cation that a categorical distinction is involved.
CONCLUSION
Although AD is clearly a variable disorder, there 
is at this stage no convincing evidence for 
qualitative subtypes. This variability may well be 
best accounted for in terms of quantitative 
subtypes or a dimensional system of assessment. 
It appears that whether there are qualitative or 
quantitative subtypes of AD, or whether there is 
simply variation of a dimensional kind, can only 
be resolved by longitudinal studies of the 
disorder. A longitudinal approach needs to 
become the standard for studies investigating 
possible subtypes of AD
Thanks are due to Mr P. Duncan-Jones, Dr D. 
Grayson, Dr A. S. Henderson, and Professor P. A. P 
Moran for critical comments and helpful discussions 
on an earlier draft of this paper
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Controlled and automatic information processing in 
senile dementia: a review
A. F. J O R M1
From the NH and MRC Social Psychiatry Research Unit, The Australian National University,
Canberra, Australia
s y n o p s i s  The evidence on cognitive decline in senile dementia is reviewed with respect to 
the distinction between controlled and automatic processing. It is argued that controlled processing, 
which requires the attentional resources of the individual, declines in early senile dementia. However, 
automatic processing, which does not require attentional resources, is well maintained until late in 
the disorder. Implications of this view are drawn for the development of effective screening 
instruments which can be used for the early detection of dementia in the general population.
INTRODUCTION
Senile dementia involves a progressive.decline in 
cognitive skills from previous levels. However, it 
will be argued in this paper that the cognitive 
decline is not a uniform one. Some cognitive 
skills show decline early in the disorder while 
others are relatively well maintained until the 
severe stage. Furthermore, it will be proposed 
that this apparently uneven developmental 
course can be conveniently understood in terms 
of the distinction between controlled and 
automatic information processing (Shiffrin & 
Schneider, 1977). It will be shown that such a 
theoretical perspective is a valuable aid in the 
design of assessment instruments for the early 
detection of senile dementia.
METHODOLOGICAL PRELIMINARIES
Before reviewing the relevant literature, it is 
necessary to consider various methodological 
problems which must be addressed in studies of 
cognitive deficit in senile dementia.
Senile dementia is not a unitary disorder. The 
three major types are: senile dementia of the 
Alzheimer type (SDAT), which is histopatho- 
logically identical to presenile Alzheimer's 
Disease and comprises the majority of cases 
(Tomlinson & Henderson, 1976); multi-infarct
1 Address for correspondence: Dr A. F. Jorm, NH and MRC 
Social Psychiatry Research Unit. The Australian National University. 
GPO Box 4, Canberra, ACT 2601. Australia
dementia (MID); and mixed Alzheimer/multi­
infarct dementia. Unfortunately, many of the 
studies on cognitive deficit in senile dementia 
have not distinguished between the subtypes, 
either because the neuröpathological differences 
between them were not known at the time of the 
research or because of the difficulty of making 
differential diagnoses without autopsy. Accord­
ingly, the present review will draw conclusions 
with respect to all the major subtypes of senile 
dementia. However, it may be that the conclus­
ions are more applicable to the major subgroup, 
SDAT, but this will be determined only by 
further research planned with the relevant diag­
nostic distinctions.
Senile dementia is a developmental problem, 
since it involves both qualitative and quantitative 
changes in cognitive functions over time. As 
such, it must be studied using research designs 
appropriate to a developmental phenomenon. 
The best way to achieve this end is to study the 
aged longitudinally from the onset of dementia 
until death. A less expensive alternative is a 
cross-sectional study in which cognitive function 
is studied in relation to the assessed severity of 
the disorder in different groups of individuals. 
Unfortunately, most of the existing research on 
senile dementia has not been carried out using 
designs of this sort, although often some 
indication of the severity of the disorder in the 
group under study is given. The usefulness of 
much of the existing research, as far as the 
framework of the present review is concerned, is 
consequently limited.
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Finally, it should be noted that, although the 
present review interprets differences in the rate of 
decline of various cognitive functions in terms of 
the information processing operations they 
involve, such differences can also arise through 
differences in the discrimina ing power of the 
tests at different levels of cognitive ability. It may 
be that some tests are sensitive to the early stages 
of decline simply because they are more difficult, 
and others are sensitive to the late stages of 
decline because they are easier. Chapman & 
Chapman (1973) and Baron & Treiman (1980) 
have proposed ways of overcoming this problem, 
but their methods have not been applied in the 
area of senile dementia. There is therefore a need 
for replication of the generalizations drawn in 
the present review using these more appropriate 
methods.
THE DISTINCTION BETWEEN 
CONTROLLED AND AUTOMATIC 
PROCESSING
Schneider & Shiffrin (1977) have built a theory 
of controlled and automatic processing around 
the results of experimental work on visual search. 
In these experiments, subjects were given a set of 
targets (digits or letters) which they had to search 
for in a series of visually-presented frames (a 
square matrix of digits or letters). When they 
detected a target on a frame they had to press a 
button. The number of targets they failed to 
detect or their reaction times were the dependent 
measures of interest. Schneider & Shiffrin found 
that when certain characters were consistently 
the target items and other characters were 
consistently the distractors (called the consistent 
mapping condition), subjects improved in per­
formance from trial to trial. Furthermore, their 
performance was little affected by increases in the 
number of target characters which had to be 
remembered or the number of characters which 
had to be processed on each frame. On the other 
hand, when the target items and distractor items 
were different from trial to trial (the varied 
mapping condition), subjects showed no im­
provement with practice and their performance 
was adversely affected by increases in the number 
of targets or the number of characters on each 
frame. On the basis of these and other similar 
results, Schneider & Shiffrin drew a distinction
between controlled and automatic processing 
modes. Controlled processing was held to be 
involved in the varied mappingcondition of their 
experiments. It is demanding of attentional 
capacity, is serial in nature (one input is 
processed at a time), can easily be set up or 
altered by the individual, and is affected by other 
processing demands at the time. Hasher & Zacks 
(1979) described this form of processing as 
effortful. Automatic processing, on the other 
hand, was held to be involved in the consistent 
mapping condition of Schneider & Shiffrin's 
(1977) experiments. It demands little attentional 
capacity, is parallel in nature, is hard to change 
or suppress, and is little affected by other 
processing demands. The advantage of automatic 
processing is that it allows predictable tasks to 
be carried out while leaving attentional resources 
free to handle novel situations. Controlled 
processing must be used in unfamiliar situations 
for which no automatic sequence has ever been 
developed.
In a companion paper, Shiffrin & Schneider 
(1977) proposed a general theory which extended 
the controlled/automatic distinction beyond 
visual search to a wide range of cognitive tasks, 
includinglearningand memory retrieval. Accord­
ing to Shiffrin & Schneider’s (1977) theory, 
learning involves a transition from controlled to 
automatic processing. Learning consists of 
forming associations between elements in long­
term storage (LTS). and these elements must be 
linked through controlled processing for learning 
to be achieved. Once the new association is made, 
automatic activation of the sequence of elements 
can take place. As an example of the essential 
role of controlled processing in learning, Fisk & 
Schneider (1984) cite the experience of a man 
who, leaving his bathroom in the morning, felt 
unsure of whether he had shaved and had to feel 
his face to establish that he had. In this case, a 
highly practised automatic process was probablv 
carried out while controlled processing resources 
were used for other tasks and, consequently, no 
record of the event was placed in LTS.
Retrieval from LTS. on the other hand. ma> 
involve both automatic and controlled process­
ing. Automatic processing is involved when a 
retrieval cue automatically activates associative!) 
related information in LTS. Controlled process­
ing comes into play during reconstructive recall 
when the individual either actively searches this
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automatically activated information or raises the 
strength of particular retrieval cues relative to 
other information. As an example, automatic 
processing would probably be involved in 
retrieving one’s own name and address, since 
these are highly overlearned, while controlled 
processing might also be required in retrieving 
the name of one’s first-grade teacher. In the latter 
case, the individual might be unable to retrieve 
the name immediately and would activate 
information related to his life at that time: the 
setting of the school, his class room, and the 
teacher’s appearance. These cues activated 
through controlled processing might then lead to 
automatic retrieval of the teacher’s name.
Although it is convenient to talk of automatic 
and controlled processing as being distinct, they 
really represent extremes of a continuum and, in 
most complex cognitive tasks, each type of 
processing plays a role at various points.
Shiffrin & Schneider’s (1977) theory does not 
deal with the issue of individual differences. 
However, following Hasher & Zacks (1979), it is 
proposed here that people can differ in their 
capacity to deploy attention for controlled 
processing. Specifically, it is argued that senile 
dementia produces a major decrement in the 
capacity for controlled processing.
It might well be asked what advantage there 
is in reviewing the literature with respect to the 
distinction between controlled and automatic 
information processing. Clearly, there is a need 
to adopt some theoretical framework, but 
alternative information processing or psycho­
metric frameworks could have been used. An 
important class of alternative information pro­
cessing models are those distinguishing various 
memory systems (e.g. long-term, working 
memory) and specifying their interrelations. 
However, reviewing the evidence using such a 
framework leads to the conclusion that senile 
dementia involves deficits in all memory systems 
(Miller, 1981). In contrast, the Shiffrin & 
Schneider model appears to make a distinction 
which is relevant to understanding the non- 
uniform nature of cognitive decline in senile 
dementia. Among psychometric frameworks, 
the distinction between fluid and crystallized 
ability has been applied to the study of 
intellectual decline in the normal aged (Horn, 
1976) and could be extended to the study of senile 
dementia. In fact, crystallized ability tasks tend
to involve automatic processing in that they 
require retrieval ofconcepts and terms previously 
learned, while fluid ability tasks typically involve 
controlled processing because they require 
reasoning about unfamiliar situations. However, 
the crystallized/fluid distinction is based purely 
on a description of the contents of tests loading 
highly on particular factors found in factor- 
analytic studies of intelligence. Although it tells 
us something interesting about how intellectual 
abilities should be measured, it has no associated 
theory of cognitive processes which could 
enhance our understanding of what these 
abilities are (Hunt, 1983). Consequently, the 
fluid/crystallized distinction is less suggestive of 
future research directions than is the controlled/ 
automatic distinction.
CONTROLLED AND AUTOMATIC 
PROCESSING IN SENILE DEMENTIA
The present review proposes that controlled and 
automatic processing are differentially involved 
in the development of senile dementia. In 
particular, controlled processing is affected early 
in senile dementia, while automatic processing 
remains unaffected until the late stages of the 
disorder. If this proposal is correct, early 
dementia should be characterized by problems 
with cognitive tasks of an unfamiliar sort (which 
by their nature require attentional resources), by 
difficulties in learning (because controlled proc­
essing is essential to learning), and by problems 
in retrieval of information from LTS in 
situations where active retrieval plans need to be 
initiated. In the late stages of senile dementia 
these same problems would also be manifest (but 
in a more severe form), and the individual would 
also lose competence in cognitive tasks of a 
highly overlearned kind. None of the studies in 
the literature reviewed below has been explicitly 
designed to examine automatic and controlled 
processing and, in particular, none has used the 
type of search task on which Shiffrin & Schneider 
(1977) built their theory. However, the existing 
literature can be usefully reconceptualized 
around this distinction. It would certainly be 
useful for future research workers to explore 
controlled and automatic processes in senile 
dementia directly, using tasks explicitly designed 
for the purpose.
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REVIEW OF STUDIES ON COGNITIVE 
DEFICIT IN SENILE DEMENTIA
The review of evidence relative to the distinction 
between controlled and automatic processing in 
senile dementia is organized according to the 
type of research design. Studies which have 
adopted a longitudinal or cross-sectional design, 
and thus provide the most appropriate data 
relating to the current proposal, are discussed 
first. Secondly, evidence from the majority of 
studies, which have not adopted a design 
amenable to a developmental analysis, will be 
considered.
Developmentally-oriented studies
Only one longitudinal study of cognitive function 
in senile dementia has appeared in the literature 
(Brull el al. 1979), but it did not report data in 
such a form as to be useful for the present 
purposes. However, several cross-sectional 
studies with relevant data have been reported.
Rosen (1983) classified 31 nursing home 
residents into one of three groups on the basis of 
a mental status examination: normal elderly, 
mild SDAT, or moderate-to-severe SDAT. An 
attempt was made to screen out people with 
MID. Rosen administered a wide range of tests 
to these individuals. She found that some 
cognitive functions exhibited decline in mild 
SDAT, while others remained intact in the early 
stages and declined only later on. She found that, 
early in SDAT, patients had problems with: 
learning paired-associates; copying geometric 
forms; naming objects, actions and forms; audi­
tory comprehension of complex verbal material; 
and repetition of sentences made up of low- 
frequency words. However, they showed intact 
function on: following commands; matching 
visual forms; memory for visual forms; sentence 
reading; repetition of sentences consisting of 
high-frequency words; and naming of body 
parts, colours, letters and numbers. Of particular 
interest in these results are the findings con­
cerning relatively well-practised (and hence 
automated) tasks compared with less familiar 
(and hence controlled) ones. For instance, 
naming was unimpaired for body parts, colours, 
letters and numbers, but was impaired for other 
objects, actions and forms. Similarly, repetition 
of sentences was unimpaired for high-frequency 
words but was impaired for low-frequency
words. Generally speaking, it was the tasks 
requiring controlled processing that were im­
paired early in SDAT. The moderate-to-severe 
group was even more impaired on those tasks 
found to produce differences for the mild group. 
In addition, they had impairments on the tasks 
of visual memory, matching visual forms, 
naming of body parts and colours, following 
commands, and reading sentences made up of 
low-frequency words. However, they were 
unimpaired at letter and number naming, and 
repetition and reading of sentences consisting of 
high-frequency words. The cognitive tasks intact 
in moderate-to-severe dementia are clearly of the 
most automated kind.
Bayles & Tomoeda (1983) studied the naming 
performance of several types of demented 
patients cross-sectionally. The largest group of 
theirdementedpatientssuffered from Alzheimer's 
Disease These patients were classified as either 
mild or moderate cases. They were asked to name 
20 pictures of fairly common objects (such as 
piano, apple, and bear). Obviously, the naming 
of such common objects would be a well 
automated skill. It was found that the mild cases 
were able to name the pictures virtually without 
error, but the moderate group made naming 
errors on 27% of pictures. Bayles & Tomoeda
(1983) also studied a small group of severe cases 
of Alzheimer’s Disease who were still capable of 
performing the naming task. These all had severe 
naming problems, with error rates ranging from 
60 to 100%.
In a study of the same topic Kirshner ei al.
(1984) examined the naming of objects, photo­
graphs, drawings and masked drawings in a 
group of Alzheimer's Disease patients. The 
purpose of using the different stimuli was to vary 
perceptual difficulty but, in terms of the 
theoretical framework adopted here, we could 
say that they were varying the quality of the 
retrieval cue. With poorer retrieval cues (i.e. 
masked drawings), controlled processing would 
play a greater role. When the patients were 
classified according to the degree of dementia, 
the mild group showed relatively well preserved 
naming of pictures and photographs, but much 
poorer performance with masked drawing. The 
moderate and severe groups showed impairments 
at naming all stimuli, with the severe group 
showing greater overall impairment. Thus, these 
findings are also consistent with the notion of
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early deterioration of the capacity for controlled 
processing in senile dementia.
Gewirth el al. (1984) used a cross-sectional 
approach to study word association in dementia 
and aphasia. They used a mixed demented 
group, but most subjects were diagnosed as 
SDAT. Gewirth el al. gave their subjects words 
and asked them to give the first associations 
which came to mind. They classified the subjects’ 
responses in various ways, the most interesting 
for present purposes being paradigmatic (seman­
tically related to the stimulus word and of the 
same grammatical class) or syntagmatic (of a 
different grammatical class to the stimulus in a 
sentence). As the severity of dementia increased, 
the number of paradigmatic responses was found 
to decrease, but the number of syntagmatic 
responses did not change. The authors concluded 
that syntactic knowledge appears to be better 
preserved in dementia than semantic knowledge. 
Other studies (not employing a developmental 
approach) have also noted that syntactic know­
ledge is less eroded in senile dementia than 
semantic knowledge (Bayles & Boone, 1982; 
Schwartze/u/. 1979; Whitaker, 1976). Following 
both Bayles & Boone (1982) and Whitaker 
(1976), we might account for this phenomenon 
by proposing that syntactic knowledge is more 
overlearned and automatic, while semantic 
knowledge requires attentional resources for its 
application because of its less predictable nature.
Other studies
Many studies on cognitive deficit in senile 
dementia have used groups which have been 
assessed as having either mild, moderate or 
severe dementia. Other studies have compared 
tasks which differ in their controlled or automatic 
processing requirements. Both these sorts of 
studies can give some useful clues about the 
developmental course of cognitive decline in 
senile dementia. In particular, it would be 
expected that all dements should have deficits in 
controlled processing but only studies of subjects 
in the later stages of dementia would find 
problems in automatic processing. These studies 
are discussed under the type of cognitive task 
used.
Verbal and Performance IQ
Many studies have examined the WAIS per­
formance of senile dements. It has generally been
found that Performance IQ declines more than 
Verbal IQ (Inglis, 1958; Alexander, 1973). Not 
only do WAIS Verbal and Performance items 
differ in the extent to which they involve 
linguistic functions, but also in the extent to 
which they involve automatic or controlled 
processing. The Verbal half of the scale tends to 
test skills that are reasonably automated, while 
the Performance half involves largely unfamiliar 
tasks. Of course, language tasks are not 
necessarily of an automated kind and we would 
expect greater deficits on those requiring con­
trolled processing. Studies looking at particular 
aspects of language are examined next.
Vocabulary
Lexical knowledge is highly automated, being 
used continually. It should therefore be unaffected 
in the early stages of senile dementia. Consistent 
with this expectation, Vocabulary is often 
considered to be one of the best preserved 
subtests of the WAIS in senile dementia, 
although decline does occur (Alexander, 1973; 
Crookes, 1974; Inglis, 1958). Senile dements 
have also been reported to do relatively well on 
the Mill Hill Vocabulary Scale, even when 
cognitive impairment was evident on a battery of 
other tasks (Irving el al. 1970), and a similar 
pattern of results has been found with a picture 
vocabulary scale (Inglis, 1959). Even in a 
naturalistic study of the range of vocabulary 
used in free speech, early cases of Alzheimer’s 
Disease were found to have a distribution of 
vocabulary usage virtually identical to that of 
controls (Miller & Hague, 1975).
Syntactic and semantic knowledge
The view that syntactic processes were more 
automated than semantic processes was men­
tioned earlier when discussing developmentally- 
oriented studies. Bayles & Boone (1982) 
administered a battery of language tasks to a 
group suffering from SDAT and a control group. 
They carried out a discriminant analysis and 
found that tasks drawing on semantic knowledge 
were weighted most heavily in the discriminant 
function. Bayles & Boone (1982) concluded that 
senile dementia involves a greater erosion of 
semantic knowledge than syntactic or phono­
logical knowledge. They attributed this profile of 
skill erosion to the automatic and unconscious 
nature of syntactic and phonological processes
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compared with the unpredictable nature of 
semantic processes which requires conscious 
thought. Case studies of dementia by Whitaker 
(1976) and Schwartz et al. (1979) have come to 
similar conclusions. Whitaker (1976) described a 
woman who had a severe impairment of the 
creative and volitional uses of language. How­
ever. she had normal speech input and output as 
shown by her capacity for echolalia. Further­
more, when given grammatically incorrect 
sentences to repeat she would alter them to 
the correct form -  for example, she would make 
the noun and verb in a sentence agree in number. 
Whitaker (1976) interpreted this type of be­
haviour as indicating the preservation of 
overlearned aspects of grammatical knowledge 
which had become automatic. Schwartz et al.'s 
(1979) report also described a woman with 
marked impairment of semantic processing. She 
was found to have a breakdown of semantic 
categories so that words were used to refer to a 
broader class of referents (e.g_both dogs and cats 
were called 'dogs'). Nevertheless, her syntactic 
processes were well preserved. When given a 
simple declarative sentence she could produce 
the negative, plural, question, and past tense 
forms. She also indicated comprehension of 
actives and passives, comparative adjectives, and 
spatial prepositions by pointing to appropriate 
pictures in a multiple-choice situation. Generally 
speaking, then, the semantic aspects of language 
are more affected than the syntactic in senile 
dementia.
Reading
The ability to read familiar words aloud is a 
highly automated skill in the adult reader, 
involving direct access to meaning and pronun­
ciation from the cues provided by the printed 
word (Jorm & Share, 1983). La Berge & Samuels 
(1974) have presented evidence and proposed a 
theory relating to how the identification of 
printed words comes to be progressively auto­
mated with experience. Their views share much 
in common with Shiffrin & Schneider's (1977) 
account of the development of automaticity in 
visual search tasks. Such automated visual word 
identification skills seem to be well preserved in 
senile dementia. Nelson & McKenna (1975) and 
Ruddle & Bradshaw (1982) have found that 
word reading skills are maintained even when
other aspects of intellectual function have 
markedly deteriorated. Nelson & O'Connell 
(1978) have further examined reading perform­
ance on irregular words (such as psalm and debt) 
which can only be pronounced correctly by 
retrieving previously stored information, and 
compared this with performance on regular 
words which can be worked out using a 
phonological recoding strategy as well as read 
by direct retrieval. Only on quite long regular 
words (such as adventurously and chitterling) 
were the demented subjects impaired relative to 
controls. These are words which would often 
have required the subjects to employ a controlled 
phonological recoding strategy rather than to 
rely on automated direct retrieval of a word's 
name. As yet. little work has been done on tasks 
like spelling and writing which are closely related 
to reading. However, in Caird’s (1965) study, 
senile dements were found to be able to write 
high-frequency phrases (e.g. United States of 
America) as quickly as control psychiatric 
patients.
Naming
The process of naming is like that involved in 
reading familiar words aloud, except that the 
stimulus is an object or picture rather than a 
written word. With common words it is a highly 
automated skill, but with rare words the retrieval 
process involved may not be simple and 
automatic (Brown & McNeill, 1966). Conse­
quently, it would be predicted that naming with 
common words should be unimpaired until the 
later stages of senile dementia, while naming with 
rare words would be impaired much earlier. 
Barker & Lawson (1968) found that senile 
dements were indeed more impaired at naming 
objects with low-frequency names than objects 
wi t h hi gh-frequency names. This findingex tended 
to naming times as well as errors (Lawson & 
Barker, 1968). Rochford (1971) found that, 
although dements made frequent errors naming 
outline drawings, they made few' errors at 
naming body parts. The greater familiarity with 
body parts may explain this finding. Little work 
has been done on more complex name retrieval 
tasks. However. Caird (1965) found that the time 
taken to name the days of the week (a highly 
overlearned task) was no slower in senile 
dements than in control psychiatric patients.
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Learning
According to ShifTrin & Schneider (1977), the 
learning of new material requires controlled 
processing. It would therefore be expected that 
problems in learning should be characteristic of 
all stages of senile dementia. Such problems have 
indeed been found with a range of laboratory 
learning tasks, such as paired-associated learning 
of word pairs (Caird, 1965; Caird et al. 1962; 
Inglis, 1959; Irving et al. 1970; Kaszniak et al. 
1979; Kendrick & Post, 1967), serial learning of 
word lists (Weingartner et al. 1981), learning 
definitions of unfamiliar words (Irving et at. 
1970; Kendrick et al. 1965; Kendrick & Post, 
1967), and learning of supraspan digit strings 
(Miller, 1973). All of these tasks have tested 
recall, but deficits are also found when recog­
nition memory is tested (Caird, 1965; Miller, 1975, 
1978; Morris et al. 1983; Wilson et al. 1983b,
1982). Fewer studies have been carried out on the 
learning of non-verbal material, but Miller & 
Lewis (1977) found deficiencies in recognition 
memory for geometric designs, while Wilson 
et al. (1982) found a similar deficiency with 
memory for faces. Inglis (1959) even found a 
learning deficit on a manipulative task in which 
subjects had to learn to find a fixed peg quickly in 
a matrix board of pegs. These various studies 
which demonstrated learning deficits have 
spanned a wide range of subjects, some of whom 
(e.g. in the Miller studies) were in the early 
stages of the disorder. Learning problems thus 
appear to be very characteristic of senile 
dementia. The exact nature of the learning 
problems in senile dementia is not touched by 
many of the above studies; it could be in the 
controlled processes of either storage or in 
retrieval. Some data relevant to these issues are 
discussed in the following sections.
Storage processes
ShifTrin & Schneider (1977) have proposed that 
what is attended to and given controlled 
processing is stored in LTS. Hasher & Zacks 
(1979) include imagery, rehearsal, organization, 
and mnemonic techniques as specific types of 
such controlled processing. Assuming that senile 
dements have particular difficulty with controlled 
processing, they should show deficiencies in these 
particular storage processes, even in the early
stages of dementia. In fact, a number of studies 
have indicated storage process deficits of these 
kinds. For example, several studies have examined 
the primacy effect in free recall of word lists. The 
primacy effect is generally assumed to result from 
extra rehearsal of the early items of a list 
(Rundus & Atkinson, 1970). Thus, a failure to 
employ rehearsal should result in a reduced 
primacy effect. Using a task involving free recall 
of words, Miller (1971) found hardly any 
primacy effect in subjects with Alzheimer’s 
Disease. These patients were probably in the 
early phases of the disease. Similarly, Gibson 
(1981) found little primacy with free recall of 
either words or pictures in a group of senile 
dements, and Wilson et al. (1983a) found that 
Alzheimer’s subjects have a pronounced deficit 
in the ‘secondary memory' component of the 
free recall curve (which would include the 
primacy effect). In contrast, the recency com­
ponent of free recall appears to be much less 
affected in these studies. The use of organization 
in memory by demented subjects has been 
investigated by Weingartner et al. (1981). They 
tested free recall of lists of unrelated or related 
words, presenting the related words in either 
clustered or unclustered form. As would be 
expected, controls were found to perform better 
with related words than with unrelated words, 
but the demented subjects were poor at all lists, 
even the clustered list. Furthermore, there was no 
evidence of organization in the order of the 
demented subjects' recall. Thus senile dements 
appear to have great difficulty organizing 
information in memory. The use of imagery and 
other mnemonic techniques by senile dements 
has yet to be investigated.
Retrieval processes
According to ShifTrin & Schneider (1977). 
retrieval from LTS has a large automatic 
component. Reviewed above are studies of 
reading and vocabulary which suggest the 
maintenance of such automatic retrieval processes 
in seniledementia. However,controlled processes 
are involved in many instances of retrieval 
Baddeley (1982) has used the term recollection 
to refer to this active problem-solving kind of 
retrieval. Recollection involves an active process 
of setting up likely retrieval cues and evaluating 
the plausibility of the information retrieved
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Problems with retrieval of this kind may be 
responsible for Wilson et al. 's (1981) finding that 
early cases of senile dementia perform poorly on 
tests of memory for remote events involving 
famous faces and incidents from previous 
decades. The performance of senile dements on 
verbal fluency tests provides another source of 
evidence on theircapacity forcontrolled retrieval. 
These tasks involve retrieving as many instances 
as possible from a category given by the tester. 
Miller & Hague (1975) and Miller (1984) have 
found that Alzheimer’s Disease patients are able 
to produce fewer instances of words beginning 
with a particular letter within a specified time 
period. Similarly, Weingartner et al. (1981) 
found senile dements to be poorer at producing 
w'ords that belonged to a semantic category as 
well as words that started with a particular letter. 
In all these three studies, the subjects were 
generally in the early stages of their dementia. 
Although it is apparent from these studies that 
retrieval problems are characteristic of even the 
early stages of senile dementia, little detailed 
study has been carried out on the process of 
retrieval in senile dementia. However, there is 
some evidence that Alzheimer’s Disease patients 
tend to respond with intrusions deriving from 
earlier appropriate responses (Fuld et al. 1981). 
An example of this would be where a subject 
names an object correctly and then gives this 
same response some time later to another ob­
ject. In Baddeley’s (1982) terms, these people 
appear not to be evaluating the appropriateness 
of the responses they retrieve. Problems with 
the controlled aspects of retrieval relative 
to the automatic aspects may possibly explain 
the effectiveness of cued recall in senile de­
mentia. Miller (1975) and Morris et al. (1983) 
have found that the recall of word lists by 
dements is close to that of normals when they are 
given either the initial letter or first few letters of 
the correct responses as retrieval cues. It might 
be that providing retrieval cues of this kind serves 
to reduce the demand for controlled processing 
during retrieval.
IS THE PATTERN OF DECLINE 
SPECIFIC TO SENILE DEMENTIA?
Having argued that much of the evidence on 
cognitive deficit in senile dementia can be 
interpreted in terms of early decline in the
capacity forcontrolled processing together with 
preservation of automatic processes until late in 
the disorder, it must now be asked whether 
decline in controlled processes is characteristic of 
other states or specific to senile dementia. In fact, 
there is some evidence that decline in controlled 
processing is characteristic of several states, 
including high arousal, depression, and normal 
aging(Hasher& Zacks, 1979). The non-specificity 
of decline in controlled processing might be held 
as a weakness of the controlled/automatic 
framework in that it is too broad to distinguish 
the subtle qualitative differences between the 
cognitive deficits in these states. Alternatively, it 
may be that these states do indeed result in a 
qualitatively similar cognitive deficit and that the 
distinction between controlled and automatic 
processing captures this common deficit nicely. 
The latter view is taken by Hasher & Zacks 
(1979) who argue that a variety of states have a 
common influence on attentional capacity. These 
states would then be distinguishable from each 
other on other than cognitive grounds; for 
example, dementia can be differentiated from 
depression on the basis of motivational and 
emotional changes (Gurland et al. 1982). and it 
can be differentiated from normal aging on the 
basis of the severity of the cognitive changes. The 
relationship of cognitive decline in senile 
dementia to that in normal aging is particularly 
interesting, since it has been argued that SDAT 
is closely related to normal aging at the 
neuropathological level (Drachman. 1983)
EARLY DETECTION OF SENILE 
DEMENTIA
Henderson (1983) and Henderson & Huppert 
(1984) have given four reasons why effective 
screening techniques for senile dementia need to 
be developed. The first two reasons relate to 
benefits for research. Screening techniques are 
useful for epidemiological studies seeking to 
study senile dementia in the general population 
rather than in biased institutional samples. They 
will also help in studies of the natural history of 
mild dementia where research workers wish to 
determine which early cases of cognitive impair­
ment progress to dementia and which remain 
stable. Then there are reasons relating to clinical 
usefulness. Medical practitioners need to know 
whether their patients are suffering from early
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dementia in order to guide their choice of 
treatment. For example, anticholinergic drugs 
are known to worsen dementia and could be 
avoided. Lastly, there is the promise that drugs 
for the amelioration of the cognitive impairment 
in senile dementia will be developed in coming 
decades, and early detection will be necessary for 
these treatments to be instituted. Kendrick 
(1982) has given similar reasons for developing 
assessment instruments. Cooper & Bickel (1984) 
have considered the issue of whether population 
screening for the early detection of senile 
dementia should be carried out. They believe that 
this approach may have promise for the future, 
but much additional research needs to be done. 
A major problem is that effective screening 
instruments suitable for use in the general 
community (rather than with institutionalized 
populations) have not been developed.
Cooper & Bickel (1984) consider that the most 
promising screening instruments are the brief 
dementia scales. These scales consist of between 
10 and 35 items and can be administered 
reasonably quickly by someone with minimal 
training. The scales are not based on particular 
views of cognitive decline in senile dementia, but 
rather appear to reflect the clinical intuitions of 
the originators as well as the borrowing of items 
from earlier scales. Cooper & Bickel (1984) claim 
that most existing scales derive from one 
constructed by Hopkins & Roth (1953). The 
validation of these scales has usually been 
carried out by comparing their classification of 
cases using a cut-off score with the diagnoses of 
experienced clinicians using clear-cut institu­
tionalized cases. With the advanced cases of 
dementia used in these validation studies the 
dementia scales perform quite well, but when 
studies have been earned out with community or 
general hospital samples the scales are often 
found to lack sensitivity. For example, using the 
Mental Status Questionnaire (Kahn el al. 1960) 
and the Short Portable Mental Status Question­
naire (Pfeiffer, 1975) with a community sample, 
Fillenbaum (1980) found that they correctly 
identified 96% of cases without, but only 55% 
of those with, senile dementia. Similarly, in 
Pfeiffer's (1975) own validation study with a 
community sample, the Short Portable Mental 
Status Questionnaire correctly identified 52 of 
53 normals, but only 7 out of 27 cases w'ith 
dementia. In other words, these instruments have
a high false negative rate in community samples 
where cases of mild dementia would be more 
common. The Mini-Mental State (Folstein el al. 
1975), on the other hand, has been found to 
perform very well with general hospital patients. 
Anthony et al. (1982) found that it correctly 
classified 87% of the patients with dementia and 
82% of those without.
The variable performance of dementia scales 
with non-institutionalized samples may reflect 
the nature of the cognitive deficits tapped by the 
scales. From the present theoretical perspective, 
items tapping controlled processing would be 
most sensitive to the deficit in early dementia, 
whereas items tapping automatic processing 
would be most sensitive to late dementia. 
However, the Mental Status Questionnaire and 
the Short Portable Mental Status Questionnaire 
(as well as most of the other dementia scales 
listed by Cooper & Bickel, 1984) have a 
preponderance of items tapping automatic 
cognitive processes. Such items include: When 
were you born? Who is the President of the 
United States'? W'hat is your telephone number? 
What was your mother’s maiden name? People 
are heavily exposed to these items of information 
and receive much practice at retrieving them. 
Items of a novel sort requiring controlled 
processing are less common on dementia scales, 
with the exception of the Mini-Mental State 
which contains a number of items of this sort as 
well as the more automatic kind -  for example, 
copy two intersecting pentagons; carry out a 
three-stage command; learn and later recall a list 
of three objects; count backwards from 100 by 
7s; write a sentence of patient's choice; read a 
phrase with comprehension. If we define items 
which can be answered correctly only by direct 
retrieval from LTS as requiring automatic pro­
cessing, while items which can be answered by a 
problem-solving process are defined as involving 
controlled processing, then we find that none of 
the 10 items on the Mental Status Questionnaire 
and only one of the 10 items on the Short 
Portable Mental Status Questionnaire involve 
controlled processing. In contrast, 19 of the 30 
items on the Mini-Mental State involve control­
led processing If the aim of a dementia scale is 
to discriminate degrees of dementia from mild to 
severe, both types of items are required; 
however, for the detection Tearly dementia the 
measurement of controlled processes may be
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more appropriate. The Mini-Mental State thus 
appears to offer a more balanced coverage of 
controlled and automatic processing modes.
A major limitation of the use of dementia 
scales with community samples is that they can 
detect only poor cognitive function and cannot 
distinguish the various sources of this deficiency. 
Thus, as Anthony el al. (1982) and Jacobs el al.
(1977) have found, people with poor education 
or low intelligence may produce low scores as a 
result of pre-existing low cognitive ability rather 
than a decline due to dementia. The basic 
problem is that dementia scales are attempting 
to measure cognitive decline with assessment at 
only one point in time At least two time points 
are needed to establish a downward course but 
in clinical practice these cannot usually be 
obtained. A possible solution lies in an analysis 
of the differential decline of automatic and 
controlled processing in early senile dementia. If 
automatic processes are well maintained in early 
dementia, they provide us with a good index of 
premorbid cognitive ability. Better educated and 
more intelligent people usually have a broader 
range of automated skills (Hunt. 1978). The 
degree of decline could then be measured by 
comparing the resistant automatic processing 
skills with the controlled processing skills which 
are affected early in the disorder. Such a method 
of estimating premorbid ability would not be 
appropriate in severe dementia, but in these cases 
there is little room for diagnostic uncertainty 
because the cognitive impairment is so far below 
the normal range. The basic concept behind this 
proposal is, of course, not new. It formed the 
basis for the deterioration index of the WAIS 
(Wechsler, 1958) as well as Nelson & O'Connell's
(1978) work comparing reading ability on 
irregular words and unfamiliar regular words. 
However, these attempts were based on empirical 
observations .rather than on an attempt to 
elucidate the nature of the cognitive decline in 
senile dementia from a theoretical perspective. 
As Rabbitt (1982) has argued, attempts to assess 
cognitive skills in the aged can benefit from the 
perspectives provided by information processing 
models of performance.
It should be pointed out. however, that the 
proposal to measure cognitive decline by 
comparing controlled and automatic processing 
is purely programmatical and should not be 
construed as offering a practical method at this
time. Naturally, everybody performs better at 
tasks relying on automatic processing. We would 
need to know the extent of the discrepancy in 
the normal population before being able to say 
that a particular individual has a significantly 
greater discrepancy. Extensive norms would 
therefore need to be collected to make this 
proposal a reality. Although existing techniques, 
such as the WAIS deterioration index, have the 
advantage of being based on already established 
norms, both the appropriateness of these norms 
for the elderly and the validity of the deterioration 
index itself have been questioned (Miller. 1981).
Although the major benefit of the present 
theoretical perspective may be in aiding the 
development of instruments for the early 
detection of cognitive decline, a further potential 
area of application might be found in the 
management of senile dementia. It would be 
predicted that patients assessed as having 
deficiencies in controlled processing but relatively 
preserved automatic processing, such as mild 
dements, would function best in environments 
which minimized the need for controlled pro­
cessing. If such people have lived in a stable 
environment before the onset of their dementia, 
they would have developed a repertoire of 
automaticskillsrelatingtothisenvironment -  for 
example, a daily routine of activities, know ledge 
of how to carry on ritualized social interactions, 
how to find one's w ay around, how to dress, cook 
and clean in this environemnt. However, these 
individuals would have trouble to the extent that 
this environment demanded response to change 
and noveUy. Perhaps more disastrous for the 
maintenance of these automated skills would be 
major changes in the whole environment -  for 
example, a move of house or into an institution. 
This sort of major change would render the 
established automated skills largely irrelevant, 
and the individual would lack the capacity for 
controlled processing which is necessary for the 
development of a repertoire of automated skills 
appropriate to the new environment. In fact. 
Brull et al. (1979) have reported that senile 
dements exhibit major and permanent cognitive 
decline associated with institutionalization, al­
though the data they present do not allow an 
assessment of whether this is due to the loss of 
automated skills in particular. The major 
implication of the present perspective for 
management of senile dementia is therefore that
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mild dements should be maintained as long as 
possible in the environment with which they are 
familiar.
Thanks are due to Dr A. S. Henderson for providing 
comments on an earlier draft of this paper. The paper 
was written while the author was on sabbatical leave 
at the Department of Psychology, Carnegie-Mellon 
University.
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Brief Report
EFFECTS OF CHOLINERGIC ENHANCEMENT 
THERAPIES ON MEMORY FUNCTION IN 
ALZHEIMER’S DISEASE: A META-ANALYSIS OF 
THE LITERATURE
A nthony F. Jorm
A quantitative analysis of the literature on cholinergic enhancement of 
memory function in Alzheimer’s disease showed that such therapies 
do have an effect if dosages are individualised. Treatments that 
combine a precursor with an anticholinesterase, however, appear to 
be the most promising for clinically useful results. The number of 
studies that have evaluated this combination treatment is small, but 
the present analysis indicates that further clinical trials would be most 
worthwhile.
Introduction
Following the discovery that there is a major 
cholinergic deficit in Alzheimer’ s disease (AD), 
there have been a spate a studies attempting to 
treat the disease by pharmacological enhancement 
o f the cholinergic system. These therapeutic 
attempts can be placed into three major classes. 
The largest group o f studies has attempted to 
fac ilita te  the production and release o f 
acetylcholine by administering the precursors 
choline and lecithin. Another group o f studies has 
attempted to in h ib it the breakdown o f 
a c e ty lc h o lin e  by admi n i s t e r i ng  the 
anticholinesterase drugs physostigmine and TH A 
(tetrahydroaminoacridine). A third group of 
studies has combined these strategies by 
admi n i s t e r i ng  both  precursors  and 
anticholinesterase drugs. There have also been 
single studies on other cholinergic agonists, 
arecoline and RS86. The general consensus in 
reviews of this literature seems to be that 
precursor loading has little effect, but ‘that the 
other approaches may have some promise (Blass & 
Weksler 1983; Crook 1983; Johns et al. 1983). The 
effects o f these treatments, however, seem to vary 
greatly from study to study, suggesting that
differences in experimental design and patient 
characteristics mav be important.
Within the social sciences, meta-analysis has 
become increasingly popular for sorting out 
apparently inconsistent literatures o f this kind 
(Glass ei al. 1981). Meta-analysis is a family of 
approaches for quantitative integration of a 
research literature and can be contrasted with the 
traditional narrative literature review. Meta­
analysis can also be usefully applied in medical 
research and is particularly useful in the 
integration of results from therapeutic outcome 
studies.
In a meta-analysis of outcome research, a 
measure of effect size (d) can be calculated as a 
common metric to make comparisons across 
studies. In the meta-analysis reported here, 
d = (M t-M c)/Sc, where M. is the mean score at the 
end of treatment, M c is the mean at the end ot the 
control period, and Sc is (he standard deviation at 
the end of the control period. By averaging effect 
sizes over a group of comparable studies, it is 
possible to arrive at an estimate o f the typical 
effects to be expected from the particular 
treatment. In addition, a meta-analysis can be 
enhanced by coding studies in terms o f their
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characteristics (e.g.. sample size, dosage, duration 
of treatment, degree of blinding) and assessing 
whether effect sizes vary systematically from study 
to study as a function of these characteristics.
Reported here is a meta-analysis of studies into 
cholinergic enhancement therapies which have 
included a measure derived from a memory task as 
a dependent variable. The aim was to estimate the 
typical effect size of the three major classes of 
cholinergic enhancement therapies and to see 
whether the variable results in the literature could 
be accounted for in terms of study characteristics.
Method
A MEDLARS computer search of the topic was 
carried out and the reference lists of any suitable 
papers were scanned to find further papers. By 
this means, 60 papers reporting results of 
cholinergic enhancement therapies were located 
up to the end of 1984. These papers were found to 
come from only 46 different studies, as some were 
reported in several places (in one case, a single 
study was published in four slightly different 
forms). Of these 46 studies, 11 were excluded from 
the meta-analysis because they had less than three 
subjects, reported a series of individual case 
studies, did not include a memory measure fitting 
the concept of episodic memory (Tulving 1983), 
combined the treatment with a non-cholinergic 
therapy, or were the only study of their kind (e.g., 
used RS86 as a treatment). Of the 35 remaining 
studies, 11 did not report sufficient data for 
calculation of an effect size. Letters requesting 
suitable data were therefore sent to their authors, 
but only one was able to supply what was 
required.
For the 25 remaining studies effect sizes were 
calculated using the methods described by Glass et 
al. (1981). Separate effect sizes were calculated for 
each treatment in a study. If different doses or 
mode of administration (e.g., oral versus 
parenteral) were used, these were regarded as 
separate treatments. If several memory measures 
were used in a study, the effect sizes for each were 
averaged to yield a single value tor each treatment.
Study characteristics were coded in four broad 
areas: subject characteristics (age, diagnostic
criteria used, sex ratio, residence, degree of 
dementia, attrition rate), treatment characteristics 
(type of drug, dosage, route of administration, 
treatment duration), design characteristics (degree 
of blinding, type of control group, experimental 
design, threats to internal validity, biases in 
subject selection or reporting of outcomes), and 
outcome measure characteristics (quality of data 
from which effect sizes were calculated, number 
of different memory measures).
Results
Effect sizes were corrected for bias using the 
method of Hedges (1981). Table 1 gives the means 
and standard deviations of the effect sizes for the 
three major classes of treatment. Also shown is 
the number of studies reporting results for each 
type of treatment and the number of effect sizes 
derived from these studies. There was a significant 
difference between the effect sizes for these classes 
of treatment (F = 6.78, df = 2.34, p<0.01). Post 
hoc comparisons of means using the modified 
LSD procedure (Nie el al. 1975) showed that the 
combination treatments did significantly better 
than the precursor (p<0.01) and anticholinesterase 
treatments (p<0.05). However, there was 
considerable variability in effect sizes and this was 
assessed for re la t ionsh ip s  with study 
characteristics. A number of significant 
relationships emerged, but it must be remembered 
that with so many study characteristics being 
investigated, some of these may be due to chance.
The characteristic which emerged most 
consistently as being important was whether an 
optimal dosage was determined for each patient or 
the dosage was standardised. For the precursor 
therapies, the two effects based on individualised 
dosages had a mean of 0.40 as against -0.03 for 
the other 20 effects (t=2.40, df = 20, p<0.05, 
two-tailed). Similarly, for the anticholinesterase 
therapies the five effects from individualised 
dosages gave a mean of 0.31 compared to -0.23 
for the five effects based on standardised dosages 
(t = 3.20, df = 8, p<0.05, two-tailed). With the 
combination treatments the respective means w'ere 
1.20 (based on three effects) and 0.00 (based on 
tw'o effects), but the difference was only of
T ablf 1 Effect sizes derived f rom studies of  various cholinergic enhancement therapies
No O!
ellect V  o!
Type of  therapy Mean ot d St) of  d studies'
Precursor 0.01 0 27 22 ;h
Anticholinesterase 0.04 0.39 10 s
Combination 0 72 0 79 c
* Totals io more than 25 because of studies evaluating mote than one clave of therapv
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borderline significance (t = 2.63, df = 3, p<0.05, 
one-tailed). Also of interest was a borderline 
significant tendency for the effect of precursor 
therapies to be positively related to the average age 
of the patients (r =0.41, p<0.05, one-tailed).
Only two other study characteristics were 
significantly related to outcome. For the precursor 
therapies, the eight effects from studies which 
reported results on only a selection of their 
dependent measures were greater than the 14 
effects which did not involve selective reporting 
(means of 0.18 and -0.08, t = 2.50, d f = 20, 
p<0.05, two-tailed). With the combination 
therapies, studies with a greater number of 
dependent measures tended to have weaker effects 
(r = -  0.88, p<0.05, two-tailed), probably because 
extreme values are more likely to be reduced when 
several dependent measures are averaged.
Discussion
The results indicate that all treatments produce 
some improvement in memory function provided 
the dosages are individualised. However, 
treatments which combine a precursor with an 
anticholinesterase appear to offer the greatest 
promise for clinically useful results. If we are 
willing to assume that memory function in AD is a 
normally distributed variable, then a mean effect 
size of 0.72, which these therapies had, would 
indicate that the average treated patient performs 
better than 76°7o of untreated patients. For an 
effect size of 1.20, which occurred when the 
dosages were individualised, the average treated 
patient would do better than 88% of untreated 
patients. Whether such an effect size indicates 
clinical usefulness depends on how far the 
memory of typical AD patients is below normal. 
If, for example, AD patients averaged two 
standard deviations below' normal on memory 
tests, then such a treatment would be highly 
successful. If, on the other hand, they were five 
standard deviations below normal, the treatment 
would probably be of little clinical use because 
their performance after treatment would still be 
well outside the normal range. Unfortunately, we 
do not know' how patients in the studies reviewed 
would compare to normal subjects, but an effect 
size of 1.20 could well be clinically useful.
The tendency for older patients to respond 
better to precursor therapies than younger patients 
is noteworthy because o f suggestions that there are 
neurochemical differences between younger and 
older AD patients (Rossor el at. 1984). Younger 
patients tend to have more broadly based 
deficiencies involving several neurotransrnitter 
systems, while older patients have a defic ient
more specifically involving the cholinergic system. 
Therefore, cholinergic enhancement therapies 
might be expected to be more useful for older AD 
patients. However, no age effect was evident with 
either the anticholinesterase or combination 
treatments.
There are a number o f limitations in the present 
analysis. First, only studies using memory 
measures were included, yet AD involves 
intellectual and personality changes as well. The 
reason for limiting the analysis only to memory is 
that too few studies employed other types of 
dependent measures to make a meta-analysis 
feasible. Only 10 effect sizes were available for 
intelligence measures, and even fewer for 
personality changes. It can, however, be reported 
that memory and intelligence effect sizes 
correlated 0.49 for die nine cases where both 
measures were taken for the same group of
pat lents.
A second lim itation is that data for calculation 
of effect sizes were not available for 10 of the 35 
suitable studies. It is possible that some sort of 
bias was introduced, if  the excluded studies had 
different effect sizes from those included. The 
problem is a common one in meta-analysis and 
there appears to be no easy resolution. It is
important, however, that effect sizes could be 
calculated for all studies o f the combination
treatments that produced the most promising 
results.
Finally, it must be noted that only five studies 
have been carried out on combination precursor- 
anticholinesterase treatments, and that the 
combined total sample size involved is only 32 
patients. Nevertheless, the evidence from the 
present study points directly to the need for
further work on this promising lead, in an area of 
considerable public health importance.
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E D I T O R I A L
Is case-ascertainment of Alzheimer’s disease in field surveys
practicable? 1
Research on Alzheimer’s disease (AD) has recently burgeoned because of its public health 
importance and scientific opportunities. While biological investigations are energetically pursued 
and now carry considerable promise, clinical and epidemiological research may also have a 
contribution to make (Khachaturian, 1985). Such work may help in identifying subtypes of AD, 
in establishing its natural history and in finding clues to its aetiology. But here a major obstacle 
arises: the cases studied should be of Alzheimer’s disease, not other dementias. This requires highly 
reliable and valid diagnosis during life. Only five years ago, Masters et al. (1981, p. 165) expressed 
pessimism about the problem, asserting that ‘Until criteria are established for diagnosis, it seems 
almost pointless to attempt an epidemiological analysis . . . There does not even appear to be any 
reliable information on the accuracy of clinical diagnosis in a large enough series of patients with 
AD. Therefore, no estimate is available on the degree of case ascertainment that might be expected 
from population surveys’.
For clinical research, the situation is now much improved: there are research diagnostic criteria 
for AD; and information on the accuracy of clinical diagnosis has been obtained. But there is no 
experience of trying to use these criteria in field surveys; and nothing is known about the accuracy 
of the diagnoses obtained under survey conditions. Ascertainment of cases of Alzheimer’s disease 
necessarily must proceed in two stages: the diagnosis of dementia; then the diagnosis of AD itself, 
with the exclusion of other causes of dementia. Here we examine what is presently knowm about 
reliability and validity at both these stages; and how practicable it is to achieve accurate 
case-ascertainment in field studies.
DIAGNOSING DEMENTIA IN FIELD SURVEYS
Case-finding of dementia in field surveys, without its further differentiation, presents at least as much 
difficulty as case-ascertainment of other psychiatric disorders. An exhaustive meta-analysis of 47 
prevalence studies by Jorm et al. (1987) has shown that rates obtained for moderate and severe 
dementia differ markedly from study to study; and rates for mild dementia are even more variable. 
These differences may reflect a lack of agreement between diagnostic criteria as much as true 
differences in prevalence.
The diagnosis of mild dementia in community surveys calls for particular attention. Henderson 
& Huppert (1984) drew attention to the scientific importance of such studies but pointed to the 
great variation in reported rates, and to the dilemma posed by not having adequate diagnostic 
criteria to study a condition in which the distinctive features are not yet known. These authors 
advocated that standardized but provisional criteria should now be used in prospective longitudinal 
studies, so that the features and natural history of mild dementia may be clarified.
For dementia of all levels of severity, even the advent of standard diagnostic criteria for dementia 
(e.g. DSM-III) does not guarantee comparability across studies. For example. Kay et al. (1985) 
reported difficulty in using DSM-III criteria for dementia, because it w'as unclear how each criterion 
should be translated into actual items in the clinical examination. Furthermore, changing the number 
of errors required to indicate the presence of, say, ‘memory impairment’, made an appreciable 
difference to the prevalence rates.
1 Address for correspondence Dr A S Henderson. NH&MRC Social Psychiatry Research Unit. The Australian National University. 
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But even where rates are found to be similar, Kay el al. (1987) have found that the different criteria 
lead to the diagnosis of different individuals, particularly for mild dementia. This observation has 
serious implications for epidemiological research. Since none of the sets of criteria has been 
validated, different groups of persons may be suffering from different syndromes; and they may have 
had different exposures to postulated risk factors. Furthermore, it should be noted that such 
uncertainty is about the diagnosis of dementia, before one soes on to make diagnosis specifically 
of AD.
DIAGNOSING AD IN FIELD SURVEYS
There are now at least 16 field surveys where an attempt has been made to separate the prevalence 
of AD-type dementia from that of other dementias (Jorm ei al. 1987). The most recently completed 
survey of this type is Folstein el al.'s (1986) prevalence study in East Baltimore, which achieved 
a differential diagnosis of dementia in a sample of 923 elderly persons. Flagnell et al. (1981, 1983) 
and Nilsson (1984) have also reported incidence rates specifically for AD and multi-infarct dementia 
(MID). However, these surveys provide no information on the validity of such diagnoses. For this, 
it is necessary at present to retreat to studies based on hospital series, where validation at autopsy 
is more practicable.
Sulkava et al. (1983) have reported the clinical and autopsy findings on 27 hospital patients in 
Helsinki, diagnosed during life as having 'primary degenerative dementia', which can be taken as 
almost a synonym for the clinical diagnosis of AD. Sulkava et al. set out seven clinical criteria by 
which such a diagnosis was made. At post mortem, 22 (82%) had neuropathological changes typical 
of AD. The other five cases had degenerative encephalopathies of other types, which do not yet 
have formal recognition as disease entities, but which Sulkava ei al. described with care. Four of 
these five cases had a history of a clinically similar dementia in a sibling, while only one-fifth of 
the AD cases had a history of dementia in any first-degree relative. It is to be hoped that Sulkava 
and his colleagues will later obtain post mortem findings on the complete series of 71 hospital cases.
A second study, by Mölsä et al. (1985) in Turku, reported the neuropathological findings in 58 
persons clinically diagnosed as having a dementia. They found that the clinical diagnosis of AD 
had 71% sensitivity and 73% specificity. Importantly, the clinical diagnosis of mixed AD and MID 
was found to have only 17% sensitivity and 92% specificity. MID was diagnosed with 73% sensitivity 
and 77% specificity.
A striking feature of the Mölsä et al. study was the difficulty of accurately diagnosing mixed 
AD-MID on clinical grounds. Six patients were neuropathologically diagnosed as having this 
combination. However, in the clinical diagnosis three were judged to have AD and two MID. 
Neuropathological studies of hospital samples show that mixed AD-MID is quite common (Roth, 
1971). Given that both AD and MID become more prevalent with increasing old age, then their 
co-occurrence would be expected to become a major diagnostic problem in the very elderly. The 
development of adequate clinical instruments for the diagnosis of mixed AD-MID is essential if 
successful field studies are to be carried out. Otherwise the danger is that mixed AD-MID cases will 
be added to the AD or MID cases to give a misleading picture. However, as yet, an adequate 
approach to the clinical diagnosis of mixed AD-MID does not exist.
Mölsä et al. (1985) attempted to differentiate AD, MID and mixed AD-MID using the widely 
used Ischaemic Score of Hachinski et al. (1975). with a low score indicating AD, a high score MID. 
and an intermediate score a mixed dementia. The inadequacies of the Ischaemic Score have been 
reviewed by Liston & La Rue (1983). They have concluded that a low score tends to rule out MID 
and is therefore useful in diagnosis of AD by exclusion. However, a high score does not necessarily 
indicate a vascular origin to a dementia because it is impossible to know the extent to which ischaemic 
changes are contributing to the dementia. Recently, Muckle & Roy (1985) have shown that levels 
of high-density lipoprotein cholesterol are reduced in MID and have suggested that this could be 
useful in differential diagnosis. However, this test would appear to have the same problems in dealing 
with mixed AD-MID as the Ischaemic Score. Clearly, any unidimensional diagnostic test, in which
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to 197 for both cases and controls to show a relative risk of 3; (this calculation is based on a Type 
1 error rate of 0 05 and a Type II rate of 0-10). As another example, with an exposure rate of rate 
of 0 5 (50%) in the control population, the sample size would have to be increased from 25 to 44 
to show a relative risk of 9. It is appropriate to express these increases as a percentage to show the 
increment in resources required for the study. Although the absolute size of the increase is greater 
in the first example than in the second, the percentage increases show the opposite trend (48% v. 
76%) because of the small sample size initially required in the second case. Fig. 1 shows the 
percentage increase required in sample size for several exposure rates (Po) and relative risks (R). 
It can be seen that the percentage increase can be sizeable even with a fairly small misclassification 
rate.
250 t
Po = 0 5
200 -
Po = 0 5
150 -
R = 3
Po = 01
Po = 0-1
Misclassification of cases (%)
Fig. 1 Percentage increase in number of subjects required for case-control studies as a function of misclassification of cases (with 
alpha = 0 05. beta = 010. 2-tailed).
In making these calculations, we have assumed that all the controls in a case-control study are 
genuine non-cases. But in field studies the situation is even more complex, because there is the 
problem of missing true cases of AD as well as the inevitable presence of false positives. Therefore, 
for aetiological research on cases ascertained in the community, much caution will be needed because 
of this misclassification, until it can be reduced. One solution is to carry out case-control studies 
of AD on hospital samples, where diagnosis is more likely to be accurate. However, the disadvantage 
of hospital-based studies is that they may be dealing with a biassed sample of AD cases and there­
fore not yield results clearly generalizable to the general population. The factors which lead some 
cases to be referred to specialist clinics produce a presently unknown degree of bias.
REQUIREMENTS FOR THE DIAGNOSIS OF AD IN FIELD SURVEYS
If there is to be an epidemiology of AD in samples of the general population, a major task now 
is to achieve a high level of diagnostic accuracy. The National Institute of Neurological and 
Communicative Disorders and Stroke -  Alzheimer’s Disease and Related Disorders Association 
(NINCDS-ADRDA) criteria (McKhann et al. 1984) are certainly the most developed so far. For 
the diagnosis of probable AD. these require the following: the presence of dementia documented 
by a test such as the Mini-Mental State Examination (Folstein et al. 1975) and confirmed by
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neuropsychological tests; deficits in 2 or more areas of cognition; progressive worsening of memory 
and other cognitive functions; clear consciousness; onset between 40 and 90 years; and the absence 
of systemic or other brain disorders which could account for the above deficits. The diagnosis of 
probable AD is then supported by the additional presence of the following: specific cognitive defects 
such as aphasia, apraxia or agnosia; impairment in activities of daily living or behaviour; a family 
history of dementia; a normal lumbar puncture and EEG; and evidence from serial scans of 
progressive cerebral atrophy. These criteria were designed for use in hospital-based studies and to 
our knowledge no attempt has yet been made to use them under field survey conditions. The 
diagnostic criteria for research in the forthcoming International Classification of Diseases (ICD-10) 
may be more relevant for epidemiological studies.
Whatever diagnostic criteria are adopted in a field survey, persons who are considered possible 
cases of AD will almost certainly need to be invited to a hospital for further investigation. This 
exercise raises four questions: sample attrition in a multi-stage assessment; the cost of screening, 
including special investigations, in a research survey; the ethics of requesting a person with a 
dementia to come to a hospital for further assessment; and the benefits to be gained from the exercise, 
for both the patient and his family and for medical research.
Full clinical assessment assumes, of course, that elderly persons contacted in the course of a field 
survey would be willing to come to a hospital and submit to major tests. Inevitably, there is a refusal 
rate at any stage of a study. In a two-stage or multi-stage study, these refusal rates compound and 
may lead to quite serious biases. For example, in the Baltimore study of the Epidemiologic 
Catchment Area Program, AD was clinically diagnosed using a three-stage approach (Folstein 
et al. 1986). In the first stage, the Mini-Mental State was used to measure cognitive impairment with 
a response rate of 75%. The second stage was a community-based psychiatric examination with a 
response rate of 67%. Finally, a hospital-based dementia examination was carried out with a 78% 
response rate. Although the response rate was reasonably good at each stage, the compounding effect 
is considerable, giving only a 39% response (0 75 x 0-67 x 0-78) over the three stages. This attribution 
occurred despite payment to participants at each stage and the employment of full-time recruiters 
to ensure a high acceptance rate at the second and third stages. Refusal rates might not be such 
an important problem if it were known that refusal is independent of diagnostic status. However, 
imagine the consequences if the demented are more or less likely to refuse than the non-demented, or 
if AD cases are more or less likely to refuse than MID cases. There could be considerable bias in 
prevalence rates for AD and even in the ratio of AD cases to MID cases. Folstein et al. were surprised 
to find that MID was the more common dementia in their study. The role of differential refusal 
rates in producing this result is unfortunately impossible to assess.
The additional costs of making a specific diagnosis are not trivial. In a recent community survey 
of dementia, Kay et al. (1985) found that 14% (39 out of 274 respondents in their weighted sample) 
met DSM-III criteria for dementia of at least mild severity. To move from this to a specific diagnosis 
of AD or other dementia, using the NINCDS/ADRDA criteria, would have required the following 
additional information and estimated expenditure: a medical history from an informant, taking 
approximately 30 minutes, and a neurological examination of the sensory and motor systems 
(AUSS78 or £37); neuropsychological testing taking approximately 45 minutes ($80 or £38): 
transport to and from hospital by taxi ($20 or £10); a CT scan ($91 or £44); and approximately 
$47 or £23 for blood tests, including VDRL. B12 assay and thyroid function. The total involved 
for the 39 individuals would have been over $12000 (£5760), a not inconsiderable additional sum. 
considering the total budget for the study was AUS$29692 (£14252).
The main ethical question is whether it is justifiable to impose investigations, and the resulting 
diagnosis, on a person for whom medical attention may not have been sought, either by that person 
or by relatives. This leads in turn to the third problem, concerning the benefits to be derived from 
the exercise. In many cases there are likely to be definite benefits in having a diagnosis made. The 
individual himself, his family and his general practitioner are each at a disadvantage when dementia 
is present but unrecognized. Reversible causes of cognitive impairment are all well worth diagnosing 
However, a field survey will turn up many milder cases who show only slow progression The
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longitudinal study of dementia by Brull el al. (1979) found such cases to be quite common. Where 
progression is slow there may be disadvantages to the person concerned in having the diagnosis of 
dementia made.
Is case-finding of AD in general population samples likely to advance knowledge about aetiology? 
The prevalence or, if possible, the incidence of AD in contrasted general populations could be 
important information: if rates vary, as in coronary heart disease, this would be a pointer to 
environmental factors, including exposure to toxins, chemical substances in the diet or water supply, 
or to infectious agents. Cohort studies, particularly if cross-national in design, could throw light 
on factors related to regional differences in both the incidence and course of such dementias. Such 
studies have already been strongly advocated by a WHO Scientific Group on Senile Dementia 
(WHO, 1986).
CONCLUSIONS AND RECOMMENDATIONS
Epidemiological research on the aetiology of AD is a worthwhile endeavour because it may 
complement, and possibly enrich, biological research in the laboratory through providing leads to 
causal agents. The present evidence is that clinical diagnosis of AD is correct at best 80% of the 
time. If the search for risk factors is to be practicable, investigators must allow for this, or an even 
higher misclassification rate, in calculating the sample size required, whether in field surveys or 
hospital-based case-control studies.
Since the NINCDS/ADRDA diagnostic criteria were not designed with field surveys in mind, 
there is now a need for the development of criteria specifically designed for field research. This is 
a difficult task, because they should carry a high probability of being valid, yet be useable under 
survey conditions. Once such criteria have been prepared, an instrument and assessment procedure 
can be constructed to service them; and this sequence should not be reversed. That is, diagnostic 
criteria should first be established, albeit provisionally; and only then should a standardized 
interview and examination by constructed. This has unfortunately not been the sequence in the 
development for well-known instruments such as the Geriatric Mental State (GMS) Examination 
(Copeland et al. 1976) or the Comprehensive Assessment and Referral Evaluation (CARE) (Gurland 
et al. 1977). Such instruments have had to be forced into servicing various diagnostic criteria. Kay 
et al. (1985) found this process difficult, if not unsatisfactory.
Furthermore, if incidence or prevalence is to be estimated in different geographic sites, the 
instruments based on the criteria should be culturally, socio-economically and educationally 
unbiassed. This is likely to prove extremely demanding. To provide accurate results, a standardized 
assessment would need to have three components: an examination of the elderly person; an 
informant interview; and set of clinical investigations including blood tests and possibly a CT scan. 
The design of such an assessment procedure is certainly possible and may attain the level of 
diagnostic accuracy found in hospital-based studies. Although the cost involved would be 
substantially greater than for an ordinary psychiatric field survey involving only an examination of 
the elderly person, this problem is hardly insurmountable.
That each of these 3 components would involve a certain refusal rate is a much greater concern, 
and, even if the refusal rate were low for each, the cumulative effect could be substantial. The biases 
introduced into the final sample would then be unknown. Here we have a dilemma. As the accuracy 
of diagnosis is improved by adding additional assessment components, the refusal rate and 
consequent bias in the sample becomes greater. We have shown that the degree of diagnostic error 
found in hospital-based studies can have serious consequences, so it would be pointless to advocate 
a diagnostic procedure less comprehensive than these studies have used. The difficulty is even more 
apparent if one holds that a diagnosis of AD cannot be made on cross-sectional data alone, and that 
a repeat examination is necessary some months later. At the present time, there are 16 field surveys 
which have attempted a clinical diagnosis of AD-tvpe dementia. Few would match up to the 
diagnostic procedures of hospital-based studies. Consequently, it is difficult to give great credence 
to their results.
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The priority now is to tackle the methodological problems of diagnosing AD in the field. In this, 
the tasks are: the development of valid diagnostic criteria for field surveys; the translation of these 
into specific instruments; determining the acceptability of these instruments to elderly people living 
in the community; obtaining very high acceptance rates at each stage; and establishing the reliability 
and validity of the resulting diagnoses in contrasted populations. Such work requires international 
co-ordination so that uniform criteria and case-finding instruments can be assured; and so that 
valuable data from several sites can be pooled or contrasted. The World Health Organization is 
well placed to make a unique contribution in this. Only w'hen these developmental tasks are complete 
will we know whether case ascertainment of AD in field surveys is practicable.
A. S. H E N D E R S O N  A N D  A. F. J O R M
Dr David Grayson kindly provided the statistical calculations on which Fig. 1 is based.
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The prevalence of dementia:
A quantitative integration of the literature
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ABSTRACT - Daia from studies of dementia prevalence between 1945 to 1985 were 
analyzed statistically. Prevalence rates were found to vary as a function of meth- 
o o ogical differences between studies. However, despite these differences the 
relationship between prevalence and age was found to be consistent across stud.es 
with rates doubling every 5.1 years. Across studies. Alzheimer's disease (AD) was 
found to be more common in women, with a tendency for multi-infarct dementia 
(MID, to be more common in men. There were also national differences in the 
relative prevalence of AD and MID, with MID being more commmon in Japanese 
and Russian stud.es. no d.fference in Finnish and American studies, and an excess of 
AD in other Western European countries.
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With the ageing of the world’s population, it is 
important to have accurate data on the preva­
lence of dementia. Prevalence studies are par­
ticularly valuable if they can be directly com­
pared to each other, because confirmed findings 
increase our confidence in the accuracy of preva­
lence estimates. Although considerable research 
has been carried out on the topic, the prevalence 
rates derived from various studies differ consid­
erably. Henderson & Kay (I) have argued that 
the variation is so great that it is difficult to 
make any generalizations about the prevalence of 
dementia. They have presented a broad model to 
explain this variation in rates: variation in esti­
mated prevalence may be due to true differences 
in incidence or duration of dementia, but the 
variation may also be due to methodological 
differences, such as different criteria for diag­
nosis and varying thoroughness of case finding. 
They have argued that because these meth­
odological differences are likely to be substan­
tial. there is little chance of detecting any varia­
tion in true prevalence,
Others have been less pessimistic about com­
parisons between different dementia prevalence 
studies. For example, Kay & Bergmann (2) 
regarded the findings of Nielson et al. (3), Kay et 
al. (4) and Kaneko (5) as being so comparable 
that they pooled their data to arrive at more 
accurate age-specific prevalence rates. Preston
(6) has also argued that there is an underlying 
consistency behind many prevalence studies. He 
derived a formula for calculating age-specific 
rates from the prevalence data of Campbell et al.
(7) and found that this formula gave a good fit 
to the data from six other prevalence studies.
The issue of whether methodological features 
are a source of variation in prevalence rates can 
be answered to some extent by a quantitative 
analysis of the published studies. If, for example, 
thoroughness of case finding is a source of varia­
tion in rates, studies which involve more detailed 
information gathering should result in higher 
rates. More generally, it is possible to code the 
methodological features of each study and corre­
late these with reported prevalence rates. This
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approach will of course be limited by the extent 
to which methodological differences can be 
gleaned from the published reports. Some dif­
ferences, such as the degree of severity entailed 
by the adjectives “moderate" or “severe” are 
impossible to assess. Nevertheless, there are 
many methodological differences which are read­
ily amenable to this approach.
If groups of relatively homogenous prevalence 
studies can be found, it is reasonable to pool 
such data to arrive at more accurate estimates. 
This possibility becomes particularly important 
in estimating age-specific prevalence rates. Policy 
planners need prevalence rates specific to fairly 
narrow age ranges (e.g. 65-69, 79-74, etc.) in 
order to estimate total prevalence for a popula­
tion of a different age structure to that originally 
studied. Crude prevalence rates for persons aged 
65 + arc fairly useless in a situation where the 
very old (aged 80 + ) are becoming an in­
creasingly greater percentage of the total aged 
population (8). Accurate estimation of age-spe­
cific rates, however, requires very large samples. 
It is presumably for this reason that such rates 
are seldom reported in prevalence studies. How­
ever, by pooling data over several comparable 
studies, it becomes possible to arrive at much 
better estimates.
A final important issue is the relative impor­
tance of various diseases causing dementia in the 
elderly, particularly Alzheimer's disease (AD) 
and multi-infarct dementia (MID). Neuropath- 
ological studies from Western European samples 
invariably indicate that AD accounts for most 
cases of dementia. However, Henderson (9) has 
pointed out that many of the prevalence studies 
which attempted a differentiation between AD 
and MID on clinical grounds have reported the 
latter lo be more common. The discrepancy 
requires further exploration. On the one hand, 
the discrepancy may simply reflect the difficulty 
of accurate diagnosis of these disorders on clini­
cal grounds (10). However, since many of the 
studies cited by Henderson (9) came from Japan, 
there may be regional differences in the relative 
prevalence of AD and MID.
In this paper, we report some quantitative 
analyses of data derived from published preva­
lence studies relevant to these issues. Specifically,
the analyses were aimed at: (1) assessing whether 
there is variation in prevalence rates due to meth­
odological differences between studies, (2) pool­
ing data from comparable studies to yield more 
reliable estimates of age-specific prevalence rates, 
and (3) analyzing the data on the relative preva­
lence of AD and MID, particularly in regard to 
regional differences.
Method
Locating studies
A MEDLINE search and previous review papers 
were used to locate relevant prevalence studies 
published up to 1985. Studies were excluded 
from further consideration if they were based on 
limited psychiatric case registers, did not involve 
a broad community sample, or were reported 
prior to 1945. A total of 47 prevalence studies 
met these criteria for inclusion and are listed in 
Table 1.
Coding of studies
Coding sheets were drawn up on which the features 
of each study could be recorded. Broadly speaking, 
the features coded related to (a) the design of the 
study (b) the characteristics of the sample, and (c) 
the methods of assessment and diagnosis. The age- 
specific prevalence rales were also recorded in as 
much detail as each study provided. The specific 
features coded were as follows:
Design o f the study. Purpose of the study (inves­
tigation of mental health problems or both physi­
cal and mental health problems); age range stud­
ied (whole adult population or elderly only); 
years when the asessments for prevalence pur­
poses were carried out; country studied; type of 
community studied (city, town, or rural area); 
type of population covered (broad population or 
specific ethnic or cultural group); wealth of the 
community studied compared with the rest of the 
country.
Characteristics o f the sample. Sample size; 
refusal rate; percentage of males in the sample; 
types of residence included (homes in the com-
PREVALENCE OF DEMENTIA 467
Table I
Dementi* prevalence m id i«  1945-1985
A u th o r/t Year Country Other relevant publications
Akesson (11) 1969 Sweden
Ben-Arie ci al. (12) 1983 South A frica
Bcnticn (13) 1970 Norway
Bollerup (14) 1975 Denmark
Bremer (15) 1951 Norway
Broe et al. (16) 1976 Britain
Campbell et al. (7) 1983 New Zealand
Cooper (17) 1984 Germany
Copeland (18) 1981 Britain Gurland et al. (19)
Essen-Möller et al. (20) 1956 Sweden
Gavrilova (21) 1984 U.S.S.R
Gilmore (22) 1974 Britain
Gruenberg (23) 1961 U.S.A New York Slate Department o f 
Mental Hygiene (24)
Gurland et al. (19) 1983 U.S.A .
Hagnell et al. (25) 1981 Sweden
Hasegawa (26) 1979 Japan Hasegawa et al. (27)
Hasegawa et al. (28) 1984 Japan
Jensen (29) 1963 Denmark
Kaneko (Study 1) (5) 1975 Japan
Kaneko (Study 2) (5) 1975 Japan
Karasawa et al. (30) 1982 Japan
Kalo (31) 1969 Japan
Kay et al. (4) 1964 Britain Kay et al (32)
Kay et al. (33) 1984 Australia
Kidson (34) 1967 Australia Kidson & Jones (35)
Kramer et al. (36) 1985 U S A Myers et al (37). 
Folstein et al (38)
Leighton et al. (39) 1963 Canada
Lin (40) 1953 Taiwan
Lin et al. (41) 1969 Taiwan
Magnusson & Helgason (42) 1981 Iceland
Maule et al (43) 1984 Britain
Mölsä et al. (44) 1982 Finland
Myers el al. (St. Louis Study) (38) 1984 U.S.A
Nielsen, B. et al. (45) 1982 Denmark
Nielsen. J. (3) 1962 Denmark
Nilsson & Persson (46) 1984 Sweden
Parsons (47) 1965 Britain
Pasamanick et al. (48) 1957 U.S.A
Pinessi et al. (49) 1984 Italy
Primrose (50) 1962 Britain
Robertson et al. (51) 1984 Canada
Schoenberg et al. (52) 1981 U .S.A .
Sheldon (53) 1948 Britain
Sternberg & Gavrilowa (54) 1978 U.S.S.R. Gavrilova (55)
Sulkava et al. (56) 1985 Finland
Weissman et al. (57) 1985 U.S.A Myers et al (37)
Weyerer (58) 1983 Germany
munity, nursing homes, hospitals); type of sam­
pling (total delimited population, random sample 
based on census lists, electoral roll, or house­
holds); age-sex structure of the sample.
Methods o f  assessment and diagnosis. Type of 
person collecting the information (general practi­
tioner, psychiatrist, neurologist, etc.); type of per­
son making the diagnosis; information sources on
JO*
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Tab ic  2
Dem entia prevalence rate*
Study Age range D e fin ition  o f  dementia 
o f  e lde rly
Severity
code
(a)
Prevalence rates
(b)
Akcsson ( I I ) 65 + Dementia (c) 3 1 3 (d)
B cn -A rie  et al. (12) 65 + Dementia 1 8.6 (3 6)
Broe et al. (16) 65 + Dementia (c) 1 8.3 (3 8) (d)
C am pbe ll et al. (7) 65 + Dementia 2 7.7 (d)
Cooper (17) 65 + Senile and arterio- 3 4 2
sclerotic dementia
C opeland (18) 65 + Pervasive dementia (c) 2 2.3
G ilm o re  (22) 65 + Dementia 1 13.6
G ruenberg (23) 65 + C ertifiab le 2 7.2 (d)
G u rla n d  et al. (19) 65 + Pervasive dementia (c) 2 4.9
Hasegawa (26) 65 + Age-related dementia (c) 1 4.5 (3 0) (d)
Hasegawa et al. (28) 65 + Dementia (c ) 1 4 8 (2 4) (d)
Jensen (29) 65 + Senile dementia 1 8.2 (1 1)
Kaneko (S tudy 1) (5) 65 + Dementia (c) 2 7.2 (d)
Karasawa et al. (30) 65 + Dementia (C ) 1 4 6 (2 7) (e)
K ay et al. (4) 65 + C hron ic bra in syn- (C ) 3 6 4 (d)
- drom e
K ram er et al. (36) 65 + Dementia (C ) 3 6 4 (d)
M ö lsä  et al. (44) 65 + Dementia (c) 2 2.0 (d)
M yers et al. (38) 65 + C ognitive im pairm ent 1 20.3 (4  0)
N ielsen, J. (3) 65 + Senile dementia 1 18.5 (3.1) (d)
Parsons (47) 65 + Serious dem entia, self 3 4 4
care impossible
Pasam anick et al. (48) 65 + Unspecified psychosis 2 2.8
Pinessi et a l. (49) 65 + Prim ary dementias 1 2 0 (d)
P rim rose  (50) 65 + Senile, arte riosclerotic (c) 2 3 6
and mixed dementias
Robertson et al (51) 65 + Dementia 2 7.8
Sheldon (53) 65 + D efin ite  mental 2 3 9 (d)
fa ilu re , demented
S u lkava  et al (56) 65 + Oemenua (Cl 3 6 7 <d|
W eissm an et al (57) 65 + C ognitive im pairm ent 1 5 4 ( 3 4 ) (d)
W eyercr (58) 65 + Senile dementia 2 7.5
Bentsen (13) 60 + Vascular and senile 2 5 3
psychosis
B o lle ru p  (14) 70 Dementias (c) 2 5 0
Brem er (15) 60 + Senile psychosis 3 2.5 (d)
E ssen-M ö lle r et al. (20) 60 + Senile and anerioscle- 1 15.8 (5.0) (d)
ro tic  deterio ra tion
G a v rilo v a  (21) 60 + Senile, vascular, and (C) 2 3.4
mixed dementias
H a gne ll et a l. (25) 60 + Age psychosis 1 5.7 (d)
K a neko  (S tudy  2) (5) 60 + Senile, vascular and ( C ) 2 4.4 (e)
mixed dementias
(a) S everity code: I - M ild  to  severe.
2 -  M odera te  and severe o n ly
3 -  Severe o n ly .
(b ) Rates shown correspond to  severity  code . I f  rates fo r m oderate and severe were available as well as m ild  to severe, these are 
show n in  brackets.
(c) A  b reakdow n in to  S D A T  and M ID  also available
(d ) Some age breakdow n o f  rates is a va ila b le , a llow ing the f it t in g  o f the m odel re la ting  age and prevalence
(e) Some age breakdow n o f  data is a va ila b le , but insu ffic ien t to  a llow  m odel f it t in g
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Tabic 2 (continued) 
Dementia prevalence rata
Study Age range Definition of dementia 
of elderly
Severity
code
(a)
Prevalence rales 
(b)
Kato (31) 60 + Organic psychosis 3 1.2
Kay ct al. (33) 70 + Dementia 1 13 9 (4 8) (d)
Kidson (34) 60 -f Dementia 2 2.8
Leighton cl al. (39) 60 + Senility 3 5 9 (d )
Lin (40) 60 + Senile psychosis 3 0.7 (e)
Lin cl at. (41) 61 + Senile psychosis 3 0.5 (e)
Magnusson A Helgason (42) 74-76 Senile, vascular and 1 10.5 (3.6)
80-82 mixed dementias 1 18.8 (7.8)
M aulc cl al. (43) 62 + Chronic brain 1 8 6 (2.9) (d)
syndrome
Nielsen B. cl al. (45) 70 + Serious dementia. 3 2.6 (e)
self-care impossible
Nilsson A  Pcrsson (46) 70. 75, 79 Dementia 1 4 6. 8.3. 17.3 (e)
Schoenberg et al. (52) 60 + Dementia (c) 3 1.8 (d)
Sternberg A Gavrtlowa (54) 60 + Vascular and senile (c ) 1 6.4 (3.5) (e)
psychosis
which the diagnosis was based (interview with 
subject, informant or physician, medical records); 
whether formal cognitive testing was used; period 
o f observation on which diagnosis was based (sin­
gle interview or period o f observation); whether 
person making diagnosis actually saw the subject; 
diagnostic criteria used (e.g. ICD, D S M -llI, text­
book system); whether multi-infarct dementia and 
Alzheimer’s disease were differentiated; symp­
toms used to differentiate the two types o f demen­
tia; number o f months on which prevalence fig­
ures based (0 is point-prevalence); term used to 
describe the dementia (senile dementia, organic 
brain syndrome, senility, etc.); term used to 
describe severity of dementia (m ild , moderate, 
severe, etc.).
To insure accuracy of coding, each study was 
read and independently coded by two o f the 
authors. Any disagreements were settled by dis­
cussion.
Classification of terminology
After the studies had been coded, it was apparent 
that a range o f terms had been used by authors to 
describe dementia and its severity. To facilitate 
analyses, these terms were classified as either
broad or narrow. Broad terms were those thought 
to consist mainly o f dementia cases, but which 
could also include other neuropsychiatric disor­
ders. These terms were: organic brain syndrome; 
psychosis (unspecified), certifiable, chronic brain 
syndrome, cognitive impairment, organic psycho­
sis and senility. Narrow terms were those which 
were more likely solely to encompass dementia 
sufferers. These were: dementia, senile dementia, 
pervasive dementia, senile psychosis, vascular and 
senile psychosis, age-related dementia, age psy­
chosis, vascular and senile psychosis, age-related 
dementia, age psychosis, senile and arteriosclero­
tic dementias, and primary dementias.
Alternative terms used to describe Alzheimer’s 
disease were: senile dementia o f  the Alzheimer 
type, senile brain syndrome, primary degenera­
tive dementia, and senile dementia. M ulti-in farct 
dementia was variously described as: arterio­
sclerotic dementia, vascular dementia, psychosis 
with cerebral arteriosclerosis, and arteriosclerotic 
psychosis.
Dementia was regarded as severe if  it was 
described as: psychotic, serious, pervasive, cer­
tifiable, or i f  selfcare was impossible. Cases 
were regarded as moderate or mild  when so 
described by the authors. When severity was not 
specified, cases were regarded as moderate-to- 
severe.
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Results
The effect of methodological varia­
bles on reported prevalence rates
In this section we consider those studies which 
present rates for all the elderly aged 65 or more, 
for moderate and severe dementias. There were 
27 such studies (see Table 2).
Among the studies not considered, one did not 
separate the mild from moderate or severe, (22), 
sixteen presented data for other age ranges, 60+ , 
61 + , 62 + , 70 + , and three gave rates for speci­
fic age cohorts (14, 42, 46). These studies have 
not been considered in this section because o f the 
impossibility of disentangling effects due to d if­
ferent age coverage and different methodologies. 
Rales for mild dementia have also not been con­
sidered because of their particularly wide varia­
tion, indicating probable differences in definition 
or cut-off points adopted to distinguish the nor­
mal elderly from the mildly demented (c.f. 59). 
For mild dementia, definitional differences will 
overshadow other methodological variables. 
There were 11 of the 27 studies which presented 
data for mild dementia, and these varied from 
0.5% to 16.3%. This was when we excluded the 
rates o f 52.7°7o reported by Kaneko (5) for per­
sons who were “ borderline, slightly demented or 
doubtfu l”  or those of Parsons (47) who reported 
21.9% as “ slightly forgetful" and 9.6°7o as “ defi­
nitely forgetful".
The relationship between study characteristics 
and prevalence rates lor moderate and severe 
dementia among those aged 65 and over was 
considered by treating each study as a single 
observation with equal weights given to each. 
Correlation coefficients were calculated or anal­
yses o f variance performed as appropriate. These 
analyses showed no evidence o f a change in 
reported rates over time, nor did the variability 
in the range o f rates vary over time. Prevalence 
rates did not vary as a function o f the size o f a 
study, nor did the refusal rate or sex ratio appear 
to affect the reported rates significantly. O f the 
27 studies, 22 presented some data on the age 
structure o f the sample (viz. the percentage of 
the sample 65-74, and over 75). Unexpectedly, 
there was no tendency for those studies with a
higher proportion of the very elderly (75 + ) to 
report higher overall rates. However, the popula­
tions were, in fact, fairly similar in their age 
composition, as defined here. The proportion of 
those aged 75 and over, among all those 65 and 
over, varied from 21 °7o to 43%, with a mean of 
34.7%.
It is notable that studies which included 
institutionalised elderly did not report higher 
rates than those covering community residents 
only. Although a high proportion o f the institu­
tionalised elderly are normally reported as being 
demented, they represent only a small proportion 
of the total elderly population and thus (heir 
inclusion will not necessarily affect the reported 
rates greatly. For example, in Mannheim, 
Cooper (17) found that 31% of the institu­
tionalised elderly were demented compared with 
3.2% of community residents. As the institu­
tionalised represented only 3.3% of all elderly, 
however, the overall rate for dementia among all 
those over 65 was 4.2%.
Only three methodological features produced 
statistically significant differences at the P < 
0.05 level. The three studies involving purely 
rural communities had significantly lower rates 
than others. These were Nielsen et al. (3), Äkes- 
son (11) and Jensen (29). Äkesson included 
severe cases only, with moderate and mild cases 
being combined in his prevalence rates. Even 
allowing for this, a real urban-rural difference in 
Scandinavia may well exist
The second feature producing a significant d if­
ference was the type of sampling. There were six 
studies which involved the assessment o f total 
populations in which all individuals within the 
community were studied. These showed rates sig­
nificantly lower than the studies which covered 
only a random sample o f a population. Possible 
explanations for this difference are that the three 
purely rural studies were included in the total 
population studies or that the more restricted 
coverage of a sample allows a more thorough 
assessment o f each case
Thirdly, those studies which reported rates for 
mild dementia showed significantly lower rates 
on the moderate and severe dementias than those 
studies reporting moderate and severe dementias 
only. This may be due to the use of different cut
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o ff points for deciding when a case is mild or 
moderate. Where no category for “ m ild" exists, 
there could be a reluctance to exclude cases 
which arc somewhat borderline between “ m ild" 
and “ moderate".
No other methodological features produced 
differences in prevalence rates which approached 
statistical significance. For example, regional d if­
ferences were not apparent. However, there were 
few studies in each world region and these varied 
considerably among themselves.
Eighteen of the 27 studies gave separate rates 
for males and females. The difference between 
male and female rates was not significant. This 
was unexpected, since most populations have an 
excess o f women among the very elderly, in 
whom case rates are higher.
Estimation of age-specific 
rates for dementia
This section presents a statistical model for the 
integration of the results from those studies 
which provide age specific data on both preva­
lence rates and population composition. This 
model enables the estimation o f prevalence rates 
for different ages and allows a more detailed 
examination o f the extent to which differences in 
overall reported rates are due to the different age 
structures o f the samples.
The model proposed is an exponential one of 
the form :
P, = exp (K + S, + AX)
= exp (K + S,) . exp (AX)
where P, = prevalence o f dementia for ind ivid­
uals aged X years, from study i.
K = constant term, independent o f 
study and o f age.
S, = variable term, specific to study i but 
independent o f age.
A = coefficient relating prevalence to 
age, the same for all studies.
X = age in years. Data were typically 
available for specified age intervals 
o f varying widths (5, 10 or more 
years). In fitting the model an esti­
mate of the median age was taken 
as the value for X.
The model was found to give a satisfactory fit to 
the data from the 22 studies which had su ffi­
ciently detailed data for analysis (see Table 2). 
The values o f the terms A and K were estimated
as:
A = 0.137 (S.E. = 0.004)
and K = -13.50 (S.E. = 0.309)
The values o f S, were found to differ signifi­
cantly from each other.
We also tested a model which allowed the 
coefficient A to vary with study (i.e. to see 
whether dementia rales increased with age in a 
different manner from one study to another). 
Differences between the studies were not signifi­
cant, and we therefore accepted the above model 
where A was constant for all populations.
This means that, even though populations d if ­
fer significantly in the overall level of dementia, 
the manner in which these rates change with age 
is the same. Dementia prevalence will double 
with every 5.1 years o f age in the populations 
studied. The 95% confidence limits for this 
period are 4.79 to 5.37 years.
Table 3 shows the 5-year prevalence rates for 
dementia which would occur in a “ baseline" 
population, i.e. a population whose prevalence 
rates are estimated by the equation:
P = exp (-13.50 + 0.137 X)
In this equation the value of S, has been sei to 0, 
so that P is the geometric mean of rales across all 
studies. It may be thought of as an average curve 
derived from all studies. For this equation we 
have assumed that, except for older age groups, 
death rates would be constant within a 5-year 
interval. Thus the median age for the ages 60-64 
is 62.5, etc. For the age interval 85-89, the medi­
an is 87.0 and for 90-95, the median is taken as 
91.5. We have not presented any estimates for 
higher ages. The data available for these upper 
ages are somewhat scanty and so estimates are 
very unstable. There has also been some evidence 
to suggest a levelling o ff of dementia incidence 
rates for the very elderly (60).
Fig. 1 shows the estimated prevalence rates for 
the same “ baseline" population aged 60 and
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Tabic 3
Estimated prevalence rales for dementia by 5 year age intervals 
for baseline population
Age-group Median age Estimated prevalence 
(°7o)
60-64 62.5 0.7
65-69 67.5 1 .4
70-74 72.5 2.8
75-79 77.5 5 6
80-84 82.0 10.5
85-89 87.0 20.8
90-95 91.5 38.6
above. Shown as well are ihe estimated and 
observed prevalence rates for the studies by 
Campbell et al. (7) and Hasegawa et al. (28), 
where it can be seen that the fit was very close.
The observed and estimated prevalence rates 
were compared for each age group of-each study 
using Z-statistics (where Z = (O-E)/nP(  1 -P)\ O 
= observed no. o f demented; E = expected no. 
o f demented; n = sample size and P is the 
predicted rate). Only two Z-statistics were signifi­
cant at the P <  0.05 level. Out o f the 80 com­
parisons made, we could expect about four to be 
significant under the model proposed. The over­
all fit o f the model is therefore very close.
The model may be written:
P, = exp (S,) . exp (K + AX)
That is, exp (S,), is the study variable relating the 
prevalence at age X in study i to the baseline
60 6b *0 7b 60 6b »0 9*
Fig. 1. Estimated and observed prevalence rates by age, 
for baseline population and selected studies
Table 4
Values of coefficients S, for each study. Values of S, are 
derived from the model: Prevalence rate « exp (S,) * exp (K 4 
A X ) where K and A are constants independent of study and X 
is age in years
Study s . (S.E ) exp (S,)
Äkesson ( I I ) -0.991 (0.1 54)* •  • 0 .3 7
Bremer (15) 0.411 (0.499) 1.51
Broc et al. (16) -0.078 (0.171) 0.92
Campbell et al. (7) 0.094 (0.102) 1.10
Essen-Möller ei al. (20]1 0.448 (0.193)* 1.57
Gruenbcrg (23) 0.347 (0.097)* • • 1.41
Hagncll et al. (25) 0.557 (0 .175)** 1.75
Hasegawa (26) 0 133 (0.074) 1.14
Hasegawa el al. (28) -0.640 (0 .1 61 )*** 0.53
Kaneko (5) 0 325 (0.145)* 1.38
Kay et al. (4) 0.417 (0.135)** 1.52
Kay et al. (33) -0.594 (0.254)* 0.55
Kramer et al. (36) 0.230 (0.123) 1.26
Leighton et al. (39) 0.747 (0 229 )*** 2.11
Maule el al. (43) 1.006 (0 .1 42 )*** 2.73
Mölsa et al. (44) -0.742 (0.062)* * * 0.48
Nielsen (3) -0.277 (0.165) 0.76
Pincssi et al. (49) -0.627 (0.119)* * * 0.53
Schoenberg et al (52) -0.685 (0.113)* * * 0.50
Sheldon (53) -0.150 (0.230) 0.86
Sulkava et al. (56) 0.492 1.63
Weissman et al. (57) -0  422 (0 107)-* * 0.66
* Significant at the 5*7« level. 
* *  Significant at the I **• level. 
* *  Significant at ihe 0 1*?« level.
population rate at age X, presented in Table 3 and 
Fig. 1. Table 4 presents the values of the variables 
S, and exp (S,), for each o f the studies included in 
the analysis. The study variable exp (S.) 
varies from 0.37 to 2.73. This range is almost as 
great as that for the overall reported rates for ages 
65 + , which ranged from 1.1 to 7.7°7o.
Use of the statistical model to 
investigate methodological variables
We have established that dementia prevalence 
increases with age according to an exponential 
model, with rates doubling approximately every 
5 years. This model provided a good fit to data 
from 22 diverse studies. These differed signifi­
cantly, however, in their ratet for any given age. 
Thus the large differences in reported prevalence 
rates cannot be explained by differing age com­
positions of the populations studied.
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Tabic 5
D ifferences between prevalence rates fo r fixed age by m ethodo log ica l variables (M ). Values o f  M  are derived from  the m odel: 
Prevalence ra le » exp (M )*  exp (K + A X ), where K is a constant and A  a constant re la ting  prevalence to  age X
Study characteristics M (S E ) exp (M ) n o f studies
Purpose o f  study
M ental health problems -0 40 (0 04) 0 67 19
M enta l and physical health problems 0 40 (0 04) 1.49 3
Age range studied
A ll adults 0 121 (0.027) 113 9
E lderly  on ly -0 121 (0.027) 0.89 12
C o un try  studied
Scandinavia -0.285 (0.044) 0.75 7
B rita in 0.517 (0.073) 1.68 4
Australasia 0.138 <0 082) 115 2
N o rth  Am erica 0 020 (0.052) 1.02 5
Japan 0.157 - 1 17 3
C entra l Europe -0  547 (0101 ) 0 58 1
Type o f  com m u n ity
Urban on ly -0.089 <0 04 ) 0.91 14
Rural on ly -0.079 <0 06 ) 0 92 4
M ixed 0 168 - 118 4
Residence
C o m m u n ity  residents only 0.180 (0.025) 1.120 10
N ursing homes included
hospitals and nursing homes included -0.180 <0 025) 0 84 1 I
Type o f sample
T o ta l de lim ited  population -0 393 (0.025) 0.67 8
Random  sample 0.393 (0.025) 1 48 13
Person m aking assessment
GP 0 037 <0 164) 1 04 2
Psychiatrist 0.394 (0.077) 1.48 5
Neuro logist -0.589 (0 066) 0.55 3
O ther 0 158 - 1 17 12
Person m aking diagnosis
GP -0 002 (0 175) 1 00 2
Psychiatrist 0 309 (0.069) 1.36 7
N euro logist -0.407 (0.057) 0 62 5
A lg o r ith m -0 104 (0 077) 0 90 3
O ther 0.204 - 1.23 5
O b jec tive  cogn itive  testing used
Ves 0.022 (0.028) 1.02 (n.s.) 9
No -0.022 (0.028) 0.98 12
P eriod o f  observation
Single in terview -0.153 (0.053) 0.86 19
Period 0 153 <0 053) 117 3
D ignostic ian  see patient"’
No 0.298 (0 056) 1.35 3
Yes -0 154 <0 038) 0.86 11
Sometimes -0  142 - 0.87 4
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Tabic 5 (continued)
Study characteristics M (S.E.) exp (M ) n of studies
Diagnostic criterion used
DSM 0 420 (0.054) 1 52 3
ICD - -
Textbook (Roth) -0 427 (0 037) 0 65 8
Others/not specified 0 007 1 01 11
Differentiation of SDAT and M ID
Yes -0.239 (0.026) 0.78 10
No 0.239 (0.026) 1.27 12
Breadth of diagnostic category
Broad 0.244 (0.031) 1.28 5
Narrow -0 244 (0.031) 0.78 17
Severity of dementia
Mild, moderate and severe 0.079 (0 025) 1.08 10
Moderate and severe
Severe only -0.079 (0 025) 0 92 12
To investigate further whether differences in 
overall levels could be explained by methodological 
variables, a series o f models were fitted o f the form:
P = exp (K + M, + AX)
where M, refers to the jth  category o f a particu­
lar methodological variable (e.g. definition o f de­
mentia being broad or narrow). An analysis o f 
methodological variables using this statistical 
model is considerably more powerful than the 
analysis involving crude prevalence rates re­
ported in an earlier section because the variance 
due to age is taken into account. Therefore, the 
influence o f methodological variables on preva­
lence rates should be more readily detected in 
these more sophisticated analyses.
The results o f these analyses are presented in 
Table 5. Virtually all the methodological varia­
bles had a significant effect on the reported 
rates. The only exception to this was whether 
cognitive testing was used in the assessment o f 
dementia. The amount o f variation due to the 
particular methodology is estimated by the factor 
exp (Mj) shown in Table 5. Thus it can be seen, 
for example, that those studies using a broad 
definition of dementia had rates significantly 
higher, by 64%, than those studies using a nar­
row definition, for fixed age.
Differences were not always in the exptected 
direction, and it is likely they are simply reflect­
ing other correlated charateristics o f the studies 
involved. For example, the studies which in­
cluded the institutionalised had rates significantly 
lower than the community surveys which ex­
cluded the institutionalized. Sim ilarly, the rural 
studies were no different from the urban studies, 
although the four mixed urban/rural studies had 
higher rates.
Fifteen of the 22 studies provided separate 
male and female rates to which the model could 
be fitted. There was no significant difference 
between the age-adjusted rates, although there 
were some study-specific differences. Molsä et al. 
(44) found that female rates were significantly 
higher than male, whereas Sheldon (53) found 
male rates significantly higher than female.
These comparisons have been based on 22 
widely differing studies, not all o f which gave 
very detailed age-specific data. Thus the d if­
ferences reported must be regarded only as an 
indication of the possible magnitude and direc­
tion o f the influence o f methodological variables, 
and show that they are important.
Comparison of rates for senile 
dementia of the Alzheimer’s type 
and multi-infarct dementia
Among the present series o f 47 studies, there 
were 18 which presented some separation o f rates 
into those for AD and M ID  (see Table 2).
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The detail in breakdown by age, severity and 
sex varied greatly but was considerably less than 
that provided for all dementias combined. There 
were only seven studies with sufficient age-speci­
fic data to allow the fitting of the exponential 
model:
P„ = exp (K + S„ + A,X)
where subscript i refers to the ith study, and j 
refers to the type of dementia, such that j = 0 
for AD and j = 1 for MID. Other variables are 
as previously defined.
This model assumes that rates for dementias 
increase with age (X) but that the rate of increase 
may be different for each dementia. Similarly, it 
allows for differences between the studies de­
pending on the type of dementia.
Questions of interest are: do rates increase 
with age in the same manner for AD and MID? 
(i.e., is A^  = A,); is the relative importance of 
AD versus MID as a cause of dementia the same 
in all studies? (i.e., does = S, + C, when C is 
a constant value for all studies); are there dif­
ferences between the sexes, both in the way rates 
increase with age and in the relative importance 
of AD and MID?
A series of models looking at these questions 
were fitted to the data from three Scandinavian 
studies (11, 44, 56), one US study (37), two 
Japanese studies (5, 28) and one UK study (16).
The model was found to be satisfactory for 
AD cases alone, but not for MID. The poor fit 
for MID was found to be due to the very high 
MID rate (26%) among the 85+ age group in 
the Kramer et al. study. However, this value had 
a high standard error of 23%. This MID rate 
was based on the results of a three-stage exam­
ination and selection procedure. The above 
model did not take into account the multi-stage 
sampling method and thus greatly under-estimat­
ed the S.E. of this estimate. When the US study 
was not included, the general model gave a satis­
factory fit. Prevalence rates of MID doubled 
every 5.3 years (95% confidence limits: 4.6—6.3), 
while rates of SDAT doubled every 4.5 years 
(95% limits: 4.0-5.0). The relative importance of 
MID and AD rates differed significantly from 
one study to the other. The two Finnish studies
»Tabic 6
Relative prevalence of AD and MID. Values of R arc derived 
from the model: Prevalence rate *= exp (K + RY), where K is 
a constant, and R is a region specific constant reflecting the 
relative prevalence of AD and MID in each region, and Y = I 
for AD and Y = -1 for MID
Region n of studies R Multiplicative
factor for.
AD MID
exp (R) exp (-R)
Japan 4 -0 364 *•* 0.69 1.44
Russia 2 -0 149 “ 0.86 1.16
Scandinavia 3 0.160 *•* 1.17 0.85
Britain 4 0.360 *•* 1 43 0 70
USA 3 0 647 ns 1 05 0 95
** Significant at 0.01 level
**• Significant at 0 001 level
(44, 56) showed no significant difference between 
the age adjusted rates for AD and MID; the 
studies of Broe et al. (16) and Akesson (11) 
showed rates of AD significantly higher than 
MID (in the ratio of about 1.5 to 0.65) while the 
two Japanese studies (5, 28) show rates of AD as 
being significantly lower than those of MID (in 
the ratio 0.58 to 1.7 and 0.67 to 1.5, respec­
tively).
These results were further confirmed by a con­
sideration of the 18 studies providing overall 
rates for AD and MID. Two of these could not 
be included. Karasawa et al. (30) gave rates of 
AD as 0.6%, MID as 1.7% and mixed as 2.3%, 
but provided no population data; and Bollerup, 
who found AD in 1.3% and MID in 1.9% of his 
cases, only included people aged 70 years. In the 
16 remaining studies the relative importance of 
the two causes of dementia varied significantly 
from one region to the other, with the Japanese 
and Russian studies showing a significant excess 
of MID cases, the Finnish and US studies show­
ing no significant difference and the other studies 
all showing an excess of AD cases over MID 
There were only three studies with sufficient 
detail to allow a consideration of differences due 
to age, sex and type of dementia. These were 
Mölsä et al. (44), Akesson (11) and Kaneko (5). 
For AD, age-adjusted rales for females were 
significantly higher than those for males, where
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Tabic 7
Prevalence of  AD and M ID  by sex. (Rales are simple averages 
of reported rales in perccnl)
Region n o f  
studies
A D M I D
Males Females Males Females
Japan 4 0  S 1 . 5 3 3 2 . 7
Russia i 1 1 3 8 6 1 2 1
Scandinavia 3 1 6 2 2 1 0 1 4
Britain 3 3 0 4  9 4 4 2 . 7
USA 2 0 . 7 2 . 1 3 . 5 0 . 8
the ratio of female to male rates was 1.30 to 0.77 
(exp (± S), where S is estimated as 0.26, with 
S.E. = 0.08). For MID, there was no significant 
sex difference.
This tendency is confirmed by the 13 studies 
reporting overall rates for AD and MID for each 
sex. The rates for AD tended to be higher among 
females than males, whereas the rates for MID 
tended to be higher among males (see Table 7).
Discussion
The major aim of the above analysis was to 
investigate the extent to which data already avail­
able concerning the prevalence of dementia 
among the elderly could be integrated to provide 
the detailed estimates of age-specific prevalence 
rates needed by policy planners and researchers. 
The analysis showed that across a dtverse range 
of 22 different studies, the relationship between 
prevalence and age was remarkably consistent, 
with estimated prevalence rates doubling every 
5.1 years, up to the age of about 95. The 95% 
confidence interval for this doubling period is 
4.8-5.4 years.
However, the actual levels of dementia varied 
greatly from one study to another. It was shewn 
that methodological variables such as definition 
of dementia, the design of the study, the charac­
teristics of the sample and methods of assessment 
and diagnosis all had a significant effect on the 
levels reported but no single variable could satis­
factorily explain the variation. It may be that 
true regional differences do exist, but their mag­
nitude is impossible to assess with existing data, 
because of the many methodological differences 
between studies. Unless different studies can
demonstrate the similarities of their methodol­
ogies, no firm conclusions may be drawn as to 
their relative age-adjusted prevalence rates. Par­
ticular attention needs to be given to questions of 
definition, especially of the cut-off points be- 
iween the normal elderly and the mildly, moder­
ately or severely demented. The studies which 
included no category of “mild" dementia, but 
had only “moderate or severe” , consistently had 
higher overall rates than those studies which pre­
sented separate categories of mild and moderate 
or severe. The problem of ill-defined cut-offs, 
even when using diagnostic criteria such as DSM- 
111, has been discussed at length elsewhere (59, 
61).
The analysis also looked at possible sex dif­
ferences in the prevalence of dementia. There 
were no overall differences after adjusting for 
age, although one study produced a significantly 
higher rate of dementia for women (44) and 
another found a significantly higher rate for men 
(54). When the analysis was limited to AD only, 
however, it was found that women had signifi­
cantly higher rates than men, while they did not 
differ for MID. However, only three studies 
provided age-specific data relevant to this issue.
When the relative importance of the two prin­
cipal causes of the dementia syndrome, AD and 
MID, were considered, there were significant 
regional differences, with the Japanese and Rus­
sian studies reporting higher rates of MID than 
AD, whereas all other studies showed either no 
significant difference or significantly higher rates 
of AD than MID. The only exception was the US 
study of Kramer et al. (36). The relative impor­
tance of each varied considerably, and may be 
explained, in part, by the way mixed cases were 
handled. The Japanese studies of Hasegawa et 
al. (28) and Karasawa et al. (30) and that of 
Kramer et al. (36) all reported rates for mixed 
cases independently of the AD and MID cases, 
whereas most of the other studies made no 
indication of how the mixed cases were handled 
On the other hand, there have been reports of 
particularly high rates of stroke in Japan, consis­
tent with the higher rates for MID (62). There is 
clearly a need for a cross-national studs ol this 
issue using identical methodologies across coun­
tries
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J erhaps (he most important conclusions to 
emerge from the present analysis is that (here is 
no simple answer to the question “ What is the 
prevalence of dementia in a parlicualr communi- 
ly ' answer varies depending on how we
wish to define and measure dementia. Given a 
particular measuring instrument and an algo­
rithm for diagnosis, an answer is possible. This 
conclusion has important implications for future 
prevalence studies. I f  a prevalence study is ear­
ned out in an attempt to discover risk factors by 
comparing the results with those from other 
communities, then it is essential that identical 
methodologies be used in the studies being com­
pared. Otherwise any true differences in preva­
lence will be obscured by methodological d if ­
ferences. On the other hand, i f  the aim o f a 
prevalence study is to estimate the size o f the 
problem for administrative purposes, then the 
definition of dementia should be linked to the 
need for particular services. For example, i f  
nursing home beds are to be assigned for a 
particular level o f impairment, then this level o f 
impairment might form the basis o f the cu to ff 
for defining dementia. However, because the 
prevalence of dementia has been shown to dou­
ble every 5.1 years, irrespective o f methodology, 
ii may not be necesccary to survey all ages in 
detail to arrive at age-specific rates. A good 
estimate of prevalence for a single 5-year age 
range can be used to estimate the prevalences at 
other ages. In choosing a particular age range to 
survey, it is optimal to choose one in which the 
prevalence of dementia is not too low (e.g. 60- 
65) nor the size of th* population too small (e.g 
85-90). A reasonable c 'mpromise might be to 
study people in their 70s in etail and project the 
results to other age ranges.
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A METHOD FOR CALCULATING 
PROJECTED INCREASES IN THE 
NUMBER OF DEMENTIA SUFFERERS
C ? »
A.F. Jonn and A.E. Korten
A new method of projecting increases in the number of dementia cases is 
described. This method is based on a statistical analysis of all published 
prevalence studies which shows that prevalence rate rises exponentially with 
age. The method can be easily applied to any age-specific population projec­
tions. When applied to Australia and New Zealand, the method shows that the 
increase in dementia will greatly exceed the total population growth rate, and 
even surpass the expected rise in the elderly group over the next third of a cen­
tury. The method predicts that the Australian demented population will in­
crease by 136-139% between 1984 and 2021, compared to a general population 
increase of only 42-54%. Over the period 1982 to 2016, the New Zealand de­
mented population will grow by 96-100% against a rise of 18-26% in the general 
population. The validity of this method and its implication for future service 
demands are discussed.
Australian and New Zealand Journal of Psychiatry 1988; 22:183-189
Introduction
It is widely acknowledged that the ageing of the 
population w ill produce a considerable increase in the 
prevalence o f dementia. Estimating the extent o f this 
increase has important implications in planning for fu­
ture service requirements. In the past, estimates have 
been made by taking official population projections 
for the elderly and applying empirically derived 
dementia prevalence rates to these. Varying projec­
tions o f the number of dementia cases may result 
depending on the particular study from which the 
prevalence rates are taken. Thus, the problem o f which
N H &M RC Social Psychiatry Research Unit. The Australian 
National University, (IPO Box 4. Canberra, Australia 2601
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prevalence rates to use has presented a major stum­
bling block to researchers and service planners alike. 
The importance of this problem was high-lighted 
recently by Jorm. Korten & Henderson [ 1 j who iden­
tified 47 separate studies on the prevalence o f demen­
tia published in the period 1945-1985, many yielding 
quite disparate prevalence rates. As a consequence, 
past projections of the rise in dementia cases have 
varied widely, making service planning d ifficu lt.
The magnitude of this problem can be appreciated 
by considering some past projections for Australia and 
New Zealand dementia cases. For example. Hender­
son (21 used prevalence rates derived from a subjec­
tive analysis of five studies to give rough projections 
o f the increase in dementia cases in Australia and Neu 
Zealand. He estimated there were 1 10.000 cases in 
Australia in 1983 and that this would increase to 
210,000 by 2001. Similarly. Henderson and Jorm [3| 
used rates from two particular studies to calculate 
projections for Australia alone. Their approach
•. • ■*> v -/A .
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yielded estimates of 97.800or I 15.000 for 19X6. rising 
to 173.300 or 194,200 for 2006. Preston |4| used rates 
derived from a New Zealand study to estimate that 
Australia had 84.396 cases in 1981. rising to 173.416 
m 2001. The wide variation in these estimates well il­
lustrates the problem produced by arbitrarily selecting 
single or pooled prevalence rates from the literature.
In an attempt to make sense of the many prevalence 
studies. Jorm, Korten &  Henderson (11 carried out a 
meta-analysis of the 47 published empirical investiga­
tions. Of particular interest was their analysis of 22 
studies which provided information on age- specific 
rates and population composition. While the 
prevalence rates differed significantly from study to 
study, they found that rates varied with age in a surpris­
ingly consistent manner. Specifically the meta­
analysis revealed that the prevalence of dementia 
increases exponentially with age.
Jorm. Korten & Henderson [ 1 ] proposed a statistical 
model which gave a good fit to the published data. The 
model is an exponential one of the form:
Pi = exp (Si - 13.50 + 0.137 X) 
where
Pi = prevalence rate of dementia for in­
dividuals aged X years from study 
i;
Si = variable term, specific to study i.
but independent of age; and 
X = age in years
This model says that prevalence rates (P,) rise ex­
ponentially with age (X) in all studies, but the actual 
rates differ from study to study by a multiplicative fac­
tor, exp (S,). The differences in reported rates are like­
ly to be due to the many methodological differences 
between studies, but may also reflect true differences 
m rates. One likely source of variation in rates is the 
definition of dementia adopted in a study. As Jorm & 
Henderson (5| have pointed out, cognitive impairment 
is continuous with normal ageing and different 
prevalence rates will result depending on where along 
this continuum the cut-off is placed for defining a case 
of dementia.
The above model can be simplified by setting the 
"study” variable (Si) to 0:
P = exp (-13.50 + 0.137 X)
We have termed this the "baseline model", which 
may be thought of as the average exponential curve 
derived from all studies. This model is represented 
graphically in Figure I. As well, this Figure shows the
exponential model's account of data from two studies, 
one from New Zealand (6|. and the other from Japan 
171. Although the prevalence rates are much higher in 
the New Zealand than in the Japanese study, both fol­
low the same exponential form.
On the surface, the statistical model would seem to 
provide no solution to the problem of choosing rates 
for carrying out projections, because it offers a variety 
of rates depending on the value of Si. However, the ex­
ponential model has an interesting property which 
makes possible projections of relative increases in 
prevalence. If \xe take data on population composition 
for a base year and calculate the prevalence of demen­
tia using the exponential model, we will arrive at an 
arbitrary prevalence figure which is dependent on the 
value of Si chosen. Howjever. if wedoexactlx the same 
for some future year (say. projections for 10 years 
hence) and then divide the future prevalence by the 
base year prevalence, the percentage increase in 
dementia which is so estimated will be the same 
whatever the xalue of S, chosen (See Note) That is. 
the model always results in the same estimate of per­
centage increase in dementia cases, no matter whether 
the actual numbers estimated are verx large or very 
small. Because the value of S, chosen is of no 
relevance, it is simplest to use the baseline model in 
which this variable is set to 0.
This paper illustrates how the exponential model can 
be used to estimate increases in dementia prevalence 
relative to some base year. This method can readily be 
applied to population projections for any community. 
Its practical value can clearly be demonstrated by ap­
plying it to the populations of Australia and Nexx 
Zealand.
Illustration of the Method
Here the method is illustrated using the estimated 
population composition of Australia for 1984 and the 
projected composition for 1988 (8 ]. The Table shows 
the age-specific population composition for the elder­
ly and the corresponding prevalence rates for demen­
tia derived from the baseline model. These estimated 
prevalence rates were derived bx substituting the 
median age of each age group for X h : Nine
equation (see 11 ]. for method ot calcul ...edian
ages). Prevalences were then calculated ox multiplex­
ing each population estimate bx the appropriate 
prevalence rate. Totalling the age-specific prex alences 
gives a figure of 87.170 cases for 1984 and a projected 
figure of 100.290 for 1988 The percentage increase
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Table M ethod o f  C a lc u la tin g  Dem entia  Prevalence in  A us tra lia  fo r  I9S-I and I9iS’<S’
Year I9P-I
A g e  G r o u p P o p u l a t i o n P r e v a l e n c e E s t i m a t e d
E s t i m a t e R a t e P r e v a l e n c e
( 1 0 0 0 s ) ( % ) ( 1 0 0 0 s )
60-64 684.9 0.72 4.93
65-69 538.6 1 42 7.65
70-74 448.7 2 82 12.65
75-79 297.6 5.60 16.67
80-84 170 8 11.11 18.98
85+ 111.4 23 60 25.29
87.17
Year I9SS
A g e  G r o u p P o p u l a t i o n P r e v a l e n c e P r o j e c t e d
P r o j e c t i o n R a t e P r e v a l e n c e
( 1 0 0 0 s ) * ( % ) ( 1 0 0 0 s )
60-64 715.0 0.72 5 15
65-69 611 9 1 42 8.69
70-74 477.1 2 82 13 45
75-79 351.8 5.60 19 70
80-84 201.1 1111 22.34
85+ 131.2 23.60 30.96 
i00 29
^A ustra lian  Bureau of S tatistics. Series A  &  B
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from 1984 to 1988 is therefore projected to be 
100 x (100290 - 87170)/87 I 70 = 15%. The actual 
f igures of 87.170 and 100.290 are arbitrary. One could 
quite legitimately take other values of Si derived from 
particular studies and arrive at very different f igures. 
However, the percentage increase would always be 
15%. As an example, if the exponential curve derived 
from Hasegawa et ul.'s Japanese study (see Figure 1) 
were used, figures of 45,980 for 1984 and 53,030 for 
1988 would be obtained, but the increase in dementia 
prevalence would remain 15%.
Projections for Australia
The above method can be applied to population 
projections for Australia to yield an estimate of the in­
crease in dementia cases expected in the next century. 
The Australian Bureau of Statistics |8| has published 
population estimates for 1981 and 1984 and projec­
tions up to 2021. Three different projections are avail­
able for the country as a whole. Series A & B. Series 
C and Series D. Series A & B and Series D represent 
minimum and maximum projected populations. As far 
as the elderly are concerned. Series A & B and Series 
D differ only minimally. Figure 2 shows the projected 
increase in dementia cases from the base year of 1984.
It can be seen that the increase in dementia cases is 
expected to exceed greatly the increase in the total 
population and also the increase in the elderly popula­
tion (aged 65+). Between 1984 and 2001. the general 
population will increase by 22-26%. while the de­
mented population (ascalculated from the model) will 
increase by 70-71%. Between 1984 and 2021. the in­
crease will be 42-54% for the general population and 
136-139% for dementia cases. As a percentage of the 
general population, the dementia group w ill increase 
by 36-39% between 1984 and 2001. by 46-53% by the 
year 201 1 and 56-66% by 2021. These figures, derived 
from the model, dramatically illustrate the dispropor­
tionate growth in dementia sufferers over the next third 
of a century.
Not only are dementia sufferers increasing faster 
than the general population, but in future they will 
comprise a greater proportion of the elderly population 
than they do now It is impossible to estimate this 
proportion in absolute terms, but we can express u as 
an increase over the base year of 1984. I sing the 
Series A & B projections, the number of dementia 
cases divided by the number of the elderly will be 20% 
higher in 2001 than in 1984. The greater increase in 
dementia cases is due to the fact that the fastest popula­
tion grow th is expected for the very elderly amongst 
whom dementia prevalence is highest. In 201 I. this 
proportion will be 21% greater than in 1984. but b\ 
2021 the increase over 1984 will reduce to 9% as the 
post-war baby boom swells the numbers of the 
younger elderly.
Projections for New Zealand
The Department of Statistics |9] offers 14 different 
projections for the New' Zealand population from the 
base year of 1982. Six of these projections. B( 1) tc 
B(3) and C( 1) to C(3), are considered to represent the 
most likely alternatives. Of these six, B( 1) and C(3 
are the maximum and minimum projections and have 
therefore been used here to estimate the increase ir 
dementia cases. Figure 3 shows the projected increase; 
in the total population, the elderly population (aget 
65+). and number of dementia cases from the base vea 
of 1982. As w ith Australia, the percentage increase u 
dementia cases is projected to be much greater than tin 
increase in the total population, and also greater that 
the increase in the elderly population. Between 198! 
and 2001. the general population will increase by 15 
19%, while the demented population is estimated t< 
increase by 66-68%. Between 1982 and 2016. the in 
crease w ill be 18-26% for the general population am 
96-100% for dementia cases. As a percentage of th 
general population, the dementia group will increas 
by 41-44% between 1982 and 2001, and by 59-65f 
by the year 2016. As with Australia, there is expecte 
to be disproportionate growth in dementia sufferer 
over coming decades
Discussion
The projections provided here are a useful guide t 
future serx ice requirements for dementia sufferers. A 
increase in dementia prevalence can be taken to impl 
a corresponding increase in total service requiremen 
for dementia sufferers. However, this should not t 
taken to imply that demand for each type of serx k 
w'ill increase by the same amount. Over a long periO' 
the pattern of serx ice provision will change. For e 
ample, there has been a policy shift in Australia toxx ai 
encouraging community care for elderly people 
place of residential care, partly in response to the bu 
geoning cost of residential care 110]. If a success) 
pharmacological treatment for Alzheimer's disea 
were to emerge, this too xvould change the pattern 
service provision considerably. Although tf 
provision of particular services may rise or tall.
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depending on advances in knowledge and economic 
considerations, the demand for dementia services of 
some sort w ill rise along with the increase in 
prevalence. An implication of this rise in demand is 
that knowledge o f dementia w ill merit greater atten­
tion in the training o f health and welfare professionals. 
Furthermore, as the ratio of dementia cases to middle- 
aged care-givers increases, more families w ill have an 
aged relative with dementia. For this reason, the 
problems of care- givers will warrant increased atten­
tion by health and welfare service providers.
With all methods o f projection, there is some room 
for uncertainty. Inaccuracies in projecting the number 
of dementia cases could arise in three ways. Firstly, 
the general population projections on which the 
method relies could prove to be inaccurate. These 
projections are based on particular assumptions about 
fertility, mortality and migration. However, in the case 
o f the elderly, carrying out projections is far less haz­
ardous than in the case of the young, because the elder­
ly o f coming decades have already been bom and can 
be counted. A second source of inaccuracy would 
occur if  the incidence of dementia were to change over 
coming decades. The only study to investigate chan­
ges in incidence is the Lundby study carried out in 
Sweden and it found no significant change from 1947- 
57 to 1957-72 [ 11). A third source of inaccuracy is a 
change in survival o f dementia sufferers. It is now 
generally recognized that dementia sufferers have a 
lower life expectancy than others [12]. A number of 
studies of hospitalized dementia sufferers in Britain in­
dicate that survival is increasing [13.14], How'ever. 
there is only one study of changes in survival using a 
general population sample (again, the Lundby study) 
and this did not find a significant improvement in sur­
vival [ 15], If an improvement in survival o f dementia 
sufferers were to occur in future years, its exact effects 
on the number o f cases is d ifficult to predict.
The exponential rise in dementia prevalence rate 
with age implies that the number o f dementia cases 
w ill rise rapidly where a population is ageing. It has 
been show'll that in Australia and New Zealand the ex­
pected increase in dementia cases w ill greatly exceed 
the increase in the total population and even the in­
crease in the elderly population. The method applied 
here to the Australian and New Zealand can be easily 
applied to any other population. A ll that is required is 
a set o f age-specific population projections. The 
method provides a convenient solution to the problem 
o f choosing particular prevalence rates from the
plethora available in the literature.
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Note
Assume the population data is given by (N,k) where 
Njk is the population for the kth age group in year j. It 
Xk is the median age for the kth age group, then the 
number o f dementia cases for year j w ill be:
exp(Sj)k.IN|k.exp(- 13.50 + 0.137 Xk) 
k
If  the ratio o f prevalences for two different values of 
j are taken, the constant term exp(Si) w ill cancel out to 
g ive a figure  ind ica ting  changes in dementia 
prevalence due to changes in population composition 
only.
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Projected increases in the number of dementia 
cases for 29 developed countries: application 
of a new method for making projections
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ABSTRACT - A method is described for making projections o f increases in 
dementia cases over a given base year. The method is based on a statistical model 
relating dementia prevalence to age that is derived from the results o f all published 
prevalence studies. This method was applied to United Nations population projec­
tions for 29 developed countries to arrive at expected increases in number of 
dementia cases in each country for the period 1980 to 2025.
Received January 25, 1988; accepted fo r  publication A p ril 23, 1988
There is a general worldwide trend towards an 
aging population, particularly in the developed 
countries. This demographic shift is due both to 
increased lifespan and to falling birth rates, mak­
ing the elderly a progressively larger proportion 
o f the total population (1). An implication of 
this change is that any chronic disorders that are 
particularly prominent in the elderly w ill increase 
in prevalence. Undoubtedly, the most important 
o f the psychiatric disorders, in terms o f health 
and welfare costs, is dementia.
Estimating possible changes in the prevalence of 
dementia is of practical use in planning the future 
demand for services. Estimates o f the increase in 
number o f dementia cases have been made in a 
number o f countries. The general method used to 
make projections for dementia cases is to take some 
age-specific prevalence rates and apply these to 
published population projections. For example, 
Kramer (2) took prevalence rates from the Lundbv 
study (3) and applied these to United States popula­
tion projections from 1980-2005 to arrive at an 
estimate o f the increase in number o f dementia 
cases. Similarly, Rocca & Amaducci (4) took the 
prevalence rates o f Broe et al. (5) and applied these
to United Nations population projections for a 
number o f countries from 1980 to 2000. The prob­
lem with this method is that results may vary consid­
erably depending on the particular prevalence rates 
chosen. The definition o f dementia and method of 
investigation vary greatly from one prevalence study 
toanother, producingapparent differencesin rates. 
One way around the problem is to synthesize the 
data from several studies. Ineichen (6) has used this 
approach in Great Britain, but his method o f syn­
thesizing rates from various studies involved a rou­
gh impressionistic approach that is not satisfactory.
An alternative approach to integrating preva­
lence data across studies has been used by Jorm 
et al. (7), who carried out a quantitative synthesis 
o f all published age-specific prevalence data. 
They found that these could be fitted by a statis­
tical model o f the form:
P, = exp (S, 13.50 -  0.137X)
where P, = prevalence rate o f dementia for indi­
viduals aged X years from study /;
S; = variable term, specific to study i. but inde­
pendent o f age; and 
X = age in years.
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Put into words, this model says that prevalence 
rate (P,) increases exponentially with age (X) in 
all studies. However, the actual prevalence rates 
differ from study to study. This variation in rates 
between studies is described by the multiplicative 
(actor exp (S, ) that is unique to each study. Put 
another way, although prevalence rates differ 
considerably across studies, the way they increase 
with age always takes the same exponential form.
On the surface, this statistical integration of 
data from prevalence studies would seem to 
provide no solution to the somewhat arbitrary 
results obtained when projections are based on 
prevalence rates from a particular study. The 
statistical model seems merely to state formally 
the problem, i.e. that rates differ considerably 
from study to study and no “ true” prevalence 
rales can be given. However Jorm & Korten (8) 
have pointed out an interesting implication of 
this type o f exponential model. Although the 
actual prevalence o f dementia w ill vary depend­
ing on the value o f the “ study” variable (exp (S,)) 
chosen, the percentage increase over a particular 
base year is invariant over values of exp (S,). To 
give a specific example, i f  we estimate the preva­
lence o f dementia for 1980 and also for 1990, 
using particular age-specific prevalence rates 
based on an arbitrary value o f exp (S,), the actual 
prevalences w ill be arbitrary. However, the ratio 
o f 1990 prevalence to 1980 prevalence will be the 
same, whatever the value o f exp (S,) chosen, 
because the value o f exp (S,) appears on both the 
top and bottom o f the ratio and its effect is 
cancelled out. Because the rate o f increase over a 
given base year is invariant over values o f the 
“ study” variable, we can simplify matters by 
setting it to 0, so that:
P, = exp (-13.50 + 0.137X)
This simplified model, which is based on results 
from all published prevalence studies, can then 
be used to make non-arbitrary projections of 
increases in dementia cases relative to some base 
year.
Jorm & Korten (8) have recently shown how this 
approach can be applied using population projec­
tions for Australia and New Zealand. In the pres­
ent paper, we have applied the method to popula­
tion projections from the United Nations (9). This 
publication gives population estimates for 1980 
and projections up to 2025 for all the countries of 
the world. We have taken the figures for the 29 
developed countries that had populations o f 3 m il­
lion or more in 1980and carried out projections for 
increases in number o f dementia cases.
Material and methods
The United Nations publication gives population 
estimates for 1980 and projections at five-year 
intervals up to 2025. Three series o f projections 
are given: the high, medium and low variants. 
Here, we used only the medium variant. For 
most countries, the three variants are identical 
for the elderly population and, for those coun­
tries where the variants are different, the d iffe r­
ences are relatively small. The specific age group­
ings used from the projections were: 60-64, 65- 
69, 70-74, 75-79, and ^  80 years. The following 
dementia prevalence rates were used for these 
respective age groups: 0.7%, 1.4°7o, 2.8%, 5.6% 
and 11.9%. A ll dementia projections were 
expressed as a percentage increase in prevalence 
rates over the rate for the base year o f 1980. For 
purposes of comparison, the projected total pop­
ulation and elderly population (aged ^  60) were 
also expressed as percentage increases over their 
respective values for 1980.
Results
Projections for the 29 developed countries with 
populations of three million or more are given in 
Figs. 1-29 (the tables on which the figures are 
based are available from the authors).
It is apparent that the projections for increases 
in both dementia and population vary consider­
ably from one country to another, but a number 
o f different patterns can be discerned. In all 
countries there is an overall increase projected 
for the number o f elderly persons, and for the 
prevalence of dementia, between 1980 and 2025. 
Both the demented and elderly w ill have a greater 
increase than the total population. The total pop­
ulation will have remained relatively stable or 
even decreased in some countries (e g. Sweden. 
Switzerland) while some will have increased b\
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30% or more (e.g. Australia, Canada, New Zea­
land, Romania, United States, USSR).
The increase in dementia prevalence, compared 
with population increases, also shows no single 
consistent pattern. At one extreme are the trends 
projected for Ireland, where total population 
increase will be greater than that o f the dementia 
cases until about 2020, when there is a crossover. 
A similar pattern occurs in the German Demo­
cratic Republic, where the number of dementia 
sufferers is projected to decrease until just after
1995. By the year 2025, however, the prevalence of 
dementia w ill have increased 38% relative to the 
1980 value, compared with a total population 
increase o f only 5%. Ireland and the German 
Democratic Republic are the only countries where, 
for some period, the elderly population increases 
less rapidly than the total population.
At the other extreme is the pattern projected 
for Japan. By the year 2025, the total population 
is projected to have increased by 13%, the num­
ber of elderly by 128% and the number o f 
dementia sufferers by 215% over the values for 
1980. That is, although the proportion o f the 
total population aged 60 and above w ill have 
doubled, the proportion o f the total population 
suffering dementia w ill have almost tripled over 
the same period. Among the elderly, the propor­
tion suffering dementia w ill have increased by 
38%. The trend is steady over the period and 
illustrates the dramatic increases in service 
demands that Japan can expect in the future.
Other countries that show the dementia preva­
lence increasing more rapidly than the elderly 
population are Australia. Bulgaria. Canada. Fin­
land. Greece, Italy, New Zealand. Portugal,
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Spain and Sweden. Others show very similar 
increases in both the elderly and dementia preva­
lence, implying that dementia prevalence among 
the elderly will remain fairly constant at 1980 
rates: Austria, Belgium, Bulgaria (until 1995) 
Czechoslovakia, Federal Republic of Germany, 
Greece (until 2000), Hungary, Italy (until 2000), 
Netherlands, Switzerland. Yet other countries 
show crossovers, with the increases in dementia 
cases at some periods being greater and at others 
being less than the increases in the elderly: Ire­
land, Poland, Romania, United States, USSR 
and Yugoslavia. Exceptions to the general trend 
that dementia prevalence increases more rapidly 
than the elderly population are France and the 
German Democratic Republic. In these countries 
the growth in the elderly is faster than the growth 
o f dementia. This pattern emerges when the 
younger elderly are increasing at a faster rate 
than the very elderly.
Discussion
The projections given here examine the influence 
o f one variable on dementia prevalence: the 
changes in the age composition o f a population. 
The number o f dementia cases in a population 
largely reflects the proportion of the population 
that is very elderly. The detailed age distribution 
o f the elderly in a population can be estimated 
with some confidence because the elderly o f the 
years 1985-2025 have already been born and can 
be counted. The only assumptions that need to 
be made concern patterns o f mortality.
The projections assume that the incidence rate 
and duration o f survival o f dementia cases do 
not change over the projection period. I f  either 
o f these were to change, the age-specific preva­
lence rates would change in unknown directions 
and affect the projections. Whether future 
changes in incidence rates and survival will occur 
is unknown, but some research has been carried 
out to see whether these have changed in the 
past. In the only population-based study o f the 
issue, the Lundby study, it was reported that 
both incidence rate and survival did not change 
significantly from the period 1947-1957 to 1957- 
1972 (10, 11).
The patterns obtained for the projections con­
trasted greatly, reflecting the historical and eco­
nomic events unique to each country that deter­
mine the changing age distribution o f the elderly. 
This also illustrates the need for care in making 
projections and the problems that could ensue if 
the projected increases from one country were 
blindly applied to those o f another. Knowledge 
o f the expected increase in the elderly is not 
sufficient to project changes in the number of 
dementia sufferers, which will depend crucially 
on the age composition o f the elderly.
Because the projections given here are ex­
pressed as a percentage increase over 1980, they 
can be used for estimating future resource 
requirements. If dementia cases are expected to 
increase by then we would expect a similar 
increase in demand for health and welfare ser­
vices, although changing social conditions could 
modify service demand significantly. For exam­
ple, where family living conditions are changing, 
adult children may become less inclined to live 
with or care for their elderly relatives, infirm  or 
otherwise, with a consequent increase in service 
need. Even assuming constant social conditions, 
however, all services will not need to increase the 
same amount. With greater knowledge about 
dementia, the demand for new services w ill arise 
and that for some existing services w ill decline. 
However, the need for services o f some sort will 
increase in parallel with the growth in cases.
References
1 Siegel .1 S. Hoover S 1 Demographic aspects of ihe health 
o f the elderly to the year 2000 and beyond World Health 
Stat 0  1982:35:133-202
2 Kramer M. The continuing challenge: the rising prevalence 
of mental disorders, associated chronic diseases and disab 
ling conditions. Am J Soc Psychiatry ’iv83:J:13-24.
3 Hagnell O. Ojesjo L A prospective study concerning 
mental disorders of a total population investigated in 194". 
1957 and I972 The Lundby Study 111 (preliminar\ report) 
Acta Psychiatr Scand l97 5:Suppl 26.3:1-11
4. Rocca W, Amaducci L Proieziom demografiche per la 
popolazione anziana trail 1980 ed il 2(KX): possibili con 
ceguenze per la precalenza delia demenza senile In: A lii 
dell ’85 Congresso della societa’ Italiana di Medicina Inter 
na, Vol. I Roma Luigi Pozzi. 1984:"3-"6
5. Broe Ci A, Akhtar A I. Andrews G R. Caird F i. Gilmore 
A J I, McLennan VV I Neurological di-orders in the el­
derly at home l Neurol Neurosurg P- .hiatrs 1976:5y 
262-366
500 A F JORM ET AL
6 Ineichcn B. Measuring ihe rising lide: How many dementia 
cases will there be by 2001? Br J Psychiatry 1987 :/50 :193-200.
7. Jorm A F, Korten A E. Henderson A S. The prevalence 
of dementia: a quantitative integration o f the literature. 
Acta Psychiatr Scand 1987:76:465-479.
8 Jorm A F, Korten A E. A method for calculating pro­
jected increases in the number of dementia sufferers. Aust 
NZ J Psychiatry 1988:22:183-189
9 United Nations Department of International Economic 
and Social Affairs. Global estimates and projections of 
population by sex and age: the 1984 assessment New 
York: United Nations, 1987.
10 Rorsman B, Hagnell O, Lanke J. Prevalence of age psy­
chosis and mortality among aged psychotics in the Lundbv 
Study. Changes over time during a 25-year observation 
period Neuropsychobiology 1985:/J: 167-172.
1 I Rorsman B, Hagnell O, Lanke J. Prevalence and incidence 
of senile and multi-infarct dementia in the Lundby study: a 
comparison between the time periods 1947-1957 and 1957- 
1972 Neuropsychobiology 19S6:15:122-129
Address
.4 /-. Jorm, Ph D 
Senior Research Fellow
NH & MRC Social Psychiatry Research Unit
The Australian National University
GPO Box 4
Canberra ACT 2617
Australia
Acta Psychiatr Scand 1989:79:179-185
Key words: dementia: Alzheimer s disease: epidemiology 
death certificate. Australia
Regional differences in mortality from dementia in 
Australia: an analysis of death certificate data
A.F. Jorm. A S. Henderson. PA Jacomb
NH&MRC Social Psychiatry Research Unit, Australian 
National University. Canberra. Australia
ABSTRACT — Australian death certificate data were analysed to determine whether they 
can provide useful information on regional differences in the prevalence of dementia. Strong 
differences between the Australian states were found in the prevalence of dementing dis­
orders at death. However, evidence indicated that death certification practices influenced the 
prevalence rates found: a) the reported prevalence of various dementing disorders at death 
has changed greatly over quite a short period; b) the prevalence of dementing disorders at 
death was more strongly influenced by place o f death than by place of birth; and c) the d if­
ferences between states were a result o f very high rates in particular regions which, in onö 
case, could be traced to the death certification practices of a single medical practitioner. It is 
concluded that death certificate data are not useful for investigating regional differences in 
the prevalence of dementia.
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The possibility of regional differences in the preval­
ence of dementia is of great epidemiological inter­
est because of the clues it would provide to aetiol­
ogy. While prevalence and incidence studies have 
been carried out in many parts of the world, the 
rates found in these studies are not directly compar­
able because of substantial differences in methodol­
ogy (1). What is needed are studies using a standard 
methodology at different sites, but such studies are 
rare. A  study of this sort is the U S /U K  Cross-na­
tional Project in which dementia prevalence was 
found to be higher in New York than London (2). 
Another source of information on regional differ­
ences is provided by comparisons of the relative 
prevalence of the two main dementing diseases: 
Alzheimer’s disease and vascular dementia. Where­
as Alzheimer’s disease is the more common de­
menting disease in Western Europe and North Am ­
erica, vascular dementia appears to predominate in 
Japan and the USSR (1). It thus appears that con­
siderable regional differences in dementia preval­
ence may exist.
Because studies of dementia prevalence are so
expensive and time-consuming, regional compari­
sons are all too rare. Some researchers have at­
tempted to circumvent the expense and difficulties 
of conventional prevalence studies by using mortal­
ity data derived from death certificates. Mortality 
data are readily available in developed countries 
and provide a potentially economical way of inves­
tigating regional differences within a country. This 
approach has been used in Norway by Vogt (3) and 
by Flaten (4). They found considerable variation in 
dementia mortality within Norway and correlated 
this with the aluminium content of the water supply. 
Similarly, in Great Britain. Edwardson et al. (5) 
have commented on the considerable regional d if­
ferences in that country and have speculated that 
the mineral content of soil or water could be a caus­
ative factor. However. Martvn & Pippard (6) have 
questioned the use of death certificate data for in­
vestigating regional differences. They found that 
only a minority of people diagnosed during life as 
demented had the diagnosis recorded on their death 
certificates. Martvn & Pippard (6) also reported 
that many deaths certified as caused by dementia
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come from residents of long-stay institutions. They 
argued that the presence of such institutions in cer­
tain regions raises the reported mortality from de­
mentia in those regions. We were conscious that a 
similar situation has already been found with regard 
to suicide rates within one country. Barraclough & 
Hughes (7) describe how the apparent difference in 
rates between Scotland and England can be ex­
plained by a different procedure for classifying 
unnatural or sudden deaths, and how an individual 
coroner can adopt a pattern that greatly alters the 
suicide rate reported for one district.
To evaluate the usefulness of death certificate 
data, we carried out an analysis of differences be­
tween states in Australia over the period 1979 to 
1985. Our aim was to discover whether differences 
exist and, if so, whether these could be explained in 
terms of differences in certification practices.
Material and methods
The Australian Bureau of Statistics holds national 
records of underlying causes of death as coded from 
death certificates. During the period 1979-1985, 
cause of death was coded according to ICD-9. 
Deaths recorded as caused by dementia (1CD 290), 
senility (ICD 797) and Alzheimer’s disease (ICD 
331.0) were analysed. Senile degeneration of the 
brain (ICD 312.2) was also examined, but was so 
rarely recorded that it was ignored in the present 
analyses. It is the policy of the Australian Bureau of 
Statistics not to release data where particular indi­
viduals might be identifiable. Therefore, cells con­
taining small frequencies had to be collapsed for 
some cross-tabulations. To calculate death rates, 
population data from the 1981 Australian census 
were used. This is the census closest to the middle 
of the period under examination.
Results
Following the procedure of Aubert et al. (8), deaths 
from a particular cause were expressed in terms of 
prevalence at death per 100,000 deaths as well as 
prevalence at death per 100,000 population. Fig. 1. 
shows deaths from dementia, senility and Alzhei­
mer’s disease broken down by age and sex. A ll 
causes rise steeply with age and tend to be more 
commonly reported for females than males. Senility
shows a particularly steep rise with age and appears 
to be a cause of death largely limited to the very el­
derly.
Fig. 2. shows the prevalence at death of these 
causes over the period 1979-1985. Whereas the 
prevalences of dementia and Alzheimer’s disease 
have risen steadily, the prevalence of senility has 
shown the opposite trend. The rise in Alzheimer's 
disease is particularly striking, being almost tenfold 
over the period. By contrast, dementia increased 
around twofold over the period, and the prevalence 
of senility halved. Given that dementia and senility 
showed much less change over the period, they 
were focused on for potential regional differences. 
Any regional differences in Alzheimer’s disease 
could easily be attributed to differential rates of 
change in diagnostic practice.
Prevalence at death from dementia and senility 
was examined for the 6 Australian states: New 
South Wales. Victoria, Queensland, South Austral­
ia, Western Australia and Tasmania. The Australian 
territories were excluded because of their small 
populations. Fig. 3. shows the data on state differ­
ences in dementia and senility. The states are very 
similar except for the much higher prevalence at 
death of dementia in Tasmania and of senility in 
South Australia. Because of the potential epidemio­
logical importance of these higher rates, the reasons 
for them were explored further.
The higher rate of dementia in Tasmania and of 
senility in South Australia could reflect real d iffer­
ences in prevalence or they could result from differ­
ences in diagnostic practice. To distinguish these 
possibilities, deaths from dementia and senility 
were examined as a function of place of birth and 
place of death. If differences in diagnostic practice 
were involved, then the place of death should be the 
sole determinant of the higher rates. The relevant 
rates are shown in Tables 1 and 2. Prevalence at 
death is more a function of place of death than 
place of birth. However, people who were born 
elsewhere but died in Tasmania did not have as high 
a rate of dementia as people who both were born 
and died in that state. Table 2 shows that a similar 
pattern occurred with senility in South Australia. 
That is, although place of death is the major de­
terminant, place of birth also seems to have some 
influence on the rate. Although such data are ex­
plainable in terms of diagnostic practice, other ex-
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planations arc possible. For example, a toxic expo­
sure could produce higher rates, with place of death 
being a better index of length of exposure than 
place of birth. This sort of effect would occur if 
people tended to migrate to the place of the toxic 
exposure in their youth rather than in later life.
Tabic I
Prevalence of dementia at death per 100.000 deaths according to 
place of birth and place of death (based on all dementia deaths in 
Australia, 197V-1985)
Place of birth Place of death
Tasmania Rest of Australia
Tasmania 1481 703
Rest of Australia 1084 572
Table 2
Prevalence of senility at death per 100,000 deaths according to 
place of birth and place of death (based on all senility deaths in 
Australia. 1979-1985)
Place of birth Place of death
South Australia Rest of Australia
South Australia 431 164
Rest of Australia 291 84
To further determine whether diagnostic practice 
is responsible, analysis of regions within Tasmania 
and South Australia was carried out. Table 3 gives 
the prevalence of dementia at death for the 4 re­
gions of Tasmania. The rates are very different ac­
ross the 4 regions, but the Northern Region has a 
particularly high rate. If the Northern Region is ex­
cluded, the prevalence at death declines from 1473 
to 1015 per 100,000 deaths. An analysis of deaths 
caused by dementia in the Northern Region was 
carried out and it was found that 43% of them em­
anated from a single medical practitioner associated 
with a particular institution. It thus appears that the 
diagnostic practices of a single practitioner can 
have a considerable effect on rates for a whole re­
gion, which in this case had a population around 
115.000. A similar analysis was carried out of re­
gional differences in deaths from senility within 
South Australia. Table 4 gives the prevalence at 
death for the 7 regions' of this state. The Northern 
Region stands out as particularly high and the 
South East Region as particularly low. If the Nor­
thern Region is excluded, the prevalence at death of 
senility declines from 366 to 286 per 100.000. The
Table 3
Mortality from dementia in regions of Tasmania
Region Prevalence at death Prevalence at death
per 100.000 deaths per 100.000 population
Hobart 1238 10
Southern 388 3
Northern 2588 22
Mersey-Lyell 785 6
Total 1473 12
Total excluding Northern 1015 8
Table 4
Mortality from senility in regions of 
South Australia
Region Prevalence at death Prevalence at death
per 100.000 deaths per 100.000 population
Adelaide 279 “>
Eyre 294 2
Murraylands 303 2
Northern 1697 10
Outer Adelaide 487 4
South East 36 0
Yorke & Lower North 340 4
Total 366 3
Total excluding Northern 286 :
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effects of this one region on the total state figures 
are therefore substantial. We were unable to ascer­
tain whether particular practitioners were respon­
sible for the high rate in this region because of the 
unwillingness of the state authorities to release 
information that might identify particular individu­
als.
Discussion
Our analysis of Australian death certificate data on 
dementia and senility has shown major regional 
differences with a high rate of dementia in Tasma­
nia and of senility in South Australia. However, 
these differences seem to be an artefact of diagnos­
tic practice. A  cross-tabulation of cause of death by 
place of birth and place of death revealed that place 
of death is the more important influence on wheth­
er these diseases are recorded as a cause of death. 
The high rates in Tasmania and South Australia 
were also largely confined to particular regions 
within these states. In the case of Tasmania, the 
very high rate of dementia at death in the Northern 
Region proved to be greatly influenced by the 
death certification practices of one particular medi­
cal practitioner. We were unfortunately unable to 
carry out a similar analysis for South Australia.
The rapid change in the prevalence of these 
causes of death over 7 years gives cause to question 
the usefulness of death certificate data. While de­
mentia and Alzheimer’s disease became more pre­
valent causes of death, senility declined. Similar 
changes have been reported in Canada (9), the Un­
ited States (8) and Great Britain (6). It is unlikely 
that the true prevalence of these diseases has in­
creased so rapidly over only 7 years, so a change in 
diagnostic fashion must be considered a likely ex­
planation. There can be no doubt that there has 
been increasing public and professional awareness 
of Alzheimer’s disease and dementia generally in 
Australia over recent years, and this could easily ex­
plain the trend.
The present results support the conclusion of 
Martyn &  Pippard (6) that death certificate data are 
inadequate for examining regional differences and 
suggest caution in accepting the use of such data by 
Flaten (4), Vogt (3) and Edwardson et al. (5). 
However, as far as the studies in Norway are con­
cerned, it must be emphasized that Norway codes 
the contributing causes of death as well as an un­
derlying cause. In this respect, it differs from Aus­
tralia and most other countries. It may be that 
diagnostic practices have less influence where mul­
tiple diseases arc coded for each death. Neverthe­
less, those who use death certificate data to study 
regional differences have the onus of demonstrating 
its validity.
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M onozygotic tw ins d iscordant for 
A lzheim er’s disease
H. Creasey, MBBS, FRACP; A. Jorm, PhD; W. Longley, MSc, MA; G.A. Broe, MBBS, BA, FRACP;
and A.S. Henderson, MD, FRACP
Article a b s t ra c t— We identified 3 pairs of monozygotic twins discordant for probable Alzheimer's disease from a twin register 
and found no systematic differences in potential risk factor exposures between affected and unaffected twins. Such cases predict a 
role for environmental factors in the etiology or clinical onset of Alzheimer’s disease.
NEUROLOGY 1989;39:1474-1476
Recent DNA and family history studies of Alzheimer’s 
disease (AD) have suggested a major etiologic role for 
genetic factors in this disorder. However, the literature 
contains reports on 33 pairs of monozygotic (MZ) 
twins, 17 discordant and 16 concordant for definite or 
probable AD1 11 (table). The regular occurrence of dis­
cordant MZ pairs suggests that environmental factors 
are also etiologically important. To explore further pos­
sible environmental-genetic interactions in AD, we as­
sessed MZ twins discordant for AD for differences in 
potential risk factor exposure by informant interviews, 
and compared these with previous reports.
Methods. MZ twins discordant for probable AD were sought 
through the National Health & Medical Research Council 
Australian Twin Registry. The registry contains more than 
16.000 twin pairs, of which 640 twin pairs were aged 60 or older 
at commencement of the study. Of these, 287 were MZ and 393 
dizygotic (DZ). All registry MZ twin pairs aged 60 and over in 
which both twins were still alive (n = 153) were sent a letter 
with a return mail questionnaire to be completed by each twin 
and an independent informant regarding presence or absence 
of symptoms suggestive of dementia (such as memory loss and 
difficulty managing one’s affairs). If only 1 twin of a pair
replied, the other was followed up by telephone. Additionally, 
the Victorian Alzheimer’s Disease and Related Disorders So­
ciety newsletter advertised for MZ twins discordant for AD.
Twins possibly discordant for AD, identified from the 
questionnaires, were followed up with a home visit by a neu­
rologist only, or a neurologist and a neuropsychologist. 
Spouses of ail twins were interviewed by a trained, medically 
naive interviewer regarding potential risk factors. Twins pos­
sibly concordant for AD were not studied since the purpose of 
the study was to seek possible factors for discordancy.
Diagnoses of AD were according to DSM-III criteria. Ab­
sence of AD was established by informant history and mini­
mental state scores (MMS) 12 and was supplemented by neuro­
psychological assessment in 2 cases. Monozygosity was con­
firmed by physical likeness and history of physical likeness 
over lifetime by unaffected twin and spouses, and was sup­
ported by review of photographs and, in 2 sets, by identical 
loop fingerprint patterns within the twin pair.
Results. Two pairs of MZ twins discordant for AD 
were identified from 103 who provided written replies 
(giving a 67% response rate to the questionnaire). A 3rd 
set was identified from the newsletter. Set 1 were men 
aged 85 years, with onset in the affected firstborn at age
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Table.  MZ twins with definite* or probablet  AD
C o n c o r d a n t
A g e  ( y r s l L a t e n c y  o f  o n s e t
F i r s t F i r s t e a r l i e s t ( y r s )  f o r  2 n d -
a u t h o r S e x a f f e c t e d a f f e c t e d a f f e c t e d  t w i n
S h a r m a n  * M 1 st b o r n * * ♦ : u 0
C«x»k4 F 1 st b o r n *  *§ 6 8 15
K i lp a t r i c k  4* F T o g e t h e r * *  + 5 0 0
E m b r v * F U n k n o w n « * 6 8 6
Nee** F 1 st b o r n * 6 8 o
F 1 st b o r n *  - 6 0 i
M 2 n d  b o r n  ♦ 4 5 5
F 2 n d  b o r n 7 2 7
F 2 n d  b o r n  ■»■ 6 3 10
F T o g e t h e r  + 7 0 0
M T o g e t h e r  *■ 5 7 0
F  i t c h  1° F 2 n d  b o r n  + 7 9 1
M U n k n o w n
• la r v ik  1 1 I s e t s ,  u n s p e c i f i e d
M e a n  z  S E 6 1 .2  i  8 .2 3 .9  :  1 5
D i s c o r d a n t
A g e  o n s e t F o l l o w - u p
F i r s t A f f e c t e d (yrs) ( y r s )
a u t h o r S e x t w i n a f f e c t e d  t w i n n o r m a l  t w i n
D a v i d s o n  l F 2 n d  b o r n *  - 5 0 2 3
H u n t e r - F U n k n o w n § * 4 9 17
R e n v o iz e " F 2 n d  b o m *  — 4 9 2 0
L u x e n b e r g * M 1 st  b o r n  - 5 2 7
N e e « M 1 s t  b o r n  +■ 6 1 7
F 1 s t  b o r n  + 8 0 6
F 1 s t  b o r n 5 6 S
M 1 s t  b o r n  - 5 8 12
F 1 s t  b o r n  - 7 0 8
M 2 n d  b o r n  — 5 4 10
F 2 n d  b o r n  — 7 3 11
M 2 n d  b o r n  - 5 2 7
M 2 n d  b o r n  - 6 2 10
F 2 n d  b o r n  - 4 9 11
•J a r v ik  11 3  s e t s ,  u n s p e c i f i e d
C u r r e n t  r e p o r t M 1st b o r n  - 7 ft *
M 1 s t  b o r n  - 6 0 14
F 2 n d  b o r n  - 5 8 9
M e a n  r  S E 6 0  0  :  7 .9 1 1 0  ;  1 .2
* Definite AD “  autopsv proven. "  * definite for both tw ins
♦ Probable AD * clinical diagnosis only 
§ Data not available
+• Positive family history 
~ Negative familv history
78. MMS scores were 3 in the affected and 25 in the 
unaffected twin. Set 2 were men aged 74, with onset in 
the affected firstborn twin at age 60. MMS scores were 5 
in the affected and 28 in the unaffected twin. Set 3 were 
women aged 67 years, with onset in the affected sec- 
ondborn twin at age 58. MMS scores were 16 in the 
affected and 29 in the unaffected twin.
There were no consistent differences in potential risk 
factors across the pairs. Factors found in the affected 
twin only included less education, better school perfor­
mance, blood donation, bladder calculi, deafness, pneu­
monia, diphtheria, anal fistula, cholecystectomy, infan­
tile gastroenteritis, sedative use, and higher fish content 
in the diet. Factors found in the unaffected twin only 
included artesian ground water use, snoring, farm expo­
sure, pulmonary emboli, bronchitis, hay fever, scarlet 
fever, atrial fibrillation, bowel cancer, and shingles. 
Common to both affected and unaffected twins were 
similar employment, inguinal hernias, tonsillectomies, 
prostatectomies, skin cancers, smoking, cataracts,
shoulder calcification, hysterectomies, diverticulitis, 
and living in the tropics.
Discussion. We have described 3 MZ twin pairs dis­
cordant for probable AD. Their existence suggests a role 
for environmental factors in the etiology or clinical 
onset of AD.
Kallmann et al13 were the 1st to suggest that AD was 
not always concordant in MZ twins. They studied 29 
twin pairs, in whom 1 twin was deceased and had suf­
fered from a psychosis, and found that 4 pairs were 
discordant and 7 pairs concordant for psychosis. In 108 
twin pairs over age 59 years with the index twin showing 
“senile psychosis,” a diagnosis that probably included 
senile dementia of the AD type, the corrected expec­
tancy rate for MZ cotwins having this disorder was 
42.8%. Subsequent reports (table) include case reports, 
or voluntary surveys such as ours, 1 of which included a 
longitudinal follow-up of part of Kallmann’s sample.“ 
Pathologic confirmation exists for 3 sets of concordant 
pairs,3 5 half of 2 sets of concordant3 and 3 sets of 
discordant pairs (affected twin only).'-2 " There has been 
no autopsy study of an unaffected twin to show absence 
of AD changes. Monozygosity has been determined by 
physical identity in 20 pairs, with blood testing in 11. 
There are no reports of blood testing altering the sug­
gested zygosity in AD. Use of physical appearance alone 
has an accuracy of 95 to 98%.14
Environmental factors mentioned as different be­
tween affected and unaffected twins in other studies 
include childhood typhoid, influenza, whooping cough, 
acne rosacea, femoral bruit, hypertension, more educa­
tion, poorer school performance, and head injury in the 
affected twin; and overseas travel, dermatitis, cardiac 
murmur and arrhythmia, lung cancer, smoking, alcohol 
use, operations, pneumonia, and central retinal vein 
occlusion in the unaffected twin. This scatter is similar 
to that found in our 3 twin pairs and does not appear to 
highlight any 1 group of risk factors.
The presence or absence of a family history varied 
among the concordant and discordant twins. While, 
from information available, 8/10 concordant pairs had a 
parent or nontwin sibling with dementia and 2/10 did 
not, only 4/16 discordant twins had a history of a parent 
or nontwin sibling with a dementia, while 12/16 did not.
Familial AD would appear to involve several genes. 
Perhaps each of these genes contains variations that are 
susceptible to different environmental effects. Another 
possibility is that AD, whether clinically or patholog­
ically defined, is not a single disorder, and that the 
disease in concordant twins is different from that in 
discordant twins.
Within the concordant MZ twins, differences in 
onset between the twin pairs ranged from 0 to 15 years, 
with a mean of 4 years. Follow-up of unaffected twins in 
the MZ discordant pairs from onset in the affected twin 
has ranged from 6 to 23 years, with an average of 11 
years.
Cook et al4 have argued that such unaffected twins 
may be only discordant for onset rather than the dis­
ease. Absence of any autopsy material on unaffected 
twins does not allow this to be refuted. The finding in at
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least 2 reported “discordant” sets,'2-8 and 1 of our cases, 
of some deficits on neuropsychological assessment in 
the unaffected twin suggests a possible subclinical de­
mentia may have been present. However, at least 1 
reported set,7 as well as our other cases, showed no 
evidence of neuropsychological abnormality at the time 
of testing. Certainty of discordancy can only be ad­
dressed by longitudinal observation of the unaffected 
twin and autopsy examination of their brains.
Even if one accepts discordancy as being only for 
onset of clinical symptoms in these probable AD cases, 
the chronological disparity in onset in the concordant 
cases and prolonged periods of follow-up of the un­
affected cases is not typical of dominantly inherited, 
fully penetrant neurologic disorders of adult onset, such 
as Huntington’s disease (HD). This disorder, which has 
variable age of onset even within the same family, shows 
close onset in MZ twins (0 to 6 years, average less than 1 
year in 13 sets studied), with no reports of discordancy 
in MZ twins.15 However, the latency of onset in HD is 
one-half that in AD, and the onset variability in AD 
may have purely stochastic origins. We conclude that 
environmental factors may play a major role in the 
onset of the clinical syndrome of AD, if not in the 
etiology of the disease.
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SUMMARY
In a community sample of 274 persons aged 70+ years in 1982-83, measures of depression, dementia and social 
integration made at that time were examined in relation to mortality in the following five years. The probability 
of death was increased in those diagnosed as having a dementia or a depressive disorder. The association between 
depression and mortality suggests that there may in such cases be a physical illness accompanied by a drop in 
mood. Alternatively, the symptoms of depression could also be symptoms of serious medical illness. Other symptoms, 
typical only of depression, did not predict mortality. There was no association between mortality and social inte­
gration, a finding which is contrary to previous observations.
k e y  w o r d s — Dementia, depression, social integration, mortality.
Kay et al. (1985, 1987) and Grayson et al. (1987) 
have reported a study of the prevalence of dementia 
and depression among the elderly living in the 
Hobart community. Henderson et al. (1986a,b) 
subsequently reported on social interaction and 
support in the same sample. The present study 
reports a five-year follow-up of mortality on this 
cohort, testing the hypothesis that it would be pre­
dicted by dementia, depression or poor social inte­
gration.
Previous researchers have reported that each of 
these is a predictor of mortality. The evidence is 
strongest for dementia. It has been consistently 
shown that cases of dementia identified in preva­
lence studies have reduced survival (Äkesson. 1969; 
Bergmann, 1977; Jagger and Clarke, 1988; Mag- 
nusson and Helgason, 1981; Maule et al., 1984; 
Mölsä et al., 1984; Nielsen and Biorn-Henriksen, 
1981; Rorsman et al., 1985).
There is less consistent evidence on the relation­
ship of depression to mortality in general popula­
tion samples. Kay and Bergmann (1966) found that 
functional cases (mainly anxiety and depression) 
identified in a community survey had higher mor­
tality. However, this relationship appeared to be 
mediated by concurrent physical illness in the func-
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tional cases. A more recent follow-up of a com­
munity sample by Bickel (1987) found that func­
tional psychiatric disorder predicted mortality even 
when physical illness was controlled. A similar find­
ing was reported by Murphy et al. (1988) with a 
clinical sample of depressed patients. However, 
other community studies have found no associa­
tion. Persson (1981) found that neurosis was not 
associated with excess mortality, although there 
were associations of mortality with single neurotic 
symptoms which were attributed to concurrent 
physical diseases. Similarly, Nielsen and Biorn- 
Henriksen (1981) found no relationship between 
non-organic psychiatric disorder and mortality in 
their study of the elderly; and Blazer (1982) found 
no association of depressive symptoms with mor­
tality. The absence of any clear consistency in these 
findings is likely to be attributable to the use of 
different criteria for depression, and to variation 
in the levels of physical morbidity in the samples.
Concerning social integration, there is now 
mounting evidence that it is a predictor of mor­
tality, even when baseline health status is taken 
into account (Berkman and Syme, 1979; Welin et 
al., 1985). According to a review of large prospec­
tive studies by House et al. (1988), males with low
Received 24 October 198V
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social integration have a relative risk of mortality 
ranging from 1.08 to 4.00 compared to males with 
high social integration. For females the association 
is weaker, with relative risks ranging from 1.07 to 
2.81. Social integration has been found to be asso­
ciated with mortality in the elderly (Blazer, 1982; 
Seeman et al., 1987) as well as in younger age 
groups.
METHOD
The sample
This has been previously described by Kay et 
al. (1985). Briefly, samples of persons aged 70-79 
years and 80+ years were drawn from the Hobart 
electoral roll. Interviews were obtained with 158 
and 116 persons in these respective age groups, 
representing 80.2% and 67.8% of the target samples. 
The proportion of males in the interview samples 
was 43 and 28% respectively.
Measurement o f psychiatric stale
Psychiatric state was assessed using the Canberra 
version of the Geriatric Mental State (GMS) exam­
ination (Henderson et al., 1983) in conjunction with 
the Mini-Mental State Examination (MMSE) (Fol- 
stein et al., 1975). As described by Kay et al. (1985), 
these instruments provided measures of dementia 
and depression.
For dementia, an algorithm was constructed to 
yield a DSM-III diagnosis, which was graded as 
mild, moderate or severe. Only the moderate and 
severe categories were used here, because of the 
problems associated with diagnosing mild dementia 
(Henderson and Huppert, 1984). The GMS also 
allowed the diagnosis o f ‘pervasive dementia’ using 
an algorithm similar to that described by Gurland 
et al. (1983). In addition to these diagnostic cat­
egories, cognitive ability was measured on a con­
tinuous scale from 0 to 30 by the MMSE.
Depression was also measured in several ways. 
An algorithm was constructed for the diagnosis of 
DSM-III major depression. A modified algorithm 
for DSM-III dysthymic disorder was also devised, 
but because it did not include information on the 
chronicity of symptoms, it was termed 'dysphoric 
mood’. All cases satisfying the algorithm for major 
depression were also found to satisfy the dysphoric 
mood algorithm. The algorithm for pervasive 
depression, described by Gurland et al. (1983), pro­
vided a third diagnostic index. For a continuous 
measure of depressive symptoms, Gurland et al.'s 
(1983) Rational Scale of Depression was used in 
the present analyses.
Measurement o f social integration
Social integration was measured by the Interview 
Schedule for Social Interaction (ISSI) as described 
by Henderson et al. (1981). This interview takes 
an average of 45 minutes to administer. The ISSI 
is a purpose-built instrument for the assessment 
of an individual’s social engagement and social 
resources. It is administered by interview, accord­
ing to guide notes set out by its authors. The four 
main scales are; the availability of a close, confiding 
relationship (eight items); the self-reported ade­
quacy of this (12 items); the availability of more 
diffuse social interaction, as with friends and neigh­
bours (16 items); and the self-reported adequacy 
of this (17 items). The text and scoring of the items 
are set out in Henderson et a l.{1981, pp. 203-230).
Measurement o f function in daily living
The ADL scale consisted of seven items enquir­
ing whether the subject needed help in specific 
areas. These were: going to shops, cooking, dress­
ing. heavy chores, grooming, bathing, and using 
the toilet.
Measurement o f physical health
This was obtained by self-rating in response to 
the question ‘How is your physical condition 
(health)?'. A score of 0 was given for ‘no problem’,
1 for ‘has at least some aches and pains or physical 
dysfunctions’ and 2 for ‘has numerous aches and 
pains or physical dysfunctions’.
Sociodemographic factors
Age, sex and education were also examined as 
predictors of mortality. Education was measured 
by the highest level completed on an eight-point 
scale ranging from ‘no schooling’ to ‘completed ter­
tiary college or university'.
Assessment o f mortality
Subjects w'ere originally interviewed between 
September 1982 and June 1983. Mortality was 
assessed as of 30 June 1988. giving a follow-up
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Tabic 1. Means (and standard deviations) of those who survived, those who died and those of unknown status 
on sociodemographic characteristics, physical health, psychiatric state and social support
Variable Survived 
(max. N = 134)t
Died
(max. N = 94)t
Unknown status 
(max. N = 46)t
Sociodemographic characteristics
Age* 77.43 (5.05) 81 12(5.98) 78.76(5.10)
Education 3.83 (1.28) 3.51 (1.19) 3.43 (1 35)
Physical health
Activities of daily living* 0.59(1.10) 1.82(1.90) 0.87(1.18)
Self-rating* 1.04 (0.59) 1.31 (0.59) 1.07 (0.57)
Psychiatric state
Mini-Mental State* 26.44(2.76) 24.33(4.88) 25.65 (3.08)
Rational Depression Scale 4.95(2.79) 5.56(3.75) 5.72(3.06)
Social support
Availability of social integration 8.23 (3.43) 7.18(3.70) 8.02(3.62)
Adequacy of social integration 14.35 (2.47) 14.18(2.80) 14.48(2.52)
Availability of attachment 5.64(1.96) 5.56(1.94) 5.48 (1.88)
Adequacy of attachment 8.55 (3.03) 8.68(3.14) 8.46(3.43)
* Significant difference between those who survived and those who died, < 0.01. 
t On some comparisons the Ns are slightly smaller due to missing data.
period of at least five years (but less than six years) 
for each subject. To ascertain which subjects had 
died, a search was made of death records for the 
state of Tasmania over the period. All subjects not 
identified as having died were followed up by mail 
or telephone to ascertain that they were in fact 
alive. By this procedure, 94 of the original sample 
were ascertained to be dead and 134 as still living. 
The status of 46 subjects could not be determined. 
They had either changed address and could not 
be traced or had died outside Tasmania. The pres­
ent study compared the 94 known to have died 
with the 134 known to be still alive. On some com­
parisons, the sample sizes were slightly smaller due 
to missing data in the original interview. Females 
comprised 62% of this sample.
RESULTS
Table 1 shows the mean difference on continuous 
measures of sociodemographic characteristics, 
physical health, psychiatric state and social inte­
gration, while Table 2 shows the prevalence of psy­
chiatric disorder in subjects who subsequently died 
compared to those who survived.
Both these tables also give data on the group 
whose status was unknown. On those variables 
showing mortality effects, this group was found to 
be somewhere between the dead and alive groups, 
as would be expected if it consisted of a mixture 
of dead and alive subjects. However, because this
group is of little theoretical interest, no further ana­
lyses on it are reported below.
Table 2. Prevalence (%) of psychiatric disorders in those 
who survived and those who died
Disorder Survived 
(N  = 134)
Died 
(TV = 94)
Unknown 
status 
(A = 46)
Dementia
DSM-III dementia* 0.7 11.7 2.2
Pervasive dementia* 3.7 18.1 8.7
Depression
DSM-III major depression 10.4 20.2 17.4
Dysphoric mood*t 23.9 40.4 30.4
Pervasive depression* 9.0 22.3 23.9
* Significant difference between those who survived and those 
who died, p < 0.01. 
t  Includes major depression.
The differences between the alive and dead 
groups on the continuous measures (Table 1) were 
tested using /-tests. Because some of these measures 
had non-normal distributions, Mann-Whitney U 
tests were also carried out and confirmed the results 
of the /-tests in all cases. For dichotomous measures 
(Table 2), differences between these two groups 
were tested using maximum likelihood chi-square 
tests. For all these tests, the more conservative 
p < 0.01 level was chosen to avoid excessive Type 
I errors when multiple comparisons are carried out.
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With sociodemographic factors, the two groups 
differed significantly only on age, with subjects who 
subsequently died being older. Five-year mortality 
was 31% for those aged 70-79 compared to 55% 
for those aged 80+ . There were no differences on 
education or sex. Mortality was 42% in females, 
compared to 40% in males.
As would be expected, those who subsequently 
died had poorer physical health, with higher scores 
on both the ADL and self-rated health measures. 
They were also more likely to be demented and 
to have greater cognitive impairment on the Mini- 
Mental State. Five-year mortality was 92% in 
DSM-III dementia cases compared to 38% in non­
cases, giving a relative risk of 2.42. For pervasive 
dementia, the mortality difference was 77% versus 
37%, giving a somewhat lower relative risk of 2.08. 
It thus appears that the diagnostic criteria applied 
do show differences in the incidence of later mor­
tality.
The relationship between dementia and mor­
tality could have been mediated by age, since older 
people are both more likely to die and to be 
demented. To check this possibility, logistic regres­
sions were carried out in which each of the dementia 
variables was entered as a predictor of mortality 
simultaneously with age. DSM-III dementia, per­
vasive dementia and MMSE score continued to be 
predictors of mortality even with age taken into 
account.
Those who subsequently died were significantly 
more likely to suffer from dysphoric mood and per­
vasive depression. There was a similar trend for 
major depression, but little difference on the con­
tinuous measure of depressive symptoms. For 
DSM-111 major depression, five-year mortality was 
58% in cases compared to 38% in non-cases, giving 
a relative risk of 1.53. For dysphoric mood, the 
mortality difference was 54% versus 35% (relative 
risk = 1.54), while for pervasive depression it was 
64% versus 37% (relative risk = 1.73). The various 
criteria for depression are thus rather similar in 
their ability to predict mortality, but are weaker 
predictors than the dementia criteria.
The relationship between depressive disorder 
and mortality could have been mediated by physi­
cal ill-health. Depression, however measured, had 
small but significant associations with poor per­
formance on ADL (Pearson rs of 0.28 with dys­
phoric mood, 0.33 with pervasive depression and 
0.29 with rational depression). To see whether 
depression was related to mortality independent of 
physical ill-health, a multiple logistic regression
analysis was carried out. In this analysis, age, ADL 
score, MMSE score and dysphoric mood were 
entered as predictors of mortality. Although dys­
phoric mood made a significant contribution when 
entered alone, its effect disappeared when either 
age or ADL score was entered simultaneously. 
However, dysphoric mood continued to have an 
independent effect when entered simultaneously 
with the MMSE score. It thus appears that the rela­
tionship between depressive disorder and mortality 
was mediated by physical ill-health in the present 
sample.
If depressive disorder is an indicator of terminal 
physical illness, then those who were depressed 
should tend to die earlier in the five-year follow-up 
period than the non-depressed. To test this possi­
bility, the time of death was compared in the dys­
phoric cases who died with the others who died. 
The dysphoric group was chosen because of its rela­
tively high prevalence. This group was found to 
have survived an average of 252 days less. The 
respective means were 1185.9 days (SD = 548.9) 
and 933.8 days (SD = 562.4), which were signifi­
cantly different, /(89) = 2.12,/? = 0.037. The ranges 
were 26-2122 days and 63-1975 days respectively.
It is conceivable that some of these deaths may 
have been due to suicide, and that this would be 
more probable in the depressed elderly. We were 
not able to obtain data about suicide in individuals 
in this cohort. The suicide rate in Australia for per­
sons aged 65 and over is 27 per 100.000 for men 
and six per 100,000 for women (Hassan and Carr. 
1989). The likelihood of suicide cases in the present 
sample is therefore very low.
To gain greater understandingof the relationship 
between depression and mortality, individual 
symptoms and signs contributing to dysphoric 
mood, major depression, pervasive depression and 
rational depression were examined (Table 3). 
Symptoms with expected frequencies too low to 
allow a valid chi-square have been excluded from 
the table. Significant associations with mortality 
(p < 0.01) were found for the following symptoms 
or signs: too little energy, trouble with concen­
tration, slowed down in movements, future looks 
bleak, weight loss, w'orry about health, and looks 
sad.
As shown in Table 1, mortality was not signifi­
cantly associated w ith any of the social integration 
measures. To see w'hether social integration was 
associated w'ith morbidity, the social integration 
measures were also correlated with ADL and self- 
rated health. There were small but significant asso-
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Table 3. Prevalence (%) of depressive symptoms and signs 
in those who survived and those who died
Symptom/sign
Survived 
(,V = 134)
Died
(./V =94)
Sad during Iasi month 27.6 35.1
Less interest in things 11.2 20.2
Enjoyed nothing recently 7.5 13.8
Trouble sleeping 44.0 48.9
Taking anything for sleep .34.3 43.6
Mood prevents sleep 17.9 26.6
Too little energy* 28.4 51.1
Worn out during day 29.1 4.3.6
Slowed down in thinking 38.1 40.4
Thoughts mixed up 16.4 29.8
Trouble with concentration* 4.5 14.9
Trouble with reading 9.0 11.7
Wanted to stay away from people 5.2 11.7
More irritable lately 14.9 17.0
Slowed down in movements* 17.2 35.1
Restless 17.9 10.6
Future seems bleak * 5.2 16.0
Brooding 9.0 17.0
Cried at all 14.9 25.5
Felt life not worth living 5.2 8.5
Loss of appetite 9.7 14.9
Weight loss* 7.5 21.3
Difficult to make up mind 20.1 25.5
Feel worse at specific times 5.2 13.8
Unpleasant worrying 23.9 24.5
has cried recently 14.9 25.5
Felt like crying 14.9 6.4
Sounds gloomy 6.7 16.0
Gets angry with self 38.1 38.3
Early wakening 12.7 11.7
Difficulty relaxing 29.1 16.0
Worry about health* 3.0 14.9
Looks sad* 10.4 23.4
* p  < 0.01.
ciations (p < 0.01) of the availability of social inte­
gration with self-rated health (r = -0.24) and ADL 
(/- = -0.28). but not with its adequacy (rs of -0.04 
and -0.14). These correlations imply that greater 
social integration was associated with less impair­
ment in physical health. The attachment variables 
had lower relationships with physical health. Avail­
ability of attachment was correlated -0.17 with 
self-rated health, and -0.11 with ADL. Although 
the former correlation is statistically significant, 
neither is high. Adequacy of attachment had little 
relationship to the physical health measures (rs of 
— 0.10 and -0.07).
DISCUSSION
The present study found that dementia and de­
pressive disorder, but not social integration, were 
predictors of mortality in a sample of the elderly 
living in the community. The findings with 
dementia are consistent with an extensive literature 
showing the malignancy of this syndrome.
The link between depressive disorder and mor­
tality is less straightforward. In the present data, 
depressive disorder appeared to predict mortality 
only because of its correlation with physical illness. 
Amongst those who died, depression cases tended 
to die sooner, indicating an association with termi­
nal illness, and the predictive effect of depression 
disappeared once the effect of physical illness was 
taken into account. These findings suggest that 
there may be a ‘terminal drop’ in mood analogous 
to that which has been reported for cognition. 
However, when individual depressive symptoms 
were examined, each of those which were associated 
with mortality could also be a symptom of severe 
physical illness. By contrast, depressive symptoms 
such as feeling sad in the last month, having trouble 
sleeping, feeling life is not worth living, slowed 
thinking and irritability were not predictors of mor­
tality. At this level of analysis, therefore, it cannot 
be claimed that mortality within five years was 
predicted by symptoms which are essentially de­
pressive and not open to confounding by physical 
illness.
Not all previous studies have found a link 
between functional psychiatric disorder and mor­
tality. A possible reason for these discrepant find­
ings may lie in the length of follow-up used. If 
depression is associated with terminal illness, then 
the correlation of depression with mortality will 
be most evident in shorter follow-ups. As the 
follow-up period is lengthened, the effects of 
depression associated with terminal illness will tend 
to become weaker.
The relationship of social integration to mor­
tality reported by others could not be replicated, 
even though the present study had more compre­
hensive measures of integration than previous stu­
dies. A possible reason is that the relationship 
between social integration and mortality is rather 
small, particularly for females. The present study 
had a comparatively small and predominantly 
female sample and may therefore have lacked the 
power to detect a relationship. There was, however, 
some relationship between lack of social integ­
ration and concurrent poor physical health. This
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relationship primarily involved more difTuse social 
contacts and could well have been a result of the 
inability of the physically unwell to get about and 
meet people. If the link between social support and 
mortality is to be elucidated, further longitudinal 
studies will be required, using such well-differen­
tiated measures of social support.
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In current efforts to understand the etiology of Alzhei­
mer’s disease (AD), epidemiologic methods comple­
ment those of neuropathology and molecular biology'. Of 
the 20 or more risk factors proposed for AD.1 the major­
ity were identified in the course of epidemiologic case- 
control studies. The only associated factors consis­
tently found are age itself, Down’s syndrome, and a 
history7 of dementia in a lst-degree relative. Other pro­
posed risk factors, such as head injury or other expo­
sures, remain uncertain because of low base rates in the 
population, inconsistent results across studies, the like­
lihood of information bias, and the selection of inap­
propriate controls.
The aims of this study were to (1) conduct a case- 
control study on a larger series than previously 
achieved, thereby increasing the statistical power to 
detect risk factors; (2) conduct this study in an Aus­
tralian population, where environmental factors and 
exposures may be different from those in the United 
States or Europe; (3) pay particular attention to rigor­
ous case definition; (4) include both early- and late- 
onset cases; and (5) obtain a control group matched not 
only for age and sex, but arising from the same popula­
tion base as the index cases.
M ethods. Recruitment of cases. Cases were identified from 
consecutive new referrals to dementia clinics in Sydney con- 
d^ ® d at the R epatriation General H ospital Concord 
(KGHC) and Lidcombe Hospital, attended by the same neu­
rologists (H.C., E.McC.). Patients seen at RGHC were re­
cruited by an approach to general (primary- care) practitioners
(GPs) in the catchment area of the hospital. These physicians 
were sent a letter and visited personally by one of us (E.McC.) 
with a request to refer to the RGHC all patients living in the 
community who presented to them at any time from the start 
of the study and who were recognized at tha t consultation as 
being demented. Patients already known to the GPs as being 
demented were not to be referred unless they presented to 
them for any reason during the study period.
Since RGHC is both a veterans’ and a community hospital, 
another source of referrals to the dementia clinic was from 
GPs distant from the hospital whose patients had “veteran” 
eligibility. In Australia, “entitled veterans” includes veterans 
themselves and certain dependent family members, in partic­
ular widows of entitled veterans.
In this manner, we sought to obtain all newly recognized 
cases of dementia living in the community within the geo­
graphic area around RGHC and attending their GPs during 
the study period. To augment the number of cases included in 
the study, patients referred to the Lidcombe Hospital Demen­
tia Clinic and patients from GPs distant to the geographic 
areas of both clinics also were included.
Examination of cases. All patients referred to the Dementia 
Clinics (RGHC and Lidcombe) by GPs underwent the follow­
ing assessment by a neurologist (E.McC. or H.C.). A history was 
taken from the patient and an independent history was taken 
from an accompanying relative or friend; this included a review 
of possible cognitive or behavioral change and an Activities of 
Daily Living Scale. The standardized clinical examination in­
cluded a Neurology of Aging Schedule and the Mini-Mental 
State Examination (MMSE) .2 Patients also had a comprehen­
sive neuropsychological assessment. The neuropsychological 
test battery was based on the Lurian neuropsychological ap­
proach. The battery included auditory-verbal comprehen­
sion,3 tests of orientation, vigilance, reaction time, object
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Table 1. Fam ilial or genetic factors
M atched pairs odds ratio*
Approx 95% N u m ber o f m atched pairs
P u ta tiv e  risk factor O R p  v a l u e C L + + + - —  4- —
Disorders in a 1st-
degree relative
Dementia 3 . 6 4 0.000 ( 2 . 1 0 - 6 . 3 3 ) 6 51 14 9 9
Probable AD 4 . 2 7 0.000 ( 2 . 3 4 - 7 . 8 0 ) 5 4 7 1 1 1 0 7
MID 2 . 6 7 0 . 1 3 2 ( 0 . 7 5 - 9 . 5 5 ) 0 8 3 1 5 9
Down's syndrome 1 1 . 3 3 t 0 . 0 2 4 ( 1 . 1 9 - 6 8  1) 0 5 0 1 6 5
Leukemia or reticuloses 3 . 0 0 0 . 0 8 3 ( 0 . 8 7 - 1 0 . 4 ) 3 9 3 1 5 5
Thyroid disorders 0 . 4 4 0 . 0 2 0 ( 0 . 2 2 - 0 . 8 8 ) 3 11 25 131
Cardiovascular disorders 1 .4 4 0 . 0 8 1 ( 0 . 9 6 - 2 . 1 6 ) 51 5 6 39 2 4
* The matched pairs odds ratio (OR) is the ratio of discordant pairs ( H— )/(—+) The p value corresponds to the CMH chi-square test, with the 
approximate 95% confidence limits based on the value of the CMH chi square.
+ +  Number of matched pairs with case and control both exposed.
H—  Number of matched pairs with case exposed and control not exposed.
— t- Number of matched pairs with case not exposed and control exposed.
-----Number of matched pairs with neither case nor control exposed.
t  Woolfs logit estimate for unmatched samples with corresponding test-based confidence limits. The exact p value for matched samples is 0.062 and 
the exact lower 95% confidence limit is 0.92. The exact upper limit cannot be calculated.
naming, reading, writing, drawing, apraxia, and agnosia, and 
selected tests from the Luria-Nebraska neuropsychological 
battery/ selected subtests from the Wechsler Memory Scale,5 
i 7-word list learning test, the Color Form Sorting Test,6 
'ontrolled Oral Word Association Test,7 selected Porteus 
mazes,8 selected subtests from the Wechsler Adult Intelligence 
Scale—Revised,9 and the National Adult Reading Test.10
Full blood count, sedimentation rate, biochemical screen­
ing, syphilis serology, and folate levels, thyroid function 
tests, and ANF were carried out. Sixty percent had head CTs 
and 25% had EEGs.
Cases were admitted to the study from March 1986 to 
October 1988 if they fulfilled the NINCDS-ADRDA criteria 
for probable or possible AD.11 Patients were excluded if they 
vere unable to be examined in English or lacked a suitable 
informant.
Recruitment of controls. As each case was enrolled in the 
study, the referring general practice was asked to contact and 
provide names and addresses of up to 4 persons, matched for 
sex and for age within 2 years. To reduce bias in the selection 
process, the practice secretary was asked to search the files 
systematically for a possible control subject of the same age 
and sex, beginning in the files at the same letter of the alphabet 
as the candidate case. Where no such person could be found in 
the GP’s files, an approach was made to partners in the same 
practice or to neighboring practices. Potential controls were 
approached by phone and those agreeable were visited at home 
by a neurologist (E.McC., H.C.). A brief examination included 
blood pressure, MMSE, and a shortened Neurology of Aging 
examination. A number of controls were excluded because 
they had an MMSE score of less than 26, could not be inter­
viewed in English, or had no suitable informant for risk factor 
assessment. Recruitment of controls extended from October 
1986 to February' 1989.
Risk Factor Interview. This interview was developed spe­
cifically for this study to assess previous health, family his­
tory, lifestyle, and occupational or domestic exposures. 
Medically naive professional interviewers administered it to 
the informants of the cases and controls, usually in their 
homes. The interview lasted about 2 hours. Seven inter­
viewers were trained extensively by us in the use of the Risk 
Factor Interview, with periodic refresher sessions. Through­
out, they were kept naive to the true purpose of the study.
believing it was an enquiry into aging, health, and lifestyle. 
However, as the study progressed, interviewers did become 
aware that dementia was a principal focus.
To reduce information bias, informants of cases were ap­
proached independently from the hospital clinics. To keep 
cases, controls, and their informants blind to the purpose of 
the study, they were asked to participate in a “A Health Study 
of the Elderly."
To study the reliability of information obtained, approxi­
mately of the controls were administered the interview and 
their results compared with those obtained from their in­
formants.
Statistical analysis. Data were analyzed using SAS, ver­
sion 5.12 Odds ratios for matched pairs were calculated using 
the procedure FREQ. For the majority of exposures, the Man- 
tel-Haenszel estimate of the matched pairs odds ratio is given, 
with 95% confidence limits based on the Cochran-Mantel- 
Haenszel chi-square test. Where there are no exposed controls 
(eg, family history of Down’s), the matched pairs odds ratio 
cannot be calculated. The logit estimator for unmatched sam­
ples and associated 95% confidence limits are given.
The Mantel-Haenszel estimates of the odds ratio and cor­
responding confidence limits, which are equivalent to those 
based on the McNemar test without continuity correction, 
depend only on the number of matched pairs that are discor­
dant on the exposure of interest. Exposures for which there are 
few discordant pairs will thus lead to estimates with low- 
power. This is reflected in the width of the confidence inter­
vals shown in tables 1 through 6.
The number of matched pairs that are discordant on any 
exposure will be related to the base rate of exposure among the 
controls. The closer the exposure rate is to 0.5, the greater the 
number of discordant pairs and hence the greater the power of 
the sample to detect odds ratios significantly different from 
1.00. For example, for a type I error fixed at 0.05, a type II error 
fixed at 0.10, and an exposure rate of 0.05 among the controls, 
the smallest odds ratio that will be detected in a total sample of 
170 matched pairs will be 3.85. If the exposure rate among 
controls is even less, say 0.02, then the smallest detectable odds 
ratio would be 6.0. If, however, the exposure rates were higher, 
say 0.10 or 0.50, then the m in im um  detectable odds ratio would 
be 3.0 or 22, respectively, for thesatneleveb^&^iinKl'type 
II errors and a total sample size of ITÖmati&ödlififs/ 3
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T able  2. P r e v io u s  head injury or brain  insults
Matched pairs odds ratio*
A pprox 95%  N um ber o f  m atched pairs
P u t a t i v e  r i s k  f a c t o r O R p  v a l u e C L +  + +  - -  + —
H ea d  in ju ry  
A ll s u b je c ts  a n y  t im e 1.33 0 .5 9 3 ( 0 .4 6 - 3 .8 3 ) 0 8 6 156
b e fo re  a s s e s s m e n t  
A ll su b je c ts 1 .60 0 .4 0 5 (0 .5 3 - 4 .8 4 ) 0 8 5 157
at le a st 10 years  
b efo re  a s s e s s m e n t  
M en  o n ly  (n  =  128) 1.75 0 .3 6 6 ( 0 .5 2 - 5 .8 8 ) 0 7 4 53
a n y  t im e  b efore  
a s s e s s m e n t  
M en  o n ly  (n  =  128) 2 .3 3 0 .2 0 6 (0 .6 3 - 8 .6 7 ) 0 7 3 54
at le a st 10 years  
b efo re  a s s e s s m e n t  
H is to r y  o f  b o x in g , 1 .07 0 .8 5 7 (0 .5 3 - 2 .1 6 ) 11 16 15 128
w r es tlin g , o r  rugby  
E n c e p h a lit is  o r  m e n in g it is 0 .5 0 0 .5 6 4 ( 0 .5 0 - 5 .2 6 ) 0 1 2 167
F its  o r  s e iz u r e s 1 .57 0 .3 4 6 (0 .6 1 - 4 .0 2 ) 0 1 1 7 152
S ta r v a t io n  o r  m a ln u tr it io n 1 .46 0 .3 3 6 (0 .6 8 - 3 .1 2 ) 0 16 11 139
H ea d  in ju r y /e n c e p h a lit t s /  
m e n in g iu s / f i t s  or  s e iz u r e s /  
s ta r v a lio n /b o x in g ,  w r estlin g ,  
or rugby  
A ll su b je c ts 1 .5 0 0 .121 ( 0 .9 0 - 2 .5 1 ) 19 36 2 4 91
M en  o n ly  (n  =  128) 1 .25 0 .5 0 5 ( 0 .6 5 - 2 .4 1 ) 17 20 16 11
* The matched pairs odds ratio (OR) is the ratio of discordant pairs (H— )/(— (-). The p value corresponds to the CMH chi-square test, with the 
approximate 95% confidence limits based on the value of the CMH chi square.
+ + Number of matched pairs with case and control both exposed.
-I—  Number of matched pairs with case exposed and control not exposed.
— 1- Number of matched pairs with case not exposed and control exposed.
----Number of matched pairs with neither case nor control exposed.
Results. The cases and controls. A total of 333 patients 
were referred from all sources to the 2 dementia clinics 
during the study period. Of the 135 GPs contacted, 66 
contributed a total of 153 referrals. The remaining GPs 
failed to participate, predominantly because they antic­
ipated difficulty in recruiting control subjects. Some 
had few elderly patients or few patients who spoke 
English. There were 159 patients who did not meet the 
criteria, leaving 174 patients with clinically diagnosed 
AD. Four patients were excluded because suitable con­
trols could not be found, leaving 83 cases with probable 
AD and 87 with possible AD, according to the 
NINCDS-ADRDA criteria.
Two hundred and seventy possible controls were 
contacted (264 from patients’ GPs and 6 from among 
patients referred to the general geriatric clinic by GPs). 
Of these, 222 controls were visited, and 170 were found 
to be suitable, provided a completed Risk Factor Inter­
view, and could be matched to the cases according to sex 
and age. The source of recruitment for the controls was 
as follows: 52 controls came from the same general 
practice as their matched case; 67 came from a practice 
within the same neighborhood as the case’s practice; 
and 42 came from a practice not within the same neigh­
borhood but within 20 km of the practice of the matched 
case. For 9 cases, it was necessary to draw the control 
from practices more than 20 km away from the case’s 
practice.
There were 64 men and 106 women cases matched 
with the same number of controls. For the cases, the 
mean age of the men was 77.4 (range, 64 to 96, SD 7.2 
and that of women 78.6 (range, 52 to 93, SD 7.4) while 
for the controls the mean age of the men was 77.1 (range 
63 to 93, SD 6.7) and that of women controls was 78.' 
(range, 53 to 96, SD 7.5). Among the cases, 49.4% wen 
aged 80 and above. Among the pairs of subjects matchee 
on sex, age, and GP practice, the age difference was 
year or less in 63% and 3 years or less for 93% of tin 
sample.
The proportion of spouses or lst-degree relative 
acting as informants was very similar between cases an 
controls, 87% as against 89%. Controls had a highe 
proportion of spouses (39%) and siblings (15%) wh 
acted as informants than did the patients (29% and 8% 
respectively). Offspring served as informants in 51% c 
cases and 35% of controls. The remaining informant 
(13% and 11% respectively) were mostly close relative 
by marriage, nieces or nephews and, occasionally, closi 
long-standing friends.
Reliability of informant interviews. Forty-one cor 
trols were administered the Risk Factor Interview an 
their responses compared with those obtained froi 
their informants. Of the 90 variables considered, » 
occurred within the total control sample at a rate belo 
5% and were therefore excluded from the reliahik  
analysis. For the 59 remaining variables, petoÖÖäfcBj
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T _ole 3 . P r e v io u s  il ln e s se s
M a tc h e d  p a i r s  o d d s  ra t io *
P u ta t i v e  r i s k  f a c t o r O R p  v a lu e
A p p ro x  9 5 %  
C L +  +
N u m b e r  o f  m a tc h e d  p a ir s
+  -  - - T - -
Bell’s palsy 0.67 0.655 (0.11-3.95) 0 2 3 165
H erpes zoster 0.74 0.307 (0.42-1.32) 4 20 27 119
D epressive d iso rd er 4.33 0.012 (1.37-13.7) 0 13 3 154
in last 10 years
D epressive d iso rd er 1.50 0.655 (0.25-8.87) 0 3 2 165
before last 10 years
N ervous b reakdow n  in 0.00 1.00t (0.00-10.27) 0 0 1 169
last 10 years
N ervous b reakdow n 1.67 0.480 (0.41-6.87) 0 5 3 162
before la s t 10 y ears
Severe headaches 0.73 0.267 (0.42-1.27) 1 22 30 117
C ardiac a r re s t — — — 0 0 0 170
H eart disease 0.68 0.118 (0.42-1.10) 17 28 41 84
K idney disease 1.15 0.705 (0.55-2.42) 0 15 13 142
Liver disease 1.17 0.782 (0.39-3.47) 0 7 6 157
Peptic  ulcer 0.65 0.170 (0.36-1.20) 2 17 26 125
B ronchitis, a s th m a . 0.71 0.127 (0.46-1.10) 21 35 49 65
or em physem a
A sthm a (alone) 0.83 0.670 (0.36-1.93) 1 10 12 147
T uberculosis 0.00 0 .250 t (0.00-2.74) 0 0 3 167
C hronic s in u s itis 1.08 0.841 (0.49-2.37) 1 13 12 144
Hay fever/a llerg ies 0.97 0.901 (0.60-1.58) 19 32 33 86
(w ith a s th m a )
Hay fever/a llerg ies 1.07 0.696 (0.66-1.84) 15 31 29 95
(no t as th m a )
M alaria 3.00 0.046 (1.02-8.80) 0 12 4 154
A nem ia 1.46 0.289 (0.73-2.95) 6 19 13 132
D iabetes 0.56 0.285 (0.19-1.63) 3 5 9 153
T hy ro id  disease 1.00 1.00 (0.42-2.35) 0 14 14 142
O steoporosis 0.83 0.670 (0.36-1.93) 1 10 12 147
A rth ritis 0.56 0.011 (0.36-0.87) 63 29 52 26
G laucom a 0.71 0.353 (0.34-1.47) 2 12 17 139
C a ta rac t 0.54 0.029 (0.31-0.94) 15 19 35 101
* The matched pairs odds ratio (OR) is the ratio of discordant pairs ( H— )/(—+ ). The p value corresponds to the CMH chi-aquare test, with the 
approximate 95% confidence limits based on the value of the CMH chi square.
+ + Number of matched pairs with case and control both erposecL 
+ — Number of m atched pairs with case exposed and control not exposed- 
-- 4- Number of matched pairs with case not exposed and control exposed.
-----Number of matched pairs with neither case nor control exposed.
t Exact p value given.
agreement and kappa statistics were calculated.14 
Kappa values reflect the agreement between the control 
and the informant, corrected for chance agreement. 
There were 42 variables for which kappa values were 
significantly greater than zero (p <  0.05). For 23 vari­
ables, kappa was less than 0.40,15 were in the range 0.40 
to 0.59,13 were between 0.60 and 0.79, and 8 had a value 
of kappa of at least 0.80. Percentage agreements, not 
corrected for chance, were very high. For only 1 variable 
was this below 70%, and for 40 variables it was over 
80%. These results correspond to those obtained by 
other investigators in similar studies.15-16
Comparison of cases and controls on study variables. 
To carry out comparisons of the study variables, we 
placed them into 6 categories: familial or genetic fac­
tors; previous head injury or brain insult; previous ill­
nesses; p h arm acolog ic  exp osu res and m edical 
treatments; environmental exposures; and personal at­
tributes. These are represented by tables 1 to 6.
Familial or genetic factors. Of the variables listed in 
table 1, a significant odds ratio was found for the follow­
ing: for all subjects, a history in a lst-degree relative of 
dementia or of probable AD, but not of MID. For other 
disorders, a history of Down’s syndrome in a lst-degree 
relative yielded an odds ratio of 11.33, but a history7 of 
leukemia, reticuloses, or cardiovascular disorders was 
not significant. A family history of thyroid disorder was 
negatively associated wnth AD, yielding a statistically 
significant odds ratio of 0.44.
Previous head injury or brain insults. A history of 
significant head injury was analyzed for all subjects and 
for men only. A separate analysis was made for injuries 
occurring at any time and for those that occurred 1C 
years or more before the assessment (table 2). A signifi­
cant head injury was defined as one resulting in loss ol 
consciousness for more than 15 minutes. A history ol
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T a b le  4 . P h a r m a c o lo g ic  e x p o s u re s  a n d  m e d ic a l t r e a tm e n ts
M atched p a irs  odds ratio*
P u ta tiv e  r isk  fac to r OR p value
Has never had alcohol 0.74 0.249
At least 5 drinks daily 1.05 0.879
sometime in life
Never smoked 1.32 0.302
>  1 pkt cigarettes daily 0.64 0.297
sometime in life
Never drank tea 2.00 0.248
>4 cups tea daily 1.42 0.108
sometime in life
Never drank coffee 1.55 0.123
> 4  cups coffee daily 2.25 0.166
sometime in life 
Medication use 
(daily for at least 6 months)
Laxatives 1.07 0.799
Antacids 0.96 0.891
Analgesics 0.71 0.157
Vitamin E tablets 1.30 0.532
Iron tablets 1.17 0.695
Anticonvulsants 1.00 1.00
Anxiolytics 1.29 0.386
Hormonal treatment 0.78 0.480
Antidepressants 1.10 0.827
Major tranquilizers** 24.6t 0.000
Thyroid treatm ent 2.00 0.317
Radioactive iodine 1.00 1.00
Medical treatm ents
Operations to the head 0.92 0.680
or neck, including dental, eye, 
tonsils, adenoids, thyroid, brain
Other operations (chest. 0.76 0.245
abdomen, pelvis)
Radiotherapy
ECT
Blood transfusions 
Blood donor 
Repeated injections 
General anesthetics
0.40
1.33
0.63
0.77
2.00
0.95
0.257
0.705
0.116
0.532
0.102
0.869
Approx 95% 
CL
(0.45-1.23)
(0.58-1.91)
(0.79-2.17)
(0.28-1.48)
(0.62-6.49)
(0.93-2.17)
(0.89-2.71)
(0.72-7.71)
(0.65-1.76)
(0.56-1.65)
(0.46-1.17)
(0.57-2.96)
(0.54-2.52)
(0.20-4.95)
(0.73-2.27)
(0.39-1.56)
(0.47-2.59)
(3.10-ooJ
(0.51-7.78)
(0.16-6.35)
(0.61-1.38)
(0.48-1.12)
(0.08-1.95)
(0.30-5.93)
(0.36-1.12)
(0.34-1.75)
(0.87-4.60)
(0.50-1.81)
Number of matched pairs
+ +  + - - +
11
3
56
11
0
22
18
0
5
6 
19
0
1
0
2
0
3
1
0
0
0
0
3
2
3
129
26
22
34
9
8
51
31
9
32
26
30
13
14 
4
27
14
11
18
6
3
2
4
19
10
16
18
35
21
26
14
4
36
20
4
30
27
42
10
12
4
21
18
10
0
3
3
5
3
30
13
8
19
98
124
54
136
158
61
101
157
103
111
79
147
143
162
120
138
146
151
161
164
163
163
118
145
143
4
approximate^953mÄ S ; S  W  o n t o  v l to  Ä  CMH d n  s l^ L T  '' ^  ^  COrTe9ponds 10 lhe CMH ^ i-square  teat, with the 
+ +  Number of matched pairs with case and control both exposed.
+ -  Number of matched pairs with case exposed and control not exposed 
-  + Number of matched pairs with case not exposed and control exposed 
Number of matched pairs with neither case nor control exposed.
“  were talcing tranquilizers other than in the 10 years preceding assessment
t Woolfs logit estimate for unmatched samples with exact lower 95% confidence limit. The ei! exact upper limit cannot be calculated.
boxing, wrestling, or rugby, sports commonly associ­
ated with repeated head injury, was also examined. The 
estimated odds ratios for these exposures were rela­
tively small; none was statistically significant. Insults to 
the brain, such as encephalitis, meningitis, fits or sei­
zures, or starvation or malnutrition were not reported 
significantly more frequently in cases. A composite 
measure of all these brain insults likewise proved nega­
tive.
Previous illnesses. Among the variables listed in 
table 3, only a depressive disorder in the last 10 years or 
a history of malaria gave odds ratios significantly 
greater than one. There were 13 cases and 3 controls
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with recent depression. For depression prior to 10 years 
before assessment, there was no excess among the cases. 
For malaria, there were 12 exposed cases and 4 exposed 
controls. But 11 of the 12 cases and all 4 controls had 
seen active service during World War II, suggesting that 
the apparent association with malaria is an artifact of 
study design as a consequence of conducting the study 
in a hospital with selective access to veterans. Arthritis 
and the presence of cataracts were also negatively asso­
ciated with AD. None of the other disorders yielded a 
statistically significant odds ratio (p >  0.05).
Pharmacologic exposures and medical treatments. 
Table 4 shows the exposures examined. Only the^ise of
Table 5. E n v ir o n m e n t a l  e x p o s u r e s
M atched pairs odds ratio*
OR p  value
A pprox 95% 
CL -1- +
N um ber of m atched D airs
+ -  -  + —
1.40 0.157 (0.88-2.23) 10 43 31 86
0.65 0.194 (0.34-1.24) 6 15 23 126
1.22 0.377 (0.79-1.88) 31 45 37 57
0.54 0.180 (0.22-1.33) 1 7 13 149
0.25 0.180 (0.03-1.89) 0 1 4 165
0.60 0.480 (0.15-2.47) 0 3 5 162
1.77 0.434 (0.90-3.46) 1 23 13 133
P u ta tiv e  risk factor
Lived on a farm > 2  years 
Lived > 2  years in a 
mining town 
Lived > 2  years with 
tank water only 
Lived > 2  years with 
artesian bore water 
Prisoner of war/ 
concentration camp 
Orphaned/adopted/ 
fostered by age 12 
Never ate fish
'  — j rat i0.f0R)  ^  rat,° ° f discordant pairs ( + - ) / ( - + ) .  The p value corresponds to the CMH chi-square test, with the 
approximate 95% confidence limits based on the value of the CMH chi square.
+ + Number of matched pairs with case and control both exposed.
-I Number of matched pairs with case exposed and control not exposed.
-  +  Number of matched pairs with case not exposed and control exposed.
Number of matched pairs with neither case nor control exposed.
major tranquilizers yielded a significant odds ratio. But 
of the 19 cases, only 3 had been taking a major tran­
quilizer prior to 10 years before the assessment. The 
remaining 16 had had it recently prescribed.
Environmental exposures. None of the exposures 
examined showed a significant odds ratio (table 5).
Personal attributes. There was no statistically sig­
nificant difference between cases and controls regard­
ing handedness, nose-picking, nail-biting, snoring, or 
the tendency to be overactive or fidgety. Cases were 
significantly more likely than controls to have had a 
lifestyle that involved so little physical exercise that 
they were regarded as less active than their age peers; 
odds ratios were significant for both the 10 years prior to 
assessment and for time periods more distant (table 6).
Discussion. Possible selection effects. Cases. The pa­
tients with AD admitted to the study were referred from 
general (primary care) practitioners, and may con­
ceivably have differed from all incident or prevalent 
patients with AD during the collection period in respect 
to at least 4 attributes. First, the patients recognized by 
the GPs may have been more conspicuous medically or 
in their social functioning. They may therefore have 
been more likely to live with relatives than alone and 
thereby be taken to a doctor, and more likely to have 
comorbidity or a more advanced dementia. Second, 
they or their families may have been more compliant 
concerning referral to the Dementia Clinic compared 
with those who were in the practice but not referred. 
Third, there may have been some patients with demen­
tia whom the GPs referred to private specialists rather 
than to the 2 clinics. Fourth, a proportion of the cases 
may have been erroneously diagnosed as having AD. 
Estimates of misclassification in hospital settings, 
based on autopsy confirmation, have ranged between 
and 20%* using the NINCDS-ADRDA criteria. 
This study has a comparable misclassification rate of
11% (9 autopsies). Earlier studies with less standardized 
criteria showed misclassification in the range of 20 to 
50%.20 Kukull et al21 found only modest reliability be­
tween 4 physicians applying NINCDS-ADRDA crite­
ria to 62 patients ( k = 0.64). We did not measure the 
reliability between the 2 clinicians in the present study; 
however, both were neurologists experienced in demen­
tia.
Controls. One strength of the control group in this 
study is that, unlike hospital or community controls, 
they are likely to have had a similar level of non-neuro- 
logic morbidity, and to have come from a social environ- 
m ent sim ilar to th a t of the cases. They may 
nevertheless have been selected by the general practice 
staff because they had recently consulted them for some 
non-neurologic complaint. They may therefore be ex­
pected to have had 1 or more medical disorders, but lack 
evidence of cognitive decline. It is also probable that 
they self-selected when first approached, by cooperat­
ing in a study that was unlikely to have any benefit for 
them. In responding to the Risk Factor Interview, in­
formants of cases are likely to have had different moti­
vation from the controls’ informants. This difference 
lies mainly in “effort after meaning” on the part of 
informants for the cases, as described by Bartlett22 and 
Brown et al,23 whereby past events or experiences are 
preferentially recalled in an attempt to explain current 
illness.
interpretation of risk factors. Of the 87 variables 
examined, only 10 had statistically significant odds 
ratios: a history of dementia, probable AD, or Down’s 
syndrome in a lst-degree relative; depression during the 
previous 10 years; a history of malaria; recent use of a 
major tranquilizer; and underactivity in both the recent 
and more distant past. A family history of thyroid disor­
der in lst-degree relatives, arthritis, or cataracts were 
negatively associated with AD.
Familial and genetic factors. A significant odds ratio
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T a b le  6 . P e r s o n a l  a t t r i b u t e s
P u ta tiv e  r isk  factor
Left handedness 
Nose picking 
Nail biting
Physically overactive in 
previous 10 years 
Physically overactive 
before 10 years ago 
Physically underactive in 
previous 10 years t 
Physically underactive 
before 10 years agot 
Loud snorer in previous 
10 years
Loud snorer before 
10 years ago 
Early graying ( <  40) $ 
Early balding (<40)$  
Menopause before age 45 
(women only, n = 212)
O R
0.55
1.67
0.90
1.54
1.07
6.25
3.50
0.97
0.80
0.87
0.44
0.61
Matched pairs odds ra tio *
A p p rox  95%
p value
0.225
0.317
0.819
0.085
0.796
0.000
0.018
0.903
0.414
0.647
0.166
0.194
(0.21-1.45)
(0.61-4.54)
(0.37-2.21)
(094-2.51)
(0.64-1.77)
(2.49-15.7)
(126-9.62)
(0.60-1.57)
(0.47-1.37)
(0.48-1.58)
(0.14-1.40)
(029-1.28)
N u m b er  o f  m a t^ h ^
+  +
1
1
1
13
6
10
9
40
-  +
11
6
10
26
20
4
11
23
9
18
152
153 
150
91
100
125
156
75
- ;  nZ  £  2 22S2 E  2£ 223 2 S S 2 Ä  Ä
-  -  Number of match«! pans with neither case nor control exposed
1 ANOVA aS k C d ° f ? 5  CSSeS " “! 1 2 7 001111013 on}y. resulting in 85 matched pairs, t  ANOVAs on age of graying or balding gave no significant differences.
was found for a history of dementia and for probable A1 
among lst-degree relatives. These risk factors probabl 
reler to the same condition. It is noteworthy that thi 
study had a predominantly older population- 49 4% 0 
patients were aged 80 or above. Other case-control stud 
les finding an association with family history of demen 
tia have dealt with predominantly early-onset cases 
The oniy study of late-onset cases found no associatioi 
with family history.2'1 Although it is conceivable tha 
the present finding of an association with family histor 
of dementia is due to biased recall by informants whi 
seek to explain the subjects’ dementia, such bias i 
unlikely for a family history of Down’s syndrome sine, 
the possibility of an association between this and AD i< 
not widely known. There were 5 patients and no con' 
trols with Down s relatives, yielding an unmatched odd; 
ratio of 11.33. Although this is marginally significam 
(exact-p — 0.06), it is important in that it confirm: 
previous findings of this association.1* A family history 
of leukemia, reticuloses, and cardiovascular disorder?
vixe negative association with a family history of thy 
disorders has yet to be found. It is possible that this is 
result peculiar to this particular sample.
Previous head injury or brain insults. For this stud 
we hypothesized that a previous head injury oth, 
bram insults, or summation of such insults sufficient i 
cause neuronal loss could act as a risk factor for AD t 
interacting with genetic risk to induce an earlier ons, 
of the clinical disorder. We considered it uncle?
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whether the previously reported association of AD with 
head injury in a number of case-control studies16-25-26 
represented informant bias, particularly through effort 
after meaning, or had true biologic significance.
In the present study, we defined head injury to ex­
clude brief loss of consciousness (less than 15 minutes) 
and gave careful consideration to the timing of the 
injury, whether it took place in the 10 years prior to 
assessment or earlier in life. We found no significant 
difference between cases and controls for any of these 
groupings (table 2). Since head injury is more common 
in men, we repeated this analysis in male subjects, again 
without a significant finding. We found no significant 
difference for a history of having engaged in boxing, 
wrestling, or rugby, sports in which repeated head inju­
ries are likely to be sustained. Abalan27 proposed expo­
sure to starvation as a risk factor, but we did not find it 
positive in this series. A composite measure of all brain 
insults hypothesized as potentially causing neuronal 
loss (head injury, encephalitis, meningitis, seizures, 
starvation, boxing, wrestling, or rugby) designed to de­
tect summation of the individually weaker effects was 
also negative.
The status of head injury as a risk factor for AD 
remains in doubt in terms of biologic significance. Al­
though 3 studies have described positive findings16-25-26 
and a consistent trend is present in other studies with­
out reaching significance, this study agrees with 7 oth­
ers tha t do not find head iniunv itn Jip a jprri u ti 
factor.2*-28-32 Relevant factors iri’pjreviousSS^SiSgns
are the inclusion of head injury with brief loss nf ™ 
scousness— ^ iu a  and the £ c|usion
occurnng withm 10 years of a s s e s s m e n t 's . ^ ^  
Both these factors reduce the biologic plausibility of
. n t Z ^ b r n s 3 nSk faCt0r “ d ™ y a J c o n t r i Z :  £
Previous illnesses. Only a history of depression and 
,f maJana gave increased odds ratios (table 3) The
aSCertained must have been sub- otantial, in that they were accepted only if the patient
had been treated by a psychiatrist. But when we e x l  
med the timing of depression, we found a significant 
odds ratio only for depression in the previous 10 years 
and not earlier. This makes it likely that the depressive 
disorders were prodromal, or co-occurred with eariy 
AD, as consistently observed in other clinical and com
3 v y d ^ n t ' f  38 ‘V “* “ 8 Unllkdy th3t <feP«ss°onlearly distant from the onset of dementia is a risk 
. 3CL0r.
Malana gave an odds ratio of 3.00. We believe 
hough, that this is an artifact due to referral of veterans 
to the participating services. We did not match the 
controls for veteran status. Many Australian veterans 
had served ,n the Far East and Pacific dunng World
' A T Z T  they may have conlracted malaria.
e failed to confirm the reported positive associa- 
ion between AD and thyroid disease.16 In fact we 
■ound that a family history of thyroid disorder had a 
negative association with AD. Like others, we failed to 
hnd an association between AD and either diabetes or 
herpes zoster, ■ « * «  In a community-based c a s e Z  
trol study, Dewey et al« found that a history of head­
ache conferred a reduced risk of subsequent dementia 
wi an odds ratio of0.488. The present findings did not 
confirm such an effect, though there was a trend in the 
same direction.
Henderson42 hypothesized that senile macular de- 
generarion or cataracts are risk factors for AD since 
both brain and eye are derived from ectoderm. The
c a tar act ^ 3o«o T a n  ?lgnificant d e l a t io n  between
th^nronosp/T K  ^  ^  m the °PP°sit€ direction to at proposed. Three studies found no significant rela-
X c h 's h betdeen AIl arld arthritis’ unhke this study which showed a significant negative association
d /  T T 0' '? 10 expos“ res and medical treatments
andAlfh 68 ' a4 e SUggeSted that age-related changes and Alzheimer s disease may be linked to the long-term
abuse of alcohol.«.« However, it is very difficult “
evaluate alcohol as a risk factor because the clinical
. T T T  ° l  T USUally involves the exclusion of pa- 
t ents who have been alcoholic. We used such an exdu- 
sion procedure in the present study, so “ is not
S T Ä A S Ä S tS T  "  A
« ■ ä - s i s ä s :
Ä c s s a ;
the brains of persons who abused phenacetinfall
with negative findings. The high odds ratio for use of 
major tranquilizers is almost certainly attributable to 
their prescription for symptomatic treatment of early 
dementia. This is borne out by there being only 3 cases 
and no controls who had had a major tranquilizer more 
than 10 years before assessment.
Environmental exposures. The variables examined 
were prompted by a plausible association between AD 
and exposure to livestock, toxic minerals, a period of 
deprivation, or the absence of fish in the diet. The 
depravation of a pnsoner of war would, of course in 
elude starvation, which was considered above. None of 
these factors was significant.
Personal attributes. Seltzer and Sherwin46 proposed 
an association between handedness and AD Thev 
found left-handedness to be more common in early7 
onset than in late-onset patients, but did not use a 
control group. Later, in a case-control study of mainly 
late-onset patients, de Leon et al47 reported that left- 
handedness was less frequent in cases than controls. 
However, we could find no association between AD and 
handedness in the present study. For nose-picking oth­
ers have proposed that the olfactory mucosa and olfac­
tory pathway may be the route whereby a toxic agent 
enters the brain.4« -  This prompted us to enquire about 
habitual nose-picking, but with negative result. Like- 
wise nafi-bitmg might be a habit that mcreases the 
ikelihood of ingesting an mfectious agent from the 
mgers. We also asked informants whether subjects 
were much more overactive, fidgety, or restless than 
others of the same age, or if they had been engaged in 
activities involving little physical exercise, making 
• eni comPara^ vely underactive. Overactivity was not 
significant as a risk factor. Underactivity, however, was 
significant both in the 10 years preceding assessment 
when it could well be associated with the dementia, and 
in the period more than 10 years ago. We asked about 
snoring since Erkinjunnti et al51 claimed it to be associ­
ated with AD, but did not find it a risk factor either in 
the immediate past, when it could be considered a sec- 
ondary feature of the dementia, or in periods longer 
than 10 years before assessment. Since the bram is itself 
ectodermal in origin, we had hypothesized an associa- 
lon with features of accelerated ectodermal aging such 
as cataract, premature balding, or graying. Cataracts 
were negatively associated with AD. None of the other 
associations was supported, nor was age at menopause.
in summary, this study has so far identified 4 risk 
factors for AD: a history of dementia, probable AD or 
Down s syndrome in a lst-degree relative, and underac- 
tivity both in the recent and more distant past. The 
atter was therefore not adequately explained as simplv 
an associated or prodromal feature of early dementia 
1 his was the explanation for 2 other variables with 
statistically significant odds ratios: a depressive disor- 
der in the previous 10 years and recent use of a tran­
quilizer. A history of malana is also unlikely to be an 
etiologic factor for AD but may instead be an artifact 
introduced through the controls’ not having been 
matched for veteran status.
This case-control study did not support previously 
reported or suggested associations with head injury,
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starvation, thyroid disease, analgesics, antacid use (alu­
minum exposure), alcohol abuse, smoking, and left- 
handedness.
In a previous paper examining elderly identical twins 
discordant for AD, we suggested52 that some environ­
mental exposure is likely to contribute to the onset of 
AD. \  et the present study has identified no single envi­
ronmental (actor despite being among the largest case- 
control studies undertaken. The present data point to- 
^m"d a genetic contribution, although even this claim is 
tempered by the possibility of biased reporting of a 
family history due to effort after meaning and greater 
awareness of dementia in afflicted families. It seems 
that the following possibilities can be proposed: (1) the 
exposure responsible for AD was not enquired about; (2) 
it acts not alone but in interaction with 1 or more other 
factors, (3) there are several low-frequency exposures 
contributing to AD; (4) there is no environmental expo­
sure that contributes to AD; or (5) the retrospective 
informant interview, as used in this and similar studies, 
does not measure the exposure adequately, but a more 
carefully designed and detailed interview might elicit 
significantly different responses in cases and controls.
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Summary. The relative occurrence of Alzheimer’s and 
vascular dementias is examined in various countries using 
data of four types: incidence, prevalence, clinic and neuro- 
pathological studies. There is clear evidence that Alz­
heimer’s dementia is more common than vascular de­
mentia in Great Britain and North America and, to a 
lesser extent, in Scandinavia. The evidence from other 
countries with predominantly Caucasian populations is 
more limited, but also supports a predominance of Alz­
heimer’s dementia. By contrast, the evidence from Japan 
generally shows that vascular dementia is more com­
mon. The more limited evidence available from China 
also supports a preponderance of vascular dementia. 
There is a need for studies directly comparing the occur­
rence of Alzheimer’s dementia in Caucasian and Orien­
tal populations.
Key words: Dementia -  Alzheimer's disease -  Vascular 
dementia -  Prevalence studies -  Incidence studies
Introduction
If it could be established that there are differences be­
tween countries in the occurrence of Alzheimer's or vas­
cular dementias, this would be an important clue to the 
aetiology of these disorders. However, making compari­
sons across countries is not a simple matter. If separate 
studies are carried out in different countries, any differ­
ence in prevalence or incidence rates is more likely to be 
due to differences in the methodologies of the studies 
than to true national differences in disease occurrence. 
For example, in their meta-analysis of dementia preva­
lence studies, Jorm et al. (1987) found that methodolog­
ical differences between studies had an important influ­
ence on the prevalence rates found. In particular, studies 
produce higher or lower rates depending on where the 
cutoff is placed for defining a person as demented rather 
than normal. This is because there is no qualitative 
boundary for separating dementia from normal ageing. 
To make meaningful comparisons of prevalence and in­
cidence rates across countries, identical methodologies 
need to be used at the various sites. Unfortunately, with
the exception of the US/UK Cross-national Project (Gur- 
land et al. 1983), studies based on identical methodo­
logies in different countries do not exist.
While direct comparisons of prevalence and incidence 
rates across studies are not meaningful, there is an alter­
native way of making cross-national comparisons. This 
involves comparing the relative prevalence or incidence 
of dementing disorders, rather than the absolute rates. 
Within a single study, the same methodology is being 
used to estimate the occurrence of both dementias. If the 
rate for one dementing disorder is divided by the rate for 
the other, it does not matter that the absolute rates are 
affected by the cutoff for defining cases. Such an ap­
proach ignores the overall rates for dementia and simply 
examines how the dementia cases are subdivided into 
different disorders. Even making comparisons of rela­
tive rates across studies does, however, have its prob­
lems. Alzheimer’s and vascular dementias are themselves 
not clearly defined categories, particularly in the very 
elderly, who may suffer from both disorders to some de­
gree. Depending on the diagnostic procedure used, stud­
ies may vary in whether they assign certain cases to the 
Alzheimer’s, vascular or mixed categories. While ack­
nowledging that this problem exists, the present paper 
attempts to discover whether there are cross-national 
differences in the relative occurrence of the two major 
dementing disorders.
In making cross-national comparisons of the relative 
occurrence of Alzheimer's and vascular dementias, there 
are various kinds of studies that can be examined. Four 
are examined here: incidence, prevalence, clinic and 
neuropathological studies. Incidence studies are, in prin­
ciple, the most relevant for studying cross-national dif­
ferences. They are based on either total populations of 
defined areas or representative samples of larger popu­
lations, and estimate the rate of new onsets of dementing 
diseases. Unfortunately, because of the time and cost in­
volved in carrying out incidence studies, they are few 
in number. Furthermore, the diagnostic procedures in­
volved in incidence studies are often rudimentary. Even 
with the facilities of specialist clinics, there is error in­
volved in the clinical diagnosis of dementing diseases. In 
a general population survey, the extent of investigation 
which can be carried out is generally more limited than 
in a specialist clinic, making diagnostic error more likely.
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Prevalence studies are much more numerous than in­
cidence studies. They share with incidence studies the 
advantage of representativeness and the disadvantage of 
more rudimentary diagnostic procedures. However, thev 
are theoretically less interesting than incidence studies, 
because prevalence is a function of duration of survival 
as well as of incidence. Thus, any differences found in 
the relative prevalence ot Alzheimer's and vascular de­
mentias may be due to either differences in relative inci­
dence or differences in relative survival.
Clinic studies are those which report the diagnostic- 
breakdown of patients assessed at specialist dementia 
clinics. They typically involve more rigorous diagnostic 
procedures than incidence or prevalence studies, but suf­
fer from a lack of representativeness of the patients 
seen. Only a subset of cases in a community will ever be 
seen at such clinics and the selection mechanisms in­
volved are unknown.
The final kind of study involves the neuropathologi- 
cal examination of series of dementia cases at autopsy. 
Such studies estimate the relative prevalence of dement­
ing disorders at the point of death. Because autopsy con­
firmation is considered necessary for the definitive diag­
nosis of Alzheimer’s and vascular dementias, these stud­
ies have the greatest diagnostic validity. However, they 
also involve the least representative sampling, because 
only a subset of patients receiving specialist diagnostic 
services during life will come to autopsy. Again, the 
selection mechanisms involved are unknown.
All four kinds of study have their strengths and weak­
nesses. Basically, there is a trade-off between represen­
tativeness of sampling and validity of diagnosis. As well, 
there is the issue of measuring disease occurrence via the 
theoretically meaningful incidence rate or the more am­
biguous prevalence rate. All but the incidence studies 
are potentially influenced by differences between disor­
ders in duration of survival. The approach taken here is 
to use all four kinds of study, recognizing that none is 
perfect. If, however, consistent findings emerge from all 
types of study, considerable confidence can be placed in 
the results obtained. On the other hand, inconsistencies 
between the different types of study require considera­
tion of the possible mechanisms involved.
Methods
An effort was made to locate all relevant studies using published 
reviews of dementia epidemiology and computer searches of the 
more recent literature. Studies were included if they fell into one 
of the four classes mentioned above and gave a diagnostic break­
down of Alzheimer's and vascular dementias. The classification of 
these disorders has changed somewhat over the years, so certain 
assumptions had to be made. It was assumed that individuals clas­
sified as having senile dementia, senile psychosis, senile brain dis­
ease, primary degenerative dementia, senile dementia of the Alz­
heimer type and Alzheimer's disease were suffering from the same 
disorder. Similarly, individuals classified as having arteriosclerotic 
psychosis, arteriosclerotic dementia, cerebral arteriosclerosis, multi­
infarct dementia, dementia with cerebral infarcts, vascular enceph­
alopathy and vascular dementia were regarded as having the same 
disorder.
The following incidence studies were used; Akesson (1969). 
Bergmann et al. (1971), Kokmen et al. (1988), Li et al. (unpub­
lished). Mölsä et al. (1982), Nilsson (1984) and Rorsman et al. (1986).
The prevalence studies used were: Akesson (1969), Bollerup
(1975) , Brayne and Calloway (1989), Broe et al. (1976), Chen 
(1987), D'Alessandro et al. (1988), Evans et al. (1989), Folstein et 
al. (1985), Fukunishi et al. (1989). Gavrilova (1984), Gavrilova et 
al. (1987), Gurland et al. (1983). Hasegawa et al. (1983), Hase- 
gawa et al. (1986), Ichinowatari et al. (1987). Kaneko (1975), 
Karasawa et al. (1982), Kay et al. (1964). Kuang and Zhao (1984), 
Li et al. (1989), Makiya (1978). Mölsä et al. (1982), Motohiro et 
al. (1985), O’Connor et al. (1989). Pinessi et al. (1984), Rocca et 
al. (1990). Rorsman et al. (1986). Schoenberg et al. (1985), Shiba- 
yama et al. (1986), Sternberg and Gawrilowa (1978), Sulkava et al.
(1985) , Zhang et al. (1990) and Zhao (1986).
The clinic studies were: Cummings and Benson (1983), Erkin- 
juntti et al. (1987), Freemon (1976), Garcia et al. (1981), Hutton 
(1981), Larson et al. (1986). Maletta et al. (1982), Marsden and 
Harrison (1972), Philpot and Levy (1987), Rabins (1981), Smith 
and Kiloh (1981), Thai et al. (1988) and Victorates et al. (1977).
The neuropathological studies were: Birkett (1972), Boiler et 
al. (1989), De La Monte et al. (1989), Erkinjuntti et al. (1988), 
Gustafson and Nilsson (1982). Homer et al. (1988), Jellinger
(1976) , Kokmen et al. (1987). Malamud (1972), Matsushita and 
Ishii (1979), Mölsä et al. (1985). Moritmatsu et al. (1975), Müller 
and Schwartz (1978), Nishihara and Ishii (1986), Ojeda et al.
(1986) , Rosen et al. (1980). St. Clair and Whallev (1983), Todorov 
et al. (1975), Tomlinson et al. (1970), Tomonaga (1979), Ulrich et 
al. (1986), Wade et al. (1987) and Wilcock and Esiri (1982).
To estimate the relative occurrence of Alzheimer’s and vascu­
lar dementias, the number of Alzheimer's cases was divided by the 
number of vascular cases. Cases of mixed dementia, if classified 
separately, were ignored. A ratio of this sort has an assymmetrical 
distribution, with higher rates of Alzheimer's dementia producing 
ratios from 1 up to while high rates of vascular dementia pro­
duce ratios from 1 down to 0. To overcome this asymmetry, a 
logarithmic transformation (to base 10) was applied. With logarith­
mically transformed occurrence ratios, positive values indicate a 
higher rate of Alzheimer's dementia, negative values a higher rate 
of vascular dementia, and 0 indicates equal rates.
To make cross-national comparisons, studies were grouped by 
country. Because the number of studies from a particular country 
was often small, some adjacent countries with similar racial com­
position and culture were grouped together.
Results
Figure 1 shows the results from the four types of study. 
Moving from left to right along the horizontal axes of 
Fig. I are European countries, then countries with popu­
lations derived predominantly from European emigration 
(United States, Canada, Australia), and finally Oriental 
countries (China and Japan). Most studies provided a 
single data point in Fig.l. However, studies reporting 
both prevalence and incidence data, or reporting data on 
two samples, have provided two data points.
The incidence studies cover only a small range of 
countries. Four of the seven studies come from Scan­
dinavia, and two of these found the incidence of Alz­
heimer's dementia to be greater. The British and Ameri­
can studies both found Alzheimer's dementia to have the 
greater incidence. By contrast, the sole Chinese study 
found a greater incidence for vascular dementia.
In the prevalence studies, the evidence generally 
shows Alzheimer's dementia to be more prevalent in 
European and North American studies. The notable ex­
ceptions are the Russian studies, which have consistently 
reported vascular dementia to be more prevalent. The 
studies from the Oriental countries have also fairly con­
sistently reported vascular dementia to be more prevalent.
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Fig. 1. Ratio of occurrence of Alzheimer's dementia to vascular dementia (logarithmically transformed) from studies in various countries. 
The two open circles represent data from the same study but using different quantitative definitions of Alzheimer’s and vascular dementias
Clinic studies also cover only a limited range of coun­
tries. However, they have fairly consistently showed a 
greater occurrence of Alzheimer's dementia. The sole 
Scandinavian study stands out as having reported an 
even balance between the two major dementing disorders.
The neuropathological studies mainly show a greater 
prevalence of Alzheimer's dementia, with the exception 
of those from Japan, which generally show the opposite 
pattern.
Discussion
The amount of evidence available from different coun­
tries varies greatly. Only Great Britain, Scandinavia and 
North America have data available from all four types of 
study. In Great Britain and North America it is clear 
that Alzheimer’s dementia predominates over vascular 
dementia. In Scandinavia, the evidence is more mixed, 
but still favours a preponderance of Alzheimer's demen­
tia. It may be that vascular dementia is relatively more
common in Scandinavia than in Great Britain and North 
America, or there could be some difference in diagnostic 
practice between these regions. In the rest of Europe, 
and in Australia, what evidence there is favours a great­
er occurrence of Alzheimer’s dementia, with the notable 
exception of the three Russian prevalence studies, which 
reported an excess of vascular dementia. There is, how­
ever, good reason to doubt the results of the Russian 
prevalence studies. Shefer (1985, 1987) has carried out 
neuropathological examinations of series of dementia 
cases diagnosed by Russian psychiatrists and found that 
vascular dementia is considerably overdiagnosed there 
at the expense of Alzheimer’s dementia. The Russian re­
sults may therefore be attributed to national diagnostic 
fashion. Consequently, it can be concluded that Alz­
heimer’s dementia is the more common disorder in Eu­
rope and in countries with populations largely derived 
from European emigration.
In the Orient, however, the picture is quite different. 
Both the Chinese and Japanese prevalence studies have
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fairly consistently reported a higher prevalence of vascu­
lar compared to Alzheimer's dementia. The sole Chi­
nese incidence study also showed a greater incidence of 
vascular dementia. In the case of Japan, neuropatholog- 
ical studies confirm this pattern. The different occur­
rence ratios found in the Orient, if valid, could be due to 
either a greater occurrence of vascular dementia or a les­
ser occurrence of Alzheimer’s dementia. Of course, both 
possibilities could be simultaneously true. The possibil­
ity that vascular dementia is more common is supported 
by data from a cross-national study of stroke showing 
that Japan has a particularly high incidence (Aho et al. 
1980). If the incidence of vascular dementia is higher, 
then the overall incidence of dementia in Japan should 
be higher unless there is a reduced incidence of Alz­
heimer’s dementia to compensate. To give a numerical 
illustration, if the ratio of Alzheimer’s dementia to vas­
cular dementia was 0.67 for Japan and 4.0 for North 
America, but there was no difference in the occurrence 
of Alzheimer’s dementia, then the occurrence of the two 
disorders combined would be twice as high in Japan as 
in North America. If, on the other hand, Alzheimer’s 
dementia were found to be less common in the Orient 
than in Caucasian populations, this would be an impor­
tant aetiological clue. There is a need for studies of the 
occurrence of dementia and specific dementing disorders 
in Japan (and China) compared with Europe and North 
America, using as similar methodologies as possible. 
However, as Henderson (1990) has argued, such studies 
would be difficult to untertake. Possibly more feasible 
would be studies in single countries which have both 
Caucasian and Oriental ethnic groups.
More generally, it is apparent that information on the 
relative occurrence of dementing disorders is lacking for 
much of the world. There is no information available on 
Latin America, Africa and much of Asia, and it is quite 
possible that the epidemiology of dementia in these re­
gions is different from that seen in the developed coun­
tries investigated so far. If this area were to be tackled, 
it would be preferable to conduct studies of incidence, 
because differential survival in many such countries might 
lead to misleadingly low prevalence estimates. Well-de­
signed studies in contrasted populations or ethnic groups 
may offer an important contribution to understanding 
the causes of dementia.
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Season of birth for Alzheimer’s disease in the 
Southern Hemisphere
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From the NH & MRC Social Psychiatry Research Unit. The Australian National University, Canberra; and 
Department of Geriatric Medicine, Repatriation General Hospital, Concord, Australia
s y n o p s i s  Season of birth was compared in 170 clinically diagnosed cases of Alzheimer’s disease 
(AD) in Australia and 170 matched controls. A further comparison was made with a large 
population sample of the elderly. No evidence for seasonality of birth was found. This finding held 
not only for the total series of 170 cases, but also for the 143 born in the Southern Hemisphere, for
sporadic cases, and for those with earlier onset, 
the positive finding in London by Philpot el al.
INTRODUCTION
A large number of variables have been examined 
as possible risk factors for Alzheimer’s disease 
(AD) (Henderson, 1989; Jorm, 1990). However, 
there has been only one investigation of season­
ality of birth in AD. Philpot et al. (1989) 
compared a series of 193 clinically diagnosed 
cases of AD aged 65 and over, seen at the 
Maudsley Hospital, London, with an age- 
matched census sample of 215 417 persons. They 
found a statistically significant excess of births 
in the first quarter of the year for those 118 AD 
cases who had no known family history of 
dementia. This excess was not found among 
those likely to be familial cases. Demonstration 
of seasonality of birth would suggest, inter alia, 
the possibility of some perinatal exposure or 
insult conferring an increased vulnerability to 
AD many decades later.
We report here a study of season of birth for 
AD in Australia, conducted as part of a case- 
control study. Other aspects of the study have 
been reported elsewhere (Broe et al. 1991). If a 
seasonality effect does exist in the birth of 
persons who later develop AD, and if it operates 
in the Southern Hemisphere at the latitude of 
Sydney, an excess of births should be found in 
the third quarter of the year for AD cases,
1 Address for correspondence: Professor A. S. Henderson, NH & 
MRC Social Psychiatry Research Unit, The Australian National 
University, GPO Box 4, Canberra. ACT 2601, Australia.
These negative findings in Australia contrast with
though possibly among sporadic cases only. If 
such a seasonal effect were found in both 
hemispheres, it would suggest that some neo­
natal event may contribute to the onset of 
Alzheimer’s disease in late life.
METHOD
A case-control study of AD was undertaken in 
two Sydney hospitals (Broe et al. 1991). One 
hundred and seventy persons were clinically 
diagnosed by either of two neurologists (E. McC. 
and H.C.) as cases of AD, 83 being ’probable' 
and 87 being ‘possible’ by the NINCDS- 
ADRDA criteria (McKhann et al. 1984). An 
equal number of controls were recruited from 
the same or a neighbouring general practice as 
each case, and were matched for age and gender. 
The controls were examined in their homes by 
one of the neurologists and excluded if they had 
a Mini-Mental State Examination (Folstein et 
al. 1975) score of less than 26, could not be 
interviewed in English, or had no suitable 
informant for risk factor assessment. Informants 
were mostly spouses, siblings or offspring.
As part of this risk factor assessment, the 
informants of both cases and controls were 
asked to identify all first-degree relatives of the 
subjects, and then to report whether each relative 
had a history of ‘severe memory loss, mental 
confusion or dementia’. From the descriptions 
given of relatives with memory loss, each was
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Table 1. Number o f births per quarter o f year -  cases and controls
Population Control Roger's
Q uarter of year comparison comparison teS(
Total ——------------------------------------------------- x*  value* x 2 value* valuet
births 1st 2nd 3rd 4th ( P  value) ( P  value) ( P  value)
All cases 170 33 47 45 45 1 51 (068) 1 48 (0 69) 2 18(0-34)
' Familial' cases 52 5 14 15 18 6-88 (0 08) 4 22 (0 24) 4 46 (Oi l )
Sporadic' cases 118 28 33 30 27 0 95 (0 81) 1 91 (0 59) 1 34 (0 51)
Early-onset 
( < 75 yr) cases
83 14 23 23 23 2 72 (0 44) 2 54 (0 67) 1 95 (0 38)
Late-onset 
(5* 75 yr)
87 19 24 22 22 2 86 (0 41) 0 95 (0 81) 0 30 (0 86)
All controls 170 38 38 45 49 — — —
Population sample} 37 534 0-245 0-243 0 258 0-253 — — —
* x 1 test with 3 degrees of freedom, 
t  test with 2 degrees of freedom.
J Shows proportion o f births in each quarter
classified as most likely having AD, multi­
infarct dementia, other dementia, or no de­
mentia. Where there was at least one first-degree 
relative with likely AD, an index case was 
regarded as ‘familial’, otherwise as ‘sporadic’. 
Early-onset cases were arbitrarily defined as 
those with an estimated onset of AD before 75 
years.
For examination of seasonality in the birth 
dates of cases, a second comparison group was 
added. A large population sample was drawn of 
persons in similar age-groups as the cases. This 
sample of persons aged 60 years and over 
(N = 37 534) was obtained from the Australian 
Electoral Roll for the city of Canberra and its 
surrounding district of Eden-Monaro. While 
this is geographically close to Sydney, it is not 
the same community from which the AD cases 
were derived. Data on the date of birth for the 
elderly in the same Sydney community were not 
available to the authors. It was not possible to 
stratify the population sample by place of birth 
(Northern or Southern Hemisphere). Based on 
census data for the whole of Australia, we expect 
about 23 % of the sample would have been born 
in the Northern Hemisphere (Australian Bureau 
of Statistics, 1989).
The population sample was used to estimate 
the expected number of births in each quarter 
for comparison with the cases. The y 2 test was 
used to test variations in quarterly birth rates 
among cases compared with the sample of 
controls and compared with expected births 
based on the population sample. Cyclic trends in 
monthly and quarterly rates were also tested
using the methods of Edwards (1961) and Roger 
(1977). These methods examine seasonal trends 
without reference to a control group.
RESULTS
Table 1 shows the number of cases born in each 
quarter of the year, broken down according to 
whether the cases reported a family history or 
not (‘familial’ or ‘sporadic’), and whether onset 
was before age 75 or not. The Table also shows 
the distribution of births among the control 
sample and the proportion of births in each 
quarter for the population sample. The popu­
lation sample was used to calculate the expected 
number of births within each quarter for each 
sample of cases. The corresponding y 2 tests to 
compare the observed and expected number of 
births across quarters were not significant. 
Similarly, the tests comparing the case and 
control samples were not significant. Finally, 
Roger’s test for cyclic trend was made for each 
sample of cases and again none was significant. 
An analysis of monthly figures using Roger’s 
method also gave non-significant results.
Since 16% of the sample of cases and 21 % of 
the controls were born in the Northern Hemi­
sphere, the analysis was repeated for Southern 
Hemisphere births only. The results are shown 
in Table 2. The data from the population sample 
could not be adjusted for Northern births 
because this information was not available to us. 
Once again, there were no statistically significant 
differences. The cases with a family history of 
AD showed a marginally significant cyclic trend
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Table 2. Number o f births in Southern Hemisphere per quarter -  cases and controls
Control Roger’s
Quarter o f year comparison test
Total x 2 value* ;y2 valuef
births 1st 2nd 3rd 4th ( P  value) ( P  value)
All cases 143 27 35 42 39 1 58 (0 66) 3 37 (0 19)
' Familial ’ cases 44 3 12 14 15 6 43 (0 09) 5 91 (005)
'S porad ic’ cases 99 24 23 28 24 0 53 (0 91) 0-34 (0 84)
Early-onset cases 74 12 21 21 20 2 58 (0 46) 2 22 (0 33)
( < 75 yr) 
Late-onset cases 69 15 14 21 19 0 52 (0 91) 1 77 (0 41)
( 5  75 yr)
All controls 135 33 29 35 38
* * 2 test with 3 degrees of freedom, 
t  ,v2 lest with 2 degrees of freedom.
by Roger’s method {P =  005), showing pro­
portionally fewer births in the Southern summer 
months of January and February.
DISCUSSION
In contrast to the one previous study by Philpot 
et al. (1989) on an English series, we have found 
no evidence for seasonality of birth for cases of 
AD in Australia. This finding holds not only for 
the total series of 170 cases, but also for those 
born in the Southern Hemisphere, for sporadic 
cases, and for those with earlier onset. For the 
44 'fam ilial’ cases born in the Southern Hemi­
sphere, a marginally significant cyclic trend was 
noted. Given the small sample size, the number 
of tests being conducted on the overall sample, 
and the possible error in classifying cases as 
familial or sporadic, it seems likely that this is a 
Type 1 error. The finding is also inconsistent 
with that of Philpot et al. (1989) who found an 
effect with sporadic cases only.
The series of 193 AD cases reported by 
Philpot et al. were mainly persons who had been 
referred to clinics at the Maudsley Hospital. Our 
cases were likewise referred to the dementia 
clinics at two Sydney hospitals. There is no 
plausible basis for a selection effect in referral 
which would influence seasonality of birth in 
London but not in Sydney. The one attribute in 
which the two series may have differed is the 
quality of information on family history. In our 
study, each first-degree relative was identified by 
the informant, who was then asked if that 
person had ever had ‘severe memory loss, mental 
confusion or dementia, even in the year or two 
before death’. Sixty of the 170 case informants
and 48 of the 170 control informants were 
unable to answer this question for at least one of 
the subject’s first-degree relatives. Informants 
who were children had the greatest difficulty 
answering questions about their grandparents 
who had died many years earlier, and there were 
also problems in families who had scattered and 
maintained no contact. Among the 118 cases 
considered to be sporadic, there may have been 
some who were in fact familial. Misclassification 
of the 52 cases who reported a family history of 
AD is also possible. It is often difficult for an 
informant, reporting on the last year or two of a 
very elderly, frail person, to distinguish the one 
who had ‘just faded away with age’ from the 
one who had suffered ‘mental confusion’. 
However, results were unchanged if only cases 
and controls with complete data were con­
sidered. It is unclear if the accuracy of ascer­
taining familial and sporadic cases was similar 
in the London and Sydney studies.
We conclude that in this Australian sample of 
AD cases, there is no evidence for seasonality of 
birth, a finding contrary to the one previous 
study. It may be that a birth seasonality effect 
does exist, but only in climates associated with 
higher latitudes. Alternatively, there may con­
ceivably have been a Type 1 error in the London 
study or a Type 2 error in the Sydney study. As 
our sample consisted of only 170 cases, of whom 
143 were born in the Southern Hemisphere, 
seasonal trends would need to be considerable 
before they could be detected with high power. 
For example, suppose there was truly an effect 
of the magnitude observed by Philpot et al. 
(1989), with 0-34 of births in the first quarter, 
compared to 0-22 in each of the other three
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quarters; and suppose we compared the ob­
served frequency of births in each quarter to the 
distribution of births in the population sample. 
Then, for a Type 1 error of 0 05 and a sample of 
170 cases, the probability of a Type 2 error 
would be 0-4. For a sample of 140 cases, the 
probability of a Type 2 error would be about 0 5 
(Cohen, 1977). In the light of this, the hypothesis 
that there is a birth seasonality effect in AD 
requires further evidence, which should include 
data from different latitudes.
We wish to thank Dr Andrew Mackinnon for 
extracting the population sample data from the 
electoral roll.
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Psychiatric History and Related 
Exposures as Risk Factors for 
Alzheimer's Disease: A Collaborative 
Re-Analysis of Case-Control Studies
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K KONDO, J A MORTIMER, W A ROCCA, S L SHALAT, H SOININEN, A HOFMAN FOR THE EURODEM 
RISK FACTORS RESEARCH GROUPt
Jorm A F (NH and MRC Social Psychiatry Research Unit. The Australian National University, Canberra, Australia), van 
Duijn C M, Chandra V, Fratiglioni L, Graves A Ö, Heyman A, Kokmen E, Kondo K, Mortimer J A, Rocca W A, Shalat S L, 
Soininen H, Hofman A for the EURODEM Risk Factors Research Group. Psychiatric history and related exposures as 
risk factors for Alzheimer's Disease: A collaborative re-analysis of case-control studies. International Journal of Epi­
demiology 1991; 20 (Suppl 2): S43-S47.
Data from case-control studies of Alzheimer's disease (AD) were pooled to examine the possible roles of history of 
depression, anti-depressant treatment and adverse life events as risk factors. History of depression was found to be 
associated with AD, although the effect was confined to late onset cases. The association held for episodes of depres­
sion more than 10 years before AD onset, as well as for episodes occurring within a decade of onset. No association 
was found with anti-depressant treatment. However, data were only available from two studies, limiting the power of 
the analysis. Also, no association was found with the three major life events considered in the pooled analysis: death 
of spouse, death of a child and divorce.
INTRODUCTION
This paper considers whether individuals who have a 
history of psychiatric disorder are more likely to 
develop Alzheimer's disease (AD). While there is a 
potentially large numberof psychiatric disorders which 
could be investigated as risk factors for AD, many of 
these present severe methodological problems. In 
making a clinical diagnosis of AD, it is necessary to 
exclude disorders which could provide an alternative 
explanation of the dementia. In practice, this means 
that subjects with a range of psychiatric disorders, 
including psychotic disorders, mental retardation and 
alcohol abuse, may be excluded. Because of the exclu­
sion procedure involved in making a clinical diagnosis 
of AD. such disorders cannot be easily researched as 
potential risk factors. In practice, the major psychiatric
’ N H & M R C  Social Psychiatry Research Unit The Australian 
National University. Canberra. Australia
tE U R O D E M . Department of Epidemiology and Biostatisucs. 
Erasmus University Medical School. Rotterdam. The Netherlands 
Reprint requests: E U R O D E M . Department of Epidemiology and 
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disorders which can be investigated by the case-control 
method are those involving anxiety and depression 
However, depression is the only disorder which has 
been systematically investigated in case-control stud­
ies. History of depression has been considered in a 
number of studies, with four of these reporting this 
exposure to be significantly more common in cases 
than contro ls.H ow ever, this difference could be due 
to depression being an early manifestation of AD . It 
has been reported in clinical studies that elderly 
patients thought to be suffering from depression can 
progress to clear dementia over a period of a fev. 
years." In order to allow for this possibility, studies of 
history of depression need to pay close attention to the 
timing of depressive episodes.
There are other exposures related to psychiatric 
history which are of interest as potential risk factors, in 
particular psychiatric treatments and adverse life 
events. Treatments of psychiatric disorders are ol 
interest as potential risk factors because they alter neu 
rotransmitter functioning and have been implicated ir 
other neurological disorders viz. Parkinsonism and tar­
dive dyskinesia. Among the treatments which could be
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La b i  t I Results from case-control studies examining history o f 
depression as a risk factor (or A D
Exposure frequency
Study Cases Controls RR 95% Cl
Studies which assessed depression before AD onset
Australia 11/170 4/170 2.75 0 88-8 56
USA. Bedford4 4/103 8/208 0.83 0.22-3 14
U SA . M inneapolis' 4/78 1/48 3.00 0.32-28.62
USA. Rochester1’ 36/392 21/392 1.84 1.04-3.25
All studies 55/743 34/818 1.82 1 16-2 86
Studies which assessed depression at any time during life:
Finland41 0/62 2/53 0.00 0.01-3.65
USA, Durham " 7/45 6/92 2.86 0.82-10.02
considered are electroconvulsive therapy, lithium, 
anti-depressants and major and minor tranquillizers. 
Treatments such as Irthium and ECT have seldom been 
assessed in case-control studies, perhaps because they 
are fairly rare in the population. Major tranquillizers 
are difficult to assess as a risk factor for two reasons. 
Firstly, they are used to treat psychotic disorders which 
may be an exclusion factor in diagnosing AD. 
Secondly, they may be associated with AD because 
major tranquillizers are sometimes used to control 
behaviour problems which accompany the disease. 
Minor tranquillizers and anti-depressants could poten­
tially be investigated in case-control studies, but have 
been assessed in relatively few studies. Only one study 
collected data on both minor tranquillizers and anti­
depressants, one collected data on anti-depressants 
only and another on minor tranquillizers only. None of 
these studies reported significant associations. 2 3 6 
Nevertheless, these exposures merit further investiga­
tion. Unfortunately, one of the studies examining 
minor tranquillizers used a different method for assess­
ing this exposure in cases compared to controls and is 
therefore not comparable with the other study. The 
studies examining anti-depressants are, however, 
comparable and were included in the present re-analy­
sis. Anti-depressant treatment may be a risk factor for
Table 3 Time at which depression occurred in relation to AD  onset
Exposure frequency
Group Cases Controls RR 95% Cl
Depression up to 10 years before AD onset:
All subjects 19/742 13/818 1.60 0.77-3.30
Early onset 7/203 10^275 0.71 0 25-1 98
Late onset 12/523 3/509 4.46 1 24-16 02
Depression more than 10 years before AD onset-
All subjects 35/742 21/818 1.92 1 11-3.32
Early onset 7/203 6/275 1.70 0 51-5.65
Late onset 28/523 15/509 2.01 1.06-3.80
T able. 2 History of depression as a risk factor ,n subgroups o f cases
Exposure frequency
Subgroup Cases Controls RR 95% Cl
Familial’ 4/79 3/93 1 .34 0 30-5.93
Sporadic" 9/149 9/206 1 54 0.55-4.26
Female 34/377 19/377 1 93 L0S-3.55
Male 21 /366 15/44 1 1 68 0.83-3.41
Early onset 14/203 16/278 1 01 0.45-2.26
Late onset 41/524 18/509 2 44 1.36-4.36
‘ Data available only from Australia and USA. Bedford
AD because of the anti-cholinergic effect of many anti­
depressants and the role of this transmitter system in 
the disease.
Adverse life events have been investigated as trig­
gers for many psychiatric disorders and have also been 
assessed in several case-control studies of AD. A small 
early study found more stressful life events in cases of 
‘organic brain syndrome’ during the five years before 
onset . 7 However, larger case-control studies of AD 
have been negative. 2'8 4 The major problem in assessing 
life events in AD is that it necessarily has to be via 
informants and involves recalling events which may 
have occurred in the distant past. The accuracy of the 
data may sometimes be doubtful and informants of 
cases may be more likely to recall events in line with 
their preconceptions about possible links. A solution is 
to consider only clearly-defined major life events which 
would presumably always be known to an informant 
e.g. death of a spouse, death of a child, divorce. Such 
life events have been researched in a number of case- 
control studies and are the focus of analysis here.
To summarize, history of psychiatric disorders, psy­
chiatric treatments and severe life events have all been 
considered as potential risk factors for AD. However, 
either because of methodological problems in collect­
ing the relevant data or because too few data are avail­
able, only a subset of these exposures were included in 
the collaborative re-analvsis reported here. The speci­
fic exposures considered in the re-analysis were history 
of depression, treatment with anti-depressants and 
severe well-defined life events viz. death of a spouse, 
death of a child and divorce.
T able 4 Results from case-control studies examining anri-depressant 
treatment as a risk factor for AD
Exposure frequency
Study Cases Controls RR 95% Cl
Australia 14/151 13/167 1 22 0.51-2 95
USA, Minneapolis 3/74 1/48 1 00 0.06-15 86
All studies 17/225 14/215 1.20 0.52-2 78
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Table 5 Results from case-control studies examining death o f a spouse 
as a risk factor
Exposure frequency
Siudv Cases Controls RR 95% Cl
Australia' 85/170 86/170 0.97 0.58-1 62
Finland*'' 27/65 21/53 114 0.54-2 40
Italy* 18/116 21/97 0.45 016-1 31
N etherlands1'' 44/198 21/198 2.36 1.34-4 17
U SA . Denver” 36/61 39/61 0.63 0.20-1 91
USA. Durham " 7/46 15/92 0.91 0.32-2.58
USA, M inneapolis' 8/78 6/48 0.40 0.08-2.07
All matched studies 198/669 188/666 1.12 0.83-1.51
All matched
studies—excluding
Netherlands 154/471 167/468 0.78 0.54-1.14
'U nm atched study
METHODS
Data from 11 case-control studies were considered for 
inclusion in the present re-analysis.2"1'6 8-14 Data on 
history of depression were collected in six of the stud­
ies^-1611 15 In all of these studies only medically-treated 
depression was considered. In four of these studies, 
this exposure was assessed through an interview with 
an informant, in one study it was assessed from medical 
records1' and in another from subject and informant 
interviews checked from medical records.6 Four of the 
six studies also collected data on when the depression 
was diagnosed.2"113 Two studies recorded age at diag­
nosis while the other two recorded the date of diag­
nosis. In the present re-analysis, only episodes of 
depression which occurred more than one year before 
onset of AD were considered.
Two studies collected data on use of anti-depres­
sants.23 Both relied on informants’ reports of this 
exposure. Anti-depressant use was considered as an 
exposure if it occurred at any time over a subject’s life.
T able 7 Results from case-control studies examining divorce as a risk 
factor
Exposure frequency
Study Cases Controls RR 95% Cl
Australia 5/170 9/170 0.50 0.15-1.66
Finland 3/63 3/53 0.83 0.16-4.31
Italy 2/116 3/97 0.33 0.03-3.17
Netherlands 23/198 12/198 2.10 1.00-4.41
USA. Denver 17/63 18/60 0.92 0.40-2.08
U S A . Durham 0/46 0/92 — —
USA. Minneapolis 1/78 0/48 — —
All matched studies 
All matched
48/671 42/665 1.15 0.72-1.84
studies— excluding 
Netherlands 25/473 30/467 0.74 0.39-1.38
Table 6 Results from case-control studies examining death o f a child 
as a risk factor
Exposure frequency
Study Cases Controls RR 95% Cl
Australia 33/170 34/170 0 96 0.55-1.66
Italy 24/116 14/96 1 34 0.63-2.81
Netherlands 27/198 19/198 1 45 0.79-2.66
USA. Denver 20/63 17/60 1 30 0.57-2.97
USA. M inneapolis 9/78 6/48 100 0.25-4.02
All studies 11 3/625 90/572 1.20 0.87-1.65
Five of the 11 case-control studies collected at least 
some data on life events.2 3 8 912 The range of life events 
covered varied considerably from study to study. The 
only events recorded with any consistency were death 
of a spouse, death of a child and divorce. Data on death 
of a spouse and divorce were collected in four stud­
ies,38912 while data on death of a child were collected 
in five.2 3-8,9-12 However, in three other studies, death of 
a spouse or divorce could be inferred through data on 
current marital status.2 611 It is possible that some sub­
jects re-married after being widowed or divorced, in 
which case the frequency of these exposures would be 
underestimated. However, in most cases current mar­
ital status would be a good indicator of these life 
events. In all studies, the data on life events were col­
lected through interviews with informants. In the pres­
ent re-analysis, the life events were included as an 
exposure if they occurred at any time over a subject’s 
life.
The data from the case-control studies were pooled 
using the methods described in a companion paper.15
RESULTS
Table 1 shows the results from the four studies which 
provided data on episodes of depression which 
occurred before onset of AD, together with the results 
from pooling their data. Data on history of depression
T able 8 Results from case-control studies examining any o f the three 
life events (death o f spouse, death o f child, divorce)
Exposure frequency
Study Cases Controls RR 95% Cl
Australia 99/170 94/170 1.16 0.73-1.86
Italy 38/116 31/96 0.84 0.38-1 88
Netherlands 81/198 47/198 2.32 1.48-3.64
USA, Denver 50/61 45/58 1.50 0.53-4.21
USA, M inneapolis 16/78 12/48 0.63 0.20-1 91
All studies 284/623 229/570 1.43 1 09-1 89
All studies— excluding 
N etherlands 203/425 182/372 1.05 0.74-1.50
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Ta b lk  9 Death o f a spouse as a risk factor in subgroups o f eases
Subgroup
Exposure frequency 
Cases Controls RR 95% Cl
A ll matched studies:
Familial 71/227 61/250 1 48 0 92-2.39
Sporadic 86/307 87/309 0 98 0.63-1 51
Female 164/382 149/401 1 37 0 96-1.95
Male 34/287 39/265 0 63 0 34-1 16
Early onset 73/415 58/425 1 47 0.98-2 19
Late onset 122/236 128/216 0 71 0 43-1.16
A ll matched studies— excluding Netherland s
Familial 49/131 49/154 119 0.65-2.19
Sporadic 64/205 78/207 0 57 0.32-1.01
Female 123/258 135/277 0.82 0 52-1.28
Male 31/213 32/191 0 70 0 35-1.38
Early onset 31/228 38/238 0.86 0 48-1.55
Late onset 122/236 128/216 0.71 0.43-1 16
were also available from two other studies, but age at 
which depression occurred was not determined. 
Nevertheless, the results from these studies are worthy 
of mention and are shown in the lower part of Table 1 
Overall, the data indicate that there is an association 
between history of depression and AD
The data on history of depression were analysed sep­
arately for various subgroups of cases, giving the 
results shown in Table 2. The RRs are similar for famil­
ial and sporadic cases and for males and females, but 
late onset cases (2= 70 years) have a larger RR than 
early onset cases. However, this difference only 
approaches statistical significance (p = 0.08).
To assess whether depression may have been associ­
ated with AD as a prodromal feature, separate analy­
ses were carried out for episodes up to 10 years before 
AD onset and more than 10 years before onset. The 
results of these analyses are shown in Table 3. It
Table 10 Death o f a child as a risk factor m subgroups o f  cases 
Exposure frequency
Subgroup Cases Controls RR 9<;<yo £-|
Familial
Sporadic
Female
Male
Earlv onset 
Late onset
30/2(U
59/28$
74/35.7
39/272
61/776
52/23$
71/199
41/271
62/339
28/233
34/346
55/215
0.96 0 .56 -166
139 0.87-2.20
1 15 0.78-1.71
129 0.76-2.20
165 1.05-2.57
0.87 0.54-1.38
appears that AD is associated with depression in both 
periods.
The results from the two studies of anti-depressant 
use are shown in Table 4. When the results were 
pooled, there w-as no association. Because of the small 
number of studies involved, it was not feasible to do an 
analysis by subgroups
The results from studies examining life events are 
shown in Tables 5-8. These Tables give the RRs for 
particular life events as well as for experiencing any of 
the three major events analysed here. It can be seen 
that only the Netherlands study found any association. 
The results from this study were found to differ signifi­
cantly from other studies for death of a spouse, divorce 
and for experiencing any of the three events. The bot­
tom of Tables 5. 7 and 8 shows the pooled analyses 
when all studies with matched designs are included and 
also when the Netherlands study is excluded. When all 
studies are included there are associations between 
AD and having experienced any of the three life 
events. However, once the Netherlands study is 
excluded, no association remains.
Tables 9-12 shows the results of pooled analyses of 
life events with various subgroups. Again, a number of
T able 11 Divorce as a risk factor m subgroups o f cases
Exposure frequency
Subgroup Cases Controls RR 95% Cl
A ll matched studies:
Familial 14/229 23/250 0.53 0.24-1.13
Sporadic 27/307 16/308 1 83 0 91-3.70
Female 32/384 30/401 1.09 0 62-1 91
Male 16/287 12/264 1 30 0.57-2 97
Early onset 25/415 16/425 1.57 0 80-3 07
Late onset 20/238 26/215 0 68 0 34—1 39
A ll matched studies— excluding Netherlands
Familial 7/133 15/154 0 27 0.08-0 98
Sporadic 11/205 12/206 0.80 0.32-2.03
Female 16/260 23/277 0 59 0.27-1 29
Male 9/213 7/190 1 17 0.39-3.47
Early onset 5/228 4/238 1 00 0.25-4.00
Late onset 20/238 26/215 0.68 0 34-1.39
Table 12 Any o f the three life  events in subgroups o f cases
Exposure frequence
Subgroup Cases Controls RR 95% C l
A ll studies
Familial 88/202 76/198 1.33 0.85-2 09
Sporadic 139/288 109/270 1 53 1.02-2.27
Female 208/351 165/338 1 73 1.22-2 46
Male 76/272 64/232 1 03 0.65-1.63
Early onset 132/376 81/346 1.93 1.34-2.78
Late onset 148/236 146/213 0.85 0.54-1.34
A ll studies— excluding Netherlands
Familial 54/106 51/102 1 11 0.59-2 10
Sporadic 92/186 87/168 0.86 0.51-1.47
Female 144/22- 134/214 1.09 0 68-1.74
Male 59/198 48/158 1.00 0.57-1 74
Early onset 55/189 36/159 1 47 0.82-2.64
Late onset 148/236 146/213 0 85 0.54—1 34
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associations arc present when the Netherlands study is 
included, bui these disappear when it is excluded.
DISCUSSION
O f the three types o f exposures considered here, only 
history of depression emerged as a risk factor for AD. 
This association was confined to late onset cases. 
Depression was found to he more common, not only in 
the decade before onset o f A D , but also earlier in life, 
implying that it is not simply a prodromal feature of 
A D  Recall bias on the part of informants is not a 
plausible explanation of this association, because it 
was also observed in the one case-control study which 
used medical records to determine exposures.1' While 
the evidence for an association appears convincing, the 
findings require replication in prospective studies 
involving confirmed cases of depression and controls. 
It would be particularly interesting to know whether 
one type o f depression (e.g. bipolar, unipolar) specific­
ally confers risk.
What explanations might be given for an association 
with history of depression0 One possibility, considered 
in the present analysis, is that anti-depressant treat­
ment is responsible, perhaps because of the anti-chol­
inergic effects of many anti-depressants. While the 
present data did not support a role for anti-depressants 
they came from only two studies and these studies did 
not specifically examine anti-depressants which have 
anti-cholinergic effects. Another possibility is that the 
neurotransmitter systems disrupted in depression also 
have some involvement in AD . For example, the nor­
adrenergic system has been implicated in depression 
and is sometimes found to be abnormal in A D . How­
ever. noradrenergic abnormalities have been reported 
as confined to early onset cases,16 whereas the present 
data show that history of depression is associated with 
late onset A D . A  third explanation, not necessarily 
incompatible with the previous one, is that individuals 
with a history of depression already have a subtle cog­
nitive defic it,17 so that they more quickly reach the 
threshold for the appearance of dementia in old age.
When adverse life events were examined, no associ­
ation with A D  was found except in the Netherlands 
study. The results from this study were not homog­
eneous with those from other studies. When the Neth­
erlands results were excluded, no association was 
found in the pooled data. The anomalous results from 
the Netherlands may have been due to the method of 
control selection. Matched controls were selected 
randomly from the general population, but only 61% 
of the selected individuals agreed to participate, 
requiring the selection of substitutes. The controls 
included in the study may have been a biased sample
with respect to life events. Given the overall negative 
results in the pooled analyses, further research on life 
events as a risk factor for AD would not seem 
profitable.
The pooled analyses reported here cover only a 
small number of exposures from the domain of psychi­
atric history. There is still a need for data to be gath­
ered on history of psychiatric disorders other than 
depression and on history of psychiatric treatments.
REFERENCES
1 Barclay L L. Khcyfcls S. Zemcov A. Blass J P. McDowell F H Risk 
factors in Alzheimer's Disease In: Fisher A. Flanin I. Lach- 
man C. cds Alzheimer's and Parkinson's diseases New York 
Plenum. 1985 pp 141-6
' Broc G A. Flenderson A S. Creasey H . etal A case-control study of 
Alzheimer's disease in Australia Neurology 1990. 40: 
1698-1707
French L R. Schuman L M. Mortimer J A. Hutton J T. Boatman 
R A. Christians B A case-control study of dementia of the 
Alzheimer type. Am J Epidemiol 1985; 121: 414-21 
4 Shalat S L. Seltzer B. Pidcock C. Baker E L Risk (actors for A lz ­
heimer's disease: A case-control study. Neurology 1987; 37: 
1630-3.
Reding M J. Haycox J. Blass J P Depression in patients referred to a 
dementia clinic: A three-year prospective study. Arch Neurol 
1985; 42: 894-6
" Soininen H . Heinonen O P. Clinical and etiological aspects of senile 
dementia Eur Neurol 1982. 21: 401-10 
Amster L E. Krauss H H The relationship between life crises and 
mental deterioration in old age Ini J Aging Hum Dev 1974; 5: 
51-5.
' Amaducci L A . Fratigliom L. Rocca W A. eta/ Risk factors for c lin i­
cally diagnosed Alzheimer's disease: A case-control studv of 
an Italian population Neurology 1986: 36: 922-31 
'Chandra V. Philipose V. Bell P A. Lazaroff A. Schoenberg B S 
Case-control study of late onset probable Alzheimer's 
disease' Neurology 1987. 37: 1295-30(1 
" Graves A B. White E. Koepsell T. ei at A case-control study of Alz 
hcimer's disease Ann Neurol 1990: 28: 766-74 
Hevman A, Wilkinson W E. Stafford J A. Helms M J. Sigmon A  H. 
Weinberg T. Alzheimer's disease: A study of epidemiological 
aspects Ann Neurol 1984. 15: 335—II 
Hofman A . Schulte W. Tanja T A eial Histors of dementia and Par­
kinson's disease in Ist-degrec relatives of patients with A lz ­
heimer's disease Neurology 1989:39: 1589-92 
Kokmen E. Beard C M. Chandra V. Offord K P. Schoenberg B S. 
Ballard D J Clinical risk factors for Alzheimer's disease A 
population-based case-control study Neurology 1991. in 
press.
4 Kondo K. Yamashita I A case control study of Alzheimer's disease 
in Japan, association with inactive psychosocial behaviors In 
Hasegawa K. Homma A. eds Psychogeriatrics: Biomedical 
and Social Advances Amsterdam: Exerpia Medica. 1990. pp 
49-53.
van Duijn C M. Stijnen T. Hofman A Risk factors for Alzheimer's 
disease: Overview of the EURODEM collaborative re-analv- 
sis of case-control studies. Im J Epidemiol. 1991 20 (Suppl 2): 
S4—S12.
* Rossor M N. Iversen L L. Reynolds G P. Mountjov C R Roth M 
Neurochemical characteristics of early and late onset types of 
Alzheimer's disease Brit Med J 1984 . 288 : 961—4 
Miller W R Psychological deficit in depression Psychol Bull I9~5 
82: 238-60
In te rna tiona l Journal o( Epidem iology 
© In te rn a tio n a l E p idem iologica l Association 1991
Vol 20. No 2 (Suppl. 2) 
Printed in Great B rita in
Familial Aggregation of Alzheimer's 
Disease and Related Disorders: A 
Collaborative Re-Analysis of 
Case-Control Studies
C M VAN DU IJN ,*t D CLAYTON, V CHANDRA, L FRATIGLIONI, A B GRAVES, A HEYMAN, A F JORM, 
E KOKMEN, K KONDO, J A MORTIMER, W A ROCCA, S L SHALAT, H SOININEN, A HOFMAN FOR 
THE EURODEM RISK FACTORS RESEARCH GROUP.t
van D uijn C M (Departm ent of Epidem iology and B iostatistics. Erasmus U niversity Medical Scnool, R otterdam . The 
Netherlands), C layton D, Chandra V, Fratig liorii l .  Graves A B. Heyman A, Jorm  A F. Kokmen E, Kondo K. M o rtim e r J A, 
Rocca W  A. Shalat S L. Soininen H. Hofman A for the EURODEM Risk Factors Research Group. Familial aggregation of 
A lzhe im er s Disease and related disorders: A collaborative re-analysis o f case-control studies. In te rna tiona l Jou rna l o f 
E pidem io logy, 1991. 20 (Suppl 2): S13-S20.
Case-control studies of A lzheimer's disease were re-analysed to exam ine the association of A lzheim er's disease w ith  
fam ily  h is to ry in first degree relatives of dementia, D own's syndrom e and Parkinson's disease. Overall, the re la tive risk 
o f A lzhe im er s disease for those w ith at least one first degree re lative w ith  dem entia was 3.5 (95% confidence interval 
2.6-4.6). S tra tifica tion  according to age o f onset of A lzhe im er's disease showed that the relative risk decreased w ith 
increasing onset age. However, among patients w ith  an onset o f disease after 80 years, there were still s ian ifican tly  
m ore subjects w ith  one or more first degree relatives w ith  dem entia as com pared to contro ls (relative risk 2.6; 95% 
confidence interval 1.3-5.2). The relative risk of A lzheim er's disease was s ign ifican tly  low er in patients w ho  had one 
firs t degree re lative w ith  dementia (relative risk 2.6, 95% confidence interval 2.0-3.5) as com pared to those w ho  had 
tw o or m ore affected relatives (relative risk 7.5; 95% confidence interval- 3.3-16.7). Furthermore, the re-analysis 
s ow ed a s ign ificant association between Alzheimer s disease and fam ily  h isto ry o f Down's syndrom e (re la tive risk 
2.7; 95% confidence interval 1.2-5.7), w hich was strongest in those patients w ho had a positive fam ily  h is to ry  of 
dem entia . The re lative risk of A lzheim er's disease for those w ith  a positive fam ily  h is to ry of Parkinson's disease was 2 4 
(95% confidence interval 1.0-5.8).
IN TRO DU CTIO N
Although the cause of Alzheimer's disease (A D ) is still 
unknown, genetic factors seem to play an important 
role in its aetiology. U V 5  Together with age. a positive 
family history of dementia is one of the few established 
risk factors of A D . 6 AD  has also been linked with a 
family history of Down’s syndrome and of Parkinson's 
disease 61 In this paper we present a re-analvsis of 
case-control studies that examined familial aegrega- 
tion of A D  and other disorders. 7 16 The aims of this 
analysis were to compare risk estimates from the indi-
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vidual studies, to analyse the pooled data in order to 
obtain stable risk estimates, and to study subgroups in 
the pooled data set. based on gender, onset age and 
family history of dementia. First, we w ill brieflv review 
the evidence for an association of A D  with family 
history of dementia. Down's syndrome and Parkin­
son’s disease
Familial aggregation of Alzheimer's disease has been 
long recognised. 1718 In a number of families the disease 
is apparently inherited as an autosomal dominant dis­
order . 2 It has been suggested that all cases of AD may 
be due to autosomal dominant inheritance.u , '2: Other 
studies have suggested a more complex mechanism, in 
which genetic as w’ell as environmental factors may be 
implicated.2*^*' There is some evidence from genetic 
studies that the strength of familial aggregation of AD  
may vary with age of onset. Heston has suggested that 
familial aggregation of AD may be specific to early
S13
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onset patients. In his study, familial aggregation was 
observed only in early onset patients. The risk in rela­
tives of autopsy-proven patients diagnosed after the 
age of 70 years was not statistically different from the 
nsk in the general population Thai and coworkers 
reported that nearly 50% of the patients with early 
onset of disease (<55 years) had a positive familv 
history of dementia, as compared to only 25% of those 
with a late onset.27 Although several studies have also 
supported this hypothesis,1' u modification of the 
association between AD and family history of demen­
tia by age of onset was not observed in other 
studies.29-31
Family history of dementia has been studied in a 
variety of case-control studies.7'9 "'I315 IVV5-36 Nine 
studies reported a significantly higher risk of AD for 
relatives of patients with dementia. The only study that 
failed to show familial aggregation of AD was of late 
onset patients.12 In studies that comprised only early 
onset cases, an increase in risk of AD for subjects with 
a positive family history of dementia was consistently 
reported.7 9 33
Family history o f  D ow n’s syndrome has been associ­
ated with AD There is much evidence for a link 
between AD and Down s syndrome. The Alzheimer 
type neuropathological changes have been shown in 
patients with Down's syndrome37^ 39 and genetic linkage 
to chromosome 21 has been reported in a number of 
families in which AD was apparently inherited as an 
autosomal dominant disorder. ' These observations 
have led to the hypothesis of familial aggregation of 
A D  with Down’s syndrome. A higher frequenev of 
presenile AD than expected has been observed in rela­
tives of patients with Down's syndrome.11' but this find­
ing was not confirmed by a study of the family history 
of dementia of 188 patients with trisomy 21 and 185 
controls.41 It cannot be excluded, however, that AD is 
associated with family history of Down s syndrome due 
to translocations on chromosome 21 41 Studies of the 
family history of Down’s syndrome ot patients with 
A D  have also yielded equivocal results. Tamily history 
of Down s syndrome has been studied in ten stud- 
jes 9." K-'ö w.2CU6 JI.32.42 Although seven studies observed 
more patients with a positive family history of Down s 
syndrome as compared to controls.9 1112 16 26 3132 a sig­
nificant association was established in only three stud­
ies.916-6 The study of Heston suggested that the risk 
was only increased for early onset A D .26 In three stud­
ies that have examined family history of Down’s syn­
drome, no patients or controls with a positive family 
history were found. ' So far it has not been possible 
to discern whether the negative findings of these stud­
ies reflect the low rate of occurrence of Down’s syn­
drome (1 in 7(X) in the general population) or a true 
lack of association Another issue to resolve is whether 
familial aggregation of AD with Down’s syndrome is 
found more in familial cases specifically, as would be 
predicted by a genetic link between AD and Down's 
syndrome.
Parkinson's disease is a neurological disorder that 
has been associated with A D . AD and Parkinson s 
disease share several neuropathological character­
istics4' and it has been suggested that AD and Par­
kinson's disease may have a common aetiology.44 Two 
case-control studies of AD have investigated family 
history of Parkinson's disease.711 In both studies there 
were more Alzheimer patients with a first degree rela­
tive with Parkinson's disease as compared to age- and 
sex-matched population controls. In the largest studv. 
a significant increase in risk was observed, particularly 
in men with early onset of A D . 7
METHODS
Family history data have been assessed in seven case- 
control studies in this re-analysis45 in which the data 
had been collected symmetrically for patients and con­
trols (Table 1) 9 !V1V16 Family history was obtained 
in five studies by a personal interview.'91112" in one 
study by telephone interview" and in one studv bv a 
questionnaire mailed to the informant." In the Dutch 
study family history data were alwavs verified by a 
second informant who was a first degree relative of the 
participant. The analysis was restricted to disorders in 
first degree relatives. To increase comparability, we 
restricted the case-control comparisons to control sub­
jects derived from the population.
All seven studies collected data on family historv ot 
dementia. The analysis included all first degree rela­
tives with a history of dementia, not A D  specificallv. 
because anamnestic information on the cause ot 
dementia is not likely to be reliable. In addition, 
affected relatives may have been diagnosed vears 
before, when the diagnosis of A D  may have been less 
accurate Family history of D ow n’s syndrome has been 
assessed in seven studies.7 9111216 In two studies, no dis­
tinction was made between D ow n’s syndrome and 
mental retardation 9 " Family history of Parkinson's 
disease has been studied in two investigations.' 11 Both 
studies have excluded patients with a historv of Par­
kinson’s disease before the onset of A D  In the Dutch 
study the diagnosis of Parkinson's disease was checked 
with independent medical records.7 The number of 
first degree relatives, a putative confounder, was avail­
able in six of the seven eligible studies (Table 1)
The strength of the association was assessed bv com­
puting the odds ratio as an estimate of the relative risk
f a m i l y  h i s t o r y  AND A L Z H E IM E R 'S  DISEASE SI 5
I ' " "  1 o f  die F U R O M IM  coll,,ho rnlwe analysis o f  case-control studies that assessed family history 
Parkinson s disease
o f ile n ie n lia . D o w n  v w n d ro n te  01
Cases Controls D em entia
Number
Aus tral ia" 170 170
—
Ita ly" 1 lb 97
4
N e th e r l a n d s ’ 198 198 4
U SA . Bedford 107 102
U S A .  D e n v e r 1 64 64
U SA . Durham'' 4 b 92 4
U S A . S ea t t le1' 140 1.40
*
(RR). Conditional logistic regression analysis was used 
to take the effects of education, the number of siblings 
and the matching variables age and gender into 
account.4“’ In this paper, we present the adjusted rela­
tive risks with 95% confidence intervals (95% Cl). 
Stratified analyses were conducted based on gender, 
onset age and family history of dementia. For the latter 
subgroup, the family history was considered positive 
for those who had at least one first degree relative with 
dementia
RESULTS
Family history of dementia
Table 2 shows the relative risks of AD for first degree 
relatives of patients with dementia in the seven individ­
ual studies and in the pooled analysis. Overall, the 
relative risk of AD for those with at least one first 
degree relative with dementia was 3.5 (95% Cl 2.6- 
4.6). The test for heterogeneity indicated no evidence 
for heterogeneity in relative risks, except for the risk 
observed in the Denver study., :The latter study of late 
onset AD (onset age 70 years or over) deviated signifi­
cantly (p = 0.01) from the other studies in the overall 
analysis as well as in a subgroup analysis of late onset
U ttLt 2 Family fmiory o f dementia and the relative risk o f 
Alzheimer's disease
Exposure frequency
S,udV Cases Controls RR* 95% Cl
Australia 58/170
Italy 29/116
Netherlands 9o/198
USA. Bedford 21/103
USA. Denver 21/54
USA. Durham 25/44
U SA . Seattle 55/129
Overall analvsis 305/814
Excluding USA.
Denver 284/760
21/170 3 8 2 1-6.9
12/97 2.6 1.0-7 5
37/198 4.8 2 8-8.1
9/162 4.4 1 8-10 7
18/50 1 0 0.5-2 2
14/87 7.2 2 7-191
29/130 2 5 1 4-4 4
140/894 3 5 2 6-4 6
122/844 3.6 2.7—4 9
Alzheimer patients In the present study, the relative 
risks were similar for men (RR 3.9; 95% Cl 2.5-6 5) 
and women (RR 3 3; 95% Cl 2.3-4.6). Stratification 
according to age of onset of AD showed that the rela­
tive risk decreased with increasing onset age (Table 3). 
Although there were still significantly more late onset 
patients with a positive family history of dementia than 
controls, the relative risk differed significantly from 
the risk of early onset patients (onset before the age of 
70 years). Iable 4 shows that this finding was due to a 
lower relative risk for late onset AD for subjects with a 
demented parent The percentage of patients of whom 
one of the parents was affected with dementia 
decreased with increasing onset age (Figure 1). The 
prevalence of dementia in parents of control subjects 
did not show a trend across the age strata Figure 2 
shows that the percentage of patients with one or more 
affected siblings increased with increasing onset age. 
Table 5 gives the relative risk for AD according to the 
number of first degree relatives with a history of 
dementia. There were 49 patients with two or more 
first degree relatives as compared to seven controls 
(RR 7.5; 95% Cl 3 3—16.7). The risk of AD increased 
with the numoer of affected relatives (p-value for trend 
= 0.008) This trend was observed m earlv onset 
patients (p =0.013) as well as late onset patients (p = 
0.005).
Family History of Down s Svndrome
In all studies included in the re-analvsis there were
T a b l e  3 Family history o r  dem entia and the relative risk o f
A lzheim er's disease by onset age
Onset age
E x p o s u r e  frequency
C a s e s Controls RR- 9 5 %  C l(years)
« 5 9 9 7 /2 7 2 5 7 /3 2 7 4 0 2 4 - 6  1
6 0 - 6 9 '6 /1  S3 5 1 /2 0 5 5 3 2 8 - 1 0  0
7 0 - 7 9 7 7 .1 9 6 4 3 /1 9 8 2 .3 1 4 - 4  6
8 0  + J l / 1 2 2 2 0 /1 2 3 2 6 1 5 - 5  2
■ Adjusted for age gender number of siblings and education
Adjusted for age. gender, number of siblings and education
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F\m  k 4 fa m ily  h is tory  o f  dementia und ih r  re la tive  risk of 
A lzheim er's disease hv re lationship
Fam ily  histors 
D em entia
Exposure frequency
RR • 95%  C lCases C ontro ls
Parents 190/814 95/894 2 3 I 8 -3  I
S iblings 10I/814 23/894 4 8 2 9 -7  8
O nsci padem  before the age o f 70 years
Parents 115/453 43/528 3 5 2 3-5 2
Siblings 40/453 9/528 4 4 2 .1-9 .0
O nsci pa tien t at age o f 70 years or over:
Parents 63/308 47/307 I 4 0 9 -2  I
Stblings 57/308 14/307 4 7 2 5-9 0
'A d ju s te d  fo r age. gender, num bers o f sib lings and education
more patients with a positive family history of Down’s 
syndrome as compared to controls (Table 6). The test 
for heterogeneity indicated that there was no evidence 
for heterogeneity across studies. Overall, the relative 
risk of AD was 2.7 (95% Cl 1.2-5 7) for first degree 
relatives of patients with Down’s syndrome. Similar 
risks were observed for men and women and for earlv 
onset and late onset patients (Table 7). The relative 
risk tended to be higher for patients with a positive 
family history of dementia as compared to patients 
with no family history of dementia. However, the 
difference did not reach statistical significance.
Family History o f Parkinson's Disease 
Family history of Parkinson’s disease was assessed in 
two studies (Table 8). In both studies, there were more 
patients with a positive family history of Parkinson’s
disease as compared to controls Pooling ol the studies 
yielded a relative risk for AD of 2.4 (957« Cl l .0-5.8) 
for those with a first degree relative with Parkinson’s 
disease. No significant differences in relative risks were 
observed comparing men versus women, patients with 
a positive family history of dementia versus patients 
with no family history and early onset versus late onset 
patients (Table 9). However, relative risks tended to be 
higher for men and for patients with no family history 
of dementia.
DISCUSSION
This re-analysis of case-control studies of AD showed 
familial aggregation of dementia in both early onset 
and late onset AD. Significantly more Alzheimer 
patients than controls had a first degree relative with 
Down's syndrome. Furthermore the re-analysis sup­
ported a higher frequency of Parkinson’s disease in 
first degree relatives of patients with AD 
These findings must be interpreted in light of the 
various problems encountered in case-control studies 
of AD As the majority of studies were hospital-based 
for case selection, selection bias may result from differ­
ential referral of patients according to family history of 
dementia/' The pooled risk estimate, however, was 
very similar to the relative risks observed in the popu­
lation-based studies of Hofman et al. and Broe et a l.16 
Another issue related to selection bias is that all studies 
included prevalent patients/' Observed associations 
may therefore relate to predictors of survival rather 
than to the risk of AD. However, in a sub-analysis of 
incident patients, i.e. patients included in the study 
within one year of diagnosis, risk estimates remained
% with positive family history
10 —
o J—
60-69 70-79
Onset age (years)
controls
FiCUki I Percentage o f  A lzhe im er cases and contro ls w ith a pos itive  fa m ih  h is to ry  o f  de men tin in 
the parents
PA Mi l  Y HI STOKY A M )  AI /  HI I Ml  R N  I l l Sf  ASI S 17
controls
1'K.i‘Ri 2 Percentage of Alzheimer cases und< tmirols w ith a posiln e lamilv htsiors <■/ dementia in 
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virtually the same. As to information bias, non-differ­
ential misclassification may occur when assessing 
disease history in first degree relatives. A related issue 
is that we did not distinguish the type of dementia in 
relatives, which may not always have been of the Alz­
heimer type. Similarly, for Down's syndrome no dis­
tinction was made between Down’s syndrome and 
mental retardation in two studies.‘M: This has most 
likely led to an underestimate of the strength of associ­
ation between AD and these disorders. Another prob­
lem in assessing family history of late onset disorders 
such as AD and Parkinson's disease is that misclassih- 
cation may also occur because relatives are still at risk 
of the disease after the study or may have died before 
the expression of the disease. Assuming that such a 
censoring mechanism has been similar for first decree 
relatives of patients and controls, this type of bias can 
also be considered unlikely to affect the relative risk. 
Recall bias may be another important source of bias in 
these studies. Spurious associations may occur if rela­
tives of patients pay more attention to the occurrence 
of other diseases in their family than relatives of con-
Tabi.f. 5 Family lustors of dementia and the relative risk c f  
Alzheimer's disease by number of affected first degree relatives
N um ber of 
relatives 
with dem entia
Exposure frequency
R R ' 05% ClCases Controls
(1 slid 709 1 reference
1 206 103 2.6 2 0-3 5
2 + 49 7 7 5 3 3-16.7
'A d justed  for age. gender, number of siblings and education
trol subjects. This is more likely to occur in assessment 
of disease in relatives who arc more distantly related. 
We have therefore restricted the re-analvsis to first 
degree relatives.
In this analysis of 814 patients with clinically diag­
nosed AD“ and 894 age- and gender-matched control 
subjects we observed aggregation of dementia in the 
families of patients with early onset as well as those 
with late onset AD. For early onset AD, the risk was 
about four times elevated, which was significantly 
higher than the 2.5 elevation in risk for AD after the 
age of 70 years. The lower relative risk resulted from a 
lower prevalence of dementia in parents of late onset 
patients. No difference was observed in risks for early 
onset and late onset AD lor history of dementia in sib­
lings. An explanation for these findings may be related 
to the clustering of onset age within families.: 4 Rela­
tives of late onset patients are more likely to have a late
T a b i  fc 6 Humber o f sub/cas w ith a positne family history of D o w  n s 
svndrome in Alzheimer cases and controls
Exposure frequency 
Cases Controls R R ' 95% Cl
Australia 5/165 0/165 _ _
(tab 1/116 t|/97 — -
Netherlands 5 1 VS 3/198 I 7 0  3-13 "
USA. Denver 2/64 0/64 — —
USA . Durham ••45 4'91 3 5 1 2-5 '
Overall analysis 207588 7 '6 15 7 1 2-5 '
'Adjusted for aee. gender number of siblings and education
S 18 I N I  [ R N A  I I O N A I  JOLJKNAI ( ) l  l l ’ I D l  \ I I O I  ( K i V  ( S C I T I  ( M I N  I : i
I ' H i  I 7 lu i iu lx  h is to ry  o j  D o w n s  s s n d ro n ic  a nd  the ic la lo e  a s k  <// 
A L l ie u n e i \ disease s tra ti/u a n n n  h y  gender, fam ds h is lo rs  o /  d em en na  
a m i o nse t n ^ r
l:x |x> sn rc  I r c q u o u v
( 'rises C out rots RR- 9s"/.. ( ' I
Sir.itifk.itinn hy gender
Women ls /1 8 2 5/19.x 1 ii 1 2-7 1
Men 5/2(16 2/216 2 f) 0 (a 1(1 X
Stratification hy lamilv historv dementia 
Positive 12/227 V24K J (1 1 1-12.5
Negative 7/275 4/275 1 9 (1 6 -6  0
Stratification by onset age 
Before 65 years 9/127 .1/148 2 .x 1 1-7 5
65 years or over 9/24.1 4/241 2 /> 0 7-1(1 (1
'A djusied for age gender number «if sibling- .mil education
onset of the disease and may therefore have a higher 
chance of dying before the disease onset Since the life 
expectancy has most likely been higher for siblings 
than lor parents, the chance of expressing the disease 
may have been higher in siblings of late ons'et patients. 
Alternatively, if there is a true difference in relative 
risk for late onset AD between those who have an 
affected sibling and those who have an affected parent. 
this would suggest that familial aggregation of late 
onset AD  may be of non-genetic or multifactorial o r i­
gin. This finding is also compatible with a recessive dis­
order A second finding which mav point to 
heterogeneity is that the risk of AD was significantly 
different for those with two or more first degree rela­
tives with dementia as compared to those with one.
There were significantly more patients with a first 
degree relative with Down's syndrome than control 
subjects. Although each of the individual studies 
showed a higher frequency o f Down s syndrome in the 
familv of patients, a significant increase in risk of AD  
for subjects with a positive familv historv of Down's 
syndrome could only be shown after pooling of the 
data This may be explained by the fact that Down's 
syndrome is a relatively rare disorder and large 
numbers of relatives are therefore needed to establish 
an increase in risk Our findings confirm earlier studies
T * b i.k 8 Number of subjects with a positiu famils historx o ' lJar- 
kinson s disease in Alzheimer coxes and controls
Exposure frequency
Cases Controls RR 95a . C l
llu l\ 6 114 .1/96 - ,, 0 4-14 ,X
Netherlands 14/198 5/198 :.s 1 0 - | f l  8
Overall analysis 20/312 8/294 2 -i I 0 -5 8
Adjusted lor age. gender, number o f sibling- and education
ol lamily historv of Down s syndrome ' " Although
risks were not significantly different when stratifying 
for lamilv historv of dementia. a significant increase in 
relative risk was only observed in patients with a post 
live lamily history. This finding is compatible with a 
genetic link between A D  and Down's svndrome The 
re-analvsis of case-control studies did not confirm the 
hypothesis that the increase in risk was specific to carls 
onset patients " In actiological terms, this finding mav 
be of interest because if there is a true association 
between AD and Down's s\ ndrome. our finding would 
predict a link with chromosome 21 for both early onset 
-is well as late onset A D . However, to date, genetic 
linkage of AD  to chromosome 21 has been shown in 
families with early onset A D ' 'bu t not in families with 
late onset of d ise a se .J>J
In this analysis we observed familial aggregation of 
A D  with Parkinson s disease, although patients with 
Parkinson's disease before the onset of AD  were 
excluded in the case selection The relative risk tended 
to be higher in men as compared to women. In the 
interpretation ol these findings it is important to note 
that the diagnosis of A D  w as clinically assessed Since 
the type of dementia yvas not confirmed pathologically, 
yve cannot exclude the possibility that the higher fre­
quency of Parkinson's disease has occurred specifically 
in the family of patients yvho suffered from dementia 
caused by parkinsonism or Lewv body disease
In conclusion, this re-analysis confirmed earlier 
studies that reported fam ilial aggregation of early 
onset AD. In contrast to earlier studies, the re-analysis 
also showed familial aggregation of late onset A D . The 
association heiyyeen A D  and family historv of demen­
tia hoyvcver. was yveaker in late onset patients. Pool­
ing ol the data showed a significant increase in relative 
risk of AD  for subjects w ith a first degree relative with 
Doyen s syndrome Individual studies mav have lacked
1 «Hi L I  umilc hislors o] Parkinson s disease amt liie rcliilis e risk ol 
Alzheimer s discasi stratificanoii h \ gender icimd\ h.itorx o l deinen 
no. and onset age
Exposure (requeues 
Cases Controls R R ' 95 . C l
Stratification b\ gender.
W'omen 11-198 (si I 86 1 D (I 5—J 9
M en 9/114 2/108 -i II 9 -2 0  9
Sir.nitK .iiion b\ i . i im is  historx dem entia
Posit I'C A-124 4/121 : - o 5 -0  I
NceaO' e ! V-ISS 4-1 71 i i  O -l ! -
Slraiilieaiion h\ o.' age
Before 65 v ear- 16/27.'' x.258 1 o - ;
65 year -  or < ivei 4 29 <1/25
A d m -te d  lo r  age slender n u m b e r o l sibling's und educa tion
I'AMII V HISTORY A M ) a i ./ . iu  i m i .k s d is i AS1
s l.ilis ltca l power to assess an associalion I lie rc-analy- 
sis also supported the hypothesis o l familial aggrega­
tion  o f Parkinson's disease w ith  A D  However, this 
fin d in g  should he con firm ed  in a study of autopsied 
pa tients
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Maternal Age and Alzheimer's 
Disease: A Collaborative Re-analysis 
of Case-Control Studies
W A ROCCA,* C M VAN DUIJN,t D CLAYTON, V CHANDRA, L FRATIGLIONI, A B GRAVES,
A HEYMAN, A F JORM, E KOKMEN, K KONDO, J A MORTIMER, S L SHALAT, H SOININEN,
A HOFMAN FOR THE EURODEM RISK FACTORS RESEARCH GROUP.t
V o l 20, No 2 (S u p p l 2/ 
P r in ted  in Great Br i ta in
R °cca W  A (SMID Centre, Via II Prato 58-62, 50123 Florence, Ita ly) van D uijn  C M, Clayton D. Chandra V. F ratig lion i L 
ncM D S *  c' Hevm ^ n A ' Jo rm  A F' Kokmen E, Kondo K, M o rtim e r J A, Shalat S L, Soim nen H, Hofm an A fo r the EURO­
D E M  Risk Factors Research Group. M aternal age and A lzhe im e r’s disease: A co llabora tive re-analysis of case-control 
studies. In te rna tiona l Jo u rn a l o f  E p idem io logy  1991, 20 (Suppl 2): S21- S 27.
To investigate the possib le association between A lzhe im er's  disease and late maternal age at index birth, we con­
ducted a co llabora tive  re-analysis of existing case-control data sets. Of the 11 studies pa rtic ipa ting  in the EURODEM 
project, fou r were included in the analyses regarding m aterna l age. In all fou r studies, cases w ere matched to contro ls 
by age and gender, and on ly  population con tro ls  were considered. Analyses were conducted on the ind iv idua l data 
sets, on the Pooled sam ple, and on subgroups defined by gender, age at onset, and fam ilia l aggregation of dementia.
aternal age o f 40 years and over was found  to be suggestive ly  associated w ith  a h igher risk o f A lzheim er's disease 
overa re ative risk -  1.7; 95% confidence intervals: 1.0-2.9). In subgroup analyses, the association was statistica lly 
s 'gm ficant fo r w om en and fo r sporadic cases. Adjustm ents fo r education or analyses restricted to case-control pairs 
m atched by type o f respondent d id not m o d ify  these results no ticeab ly . The association was con firm ed by a test o f con­
sistency w ith  the D ow n's syndrom e risk m ode l; results o f th is  test w ere again m ore de fin ite  fo r sporadic A lzheim er's 
, ' seas/ 1'n a d d lt,o n ' three of the four studies also suggested an increased risk for m aternal age at index b irth between 
5 and 19 years (overall re la tive risk = 1.5; 95% confidence in te rva ls : 0.8-3.0). A lthough consistency across studies 
was not a lw ays com plete , on ly  some of the increased re la tive risks reached statistica l s ignificance, and in fo rm ation  
regard ing m aterna l age ob ta ined through a next-of-kin in te rv ie w  m ay have lim ita tions, ou r study suggests that both 
early and late m aternal age should be fu rthe r investigated as possib le  risk factors for A lzhe im er's  disease.
INTRODUCTION
A link between Down's syndrome and Alzheimer's 
disease (AD) was suggested by the observation that 
patients with Down s syndrome often develop demen­
tia if they survive beyond age 40; in addition, the path­
ological and neurochemical changes found in the 
brains of Down's syndrome patients are similar to 
those found in A D .1 Epidemiological data suggest 
some degree of familial aggregation between Down’s 
syndrome and AD, raising the possibility of a common 
genetic predisposition.23 In summary, a link between 
AD and Down’s syndrome exists on clinical, path­
ological. neurochemical, and epidemiological
‘ SMID Centre. Via II Prato 58. 50123 Florence. Italy 
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grounds; however, the biological explanation of this 
link is still not apparent.'
Because of the analogy with Down's svndrome. in 
which the risk rises with increasing maternal age. sev­
eral researchers investigated late maternal age at the 
subject's birth as a possible risk factor for AD. We 
were able to trace 12 studies reporting on this specific 
putative risk factor;'1' 1*’ one additional study looked at 
the dementia syndrome.1'’ Surprisingly, maternal age 
was one of the most widely investigated risk factors for 
AD. In some studies, maternal age was included in a 
broader list of suspected factors; however, several 
other investigations were specifically designed to test 
this hypothesis. The results, as reported in the liter­
ature. are summarized in Table 1.
Cohen et al and Whalley et al found the mean age of 
the mother at the subject's birth to be significantly 
higher in cases than in contro ls /' However, the differ­
ence in mean age was not significant in later studies by
S21
S22 INTERNATI ONAL J OURNAI  OT EP I DEMI OLOGY ( SUP P LEMENT 2)
T a b u  I Association between A lzhe im er's  disease and hue m aternal age at index  birth las reported m  the lileraliirel
Alzheimer's Controls
disease type & No Measure of Significance
Author No of cases (a) Association (hi te l C omments
Cohen et al I982'* 1 80 ( P ) 590 Difference in mean S Mean maternal age at patient's birth vs
age = 8 5  vears mean age at control's birth
Whallcv et al 1982' 69 ( P ) 207 Difference in mean s (As abase) Significant difference also
age = 2.0 scars for age of father
Kncscvich et at 42 <H) 42 Difference in mean NS (As abuse) Non significant negative
1982" age 2 1 vears difference
Corkin ct ul 1983 17 (P) 34 Dillerenee in mean NS (As abo\c )  No significant difference
age = 0 3 years (or age of father
Hcyman et al 1983'’ 36 (P) 36 Difference in mean NS (As above) No significant difference
age = 0 2  vears for age of father
English & Cohen 69 (P + H ) 94 RR = 0 4 NS Mother's age 25-29 vs <25
1985" RR = 1 (I NS Mother's age 30-34 vs <25
RR = 0 7 NS Mother's age 35-39 vs <25
RR = 1 4 NS Mother's age 540 vs <25
Amaducci et al 116 (H) 116 (H )R R  = 2 5 NS Mother's age >40 vs €40.
1986'" (P) 97 (P) RR = 4 7 S Inconsistent findings for paternal age 
in the 2 control groups
While et al 1986" 112 (Sibs) 92 Id l Difference in mean NS le i Mean maternal age at birth of patient
age = 1 sears vs mean age at birth of non-affected 
siblings
Urakami et al 77 (H) 52 (f) Difference in mean S Mean maternal age at patient's birth
1988'- age = 2.5 sears vs mean age at control's birth. 
Significant difference also for age of 
father
De Braekelecr et al 120 (sibs) (g) Difference in mean [SI th l Mean maternal age at birth was lower
1988" age = - 2  1 years for Alzheimer's disease cases than for 
normal siblings Significant negative 
difference also for paternal age
Schoenberg et al 87 (H ) 87 (H) RR = 5 U S •Mother's age >4(1 vs €40
1988" in (sporadic 
cases only)
(P) 71 (P) RR = 4 7 S
Holman et al 1990" 184 (P) 184 RR = 1 1 l/i NS Mother's age 54<) vs <  40 
No significant difference also for age 
of father
94 (P) 94 RR = 0 9 tk i NS (As above)
(sporadic 
cases only)
a (H) = Hospital controls: (P) = Population controls
b RR = Relative Risk, this is the ratio of the risk of disease in those with the factoi to the risk of disease in those w ithout the factor The relative risk 
was estimated through the odds ratio 
c S = p<  = 0.05; NS = p>0.05
d Also 200 randomly selected births were used as controls (population controls) in the studs 
e p = 0 07; the p value was nearly significant
f Controls were patients affected by multi-infarct dementia Both cases and control were population-based 
g Unspecified number of Alzheimer's disease patients siblings Also spouses and six population control groups were used 
h Significant opposite findings: maternal age at birth was significantly lower for cases than for normal siblings
I Re-analvses of the Italian case-control study.1"
j The difference in mean maternal age was also reported = 0 7 years (NS)
k The difference in mean maternal age was also reported = 0 3  vears (NS)
Knesevich ei al, Corkin et al. and Hevman et al.'** 
English and Cohen computed a series of relative risks 
for different ages of the mother: the study failed to 
show a trend of increasing risk of AD in the offspring 
with increasing age of the mother.4 The Italian case-
control study showed a significant association when 
comparing cases to population controls: the associ­
ation was suggestive but did not reach statistical signifi­
cance in the comparison with hospital controls.W hite  
et al. found the mean age of the mother at the subject's
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tin ill to he higher tor cases than lor unallected siblings 
(p = 007); however, the difference did not reach con­
ventional statistical significance. The authors sug­
gested that late maternal age might he an important 
nsh I actor only for a subgroup of AD cases."
Among more recent studies, one conducted in 
Japan, showed a significant case-control difference for 
both maternal and paternal age;1 however, another 
investigation from Canada showed a significant diffci 
once for both maternal and paternal age in the opposite 
direction; maternal and paternal ages were more 
advanced at unaffected siblings' than at AD patients' 
birth. In addition, no association with late maternal 
age w-as found using spouses or six population control 
groups for comparison: such consistent findings 
strengthen the negative result.1’ Also the study by Hof- 
man ci al, conducted in the Netherlands, failed to show 
a significant association.1'
Despite these inconsistent findings, two facts are in 
support of a possible association. First, Table 1 shows 
that in all studies to date, except two, the mean 
maternal age for cases was consistently greater than for 
controls; the difference reached statistical significance 
in some studies. Second, recent subgroup analyses of 
the Italian case-control study suggested that late 
maternal age is a specific risk factor for sporadic AD 
but not for familial AD U Therefore, some of the 
current negative epidemiological data might simply be 
due to an intermixture of familial and sporadic cases of 
AD in the study sample. ’,J
To further test the possible association between AD 
and late maternal age, w'e conducted a collaborative 
re-analysis of existing case-control data sets as part of 
the European Community Concerted Action 
Epidemiology and Prevention of Dementia' 
(EURODEM).
METHODS
Details regarding the overall methodology of the 
EURODEM collaborative re-analysis of case-control 
studies are reported elsewhere.1’ Of the 11 case-con­
trol studies contributed to the project, only seven 
investigated late maternal age and employed a sym­
metrical method of data collection. Of those seven 
studies, three were excluded because the response rate 
regarding maternal age was under 60% for either cases 
or controls (USA. Denver: USA. Durham: and USA. 
Minneapolis).1' In summary, only four case-control 
studies w'ere included in the present re-analvses; their 
geographical location and sample size are reported in 
Table 2.
In all four studies, cases were matched to controls by 
age and gender, and only population controls w>ere
considered. Consistent xsith the matched design, only 
matched-pair analyses were conducted. The relative 
risk was estimated through the calculation of the odds 
ratio. Statistical testing was done al the conventional 
two-tailed levei of 0.05.
In a first statistical approach, the relationship 
between AD and maternal age was investigated cate­
gorizing maternal age in six classes: 15-19; 20-24; 
25- 29; 30-54. 35-39; and 40 years and over. The age 
class 25-29 vears. which was the most frequent, served 
as reference Relative risks and 95"/« confidence inter­
vals for each age category compared to the reference 
one were obtained through the conditional logistic 
regression for matched sets.1'11' Analyses were con­
ducted on the individual data sets, on the pooled 
sample, and on subgroups of the pooled sample 
defined by gender, age at onset, and familial aggrega­
tion of AD cases. A case of AD was defined as early 
onset" when the symptoms of the disease started before 
age 70 years, as ‘late onset' otherwise. A case of AD 
was defined as sporadic' when the patient had no 
knowm first degree relative affected by dementia, 
otherwise as familial'. To investigate the independent 
effect of maternal age after adjustment for education, 
education was included in the conditional logistic 
regression model in pooled analyses.17 Finally, some 
analvses were repeated on the restricted sample of 
pairs matched by type of respondent.17
In a second statistical approach, we tested the 
hypothesis that the relationship between maternal age 
and AD follows the same risk curve as in Down's syn­
drome In most current studies, the incidence of 
Down's syndrome was found to increase slowly until 
age 30-35 years, and rapidly thereafter.*121 To test 
whether this risk curve is a model also for AD. age of 
the mother was transformed as follows: (1) for 
maternal ages equal to 30 years or less, the new vari­
able value was zero: (2) for maternal ages over 30. the 
new variable value was the actual maternal age minus 
30 years. The distributions of this transformed variable 
among cases and matched controls were compared 
using the paired t-test. Analyses were conducted on 
individual studies, on the pooled sample, and on spor­
adic AD cases in individual studies
RESULTS
Table 2 shows the relationship between Alzheimer's 
disease and maternal age at index birth in individual 
studies and in the pooled sample. The relative risks 
were approximately one in all studies between ages 
20-24 and 35-39 years. The relative risk for maternal 
age between 15 and 19 vears was increased in three of 
the four studies, and reached statistical significance in
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Relative risk anti 95% confidence intervals ol index ace categoiy vs rclcrcncc '
Sample —---------—--------------------------------- --------------------
Case-control (informative 25-29
study pairs) 15-19 20-24 (Reference) 4(1-34 ts 4 V 4(1.
Australia'' 112 2 4 (tl.4-l.V7) <16(0.3-1 4) 1 0 1 1 (O 5-2 2) 1 6 (0 6-4 6) 1 4 (II 5-3 7)
Exposure frequency, eases 4/112 18/112 4 V I12 2s. 1 12 1 S/1 12 12/112
Exposure frequency, controls 2/112 27/112 ■'6/112 2~ 1 12 1 l/l 1 1 9 112
Italy"' 67 1 8 (t) 3-10 (1) 0 9(11.3-2 S) 1 0 It ? (11 2- 1 9) 1 S (0 4-8 (1) 4 8(1 2-19 2) 
|0 03]
Exposure frequency, cases 4/67 11/67 1 7/67 1 V67 7/67 1 5/67
Exposure frequency, controls 2/67 14/67 21/67 22/67 5/67 3/67
The Netherlands1' 175 6 5(1.4—30.5) 
(0-021
0.9(0.5-1 6) 1 0 1 0(0  6-1 8) 0 .6 (0  3-1 2) 1 4 (0 6-3 4)
Exposure frequency, cases 13/175 34/173 51/173 44/173 17/173 14/173
Exposure frequency, controls 2/173 41V173 51/173 42/173 27/173 11/173
USA. Seattle“’ 94 0.3(0 1-1.3) 1.5 (0.6-3 5) 10 0.8(0 4-1 9) 1 0 (0  3-3 0) 1.2(0 3—4.5)
Exposure frequency, cases 4/94 24/94 27/94 19/94 14/94 6/94
Exposure frequency, controls 11/94 16/94 27/94 23/94 12/94 5/94
Total sample 446 1.5 (0.8—3.0) 0 9 (0 .6 -1  4) 1 0 0 .9 (0 6 -1 .3 ) 1 .0 (06-1  6) 1.7(1.0-2.9) 
|(>04|
Exposure frequency, cases 25/446 87/446 130/446 104/446 53/446 47/446
Exposure frequency, controls 17/446 97/446 135/446 1 14/446 55/446 28/446
■P values smaller or equal to 0.05 are reported in square brackets under the relative risk Results did not change noticeably after adjustment for 
education, (dichotomized: less than 9 years: 9 years or more) or restricting the sample to case-control pairs matched by type of respondent
one. The relative risk for maternal age of 40 years and 
over was consistently greater than one in all four stud­
ies; the association was significant in one study and in 
the pooled sample.
Table 3 shows the relationship between AD and 
maternal age in subgroups of cases and their corre­
sponding matched controls. While there was no trend 
for male AD patients, female AD patients showed 
increased relative risks for both early and late maternal 
age. The increased relative risk for age 40 years and 
over was statistically significant. For both early onset 
and late onset cases, the relative risks for age 40 and 
over were suggestively increased; however, they did 
not reach statistical significance. The relative risk for 
maternal age between 15 and 19 years was significantly 
increased among early onset AD cases, but not among 
late onset cases. The relative risk was significantly 
increased for maternal age of 40 years and over among 
sporadic cases but not among familial cases. Results 
reported in Tables 2 and 3 did not change noticeably 
after adjustment for education, or restricting the 
sample to case-control pairs matched by type of 
respondent.
Tests of consistency with the Down's svndrome risk 
curve showed statistically significant findings in one 
study and in the pooled sample (Table 4). In two other 
studies, the difference between cases and controls for
the modified maternal age variable was consistent with 
the hypothesis, but did not reach statistical signifi­
cance. In one study the difference was very small 
(Table 4). Table 5 shows the same test of consistency 
with the Down's syndrome model conducted on spor­
adic AD cases and their matched controls. In all four 
studies, the difference of the modified maternal age 
variable between cases and controls was consistent 
with the hypothesis. In two studies and in the pooled 
sample the difference reached statistical significance.
DISCUSSION
The present study was a collaborative re-analysis of 
existing data sets investigating the association between 
late maternal age and AD. Unfortunately, not all exist­
ing studies as listed in Table 1 could be included. Since 
the investigation of maternal age was part of the 
EURODEM project, regarding all major risk factors 
for AD.17 only studies which investigated several risk 
factors participated in this activity. The selection of 
only some of the data sets regarding this association 
might have influenced our results. In addition, we 
excluded three of the seven case-control studies which 
investigated maternal age and were included in the 
project because the question regarding maternal age 
had a low response rate. On the other hand, both the 
reasons for inclusion in the project and the exclusion
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I aiii i 3 A sstIt u n io n  be tw een  A lz h e im e r 's  d isease a n d  m m e r iw l age a i indes  h tr tb  in  subg roups
Relative risk .uul 95% confidence intervals ol miles .«jie catcgorx vs reference*
Sample '  ~~ -------—-— -
C 'ase-control (inform ative 25-29
s u u lv  pairs) 15-19 20-24 ( R e fe re n c e ) 3 0 - 14 35-39 4(D
l o l id  sam ple  446 1 5 (O K 1 0) 0 0 (0.6- 1 4) 1 o 0 <1 (0 6 1 3| 1 0(0 6-1 (,) F7 (1 0-2 9) 
[<>04|
( i  ende  r
M e n  I7S 0 7 (0.2-2  0) 0 6 (O V 1 l | l i i 0 5(0 3-1 0) 
1» " '1
0 7(0 3-| 4) 0 .8(0  3- 1 9)
l-.xposure frequency, eases 10/178 12/178 43 P.H 48/178 25/178 16/178
F.xposure frequency, controls 9/178 39/178 3 M  78 61/178 25/178 13/178
Women 268 2 2 (0 9-5 4) 1 2 (0 7-1 9) 1 0 1 3 (0 8-2 0) 1 2 (0 6-2 2) 2_4 (1 2—1 8) 
(0.009|
Exposure frequency, cases 15/268 55/268 83/268 56/268 28/268 31/268
Exposure frequency, controls 8/268 58/268 104/268 53/268 30/268 15/268
A g e  a t onse t*
Age <70 years 265 4_2(1 4—130) 
10 0)1
0 .8 (0  5-1 3) 1 0 1 (1 (0.6-1 6) 0 8 (0  4-1 4) 1.8 (0 .9-3 7)
Exposure frequency, cases 17/265 47/265 78/265 67/265 28/265 28/265
Exposure frequency, controls 4/265 62/265 80/265 6.8/265 35/265 16/265
Age S 70 years 156 0.5 (0 2-1 6) 1 3(0 7-2 6) 1 o 0 9 (0  5-1 6) 1 2 (0.5-2 9) 2.0(0 8-4 7)
Exposure frequency, cases (VI 56 36/156 470 56 30/156 19/156 18/156
Exposure frequency, controls 12/156 30/156 51156 38/156 16/156 9/156
F a m il ia l aggregauon%
Sporadic A D  241 1 3 (0 .5 -1 7 ) 1.0(0 6-1 7) 1 0 0 7(0  4-1 2) 1 2(0 6-2.4) 2.7 (1 .2-5 9) 
[0 .011
Exposure frequency, cases 1 1/241 52/241 68,24 1 53/241 29/241 28/241
Exposure frequency, controls 8/241 53/241 72.241 70/241 27/241 11/241
Familial A D  185 1 6 (0 6 -4 .0 ) 0 9 (0.5-1 6) 1 o 1.2(0 7-2 1) 0 9 (0 4-1 7) 1 3 (0  6-2 9)
Exposure frequency, cases 14/185 31/185 55/185 45/185 22/185 18/185
Exposure frequency, controls 9/185 37/185 58/185 39/185 27/185 15/185
*P values smaller or equal to 0.05 are reported in square brackets under the relative risk Results did not change noticeably after adjustment for 
education, (dichotom ized: less than 9 years. 9 years or more) or restricting the sample to case-control pairs matched bv type of respondent 
(In form ation about age at onset o f A lzheim er's disease was missing in 25 cases
(Sporadic A D  = No first degree relatives affected by dementia. Familial A D  = A t least one first degree relative affected by dementia In form ation 
regarding fam ilial aggregation o f dementia was missing in 20 cases
criteria used were independent from the results of the 
studies, and no major selection bais should have 
occurred.
Of the four case-control studies included, two had 
been previously published;""' therefore, they were 
also listed in Table 1. Results from one study were in 
press at the time.”  Results from the fourth study are 
reported here for the first time.'4 For the published 
data, we reported here new analyses not available in 
the original publications
Our analyses suggest that late maternal age could be 
a risk factor for AD. We found a consistently increased 
risk for maternal age of 40 years and over as compared 
to maternal age of 25-29 years. This increase reached 
statistical significance in one study and in the pooled 
sample. An increased risk of AD with late maternal 
age was suggested also by the analyses based on the
Down's syndrome risk curve. Our data were consistent 
with this model in three of the four studies, and 
reached statistical significance in one. Three of the four 
studies also suggested a possible increased risk for 
births occurring at very young maternal age; the differ­
ence was significant in one study. In summary, our 
analyses suggest that there could be an association 
between both early and late maternal ages and the risk 
of AD
Important results came from subgroup analyses We 
identified two subgroups of AD patients with a more 
definite maternal age effect; women and sporadic 
cases. In particular, sporadic AD showed consistency 
with the Down's syndrome risk model in all four stud­
ies. The case-control difference for the transformed 
maternal age variable reached statistical significance in 
two studies and in the pooled sample Our analyses
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I aim  I -1 A s s o c ia tio n  between A lz h e im e r 's  d isc  use a m i n u n ,-n u ll age a t in de x  b ir th  Test n l co ns is te nce  w ith  llte  D o w n  s s e n ,I ro n ic  r is k  < net e
( . a s c - c o n i m l  
si udv
Mean 
in eases' 
(a)
Mean in 
controls" 
<b)
Mean
dilletenee
(a -b )
Simulant e m u  
ol the mean 
difference
M atched pair
t test
p value ■
Australia 2 57 2 HI (1 s(r I I  S t il tl 2b
llalv J 17 1 (si 2 so 0  X 5 7 (1 (V IS
I he Netherlands 2 (IK 2 1 v (1 lb  r I I  4112 (1 d ig -
1 S A . Seattle 2 22 I 7 ; n 4*) i t  s ( |7 tl '4
lolal sample 2 V 1 l»5 (1 hO 0  : < v ' ( l  0 2
M aternal age was transformed .is follows II inalcrn.il age 5 0 . then new variable 0. 11 m . iU  t n.tl .ii% - 'v 'd  I lien new ' at table - t m aternal age
3d)
P values smaller or equal ln (I (15 arc underlined.
: I he negative sign indicates that the mean difference of the modified maternal age variable between eases and matched controls was in the opposite 
direction
confirm the previously suggested association between 
sporadic A D  and late maternal age.14 The identifica­
tion of women and sporadic cases as the AD subgroups 
more specifically associated may be important in sug­
gesting actiological mechanisms or alternative 
explanations of the observed link.
In interpreting our results, the major caveat pertains 
to the quality of information regarding exposure. In 
three of the four studies the age of the mother at birth 
of a given case or control was obtained through a face- 
to-face interview with a next-of-kin; in one study, the 
interview was by telephone. This indirect data col­
lection may interfere with the quality of information. 
In addition, in three studies, cases and controls were 
not matched by type of respondent: for example, a 
spouse could be interviewed for a case and a sibling for 
the matched control. Failure to match by type of 
informant may have created differences in the quality 
of response between cases and controls. A sibling 
(sharing parents with the study subject) may tend to 
recall the age of the mother at index birth more pre­
cisely than a spouse (coming from a different family) or 
an offspring (part of a different generation). On the 
other hand, in one of the four studies, cases and con­
trols were matched by type of respondent (USA. Seat­
tle),22 and our analyses restricted to pairs matched by
type o f respondent did not modify the results 
noticeably.
In a study of the reliability of the next-of-kin inter­
view. the authors found a non-response rate regarding 
maternal age of 10% at direct interview and o f 27% ai 
next-of-kin inters tew. - ' This suggests that in all studies 
based on this approach there is an important loss of 
information due to non-response. The percentages ol 
non-response regarding maternal age in the four stud 
ies considered here were as follows: 28% in cases and 
0% in controls for the Australian study; 18% in both 
cases and controls for the Italian study; 7% in cases and 
6% in controls for the Dutch study; and 16% in cases 
and 15% in controls for the American study. The loss 
of information may be increased by the matched-pan 
study design in which analyses are restricted to pairs 
with complete information This fact may reduce the 
power of the statistical test used for analysis.
On the other hand, the reliability study mentioned 
above showed that among those who responded, the 
agreement regarding maternal age between nexi-of- 
kin and direct interview was good (88% ).2' Therefore, 
despite the quantitative loss of in form ation. the qualm 
of the information appears to be acceptable. \n addi­
tion. we have no reason to believe that the next-of-kin 
of cases would be motivated to report more extreme 
maternal ages than the next-of-kin of controls
Table 5 Association between sporadic Alzhetnier's disease and mater mil age at index birth Test ol consistent s » nh the Down's s\ ndrom e risk c u rs ,
Case-control 
study
Mean 
in cases" 
(a)
Mean in 
controls* 
(6 )
M ean
difference
(a -b l
Standard error 
ol the mean 
difference
M atched-pair  
l ie s t  
p va lu e 7
Australia 2.43 1 27 1 16 0 54SI 0.04
Italy 4.65 1.61 3 04 0 04 7 0  002
The Netherlands 2 52 2.02 0 30 0 s44 0 5.X
L SA . Seattle 1 dX 1 6.N 0 50 0 625 0  M
Total sample 2.77 1 70 1.07 0 33d 0 002
'M aternal age was transformed as follows: If maternal age <  = 30. then new variable = 0. if maternal age > V i  t hen new variable = t matero  
age-30).
values smaller or equal to 0.05 are underlined
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It is premature to discuss the possible interpretation 
ol the suggested association between late maternal age 
•uid A D . Further data arc needed to test this hypoth­
esis Since analogy w ith Down's svndrome and poss­
ible chromosomal mechanisms have been widely 
debated.' this remains the major w ork ing hypothesis 
I lowever. other indirect and non-gcnetic mechanisms 
might explain the association. This line o f interpret;! 
non is suggested by the fact that both extremes of 
maternal age seem to be associated w ith  an increased 
risk Early and late maternal age at b irth  o f a subject 
may. fo r example, influence the psychological and cog­
nitive development o f the child so as to make her or 
him predisposed to A D  in later life.
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A re-analysis of the data from 11 case-control studies was pe r fo rmed to invest igate the association between head 
trauma and Alzheimer s disease (AD). To increase com parab i l i ty  of studies, exposures were limited to head trauma 
with 'oss of consciousness (hereafter referred to as head trauma ')  and com par isons  were restricted to com m un i ty  
(versus hospi tal) controls Test for heterogeneity across studies was negative, consequently, data were pooled in s u b ­
sequent analyses. The pooled relative risk for head trauma was 1.82 (95% confidence interval 1 26-2 67! Stratif ied 
analyses showed stronger associations in cases w i thou t  a posit ive fam ily  h isto ry  of dement ia  and in males (versus 
females). Adjustment of the pooled relative risk for fam i ly  his to ry of dement ia ,  education and alcohol consumpt ion  oid 
not alter s ignif icantly the association between head t rauma and AD There was no interaction effect between head 
trauma and family  history of dementia, suggesting that these risk factors operate independently. Mean age of onset 
was not s ignif icantly different m cases with  a history of head t rauma com pared to cases w i thou t  such a history The 
findings of the pooled analysis support an association between reported head trauma and AD
IN TRO DU CTIO N
Several exposures are known to he capable bv them 
selves of precipitating dementia syndromes These 
include severe head trauma, acute infections, and 
excessive use of alcohol and drugs. Although we know 
that these factors can cause irreversible cognitive 
deficits, their role in the aetiology of Alzheimer s 
disease (A D ) is less clear In this paper, we review the 
evidence for an association between head trauma and 
A D . and present findings from a meta-analvsis of orig­
inal data collected in 11 case-control studies oi AD  
Head trauma has been linked with pathologically - 
confirmed A D  in several individual case reports 
1 he degree to which these associations can be 
explained as chance coincidences is unknown The
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case of a steelworker who developed Alzheimer s 
disease eight years after a severe head trauma at age 
22'" is perhaps the most difficult to dismiss The 
extremely low incidence of AD  at age 30 and the 
absence of a family history of dementia in this case 
increases the likelihood that trauma may have played a 
significant aetiological role
The most well-established association between head 
trauma and dcgeneialive neurological disease is the 
syndrome of dementia pugnistica that can follow a 
career o f professional or amateur boxing.1 This sy n­
drome. w'hich usually is only mildly progressive fol 
lowing cessation of boxing.1' is associated 
pathologically with an accumulation of neurofibrillary 
tangles in the cerebral cortex and brainstem The 
other pri.narv lesion of A D . the senile plaque, had 
been considered to be absent in this condition How 
ever, a recent paper bv Roberts ct a t . in which they re 
analvsed slides from dementia pugilisttea cases using 
modern immunocyiochcnucal methods, demonstrated 
an accumulation of beta amvloid protein comparable 
to that seen in A D . accompanied bv the formation of
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diilusc scmlc plaques O llier similarities between 
clement i.i pugihstica and AD include atropliv of cells in 
the nucleus basalts ol Meynert and lossol cortical chol 
inergic markers.'1 Thus, these two conditions appear 
to have more similarities than believed previously
Table 1 summarizes the findings of eight published, 
pair-matched case-control studies of A D "'<" , : : for 
which data on head trauma exposure were available 
Ihree of these studies found a significant positive 
association with head trauma, two for comparisons 
with community control subjects.” ' and one for com­
parisons with hospital controls, but not commonlv con­
trols 1 A ll but one ol these studies reported odds ratios 
m excess of 1.0; none demonstrated an inverse 
association
In addition to the studies listed in Table 1, two stud­
ios in which cases and controls were frequenev- 
malched by age and sex have been reporfed. Somincn 
and Heinonen1 compared 63 institutionalized patients 
with AD with a mixed control group of 33 individuals 
residing in institutions and 58 living in the community 
I hey reported that 6 cases and I 3 controls had a history 
ol head injurs (odds ratio =  0.6). Paschalis ct a l:‘ 
reported the findings of a case-control study with 103 
AD patients and 90 community controls. The odds
■ sm I I Odds ralios. statistical significance </><0 051 and /lower fo i 
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A major concern m interpreting the findings ol the 
existing case-control studies is their low statistical 
power to demonstrate an association with head 
trauma. The last column ol Table I gives the prob­
ability' that individual studies would detect an odds 
ratio ol 2.0 with an alpha o! 0 05. based on the number 
of discordant |iairs identified.' None ol the published 
studies had more than a 41"',. chance of delecting an 
odds ratio ol 2.0 Indeed, the average statistical poyver 
was less than 20% Thus for a true association with an 
odds ratio ol 2.0. onlv one in five studies might be 
expected to demonstrate this association. This fre­
quency is very similar to the propoition of studies in 
Table I that demonstrated a significant association 
(lyvo out of eight) for case-community control 
comparisons.
The use of meta-anaKtical techniques is especially 
appropriate for studying relatively rare exposures such 
as a history of head iniury. yvhich is generally reported 
to have occurred in only 5-10% of elderlv individuals 
yviihout A D  (Table 2) T he principal considerations in 
applying this technique are comparability of exposure 
ascertainment and heterogeneity across studies. In the 
mcia-analvsis presented beloyx. these issues arc 
addressed
( )thcr questions considered in this paper include the 
role of genetic susceptibility and gender in modifying 
the risk of A D  folloyy ing a head trauma episode and the 
issue of whether head trauma constitutes a risk factor 
selectively for early or late onset dementia.
METHODS
A general description ot the methods used in the col­
laborative re-analysis is given in van Duijn ei a ir*  In 
order vo provide a comparable exposure measure for
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the I 1 studies included in the analysis, we decided to 
locus on head injury with loss of consciousness of am 
duration. Data on such an exposure were available lor 
seven studies, which constituted the basis for the 
pooled analyses Estimates ol relative risk (RR) and 
95% confidence intervals (Cl) for three other studies in 
which the severity of head trauma could not be deter­
mined in individual cases' * " are reported separately 
A further restriction imposed'to increase compara­
bility across studies was to limit comparisons of cases to 
controls identified from the community We report RR 
estimates and 95% Cl for comparisons with hospital 
controls for two studies.' 4 However, these data are not 
included in the pooled anaivses.
Although most studies ascertained head trauma with 
loss of consciousness in a similar manner, some used 
stricter definitions. Broe et at" required a minimum 
period of unconsciousness of 15 minutes. Kokmcn ci 
o l counted only those cases admitted to hospitals with 
loss of consciousness or amnesia. Amaducci et o l 
ascertained episodes of head trauma that caused 
memory loss, confusion or coma. Although the latter 
investigators did not require loss of consciousness for 
an episode to be counted, head injuries fulfilling these 
criteria are likely to have been more severe than those 
determined by a simple loss of consciousness.
Family history of dementing illness was defined b\ 
having at least one affected first order relative (van 
Duijn et a l:*). A dichotomous variable for education 
was created, categorizing individuals into those with 12 
or more years of education versus those with less edu 
cation Finally, a three-level categorical variable was 
used to identify people with low. medium or high pure 
alcohol consumption per week. as described bv Graves 
et ol.27
Analyses were performed using a mainframe version 
of $AS at the Department of Epidemiology and Bio- 
statistics at Erasmus University in Rotterdam, thv 
Netherlands. F'equcncv distributions were obtained 
for ail variables to be used in the analyses. Contingency 
tables were developed for associations between cova- 
riales as vvell as for case-control comparisons of the 
head trauma-disease associations in individual studies 
The odds ratio was used to estimate relative risk 
(RR).24' For individual pair-matched studies. 95% CI 
for RR were estimated from confidence intervals ol a 
binomial parameter representing the proportion of the 
total discordant pairs in which the case was exposed 
and the control not exposed ' tp 37S i Because various 
test-based methods of estimating confidence intervals 
have been used in published studies, the 95% CI for 
individual studies reported in this paper may differ 
somewhat from published values. Confidence intervals
in unmatched studies were estimated by Wool! s 
Method" (p 1761 Finally ,|V"- Cl foi RR 1,1 ll"-‘ ‘■'on- 
dmonal loiusnc regressions were estimated from maxi 
mum likelihood determined parametcis.
Statistical power ('I individual and pooled matched 
studies was estimated using the procedure outlined in 
Schlcsselman2 (p 162) Differences in RR for sub­
croups defined bv family history, gender and age at 
onset were assessed bv Woolf s test for heterogeneity 
(p 194) Conditional logistic regression analyses for 
head trauma with loss ol consciousness were carried 
out on pooled data adjusted for family history, edu­
cation and alcohol consumption. Interaction effects 
were studied foi the matching variables, age and 
gender
RESULTS
Estimated RR foi Head Trauma in Individual Studies 
Estimated RR tor head trauma with loss of conscious­
ness in individual studies and their associated 95% Cl 
are presented in fable 2 I wo observations arc note­
worthy First, despite considerable variation in the 
estimated RR among studies, all RR exceeded 1 0 
Second, in all studies, the 95% Cl included 1.0 The 
relatively large size ol the confidence intervals is con­
sistent with the low statistical power of individual stud 
ics. evident in Table 1
Table 3 lists the RR and associated CI tor the three 
studies in which head trauma was not defined by loss of 
consciousness, as well as the two comparisons with 
hospital controls Estimated RR ranged from 2.4 to 
IS (I. and in three out of the live comparisons the 95%
Cl included 1.0 Again, confluence intervals were very 
lurae. and despite substantial differences in estimated 
RR there was considerable overlap
Heterogeneity across Studies
A series of seven conditional logistic regressions 
adjusted for the interaction between each individual 
>tudv and head trauma were performed. None of the 
interaction terms were significant, suggesting absence 
of heterogeneitv across studies in the association 
between head trauma and Alzheimer's disease The 
lack of heterogeneitv can be appreciated from an 
inspection of the confidence intervals of individual 
studies in Table 2 which display a large degree of 
overlap
Unadjusted RR for Head houma with Loss of 
Consciousness
Given the lack ol heterogeneity, data Irom the seven 
studies in Table 2 were pooled tor further analyses 
The resulting pooled RR estimate lor these studies was
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1.82 (95% C l: 1.26-2.67). In contrast to the low power 
of individual studies (Table 1). the pooled data pro­
vided a power of 0.97 to identify an odds ratio of 2.0 
with an alpha of 0.05
When cases were stratified into those with and with­
out a fam ily history of dementia (Table 4), a stronger 
association was evident for those cases without a posi­
tive fam ily history ('sporadic cases') in comparison to 
those with such a history ('fam ilial cases'). However, 
the difference in estimated RR for these two strata was 
not statistically significant ( y  = 1.17. p = 0.30).
Stratification of cases by age of onset (<  age 70. $ 
age 70) demonstrated no effect of this variable on the 
RR or 95% C l. which were very similar (Table 4). As 
expected, the difference in estimated RR for these 
strata was not statistically significant (x‘ = 0 039. p = 
0 86 ) .
When cases were stratified by gender (Table 4). 
large differences were evident. Female gender was 
associated wfith a small and non-sigmficant inverse 
association, w-hile male gender was associated with an 
elevation of the RR. Ninety five per cent Cl for the two 
genders had little overlap, and the difference in esti­
mated RR between strata was statistically significant 
(X: = 8.03. p = 0.005)
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adic status, uee o l onset and gender
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Adjusted RR fo r Head liututui
Fable 5 presents the results from a senes of conditional 
logistic regression models on the pooled data. ad|ustcd 
lor family history, gender and age ot onset Although 
adjustment for family history resulted in a slight 
decrease in the estimated RR and adjustment for the 
interaction effect ot gender and head trauma a small 
increase, the 95".. C l for head trauma in the different 
models had considerable overlap In all models, the 
association between head trauma and AD  remained 
significant
As described above, stratification of cases into those 
with and without a family history o f dementia demon­
strated a lower RR for familial cases and their matched 
controls. However, this analysis neglected family 
history of dementia in the controls. The possibility that 
a family history of dementia may increase or decrease 
the susceptibility to AD following a head trauma epi­
sode was investigated by including the interaction 
effect, familv history X head trauma, in a conditional 
logistic regression model together w ith main effects tor 
family history and head trauma. This inclusion resulted 
in no further explained variance (x ‘ = 0.00. R = 
0.00. p = 0.979)
Table 6 presents findings from a second series of 
regression models adjusted for education, family 
history and alcohol consumption. As before, these 
adjustments had little effect on either the pooled head 
trauma RR or the associated 95% C l
Graves ei uR reported that the estimated RR of AD 
increased as the time betyyeen the last head trauma and 
disease onset diminished This trend was also evident 
in the pooled data (Table 7) When head traumas yvere 
dichotomized into those occurring more than 10 years 
prior to the age of disease onset and those occurring 
within 10 years of onset and these tyvo predictors yvere 
included in a single conditional logistic regression 
model, the estimated RR for head trauma within 10 
years of disease onset (5.53) w as more than three times 
that for head trauma occurring more than 10 years 
prior to onset (1.63) Hoyvever. both RRs were statis-
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neatly significant, and the 95% Cl exhibited consider­
able overlap
Timing o f the Head Injury and Age ai Onset 
Cases and controls did not differ significantly in mean 
age at the time of head trauma (t -  1.27. p = 0.21). 
For both cases and controls, the mean age of reported 
head traumas was in the mid to late 30s.
To determine whether head trauma accelerates 
onset of the disease, the age of onset in cases with a 
history of head trauma was compared to that of cases 
without such a history Because of the possibility that 
the age of onset in familial cases may be genetically 
determined. comparisons were carried out for sporadic 
and familial cases separately. In neither group was 
there a significant difference in age of onset by expo­
sure status. For familial cases, mean age of onset was 
slightly higher for cases with head trauma than without 
(67.3 versus 66.1 years) This difference was not statis­
tically significant (t = 0.52. p = 0.60). For sporadic 
cases, the mean age of onset also was higher in those 
with a history of head injury (66.6 versus 64.5 years), 
but again this difference was not significant (t = 1.14. 
p = 0.25).
Finally, given the finding ot a larger RR for head 
traumas occurring closer to the time of disease onset, 
we examined the predictors of the lag time in cases 
(tune between head injury and disease onset). As 
shown in Table 8. neither gender nor family history ot 
dementia were significant predictors of the lag time 
However, a relatively strong effect of education was 
lound. individuals with lower education being more 
hkelv to report head injuries with shorter lag times
Fxbli  7 E s tim a te d  re la t iv e  r is k s  f o r  head  tra u m a  o c c u r r in g  m o re  a n d  
less th a n  10 years p n o r  to  disease onse t
Variable RR 95% Cl
Head trauma
«10 years 5.33 1 55—IS 30
Head trauma
>10 years 163 1.04-2 57
DISCUSSION
The findings of the meta-analvsis provide support for 
an association between reported head trauma with loss 
of consciousness and Alzheimer s disease. In all seven 
pair-matched case-control studies, estimated RRs for 
severe head trauma exceeded 1.0 The low statistical 
power of such studies to identity odds ratios of 2.0 is 
evideni in the large confidence intervals, which in all 
studies included 1 0
For previously-reported significant odds ratios for 
head trauma " ‘ either the severity ol head trauma was 
not specified.' comparisons were reported with hospi­
tal controls.'or data were analysed in a different man­
ner than in the present study.'' Graves ei aT excluded 
pairs concordant for head injury with or without loss of 
consciousness in their analysis of the effect of head 
trauma with loss of consciousness. This convention led 
to a somewhat higher estimated RR (RR = 3.(1. 
p<0.05) than that found in the present analysis in 
which pairs including head injury with and yvithout loss 
of consciousness were retained as discordant for head 
injury with loss of consciousness.
In the pooled analyses reported here, we have taken 
a conservative approach of including only those head 
traumas which involved loss of consciousness or 
equivalent indicators of severity Mild head traumas 
were excluded, because of the likelihood that they 
yvould be susceptible to greater recall bias. Some sup­
port for this possibility is provided by Graves et aT yvho 
reported a higher odds ratio for episodes of head 
trauma without loss of consciousness than for those 
episodes that involved a period of unconsciousness
To avoid the possible confounding yvith other dis­
eases that accompanies the use of hospital controls, the 
meta-analvsis yvas restricted to case-community con­
trol comparisons. In both studies in yvhich hospital con­
trols were studied.' ‘ the odds ratios for head trauma 
exceeded those seen in all but one of the case-com­
munity control comparisons. Thus, selection of com­
munity versus hospital controls led to a more 
conservative estimate of the head trauma RR
Although the estimated RRs in the seven studies 
ranged from 1.17 to 6.0. all of the 95% Cl included the 
pooled estimate of RR (1.82) and there yvas no evi­
dence for heterogeneity. Adjustment for family history
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ol dementing illness, gender, age, education and 
alcohol consumption resulted in small increases and 
decreases m the pooled head trauma RR However, 
there was little  indication that any of these factors con 
stituted signilicant confounders
Stratified analyses were performed to assess the role 
ol fam ili.il/sporadic case status, age-ai-onsct (early, 
late), and gender as effect modifiers Although head 
trauma appeared to he as strong a risk factor for late - 
onset as carly-onsct A D , the estimated RR for spor­
adic cases was higher (though not significantly so) than 
that lo r fam ilial cases. Th** definition o f sporadic and 
fam ilia l cases, while conform ing to that in previous 
studies, does not take into account the chance occur­
rence of secondary cases o f dementia in fam ilia l' fam­
ilies or the number and age o f relatives at risk in 
sporadic' families. M ^classification o f genetic and 
non-gcnelic cases, which is very likely, would tend to 
reduce the difference in estimated RRs between these 
groups Ihus. the difference between sporadic and 
fam ilia l cases in this analysis probably represents an 
underestimate o f the true difference
An unexpected finding was the very strong effect 
m odification of gender. In stratified analvses. the esti­
mated RR for males was 2.67. while for females the 
RR was less than 1.0. The 95% Cl for these strata 
showed very little  overlap. O verall, male controls were 
2.2 times as like ly to have been reported to have had a 
head trauma as female controls (exposure rates, male: 
7.1%. female .3.2%). I his ratio is very sim ilar to that 
reported in a large scale community survey o f head 
trauma y suggesting that ascertainment o f head trauma 
in male and female controls was prohablv unbiased by 
gender However, in that study, cumulative incidence 
rates for males were 20% by age 75 and 8% for females 
by the same age. Most o f the rates in Table 2 (w ith  the 
exception o f the study by M ortim er ei at'') were con­
siderably lower, suggesting a substantial degree of 
underascertainment. To have an effect on the esti­
mated RR in the direction observed, the underascer- 
tainment ol head trauma exposure would need to be 
greater for female cases as compared to female con­
trols A lternative ly, underascertainment o f head 
trauma in male controls could be partly responsible. It 
is also conceivable that gender may plav a significant 
role in m odifying the effect o f severe head trauma 
through an as vet unknown mechanism
The possibility that head trauma causes A D  in gen­
etically susceptible individuals was not supported bv 
the pooled analysis, which demonstrated no in terac­
tion effect between fam ily history o f dementia and 
head trauma This finding suggests that fam ily histqrv 
o f dementia and head trauma explain individual com
ponents ol the variance and represent independent 
causal pathways.
1 he fact that the estimated RR for head injuries 
occurring within 10 years o f disease onset was more 
than three times as large as that for head injuries occur­
ring prio r to that time is consistent with two explana­
tions: (1) there is a tendency for informants for cases to 
associate*disease onset w ith  recent episodes o f head 
traum a, which therefore are recalled better than those 
occurring recently in contro ls; and (2) the ab ility  o f the 
brain to recover from damage resulting from a head 
in ju ry  may be greater at younger ages. The first 
explanation requires the additional assumption that 
enhanced recall by case in form ants would not operate 
for head injuries occurring many years prio r to disease 
onset. There is no a prio ri reason to believe that this is 
true Furthermore, the mean age at which head 
in juries were reported to occur was not significantly 
d iffe rent between cases and controls, making this 
explanation unlikely The second explanation, 
reduced or slowed recovery o f brain tissue fo llow ing 
in ju ry w ith advancing age. is consistent w ith the find ­
ings o f studies in both animals and humans
The finding of a significant association between 
lower education level and a shorter duration o f time 
from  head trauma to disease onset may reflect e ither a 
decreased reserve capacity or a reporting bias. Low 
education level has recently been implicated as a risk 
factor for Alzheimer's d isease .1 ' Individuals with 
lower education level may be less able to compensate 
for damage to functioning brain tissue that follows 
head trauma, accelerating the onset o f c lin ica lly  diag- 
nosable dementia. However, the possib ility that 
in form ants for people o f lower education level have 
poorer recall of head traum a occurring many years 
p rio r to disease onset cannot be discounted. A lthough 
we found that education predicted lag tim e, inclusion 
of in teraction terms for education X head traum a in a 
number of logistic models fa iled to demonstrate m od i­
fication o f the head trauma effect by education
Finally, the possibility o f d iffe rentia l recall between 
in form ants tor cases and contro ls as an explanation fot 
the association w ith head traum a across studies needs 
to be considered Beceause it is highly un like ly  that 
in form ants for case> would report serious head trauma 
that did not occur, it is necessary to posit that contro l 
in form ants failed to recall s im ilar episodes. U n fo r­
tunately. it is impossible to determ ine the degree of 
agreement between cases' in form ants and cases (who 
by v irtue of their memorv im pairm ent are not reliable 
reporters), so that the degree o f underascertainment of 
head trauma in cases is unknow n in retrospective stud 
ies In most studies no attem pt was made to b lind inter
viewers oi informants to tlie purpose of the study. Mor- 
tmie1 ci a! did blind both interviewers and informants 
and reported an odds ratio of 2.8 for head trauma with 
loss of consciousness (Table 2). In Kokmcn's study, 
medic.il ret orris were used to ascertain episodes of 
head tiauma. Therefore, recall bias was not an issue 
I his study found an estimated RR for head trauma of 
I 43
One other issue relevant to recall bias is the role of 
differences in the informants used for cases and con­
trols To control for this possible source of bias, case/ 
control pairs for which the type of informant (spouse, 
sibling, etc.) was not matched were excluded. The 
pooled head trauma RR for the remaining case/control 
pairs matched bv type of informant was slightly higher 
than that for the entire sample (2 13. 93°/, CI 
1 37-3.42).
If head trauma constitutes a true risk factor for AD. 
it is necessary to explain how a head in|urv decades 
prior to disease onset can influence the occurrence of 
the disease. In previous publications.’ '* we have suc- 
gested two explanations. First, head trauma may dam­
age the blood brain barrier, resulting in loss of 
immunological protection of brain tissue and/or entry 
of viruses and toxins that could produce damage many 
years later Second, head injuries may lead to loss of 
functioning brain tissue, but not enouc.li to cause a 
readily detectable-cognitive loss .It is well known that 
the brain possesses a large degree of redundancy and 
that substantial neuronal damage can occur before 
clinical symptoms emerge.1" The gradual loss of func­
tioning brain tissue during ageing coupled with the 
damage sustained during a head injurv earlier in life 
could accelerate the time at which a critical threshold is 
reached, resulting in clmically-diagnosable dementia 
Although two studies have reported that Alzheimer 
patients with severe head injuries experience an earlier 
onset of disease this finding was not confirmed by 
the pooled analysis, in which no difference in onset ace 
was found between those patients with a historv of 
head trauma and those without such a historv
CONCLUSIONS
Whether head trauma constitutes a significant risk fac­
tor for AD has been a hotlv-debated issue One 
assumption underlying this debate is that studies per­
formed following the original publication of this find­
ing3'' provided an opportunity to systematical! v test the 
hypothesis. If this had been the case, one might have 
concluded from the relatively small number of signifi­
cant associations reported in subsequent studies that 
head trauma was not a consistent risk factor. However, 
examination of the power of such studies to detect a
significant odds ratio (Table I) provides an alternative 
explanation that m itself, no study had sufficient 
power to address the hypothesis.
Meta-analysis provides a powerful tool to examine 
risk factors like head trauma that occur with low fre­
quency in the general population Furthermore. it pro­
vides sufficient power to examine more complex 
statistical models and to idcnufv subtle and previously 
unappreciated associations, such as the effect modi­
fication hy gender observed in the present analysis 
One important implication of this work is that the 
value of small case-control studies of AD lies in their 
ability to be combined with other studies to uncover 
weak associations A strong argument can be made for 
standardizing data collection procedures to enhance 
the utility of this effort
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a re analysis of eight case-control studies on A lzheimer s disease we explored several medical conditions that had 
prev iously  been suggested as possible risk factors for A lzheimer's  disease History of hypothyro id ism  was increased 
m cases as compared to controls (relative risk 2.3; 95% confidence interval 1 0 -5  4) Severe headaches and m iq tam e 
were inversely related to Alzheimer's disease (relative risk 0 7. 95% confidence interval 0 5-1 0) More cases than con 
ro s reported epilepsy before onset of A lzheimer's disease (relative risk 1 6; 95% confidence interval 0.7-3.5). espeo
a y or epilepsy w ith  an onset with in 10 years of onset of dementia Neurotropic viruses, allergic conditions general
anaesthesia and blood transfusions were not associated with A lz h e im e r 's  disease
IN T R O D U C T IO N
In this article we present the results of an analvsis o! 
several exposures from the medical history as putative 
risk (actors lor Alzheimer's disease (A D ) .  Unti l  now 
most studies tailed to demonstrate an\ major premor 
hid clinical leature to be cons is ten t  associated with 
the risk of A D  except for head trauma, which is dis 
cussed in another paper in this supplement. ' However, 
several disorders have been provisionally associated 
with a D because of positive findings in one or more 
studies, or based on theoretical considerations. In this 
analvsis we focused on medical conditions that have 
previously been put forward as possible related to A D  
namely thyroid disorders, infections with ncurotropic 
vnuses. encephalitis and meningitis blood transfu­
sions. allergic conditions, arthri tis, epilepsy, migraine 
and general anaesthesia.
An increased risk of A D  m women with a history ol
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thyroid disease was reported In Hcvnutn Several 
investigators have sought to reproduce this f inding 
without success Lope/ ci o l compared the preva­
lence ol pathologically and clinically documented th\ 
mid disorders between ol patients with A D  and ' I  
age-matched non-demented individuals Except loi 
carcinomas, .ill kinds of abnormalitv occurred in a 
higher percentage of the A D  patients than of the con 
trols. although none of the differences reached signif i­
cance The\ concluded that their results did not 
support a relationship between A D  and th \ ro id  
abnormalities."
The transmissibilitv of several spongiform encepna 
lopathies like kuru. Creutzfe ld t-Jakob disease and 
scrapie, raised the hypothesis o f  a possible infectious 
aetiology of other chronic degenerative diseases ol the 
central nervous system, such as A D  and Parkinson's 
disease Although the failure to transmit A D  to a n i ­
mals has long been interpreted as evidence against the 
role of an infectious agent. me hvpothesis of an 
unknown infective agent involved in the pathogenesis 
has never been completely abandoned Manueiid is  c i 
o l hypothesized that mlectivitv might occur onh  at 
early stages of A D  and inoculated hamsters w ith hu fh  
coats ol relatives ol patients with a positive tamilv
M l  D K  AI  MI N I D K 'I A I M )  AI /  Ml  I M  I K N D I M  A M
history ol AD Hicy loiinti an increase m spongiform 
encephalopathies among the hamsters 1 If an infective 
agent should indeed he involved in the pathogenesis ol 
AD, this might he transn scans
mg recipients ol blood transfusions to he at a highei 
risk of developing AD
Othei authors have suggested an alternative infec­
tion hypothesis, in which the involved pathogen could 
he an ubiquitous one. affecting geneticalh susceptible 
subjects hv either vertical or horizontal transmission, 
or both 1 IJ The neurotropic viruses are among the 
potential candidates for obvious reasons Bharucha ci 
aI drew attention to a possible role of herpes zoster In 
a register based case-control study on AD thev found 
this condition to be more prevalent in cases as com­
pared to controls, although not significantly f his 
finding has not been confirmed in other case-control 
studies. Ball suggested that retrograde spread ol 
herpes simplex virus type I from the trigeminal gan­
glion might he involved."’ This hypothesis has been 
investigated in several neuiopathologic.il and neu- 
roimmunological studies. Though initiallv several 
negative studies were reported.1 a more recent studs 
found evidence lor increased presence ol tvpe I herpes 
simplex in the brains of AD patients as compared to 
controls
Several changes in immune function base been 
described in AD suggesting an activated immune 
system, but the mechanism of activation is still 
unknown " In particular it is unclear whether the 
immunological changes arc causally related to the 
disease, or merelv a result of the degenerative pro­
cesses 1 ~ It has also been suggested that thev might 
reflect enhanced immunological suppression bv a 
chronic viral inlection, thus lending supnort to »he 
infection hypothesis 1 To date no convincing evidence 
exists for an association between any specific auto­
immune disorder and AD Allergic conditions mav 
reflect a more generally over active immune svsiem 
However, case-control studies that examined atopic 
conditions in relation to AD did not «how anv Mendi­
cant association Jenkinson ei al reported on a 
lower prevalence of rheumatoid arthritis in AD 
patients as compared to non-dcme:ited sublets m a 
geriatic hospital based survey 24 This finding has not 
been confirmed by others.
Seizures are known to develop in the clinical course 
ol AD.-' It is as yet unknown whether this is simplv the 
result of degeneration of brain tissue or of the involve 
ment of other epileptogenic mechanisms In the studv 
of Hofman ci al the risk of AD was increased in 
patients with epilepsy (unpublished data), suggesting 
that epilepsy itself might be a risk factor for AD as 
well.
Dewey ci al pointed to the lower frequency of head­
aches m A D patients as compared to contiols Sum lai 
results, though not significant, were reported in two 
other studies in which migraine and severe headaches 
before disease onset were investigated I hese find­
ings are of interest in view of the literature on the 
pathogenesis ol migraine. Although the pathogenetic 
mechanism m migraine is not completely clear, seroto­
nin seems to plav a role in i t /7 and also ncurocxcitatorv 
plasma ammo acids are elevated in migraine ’’Seroto­
nin can modulate learning and memory processes. " 
and serotonin receptors are decreased in AD Vl
General anaesthesia has been considered in several 
case-control studies as a possible risk factor lor 
Al). * ' but no associations have been reported to 
date
METHODS
Data ol 11 case-control studies were available for this 
collaborative re-analvsis.: ' " ” '4 A descriptive over­
view ol these studies and of the general stiuiegy ol 
analysis is given bv van Dupnerr// ' Eight studies were 
eligible for the investigation of exposures from the 
medical history '' ' '■ One study, the study from 
Rochester, was completely register based Medical 
records arc likely to provide different information than 
can be obtained from an interview with an informant, 
and this might jeopardize comparability Therefore, it 
applicable, all analyses were done both including and 
excluding the Rochester dataset. In case this consider­
ably influenced the point estimate, results of both the 
analyses arc presented
With regard to the analyses on specific exposures 
inclusion was dependent upon data availability, speci­
ficity of the assessment within studies, and compara­
bility of the investigated exposures across studies. An 
overview of the studies that contributed data to the 
analyses is presented in Tabic 1 Only diseases that 
occurred at least one year before onset of AD were 
included Although all studies investigated the occur­
rence ol thyroid disorders at anv time during a subject's 
life, two studies were excluded from the overall analv- 
sis of any kind of thyroid disease, one because onl\ 
hypothyroidism had been asked fo r / ’ and the other 
because hypothyroidism was one of the exclusion cri­
teria for entry into the studv " Specific types of thyroid 
disorders could be studied in five dataset'-, three ot 
which allowed for a functional classification of hvpoth 
vroidism. hvpcrthv roidism goitre and other '"In the 
Rochester dataset no specification of the functional 
status of patients with adenoma was given this studv 
w'as excluded from the analyses of goitre and 
hyperthyroidism
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Rheumatoid arthritis X
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Poliomyelitis
X
Herpes simplex K v X
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Six studies had collected data on atopv. either by 
separate questions regarding various allergic condi- 
ll0ns or bv one question covering all manifesta­
tions o f an allergic constitution s For the analysis on 
atopic constitution the answers to the questions 
regarding hay fever, allergic rhinitis, lood allergies, 
and allergic eczema were combined Four studies 
explicitly ascertained hay fever.7’' - ' ' 51 For the inves­
tigation of epilepsy prio r to onset o f A D . studies that 
had not specified age o f onset o f the epilepsy were 
excluded As in one o f the remaining studies none o f 
the cases nor any o f the controls reported epilepsy 
before onset o f A D . four studies effeciivelv con trib ­
uted data to examine this e x p o s u r e / R h e u m a ­
toid arthritis was only assessed in the study from  
Seattle. USA and in a subset o f the Dutch studv. 1 hree 
other studies included a sim ilar question, asking 
whether the subject had ever had arthritis.-' T> The 
exposure thus measured is a mixed bag of all kinds o f 
jo int related complaints, in this age group probably 
mainly osteoarthritis. Severe headaches and m igraine 
vl,Clv' combined in most studies that investigated 
this - * ’1 Occurrence o f herpes zoster, polio, herpes 
simplex, and encephalitis or meningitis, as well as 
exposure to general anaesthesia and blood transfu­
sions. were assessed by direct questions that were 
much the same in the different studies Four studies 
had collected in form ation on the frequency o f general 
anaesthesia. ' " To investigate a possible^ dose- 
response relationship the exposure was dichotom ized 
into once and more than once
RESULTS
The results ot the analyses for thyroid disease a
shown in Fable 2 The relative risk lo r anv kind o f th y ­
roid disease p rio r to onset o f A D  was I t) (95% con­
fidence interval 0 X -l ,•>) There was no effect 
modification h\ age of onset, gender, or fam ilv history 
of dementia For the d iffe ren t types o f thvroid d isorder 
no association was found w ith hvperthvro id ism  and 
goitre 1 he risk for hypothyro id ism , however, was sig-
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O v e r a l l  w i t h o u t
R o c h e s t e r  U S A 7 ’2 h 3 2 A 4 0 ;  - - v - 2 2  1
< J o i t  re
A u s t r a l i a I ' l t O 2 /1 (3 6 ■) ^ ' 0 - 1 . 8  3
11 a 1 d H  15 4 / 9 7 ii I ,  u - 2  3
S e a t t l e  U S A I I  / 12<s 1 2 / 1 2 7 1 o \ - 2  ~
O v e r a l l  a n a l y s t s I 2 ' 4 U S 1 8 / 3 9 0 , n i 1 N— ! -1
Adjusted for age and gender
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mlu.iuiK increased, (lie relative risk being 2 3 with a 
95% C I of I 0 to 5.4. I bis effect was consistent lor the 
sindics involved. I lie minimum interval between onset 
ol hypothyroidism and onset of dementia was six years, 
ss nh <m average of 20 years for cases and 16 years lor 
com rols
fable ' shows the results of the evaluation ol 
immune related disorders and of osteoarthritis. Hie 
odds ratios lor atopy as well as for hav fever were not 
significantly different from I The relative risk for 
rheumatoid arthritis was 1.0. Osteoarthritis was sigmli 
cantly less common in cases than in controls, the rela­
tive risk being 0.7. with a 95% Cl of 0.5-1.0
Results from pooling the data on several infections 
that had occurred at any time over a subject’s life prior 
to onset of AD are presented in Table 4 None of the 
neurotropic viruses, nor encephalitis or meningitis, 
was significantly associated with AD.
The overall relative risk for epilepsy was 1.6 (95% 
Cl 0 7-3 5) All studies consistently showed a positive 
association (Table 5). No differences were found 
between familial and sporadic cases, or between men 
and women. The risk seemed to be higher for cases 
with an early onset of AD. but this effect was mainlv 
due to the high relative risk in the Dutch study. To 
investigate a possible relation between the aec of onset 
of epilepsy and the onset ol AD. separate analyses 
were conducted for epilepsy presenting up to 10 years 
and more than 10 years before AD onset The relative 
risk was 2 5 (95% Cl 0.4—13.9) when the interval was 
less than 10 years, and 1.4 (95% Cl 0.6-3.4) when it 
was 10 years or more.
In Tahle 6 the results for the analysts on severe head­
aches and migraine are given The overall analvsis 
uelded a relative risk of 0.7 with a 95% Cl of 0.5 to 1.0 
All studies, except one that had onlv included men. 
gave point estimates below 10 Interaction betw-een 
gender and headaches w-as significant at the 5% level 
The number of subjects involved permitted separate 
analyses for men and women Women had a consis­
tently lower risk than men The overall relative risk tor 
men was 11 (95% C! 0.6-2.0) and tor women 0.6
T*8i t 3 Immune-relaied disorders und osteoarthritis as risk factors 
for Alzheimer i docasi
Exposure frequency
Cases C o n t r o l s R R - 9 5 %  C l
A t o p y 1 7 2 /6 7 0 i 9 0 /6 84 • 1 V n . 6 - 1  2
H a v  f e v e r 3 1 /4 4 5 5 8 —54 ‘ 1 ,S U 5 - 1  2
R h e u m a t o i d  a r t h r i t i s io/2;h) 10. 2th: ! ii 11 4 - 2  '1
O s t e o a r t h r i t i s 131/277 168 302 1» 7 ii  5 - 1  0
(95% Cl 0 4 4) 9) There were no significant interac­
tions with age of onset or familial aggregation
The medical treatments that were investigated are 
IHescntcd in Table 7 The relative risk lor blood trans­
fusions was 0.6. and the 95% confidence interval was
0 4-0 9. General anaesthesia proved to be a very com­
mon exposure, one that was not associated with the 
t isk of AD Dichotomizing this exposure into once and 
more than once yielded no significant associations 
either
DISCUSSION
1 he potential biases of most concern in this study arc 
selection bias, including prevalence-incidence bias and 
referral bias, and information bias, including recall 
bias As to prevalence-incidence bias, since the condi­
tions under study have only a limned effect upon sur­
vival the results are unlikely to be seriously affected by 
the inclusion of prevalent cases There are however 
three other possible sources of selection bias. Firstly, 
controls should be derived from the same population 
as the cases. In studies in which the cases originate 
trom the general population, population based con­
trols are preferred. Most of the studies used hospital 
based cases and it might be argued that hospital based 
controls would constitute a more reasonable reference 
group for these studies However, this is only true if the 
controls arc selected on the basis of another disease 
that is neither related to AD nor associated with the 
risk factors that arc being investigated Furthermore, 
the hospital’s catchment area for this reference illness 
and for AD should be identical. When these strict con­
ditions arc not met. population based controls might 
be preferable to hospital based controls for the eval­
uation of medical conditions and exposures. The tw'o 
studies that had used both hospital and population con­
trols. as well as the study that had only used hospital 
controls." did not spec\(\ which reference illnesses 
were eligible Therefore, we decided to include only 
population based controls :n the analyses. Selection 
bias ma\ also occur w'hen AD patients w ith comorbid-
I xh i  I *• curoiropii viruses and encephalitis as risk (actors for A h  
heimer s disease
f-xposurc (requeues
Condition C a s e s C o n t r o l s R R ' 95% Cl
R o l u  »in ve l i l i '* 5 / 4 5 5 7 / 4 6 7 (1 N (1 3 - 2  7
H e r p e s  / o s i e r H X i /1  I t  1.3 1 0 5 .1  ! H i 1 1 V ( 1 . 6 - 1  2
H e t p e s  ' i m p l e x '44 /  5 i 4 ? 8 / 2 * A : 2 O . S - I  X
\ n i c p h a l n i N  
m e n i n g i t i s '■ HIM 5 /1 HC 1 • • (i 5 -5  3
' Adjus ted lor age and gender ' Adjusted lor ace and tender
S4(l INI  I K N A I I O N A I  J O U K N A I  Ol  I I’lOl  M I O l . O G  Y ( SUI ’I’l.f MI N I 2l
I ami I S l./ulepsI as a risk /</</<» !<" A l :ln l i n e  ' disease
Exposure (requeues
C ascs ( onirok R R ‘ C l
Australia Wl 6.1 4/166 1 S tl 4 S
Netherlands 4 / m I/I9X 1 (1 (I 4 \n (I
Bedford. USA 1/98 1.174 1 s (1 2 -SS 7
Rochester USA (v iv : S/W 2 I 2 (1 4-1 d
Overall analvsis I7/X5I 1 i / d in 1 6 tl 7 1 s
Overall without
Rochester. USA ! 1/4 Sd 6/Sis 2 2 (1 S-S d
‘ Adjusted for age and gender
ity have a higher chance to come to medical attention 
and to be subsequently selected into a hospital based or 
register based study. Whether this has indeed influ­
enced (he results can only he evaluated in population 
based studies. Finally, the incentive for AD patients 
and their relatives to participate in a study like the 
case-control studies included in this analysis is more 
obvious than for controls. This is reflected in higher 
response rates among cases than controls in most of the 
studies " The willingness of controls to participate may 
depend upon their health and the importance they 
ascribe to health-related issues. This may have particu­
larly affected the assessment of chronic, non-specific 
conditions like arthritis and headaches or exposures 
related to medical consumption, such as blood 
transfusions.
With regard to information bias, we tried to over­
come this problem partly by only including studies in
I ab ; r 6 Sei ere headaches migraine a\ a risk factor for Alzheimer s 
disease
Exposure frequents
Cases Controls RR* 95% Cl
All studs subjects 
Australia 
Netherlands 
Durham. USA 
Minneapolis U3A 
Overall analysis 
Vier,
Australia 
Netherlands 
Durham USA 
Minneapolis. USA 
Overall analvsts 
Women 
Australia 
Netherlands 
Durham. USA 
Overall analysis
21/UK 11.156
25098 IV Ids
9/45 1(i/K8
>1/72 7/48
68/461 1(11/490
7/54 11/59
6/74 4/~,
4/|4 8'10
11/72 7/48
28/2U 10/211
16/94 20/97
Id. 124 29/124
VII 22/5n
40/24d ■’1/279
0.8 0 .4-1  4
0 7 ( ) 4 - |  1
o 5 0 2-1 1
1 1 0 5 -1  8
0 7 o s - 1  U
0 d U 1-2  4
1 1 0 4 -7  0
1 0 0 1-1  S
1 1 0 5 -1  8
1 1 0 6 -2  0
0 7 O 1-1 S
0 (> 0 1-1 1
0 1 0 l - l  It
0 .6 0 4 -0  9
which data had been collected symmetrically through 
surrogate informants for controls as well as loi cases 
1'fic tvpc of surrogate respondent may also influence 
the quality ol the data, and the ability of dillerem t v p c s  
of informants to provide valid information vanes In 
topicT' However, ihe effect of tins source ol bias, it 
any. would presumably be non-diflerenlial misclassili 
cation. Finally, selective recall bias may distort the 
evaluation of conditions which the informant suspects 
may be related to AD. The conditions most likely to be 
subjected to recall bias in the present analvsis arc head 
aches and epilepsy. For epilepsy we cannot rule out the 
possibility that this has indeed been the case For head­
aches we found however an effect opposite to what one 
would expect if recall bias were the only explanatory 
factor.
All analvses were adjusted for age and gender. Sep­
arate analyses adjusting for familial history of demen­
tia and education yielded similar results. As we are not 
aware of any other variables that are related to both 
AD and the conditions under study, confounding is 
unlikely to be a problem in these analyses
Since multiple, tests of significance are done vin the 
same dataset, some of the significant findings may 
represent chance results We tried to reduce this risk by 
only investigating factors about which we had at least 
some a p r i o n  hypothesis. Even with the pooling the 
statistical power mav have been too low to detect fac­
tors with a moderately increased risk ol AD but a lose 
frequency.
One of the most interesting findings in this analysis is 
related to thyroid disease. We found an increased risk 
in patients with history of hypothyroidism As most 
people are not aware of an\ relation between thyroid 
disease and AD, recall bias is not a plausible explana­
tion Hypothyroidism itself can cause disturbance ol 
cognitive function. However, the greater frequency <.4 
hvpothvroidism among cases as compared to controls 
was not related to disease onset and it is therefore 
unlikely that this effect v.as due to misdiagnosis of the 
dementia We had no a p r io r i hypothesis concerning an 
increased risk of AD in patients with hypothyroidism 
so we are cautious in our inference as this may be a 
mere chance result Besides, the classification we used
1 abi f 7 Rlood transfusions and general anaesthesia js risk factor • 
Alzheimer s disease
Exposure frequent'
Cases Controls RR' d S"/„ ( |
Blood transfusions 71/521 1I2.-S02 u t . 0 -i-i' -
General anaesthesia S27/10d.v S.1S/UU I " i i S- l •
' Adjusted for age and gender ‘ Adjusted for age and gender
Mr  D K  AI  H I N I O R Y  A M )  AI  / I I I  I MI  U S  OI SI  ASI S41
lor specific kinds ol ihyroid disorder was a radier ei ude 
one h.ised on functional status as reported bv inform 
ants I lus lack ol aeliological precision and the small 
number of studies involved in these sub-analyses i e s  
trict the potential lo draw firm conclusions II the 
association we found is indeed a real effect, a possible 
explanation might focus on the role ol thvroid hor 
inone, which is known to have an influence on matu­
ration of the nervous system and on neuritic 
outgrowth.' s Furthermore, thyroid hormone is func­
tionally related to several other hormones and trophic 
factors that have been reported in relation to AD  
Unfortunately, we were not able to investigate the role 
of thyroid medication, as this was not measured in a 
comparable way among studies.
The finding of an increased risk of AD in patients 
with epilepsy, particularly if the epilepsy lirst pre­
sented in the 10 years directly preceding the onset ol 
AD . suggests that epileptic seizures are among the first 
symptoms which AD  can present with Howevci 
recall bias on the part of the informants cannot he 
excluded as a possible explanation. As all studies 
showed a consistent trend, the lack of statistical sigmli 
cancc may be due to the limited power to detect rela 
live risks below 2.0, given the lowexposure rate among 
controls (1%).
None of the viral exposures we investigated yielded 
an association with AD For some ol these exposures 
this may have been due to methodological limitations 
For both poliomyelitis and encephalitis or meningitis 
the number o f subjects that reported clinically manifest 
disease appeared to be too small to reliably assess an 
association with A D  For herpes simplex the clinical 
manifestation of the infection probably inadcquatelx 
measures the real exposure of interest, which is retro- 
giadc spread of the virus from the trigeminal ganglion 
It is not known which factors can mediate this process 
Other research methods, e g. vtro\ogica\ and neuro 
pathological studies, are required to investigate this 
question. For herpes zoster no relation was found 
either. Most individuals contract varicella during their 
lifetime and an exacerbation of herpes zoster often 
reflects an impaired immune system. Since the 
numbers of exposed subjects were sufficiently large to 
examine this condition, we feel that on the basis of this 
analysis herpes zoster can be excluded as related to 
AD
The interpretation of the decreased risk in osteoar 
thrms and severe headaches is not directly clear 
Although A D  patients m<iv have less morbidity before 
onset of dementia than age-matched controls, selec­
tion bias in the controls is a more plausible explanation 
for these findings. Recently, use of anti-mflammator\
di ugs has been reported to lie possibly inversely associ­
ated with AD If dux speculative theory were true it 
might he anothet explanation lor the lower frequency 
of osteoarthritis and headaches among AD patients, as 
prolonged use ot non steroid anti-inflammatory drugs 
is often implied in these conditions Apart Irom that, 
the findings for migraine and severe headaches are 
intriguing because of the involvement of serotonin and 
ncuroexcitalorv plasma amino acids in migraine, as 
mentioned before Wc have, however, no explana­
tion for the different findings for men as compared to 
women.
Contrary it) our a p r io r i  hypothesis, the risk ot AD 
was lower in subjects who had received at least one 
blood transfusion Probably this is also the result ol 
selection bias. Unfortunately, the study that could be 
expected to have the most accurate data, namely those 
directly based on medical records, did not investigate 
this exposure
CONCLUSIONS
A serious constraint ol this re-analysis was the con­
siderable potential lor bias, inherent in the design of 
most of the studies included in the analysis. Besides 
several exposures were assessed in a crude and incon­
sistent way across studies None of the medical condi­
tions w-e evaluated in this analysis was convincingly 
associated with A D  For some of the exposures the 
findings are regarded us tentative. This applies in par­
ticular to migraine As selection and recall bias cannot 
be excluded, migraine needs further assessment Our 
finding that hypothx roidism is positively associated 
w ith the risk of A D  also warrants further evaluation ol 
this disorder as a risk factor for AD. Allergies, herpes 
zoster, general anaesthesia and blood transfusions are 
unlikely to be risk factors for AD
To overcome some of the limitations of retrospective 
case-control studies to assess medical conditions as 
possible risk factors tor AD . these factors need to be 
evaluated prospectively, for example in case-control 
studies nested within follow-up studies. Rare expo­
sures can be studied most efficiently in cohorts defined 
bv exposure status Much attention should be paid to a 
careful definition and standardized assessment of 
determinants, aimed to assess aetiological hypotheses
REFERENCES
\1 - ir iim e r 1 A .  van D u ijn  C M Chandra V . e ra / Head tra u m a  a- 
risk fac to r (or A lzh e im e r > disease A co lla b o ra tive  re-ana ls  m - 
• >l case-contro l studies hi i J h .puU until lo d l 20 (S upp l 2 1 
s:.s S.vs
H e \m an  A . W ilk in so n  W t  S ta llo rd  I -X r»«/ A l/h e im e r 's  d iscav. 
•X Sludv o f C p idem io loc is .il a \|V  O ' In»/ W u m l  l u s j  15
V S - 4  I
Small Ci XV M atsu vam .i s S Kom andu i i K K um ai X l . u \ ik  I I
S4 2 I N T E R N A T I O N A !  J O C R N A I  Ol  I PI Ol  M I O I  ( K. ' i  ( St I . M I N I  2)
Ihyrmd disc.tso in patients «uh  ilcincnti.i til the Al/hciinci 
type 1 Am Genau Sac 1985. 33: 53.X-39 
Hart 1.1 y I t KheyfcisS. Zemeov A. Blass I I* McDowell I II Risk 
factors in Alzheimer's disease -ti/i tlrlun that 1985. 29 
14 I —16
A matinee I l A . Fratrgliom L, Rocca W A , ei a I R isk factors tor el mi 
tails diagnosed Alzheimer s disease A ease control stutlt til 
an Italian population. Neuralay\ 16X6 36:992-71 
( handr.i V I’hiliposc V. Bell P A. I.azarofl A Schoenberg H S 
C ase control study of late onset probable Alzheimer s 
disease AVi/ro/ogi 1987; 37: 1295- I VNI 
I remit I R Sehuman 1. M. Mortimer I A Hutton J I , Boatman 
R A. Christians B A ease-control study ol dementia t>l the 
Alzheimer's type Am J L/udemial 1985. 121: 414 21 
15roe (i A Henderson A S. Crcasey W .eial A case control studs ol 
Alzheimer's disease in Australia Vct/ro/ogt I99H. 40: 
1698-17(17
( I rases A B While E. Koepsell F. Redler B V van Belle Ci Larson 
l£ B Rasktnd M. A case-control studs ol Alzheimer's d i s e a s e  
Aim Seurat 199(1. 28: 140—18
Lopez O. Huff F J. Martinez A J. Bedeut ( 0  Prevalence ol ihsroid 
abnormalities is not increased in Alzheimer's disease AVi< 
rahtul Aging 1989; 10: 247-251
Goudsmn J Morrow C H. Asher D M. cr Lvidencc for and 
against the iransmissibilny of Alzheimer s disease Seuralagi 
1980; 30: 945-50.
Manuelidis E E. dc Figuciredo J M. Kim J H. I ritch W W  Man 
uchdis I. Transmission studies from blood of Alzheimer 
disease patients and healthy relatives l‘n„ Sail Ai ad Set I S -1 
1988. 85: 4898-901.
Mozar H N. Bai D G. Howard J T Perspectives on the etiology ol 
Alzheimer's disease. JAM A  1987: 257: 1303-7 
Gautrin D .Gauth ierS  Alzheimer s disease Environmental I actors 
and etiologic hypotheses Car. J Seurat Set 1989; 16: 775-87 
Bharucha N E. Schoenberg B S. Kokmen F Dementia of Alz 
heimer s type (DAT): A case-control study of association « uh 
medical conditions and surgical procedures Venro/ngi 19X3 
33 Suppl 2: 85
Ball M J Limbic predilection in Alzheimer dementia Is reactivated 
herpesvirus involved? Can J Seurat Sc !9S2 9: 7(15-6 
Middleton P I. Petrie M. Kozak M. R e« eas t le \  B McLachlan D R 
Herpes-simplex viral genome and senile and prescmle demon 
lias of Alzheimer and Pick. Lancet 198«• i: 1038 
lavior Ci R. Crow 1 J. Markakis D A. Lofthouse R. Neelcv S Car 
.er G I Herpes-simplex virus and Alzheimer's disease t 
search tor virus DNA by spot hybridisation J Seurat Sen 
rouirg Psych 1984; 47: 1061-5
' Death A M. Haase A T. Fewster P H. Le«is E Ball M J Human 
herpes virus and Alzheimer > disease Seuropaih Appt S c ,  
rab id  199(1 16: 213-23
McGeer P L Akiyama H. Itagaki S. McGeer E G Immune o>iem 
response in Alzheimer's disease Can J Seurat S c  I9S9. 16: 
516-27
Millet A E. Neighbour P A. Katzman R Aronson M Lipkownz R 
Immunological studies in senile dementia of the Alzheimer 
type: Evidence for enhanced suppressor cell activity Ann 
Seurat I9NL 10: 506-1(1.
Bradford F Folev P. Docherty M. et at Antibodies in serum ol 
patients with Alzheimer’s disease cause immunoivsis of choi 
mergic nerve terminals from the rat cerebral cortex Can / 
Seurat Set 1989; 16: 528-34
Sh.il .u S I. Se ltz er B. i’idcock l  Baker I I Risk ( a c to r s  !oi  Alz 
he  I m e  I s d isease A case  e o u t i o t  ' t i i j v  S'eimdtrjzv I9S7.  37:
I r, M u t
1 lenkiiison M I . Bliss VI R . Bi atu A I S e o u l )  I Rheumatoid urlhri 
us and senile dementia ol the A lz h e im e r  s type Hr J filieu 
nunal 1989 . 28: X0-XS
Romanelli M I Morris J ( Asltkin k ( o b e n  I A Advanced Alz 
heimer s disease is a nsk I . ic io i loi late onset seizures Arch 
Seurat 199(1. 47: S47-S(l
DcwcvM I Davidson I A ( opel.md J R M Risk factors (or deinen 
ti.I Evidence from the Liverpool stud' ol continuing health in 
the community Ini ] Gcrmi I'wehuu I9X.X; 3: 245-49
Dalessio D J Migraine, platelets and headache prophylaxis J AMA  
1978 239: 52-53
' l eri.in M D Odmk J. Bos K D M.ilcs-v M I A  Bmvn G \ \  Neu 
loexcilalorv plasma ammo acids arc elevated m migraine 
SeuralaK\ I'8X1 40: ! '82-S6
Altman II 1 Normile II J \\ hat is the nature ol the role of the sero 
tonergic nervous system in learning jnd memory prospects 
lor development ol an effective treatment strategy lor senile 
dementia Neurabial Aging 1988 9:627-38
‘C ro s s  A J ( row I I. Ferner I N . lohnson J A Bloom S R . Corscllis 
I A N Serolonm receptor changes in slementia of (he Alz 
heintei tvpc J Ncurarhem  1984.43: I5~4—Kl
Holman A Schulte W. Tania I A ei at History ol dementia and Par 
kmson s disease m lirst degree relative- ol patients with A'z 
heimer 'disease Seuralay v i 98') 39 -'89—92
Kokmen l Beard C M ( handr.i k Ollord K !’ Schoenberg B S 
Ballard D J Clinical risk l.ictors lor Alzheimer A disease A 
population based case-control siudv \eurolay\ 1991 In 
press
Kondo K Yamashita I A case-control studv nt Alzheimer s disease 
m Japan association «uh inactive psychosocial behaviors In 
Hjsegawa K. Homm.i A teds). ISuL ayrruiiru i. liiorncdua: 
and So, nd \d \cm es  Evccrpt.i Medicj Amsterdam. Il)9tl
' Soininen II HeinonenGP Clinical and etiological aspects ol senile 
vfementia Fur Seurat 1982. 21 <il|-|H
Van Dui|n C M Sltinen T Holman A Risk (actors for Alzheimer '  
disca'c Overview ol the I L RODF.M collaborative re-analv 
' I 'o l  -j 'e-control studies Ini J L/ndemial 199I 20 (Suppl 2|:
s-i-s::
Pickle I. W Brown I M .  Biol SS I information available from sui 
rugate respondents in ..i 'c-control interview' 4 m J tipi 
dcmiai 1987, 1 IX: 96-lu.X
Hargreaves A SustaB Aranda A Avila J P.i'Cual A Fniodothv 
romne i f ' )  induces neunte  tormalion and meteases sv nthcsis 
ol a protein related to MAPIB n cultured cells ol neuronal 
origin .’.Vi IInun Hei 1988.38: 141—is
Beniamin S Cambrjv Dcakin M A Burgovne R D Lffect ol 
hv pothv roidism on the expression of three microtubule a'-;oci 
■tied proteins (IA IB and 2) ::t developing rat cerebellum 
Seurasn  1988; 27: 931-39
' Hein F. Hartikka .1 Knusel B Function of neurotrophic factors in 
the adub and aging brain and their possible use in the treat 
mem aeurodegenerative diseases S-mnibial Igr/j.t* 19X9 
It): '15- 3 7
"'McGeer P L McGeer I Rogers j Siblev Anu-inilammauirv 
bugs ..nd Alznnmei disease Lancer i'N>i 335: !‘i7~
In te rn a tio n a l Journal of E p id em io lo g y
„o' In te rn a tio n a l Ep idem io log ica l A ssociation 1991
-4  I .
Vol 20. No 2 (S upp l 21 
Ermted m G reat B ntam
Alcohol and Tobacco Consumption 
as Risk Factors for Alzheimer's 
Disease: A Collaborative Re-Analysis 
of Case-Control Studies
A B GRAVES,* C M VAN D U IJN .t V CHANDRA, L FRATIGLIONI A HEYMAN A F JORM E KOKMFM 
RISK FA?T0RASMR°S™ RCH GROu “ “ ' $ ”  S 0 ' N,NEN' A H° FMAN F° R ™ E EUR0DEM
G ra veS A ß (Health and P opu la tion Research Center. Battelle Seattle Research Center. Seattle WA USA) van Dunn C
20 (Suppl 2 ): S48-S S 7. ° °  ab° ra t'Ve re a n a |ys,s o f case-control studies. In terna tiona l Journa l o f Epidem io logy  1991,
fs ^ r e s e n ^ r 15' the secondarV analysis of orig inal data from  11 case-controi studies of A lzheim er’s disease
co n 7 u m n , a , * 0< C° nSum pt,on 3nd c i9 aEe” e sm oking Five studies were included m the meta-analys.s of alcoh0 ; 
a te o h flr  T h " '  COnSumptlon was com puted m terms of average weekly intake, measured in ounces of ’pure
e x c e s s 'e s l^ e d  ns T " “  ' °  rePreSe" '  ' ° W' m ed'Um and h '9h m,ake A na l^ s  showeS noexcess est m ated risk of A fzhe.m er s disease for any level of alcohol intake. Smoking was analysed in three different
nr PO I r ^ ' T  prevalence of sm oking (ever/never)—this included eight studies (2) am ount smoked (less than
mH d f ° ne P3h P6r d3V V6rSUS m ° re th3n ° ne p3Ck per daV>—this included seven studies and (3) pack-yea rs - 
m c lud m g  fou r studies. A s ta tis tica lly  s ign ifican t inverse association between smoking and A lzhe im er’s disease was 
se ved at all levels of analysis, w ith  a trend tow ards decreasing risk w ith  increasing consum ption (p -  n 0003) A
t T b u n h e  d iffe rence T * * *  ° bServed am on9 Patients w ith a positive fam ily  h isto ry o f demen
the o b se rved ^d is^u rba^c^ itfn ico E n  r° UP ' h "  9 r° Up Wl,h n°  Such b 'storY was n° t  statistica lly significant A lthouah 
f in d in g s ^ p o s s ^  b ia s e s r lm d  m m  ^  ,l0n A lzhe'm er‘s d 'sea^  may provide an explanation for these
n p rtiv p  rn m m  .b K f  d 6 selec" on 0F surviva l of study subjects cannot be fu lly ruled out at this tim e Pros-
ing h ,s ,o ^  age o f o n sae T o f T d,eS ° ‘ ' T “ ' " '  ° '  A l' he' m «  s d,sease a,e needed ,o docum en, in detail the smok-
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IN T R O D U C T IO N
in this paper, the evidence for an association betueen 
alcohol consumption and Alzheimer s disease ( AD) 
and cigarette smoking and A D  is reviewed and a meta- 
analvsis o f original data collected from 11 case-control 
studies is presented ' 11
Alcohol
Sincv. alcohol is a known cause o f dementia.1 heaw
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alcohol consumption that could result in cognitive oefi- 
cits is used as an exclusionary criterion for the diag­
nosis o! AD " Because alcohol has neurotoxic 
properties however, it has also been suggested as a 
putative risk (actor for A D .1'’ Furthermore, alcohol 
abuse has recently been associated with an accelerated 
rate ot cognitive decline in Alzheimer patients.1 Case- 
control studies have also examined the use of alcohol 
because of its potentially confounding effects with 
head trauma, a factor which has been shown to confer 
an increased risk for A D ,!s
Previous studies of the role of alcohol consumption 
m the aetiologv of AD  have shown no association, 
although one stud\ J found a statistically significant 
inverse relation (unmatched odds ratio (OR) = 0 46.
A L C O H O L. TO BAC C O  A N D
0.01 <p<0.t)25) I he Italian study7 found matched 
odds ratios of 2.33 (p -  0.34) and 1.00 (p = j (K)) for 
dunking 0.5 litres or more of wine or spirits daily, in 
hospital and population controls, respectively. The 
USA, Durham study7 found that patients were less 
hkely than controls to have consumed beer
(unmatched OR = 0.71) and liquor (unmatched OR =
<) 5 4 ) ,  These differences were not statistically signifi­
cant 1 he frequency of wine drinking was similar in the 
two groups (unmatched OR = 1.05) No differences 
between cases and controls were observed m the USA 
Minneapolis study' for items relating to alcohol con­
sumption, which included frequency, amount and epi­
sodic drinking. Alcohol consumption was studied but 
the results were not reported in the USA, Denver 
study, and thus arc presented below
Smoking
A reduced frequency of smokers among Alzheimer 
patients was reported as early as 1981.20 The inverse 
association between smoking and Parkinson's disease 
(PD) is well known. 22 although its causal significance 
remains controversial.27 Eight of the nine studies 
included in the current meta-analysis examined smok­
ing as a putative nsk factor for AD. The study that did 
not was based on a medical record review7 which did 
not contain smoking histories.
Of the studies included in the meta-analysis, one 
found an inverse association between smoking and
AD, one found a positive association,6 and the 
remaining seven observed no association. In the Neth­
erlands study,8 a strong inverse association (OR =
O. 40. 95% Cl: 0 20-0.80) was seen in patients with a 
history of familial aggregation of dementia; no associ­
ation was found in those without such a history (OR =
12. 9e /o Cl: 0.6-2.6). These investigators also found 
that the risk of AD decreased as the consumption of 
cigarette smoking increased.8
The USA. Bedford study6 reported an odds ratio of 
2 0 (95% Cl: 0 9-4.3) comparing smokers to never- 
smokers. Here, an increasing estimated relative risk 
was noted with increasing consumption of cigarettes 
P^(irtnd) ~ 0 006). This analysis of dose-response was 
based on categorized packs of cigarettes smoked, but 
did not incorporate the number of years of smoking In 
this study, cases from a Veterans hospital were com­
pared with neighbourhood controls selected from lists 
of registered voters. The participation rate for cases 
was 77%; for controls, 33%.6 Since veterans mav be 
expected to smoke more than the general population, 
and since smokers have been found to respond less fre­
quently to questionnaires than non-smokers.2' the 
positive result for smoking obtained in this study mav 
be spurious
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Among other studies in the literature, one26 demon­
strated a greater consumption of cigarettes in cases 
versus controls, although these results were not statis­
tically significant Two studies have reported no associ­
ation, 27 26 and two an inverse effect.1'7 2,7 Jones27 
comparedthe medical rccordsof81 patients diagnosed 
with probable AD with interviews from 112 controls 
selected from a luncheon dub and care home, and 
found no differences in the lifetime prevalence of 
smoking between the groups (OR = 1.58, p = 0.75). 
This finding might be due to the very different popula­
tions used for comparison and the different methods of 
obtaining data from cases and controls. A study by 
Barclay e( al28 found no differences in smoking habits 
between 39 probable AD patients and 39 spouse con­
trols, but such small numbers lend little statistical 
power to detect an effect; the probability of finding an 
effect is further diminished by the choice of spouse 
controls, since couples tend to share indoor air and 
often, smoking habits.
Ferini-Strambi19 recently reported an unmatched 
odds ratio for smoking prevalence of 0.47 (95% Cl: 
0.23-0.94) comparing 63 hospitalized patients with 
early onset AD to 126 neighbourhood controls. The 
methods used for control eligibility, ascertainment and 
data collection procedures among controls are unclear 
from this report Patients hospitalized for AD may dif­
fer from neighbourhood controls in important ways. It 
is unclear whether an attempt was made to adjust for 
potential confounders. and. although each case was 
matched to two controls for several factors, no demo­
graphic data are given to examine the success of such 
matching; data were analysed without employing the 
1:2 matching employed in the study design. Gross- 
berg29 compared the smoking histories of 144 AD 
patients (diagnostic criteria unspecified) with 96 con­
trols obtained from various medical clinics (unspeci­
fied) Data for cases were obtained from surrogate 
respondents by telephone interview; control inter­
views appear to have been done in-person with the 
control. The (unmatched) odds ratio was 0.33 
(p<0.0 l). Seventy-four per cent of the cases were 
female, compared with only 52% of the controls. Since 
men are more likely to smoke than women,20 this find­
ing is not unexpected. Additionally, controls may have 
been hospitalized for conditions related to smoking.
METHODS
Alcohol
Of the nine s'udies available tor inclusion in the meta- 
analysis,*-8 "J11 data for alcohol intake were available 
from six.-^ " For a complete description of the methods 
used in each study, see van Duqn. Stijnen and Hofman
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m this supplement " Two of the three excluded studies 
c ld not collcc{ data on alcohol intake, the first was a 
mcd.eal record review/ jn the second," a question was 
asked to assess alcohol problems in subjects, but no 
quantification of intake was sought Data from the 
third study ' were not yet available for re-analysis.
Of the six studies, one'' was later excluded due to the 
ack ol a reference category (non-drinkerscould not be 
. is" n8uished from light drinkers). Among the remain­
ing studies, there was tremendous variability in the 
manner in which alcohol consumption was measured 
Some of the studies had data for the amount of alcohol 
consumed, but not the duration of drinking. Data were 
gathered by grouping all alcoholic drinks as one cate­
gory, or by collecting information separately for each 
type of alcohol (wine, beer, liquor) Several studies 
gathered categorical data while others obtained 
continuous data. The most standardized way of defi­
ning this variable that would allow the inclusion of the 
largest number of studies was the amount of ‘pure 
alcohol’ consumed in an average week.
The content of pure alcohol w'as taken to be, for 
beer. 5% (average 12 Oi'drink), for wine: 10% (aver­
age 6 oz/drink) and for liquor 40% (average 1.5 oz/ 
drink) Alcoho1 measured m millilitres was converted 
to ounces. For studies that did not distinguish the tvpe 
of alcohol but instead asked for the number of all types 
of drinks, it was assumed that the ‘average drink' con­
tained 18% pure alcohol and that the size of the aver­
age drink was 6.5 oz (averages of the above figures)
For two studies/ 4 categorical data were available on 
alcohol consumption, therefore, several assumptions 
were made. For the lowest category, it was assumed 
that average intake was hall of the highest number ol 
the category. For example, if the lowest category was 
<3500 ml/week , this translated into less than 11.9 oz 
pure alcoholyweek, and the value 5.95 was used. For an 
interval category, the midpoint was used. For the high 
est calegory, the conservative choice was made to use 
the lower end of the range For example, >one fifth 
translated into >10.24 ounces pure alcohol/week, and 
the value 10.24 was used.
For the studies’58 which asked separate questions 
on wine, beer and liquor intake, the pure alcohol value 
from each type of alcohol was summed for total aver­
age intake. In the Italian study,4 questions were asked 
for all three types of alcohol, but each in a different 
way. Only the consumption ol wine was quantified in a 
manner consistent with the definition employed here 
bince wine is the most commonly consumed alcohol m 
Italy, a was thought that compatabilitv with the other 
studies could be reasonably maintained if beer and 
hquor were not included in the analysis. An analysis
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was run on tho liquor variable to justify such an exclu­
sion; 7% of the cases and 5% of the controls consumed 
hard liquor ‘very often' or every day'. This was not a 
statistically significant difference (p>0.5). Since the 
categories in the Italian data were not satisfactorily 
compatible with the other studies, analyses were con­
ducted both including and excluding this study
I he studies that were included in the mcta-analvsis 
of alcohol consumption were those from Italy.4 the 
Netherlands,8 USA. Denver.8 USA, Durham“’ and 
USA, Minneapolis Data were analysed in the man­
ner described by van Duijn ci ol (this supplement'1). 
For all variables, frequency distributions and contin­
gency table analyses were conducted before perfor­
ming conditional logistic regression analyses. The 
continuous alcohol variable that was created by con­
version of the individual studies questions to ounces of 
pure alcohol was categorized into a four-level variable 
(non-drinkers, <3.2 oz pure alcohol/week (low], 3.2- 
5 95 oz pure alcohol/week [moderate]; 5.96 k oz pure 
alcohol/week [high]) by dividing the frequencies 
among drinkers in the pooled control group into 
approximate tertiles Each level of alcohol consump­
tion was compared against the referent group of 
non-drinkers.
Analyses were conducted by computing risk esti­
mates for each tertile of alcohol consumption; in addi­
tion. a test for trend in the three levels of alcohol 
consumption was performed by including the alcohol 
variable in the model as one parameter and testing the 
statistical significance of this term. Analyses were"first 
carried out unadjusted for covariates. Regression 
models were then constructed which adjusted for 
family history ol dementia, head trauma, education 
and smoking. All included studies were matched on 
age and gender, and no further adjustment was made 
for these factors
Smoking
Eight studies were included in at least one of three 
levels of analysis for smoking One study7 did not col­
lect data on smoking habits
Information from eight studies was available on 
whether subjects had ever smoked in their lifetime In 
general, this question was asked consistently from 
study to study. Data on amount smoked daily and 
duration of smoking was much more variable. Table 1 
shows a list ot data that were available from each study 
Since the USA. Bedford studs was the only study to 
find smoking to be a risk factor tor A D . with increasing 
amount smoked conferring greater risk, analyses were 
conducted on the amount smoked in order to examine 
the effect of the USA. Bedford studs on these pooled
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1 a h i  i 1 O iin i o n  s m o k in g  a v a ila b le  f r o m  eigh t studies uu  lu d c il  in th e  
m e in  a n a lys is
Sludv location 1 vci smoked Amount Duration
Australia"’ X
llaly' X X (e) X
Netherlands' \ X (C) X
USA Ucdtord" \ X (e)
USA Denver' X X (e)
1 'SA Durham \ X (cl
USA Minneapolis X N «  ) X
LISA. Seaiile" X X(c) X
Duration in categorical form, duration used in pack-year meia 
analysis only if collected in continuous form 
(C) Data collected in continuous form 
(c) Data collected in categorical form
relative risks. Since the categories for the amount 
smoked differed from study to study, categories were 
collapsed at less than or equal to one pack per day ver­
sus more than one pack per day The USA, Denver 
study was excluded from the analyses of amount 
smoked, since the lowest category of smoking was less 
than or equal to two packs per day.
Since the amount smoked was not considered to be a 
valid measure of dose, analyses were also conducted 
on the four studies which had continuous data on dura­
tion. The USA, Durham team3 gathered data on dura­
tion by asking about the amount consumed at different 
age intervals (before age 20, between ages 20 and 39 
and after age 40). Since it was not possible to compute 
the lifetime duration of smoking from these data, this 
study was excluded from the pack-years analysis. Pack- 
years were computed by multiplying the number of 
packs per day by the duration of smoking in years. This 
required categorizing the continuous variable for 
amount in two studies.3 s The pooled distribution of 
pack-years \n the controls were categorized into ter- 
t * I es of approximately equal frequencies. This formed 
a four-level variable of never-smokers, low (<15.5 
pack-years), moderate (15.5-37.0 pack-years), and 
high (>37.0) exposure to cigarette smoking. As was 
done for alcohol, risk estimates were computed for 
each tertile of exposure, and tests for trend over expo­
sure levels were performed. Effect modification of the 
relationship between smoking and AD by age of onset, 
education, gender and family history of dementia w'as 
explored. Analyses were conducted to examine the 
potential confounding effects of education, familv 
history and previous history of head trauma
RESULTS
Alcohol
Analyses were performed on the factored four-level 
variable for ‘average weekly consumption of ounces of
pure alcohol loi each individual study, and for (hc 
meta-analvsis pooling these data Exposure rates in 
cases were, for non-drinkers. 46%. for the lowcsttcr- 
tile. 13.2%, for moderate drinkers. 22.4%, and for the 
highest tertile, 18.47« In controls, exposure raleswere 
45.6%. 12 57«. 24 7% and 17 27« lespectively. The 
conditional logistic regression results, unadjusted for 
covariates (f igure I). show that for the overall esti­
mates the estimated relative risk is approximately 1 0 
for the lowest and highest levels ol consumption, with 
the intermediate level showing a relative risk of 0.70 
All of the confidence intervals include 1.0
Table 2 presents the results from the meta-analysis 
for the unadjusted alcohol variable and adjusted for 
different covariatcs. Analyses were performed includ­
ing and excluding the Italian study The inclusion of 
family history of dementia as a covariatc changed the 
relative risks, but adjustment for smoking alone, edu­
cation alone and both of these factors together had no 
effect on the relative risk estimates
When the Italian study was excluded a different 
trend in the risk gradient with increasing alcohol intake 
was apparent Whereas a U-shaped curve was seen 
with the inclusion of this study, the estimated relative 
risk increased at the moderate level of alcohol intake 
when this study is excluded, creating the reverse effect. 
However, the relative risks are all fairly homogeneous 
in all of the analyses, and the overall conclusion must 
be one of no effect.
Smoking
Matched relative risks by individual study and for the 
pooled analysis for subjects’ lifetime smoking status 
are presented in Table 3. With the exception of the 
USA. Bedford study, these results show a consistent 
trend towards an inverse relation between smoking 
and AD The pooled analysis of these data, including 
the USA. Bedford data, demonstrates this effect to be 
statistically significant In this latter analysis, 53% of 
cases and 5970 of controls had smoked regularly at 
some time in their lives.
Table 4 presents the pooled findings for smoking at 
three levels of analysis. The first level (ever/never 
smoked) w-as conducted both including and excluding 
the USA. Bedford data, since the test for heterogen­
eity between studies suggested that these data were dif­
ferent from the rest of the studies (y: for interaction 
term of USA. Bedford study by smoking status = 2.15. 
p = 0 14). The results show a statistically significant 
inverse association regardless of the inclusion of the 
USA. Bedford data; however, the effect is slightly 
stronger w'hen those data are excluded. When the 
USA Bedford data were analysed alone the relative
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risk showed the opposite association to the results from 
the pooled analysis. This was also true when the data 
were stratified on whether the case had a positive or 
negative family history of dementia. In the pooled 
analysis, smokers with a positive family history had a 
slightly lower estimated relative risk of AD than those 
without such a history (0.70 and 0.86 respectively) 
(Table 4), but neither of these estimates was statis-
Table 2 Relative risks for meta-analysis for alcohol (in ounces pure 
alcohol per week), with 95% confidence intervals, unadjusted, adjusted 
for family history alone, ar d adjusted for family history, head trauma 
and education
Unadjusted
Adjusted for 
family history of 
dementia alone
Adjusted for 
family history of 
dementia, head 
traum a, and 
education
Including study numbers 3-6.8
Low' 1.06(0.68-1 64) 0 97 (0 59-1 60) 0.89 (0.59-1 47)
Moderate 0 70(0.46-108) 0 75.0.46-120) 0 .82(0  49-1 39)
High 1 07 (0.69-1 65) 0 89(0 52-1 51) 0 95 (0 51-! 81)
Including study numbers 3.5.6.8
Low 1 03 (0.65-1.61) 0 95 (0 56-161) 0 85 (0.48-1 50)
Moderate 0 98(0.57-1 70) 1.02 (0 53-1.94) 1 48(0.67-3 23)
High 0 80(0.50-1 28) 0 68(0 37-1 24) 0.68(0.31-1 48)
'Low = 0.6-3.2 ounces pure alcohol/week. M oderate = 3.21-5 95 
ounces pure alcohol/week.
High = 5 96 + ounces pure alcohol/week
ticallv significant (although they were marginally so) 
When the USA. Bedford data were excluded from thi 
stratified analysis, this effect was slightly stronger, an< 
the relative risk for smoking given a positive famii 
history of dementia was statistically significant (RR - 
0.63, 95% Cl: 0.41-0.94). It should be noted, howevei 
that the confidence intervals in this analysis almo; 
completely overlap and the risk estimates are nc 
statistically different from one another
The relative risks for the amount smoked (but nc 
the number of years smoked) did not differ when th 
USA, Bedford data were included in the analysis.but
T able 3 Relative risks for smoking lever versus never) with 95 
confidence intervals, unadjusted for covariaies. for individual stud 
and for pooled analysis
Exposure frequencies 95%
Study
location Cases Controls
Relative
risk
conndenc
interval
Australia 80/168 89/169 0.79 (0 47-1 3
Italy 51 / i 16 52/97 0.60 (0 26-1 3
Netherlands 99/197 110/197 0.73 (0 45-i 1
U S A . Bedford 85/102 127/lbl 1.53 (0 74-3 1
USA. Denver 17/63 23/63 0 57 (0 24-i 3
USA. Durham 25/46 50/91 0.97 (0 45-2 l
USA. Minneapolis 54/78 37/48 0.50 (0 15-1 6
U S A . Seattle 66/ i 29 75/129 0 73 (0 43-1 2
Pooled analysis 47-/899 563/955 0.78 (0.62-0.5
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r ,s k s f ' n  s m o k in g , a n d  9.5% c o n fid e n c e  in te rv a ls . b y  th ree  le e c h  o f  a n a l  / v
s tra t i f ic a t io n  b y  f a m i ly  h is to ry  o f  d e m e n tia  in  cases ( ,  , r , c l ‘“ l " 'S  U S A -
— ---------------------------- ---- ----------- casts  f o r  e ve r lncve r s m o k in g  status a nd  pack -yea r analyses
U n it o f  analysis
Study num bers included
S m oking  (e v e r /n e v e r) '
Positive fa m ily  h is to ry t  -  eases 
Negative fa m ily  h is to ry  -  eases
A m o u n t sm oked 
<  I pack per day 
>  1 pack per day 
p ( tre n d )
Pack-years
1 <15 5
2 15.5-37 0
3 >37.0 
p ( tre n d )
2- 6 .8 . 10.11 
<1 78(0 62-0 VS)- - 
0 70 (0 48-1 04)
0 8(i(0 63-l IS)
2—4.6.8.1 1 
0 84 (0 75-0.92)
0 81 (0 53-1 27)
0 11
3.4,8.11
0 7.3(0 50-1 09)
0 63 (0 42-0 95)
0 50(0 31-0 80) 
0.000.3
2-5.8.10.11 
0 72 (0 56-0 92) 
0 67 (() 4 |-0  9 4 ) 
0 81 (0 58-1 1.3)
2-4 .8 .1 I
0 80 (0 60-1 07) 
0 66 (0.44- 1 00) 
0 (12
(i
I 53(0 74-7 |7)
3 07 (0 60-15.60) 
1 24 (0 54-2 84)
Postive fa m ily  h is to ry  - cases
1 <15.5
2 15.5-37.0
3 >37.0
p ( tre n d )
0 53 (0.26-1 10) 
0 49(0 24-| 02) 
0.37 (0 17-0.81) 
0 11
N egative fa m ily  h is to ry  -  cases
1 <15 5
2 15.5-37 0
3 >37.0 
p ( tre n d )
0 85 (0 52-1 .78) 
0.69 (0 39-1 22) 
0 66(0  .33-1 34) 
Oil
'•R e la t iv e  risk  fo r  the specihed unit 
f  F am ily  h is to ry  o f  dem entia
of analysis and its 95% confidence in te rva l
trend was observed when these data were excluded 
(P„ren<t, = 0-02) (Table 4).
Analyses o f dose-response taking into account both 
the amount and the number of years smoked were 
carried out in four stud.es.3 J 811 Table 5 presents the 
distribution o f cigarette pack-years by gender and 
case-control status. The pack-year analyses show a 
decreasing trend in the estimated relative risk with 
increasing pack years consumed (p = 0.0003, Table 4) 
Additionally, the estimated relative risk of developing 
A D  in people in the highest tertile of exposure (>37 () 
pack-years) was 0.50 (95% Cl: 0.31-0.80).
When the pack-year analysis was stratified by the
,  1DlS' nbunon o f  " •  pack-years, from  fo u r  studies ,3
4. b, I I )  by gender and case-control status, number and per cent
Cases (% )  C o n tro ls (% ) Cases (% )  C o n tro ls  (% )
Never-
smokers
Pack-years:
51 (25 4) 26
<15.5 45 (22.4) 38
15.5-37,0 53 (26.3) 59
>37.0 52 (25.8) 62
(14 0) 160 (75 8) 137
(20 6) 29 (13.8) 40
(31.9) 16 (7 6) 18
(33.5) 6 (2 8) 1 !
(66 5)
(19 4) 
(8 8 ) 
(3 3)
case s family history of dementia, the inverse relation 
between smoking and AD was observed to be stronger 
among those with a positive history (Table 4). H ow ­
ever. this trend of decreasing relative risk with increas­
ing exposure to cigarette smoking was also evident in 
the stratum with a negative family history, although 
these estimates were no longer dose to statistical sig­
nificance. The strength of the trend was the same 
regardless of whether a family history of dementia was 
present or not (p = 011)
Analyses were conducted to examine potential 
effect modification by age of onset, education, gender 
and family history The relative risk for the dichot­
omous smoking variable was. for early onset (<70) 
cases, 0.89 (95% Cl: 0.67—1 19). and for late onset 
7°) cases, 0.65 (95% Cl: 0.43-0.96). These relative 
risks changed minimally when the USA, Bedford data 
were removed from the analysis (RR = 0.81, and 0.61 
for early and late onset, respectively). Among earls 
onset cases, the inverse effect of smoking was apparent 
only in familial cases, showing marginal statistical sig­
nificance (RR = 0.60. 95% Cl: 0.35-1.01); in sporadic 
cases, this relative risk showed no effect (RR = 0 99 
9^% Cl- 0.66-1 48) None of the other interaction
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parameters (education, gender, family history) 
improved the interpretation of the statistical models
Various models were constructed for the three levels 
of analysis adjusting for education (family history ol 
dementia and a history of prior head trauma were not 
associated with smoking). The relative risks for the 
pack-years analysis became somewhat stronger when 
adjusted for education (RR (95% Cl): <15 5 pack- 
years: 0.68 (0.46-1.01); 15.5-3.70 pack-years: 0.58 
(0.37-0.89); >37.0 pack-years 0.49 (0.30-0.78)). The 
difference between these estimates and the unadjusted 
figures is small, and the interpretation of the data 
remains the same
DISCUSSION
Alcohol
Despite the suggestion of an inverse association noted 
in some studies examining the role of alcohol in the 
aetiology of AD,"19 no relation was found in the 
current meta-analysis. All of the studies included in the 
meta-analysis for alcohol consumption excluded 
dementia due to alcoholism in the differential diag­
nosis of AD4 8 or as a specific exclusionary criterion :
If controls who were alcoholic were not excluded from 
eligibility in the same wav as cases, the heaviest con­
sumption of alcohol in cases mav have been under­
estimated. Although the USA, Minneapolis study' 
excluded controls with alcoholism documented bv pre­
vious treatment in the same way as cases were 
excluded, three other studies2 * * do not mention speci­
fic. exclusionary criteria related to alcohol consumption 
in potential controls. An additional two studies4' 
chose controls with various diagnoses not likelv to 
share risk factors with AD; the success of such selec­
tion for alcohol consumption is not known. Theoreti­
cally, the differential restriction of alcoholics in case 
and control selection could produce a risk estimate 
biased toward the null value However, since alcoholic 
dementia is rare (3-^% of all dementias1' '2), heavy 
alcohol consumers remain in the analysis. Thus, the 
potential underestimation of risk would not com­
pletely obscure an association if one existed.
The extreme variability among studies in the col­
lection of data on alcohol intake required that the defi­
nition of alcohol intake in the pooled analysis be rather 
broad; this definition couid not incorporate duration of 
drinking, binge drinking, and changes in drinking 
behaviour over the exposure period. The definition of 
intake used in the pooled analysis was able to take into 
account the type of alcohol consumed in those studies 
that discriminated between wine, beer and liquor, and 
the average amount and frequency of intake. Another 
limitation of the exposure definition was that manv
studies gathered categorical data, which demanded 
that certain assumptions be made regarding individ­
uals iniakc The rather conservative approach of 
assigning the starting value for the highest category 
(e g 5 96 was assigned for the category of intake 
>5.96 pure alcohol/week ) may have resulted in an 
underestimation of the relative risk in the high expo­
sure categories.
Smoking
In the pooled analysis of eight case-control studies, a 
statistically significant inverse association was 
observed between the lifetime prevalence of smoking 
and AD (RR = 0.78, 95% Cl 0 62-0.98). Analyses of 
dose-response, based on cigarette pack-years, were 
consistent with this association (p = 0.0003) A 
statistically significant decreasing trend in risk with 
increasing amount smoked was not observed when the 
USA. Bedford study'' was included in the analysis 
= 0.11), but was observed when this study was
end) 7
excluded (p = 0.02). Among early onset cases, the 
inverse association with smoking was evident only 
among those reported to have one or more relatives 
with dementia, and there was a suggestion of a stronger 
inverse trend among cases with a family history com­
pared to those without such a history, but these relative 
risks w'ere not statistically different from one another, 
and the statistical significance of the gradient was the 
same in each stratum (p =0.1 IT
* (trendI
The ability of meta-analysis to detect a subtle change 
in the estimated relative risk underscores its useful­
ness. While the observed inverse relation was not 
detectable in any one study alone, a trend is evident 
across studies (Table 3). Based on the observed 
number of discordant pairs, and assuming an alpha of 
0.05 and a detectable relative risk of 0.72 (that 
observed in the pooled analysis), the statistical power 
for the pooled analysis of smoking (eight studies) was 
82.6%. using the method of Schlesselman/3 (p 162). 
Conversely, the individual studies' powers ranged 
from a low of 9% to a high of 20% to detect this relative 
risk, with a mean pow-er of 14% Although the meta- 
analvsis affords the statistical power necessary to 
detect subtle changes in the relative risk, these findings 
should be interpreted cautiously, since the possibility 
that they are due to bias in subject selection or to fac­
tors related to differential survival in smokers versus 
non-smokers cannot, as yet. be completely ruled out 
If this association represents a veritable biological 
finding, mechanistic support could be found in the 
observed reduction in nicotinic binding site density in 
the cerebral cortex of AD patients ^ y The expen- 
mental introduction of nicotine produces an increase in
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(lie number of nicotinic cholinergic recognition sites in 
the cerebral cortex.'7 Nicotine also stimulates the 
release of acetylcholine in the cortex.3*"7 Since the 
introduction of nicotme and AD have opposing effects 
on nicotinic receptors (nicotine upregulatmg these 
receptors and a reduction seen in AD), it could be pos­
tulated that. in smokers, the density of nicotinic bind­
ing sites may be greater than in non-smokers, thus 
protecting against, or retarding the onset of disease. II 
loss of cholinergic receptors (such as nicotinic recep­
tors) is more severe in patients with a family history of 
dementia compared to those without such a’ history, 
the inverse association between smoking and AD 
would be stronger in this former group.
As in A D , reductions in nicotinic binding have been 
observed in Parkinson’s disease (PD) u PD is fre­
quently associated with cholinergic degeneration. An 
inverse association between smoking and PD has also 
been observed.’123'04^ 1 but the potential dose- 
response effect of smoking on the risk of PD remains 
unclear 214,1 J?
Several methodological questions have been 
explored in further analyses in an attempt to interpret 
the observed inverse association between smoking and 
AD. First is the possibility that due to selective factors 
m these case-control studies, controls are more likely 
than cases to have smoked. Such spurious over-rep­
resentation of smokers among controls in the meta­
analysis is unlikely, since the analyses were limited to 
case-population control comparisons onlv, and. as 
pointed out earlier, such participating controls are 
actually less likely to smoke'3 than non-participating 
controls
Although we cannot fully rule out the possibility of 
differential survival among cases and controls by 
smoking status, effective age matching eliminates this 
as a cause for concern in the interpretation of 
findings M
An analysis examining the reported age of onset of 
AD in smoking versus never smoking cases revealed 
that smokers onset was earlier than non-smokers (65.4 
versus 68.4 years, respectively, p<0.0001). Stratifica­
tion of this analysis by gender revealed no differences 
in males (p = 0.33), with the effect being limited to 
females (p = 0.002). Further analysis revealed that 
females who smoked were younger than females who 
never smoked among both cases and controls. Since 
smoking among women has become increasingly 
acceptable over time, the age of onset analyses among 
females was stratified by birth cohort (before 1900. 
1900-1920, later than 1920). This resulted in the effect 
of age of onset washing out, indicating the probable 
existence of a generational effect
Although the absence of <i difference in age of onset 
between smoking and never-smoking male cases 
argues against cigarette smoking delaying disease 
expression, the Netherlands studvJ' found that in fam­
ilies in which two or more AD patients were discordant 
for smoking, the smoking AD patient had onset an 
average of 4.2 years later than the non-smoking patient 
(personal communication, C M van Duijn) However, 
age of onset is known to vary within families which dis­
play autosomal dominant transmission,J' and small 
numbers in the Netherlands study advise hesitation in 
drawing firm conclusions. This is clearly an area which 
merits further investigation using a prospective cohort 
design in which age of onset and smoking histories are 
more accurately documented.
The relative risk for the dichotomous lifetime preva­
lence of smoking stratified by age of onset (<70; 70+) 
was statistically significant for late onset cases (RR = 
0.65, 95% Cl: 0.43-0,96) but not in early onset disease 
(RR = 0.89. 95% Cl: 0.67-1.19) Although these rela­
tive risks are not statistically different from one 
another, one might be tempted to imply that smoking is 
inversely related to AD only in late onset cases. As an 
alternative explanation, one should consider the possi­
bility that older smokers who develop AD may be 
screened out from AD case series due to co-morbid 
conditions secondary to smoking. This differential pro­
cess, which could operate passively (through death, 
through the tertiary care system and through participa­
tion procedures in epidemiological studies) or actively 
(though diagnostic exclusionary criteria for AD), 
could produce ‘purified’ older cases who smoke less 
than those who have AD but who have not been 
included in research studies for reasons related to their 
smoking. Although such a selection bias is unlikely to 
account entirely for the observed association between 
smoking and AD. it is a problem peculiar to case- 
control studies of AD and should be considered
The results presented here for smoking are clearly 
preliminary and no conclusion can yet be drawn 
regarding the role that smoking may play, if any. in the 
aetiology of AD Methodological issues arc still at 
large. Even if these preliminary findings represent a 
valid biological phenomenon, the absolute risk 
incurred by smokers to develop chronic diseases such 
as cancer and cardiovascular disease clearlv outweighs 
any ‘advantages' of smoking
CONCLUSION
A meta-analvsis is traditionally thought of as a con­
glomeration of results from published reports We 
have had the unique opportunity to conduct a secon 
darv analysis of data from 11 case-control studies of
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A D  which examined the roles of alcohol and tobacco 
consumption in the aetiology of this disease. This anal­
ysis has been particularly fruitful in validating negative 
results from previous studies on a larger data set, in the 
case of alcohol consumption. An inverse association 
between smoking and A D  has been observed for both 
lifetime prevalence of smoking and in dose-response 
analyses While we can speculate on possible biological 
mechanisms for these findings, case-control studies 
using retrospective ascertainment procedures for gath­
ering smoking histories and dating the onset of disease 
clearly leave room for a large degree of measurement 
error. Additionally, such studies are subject to selec­
tion biases in subject recruitment.
The conduct of prospective, population-based stud­
ies of incident A D  cases will help to alleviate potential 
methodological deficiencies of case-control studies 
studying patients with prevalent A D . Such prospective 
investigations will be able to document patterns of sur­
vival in smokers and non-smokers who subsequently 
develop A D . They will increase the precision of docu­
mentation of smoking histories and the dating of the 
age of onset of cognitive deficits. Until prospective 
studies investigate the role that smoking may play, if 
any, in the aetiology of A D , the biological significance 
of the findings from the meta-analysis for smoking 
must be interpreted with significant caveats in mind.
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A m eta-an a lysis, invo lv ing  the secondary analysis o f o rig ina l data from  11 case-control studies of Alzheimer s disease, 
is presented for occupational exposures to  so lven ts  and lead Three stud ies had data on occupational exposure to s o l­
vents. A m ong cases, 21.3% were reported  to  have been exposed; am ong contro ls, th is figure was com parable  
(20.9%). This yielded a pooled m atched re la tive  risk of 0.76 (95% Cl: 0 47-1.23) Four stud ies had data or, exposure to 
lead. Exposure frequencies were 6.1 % in cases and 8.3% in controls. Th is resulted in a pooled matched re la tive risk of 
0.71 (95% C l: 0.36-1.41). The m eta-analysis w as pa rticu la rly  useful in va lida ting  negative results from  ind iv idua l s tud ­
ies and in increasing the statistical pow er fo r the analysis o f lead exposure, where stra tum -specific  cell sizes w ere fre ­
qu en tly  sm a lle r than five in ind iv idua l s tud ies. H ow ever, since exposure in the various studies was ascertained in a 
ra ther broad m anner, prospective s tud ies are recom m ended which focus on h igh -risk occupational popu la tions and 
w h ich  de term ine  the incidence of A lzhe im e r's  disease in these and com parable  unexposed populations
IN T R O D U C T IO N
O ccupational exposures to solvents and lead were one 
group o f exposures considered in a meta-analysis of 
orig inal data from 11 case-control studies o f A lzh e im ­
er’s disease (A D ) 1 "  Exposure to occupational 
sources of a lum inium  as a specific risk factor of interest 
was not included in these analyses, since data fo r this 
variable were available from only one study 2
Solvents
Two studies'" suggesting that an excess relative risk 
(R R ) of presemie dementia is associated w ith  indus­
tria l solvents have prompted other investigators to 
study this putative risk factor A  Swedish case-control
‘ H e a lth  and Popu la tion  Research C ente r. B a tte lle  Seattle (Research 
C en te r. 4000 N E 4 1st S treet. W A  98105. U S A
+ E U R O D E M  D epartm ent o f E p id e m io lo g y  and B ios ta tis tics  
Erasm us U n ive rs ity  M edica l School. R o tte rd a m . The N e the rlands 
R e p rin t request E U R O D E M , D epa rtm en t o f E p id e m io lo g y  and 
B ios ta iis tics , Erasm us U n ive rs ity  M edica l S choo l. PO Box 1738 1000 
D R  R o tte rdam  The N etherlands
studv ': selected industrial workers receiving a disabil­
ity  pension (151 cases receiving disability fo r mental or 
neuropsychiatric disorders. 248 controls receiving dis­
ab ility  fo r reasons other than mental disorders). Expo­
sure to 30 years or more in an occupation knowm to use 
organic solvents was five times more common in 
people w ith a diagnosis of presemie dementia in the 
d isab ility  record than in those w ithout. However, the 
va lid ity  o f the diagnosis and the general nature ot 
exposure classification must be questioned in this 
studv. A  cohort study conducted by M ikke lscn1 fo l­
lowed 2601 Danish painters and 1790 bricklayers for 
five vears The incidence of presemie dementia, diag­
nosed again from  disability pensions, was 3.4 times 
higher in the painters, and no excess o f other neuro- 
psvchiatric disease was observed. In reference to these 
studies, Henderson14 has raised the issue that diagnos­
ing physicians w-ould probably not be blinded to expo­
sure status Consequently diagnostic suspicion bias 
mav plav a role in the excess risks observed in these 
studies. F urthe rm ore . the potential misclassification oi
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exposure in painters, who are exposed to both solvents 
and lead, as well as other neurotoxic metals, advises 
cautious interpretation of these data.
Of the case-control studies included in the current 
meta-analysis, three" ''' included information related 
to occupational solvent exposure. The USA, Bedford 
study6 produced an odds ratio of I 0 (95% C l: 0.5-1.9) 
for being exposed to solvents in any occupation. The 
USA. Durham study’ did not find any differences 
between cases and controls with respect to exposure to 
solvents (relative risk not reported). The USA, Min­
neapolis study' reported an estimated RR for occupa­
tional solvent exposure of 1 25 (95% Cl. 0.55-2.84)
Lead
The existence of neurobehavioural deficits as a con­
sequence of exposure to inorganic lead is widely 
accepted.15 In particular, heavy exposure to lead in the 
workplace has been associated with impaired memory, 
attention, concentration and psychomoior perform­
ance.16 Due to the neurotoxicity of this metal, its ability 
to cause encephalopathy,1' and case reports suggesting 
a neuropathological association between lead and 
A D ,IS W several case-control studies have investigated 
it as a potential risk factor for AD.
In the USA, Bedford study,6 the RR associated wnth 
ever working in a job involving the use of lead was 0.8 
(95% Cl: 0.3-2.0). In the USA. Durham and Denver 
studies." 5 no association was observed, and relative 
risk estimates were not reported. In the USA, Minnea­
polis study,1 the estimated RR for ever being exposed 
to ‘metals' in an occupation was 1.27 (95% Cl: 0.55- 
3.00). comparing cases to hospital controls. Thus, no 
association between occupational exposure to lead and 
case-control status was observed in any of these 
studies
METHODS
Solvents
Three studies had data available on occupational expo­
sure to solvents.216 In the USA. Bedford study,6 the 
respondent was asked whether the subject worked in 
any job that involved the use of organic solvents. In the 
USA. Durham study," respondents were asked 
whether the subject had ever been exposed to solvents 
during employment for ten hours or more per week for 
six months or longer. The USA, Minneapolis study 
asked respondents whether the subjects had ever used 
solvents or degreasers on the job. These methods of 
ascertaining data on solvents were deemed to be suf­
ficiently comparable and were thus included in the 
pooled analysis. No further level of detail on solvent 
exposure was sought. Conditional logistic regression
models were used to obtain point estimates from each 
study separately and from the pooled data. Adjust 
merit was made for education and smoking to test for 
confounding by these variables
Lead h
[•our studies were included m these analyses I he 
question in ihe USA, Bedford study was the same as 
for the solvent question in that study In the USA, 
Denver study.' a question on whether the subject was 
ever exposed to chemicals such as lead, mercury or 
arsenic was asked, and the specific chemicals 
requested When this latter variable was coded for 
lead, it was used for the present analysis. The same 
method was used in the USA, Minneapolis study,1 
where the metal was specified and coded. In the USA, 
Durham study,"’ a similar question to the solvent ques­
tion was asked for lead exposure The analyses for lead 
were conducted in the same manner as was done for 
solvents.
RESULTS
Solvents
Relative risk estimates for the individual studies and 
pooled analysis are presented in Table 1 No associ­
ation was observed between occupational exposure to 
solvents and AD. The frequency of exposure in cases 
was 21.3%; in controls, 20.9% with an unadjusted 
matched RR of 0.76 (95% Cl 0 47-1.23). When this 
estimate was adjusted for smoking and education, it 
was slightly higher (RR = 0.83. 95% Cl: 0.50-1..>9) 
Exposure to solvents was unrelated to a history of head 
trauma or family history of dementia
Lead
Table 2 presents the findings for the analyses of occu­
pational exposure to lead. Again, no association was 
observed Exposure frequencies for lead were, for 
cases, 6.1%: in controls. 8.3% The RR from the 
pooled analysis was0 71 (95% C I 0.36-1 41). T his RR 
remained unchanged when adjusted for smoking and 
education (RR = 0.74.95% CL 0.37-1.47)
Tabu I Relative risks for occupational solve,u exposure Iever versus 
never), mill 9 '%  confidence intervals, for individual studies and for 
pooled analysis
Surds
location
Exposure frequencies
Relative
risk
95%
confidence
intervalCases Controls
USA. Bedford' 22/102 39/162 (1 83 p i  4 4 - 1  5 S |
USA Durham 11/4 1 6/77
USA Minneapolis 25/78 1 5/48 (1 92 ;(i 4 i 2 (1°)
Pooled analysis 47/221 60/287 (1 76 1(1 47-1 23)
"O cases exposed— model did noi converge
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i i i n n n i  ............ palion iH thcir qucstionnaires. (lie degree of detail was
never), wnh 95% confidence intervals. unad/iLUcd. [o r  in d iv idua l so varied so as to exclude most of these studies from
studies and (o r  poo led analysis specific exposure comparison. Several studies, for
Lxposurc  frequencies 95%
instance, only included broad classification of occupa-
Study Relative confidence tion by industry type. The more detailed ascertainment
loca tion C ascs C ontro ls risk in terva l of exposures of specific compounds in individual jobs
U S A , Bedford" 18/101 Us/161 0 72 (0 28-1 85)
would enhance the ability to compare results across
U S A . D enver' 1/42 5/50 0.25* (0.0.3-2.24) studies and would facilitate pooling ol data in future
US A . D u rha m ' 2/40 4/78 0 78 ’ (0 14-4 .36) collaborative studies
U S A , M inneapolis ' 5/78 3/48 1 50 (0 25-8 98)
Pooled anals'sis 16/261 28/337 0 71 (0 36-1 41)
'O n ly  one ease exposed
DISCUSSION
We have compared and combined data from case- 
control studies examining occupational exposures to 
solvents and lead as risk factors for A D . and have 
found no association for either factor. The meta-analy­
sis was particularly useful for studying lead exposure, 
where the number of subjects in individual exposure 
strata was frequently smaller than five. Despite the fact 
that the occupational exposure questions were asked 
rather consistently between studies, how well these 
questions actually measure exposure (given that they 
are asked of a surrogate respondent and entail an ‘ever/ 
never exposed in any job ’ response) is not known/This 
method of exposure ascertainment may be subject to 
misclassification, most likely in the form of under­
estimation of exposure. Therefore, a negative finding 
for occupational exposures in AD from this meta­
analysis does not confirm the absence of an associ­
ation. For this reason, prospective studies are recom­
mended which examine the incidence of AD  in 
high-risk occupational populations exposed to various 
neurotoxins (e.g. solvents, lead, aluminium).
Some of the estimated relative risks reported from 
published papers differ from the figures presented 
here. Among these are the relative risks for solvent 
and lead exposure in the USA. Bedford study.'’ These 
differences are due to different wavs of handling the 
varied number of controls per case in this study 
Readers are referred to the paper on Methods2" in this 
Supplement for an explanation on how this was done 
forthe meta-analvsis. The resultsof the USA. Minnea­
polis study2 differ from the RRs presented here for sol­
vents because the former comparison was made with 
hospital controls: the meta-analysis used only com­
munity-based population controls in those studies with 
two control groups. Additionally, the USA. Minnea­
polis study2 reported results for all metals combined, 
whereas for the meta-analvsis. data were made avail­
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Environmental risk factors for Alzheimer’s disease: 
their relationship to age of onset and to familial or
sporadic types
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Baltimore. Maryland, USA
s y n o p s i s  Data from a case-control study of Alzheimer’s disease (AD) were analysed in relation 
to age of onset and familial/sporadic status. The analyses were restricted to environmental 
exposures which might injure the brain. Later-onset AD was found to be positively associated with 
starvation/malnutrition and with nose-picking and negatively with analgesics, while earlier-onset 
was associated with physical underactivity and nervous breakdown more than 10 years before. 
Sporadic AD was associated with starvation/malnutrition and with head injury. These analyses 
merit replication in other large case-control studies of AD.
INTRODUCTION
In a review of the evidence for risk factors in 
Alzheimer’s disease (AD), Jorm (1990) con­
cluded that only three can be regarded as 
confirmed: advanced age, a family history of 
dementia, and having Down’s syndrome. No 
other putative risk factor has consistently been 
found to be positive (Henderson, 1988; Jorm, 
1990). In particular, no environmental exposure 
has yet attracted good evidence for its con­
tribution, although there is some evidence in 
favour of head trauma as a risk factor (Hender­
son, 1988; Jorm, 1990; Anthony & Aboraya, 
1992). However, environmental exposures can 
reasonably be expected to play a role in a 
proportion of AD cases. The relative risks 
involved may be different in earlier compared to 
later-onset cases, and in familial compared to 
sporadic cases.
The hypothesis of abiotropic interaction 
advanced by Caine et al. (1986) specifically 
proposes that AD is a disorder due to en­
vironmental damage to the brain that ‘remains
1 Address for correspondence: Professor A. S. Henderson. NH & 
MRC Social Psychiatry Research Unit, The Australian National 
University. GPO Box 4, Canberra. ACT 2601. Australia
subclinical for several decades but makes those 
affected especially prone to the consequences of 
neuronal attrition'. By this hypothesis, environ­
mental damage compounds the effects of age- 
related neuronal losses. This would suggest that 
pathogenic exposures are more likely to be 
detected when the neuronal changes of ageing 
are greatest: that is, in later-onset cases of AD. 
Age of onset is also a major feature in the 
distinction made between Type I and Type II 
AD proposed by Bondareflf (1983) and Roth 
(1986). There may be some rationale for ex­
pecting environmental factors to have a greater 
relative risk in the later-onset Type I, where a 
family history of dementia is believed to be less 
common (Heston. 1981).
Family history of dementia is another variable 
which could modify the effect of environmental 
exposures. There have been two reports of an 
environmental exposure being more common in 
those without a family history (sporadic) than in 
those with (familial). Schoenberg et al. (1988) 
reported that advanced maternal age may be a 
risk factor for sporadic but not familial cases, 
and Mortimer et al. (1991) have found evidence 
that head injury may be a risk factor only in 
sporadic cases. Why an environmental factor
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should influence only sporadic cases in unclear. 
Such a finding implies that exposure to both 
genetic and environmental factors confers no 
greater risk than genetic exposure alone. An 
alternative possibility is that AD may require 
both a genetic predisposition and an environ­
mental trigger. In such cases, the relative risk- 
associated with environmental exposures should 
be greater for familial than for sporadic cases.
In a previous paper describing a case-control 
study of 170 clinically diagnosed cases of 
Alzheimer’s disease (AD) aged from 52 to 96 
years, we reported three risk factors with 
statistically significant odds ratios: a history of 
dementia or of Alzheimer-type dementia in first- 
degree relatives; a history of Down’s syndrome 
in first-degree relatives; and a history of physical 
inactivity earlier in life (Broe el al. 1990). These 
findings were based on an analysis of the total 
case series and of the entire range of putative 
risk factors. We now report an analysis in which 
environmental exposures are examined in re­
lation to age of onset and to familial/sporadic 
status. We hypothesize that environmental 
exposures that could reasonably be expected to 
injure the brain might be associated with 
different relative risks in later- versus earlier- 
onset cases and in familial versus sporadic cases. 
This hypothesis implies an interaction effect 
under a multiplicative model for the exposure 
frequencies (Everitt & Smith. 1979). The analysis 
was deliberately restricted to exposures which 
were both environmentally and biologically 
plausible as causing an insult to the brain. This 
restriction was made to reduce the likelihood of 
a Type I error in examining a large range of 
variables; and to focus only on those ex­
posures which might be relevant on theoretical 
grounds.
METHOD
Cases
Cases were identified from consecutive new 
referrals by general practitioners (GPs) to 
dementia clinics at two Sydney hospitals (Re­
patriation General Hospital Concord (RGHC) 
and Lidcombe Hospital) attended by study 
neurologists (G. A. B.. H.C. and E. McC.). Most 
referring GPs in the catchment area of RGHC 
were written to and personally visited by one of 
us (E. McC.) to request that they refer all patients
living in the community who presented during 
the study period for any complaint and were 
recognized at that consultation as being likely to 
have dementia.
Referrals to the Lidcombe Hospital Dementia 
Clinic were by GPs within its catchment area. 
Seventeen cases only were included from Lid­
combe referrals during the early study period 
prior to transfer of two of the study neurologists 
to RGHC (G A B. and H.C.).
Since RGHC is both a veterans' and a 
community hospital, another source of new 
referrals to the dementia clinic was from GPs 
whose patients had ‘ veteran' eligibility (veterans 
themselves and widows of entitled veterans). 
Twenty-seven ‘ veteran' cases were included from 
outside the geographical catchment areas of the 
study. In this manner we sought to obtain only 
newly recognized cases of dementia living in the 
community and primarily from two defined 
catchment areas.
Candidate cases were excluded if they could 
not be interviewed in English or lacked a suitable 
informant (Broe el al. 1990). In 12% of 
remaining candidate cases the nominated in­
formant refused a Risk Factor Interview, in 
which event the candidate case was eliminated 
from the study.
Examination of cases
All cases presenting at the Dementia Clinics 
were assessed by a neurologist (H.C. or 
E. McC.). This consisted of a history from both 
the patient and an accompanying relative, a 
standardized clinical examination, a Neurology 
of Ageing Examination, the Mini-Mental State 
Examination (MMSE) (Folstein et al. 1975), 
and comprehensive neuropsychological assess­
ment carried out by a neuropsychologist. Full 
blood count, sedimentation rate, biochemical 
screen, syphilis serology. B12 and folate assays, 
thyroid function and ANF were measured. A 
CT scan was undertaken in 60% and an EEG in 
25% of cases. On the basis of this assessment, 
cases were admitted to the study if they fulfilled 
the NINCDS-ADRDA criteria (McKhann et al. 
1984) for the diagnosis of probable or possible 
AD. and had a suitable informant.
Controls
For each case, the referring general practice 
was asked to contact and provide names and
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addresses of up to 4 persons matched for sex and 
for age within 2 years. To reduce bias in the 
selection process, the practice secretary was 
asked to search the files systematically for such 
controls beginning at the same letter of the 
alphabet as the candidate case. Where no such 
person could be found in the referring GPs’ files, 
an approach was made to partners in the same 
practice or to neighbouring practices. In this 
manner we obtained controls from the same or 
a neighbourhood general practice for 119 cases 
(70%) with only 9 controls (<  5 %) drawn from 
a practice more than 20 km away.
Candidate controls were approached by phone 
and those agreeable were examined by a neur­
ologist (H.C., E.McC.) in their homes where 
they underwent a brief neurological examination 
and MMSE. Candidate controls were excluded 
if they had a MMSE under 26, could not be 
interviewed in English or lacked a suitable 
informant (Broe et al. 1990). In 11% of 
remaining candidate controls the- nominated 
informant refused a Risk Factor Interview and 
the candidate control was eliminated from the 
study.
Risk factor interview
We developed this interview to cover possible 
risk factors in six areas: familial or genetic 
factors; previous head injury or brain insult; 
previous illnesses; pharmacological exposures 
and medical treatments; environmental ex­
posures; and personal attributes. An interview 
lasted about two hours, and was directed wholly 
at the informant's knowledge of the case or 
control with respect to the above six areas. The 
Risk Factor Interview was administered by seven 
medically-naive professional interviewers who 
were kept blind to the specific purpose of the 
study. Both they and the informants were 
informed that the research was ‘A Health Study 
of the Elderly’. Interviewers nevertheless 
acknowledged that towards the end of the study, 
they became aware that a major focus of the 
research was on dementia.
Age of onset of AD
The analysis w'as carried out by age of onset, 
with this having been judged by the neurologists 
on the basis of informant history at clinical 
interview.
Familial or sporadic subjects
Each informant was asked to identify all first- 
degree relatives of the case or of the control. For 
each person so identified, whether living or 
dead, the interviewer asked if she or he ever had 
‘severe memory loss, mental confusion, or 
dementia, even in the year or tw'o before death’. 
For those relatives who were reported to have 
had such a condition, further information was 
obtained about the onset, the presence of stroke, 
and the course of the dementia. A consensus 
rating was then made by 6 of us, blind to the 
case-control status of the subject, as to whether 
the relative’s dementia was likely to have been 
due to Alzheimer’s disease, vascular dementia, a 
mixed condition, or some other cause. A subject 
for whom at least one first-degree relative was 
considered likely to have had AD or a mixed 
condition was taken to be familial. The others 
were taken to be sporadic.
Statistical analysis
Analyses were performed using GLIM (release 
3.77). Since data are in the form of matched 
pairs, relative risks were estimated by the odds 
ratios obtained from the conditional maximum 
likelihood estimates of the parameters of a 
logistic regression (multiplicative) model.
For the analysis of the relationships involving 
age of onset, a term in the form of the product 
between age of onset and the exposure of interest 
was introduced into the logistic regression 
model, together with the term for the exposure 
alone, and the significance of the interaction 
term tested. If significant, it could be concluded 
that the relative risk of the exposure is modified 
by age of onset. The analyses were performed 
both for age of onset treated as a continuous 
variable, and for age of onset dichotomized to 
less than or equal to 70 or greater than 70. The 
stratified analysis only is reported in the tables, 
since there w'ere no substantive differences in the 
results. Details of this alternative analysis, as 
well as copies of all 2x2  tables for the analysis 
reported here, are available on request.
For the analysis of the relationships involving 
family history of dementia, the matched pairs 
were stratified according to whether the case 
was familial or not. This procedure is in line 
with previous studies (Schoenberg et al. 1988; 
Mortimer et al. 1991). A product (interaction)
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term was introduced into the logistic regression 
equation, and a coefficient which was sig­
nificantly different from zero indicated that the 
odds ratios in the two strata were significantly 
different.
RESULTS
The association between age of onset and 
family history
Fifty-six cases had onset judged to be at or 
before the age of 70 years, and 114 cases with 
onset after 70 years. One hundred and fifteen 
cases were judged to be sporadic, and 52 to 
be familial. The familial status could not be 
determined for three cases. Since there has been 
some evidence that earlier-onset is associated
with a family history of dementia (Heston, 
1981), this was looked for in the present series. 
No such association was found (OR (earlier- 
onset) = 3-47, OR (later-onset) = 4-75; P = 
0-53). The following analyses can therefore be 
considered to have been carried out on two 
separate classifications of this sample of cases of 
AD.
Environmental risk factors and age of onset
Table 1 shows the odds ratios separately for 
earlier-onset ( ^  70 yr) and later-onset (>  70 yr) 
case-control pairs. The P value for the inter­
action term reached 5% or less for the 
following exposures: starvation or malnutrition, 
nervous breakdown more than 10 years before, 
analgesic use, nose-picking and underactivity
Table 1. Odds ratios for exposures in early and late onset Alzheimer's disease
Estimates of odds ratios*
All cases 
and controls 
OR
Earlier onset ( $  70) Later onset ( > 70) P  value for 
interaction 
termExposure OR (+  -  ) t < -  + )t OR (+  -  )+ ( - + ) !
Head injury at least 10 years before assessment 16 10 2 2 20 6 3 0-57
History of boxing or rugby I I 0-9 6 7 1 2 10 8 0 61
Encephalitis or meningitis 0-5 0-0 0 1 1-0 1 1 0 31
Fits or seizures 16 20 6 3 12 5 4 0-63
Starvation or malnutrition 14 0-5 3 6 26 13 5 005
Depression < 10 years ago 43 10 2 2 n o 11 1 008
Depression > 10 years ago 15 30 3 i 10 1 1 054
Nervous breakdown more than 10 years ago 17 — 4 0 0 3 1 3 0 01
Severe headaches 0-7 09 8 9 0 7 14 21 063
At least 5 drinks daily sometime in life I I 08 8 10 14 14 10 0 37
Smoked > 1 packet o f cigarettes daily 06 0 5 4 8 0 7 4 6 075
sometime in life
Drank > 4 cups of tea daily sometime in life 18 15 3 "> 20 4 2 0-82
D rank > 4 cups of coffee daily sometime in life 2-2 15 3 2 30 6 2 0-57
Antacids§ 10 10 9 9 09 17 18 092
Analgesics§ 0 7 14 13 9 0 5 17 33 005
Iron tablets§ 12 10 4 4 12 10 8 0-79
Anliconvulsants§ 10 — 1 0 08 3 4 0 22
M inor tranquillizers§ 13 14 7 5 12 20 16 087
Antidepressants§ I I 1-5 3 2 10 8 8 0-69
Major tranquillizers§ — — 8 0 — 10 0 1 00
Operations to head or neck 0-9 09 13 15 09 32 34 086
Other operations 08 0-5 8 15 09 24 27 032
ECT 13 0 5 1 2 30 3 1 0-26
General anaesthetics 10 0 5 4 8 13 14 11 0 19
P.O.W. or concentration camp 0-2 0 5 1 2 0-0 0 2 028
Loud snorer > 10 years ago 08 0-9 7 8 0-8 17 21 090
Nose-picking 1-7 0-6 3 < 7 0 7 1 0-03
Underactive||:
Within last 10 years 6-2 — 14 0 28 11 4 0-02
> 10 years ago 3-5 — 7 0 1-8 7 4 0-03
* Matched pairs odds ratio (OR) is the ratio of the discordant pairs ( + - ) / ( -  * *§)
+ Number of matched pairs with case exposed and control not exposed
t Number of matched pairs with case not exposed and control exposed
§ Taken daily or almost daily for at least six months some time in life
I 31 early-onset case-control pairs and 54 lale-onset pairs only were assessed for underactivity
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later-onset was associated with nose-picking and 
starvation/mal nutrition.
Underactivity was reported more often among 
earlier-onset than later-onset cases, both for 
the 10 years preceding assessment and earlier. 
To assess underactivity, informants were asked 
whether the subject tended to be involved in 
activities which involved very little physical 
exercise, so that they were not as active as 
most people their age. Where underactivity is 
a prodromal feature of AD, it could be more 
obvious among younger cases when contrasted 
to the normal active population, and thus be 
reported more readily by informants. This does 
not explain the slight tendency for younger cases 
to have underactivity reported more often for 
periods greater than 10 years before assessment. 
There is also a possibility that underactivity is 
more likely to be reported with advancing age in 
a normal control group. The number of controls 
reporting underactivity was too small to be able 
to test this interpretation.
For later-onset AD. an association has been 
found with a history of starvation or mal­
nutrition. This was assessed by asking inform­
ants whether there had ever been any prolonged 
period in which the subject was deprived of 
enough food. This exposure mainly involved 
periods of severely limited food intake due to 
poverty in the 1920s and 1930s or during 
wartime. The period of starvation/malnutrition 
generally occurred during the early adult years. 
Such a result is consistent with Abalan's (1984) 
hypothesis that malnutrition can play an aetio­
logies! role in AD. Furthermore, the effects of 
starvation/malnutrition specifically on later- 
onset AD could be interpreted in terms of Caine 
el al.'s (1986) hypothesis of an interaction 
between ageing and early brain insult. For 
earlier-onset AD, there was no significant re­
lationship with starvation/malnutrition.
Nose-picking also emerged as a risk factor for 
later-onset cases. This exposure was assessed by 
asking informants whether the subject had ever 
had the habit of picking his or her nose. The 
present finding would support the suggestion 
of Mann & Esiri (1980) that some toxin or 
infectious particle is introduced through the 
nose to the base of the brain. It must be 
remembered, however, that in the present study 
nose-picking was assessed by informant reports, 
and would have been reported only if publicly
observable. There were 18 subjects reported to 
have had this habit, all during the 10 years prior 
to assessment, with only six reporting it for 
longer periods. It is therefore possible that 
behavioural changes occurring in the early stages 
of the disorder are being reported.
The association of nervous breakdown with 
earlier-onset AD is difficult to explain because 
we do not know what these episodes consisted 
of. Furthermore, the number of subjects with 
this exposure was small. Depression was asked 
about separately and did not show the same 
effect. There w;as. in fact, a trend for depression 
in the previous 10 years to be associated with 
later-onset AD. This trend may be attributable 
to a prodromal manifestation of the dementia 
(Henderson, 1990).
The possible protective effect from heavy use 
of analgesics from later-onset AD is contrary to 
our expectation. Murray et al. (1971) reported 
Alzheimer-type changes in the brains of women 
abusing phenacetin. but in our study the 
informant was asked about use of painkillers in 
general. These would inevitably have included 
aspirin-containing preparations. McGeer el al. 
(1990) reported that the prevalence of AD in 
patients with rheumatoid arthritis may be 
unexpectedly low. and that anti-inflammatorv 
therapy may be the explanation. The present 
findings on analgesics are consistent with this.
Sporadic and familial AD
The present study has found associations of 
sporadic AD with head injury and starvation/ 
malnutrition, and of familial AD with use ot 
minor tranquillizers.
In the present study, a head injury was defined 
to exclude brief loss of consciousness (less than 
15 minutes), while careful consideration was 
given to timing of the event, whether it had 
occurred in the last 10 years or earlier. Among 
previous studies on head trauma as a risk factor 
for AD. a few' studies have reported a significant 
association, but most found only a non-signifi­
cant trend in this direction (Jorm, 1990). Indeed, 
the present study failed to find a significant 
association when the AD cases were considered 
as a single group (Broe et al 1990). If the effect 
were confined to sporadic cases, this might 
explain some of the apparent inconsistency in 
the literature. It is noteworthy that the present 
finding is consistent with the one other study in
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which head injury was considered specifically in 
sporadic cases of AD (Mortimer et al. 1991). 
Although head injury was associated with 
sporadic AD, the related exposure to sports such 
as boxing or rugby was not. There were 26 cases 
and 26 controls who reported having practiced 
‘sports such as boxing or rugby’. All were male, 
and virtually all referred to high-school sports. 
Only three subjects referred specifically to boxing 
beyond this period at a level more likely to 
involve more serious head trauma.
Starvation/malnutrition also emerged as a 
statistically significant exposure in sporadic AD. 
Such a result is again consistent with Abalan’s 
(1984) hypothesis about the role of malnutrition 
in AD. The association of starvation/malnutn- 
tion with familial AD was not significant.
The reason for the higher odds ratio for head 
trauma and malnutrition in sporadic cases is 
unclear. It is unusual for an environmental 
exposure to have a greater effect in genetically 
less susceptible individuals. It may be that genetic 
risk has such a powerful effect that it eclipses 
environmental factors such as head trauma and 
malnutrition. Alternatively, the difference in 
odds ratios could be due to ‘effort after meaning' 
on the part of the informants who report on 
exposures. Informants who can cite a family 
history have no need to search for other 
environmental explanations of the disease.
The finding on recent use of minor tran­
quillizers in familial AD may not be meaningful. 
Inspection of the data shows a lower frequency 
of exposure in controls of familial cases (7-7%) 
than among controls of sporadic cases (16 1 %). 
The familial and sporadic cases do not them­
selves differ so greatly, exposure among familial 
cases being 23% and among sporadic cases 
16%. It is possible that minor tranquillizers 
were used for symptomatic treatment in both 
groups. Alternatively, the significance of the 
difference in the odds ratios may be a Type I 
error.
Conclusion
The present study has identified a number of 
environmental exposures which vary in their 
association with AD by age of onset or 
familial/sporadic type. However, some of these 
associations merit less serious consideration than 
others. The associations which survive critical 
scrutiny are starvation/malnutrition with later-
onset and sporadic AD, nervous breakdown and 
underactivity with earlier-onset AD, head injury 
with sporadic AD and nose-picking with later- 
onset AD. As well, analgesic use appeared to be 
protective for later-onset AD.
Because of the large number of associations 
investigated, there is inevitably the danger that a 
study such as this will pick up Type I errors. We 
have attempted to limit this danger by evaluating 
only those environmental exposures which 
seemed to have some theoretical plausibility. 
With 56 associations tested, 3 might be expected 
by chance alone w'ith a Type I error rate of 5%. 
However, 8 significant associations were found. 
Seven of these survived critical scrutiny, and one 
replicated a finding from another case-control 
study. The study is also limited by its power 
to detect real effects. Although it is one of 
the largest case-control studies of AD, power 
becomes considerably reduced when the cases 
are divided into subgroups or when exposures 
are uncommon, as is the case w'ith many of those 
studied here. Furthermore, errors in classi­
fication of cases by age of onset and famih 
history and inaccuracy of informant reports of 
exposure will all act to reduce true effect sizes 
Therefore, statistically non-significant associa­
tions should not be taken to imply that no 
association exists. Ultimately, the only pro­
tection against false conclusions is replication.
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CHOLINERGIC ‘BLOCKADE’ AS A MODEL OF THE 
COGNITIVE DEFICITS IN ALZHEIMER’S DISEASE
by H. C H R I S T E N S E N , 1 N.  M A L T B Y , 2 A. F. JORM, '  H. CRF. ASEY2
and a. a . b r o e 2
(From the 'National Health and Medical Research Council Social Psychiatry Research Unit, 
Australian National University, Canberra and the 2Department of Geriatric Medicine, University> of 
Sydney, Repatriation General Hospital, Concord, Australia)
S U M M A R Y
The performance of 44 Alzheimer patients and 33 controls was examined on tests previously found to 
be differentially affected by scopolamine administration. Tests of secondary memory, performance 
intelligence, primary memory, semantic retrieval, procedural memory and verbal intelligence were included. 
It was found that Alzheimer patients performed more poorly than controls on tests of secondary memory, 
as measured by selective reminding, recall and recognition. Procedural memory, as measured by stem 
completion, homophone spelling and transformed text reading, did not differ between Alzheimer patients 
and controls. Semantic memory', verbal intelligence and primary' memory were impaired in moderate and 
severe cases. However, patients with ‘mild- dementia, as measured by the Mini-Mental State Examination, 
did not differ from controls on tests of semantic memory, verbal intelligence and primary memory. It 
was concluded that the pattern of anterograde memory deficits and preserved abilities in mild dementia 
mimicked that previously observed in scopolamine administration in young subjects.
I NTRODUCTION
The cognitive and memory deficits which occur in Alzheimer’s disease have been 
attributed to deficient cholinergic neurotransmission (Coyle et al., 1983). The support 
for this hypothesis comes from evidence indicating that cholinergic enzymes are depleted 
in Alzheimer’s disease (see Kopelman and Corn, 1988). It is also known that the 
administration of drugs, such as scopolamine, which induce ‘blockade’ of central 
cholinergic neurons, leads to memory impairment in normal young subjects (Nissen 
et al., 1987; Broks et al., 1988; Kopelman and Corn, 1988; Rusted and Warburton, 
1988, 1989) as well as in elderly subjects (Sunderland et al., 1987; Huff et al., 1988) 
and exacerbates memory problems in Alzheimer patients (Sunderland et al., 1987; Huff 
et al., 1988).
It is still not clear, however, whether the amnesia and cognitive deficits induced by 
scopolamine are qualitatively different from the memory and cognitive deficits observed 
in Alzheimer’s disease. There appear to be four differences. First, there is evidence 
to suggest that while the disruptive effects of scopolamine are restricted to processes 
involved in secondary memory, Alzheimer’s disease is characterized by multiple memory 
deficits affecting primary as well as secondary memory (see Broks et al., 1988; Kopelman 
and Corn, 1988). Secondly, while scopolamine has not been found to disrupt verbal
Correspondence to: H Christensen. NH and MRC Social Psychiatry Research Unit. Australian National University. 
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intelligence, language (Flicker et al., 1990) or material learned prior to drug 
administration (Drachman and Leavitt. 1974; Kopelman and Corn, 1988), Alzheimer's 
disease, particularly in the later stages, is often associated with marked disruption of 
intellectual functioning and memory for previously well-known material. Thirdly, it 
is known that procedural memory' and priming are unimpaired in scopolamine 'blockade' 
(Nissen el al., 1987; Kopelman and Corn, 1988). However, whether priming or new' 
procedural learning are unaffected in Alzheimer’s disease remains unresolved (Shimamura 
el a l ., 1987; Partridge el al., 1990; Christensen and Birrell, 1991). Finally, there is 
strong evidence that the size of the secondary memory deficits following scopolamine 
is much smaller than that seen in Alzheimer’s disease.
In part these differences in cognition between scopolamine ‘blockade’ and Alzheimer's 
disease may have arisen because the deficits of scopolamine-affected volunteers have 
been compared with those of a heterogeneous group of Alzheimer patients, whose 
dementias have differed in severity. The comparison to mixed groups of Alzheimer 
patients may not be valid since there are suggestions that the number of supplementary 
neurotransmitters and the importance of their involvement in cognitive deficits increases 
as Alzheimer-type dementia progresses (see Mayes, 1988; also Kopelman, 1987). The 
validity of the cholinergic hypothesis thus needs to be tested with early or mild 
Alzheimer-type dementia.
In the present study, the pattern of deficits in Alzheimer patients at mild, moderate 
and severe stages, as measured by standard clinical assessment, was evaluated using 
tests previously administered to subjects given scopolamine. The assessment battery 
w'as designed to examine a range of cognitive abilities that have proved to be 
differentially sensitive to the effects of scopolamine. This allowed an examination of 
whether the pattern of deficits in Alzheimer’s disease differed qualitatively from that 
found following scopolamine ‘blockade' for each of these levels of severity. If cholinergic 
depletion were responsible for the deficits in the early stages, impairments should be 
evident on tasks affected by scopolamine but not on tasks unaffected by scopolamine 
in young subjects.
The test battery consisted of the following measures of secondary memory and 
performance intelligence which have been shown, often repeatedly, to be impaired 
following scopolamine administration in young subjects; verbal recall of w'ords (Drachman 
and Leavitt, 1974; Kopelman and Corn. 1988), verbal recognition (Kopelman and Corn. 
1988; Rusted and Warburton, 1988), recognition of faces (Flicker et al., 1990). selective 
reminding of words (Caine et al., 1981; Broks el al., 1988; Molchan et al., 1990) and 
digit-symbol substitution (Flicker et al.. 1990, Curran et al., 1991).
The battery also consisted of tasks known to be unaffected by scopolamine 
administration in young subjects. As a measure of primary memory, digit span forward 
and backward was used (Ostfeld and Aruguete, 1962; Drachman and Leavitt, 1974; 
Ghoneim and Mewaldt, 1975; Mohs et al., 1985; Broks et al., 1988; Kopelman and 
Corn, 1988; Curran et al.. 1991; but see Nissen et al., 1987). Two measures of priming 
were used; a word stem completion task (Kopelman and Corn, 1988) and a homophone 
spelling task. To measure procedural memory we used transformed text reading (see 
Moscovitch et al., 1986), w'hich, although not identical to the mirror reading task used 
in scopolamine ‘blockade' (Kopelman and Corn, 1988). is thought to measure the same 
underlying memory process. Verbal intelligence was measured using Similarities from
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the Wechsler Adult Intelligence Scale (Drachman and Leavitt, 1974). Finally, we 
examined retrieval from semantic memory using a verbal fluency test, which has been 
found to be unaffected by scopolamine ‘blockade’ at low dose levels (Beatty et al., 1986; 
Nissen et a l., 1987; Sunderland el al., 1987; Kopelman and Corn, 1988; Curran et al., 
1991; but see Drachman and Leavitt, 1974; Caine et al., 1981). The tests are summarized 
in Table 1.
M E T H O D S
Subjects
Forty-four patients (22 males and 22 females) who fulfilled the DSM-II1-R criteria for dementia (American 
Psychiatric Association, 1987) and the NINCDS/ADRDA criteria for probable Alzheimer’s disease 
(McKhann et al., 1984) participated in this study. To make diagnoses, histories were taken from both 
the patient and an accompanying relative or friend. This included a review of possible cognitive or behavioural 
change and an Activities of Daily Living Scale. The standardized clinical examination included a Neurology 
of Ageing Schedule and a Mini-Mental State Examination (MMSE). Full blood count, sedimentation rate, 
biochemical screening, syphilis serology, vitamin B12 and folate levels, thyroid function, and anti-nuclear 
factor were carried out. None of the subjects had any other concurrent terminal illness or end organ 
failure. They all lived at home with a carer and were all volunteers for a study evaluating the drug 
tetrahydroaminoacridine (THA) for the treatment of memory deficits associated with Alzheimer's disease. 
The patients completed a dose-finding period in which they tried doses of THA up to 100 mg daily for 
up to 2 mths. A 4-wk wash out period preceded their completion of this battery.
The patients were assigned to groups of mild, moderate and severe according to their scores on the MMSE 
(Folstein et al., 1975). Subjects scoring 21 or above on the MMSE were classed as mild, those scoring 
1 4 -2 0  were classed as moderate and those with less than 14 as severe. The classification of patients into 
these categories corresponded to data from other sources. Using an informant based rating of changes 
in memory and intelligence over the last 10 yrs (the IQCODE) fJorm and Jacomb, 1989) severe patients 
were rated as having greater deterioration [F(2,38) = 3.49, P = 0.04] than mild and moderate patients. 
While severe cases were more likely to have been ill for longer than mild cases (moderate = 3.31 yrs; 
severe = 3.78 yrs) the difference was not significant [F(2.40) = 0.09. P = 0.91 ]. Although the MMSE 
may have limitations as a measure of illness severity, it nevertheless correlated highly with staging criteria
T A B L E  I T E S T S  US E D TO E X A M I N E  THE P A T T E R N  OF  D E F I C I T S  
A ND P R E S E R V E D  A B I L I T I E S  IN ALZHEIMER'S DISEASE
Tests affected by cholinergic blockade 
in young subjects
Secondary memory 
Buschke Selective Reminding Task 
Visual Selective Reminding Task 
Word recall 
Word recognition 
Face recognition
Performance intelligence 
Symbol Digit Modalities Test
Tests unaffected by cholinergic 
blockade in young subjects
Primary memory 
Digit span forward 
Digit span backward
Priming
Word stem completion 
Homophone spelling
Procedural memory 
Transformed text reading
Retrieval from semantic memory 
Verbal fluency
Verbal intelligence 
Similarities
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used in more extensive clinical assessments, such as the CAMDEX (Brayne and Calloway, 1990). None 
of the mild or moderate patients failed to name objects on the MMSE.
Twenty-five elderly controls were recruited from the spouses of the patients who had volunteered to 
participate in the THA trial. A further eight controls were recruited from a group of carers of patients 
who had had side-effects to the drug treatment and who could no longer participate in the study. The total 
thus consisted of 33 control subjects (14 males, 19 females). The mean age and MMSE scores of the various 
groups of patients and the controls are displayed in Table 2. Additional psychometric and descriptive data 
where available are reported for the Alzheimer patients. There was no difference in years of education 
across the three Alzheimer groups [F(2.26) = 0.14, P = 0.87],
All the controls who participated were living independently at home and all were fulfilling the role of 
carer for a spouse with Alzheimer’s disease. Of 17 control subjects given the MMSE (the last 17 controls 
who were recruited for the study), scores ranged from 24 to 30 out of 30 (all but one subject had MMSE 
scores greater than or equal to 27). Only one control subject of the 88% who completed a medication 
check currently used active cholinergic drugs (oxazepam). The control and dementia subjects came from 
similar socio-economic backgrounds and were thus unlikely to differ in educational levels or ‘pre-morbid’ 
intelligence. All patients, carers of patients and controls provided informed consent.
Procedure
The following are tests affected by scopolamine ‘blockade’ in young subjects.
Buschke Selective Reminding Task. The verbal selection reminding task consisted of 10 trials of 10 words 
(Buschke and Fuld, 1974). Following each trial the subject was selectively reminded only of the words 
which he or she had missed. The Buschke lists were constructed using recommended guide-lines and word 
lists (Kraemer et al., 1983).
Muramoto Selective Reminding Task. Subjects were shown seven objects in a line and asked to remember 
where the objects were placed (see Muramoto, 1984). The objects were then covered and subjects placed 
the identical objects and three intrusion objects in front of the corresponding covered objects. Subjects
T A B L E  2 AGE AND MI NI  M E N T A L  S T A T E  E X A M I N A T I O N  S C O R E S  ( M E A N S  A N D  S T A N D A R D  
D E V I A T I O N S )  FOR A L Z H E I M E R  P A T I E N T S  AND C O N T R O L S
Alzheimer patients
Controls 
(n = 33)
M ild  
In = 16)
M oderate  
(n = 13)
Severe  
<n = 15)
Age (yrs) 69.72
(5.44)
69 81 
(6 87)
70.54
(8.90)
68.80 
(8 73)
Years of education' 9.58
(3.57)
9 92 
(3 32)
9 85 
(3 13)
10 56 
(2.83)
MMSE 28 112 
(1.45)
23.13 
(2 09)
17 07 
(2.22)
9 93 
(3.45)
WMS orientation - 4 12 
(0 81)
2.62
(1.75)
0.73 
(0 88)
WMS personal and current information - 4.62 
(0 62)
3.54 
(1 20)
2 87 
(1 13)
WMS logical memory - 3 90 
(1 45)
181
(1.44)
0 97 
(0 81)
WMS delayed memory - 0 97 
(1.88)
0 12 
(0 30)
0 07 
(0 26)
Geriatric depression scale - 14.00 
(23 15)
16.85 
(24 92)
8.67 
(4 67)
'Based on 29 patients; ‘based on only 17 subjects. WMS = Wechsler Memory Scale The 
ranges of scores on the MMSE were 24 — 30 (controls). 21 -  27 (mild patients). 14-20 (moderate 
patients) and 3-13 (severe patients)
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were then shown those objects which had been placed incorrectly before being asked to replace the objects 
in the original order. There were 10 trials.
Word list recall and recognition. Word recall and word recognition involved the presentation of 10 words 
on flash cards. The words were simultaneously said aloud. Subjects were asked to make up a sentence 
containing each word. An unannounced free recall task followed immediately. For the word recognition 
task, subjects were shown pairs of words and asked to choose which word from each pair had been presented 
previously. The words used in the word recall and recognition tasks w'ere selected from a pool of items 
which served in the construction of the five lists. Each word list could serve as the word recall list, the 
recognition (target) list, the recognition (distractor) list, the word stem baseline list or the word stem 
completion list. The purpose of these latter lists is described below. The choice of the word list used for 
each of these procedures [recall, recognition (target), recognition (distractor), word stem completion, 
baseline] was counterbalanced across subjects.
Face recognition. The face recognition section of the Rivermead Behavioural Memory Test (Wilson 
et al., 1985) was used to measure non-verbal memory.
Symbol Digit Modalities Test. The oral version of the Symbol Digit Modalities Test (Smith, 1982) was 
used as one measure of performance intelligence.
The following are tests unaffected by scopolamine ‘blockade’ in young subjects.
Digit span. Digit span forwards and backwards was administered from the Wechsler Adult Intelligence 
Scale-Revised (WAIS-R) (Wechsler, 1981).
Word stem completion. Subjects were presented w ith 10 flash cards of words w ith which they had to 
make up sentences. They were then presented with a card which displayed the first three letters of the 
words they had just seen as well as 10 ‘baseline’ word stems corresponding to words not previously presented. 
The baseline condition provided an indication of the likelihood that they would have provided the correct 
target words by chance. They were asked to give the first English word they could think of that started 
with the letters given. The extent to which subjects were able to make up a sentence (‘to elaborate’) was 
also scored, by counting the number of sentences generated w'hich contained a subject, object and verb 
(maximum = 10). As noted above, subjects were tested for recall and recognition of w'ords on equivalent 
lists of words to allow a direct comparison to be made of recall, recognition and stem completion performance.
Homophone spelling task. A homophone spelling task, originally used by Jacoby and Witherspoon (1982) 
and later by Eich (1984) was employed. It is known that when subjects are asked to spell homophones 
they spell them more frequently in the form of the more common interpretation of the homophone (‘steal’ 
not ‘steel’, ‘soul’ not ‘sole’). In this study, subjects were exposed to the less common interpretation of 
homophones in the context of questions which biased the homophone towards its less common meaning 
(e.g. ‘Is steel a type of metal?’). Following a distractor task lasting approximately 5 min (word fluency), 
subjects were asked to spell out aloud the homophones presented and some baseline homophones which 
had not been previously presented. The important observation was whether the patients would be primed 
to the same extent as normals to spell homophones in the less common interpretation after having been 
exposed to them in the context sentences. Since priming is preserved following scopolamine administration, 
the extent of homophone priming was expected to be the same for Alzheimer patients and controls. The 
homophones were selected from Galbraith and Taschman (1969). Two forms of homophone list were 
developed (List A and List B) each containing 12 homophones. Subjects heard either List A or List B 
homophones in the study phase. In the test phase, subjects were asked to spell six homophones from the 
original list and six homophones that they had not heard in the study phase. Counterbalancing of List A 
and List B was undertaken to ensure that the words served equally often as target or baseline homophones. 
For each subject the homophones in the non-heard list served as control homophones in the spelling test.
Transformed text reading. Transformed text reading was used to measure procedural learning. The 
experimental stimuli and method were similar to those of Moscovitch et al. (1986). A set of 28 sentences 
of approximately equal length was selected from the reading passages used in the Neale Analysis of Reading 
Ability (Neale, 1966). The sentences were divided into four lists of seven sentences each. The transformation 
of normal text involved rotation of each letter by 180 degrees around its vertical axis, thereby preserving 
left and right reading direction. This transformation is reported to be much easier to read than mirror 
reversal (Kolers and Perkins. 1975; Moscovitch et al., 1986), presumably because the direction of reading 
remains unchanged. The entire sentence was visible when the subject was reading it. The time taken to 
read each of 14 sentences was recorded. Approximately 1 h later, subjects were asked to read seven sentences 
previously read (old sentences) and seven sentences previously not read (new sentences). The time taken
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to read these two types of sentence at the time of the second presentation was recorded. The time taken to 
read old sentences and the time to read new sentences could be compared with the initial sentence reading 
to determine if reading time decreased as a function of practice. Subjects were also asked to judge whether 
the sentences were ‘new’ or ‘old’. The number of errors (misreading of words or failure to decode) was 
recorded. The sets were counterbalanced as much as possible so that what were old sentences for some 
subjects were new sentences for others. Three forms of the sentences were developed and subjects received 
one on a random basis.
Word fluency. Word fluency (e.g. Benton el al., 1983) was measured by giving subjects 1 min in which 
to say as many words as possible starting with a particular letter (F, A and then S). The number of words 
produced for all three letters was totalled.
Similarities. Similarities from the WAIS-R (Wechsler, 1981) was used to examine one aspect 
of verbal intelligence.
R E S U L T S
Statistics
The data were examined in two analyses. The first analysis examined the performance 
of Alzheimer patients at mild, moderate and severe stages of dementia. For most of 
the test measures this analysis involved one-way ANOVA with planned contrasts. Planned 
contrasts tested for differences between mild Alzheimer patients and controls, mild 
Alzheimer patients and more severe dementia cases (both moderate and severe) and 
between moderate and severe cases. The stem completion, homophone priming and 
transformed text reading were analysed using repeated measures MANOVA (see O’Brien 
and Kaiser, 1985). The within-subjects factor for word stem completion was exposure 
to the words in the training phase compared with no exposure (exposed stems versus 
baseline). The within-subjects factor for the homophone task was exposure to the 
uncommon interpretation compared with no exposure (exposure versus no exposure). 
For the transformed text reading, contrasts tested for differences between the time to 
read sentences in the initial presentation and the second presentation and differences 
between reading times for the initial sentences and new sentences (those not previously 
read). For the latter tasks, contrasts tested among the groups (mild, moderate and severe) 
for each of the within-subjects contrasts.
The second analysis compared the Alzheimer patients at all severity levels with controls. 
For the selective reminding tasks t-tests were used to compare test scores, word recall 
and recognition, face recognition, word fluency, recognition of transformed text, the 
Symbol Digit Modalities Test, digits backward and digits forward, and Similarities. 
Exact probabilities are reported. The word stem completion, homophone and transformed 
text tasks were analysed using repeated measures MANOVA with planned contrasts. 
Contrasts tested for differences between the two groups for each of the within-subject 
contrasts. The primary purpose of the second analysis was to examine theoretical questions 
about the nature of priming and memory effects in Alzheimer’s disease.
Subject attrition
Not all subjects completed all tests within the battery because some of the tests were 
more difficult than others. Most subjects completed all but one or two of the tests. The 
transformed text reading proved to be the most demanding task. Only 10 of the 44 patients 
completed the entire task, and 10 of the 33 control subjects were unwilling or unable
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to complete the task. Only those control subjects whose partner entered the THA trial 
completed the Buschke Selective Reminding Task.
Comparison of mild, moderate and severe dementia with controls
Table 3 and Figs 1 -3  summarize the performance of the patients divided according 
to the severity of their dementia.
Planned contrasts tested for three group differences: (i) between controls and mild 
dementia patients; (ii) between mild dementia patients and those in more severe categories 
(moderate and severe combined); (iii) between moderate and severe patients. Since we 
were concerned with examining the least affected dementia patients, the most important 
comparison was between the mild patients and the controls. All three comparisons are 
shown in Table 3.
Mild dementia patients performed more poorly than controls on the Buschke Selective
T A B L E  3. M E A N S  AND S T A N D A R D  D E V I A T I O N S  FOR S C O R E S  ON T E S T S  FOR MI LD.  
M O D E R A T E  A ND S E V E R E  D E M E N T I A  P A T I E N T S
Degree o f dementia
----------------------------------------------- Planned contrasts
Controls Mild
(n = 33) In = 16)
Moderate 
. (n = 13)
Severe 
In = 15) 1 2 3
Tests sensitive to cholinergic blockade in young subjects 
Buschke Selective Reminding Task
72.11 (11.10) 46 75 (12.12) 33.58 (12.45) 22.29 (10.43) 0.001 0.004 0.02
Visual Selective Reminding Test
68.88 (19.79) 39.00 (22.60) 31.45 (19.03) 25.67 (15.59) 0.0001 NS NS
Word recall
3.85 (1.72) 1.69 (1.30) 1.31 (0.93) 0.50 (0 65) 0.0001 NS NS
Word recognition
9.60 (1.06) 5.75(2.96) 4.62 (2.81) 4 57 (2.71) 0.001 NS NS
Face recognition
4.65 (0.54) 4.18 (0.91) 4.15 (1.34) 3.15 (2.88) NS NS 0 02
Symbol Digit Modalities Test
37.39 (9.15) 17.93 (11.41) 9.75 (6.44) 4.55 (6.76) 0.001 0.02 NS
Tests insensitive to cholinergic blockade in young subjects 
Digits forward
7.27 (1.68) 7 44(2.33) 5.84(1.99) 4 60 (1.59) NS 0.03 NS
Digits backward
6.30 (2.14) 5.56(1.97) 4.00 (1.63) 1.53 (1.12) NS 0.03 NS
Word fluency
32.21(9.67) 31.81(9.67) 21.54 (13.15) 13.20 (12.08) NS 0.02 NS
Similarities
15.54 (6.30) 15.62 (5.00) 8.60 (5.75) 5.47 (5.67) NS 0.002 NS
Numbers in cells vary. Contrast 1 compared control with mild dementia cases; contrast 2 compared mild dementia 
cases with those in the moderate and severe categories; contrast 3 compared moderate with severe cases NS = not 
significant.
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dementia dementia dementia
Groups
Fig. 1 Word stem completion scores. Black columns = test stems stippled columns = baseline stems
dementia dementia dementia
Groups
Fig. 2. Homophone spelling. Black columns = exposed homophones: stippled columns = baseline homophones.
Reminding Task [/(64) = 6.90, P < 0.001], the Visual Selective Reminding Task 
[/(58) = 5.53, P < 0.001], word recall [/(72) = 5.16. P < 0.001], word recognition 
[/(72) = 5.68, P < 0.001], and the Digit Symbol Modalities Test [/(66) = 7.23, 
P < 0.001]. Face recognition failed to reach significance [r(70) = 1.54, P = 0.13, 
pooled variance estimate].
There were no significant differences between mild dementia and control subjects 
on tests of primary memory, word stem completion, homophone priming, procedural 
memory and semantic retrieval. Thus, there were no significant differences for digits 
forward [/(72) = -0 .30 , P = 0.77], digits backward [/(73) = 1.30, P = 0.20], word 
fluency [t(72) = 0.12, P = 0.91], similarities [r(72) = 0.04, P -  0.96] or in the level 
of stem completion [F( 1,71) = 0.69, P = 0.50] {see Fig. 1). The extent of priming 
in the homophone spelling task [F(l ,70) = 1.07. P = 0.35] did not differ {see Fig. 2).
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Fig. 3. Average reading time per sentence in seconds. ■  = Controls; + = mild dementia; * = moderate dementia; 
□  = severe dementia.
Mild dementia patients were slower than controls to read the transformed text 
[F(3,38) = 5.35, P < 0.005] (see Fig. 3). However, for both groups old sentences 
were read faster than they had been an hour or so earlier. More significantly, both mild 
dementia patients and controls read previously unseen sentences faster than they had 
read sentences initially. Thus, there was no significant difference in the extent to which 
training improved reading across dementia severity.
Significance levels for comparisons between the mild and more severe cases, and 
the moderate and severe cases are given in Table 3. The mildly affected dementia patients 
did not differ from the combined moderate and severe cases on the Visual Selective 
Reminding Task, word recall, word recognition, or face recognition, but did differ on 
the Buschke Selective Reminding Task, Symbol Digit Modalities Test (P < 0.02), and 
tests of span (P < 0.03). word fluency (P < 0.02) and Similarities (P < 0.002). The 
comparisons on the MANOVA revealed significant differences between mild and 
more severe categories on word stem completion [F( 1,71) = 3.84, P = 0.026] and 
transformed text [F( 1,28) = 5.36, P < 0.005] but not on homophone completion 
[F(2,70) = 1.79, P = 0.175]. Differences between the moderate and severe patients 
were observed on the Buschke Selective Reminding Task (P < 0.02), face recognition 
(P < 0.02) and digits backward (P < 0.03). No significant differences were observed 
for stem completion, but homophone priming was marginally more pronounced in 
moderate compared with severe cases [F(l,70) = 3.07, P = 0.052]. Thus, the extent 
of homophone priming was reduced in severe dementia.
Comparison o f Alzheimer patients and controls
The results of the performance of Alzheimer patients as a group relative to control 
subjects on tests affected by cholinergic ‘blockade’ in young subjects are presented in 
Table 4.
Significant differences were observed between the performance of the controls and 
that of the Alzheimer patients on all tests of secondary memory and performance 
intelligence. On the selective reminding tasks, Alzheimer patients remembered fewer
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T A B L E  4 ME ANS .  S T A N D A R D  D E V I A T I O N S  A ND N U M B E R  OF S U B J E C T S  C O N T R I B U T I N G  
S C O R E S  TO T E S T S  A F F E C T E D  BY C H O L I N E R G I C '  B L O C K A D E  IN Y O U N G  S U B J E C T S
Controls Alzheimer patients
Test Mean SD n Mean SD n P
Secondary memory 
Selective reminding 
Verbal recall 72.11 (11 10) 26 34.83 (15.47) 42 * *
Intrusion errors 2.88 (2.64) 26 6.23 (6 56) 42 *
Visual recall 66 88 (19.79) 25 32.43 (13.40) 37 **
Intrusion errors 0.16 (0.41) 25 8.37 (7.12) 37 * *
Word recall 3.85 (1.72) 33 1.18 (1.12) 43 * *
Word recognition 9.60 (1.06) 33 5.02 (2.82) 43 * *
Face recognition 4.65 (0.54) 32 3.85 (1.29) 42 **
Inverted sentence recognition 6 04 (1.84) 22 2.00 (2.29) 9 * *
Performance IQ
Symbol Digit Modalities Test 37.39 (9 15) 33 12.02 (10.00) 37 **
*P = 0 005. **P < 0.001
words [/(66) = 11.55, P < 0.001], the positions of fewer objects [/(66) = 11.55, 
P < 0.001] and made significantly more intrusion errors in both the verbal and the 
visual versions of the test than did the elderly control subjects [/(66) = 2.95, P — 0.005;
/(60) = 7.00, P < 0.001]. For the Buschke Selective Reminding Task the difference 
was significant for Buschke’s indices of long-term retrieval, long-term storage and 
consistent long-term retrieval. Alzheimer patients produced significantly fewer correct 
words than did the controls for both recall [/(74) = 7.74, P = 0.001] and recognition 
conditions [t(74) = 9.78, P < 0.001], Patients were less able than controls to recognize 
earlier presented faces [r(72) = 9.78, P < 0.001] and had poorer recognition for the 
transformed text sentences read 1 h earlier [r(31) = 8.22, P < 0.001]. Patients who 
were able to undertake the Symbol Digit Modalities Test (84% of total) had significantly 
lower scores than controls [/(68) = 67.95, P < 0.001],
The results of the performance of Alzheimer and control subjects on tasks unaffected 
by scopolamine ‘blockade’ in young subjects are presented in Table 5.
As a group, Alzheimer patients were significantly poorer than elderly control subjects 
on digits forward [r(75) = 2.80, P = 0.006] and digits backward [r(75) = 5.02, 
P < 0.001]. Alzheimer patients successfully completed fewer baseline and test stems 
than did controls [F(l ,74) = 9.03, P = 0.004] but showed the same degree of priming 
[F( 1,74) = 1.73, P = 0.193], In a further analysis comparing stem completion with 
recognition and recall (see Fig. 4), Alzheimer patients were found to differ from controls 
in the extent to which they were able to recognize or recall the material compared with 
their ability to produce the words in response to the stems [F( 1,74) = 15.72, P < 0.001].
To explore whether elaboration was important for priming effects, subjects from the 
normal and Alzheimer groups were divided into those who were ‘good elaborators’ 
(generated 10 full sentences) and ‘poor elaborators' (those who generated nine or less). 
These data were analysed using a repeated measures two-way MANOVA (with 
elaboration and group as the two between-subjects factors and stem type as the 
within-subjects factor) (see Fig. 5). There was a significant effect for group
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T A B L E  5 ME ANS .  S T A N D A R D  D E V I A T I O N S  AND N U M B E R  OF S U B J E C T S  C O N T R I B U T I N G  
S C O R E S  ON T E S T S  U N A F F E C T E D  BY C H O L I N E R G I C  B L O C K A D E  IN Y O U N G  S U B J E C T S
Controls Alzheimer patients
Test Mean SD n Mean SD n P
Primary memory
Digits forward 7.27 (1.68) 33 6.00 (2.30) 44 *
Digits backward 6 30 (2 14) 3.3 3.72 (2.34) 44 * *
Priming
Word stem completion 5.61 (2.76) 33 4 12 (2.24) 43
Word stem baseline 2.64 (141) 33 1.93 (151) 43
Homophone exposed 2.78 (1.34) 32 2.93 (1.55) 43
Homophone not exposed 1.68 (103) 32 1.30 (LOO) 43
Procedural learning 
Average reading time per sentence (s) 
Initial presentation 44.68 (15.03) 23 79.10 (37.33) 10
Second presentation 
Old sentences 22.26 (9.24) 23 44.90 (19.89) 10
New sentences 30.96 (10.96) 23 65.70 (32.38) 10
Average number of errors per sentence 
Initial presentation 0.70 (1.33) 23 1.50 (1.08) 10
Second presentation 
Old sentences 0.30 (0.70) 23 1.10 (110) 10
New sentences 0.44 (0.84) 23 150 (1.35) 10
Retrieval from semantic memory
Word fluency 32.21 (9.67) 32 22.43 (14.83) 44 * *
Verbal IQ
Similarities 15.54 (6.30) 33 10.09 (6.92) 44 * *
*P < 0.01. **P < 0 001
I o r
Recall Recognition Stem completion
Retrie\ al condition
Fig 4 Recall, recognition and stem completion for Alzheimer patients (hatched columns) and controls (black columns)
[F( 1,72) = 5.64, P <  0.05] and elaboration [F(l ,72) = 4.58, P  < 0.05] but no group 
by elaboration interaction [F( 1,72) = 0.01, P  = 0.93], These findings indicated that 
‘good elaborators’ completed more stems than 'poor elaborators’ and that dementia
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Dementia GE Dementia PE Controls GE Controls PE 
Groups
F ig. 5. Word stem completion for good elaborators (GE) and poor elaborators (PE). Black columns = test stems; 
stippled columns = baseline stems.
patients completed fewer stems than controls, but that elaboration did not improve 
performance to a greater extent in dementia patients compared with normals.
The extent to which explicit memory was linked to word stem completion was assessed 
by correlating word recall scores (a measure of explicit memory) and word stem 
completion. For Alzheimer patients, there was no significant correlation between test 
stems or baseline stems and word recall (r = 0.10, n = 43, P = 0.27; r = 0.06, 
n = 42, P = 0.35, respectively). For controls, the correlation between number of words 
recalled and stems completed did reach significance for test but not for baseline stems 
(r = 0.35, n = 33, P = 0.02; r = -0 .01 , n = 33, P = 0.48, respectively).
There was no difference in the level of performance between the elderly controls and 
the Alzheimer patients [F( 1,73) = 0.28, P = 0.06] on the homophone spelling task 
and no significant difference between the groups in the extent to which the homophone 
exposure had an effect on spelling [F( 1,73) = 2.02, P = 0.159].
Overall the demented patients read the transformed text significantly more slowly 
than did the normal elderly controls [F(l ,31) = 21.27. P < 0.001]. However, for both 
groups, old sentences were read faster than they had been an hour or so earlier 
[F( 1,31) = 90.37, P < 0.001] and there was no significant difference in the extent 
to which the old sentences were read faster by the normal elderly controls relative to 
the Alzheimer patients [F( 1,31) = 3.97, P = 0.60] or in the extent to which the new 
sentences were read faster relative to the initial reading [F(l ,31) = 0.002, P = 0.10]. 
However, although these differences failed to reach significance, there were clear trends 
for the effects not to be as marked in the dementia patients as they were in controls. 
It must also be kept in mind that the effects were only observed in a selected sample 
of the patients (i.e. those able to complete the task). Nevertheless, the ability of those 
patients to learn following exposure to the sentences did contrast markedly with their 
almost complete inability to recognize the sentences as old (see Table 4).
Alzheimer patients made significantly more errors than did the elderly controls 
[F( 1,31) = 5.63, P < 0.05] when reading the sentences. The number of errors varied 
according to whether the sentence was initial, old or new [F(2,62) = 5.65, P < 0.01]
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but there was no significant interaction effect [F (2.62) = 0.82. P = 0.45]. Alzheimer 
patients generated fewer words to the letters in the word fluency task [/(74) = 3.46, 
P = 0.001]. The Alzheimer patients performed more poorly than controls on Similarities 
[r (75) = 9.78, P = 0.001],
As noted above, there were clear trends for differences between Alzheimer and control 
subjects to reach significance on the procedural memory tests, tasks which were unaffected 
by scolpolamine ‘blockade' in young subjects. Consequently, the issue o f whether these 
null results can confidently be interpreted as supporting the cholinergic hypothesis needs 
to be addressed. One way o f achieving this is to compare the magnitude o f the differences 
between Alzheimer and control subjects on both cholinergic sensitive and cholinergic 
insensitive tasks. I f  the magnitude o f the differences between cholinergic insensitive 
tests is much less than that for cholinergic sensitive tests, there is an argument that a 
differential effect is present. One way o f comparing the extent o f differences between 
controls and Alzheimer patients is to calculate differences in terms o f effect sizes. This 
allows direct comparison between primary/procedural memory tasks and exp lic it/flu id  
tasks using a standard difference score {see Table 6). The numbers in Table 6 express 
the number o f standard deviation units which distinguish the groups on the tasks. W ith 
the exception o f face recognition and digits backwards, the scores clearly support the 
cholinergic hypothesis in that cholinergic sensitive tests are affected on average more 
than two standard deviation units (range 1 .87 -2 .64 ), while the cholinergic insensitive 
tests are affected, on average, less than two-thirds o f a standard deviation. These findings 
clearly show that, while procedural memory tasks may be performed marginally less 
well by Alzheimer patients compared with controls, the extent to which they are affected 
is much less than cholinergic sensitive tasks
T A B L E  6 E F F E C T  S I Z E S  FOR E X P E R I M E N T A L  T A S K S  FOR 
A L Z H E I M E R  C O M P A R E D  U I T H  C O N T R O L  S U B J E C T S  A N D  M I L D  
A L Z H E I M E R  C O M P A R E D  W I T H  C O N T R O L  S U B J E C T S
A fc h e m ie r M i Id  A lz h e im e r
versus c o n tro ls versus c o n tro ls
Tests a ffec ted  by c h o lin e rg ic  b lo cka d e
Buschke S e le c tive  R e m in d in g  Task 2 64 2 21
S ym b o l D ig it  M o d a lit ie s  Test 2 61 1 92
M u ra m o to  S e le c tive  R e m in d in g  T ask 2 0 9 2 .1 4
W o rd  re c o g n itio n 2 .0 5 2 16
Inve rte d  sentence re c o g n it io n 1 .99 2 60
W o rd  reca ll 1 87 1 33
Face re c o g n itio n 0  76 0  68
Tests una ffe c te d  by c h o lin e rg ic  b lo cka d e
D ig its  b a ckw a rd 1 13 0 .3 5
S im ila r it ie s 0 .8 2 - 0  01
W o rd  fluency 0 .7 2 0 .0 4
A ve rag e  im p ro v e m e n t in re a d in g  tim e 0  67 0 86
D ig its  fo rw a rd 0  61 - 0  09
H om o p h on e  p r im in g 0  32 0  44
W o rd  stem  c o m p le tio n  p r im in g 0  30 0  33
U)‘M H C H R I S  I ( \  SI \  \ M )  O I H I RS
D I S C I S S I O N
The present study aimed to examine the pattern of deficits seen in Alzheimer's disease 
using very similar tests to those found previously to be differentially affected by 
cholinergic ‘blockade' in young subjects. It was expected that if cholinergic depletion 
was a valid model of the cognitive deficits in Alzheimer patients, they would show deficits 
in secondary memory and performance intelligence relative to controls, but show no 
deficits on tests of semantic memory, immediate registration and verbal intelligence. 
The validity of the model was assessed using mild, moderate and sev ere dementia patients.
The major finding was that Alzheimer patients as a group performed in a way that 
disconfirmed the validity of the cholinergic model, but that patients in the mild stage 
of Alzheimer’s disease showed a pattern of performance that mimicked that seen in 
cholinergic ‘blockade’ in young subjects. Thus, as a group. Alzheimer patients performed 
in a way to confirm some of the earlier observations about the differences between 
scopolamine ‘blockade’ and Alzheimer's disease (see Broks et al.. 1988; Kopelman 
and Corn, 1988); i.e. they showed impaired primary as well as secondary memory and 
deficits in semantic memory and verbal intelligence. The effects on secondary memory 
appeared to be consistent and extensive, irrespective of the content of the memory task 
(verbal, non-verbal) or the type of retrieval cue used (free recall, recognition, selective 
reminding). The results with procedural memory and repetition priming were, however, 
consistent with that predicted from what is known from scopolamine ‘blockade' studies.
However, a different picture was present for the mild dementia cases. Patients in 
the early stages showed impaired secondary memory and performance intelligence, but 
they were unimpaired on tests previously found to be unaffected by scopolamine 
administration in young subjects (Kopelman and Corn. 1988; Flicker et al., 1990); i.e. 
aspects of semantic memory, primary memory and verbal intelligence were preserved
Implications of findings for the cholinergic hypothesis
These findings have implications for the hypothesis that cholinergic depletion underlies 
the deficits seen in Alzheimer's disease. It has been suggested that, although the changes 
often observed in Alzheimer's disease differ in kind from those following scopolamine 
administration, the acute or sub-acute effects of scopolamine drug administration must 
represent a substantially reduced degree of cholmergtc depletion relative to that of 
long-term depletion that occurs with Alzheimer's disease. The finding from the present 
study that mild dementia patients exhibited no impairments in primary memory, semantic 
memory retrieval or verbal intelligence, but those in the later stages of dementia did. 
is consistent with the position that cholinergic depletion may be responsible for disabilities 
in the early stages of the disorder. Other neurotransmitters, more severe structural 
damage, or more complete cholinergic depletion may be associated with Alzheimer's 
disease as it progresses.
Limitations to the study design
Despite the finding of a perfect agreement with predictions for the mild cases on the 
anterograde tests used here, there remain a number of limitations to the scopolamine 
hypothesis, and to the methods used to test it in this study. First, there were limitations 
in the range of cognitive functions measured by the present battery of tests. Perhaps 
most importantly, aspects of retrograde amnesia were not measured. The absence ot
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(Nissen et al., 1987). Taken together, these findings and those of the present study are 
consistent with preserved repetition priming and procedural learning in both scopolamine 
studies and Alzheimer's disease.
A second respect in which the repetition priming and procedural memory tasks are 
interesting is that they illuminate the nature of priming memory in Alzheimer's disease. 
Although the present tasks have been used previously with either or both amnesic {see 
Moscovitch el al., 1986; Mayes, 1988) and Alzheimer patients (e.g. Shimamura et al., 
1987; Christensen and Birrell, 1991), they have not been given simultaneously to the 
same group of patients. Nor have they been given to patients classified into categories 
of mild, moderate and severe using clinical tests. Two questions, unresolved to date, 
and relevant to the present results are (i) whether repetition priming is impaired in 
Alzheimer's disease and (ii) whether information, particularly new information, can 
be acquired by dementia patients, and in what circumstances.
The findings which address the question of priming impairment will be discussed first. 
We found the Alzheimer patients benefited from word exposure but showed less priming 
on word stems and baseline stems. On word stem completion tasks, many investigators 
have found less priming for Alzheimer patients (Shimamura et al., 1987; Salmon et al., 
1988; Keane et al., 1991), while others have not (Partridge et al., 1990; Christensen 
and Birrell, 1991). It has been suggested that the level of priming depends on elaboration 
at encoding (Partridge et al., 1990) or on the extent to which stem completion is mediated 
by explicit memory (Randolph, 1991). In the present study, we observed that the extent 
of priming was directly related to the severity of the dementia. Dementia patients who 
scored above 20 on the MMSE did not show impaired lev els of priming, while subjects 
with moderate to severe dementia did. The extent to which subjects were capable of 
generating sentences, as measured by the number of sentences completed with a subject, 
object and verb, influenced the level of priming, but to the same extent in normal subjects 
and Alzheimer patients. This finding gives partial support to the importance of elaboration 
at encoding, although the effect of elaboration was no more important for Alzheimer 
patients than it was for controls. The extent to which explicit memory was linked to 
word stem completion was assessed using correlations between word recall scores (a 
measure of explicit memory) and word stem completion. For Alzheimer patients, there 
was no correlation between stem completion or baseline performance and explicit recall. 
For normal control subjects the correlation between explicit recall and stem completion 
did reach significance for stem completion but not for baseline. This modest correlation 
(r = 0.35) for stem completion, but not for baseline, is consistent with the interpretation 
that some proportion of the stem completion performance of normal controls is mediated 
by explicit memory. However, this result must be considered with caution since other 
studies (i.e. Kopelman and Corn. 1988) have not found significant correlations between 
free recall and primed recall. Nevertheless, the findings of the present study suggested 
that the extent of stem completion performance may be mediated by a number of variables, 
all of which have an influence, i.e. the extent of elaboration, the severity of the dementia 
and explicit memory strength in controls.
In contrast to the word stem completion task, the homophone priming task showed 
no difference in the level of priming between Alzheimer patients and controls, even 
for the moderately affected dementia patients. The findings from the transformed text 
study clearly demonstrated that new learning took place. However, as so few of the
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subjects were able to perform the task, the generalizability of the finding to Alzheimer’s 
disease as a whole is limited. The selected subgroup of dementia patients learned 
item-specific information as well as the skills which allowed them to read unseen sentences 
faster. Their learning rate was not significantly slower than that of normals despite their 
exceedingly poor explicit memory (although there was a trend that failed to reach 
significance indicating that they may have learnt more slowly). These findings support 
those of others in demonstrating new procedural knowledge acquisition in Alzheimer's 
disease (e.g. Moscovitch et al., 1986). The findings supplement previous ones in 
demonstrating new learning by mild, moderate and severe dementia patients using a 
paradigm previously used with patients of mixed aetiologies (Moscovitch et al., 1986).
It is of interest that one patient in the severe category showed improved reading times 
despite obtaining a MMSE score of less than 14 points. The question of whether the 
extent of new learning in dementia is equivalent to that of normals cannot be answered 
unequivocally at present.
Conclusion
The major finding of the present study was that the mild cases of Alzheimer-type 
dementia showed a pattern of anterograde deficits similar to that previously observed 
in scopolamine ‘blockade’. This represents an important observation, since the validity 
of the scopolamine hypothesis can only be fairly tested with a group of patients in the 
mild stages of Alzheimer’s disease, where the opportunity for other neurotransmitter 
involvement is limited. The findings of the present study give direct support to the use 
of anticholinesterase agents, particularly in the early stages. They also suggest that the 
preferable way of examining the effects of THA or similar treatments is to give a range 
of tests which are differentially affected by scopolamine in young subjects. By including 
such tests it is possible to evaluate whether these drugs improve the functioning of 
dementia patients through their cholinergic action. The use of such contrasting tests 
effectively allows the specificity of the treatment to be evaluated. The use of such a 
battery may be particularly indicated in the evaluation of new ‘cocktail’ treatments of 
Alzheimer’s disease, where newer combinations of drugs are to be evaluated against 
standard cholinergic treatment.
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Exposure History in Case-Control 
Studies of Alzheimer's Disease
A E KORTEN,*  A F JORM,* A S HENDERSON,* E McCUSKER1 AND H CREASEYt
Korten A E (NH and MRC Social Psychiatry Research Unit, The Australian National University, Canberra, ACT, 2601, 
Australia), Jorm A F, Henderson A S, McCusker E and Creasey H. Control-informant agreement on exposure history in 
case-control studies of Alzheimer's disease. International Journal o f Epidemiology 1992; 21: 1121-1131.
Data on control-informant agreement from four published case-control studies of Alzheimer's disease are compared, 
using both the kappa statistic and proportion of agreement for the presence and absence of exposures. Agreement was 
best for exposures involving lifestyle, medical interventions or disorders of more recent origin, and worst for exposures 
which involved judgements by the respondent. Agreement levels are similar across studies, and are commensurate 
with levels of specificity and sensitivity to be expected in this type of enquiry. We discuss the problems and implications 
associated with the interpretation of data from such studies of the elderly.
Case-control studies require that exposure to putative 
risk factors be assessed retrospectively, with the 
associated problems o f recall bias and inaccuracy.1 
Studies o f Alzheimer’s disease (AD) suffer the further 
disadvantage that information on exposures in cases 
must be obtained from surrogate respondents, since 
the nature of the disorder precludes the use o f the cases 
themselves. To achieve symmetry in the response 
mode, surrogate informants are used for controls as 
well as cases. This, o f course, assumes that case and 
control informants w ill have the same biases and error 
rates which, although not self-evident, can be m ini­
mised in the design stages of a study.2 Since the con­
trols themselves are capable o f providing exposure 
information, studies can be conducted to compare the 
information obtained from the informants o f controls 
with that obtained directly from the controls them­
selves. Differences in response patterns will arise both 
because informants lack knowledge o f exposures and 
because o f errors in recall which will affect informants 
and controls alike.
In this paper, we compare data on control- 
informant agreement that have been collected as part 
o f four case-control studies o f AD, and discuss 
the problems and implications associated with their 
interpretation.
* NH and MRC Social Psychiatry Research Unit, The Australian Na­
tional University, Canberra, ACT 2601, Australia.
* University o f Sydney, Department of Geriatric Medicine, Repatria­
tion General Hospital, Concord 2139, Australia.
M ETHO D
Studies o f  Control-Inform ant Agreement 
The measurement o f control-informant agreement re­
quires that there be a sample o f n pairs o f controls 
and their surrogate informants for whom exposure 
data have been obtained. There are four studies o f 
Alzheimer’s disease for which such data were available 
to us. We shall briefly describe these studies and the 
control-informant agreement data available for each.
Sydney study. The study by Broe et a l.3 involved 170 
cases o f AD  and 170 community controls matched for 
age, gender and where possible, general practice o f 
origin. Risk factor inform ation was obtained by lay in ­
terviewers from surrogate informants, mostly spouses, 
siblings or children, for both cases and controls. Forty- 
one o f the controls were also interviewed directly by a 
different interviewer using the same questionnaire. 
Where possible, this was done simultaneously with the 
inform ant interview in order to avoid any discussion 
o f responses between control and the informant. 
Reliability data are now reported here.
Seattle study. Graves’ study4 was conducted among 
130 cases o f AD. Informants were spouses living with 
the case, and controls were friends nominated by the 
case informants whose spouses acted as informants 
Risk factor interviews were conducted by telephone 
Thirty-one randomly selected controls were subse­
quently telephoned and the same interview procedure
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as for the informants was used. Published reliability 
data4 include full details of the agreements between 
control-informant pairs.
North Carolina study. The study by Heymaner o/.5 in­
volved 40 cases of AD with onset before the age of 70, 
and 80 community controls, matched for age, gender 
and race. Controls were selected by random digit 
telephone dialling. Risk factor information was ob­
tained by interviewing case and control informants, 
where possible the spouse. All control subjects were 
also interviewed directly, efforts being taken to ensure 
lack of communication between controls and their in­
formants before the interviews were complete. Relia­
bility data were published in the form of kappa 
statistics only.5
Italian study. The study by Amaducci et a tf  involved 
116 cases of AD and a sample of 116 hospital controls 
and 97 community controls from 7 different centres in 
Italy. Lay interviewers used a standardized question­
naire to obtain risk factor information from in­
formants of both cases and controls. Informants were 
either spouses or first degree relatives. For the pur­
poses of the reliability study,7 13 hospital controls and 
14 population controls were interviewed 3-4 months 
after the initial interview with the informants. A 
sample of 25 patients admitted to neurology facilities 
for disorders not affecting cognitive function were 
also selected. These patients and their next-of-kin were 
interviewed with the same instruments, care being 
taken to avoid communication between patient and 
informant before completion of the interviews. Pub­
lished data include details of the control-informant 
agreement across all pairs, with no distinction being 
made between the sources of the sample. Pairs where 
either the informant or the control/patient did not 
know an answer were excluded.
Measuring Control-informant Agreement 
Agreement data are in the form of exposure informa­
tion for a sample of n pairs of controls and their in­
formants. The results can be arranged in a 2 x 2 table 
as shown in Table 1.
If we could assume that the control response is made 
without error, we could estimate directly the sensitivity 
of the control informants relative to the controls by 
a/(a + c) and their specificity by d/(b + d). The con­
trols, however, are imperfect reporters of their own ex­
posure history, being subject to many of the same 
recall biases as the informants. It is therefore more ap­
propriate to use a statistic which looks at the agree­
ment between two imperfect measures of the exposure
TABLE I Classification o f  responses in a study o f  control-informant 
agreement
Informant
response
Control response
TotalExposed Not exposed
Exposed a b a + b
Not exposed c d c + d
Total a f  c b + d n
of interest. We have therefore used the kappa 
statistic,8 which has strong heuristic appeal since it 
measures the agreement between two raters which is 
over and above what could arise by chance alone. To 
be able to identify where disagreements are most 
severe, we have also presented indices of positive and 
negative agreement,9 where the index of positive agree­
ment or agreement on the presence of an exposure is 
given by
P po s = 2a/((a + b) + (a + c))
and the index of negative agreement, or agreement on 
the absence of exposure is
pneg = 2d/((c + d) + (b + d)).
Since kappa is also sensitive to base rates in the 
population, rates of exposure in the total control 
sample have been presented where available.
RESULTS
Tables 2-5 show the control-informant agreement data 
for those exposures which were assessed in at least two 
out of the four studies. We have considered dicho­
tomous exposures only. The Tables show values of 
kappa and their approximate standard errors.'0 For 
the studies by Broeer al., Graves and Roccaef al., data 
are also given for the proportion of agreement on the 
presence of exposure (Ppos) and the proportion of 
agreement on the absence of the exposure (Pnc?). 
Finally, the base rate for exposure among the controls 
is given where available. This is estimated from the 
actual case-control study using the full sample of 
controls.
Table 2 shows the comparisons for family history 
variables. The value of kappa for dementia in first 
degree relatives ranged from -0.07 to 0.42, with the 
values for three of the studies being very close 
to each other. There was good agreement in the detec­
tion of the absence of dementia in family members 
(p neg = 0.86, 0.92, 0.95), but low agreement bet­
ween controls and their informants on its presence
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Table 2 Comparison o f reliability statistics fo r four studies o f Alzheimer's disease. Family history variables
Study Risk factor Kappa(SE)
Agreement 
on presence
P p o s
Agreement 
on absence
Pneg
a b C d
Exposure
controls
Broe et at Dementia in first degree relatives 0.28 (0.16) 0.33 0.95 i 2 2 36 12
Graves AD in first degree relatives 0.42 (0.20) 0.55 0.86 3 i 4 15 22
Rocca et al. Dementia in first degree relatives -0.07 (0.14) 0.00 0.92 0 3 4 43 6; 12
Heyman et at. Family history of dementia 0.33 (-) - - - - - - 14.5
Broe et al. 
Graves
Leukaemia or reticuloses in 
first degree relatives
0.66 (0.32) 0.67 0.99 1 0 1 39 3.5
Rocca et al. Family history of leukaemia L00 (-) 1.00 1.00 1 0 0 51 3.2
Heyman et al. Family history of leukaemia or 
haematological malignancies
0.56 (-) 10.4
Broe et al. 
Graves
Thyroid disorders in 
first degree relatives
0.27 (0.16) 0 36 0.90 2 4 3 32 16
Rocca et al. Family history of thyroid 0.85 (0.15) 0.86 0.99 3 1 0 43 10; 14
disorder
Heyman et al.
a: Number of informant/conirol pairs where exposure present according to both informant and control, 
b: Number of informant/control pairs where exposure present according to informant and absent according to control, 
c: Number of informant/control pairs where exposure absent according to informant and present according to control, 
d: Number of informant/control pairs where exposure absent according to both informant and control.
NB Because of missing data, the sum of a, b, c and d is not always equal to the total number of pairs assessed.
* Rocca et al. used two separate control samples. The first rate shown is that for hospital controls and the second rate is for community controls.
(Ppos = 0.33, 0.55, 0). Overall agreement was high. 
Base rates varied from 6% for the hospital controls in 
the Italian study to 22% for the Seattle study. The 
other family variables had slightly higher values of 
kappa, possibly because respondents found it easier 
to remember disorders such as leukaemia than to 
decide on the presence of severe memory loss.
Table 3 shows the data for head injury, where agree­
ment for absence of injury was excellent but not for its 
presence. Base rates were not high, ranging from 2% 
to 8.5%. The resultant kappa values varied between 
-0.04 and 0.47.
Table 4 shows the results for medical conditions. 
These conditions refer to lifetime experience. Values of
TABLE 3 Comparison o f reliability statistics fo r four studies o f Alzheimer’s disease. Head injury
Study Risk factor Kappa(SE)
Agreement 
on presence 
Ppos
Agreement 
on absence
Pneg
a b C d
Exposure
controls
Broe et al. Head injury -0.04 (0.13) 0.00 0.95 0 1 3 37 3.5
Graves Head injury 0.47 (0.31) 0.50 0.97 1 0 2 28 8.5
Rocca et al. Head trauma 0.00 - 0.00 0.96 0 0 2 50 2;3
Heyman et al. Head injury 0.42 - - - - - - - 3.8
a: Number of informant/control pairs where exposure present according to both informant and control, 
b: Number of informant/control pairs where exposure present according to informant and absent according to control, 
c: Number of informant/control pairs where exposure absent according to informant and present according to control, 
d: Number of informant/control pairs where exposure absent according to both informant and control.
NB Because of missing data, the sum of a, b, c and d is not always equal to the total number of pairs assessed.
* Rocca et al. used two separate control samples. The first rate shown is that for hospital controls and the second rate is for community controls
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TABLE 4 Comparison o f  reliability statistics fo r  fo u r  studies o f  A lzheim er's disease. Medical conditions
Study Risk factor K appa(SE)
Agreement 
on presence 
Ppos
Agreement 
on absence
P neg
a b C d
Exposure
controls
Broe et al Herpes zoster 0.30 (0.17) 0.44 0.84 4 3 7 27 18
G raves Shingles 0.84 (0.16) 0.86 0.98 3 1 0 27 -
Rocca et al. Herpes zoster 0.63 (0.17) 0.67 0.95 4 0 4 42 7;4
H eym an et al. Herpes zoster 0.47 - - " ~ ~ 3.8
Broe et al 
Graves 
Rocca et al.
Depression or nervous breakdown 0.79 (0.21) 0.80 0.99 2 1 0 39 4.1
Heyman et al. Psychiatric disorders 0.54 - - “ “ ~ 7.5
Broe et al. 
Graves 
Rocca et al.
Severe headaches 0.10  (0.17) 0.27 0.84 2 5 6 99 18
Heyman et al. M igraine/severe headaches 0.63 - _ “ " ~ ~ 35
Broe et al. Kidney disease 0.28 (0.16) 0.33 0.95 1 2 2 36 8
Graves 
Rocca et al.
Renal disease “ ~ 0 0 0 31
"
Heyman et al. Renal disease 0.58 - ~ " ~ “ 20.5
Broe el al. Peptic ulcer . .  0.61 (0.18) 0.67 0 .9 4 4 1 3 33 16
Graves Ulcers 0.52 (0.24) 0.57 0.95 2 1 2 26 -
Rocca et al. Gastric troubles 0.53 (0.12) 0.69 0.84 12 $ 6 29 31; 36
Heyman et al. Stömach ulcer 0.64 - “ “ “ ~ 10.3
Broe et al. Bronchitis, asthm a, emphysema 0.69  (0.11) 0.81 0.88 13 *» 4 22 41
Graves 
Rocca et al.
Lung disease “ 1.00 0 0 0 31
Heyman et al. Lung disease 0.32 - _ ~ ~ ~ ~ 1.3
Broe et al. Asthma 1.00 - 1.00 1.00 3 0 0 38 8
Graves Asthma 0.48 (0.31) 0.50 0.97 1 0 2 28 -
Rocca et al. 
Heyman et at.
Asthma -0 .0 3  (0.13) 0.00 0.97 0 l 2 49 2.8
Broe et al. Hay fever/allergies ind. asthma 0.48 (0.14) 0.67 0.81 10 3 7 21 31
Hay fever/allergies no asthma 0.36  (0.15) 0.57 0.78 8 4 8 21 26
Chronic sinusitis 0.53 (0.24) 0.57 0.96 2 2 1 36 8
G ra\es Allergies, hay fever, 0.62  (0.19) 0.67 0.94 3 0 3 25 -
food allergies 0.47 (0.32) 0.50 0.97 1 1 1 28 -
Rocca et al Allergic rhinitis -0 .03  (0.13) 0.00 0.97 0 1 2 48 9;7
Heyman et al.
Skin allergy 0.37 (0.28) 0.40 0.97 1 1 2 48 11; 28
Broe et al. Diabetes 1.00 - 1.00 1.00 1 0 0 40 7
Graves Diabetes 0 .00  - 0.00 0.98 0 1 0 30 -
Rocca et al Diabetes mellitus 0.78 (0.10) 0.83 0.95 10 3 l 36 15:11
Heyman et al. Diabetes 0.88 - - - ~ 8.8
Broe et al. Thyroid disease 0.84  (0.14) 0.86 0.99 3 0 1 37 8
Graves Thyroid disease 1.00 - 1.00 1.00 1 0 0 29 -
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TABLE 4 Continued
Study Risk factor Kappa(SE)
Agreement 
on presence
Ppos
Agreement 
on absence
Pneg
a b C d
Exposure
controls
Rocca et at. Thyroid disease 0.73 (0.18) 0.67 0.99 3 0 2 46 3; 13
Heyman et at. Thyroid disease 0.71 - - - ” * ~ 6.3
Broe et at. Arthritis 0.46 (0.15) 0.81 0.60 22 4 6 9 68
Graves 
Rocca et at.
Rheumatoid arthritis - LOO 0 0 0 31
Heyman et al. Arthritis 0.55 - " “ - ~ 37
Broe et al. Epileptic fits 0 66 (0.32) 0.67 0.99 1 0 1 39 4
Graves 
Rocca et at. 
Heyman et at.
Epilepsy 0.00 - 0.00 0.90 0 0 1 30
a: Number of informant/conirol pairs where exposure present according to both informant and control,
b: Number of informant/control pairs where exposure present according to to informant and absent according to control,
c: Number of informant/conirol pairs where exposure absent according to informant and present according to control,
d: Number of informant/control pairs where exposure absent according to both informant and control.
NB Because of missing data, the sum of a, b, c and d is not always equal to the total number of pairs assessed.
* Rocca et al. used two separate control samples. The first rate shown is that for hospital controls and the second raic is for community controls.
kappa were fairly consistent across studies. Kappa 
tended to be lower for conditions with low rates 
(asthma, allergic rhinitis), or variables which could 
require judgement on the part of the respondent, such 
as hay fever.
Finally, in Table 5, are shown variables concerned 
with medical treatments, lifestyle and environmental 
exposures. Values of kappa are again fairly consistent 
across studies and tend to be somewhat higher than for 
other types of exposures.
DISCUSSION 
Comparison o f Exposures
The best control-informant agreement was found for 
variables involving lifestyle, medical interventions and 
clearcut disorders which could be of recent origin, such 
as thyroid disease or diabetes. This is in line with other 
studies.11 Allergies, asthma and arthritis all have fairly 
high prevalence and are prominent in the media. Since 
they may be subject to much self-diagnosis, it is not 
surprising that they show lower control-informant 
agreement than diseases which would not be diagnosed 
without a physician. The least satisfactory agree­
ment was found for exposures which involved the 
respondent in making judgements, such as what con­
stituted ‘severe’ in severe head injury, or where the ex­
posure could have occurred in the distant past and not 
be known to the informant, such as head injury which
occurred during active wartime service. Importantly, 
family history of dementia has among the lowest 
agreement statistics. The prevalence of dementia in 
first degree relatives was not high in any study so, as 
will be shown below, expected values of kappa would 
be low. Respondents were asked to remember both the 
identity of all the subjects’ first degree relatives and 
then whether any of them had suffered dementia or 
severe memory loss. The difficult decision often had to 
be made as to whether a very frail, dependent old per­
son who had ‘just faded away’ many years earlier had 
suffered severe memory loss or not.
The studies reported here are too small to allow a 
consideration of more detailed effects. For example, 
spouses or offspring could be better reporters of recent 
illness, compared to siblings who are to be preferred 
for family history or childhood experiences1112 while 
the reporting of life-threatening events could be more 
accurate than that of minor illnesses or socially 
undesirable attributes.1 Larger studies with inde­
pendent sources of validation are needed to answer 
these questions.
Comparison o f Studies
The four studies asked similar types of questions of 
their respondents. Differences in exposure rates across 
studies followed no consistent pattern, and were not 
great. They were most likely a result of differences in
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Table 5 Comparison o f reliability statistics for four studies o f Alzheimer’s disease. Medical treatments, lifestyle and environmental exposures
Study Risk factor Kappa(SE)
Agreement 
on presence
P p o s
Agreement 
on absence
P n e g
a b C d
Exposure
controls
Broe et al Ever had alcohol 0.57 (0.15) 0.91 0.67 6 2 4 29 27
Graves Alcohol problems 0.47 (0.31) 0.50 0.97 1 2 0 28 -
Rocca et al. 
Fleyman et al.
Wine drinking (>}l/day) 0.78 (0.10) 0.95 0.83 36 3 1 10 4;7
Broe et al. Ever smoked 0.81 (0.09) 0.90 0.90 19 3 1 18 52
Graves Ever smoked 0.93 (0.06) 0.97 0.96 17 1 0 13 58
Rocca et al. 
Fleyman et al.
Smoking (10 cigarettes/day) 0.92 (0.05) 0.96 0.96 26 2 0 24 50; 49
Broe et al. Antacids (daily, >6 months) 0.56 (0.15) 0.65 0.75 7 2 5 27 19
Graves Antacids (all types) 0.52 (0.24) 0.57 0.95 2 2 1 26 16
Rocca et al.
Antacids with aluminium 0.63 (0.24) 0.67 0.96 2 1 1 27 11
Heyman et al. Antacids (with aluminium) 0.84 - ~ ~ ~ “ 19
Broe et al. Analgesics (daily >6 months) 0.40 (0.15) 0.65 0.75 11 6 6 18 36
Graves Analgesics 0.63 (0.24) 0.67 0.96 2 1 1 26 9
Rocca et al. Analgesic drugs 0.62 (0.11) 0.79 0.82 19 7 3 23 37;42
Fleyman et al. Analgesics 0.85 - ~ “ ~ “
'
12.5
Broe et al. Thyroid medication 0.66 (0.32) 0.67 0.99 1 0 1 39 2
Graves 
Rocca et al.
Thyroid medication 0.65 (0.32) 0.67 0.98 1 0 1 29
Fleyman et al. Thyroid medication 0.79 - - - _ “ ~ “ 2.5
Broe et al. Hormonal treatment 0.42 (0.19) 0.50 0.91 3 2 4 32 11
Graves 
Rocca et al.
Estrogen use 0.64 (0.16) 0.71 0.91 5 0 4 21
'
Heyman et al. Estrogen replacement 0.63 - - _ ~ ~ ~ 35
Broe et al. 
Graves 
Rocca et al.
Blood transfusions 0.69 (0.17) 0.73 0.96 4 1 2 32 19
Heyman et al. Blood transfusions 0.51 - - ~ 22
Broe et al. 
Graves
General anesthetics 
General anesthetics
0.42 (0.19) 0.91 0.50
correlation on number of GA’s = 0.75
32 2 4 3 87
Rocca et al. General anaesthetic 0.81 (0.13) 0.95 0.86 19 2 0 6 86; 84
Heyman et al. Surgery with general anaesthetic 0.57 - - “ ~ ~ 91
Broe et al. Lived on a farm >2 years 0.81 (0.10) 0.86 0.95 9 0 3 29 24
Graves Lived on a farm prior to age 18 0.93 (0.07) 0.96 0.97 11 1 0 19 -
Rocca et al. Contact with farm animals 0.77 (0.09) 0.86 0.90 19 1 5 27 52; 57
Heyman et al. Contact with livestock 0.66 - * ~ ~ ~ 23
a: Number of informaru/control pairs where exposure present according to both informant and control, 
b: Number of informant/control pairs where exposure present according to informant and absent according to control, 
c: Number of informant/control pairs where exposure absent according to informant and present according to control, 
d: Number of informant/control pairs where exposure absent according to both informant and control.
NB Because of missing data, the sum of a, b, c and d is not always equal to the total number of pairs assessed.
* Rocca el at. used two separate control samples. The first rate shown is that for hospital controls and the second rate is for community controls.
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the control samples and slight variation in question 
wording. The reliability statistics for any one exposure 
are mostly of similar magnitude. Differences were 
larger when base rates of exposure were low, as in head 
injury. This reflects properties of the kappa statistic 
when base rates are low, and is discussed below. There 
was a large difference between the two studies asking 
about headaches. Broe et al. asked about headaches 
which were sufficiently severe to have produced pro­
blems with vision, vomiting or numbness, in an effort 
to obtain reports only on migraines or those headaches 
which had a mainly neurological basis. Evidently con­
trols and their informants perceived this differently, 
since only two pairs agreed on their presence. Dis­
agreement was symmetrical in that five controls but 
not their informants coded headaches as present, while 
six informants but not the controls did the same. 
Although an overall exposure rate of 18% was observed, 
kappa was only 0.10. Heyman et al. asked simply 
whether the subject had ever had ‘migraine or severe 
headaches’ which was present in 35% of controls and 
agreement was high, kappa being 0.85.
Magnitude o f Kappa-Values
Control-informant agreement has been measured for 
each of 24 exposure variables in at least two out of 
four independent case-control studies of AD, resulting 
in 79 separate estimates of kappa. Values vary con­
siderably, but are typically in the range of 0.4 to 0.75. 
It is conventional to consider values of kappa greater 
than 0.75 or so to represent excellent agreement bet­
ween two raters and values less than 0.4 or so to repre­
sent poor agreement.13 We thus have a situation where 
about 25% of the kappa values observed would be ac­
cepted as representing excellent agreement, and about 
20% as representing poor agreement. This non-trivial 
number of poor agreements is of concern and raises 
the question as to how we should treat results from a 
main study for those exposures with poor reliability.
Another convention, however, is to disregard kappa 
values if the observed exposure rate in the population is 
below 5-10%. The distribution of the observed kappa 
values by the observed exposure rates is shown in 
Figure 1. It can be seen that the particularly low values 
of kappa are associated with the lower values of ex­
posure rate and that the variability of observed kappa 
values increases with lower exposure rates. There is no 
evidence of any cutoff at 5-10%. Finally, for quite 
moderate exposure rates, values of kappa represent 
only moderate agreement by conventional standards.
Limitations o f Kappa
Misleading conclusions can arise from too heavy 
reliance on kappa values with reference only to con­
ventions concerning ‘excellent’ versus ‘poor’ agree­
ment. We consider below some of the effects on kappa
03
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Figure 1 Observed values o f kappa plotted against the observed 
exposure rales among controls
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due to very low or very high exposure rates, differences 
in positive and negative agreement and finally discuss 
what the kappa statistics can tell us about the underly­
ing error rates of controls.
It is possible to have very high overall agreement 
between controls and their informants but a low value 
of kappa, especially if the base rate of exposure is low. 
This can be seen in the example of head injury (Table 
3). Kappa values were either around zero, implying 
agreement due to chance alone, or values that were 
barely ‘moderate’ at 0.42 and 0.47. There was, 
however, excellent overall agreement (0.90, 0.94, 
0.96), deriving from the excellent agreement on the 
absence of head injury (0.95, 0.97, 0.96) but not on its 
presence (0, 0.5, 0). The kappa statistic, which can be 
expressed as a function of positive and negative agree­
ment, represents global agreement which is ‘corrected’ 
not only for chance agreement but also for differences 
in positive and negative agreement. Reference to 
Tables 2-5 shows that this pattern was repeated for 
virtually all variables with low values of kappa: ex­
posure rates were not high, negative agreement was 
very high, but positive agreement was low.
When the number of control-informant pairs is 
small and the base rates for exposure are low, kappa 
values can fluctuate markedly. The expected number 
of exposed controls in a reliability exercise will be small 
and the numbers in cells corresponding to positive ex­
posure will be small. The calculated values of kappa and 
its standard error can be quite sensitive to changes in 
the cell sizes of as little as one or two. We illustrate this 
with the data on head injury from Graves’ Seattle study. 
The agreement statistics were: kappa = 0.47, standard 
error SE(k) = 0.31, positive agreement = 0.50 and 
negative agreement = 0.97. Kappa would thus be ac­
cepted as implying moderately satisfactory agreement. 
If, however, the classification of just one controi- 
informant pair were changed, the value of kappa could 
become either 0.78, which would be regarded as imply­
ing excellent agreement, or -0.07 implying agreement 
due purely to chance. This is shown in Table 6.
Most of the values of kappa in Tables 2-5 cor­
respond to moderate levels of agreement, even when 
the base rate is not particularly low. We next illustrate 
that this is not unexpected in this type of study.
When either controls or their informants report on 
the presence of an exposure, they do so with an under­
lying but unknown error or misclassification rate. 
Kappa can be calculated without knowledge of these 
misclassification rates, but if they are known, it is 
possible to calculate the expected value of kappa.
The relationship of kappa to the population base 
rate of exposure (PQ) and the underlying levels of sensi-
Ta BLE 6 Agreement data on head injury from  Graves5 showing the 
efffects o f  small hypothetical changes in agreement between controls 
and their informants
Source of data a b c d Kappa P pos P n eg
Graves i 0 2 28 0  4 7 0.5 0.97
Hypothetical 2 0 1 28 0.78 0.8 0.98
Hypothetical 0 1 2 28 -0.07 0.0 0.95
a: Number of informant/control pairs where exposure present accord­
ing to both informant and control.
b: Number of informant/control pairs where exposure present accord­
ing to informant and absent according to control, 
c: Number of informant/control pairs where exposure absent accord­
ing to informant and present according to control, 
d: Number of informant/control pairs where exposure absent accord­
ing to both informant and control.
tivity and specificity has been formulated by Kraemer14 
in a population model. Sensitivity is the probability 
that a rater, either the control or the informant, cor­
rectly identifies the exposure as present. Specificity is 
the probability that the rater correctly identifies the 
absence of the exposure. We assume for the present 
that there is no difference between controls and in­
formants in their error rates. Kraemer showed that the 
population value of kappa, of which our observed 
value is an estimate, depends on the value of P0, 
sensitivity (Se) and specificity (Sp) in the following 
manner:
Kappa = (P0( 1—P0)/P*( 1—P*)).(Se + Sp-1)2 (1)
where P* = P0Se + (1 —P0)( 1 —Sp), the expected
observed rate of exposure in the sample. Thus for a 
population with sensitivity and specificity each being 
95%, the expected value of kappa is only 0.14 foT an 
exposure rate of 1%, 0.45 for an exposure rate of 5% 
and 0.61 for an exposure rate of 10%. However, even 
when rates of exposure are moderate and sensitivity 
and specificity are fairly high, expected values of 
kappa may be quite low. This is illustrated in Figure 1 
which shows some examples of the expected values of 
kappa for the full range of exposure rates and for 
selected values of sensitivity and specificity. The im­
plications of these results in reliability studies in 
psychiatric research are discussed by Grove er a /.15
Reference to Figure 2 allows us to make some obser­
vations concerning the range of values of kappa 
observed in the control-informant agreement studies. 
Firstly, the graph illustrates clearly the rapid fall-off in 
expected values of kappa when exposure rates are 
either very low or very high for any levels of sensitivity
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FIGURE 2 Expected values o f kappa fo r  selected values o f sensitivity 
and specificity
and specificity. Secondly, even for moderate exposure 
rates, kappa values may still be quite low.
One risk factor which has consistently been found to 
be associated with AD  has been a family history o f 
dementia. The studies on control-informant agree­
ment, however, showed disturbingly low, although 
similar, values of kappa in the range of 0.3-0.4. Rates 
of exposure did not vary greatly. The Sydney study, 
for example, identified 12% o f the control sample as 
having a family history o f dementia and found a value 
o f kappa o f 0.28 for control-informant agreement. 
Reference to Figure 1 or application o f equation (1) 
indicates that i f  sensitivity and specificity were 0.75 
and 0.90 respectively, kappa would take a value o f 0.3. 
Similarly, the same results would occur for sensitivity 
and specificity o f 0.60 and 0.95 respectively. These 
misclassification rates are not unreasonable for case- 
control studies which use informants to report on the 
presence o f dementia in relatives who may be long 
since dead or with whom they may have had little 
contact.
In retrospective case-control studies using question­
naires, error rates o f at least 10% are to be ex­
pected.1-11 Given the range o f exposure rates observed 
in the studies o f AD , the agreement statistics obtained 
are commensurate with levels o f sensitivity and 
specificity well within the limits to be expected in this 
type o f investigation.
Alternative Measures o f Agreement 
Several indices o f agreement, such as Yule’s Y, the 
phi coefficient and the odds ratio, have been proposed 
to overcome some o f the weaknesses o f the kappa 
statistic and an excellent summary is found in Cicchetti 
and Feinstein.9 Yule’s Y and the phi coefficient both 
measure association rather than agreement, are d if­
ficult to interpret heuristically, and fail to overcome all 
the weaknesses o f the kappa statistic. The odds ratio, 
calculated as ad/bc using the notation o f Table 1, also 
fails to present an immediate heuristic interpretation 
o f agreement. I f  any o f the cells o f Table 1 are zero, 
the odds ratio can be either falsely zero or falsely in­
finite, thus failing to overcome similar difficulties 
with kappa. The kappa statistic has achieved wide cur­
rency in medical research as a standard meausure of 
diagnostic agreement. No other single statistic has yet
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been proposed which overcomes its shortcomings, but 
the concurrent presentation of positive and negative 
agreements enables a better understanding and inter­
pretation of results.9
Comparison of Rates Reported by Controls and Their 
Informants
Several studies have indicated that informants gener­
ally have less knowledge than the controls about many 
exposures and these are therefore underreported. On 
the other hand, it has been found that wives are better 
at reporting dietary intake of their husbands than are 
the husbands themselves, and that they may over­
report smoking habits.11 In either situation, dis­
agreements would mean that the values of b and c in 
Table 1 would differ significantly. It is possible to test 
these disagreements using the McNemar test,16 but 
studies of control-informant agreement need to be 
considerably larger than those reported here if effects 
are to be detected. On pooling studies, however, we 
find that head injury may be underreported by control 
informants. A total of seven controls but not their 
informants reported head injury, while only one in­
formant reported an injury which was not mentioned 
by the control (P = 0.052). No other exposure ap­
pears to have been systematically over or under­
reported by informants compared with the controls.
Effects o f Misclassification on Estimates o f Odds 
Ratios
The main reasons for doing studies on control- 
informant agreement is to monitor the performance of 
survey procedures and to ensure the comparability 
with other studies. The evaluation of possible bias in 
estimates of disease risk from the actual case-control 
study would normally require a different type of in­
vestigation altogether.
There is an extensive literature documenting the 
effect of misclassification on estimates of the odds 
ratio.17' 20 When misclassification rates are the same 
for both cases and controls, estimates of the odds ratio 
will be biased towards unity. If case and control in­
formants misclassify differentially, bias may be either 
towards or away from unity. If values of sensitivity 
and specificity are knowm with accuracy, appropriate 
corrections can be made to the observed cell counts 
and adjusted odds ratios estimated.10-17 Values of sensi­
tivity and specificity derived from control-informant 
agreement studies, however, are not sufficiently ac­
curate to be used in such adjustments.
CONCLUSION
The four case-control studies of AD whose control- 
informant data are presented here used similar
methodology. The best agreement between controls 
and their informants was found for exposures involv­
ing lifestyle, medical interventions, and disorders 
which could be of recent origin and would require 
medical diagnosis. The least satisfactory agreement 
was found for exposures requiring subjective 
judgements on the part of the respondents, such as the 
presence of a family history of dementia or head in­
jury, where there was possible underreporting by in­
formants. The values of kappa'were mostly of similar 
magnitude across studies for the same exposures.
Many of the kappa values indicated only moderate 
or poor agreement. However, we have shown that this 
may be misleading. First, kappa represents agreement 
which is corrected not only for chance but also for dif­
ferences between positive and negative agreement. 
When the exposure rate is low and positive agreement 
is low, than kappa may be misleadingly low. Second, 
when the number of control-informant pairs is small 
and the exposure rate is low, kappa values can be very 
labile with marked fluctuations induced by only small 
changes in agreement between pairs. Third, at very low 
or very high values of the exposure rates, kappa rates 
fall off sharply. Finally, those kappa values observed 
in the four studies presented here which indicate com­
paratively poor agreement are consistent with levels 
of sensitivity and specificity which are reasonable 
for this type of investigation for the levels of exposure 
observed.
A family history of dementia is perhaps the only risk 
factor to have emerged strongly and consistently from 
case-control studies of AD so far, yet its statistics on 
control-informant agreement are among the lowest. It 
is therefore reassuring that not only are the agreement 
statistics consistent across studies, leading to greater 
confidence in comparing the results from any studies 
which use similar methodologies, but also that they 
can be shown to be commensurate with values of sensi­
tivity and specificity to be expected in this type of 
investigation.11-15
The consistency of findings across the four studies 
increases the confidence with which results can be ac­
cepted from collaborative analyses such as those of 
studies of Alzheimer’s disease.21 The findings are not 
limited to studies of AD but apply equally to any 
studies of the elderly using similar methodology. Given 
the small return from individual studies of control- 
informant agreement, however, it would seem profi­
table for future research to concentrate more on the 
important questions concerning differential bias bet­
ween cases and controls and the problems of over- or 
underreporting by informants.
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O rig inal C on tribu tion
Differential Diagnosis in Dementia
Principal Components Analysis of Clinical Data From a Population Survey
Anthony F. Jorm, PhD; Laura Fratiglioni, M D ; Bengt Winblad, PhD
• Objective.—To reduce all the clinical data, collected 
from an unselected group of subjects, to a small set of fac­
tors and to see how these factors correspond to standard 
clinical diagnosis of dementing disorders.
Design.— Population survey.
Setting.—General community: elderly older than 74 
years, from an area in Stockholm, Sweden.
Subjects.—Population-based sample including (1) all the 
screened positive subjects using the Mini-Mental State ex­
amination; and (2) a random sample of the screened nega­
tive subjects, matched by age and sex. A clinical examina­
tion and an informant interview were carried out. Cases 
were identified using Diagnostic and Statistical Manual of 
Mental Disorders, Revised Third Edition diagnostic criteria 
for Alzheimer's disease (AD) and other dementias.
Main Outcome Measure.— Independently from the clin­
ical diagnosis, a principal components factor analysis was 
carried out to investigate groupings among the clinical data 
(factors). Factor scores, calculated as a weighted sum of the 
symptom variables and converted to a standard score form.
Results.— Four major factors were found: cognitive im­
pairment, cerebrovascular disease, disturbed behavior, and 
depressive symptoms. The comparison of these factors with 
the clinical diagnoses showed that (1) the cognitive impair­
ment factor discriminated demented cases from nonde- 
mented; (2) the cerebrovascular disease factor discriminat­
ed vascular dementia from AD cases and nondemented; (3) 
the disturbed behavior factor discriminated AD cases from 
vascular dementia cases and nondemented, indicating be­
havioral changes characteristic of AD.
Conclusions.—This finding, if replicated, would have im­
plications for the construction of diagnostic criteria for AD.
(Arch Neurol. 1993;50:72-77)
y ^ lin ica l diagnosis in dementia involves two steps: the 
V_* diagnosis of the syndrome of dementia, and the d if­
ferentiation of diseases producing the dementia.1 Both
Accepted for publication July 20, 1992.
From the Stockholm (Sweden) Gerontology Research Center and the 
Department of Geriatric Medicine, Karolinska Institute (Drs )o’rm, 
Fratiglioni, and Winblad)and the National Health and Medical Research 
Council Social Psychiatry Research Unit, The Australian National Uni­
versity, Canberra (Dr Jorm).
Reprint requests to Stockholm Gerontology Research Center, Dalaga- 
tan 9-11, S-1 1382 Stockholm, Sweden (Dr Fratiglioni).
steps involve difficult decisions. For the diagnosis of 
dementia, there is the problem of differentiation from nor­
mal aging, when there is no clear break between the two, 
but rather is an underlying continuum from successful 
cognitive aging2 to severe dementia. For differential diag­
nosis, the main problem remains the diagnosis of A lz­
heimer's disease (AD), which is still diagnosed largely by 
excluding other dementing disorders. As well, there is 
the problem of multimorbidity, particularly in the very 
elderly, in whom dementia may not be attributable to any 
single disease process.
An important advance has been the development of d i­
agnostic criteria for both of these steps, in particular the 
Diagnostic and Statistical Manual of Mental Disorders, 
Revised Third Edition (DSM-III-R),’ National Institute of 
Neurological and Communicative Disorders and Stroke- 
Alzheimer's Disease and Related Disorders Association 
(NINCDS-ADRDA),3 and, more recently, International Clas­
sification of Diseases, 10th Revision (ICD-10) criteria.4 The use 
of clinical diagnostic criteria helps to ensure greater agree­
ment among diagnosticians and, perhaps, greater validity 
as well. The acceptance of clinical diagnostic criteria has 
been so strong that they are virtually always used in re­
search studies on dementia. Despite this acceptance by re­
searchers, the diagnostic criteria themselves have not been 
derived directly from research evidence but from the 
knowledge and clinical experience of experts. In fact, diag­
nostic criteria are usually based on the consensus of a com­
mittee of experts. As a consequence, validation of the cri­
teria becomes essential.
Criteria for clinical diagnosis can be validated using a 
pathological standard. For example, several studies have 
shown that the NINCDS-ADRDA criteria for probable AD 
produce acceptable-to-high agreement with pathological 
diagnosis.5"7 Pathological studies are, however, based on 
highly selected samples. Another approach, used herein, is 
to examine the signs and symptoms relevant to clinical d i­
agnosis. This is best carried out as part of a population sur­
vey to avoid biases in the selection of subjects. Although no 
"gold standard" is available in such studies, the statistical 
associations among the signs and symptoms can be exam­
ined. Signs and symptoms that reflect the same underlying 
pathology should be correlated with each other, but not with 
the signs and symptoms that reflect a different pathology.
The method used herein to investigate groupings among 
clinical variables is principal components analysis, which
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has been used previously to study pathological findings in 
the dementias. The aim of this technique is to reduce a 
large set of correlated variables (in our case, signs and 
symptoms) down to a smaller set of uncorrelated variables, 
known as principal components or factors. In a sense, factors 
derived from clinical variables correspond to syndromes. 
However, an important difference is that factors are con­
tinuous dimensions rather than discrete categories. Hence, 
rather than categorize people as either sick or well, prin­
cipal components analysis will arrange them along a con­
tinuum from very sick to very well For studying dem en­
tia, there are advantages in using a technique that 
combines the clinical data to form continuous variables, ie, 
at least in the very elderly, there is no clear break between 
dementing diseases and normal aging. Furthermore, p rin­
cipal components analysis handles multimorbidity easily 
because individuals do not have to be placed in mutually 
exclusive categories. Instead, they can simultaneously 
score high on several factors.
In this article, we report the results of analyses that were 
performed on clinical data collected during a population 
survey on aging and dementia, which is ongoing in Stock­
holm, Sweden (the Kungsholmen Project). The aims of this 
report are to reduce the clinical data from the Kungshol­
men Project to a small set of factors and to see how these 
factors correspond to standard clinical diagnoses.
SUBJECTS AND METHODS 
Sample
Clinical data were collected from 668 subjects who underwent 
phase 2 of the Kungsholmen Project. A descnption of the popu­
lation and the methods used have already been reported.910 
Briefly, the subjects were selected from the general population, 
aged 75 years and older, and residing in an area of Stockholm 
(Kungsholmen). The Mini-Mental State examination (MMSE)11 
was used as a screening test. All the subjects who scored less than 
24 (n=314) and a random sample of persons who scored higher 
than 23 (n=354) underwent a comprehensive clinical examination. 
Also, a relative or other informant was interviewed. The sample 
was matched by age (±5 years) and sex with the screened posi­
tive subjects.
Diagnostic Examination
The clinical examination in phase 2 was performed by one of 
three physicians. This was similar to a comprehensive examina­
tion usually performed in clinical practice, but it was structured 
and defined with scoring criteria. It included a medical history, 
physical and neurological examination, cognitive examination, 
and assessment of depression with the relevant subscale of the 
Comprehensive Psychopathological Rating Scale.12 Cognitive 
functions were tested by asking for facts of general knowledge 
and past personal information (memory); by object naming and 
comprehension of commands and sentences (language); by prob­
lem solving and interpretation of proverbs (abstract thinking); by 
examining simple motor activities, such as dressing and miming 
(praxis); by copying figures (visuospatial orientation); by calcu­
lations and mathematical problems (calculation); and by recogni­
tion of objects (gnosis). Laboratory tests were performed to detect 
secondary dementias: albumin, glucose, fructosamine, vitamin 
B12, and thyroid function tests. As well, an interview was carried 
out by a nurse with a relative of the subject or another informant. 
This interview concerned medical history of the subject and his 
or her family; present functioning of memory, orientation, lan­
guage, abstract thinking, and calculation; personality changes, 
behavioral disturbances, and loss of abilities, hobbies, and inter­
ests previously present; and time of onset and progression of the 
dementia symptoms.
The clinical diagnosis of dementia and different types of 
dementia was based on DSM-Ill-R diagnostic criteria, except for 
multi-infarct dementia. The differential diagnosis between AD
and vascular dementia was based only on clinical data because 
instrumental examinations, such as computed tomography or 
magnetic resonance imaging, were not performed in all the 
cases. As a summary of the clinical data and as an aid to diagno­
sis, the scale of Hachinski et al,J was used, with a score of greater 
than 6 indicating vascular dementia; lower than 5, AD; and 5 or 
6, mixed dementia. A diagnosis of "AD with doubts" was used 
when the data were insufficient to accept an AD diagnosis, but all 
the other dementias were less probable. Two independent diag­
noses were made by physicians working separately. Final diag­
noses were derived from a comparison of these two independent 
diagnoses.14 When there was agreement between the first and the 
second diagnoses, this was the final diagnosis. When there was 
disagreement, these data were reexamined independently and, if 
the disagreement persisted, a final diagnosis was made bv a su­
pervisor. In making their diagnoses, the physicians were "blind­
ed" to the subjects' performance on the MMSE. Staging of 
dementia was done according to the Clinical Dementia Rating 
scale15 by one physician based on the final diagnoses.
All testing procedures and the means of obtaining consent from 
subjects and informants were approved in advance by the Ethi­
cal Committee of the Karolinska Institute.
Data Analysis
The clinical variables relevant to diagnosis of dementing 
diseases were subjected to a principal components factor analy­
sis.16 The clinical variables were those used by the second physi­
cian (L.F.) in making her clinical diagnoses. Some variables were 
found to be highly correlated and, therefore, were combined be­
fore the analysis. The starting point for the principal components 
analysis was a correlation matrix involving all the clinical 
variables. However, elderly subjects often have missing data on 
some variables; therefore, if the correlation matrix was based only 
on those subjects with complete data, there would be a consider­
able loss of subjects, particularly those with deficits. The solution 
adopted for our study was to use data from subjects who had 
missing values on 10% or less of the clinical variables. When a 
value was missing, the mean value from the sample was substi­
tuted. A principal components analysis yields successive factors 
that account for progressively less of the variance present in the 
original variables. Most of the factors account for so little of the 
variance as to be of no interest. To decide on the number of fac­
tors to retain, we used a graph showing the percentage of vari­
ance accounted for by each successive factor (a screen plot). From 
the point the plot reached a plateau, the remaining factors were 
disregarded. To aid interpretation of the factors that were 
retained, a VARIMAX rotation was used.16 This technique aligns 
the factors so that they have either very large or very small cor­
relations with the original clinical variables. Factor scores were 
calculated for each of the rotated factors. These factor scores con­
sist of a weighted sum of the symptom variables, with each 
symptom being converted to a standard score and weighted ac­
cording to its correlation with the factor. The factor scores are 
standardized, with a mean of 0 and an SD of 1. The factor scores 
were used as dependent variables for subsequent analyses. In 
particular, we did the following correlations and comparisons:
1. The factor scores were correlated with continuous variables, 
like age and the MMSE score using Pearson's Product-Moment 
Correlation coefficients.16
2. The factors were compared across groups to check if gender, 
education, diagnosis, or type of informant were related to the 
factor scores. Differences between means were tested for statisti­
cal significance using either t tests or analysis of variance. Where 
t tests were carried out, an F test was first performed to examine 
the assumption of equal within-group variances. If the F test was 
not significant (P>.05), the within-group variances were regard­
ed as homogeneous and a pooled-variance estimate was used for 
the t test.16 When the within-group variances were significantly 
different, a separate variance estimate was used. One-way anal- 
vses of variance were used to compare the factor scores of three 
or more groups. If the analysis of variance test showed that there
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Table 1.— Demographic Data and Mini-Mental State Examination (MMSE) Scores of Subjects Included 
in Principal Components Analysis (Total Sample and Different Diagnostic Groups)
W o m e n , % A ge, y, M e a n ± S D M M S E  S core, M e a n ± S D
Nondem entia 81.0 84 .015 .3 26.013.1
A lzheim er's disease 83.1 8.3.815.5 14 .817 .6
A lzheim er's disease w ith  doubts 66.7 85.31.3.9 19.214 .2
Vascular dementia 77.8 84 .616 .0 14 .317 .0
Secondary dementias 80 8 84 .416 .3 14 0 i6 .1
Total 80 8 84.1 1 5.3 2 2 .8 1 6 . 8
was some difference between the groups, post hoc Scheffe tests 
were performed to find out which pairs of groups were different.16 
The P < .05 significance level was used for these comparisons.
RESULTS
There were 445 subjects w ith  suffic ient data to be 
inc luded in the analysis. O f these, 315 were norm al, 65 
were diagnosed as having AD , 12 as having A D  w ith  
doubts, 27 as having vascular dementia, and 26 were g iv ­
en o ther diagnoses (m ixed dementia, subdural hematoma, 
dem entia in Parkinson's disease, alcoholic dementia, psy­
chosis, or uncertain type o f dementia or uncertain dem en­
tia). Dem ographic data and the MMSE scores are reported 
in Table 1 for the total sample and each diagnostic 
subgroup.
The inform ants consisted o f 73 spouses, 180 ch ild ren  and 
ch ild ren -in -law , 115 other relatives, and 77 nonrelatives. 
O f the 223 subjects w ho were excluded because o f in su f­
fic ien t data, 162 lacked inform ants. Subjects w ho were ex­
cluded were more like ly  to be severely demented than 
those included (15% vs 2%) and were less like ly  to be no r­
m al (56% vs 72%). They were also more like ly  to be d iag ­
nosed as having vascular dementia (11% vs 6%).
W hen the p rinc ipa l components analysis was carried out 
on the 132 variables, most o f the factors accounted for on ly  
1% or less of the tota l sym ptom  variance. The large n u m ­
ber o f specific factors, w h ich  had on ly  one or tw o  c lin ica l 
variables corre lating w ith  them, is due to the many v a r i­
ables that were used as exclusion criteria, m a in ly  for A D  
(eg, severe head trauma, thy ro id  disease, and cancer). As 
expected, these "exclus ion" variables d id  not correlate 
w ith  other clin ica l variables to fo rm  major factors.
The first four factors accounted for 17.9%, 4.1%, 3.9%, 
and 3.4% of the sym ptom  variance, respectively, w h ile  the 
next six factors accounted fo r 2.6%, 2.3%, 1.9%, 1.9%, 1.8%, 
and 1.7%, respectively. It was decided to retain the firs t 
fou r factors fo r rota tion, bu t exp lo ra to ry  analyses were also 
carried out ro ta ting five  or six factors. The five- and 
six-factor rotations d id  not, however, produce any theo­
re tica lly  interesting factors beyond those present in the 
four-factor rotation. For th is reason, on ly the four-factor 
ro ta tion  is described.
The corre lation coefficients (loadings) o f all 132 clin ica l 
variables w ith  the fou r rotated factors are too many to be 
described herein. Instead, Table 2 shows the clin ica l v a ri­
ables w ith  loadings o f .40 or greater. It can be seen from  
Table 2 that the c lin ica l variables that loaded on factor 1 
reflect cognitive  im pa irm ent. These c lin ica l variables de­
rive  from  the physicians' exam ination and from  the in te r­
v iew  w ith  the in form ant. The clin ica l variables that load­
ed on factor 2 m ostly reflect d isturbed behavior, but some
cognitive items also contributed to this factor. A ll these 
clin ica l variables derive  on ly from  the in te rv iew  w ith  the 
inform ant. A num ber o f the in fo rm ant variables loaded on 
factors 1 and 2, ind ica ting  that some sym ptom s may be 
measures of cogn itive  im pa irm ent and d isturbed behavior. 
The clin ica l variables loading on factor 3 reflect cerebrovas­
cular disease and derive  from the physician's exam ination 
and from  the in fo rm an t, w h ile  those loading on factor 4 
reflect depressive sym ptom s and derive solely from  the 
physician.
Because the firs t factor appears to measure cognitive  
im pairm ent, it should  have a strong corre lation w ith  the 
MMSE, w h ile  the o ther factors are expected to not corre­
late as well. The corre lation coefficients for the whole 
sample and the d iffe ren t d iagnostic groups are reported in 
Table 3. The results support ou r in terpretation.
Analyses were carried out to see w hether the factor 
scores were related to various sociodem ographic charac­
teristics o f the subjects and the ir inform ants. Age of the 
subjects was found to have a corre lation o f .10 w ith  the 
cognitive im pa irm en t factor (P<.05), - .0 6  w ith  the d is­
turbed behavior factor (not significant), .13 w ith  the cere­
brovascular disease factor (P <0 .01), and -.11  w ith  the de­
pressive sym ptom s factor (P < .05). Male subjects scored 
s ign ifican tly  h igher than females on the cerebrovascular 
disease factor (means of .25 and -.0 6 , respectively; P < .05), 
w h ile  they scored low er on the depressive sym ptom s fac­
tor (means o f —.20 and .05, respectively; P < .05). Subjects 
w ith  on ly p rim a ry  education scored h igher on the cogni­
tive im pa irm ent factor than those w ith  secondary or h igh ­
er education (means o f .13and -.2 3 , respectively; P<.001). 
There were also some relationships w ith  characteristics of 
the inform ants. Subjects w ith  in form ants aged 41 through 
60 years were found to score h igher on depressive sym p­
toms than those w ith  in form ants aged 61 th rough  80 years 
(means of .19 and —.11, respectively; P < .05), w h ile  female 
in form ants were found to report more d is tu rbed  behavior 
than male in fo rm ants  (means o f .09 and -.1 9 , respective­
ly; P < .01). Type o f in fo rm ant (spouse, ch ild , o ther relative, 
nonrelative) was not related to any of the fou r factor scores.
Factor scores w ere also compared for subjects w ith  va r­
ious clin ica l diagnoses. The on ly  diagnoses to have su ffi­
cient numbers fo r m eaningfu l com parison were AD, A D  
w ith  doubts, and vascular dementia. The mean factor 
scores for these groups and for nondemented subjects are 
shown in Fig 1. W hen the means for the cogn itive  im p a ir­
ment factor were compared using a Scheffe test, all three 
groups w ith  dem entia were s ign ifican tly  d iffe ren t from  
nondemented subjects, and the A D  and vascular groups 
d iffe red  from  the A D -w ith -doub ts  group. On the disturbed 
behavior factor, the tw o groups w ith  A D  were found to
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Table 2.— Correlations Between Clinical Variables and the Four Factors in the Principal Components Analysis*
Correlation Variables Correlated to
Factor 1
.74-7,0 Handling money, object naming, calculation, names of largest cities
.69- 65 Knowing age, finding toilet, budgeting, using appliances, diamond copying, prime minister's name
.64- 60 Remembering lists, knowing, who she or he is, copying of cross, knowing date of birth, remembering what happened
the day before, concentration, reduced talkativeness, everyday problem solving
.59 .55 Use of initiative, proverb interpretation, circle copying, previous prime minister's name, distinguishing people
54- 50 Doing usual household work, finding shops, onset of disorientation gradual, changed personality, deteriorated memory,
unclear thinking, making decisions, use of initiative
.49- 45 Reduction of emotional involvement, speaking of dead people as alive, forgetting names, speaking less, apathy,
hygiene, praxis, word finding
.44-.40 Carelessness with clothes, onset o f dysmnesia gradual, motor retardation, duration of cognitive changes, knowing own
name
Factor 2
.59-.55 Unclear thinking, fluctuating confusion, hiding things, remembering what happened the day before
.54-,50 Fearfulness, depression, deteriorated memory, changed personality, quick to anger, agitation, worry, anxiety,
moodiness, complaints o f persecution
.49-.45 Remembering lists, disinhibition, accusations of stealing, old food in house, verbal aggression, carelessness with
clothes, onset of dysmnesia gradual, suicidal thoughts, less caring for others, needing to control
■44-.40______ Use o f initiative, budgeting, hallucinations, forgetting names, hygiene, onset of disorientation gradual, hypochondria
Factor 3
.79- 75 Previous stroke
.69-,65 Paresis, previous transient weakness in limbs, tendon reflexes in upper limbs
.64-,60 Grasset's signt
.59-.55 Plantar reflex, previous stroke
.54-,50 Epilepsy, previous transient memory problem
.49-,45 Tendon reflexes in lower limb, previous transient speech problem
.44-,40 Facial cranial nerve paresis
Factor 4
.64 .60 Depressed mood
.59-,55 Anxiety, depressive thinking, worry
.54-.50 No wish to live
49- 45 Hypochondriacal ideas, reduced sleep at night
.44-.40 Depressed mood (observed), autonomic emotional reactions
* AI I variables were scored so high values correspond to impairment; variables reported by informants are shown in italics. 
tSign of decreased muscular strength in the upper limbs.
Table 3.— Correlation Coefficients Between the Major Factor Scores From the Principal Components Analysis and the
MMSE (in Whole Sample and in Different Diagnostic Groups)*
Factor Score
Group
1
Cognitive
Impairment
Disturbed
Behavior CVD
1
Depressive
Symptoms
Whole sample -.8 6 -.23 -.12 -.01
Nondementia -.5 3 -.30 -.17 -.05
Alzheimer's disease -.87 -.44 -.50 -.01
Alzheimer's disease with doubts -.65 -.31 -.31 -.15
Vascular dementia -.73 -.49 -.15 -.30
Secondary dementias -.77 -.06 -.33 -.11
*MMSE indicates Mini-Mental State examination; CVD, cerebrovascular disease
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I  Nondementia 
□  AD
0  AD With Doubts 
[3  Vascular Dementia
- 1 ,0 -{  I I I
Cognitive Disturbed CVD Depressive
Impairment Behavior Symptoms
Type of Factor
Fig 1.—Mean scores on the four factors for subjects in various diagnos­
tic groups. AD indicates Alzheimer's disease; CVD, cerebrovascular 
disease.
differ significantly from the nondemented and vascular 
dementia groups. On the cerebrovascular disease factor, 
the vascular dementia group differed significantly from 
each of the other three groups, while on the depressive 
symptoms factor, the vascular dementia group differed 
from the two groups with AD.
To see how well the disturbed behavior factor discrim­
inated the AD and vascular dementia groups, the frequen­
cy distributions of the factor scores were plotted as shown 
in Fig 2. It can be seen that the distributions differ, but with 
considerable overlap. Although AD cases generally had 
some degree of disturbed behavior, the vascular cases 
sometimes did too.
COMMENT
This study showed that much of the clinical data could 
be summarized by four factors: cognitive impairment, dis­
turbed behavior, cerebrovascular disease, and depressive 
symptoms. To a large extent, these factors correspond to 
currently recognized syndromes. The cognitive impair­
ment factor discriminated AD and vascular dementia 
cases from the nondemented cases and correlated highly 
with the MMSE, which is a widely used screening test for 
dementia. This factor therefore corresponds to the syn­
drome of dementia as described in diagnostic criteria such 
as D S M - I I I - R  and I CD-10.  Likewise, the cerebrovascular 
disease factor discriminated vascular dementia cases from 
AD cases and the nondemented cases and therefore corre­
sponds to the category of "multi-infarct dementia" in 
D S M - I I I - R  and "vascular dementia" in ICD- 10 .  The de­
pressive symptoms factor corresponds to syndromes of 
depressive disorder as described in these classifications. 
Although vascular dementia cases tended to score higher 
than AD cases on the depressive symptoms factor, this 
finding may be an artifact of the diagnostic procedure. 
Vascular dementia was diagnosed using the scale of 
Hachinski et al,13 which includes depression as one of its 
items.
The unexpected result was the emergence of the dis-
#  Vascular Dementia 
□  Alzheimer's Disease
-1.50 -0.50
Score on Disturbed Behavior Factor
Fig 2 .—Percentage distribution of the cases affected by Alzheimer's dis­
ease and vascular dementia for grouped scores on the disturbed behav­
ior factor. The scores are grouped in one-interval classes and the mid­
point is reported.
turbed behavior factor. This factor does not correspond to 
any generally recognized syndrome, but AD cases tended 
to score higher on this factor than vascular dementia cases 
and nondemented subjects. The disturbed behavior factor 
appears to represent changes associated with AD. How­
ever, overlap was noted between the AD and vascular de­
mentia groups, with vascular dementia cases also some­
times having high scores. A possible explanation is that the 
vascular dementia cases with high scores were, in fact, 
cases of mixed dementia, which is, strictly speaking, a di­
agnosis requiring pathological evidence and is a diagnosis 
that is difficult to make on clinical grounds.
The results from the AD-with-doubts group are partic­
ularly interesting in the following regard. This group 
scored lower than the AD and vascular dementia groups 
on the cognitive impairment factor but scored highest on 
the disturbed behavior factor. This finding supports the 
appropriateness of the diagnosis of AD for this group, al­
though it is clear that they are atypical in terms of having 
less cognitive impairment than other AD cases.
The association between AD and disturbed behavior 
emerged even though the criteria used for making the di­
agnosis of AD (D S M - I I I - R ) make no reference to such dis­
turbances. The D S M - I I I - R  criteria for dementia do include 
personality change as a possible feature of the syndrome. 
However, disturbed behavior is not mentioned in the cri­
teria for primary degenerative dementia of the Alzheimer 
type. If these results are confirmed in other populations 
and also in younger persons, then disturbed behavior may 
be a positive feature of AD, which could be included in fu­
ture revisions of diagnostic criteria, thereby making it less 
of a diagnosis by exclusion than has so far been the case. 
Other criteria for the clinical diagnosis of AD (NINCDS- 
ADRDA, I C D - 1 0 ) also do not have disturbed behavior as 
an inclusion feature, although the NINCDS-ADRDA crite­
ria do mention certain behavior disturbances as consistent 
with the diagnosis of probable AD.
Another implication of the results is to further empha­
size the importance of informants as a source of informa­
tion in making a clinical diagnosis. Two of the factors 
identified herein (cognitive impairment and cerebrovas-
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cular disease) invo lved  variables derived from  the phys i­
cian's exam ination  and the in form ant's in te rv iew , w h ile  
the d is tu rbed  behavior factor was solely based on the in ­
form ant's in te rv iew . It is d ifficu lt fo ra  physician to observe 
behavior disturbances du ring  a re la tive ly  b rie f exam ina­
tion. Therefore, in a popula tion survey, it w o u ld  be d i f f i ­
cu lt to assess d is tu rbed behavior in any w ay o ther than by 
an in fo rm an t's  report. However, it must be recognized that 
in fo rm ants are not neutral observers. The perception o f 
d isturbed behav io r is to some extent in the eye o f the be­
holder. A lth o u g h  the type o f re lationship between the in ­
form ant and the subject was not found to affect the results, 
female in fo rm an ts  were found to rate behavior as more 
d isturbed than male inform ants. It is o f course possible that 
subjects w ith  dem entia behave d iffe ren tly  w hen in teract­
ing w ith  males and females, but it could equa lly  be a d if ­
ference in  perception o f behavior. It is therefore im portan t 
to check w hether feelings can interfere w ith  in fo rm ants ' 
assessments.
A lthough  we th in k  our find ings have some im portan t 
im p lica tions fo r c lin ica l diagnosis, they m ust be consid­
ered in lig h t o f the study's lim itations:
1. It is based on prevalent cases. Therefore, ou r find ings 
may not be applicab le  in the early phases o f dem enting 
disorders. H ow ever, because many o f the more advanced 
cases were excluded due to m issing in fo rm a tion , most o f 
the subjects exam ined d id  not have a long disease du ra tion  
(mean=4.7 years, SD=2.7 years). O u r results m ostly  come 
from  the m oderate and m ild  cases w ho are closer to disease 
onset.
2. It is based on a very old popula tion. Therefore, the 
find ings m ay not be applicable to young-o ld  subjects.
3. Selection bias could have influenced ou r find ings. In ­
su ffic ient in fo rm a tio n  or u nava ilab ility  o f in fo rm ants  were 
the most frequent causes o f exclusion. The excluded sub­
jects were more frequently  affected by severe dem entia 
and vascular dem entia than the included p opu la tion  (see 
next po in t).
4. The analysis invo lved  on ly 27 vascular dem entia 
cases because of m issing fam ily  in terview s. The p ropo rtion  
of these subjects w ith  m issing fam ily  in te rv iew s was 
greater than fo r the A D  group, and the selection was 
clearly tow ard  cases w ith  a shorter du ra tion  o f the disease. 
We cannot know  if  some bias was introduced.
5. The d iagnosis o f vascular dementia was based on ly 
on clin ica l data using the scale o f H achinski et a l13 as an 
aid. U n fo rtuna te ly , on ly  a few subjects received in s tru ­
mental exam inations, such as com puted tom ography or 
magnetic resonance im aging. Therefore, the diagnoses 
of vascular dem entia are affected by the lim ita tio n s  of 
H achinski's  scale.17 It is like ly  that, w h ile  most o f the 
A D  diagnoses were correct, some o f the subjects d iag­
nosed as hav ing  vascular dementia actua lly  had A D  or 
m ixed dem entia.
In conclusion, th is s tudy shows the usefulness o f p r in ­
cipal com ponents analysis fo r s tudy ing  d iagnostic  classi­
fication and suggests the use of behavioral disturbances in 
the d iffe ren tia l diagnosis between A D  and vascular de­
mentia. O u r find ings need replication in population-based 
surveys, idea lly  w ith  a larger num ber o f vascular dem en­
tia cases d u rin g  earlier stages of the disease, and w ith  more 
refined d iagnostic criteria  than those used in our study.
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Disability in dementia: assessment, prevention, 
and rehabilitation
A. F. JORM
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Summary
Dementia involves cognitive impairment sufficient to in­
terfere with daily living. Most cases of dementia are due to 
Alzheimer’s disease or cerebrovascular disease. Surveys show 
that dementia is one of the major causes of disability in the 
elderly, affecting personal care, everyday cognitive activities, 
and social behaviour. Several instruments relying on informa­
n t  u w  reports or behavioural observation have been developed 
to assess these various components of disability in dementia. 
Prevention o f dementia would make a major contribution to 
the postponement of disability in old age. In principle, this 
could be achieved by modifying risk factors for Alzheimer’s 
disease or vascular dementia. There is presently scope for the 
prevention o f vascular dementia, but risk factors for 
Alzheimer’s disease are not sufficiently understood. The paper 
discusses how, where dementia has already developed, pro­
grammes involving cognitive training or environmental re­
design can help to maintain skills and reduce behavioural 
disturbances.
Introduction
Dementia is a syndrome which involves impairments 
of memory and other aspects of cognitive functioning, 
and often there is personality change. This syndrome 
can result from many different diseases. However, most 
cases are due to either Alzheimer’s disease or 
cerebrovascular disease, or a combination of the two. 
Alzheimer’s disease is more common than vascular 
dementia in countries with predominantly Caucasian 
populations, while the opposite is true in China and 
Japan.1 Little is known about the relative importance of 
diseases causing dementia in other parts of the world.
The aims of this paper are to review evidence showing 
that dementia is a major cause of disability in the 
population, to describe some new methods for assessing 
disability in dementia, to examine the possibility of 
preventing the diseases causing dementia and thereby
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reducing the prevalence of disability in the population, 
and to assess the possibilities for rehabilitation in 
dementia through cognitive training, appropriate en­
vironmental design, and the management of disturbed 
behaviour.
Dementia as a cause of disability
While mild cognitive decline is very common in old 
age, this is not labelled as dementia until it reaches the 
point where there is interference with daily living. For 
example, the DSM-I11-R diagnostic criteria for demen­
tia require that the cognitive impairment ‘significantly 
interferes with work or usual social activities or relation- 
shipj^with others’ .2 Similarly, the ICD-10 diagnostic 
guidelines require ‘a decline in both memory and think­
ing which is sufficient to impair personal activities of 
daily living’ .3 It is clear from these criteria that the 
presence of disability is fundamental to the definition of 
dementia.
Assessment of disability is necessary not only for the 
diagnosis of dementia, but also for staging its severity. 
According to the DSM-11I-R criteria, dementia is 
classified as mild if ‘work or social activities are 
significantly impaired, the capacity for independent liv­
ing remains, with adequate personal hygiene and 
relatively intact judgment’ . Dementia is moderate if 
‘ independent living is hazardous, and some degree of 
supervision is necessary’ and severe if ‘activities of daily 
living are so impaired that continual supervision is 
required’ .2
A useful way of conceptualizing the relationship bet­
ween cognitive decline and disability is provided by 
Roth’s threshold model,4 which is illustrated in Figure 
1(a). According to this model the distinction between 
dementia and normal ageing is quantitative rather thaU 
qualitative. It is very common for normal elderly people 
to have Alzheimer’s brain changes and cerebrovascular 
disease. For example, a study of the brains of non- 
demented people dying between the ages of 55 and 64
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Figure I (a)The threshold model of dementia, showing an in­
dividual who becomes demented (line A) and one who does not 
(line B). (b)The threshold model, showing the operation of 
various classes of risk factors. For explanations of A, B and C, see 
text.
found that three-quarters had at least some senile pla­
ques and neurofibrillary tangles, which are the 
pathological hallmarks of Alzheimer’s disease.5 As peo­
ple age, these pathologies cause gradual loss of neurons 
in regions of the brain controlling cognitive function. 
Because of the brain’s reserve capacity, some degree of 
neuronal damage can be sustained. However, loss of 
neurons eventually reaches a critical threshold where 
compensation is no longer possible. The affected in­
dividual becomes unable to function adequately in daily 
life and is said to be demented. The rate of neuronal loss 
will vary from individual to individual, so that the 
threshold for dementia is reached at different ages. 
Some will reach an advanced age without ever reaching
the threshold, although subtle cognitive deficits may be 
present.
Epidemiological surveys of the elderly show that 
dementia is a major cause of disability. In a Scottish 
survey of elderly people living at home, 21% of those 
who were disabled had a dementia.6 Dementia was the 
second most common diagnosis in the disabled, with ar­
thritis being only slightly more prevalent. Similarly, a 
study of a general practice sample in Germany found 
that organic mental impairment was the major predictor 
of disability apart from impairment of joints and 
limbs,7 while an Australian study of elderly people liv­
ing in the community or in institutions found that 
physical impairment affecting mobility and limb func­
tion and cognitive impairment due to dementia were 
equally important as the major predictors of disability.8 
Another way to look at the contribution of dementia to 
disability is in terms of disabled life expectancy. On the 
basis of US demographic data it has been estimated that 
eliminating dementia would reduce the expected number 
of years spent in institutions after age 65 by 41% for 
males and 36% for females.9
Assessment of disability in dementia
The assessment of disability in dementia has much in 
common with the assessment of disability due to other 
impairments, but there are also some unique aspects. 
The commonly used scales for assessing activities of dai­
ly living and instrumental activities of daily living are 
appropriate for dementia, with instrumental activities 
being affected earlier in dementia than personal care ac­
tivities because of their greater cognitive demands. An 
additional area of disability of greater relevance to 
dementia than to many other impairments is disturbed 
behaviour. Disturbed behaviour will affect the demented 
person’s ability to engage in social relationships, and 
may be an important determinant of care-giver 
burden.10 All three areas of disability — personal care 
activities, instrumental activities, and disturbed 
behaviour — are intercorrelated in demented patients 
and become more severe as cognitive impairments 
increases.10
A particular issue affecting the assessment of disabili­
ty in dementia is the source of information about areas 
of disability. Disability can be measured using informa­
tion provided by the patient, by an informant, or 
through direct observation. It is simple and convenient 
for patients with physical impairments to provide infor­
mation about their own disabilities, but with cognitively 
impaired patients the information provided may be less
valid |[ has been found dial agreement between self 
reported disability and either informant reports or 
observation of disability is lower foi cognitively im 
paired patients.11-12 burihermoie, patients with 
Alzheimer’s disease appear to have less insight into their 
own disability than those with vascular dementia.11
I NS TRUMP NTS FOR ASSESSING DISABILITY IN DEMENTIA
There are a large number of instruments that have 
been developed for the assessment of dementia, but 
most are aimed at cognitive assessment or diagnosis 
rather than disability. Reviewed here are five in­
struments which are specifically designed for the assess­
ment of disability in dementia, and which cover multiple 
domains of disability.
The Clifton Assessment Procedures for the Elderly 
(CAPE) has two parts: the Cognitive Assessment Scale 
which provides a measure of cognitive impairment and a 
Behaviour Rating Scale which measures various areas of 
disability.14 The Behaviour Rating Scale is filled out by a 
nurse or someone else very familiar with the patient’s 
behaviour. Ratings are made on 18 items which cover 
the areas of physical disability, apathy, communication 
difficulties, and social disturbance. CAPE assessments 
have been found to discriminate between patients with 
dementia and those with functional psychiatric 
disorders, and to predict likelihood of discharge from 
hospital.14 Although the CAPE yields subscores for 
each domain, high intercorrelations have been found 
between them, suggesting that it is measuring a single 
dimension of disability. This finding has led to the 
development of a briefer Survey version of the CAPE, 
which consists only of an information/orientation scale 
and ratings of physical disability.15 The Survey CAPE 
appears to be adequate for screening purposes, but does 
not provide a full assessment of disability.
The London Psychogeriatric Rating Scale (LPRS) is a 
36-item rating scale yielding a total score as well as 
scores on four subscales: Mental Disorganization/Con- 
fusion, Physical Disability, Socially Irritating 
Behaviour, and Disengagement.16 Each item involves a 
description of the patient’s behaviour and is rated on a 
three-point scale by a person who knows the patient. 
The item content of the LPRS is more oriented towards 
hospital patients than other scales, but it can be adapted 
for people living in the community. The LPRS has been 
shown to predict patient outcome (discharge, continued 
hospitalization, death)16 and to discriminate demented 
inpatients from demented outpatients.17 Alzheimer’s 
patients have been found to be more disorganized/con­
fused and socially irritating than patients with other 
dementias.17 As with the C APE, the subscales of the 
LPRS are highly inter'correlated and appear to be large­
ly measuring a single dimension of disability.
As the name suggests, the Echelle Comportement et 
Adaptation (ECA) was originally developed in French, 
but is available in English.18 It contains 32 items cover­
ing physical independence, social integration, occupa­
tion and orientation, mobility, and language. These 
areas of disability were chosen to cover the principal 
survival roles specified in the World Health Organiza­
tion’s International Classification o f  Impairments, 
Disabilities, and Handicaps.19 Each item gives a choice 
of several clearly defined levels of function and the scale 
can be filled out by nursing stall' or someone else in close 
contact with the patient. The scale has been found to 
differentiate different levels of dementia and can 
discriminate amongst severely demented patients who 
score zero on cognitive tests.18 Because of its com­
prehensive coverage and well-anchored items, the ECA 
should be particularly useful in monitoring change and 
in evaluating therapeutic interventions.
The Structured Assessment o f Independent Living 
Skills (SAILS) involves 50 items covering expressive 
language, receptive language, time and orientation, 
money-related skills, instrumental activities, and social 
interaction.20 In addition to the scores in each of these 
areas, the instrument gives a combined Motor Score, 
Cognitive Score, and Total Score. The SAILS differs 
from the other scales reviewed here in that it involves 
direct observation of performance in a testing situation. 
Every item has clearly defined descriptions of perfor­
mance corresponding to each score and inter-rater 
reliability is accordingly high. The use of direct observa­
tion means that the SAILS can be used by someone who 
does not know the patient, but it also restricts the 
coverage of behavioural disturbance. The SAILS and 
the ECA differ from the CAPE and the LPRS in that 
they assess what patients can do, rather than what they 
actually do in everyday tasks.
The Cleveland Scale for Activities o f Daily Living 
(CSADL) is a new scale specially designed for 
Alzheimer’s disease patients and involves several novel 
features.21 It covers 16 categories of activity, including 
physical and instrumental activities of daily living and 
more complex activities such as communication skills 
and social behaviour. The activities are rated by infor­
mants. Each activity (e.g. bathing) is broken down into 
component behaviours, some of which involve initiative 
and active involvement (controlled components) and 
others of which involve highly practised behaviours that 
can be carried out with little attention (automatic com-
ponents). When informants rate the activities, they are 
asked to rate both whether patients do the activity and 
u bother they are capable of doing it, even if they do not. 
Informants also rate the patient’s level of independence 
before the onset of dementia in order to distinguish 
lifelong from recently acquired dependency. Only 
preliminary data are available on the CSADL at pre­
sent, and the instrument is still being refined; however, 
one interesting finding is that Alzheimer’s disease pa­
tients tend to be less impaired on the automatic com­
ponents of activities than on the controlled components. 
While the CSADL measures a number of distinctions 
not covered in previous scales (controlled vs. automatic 
components, pre-morbid vs. current activities, and com­
petence vs. performance), any judgement of the 
usefulness of these distinctions must await further 
evidence.
Prevention of dementia
I f Alzheimer’s disease and vascular dementia could be 
prevented, then so would be a major source of disabili­
ty. Prevention of a disease is often taken to entail its 
elimination, but a more realistic goal for dementing 
diseases is their postponement. Alzheimer’s disease and 
vascular dementia appear to be intimately related to the 
ageing process: the prevalence and incidence of these 
diseases rise sharply with age and the underlying 
pathologies (plaques, tangles, infarcts) are frequently 
present to some degree in elderly people who exhibit no 
disability. The elimination of these diseases would re­
quire a control of ageing processes which is not likely to 
be possible in the foreseeable future. However, with 
present knowledge, it is realistic to attempt to postpone 
these diseases to later in the lifespan. Postponement of 
dementing diseases would increase the disability-free 
lifespan and so improve quality of life, but it may not 
ultimately reduce the total burden of disability in the 
population.
Postponement of dementing diseas^'could be achiev­
ed by two means. The first is an understanding of the 
pathological mechanisms of the diseases and an in­
terference with these mechanisms. Where understanding 
is more rudimentary it may be possible to postpone 
diseases by identifying risk factors and modifying them. 
This approach will work only if the risk factors are 
modifiable and causally related to the disease. Some risk 
factors are not modifiable (e.g. age, family history of 
disease) and others may be proxies for other factors 
which are causally related (e.g. education could be a 
proxy for occupational exposures). Nevertheless, this
second approach is the more promising given our pre­
sent understanding of the major dementing diseases.
Review oe risk factors for alzheimer’S disease
A number of case-control studies have been carried 
out to investigate risk factors for Alzheimer’s disease.22 
In these studies, cases of Alzheimer’s disease are com­
pared with normal controls of the same age and sex. 
Recently, there has been a collaborative pooling of data 
from nin^-control studies of Alzheimer’s disease which r{ 
allows a more powerful evaluation of potential risk fac­
tors than has been possible from individual studies.22 
This data pooling identified a number of likely risk fac­
tors, described below.
Studies have reported links between Alzheimer’s 
disease and family history of diseases.22 Individuals 
with a close relative who had sufTered from dementia 
were found to have 3-5 times the risk of developing 
Alzheimer’s disease. The risk varied with the age of 
onset of Alzheimer’s disease, with early-onset cases 
more likely to have a family history of dementia than 
late-onset cases. Family history of Down’s syndrome 
also emerged as a risk factor. Individuals having a close 
relative with Down’s syndrome were found to have 2-7 
times the risk of Alzheimer’s disease. A family history 
of Parkinson’s disease was also found to increase risk 
for Alzheimer’s disease, but only two studies in­
vestigated this risk factor and further data are needed to 
confirm it. Pooling of data from four of the case-con­
trol studies showed a tendency for Alzheimer’s disease 
cases to have older mothers. This association is not a 
strong one, and is not found in all studies.
The data pooling also showed links between 
Alzheimer’s disease and certain aspects of medical 
history.22 Individuals with a history of head trauma in­
volving loss of consciousness were found to have 1-8 
times the risk of Alzheimer’s disease. It is a puzzle, 
however, that the association was found only for males. 
Head trauma occurring in the decade before onset of 
Alzheimer’s disease conferred much greater risk than 
head trauma earlier in life. Hypothyroidism was also 
found to be associated with 2-3 times the risk of 
developing Alzheimer’s disease. Although 
hypothyroidism can itself cause cognitive impairment, 
the average length of time between onset of 
hypothyroidism and onset of dementia was found to be 
20 years. The pooled data showed that individuals with 
a history of medically treated depression had 1 -8 times 
the risk of developing Alzheimer’s disease. This associa­
tion held for episodes of depression in the decade before
onset of Alzheimer’s disease as well as episodes occurr­
ing earlier in life.
In addition to these risk factors identified through the 
pooling of data from case-control studies, there is 
evidence to support risk factors investigated in other 
types of studies. Undoubtedly, the strongest risk factor 
for Alzheimer’s disease is old age, although it is easily 
overlooked as a risk factor. Both the prevalence and in­
cidence of the disease rise sharply with age.23
There is also an intriguing link between Down’s syn­
drome and Alzheimer’s disease. It appears that virtually 
all individuals with Down’s syndrome develop the brain 
changes characteristic of Alzheimer’s disease by the age 
of 40.24 This is due to having an extra copy of the 
amyloid precursor gene which is on chromosome 21. 
Amyloid is the major constituent of the senile plaques 
found in the brains of Alzheimer’s cases. Although 
Down’s syndrome produces very early Alzheimer brain 
changes, dementia does not develop till a much later 
age.25
The potential risk factor which has excited the most 
controversy is exposure to aluminium. Aluminium ex­
posure was initially considered as a potential risk factor 
for Alzheimer’s disease because of the observation that 
it is present in senile plaques (although even this obser­
vation has been disputed). Furthermore, when the 
human brain is exposed to aluminium there are clear 
neurotoxic effects. How'ever, the resulting syndrome is 
different from Alzheimer’s disease both clinically and 
pathologically.26 Nevertheless, many epidemiological 
studies have sought to evaluate aluminium exposure as a 
risk factor. The major sources of exposure to aliminium 
are food and fluid intake. Antacids can contain large 
amounts of aluminium and are a major potential source 
of exposure. However, studies seeking an association 
between Alzheimer’s disease and use of antacids have 
had consistently negative results.23 Aluminium in the 
water supply has been investigated by comparing the 
prevalence of the disease in regions with varying concen­
trations in drinking water. Some positive effects have 
been found, but there is considerable debate about the 
validity of the measures of disease prevalence used in 
these studies.27 Other evidence supporting a role for 
aluminium comes from a study showing that miners 
who inhaled aluminium powder to prevent silicosis have 
increased cognitive impairment28 and a treatment trial 
which produced some improvement in severe 
Alzheimer’s disease using a drug which ‘mops up’ 
aluminium and iron from the body.29
POSSIBLE PROTECTION EACTORS I OR ALZHEIMER'S 
DISEASE
While some factors may increase risk for Alzheimer’s 
disease, others may be protective. Some evidence of 
protective effects emerged from the pooling of data 
from case-control studies.22 Individuals who had ever 
smoked were found to have a 22°/o reduction in risk 
from Alzheimer’s disease.22 A protective effect is 
theoretically plausible, because Alzheimer’s disease in­
volves a loss of nicotinic receptors in the brain and 
smoking can increase the number of these receptors. 
However, the apparent protective effect could also be an 
artefact of the w'ay Alzheimer’s disease is diagnosed 
clinically. Patients with cerebrovascular disease are ex­
cluded from a diagnosis of Alzheimer’s disease, and 
smoking increases risk for such disease. Therefore 
smokers with Alzheimer’s disease will tend to be under­
represented as subjects in case-control studies.
A protective effect of anti-inflammatory drugs has 
been hypothesized based on a low prevalence of 
Alzheimer’s disease in people with rheumatoid ar­
thritis.30 The pooled data from case-control studies 
found small protective effects for osteoarthritis and 
headaches.22 A feature common to both conditions is 
that they are treated with drugs such as aspirin, which 
have anti-inflammatory effects. A low' prevalence of 
dementia has also been reported in lepers undergoing 
long-term treatment with dapsone or related drugs.31
Another possible protection factor is activity. It is a 
common belief that using the brain will somehow' pro­
tect against dementia in old age. In fact, there is some 
physiological evidence to support the notion that using 
nerve cells leads to their maintenance in old age and 
Alzheimer’s disease.32 By contrast, cells in other organ 
systems tend to be damaged through use. Evidence sup­
porting a role for activity comes from a longitudinal 
study of ageing which found that subjects who became 
demented were more likely to engage in passive activities 
20 years earlier.33 These activities included listening to 
the radio, watching TV, and reading. Furthermore, a 
case-control study of Alzheimer’s disease has found 
evidence that physical inactivity earlier in life is a risk 
factor. As well as this evidence on dementia, there is 
some research on normal ageing indicating that par­
ticipating in leisure activities and maintenance of an 
engaged lifestyle may help in the maintenance of 
cognitive skills in old age.34-35
R i yi i  w o i R isk Fac io r s f o r  Vasc u l a r  D i m i .ni ia
Risk factors for vascular dementia have received lai 
less attention from researchers than risk factors lot 
Alzheimer’s disease. However, strokes are the major 
cause o f vascular dementia and risk factors for stroke 
have been extensively investigated. Nevertheless, most 
strokes do not result in dementia and it should not be 
presumed that risk factors for the two are necessarily 
identical. The following have also been reported as risk 
factors for both stroke and vascular dementia:23
(1) Old age: as with Alzheimer’s disease, the risk for 
vascular dementia rises steeply with age. This is 
by far the most important risk factor.
(2) Hypertension: this is an important risk factor for 
vascular dementia. Not only does hypertension 
predispose to stroke, but it appears to have a 
direct association with poorer cognitive function.
(3) Family history: family history o f vascular
dementia and family history o f stroke appear to 
be risk factors for vascular dementia.
(4) Race: as noted earlier, cerebrovascular disease is 
the most common cause o f dementia in Japan 
and China, whereas Alzheimer’s disease is the 
most common in Caucasian populations. The 
difTerence is likely to be due to environmental 
factors such as diet.
(5) Diabetes: diabetes mellitus is more common in 
vascular dementia cases than in normals.
(6) Cholesterol: although overall cholesterol levels 
appear not to be related to vascular dementia, 
levels o f high-density lipoprotein cholesterol tend 
to be lower in vascular dementia cases.
(7) Smoking: there is evidence that vascular demen­
tia cases are more frequently smokers. The 
higher risk o f vascular dementia in smokers 
counterweighs its possible protective effect with 
Alzheimer’s disease.
Education  and  Dem entia
While some factors may increase or decrease risk for 
specific dementing diseases, others may have a general 
effect on dementia. One such factor is education. Given 
that dementia involves cognitive decline sufficient to 
cause interference with daily living, it might be expected 
that individuals with less education or lower cognitive 
ability might be more susceptible. There is some 
evidence to support this possibility. People with less 
education tend to perform worse on cognitive tests used
to screen for dementia. However, there is debate about 
whether this is due to bias in the screening tests or to 
differences in education levels being a risk factor for 
dementia. 36,37 While most studies of dementia 
prev alence do not find an effect of education, a study in 
China has found a higher prevalence rate in those with 
no formal education.38 Other prevalence studies, which 
come from developed countries, rarely include in­
dividuals with no formal education.
Other evidence supporting a protective effect o f 
education comes from a study of regional cerebral 
blood flow in Alzheimer’s disease.39 This study found 
that when better educated patients were matched to less 
educated patients in terms of clinical severity, the better 
educated had a greater blood flow deficit in the parieto­
temporal region. This finding suggests that the better 
educated patients were able to partially compensate for 
their brain impairment. Education may give this protec­
tive effect because it is associated with higher pre- 
morbid ability. An effect of pre-morbid ability was 
found in a 20-year longitudinal study of ageing in which 
subjects who became demented were found to have 
lower cognitive test scores 20 years previously.33 There 
is also neuropathological evidence that pre-morbid 
brain attributes might have a protective effect. One 
pathological study found a group of patients with brain 
changes characteristic of mild Alzheimer’s disease, but 
no cognitive impairment. These patients were found to 
have large brains and a greater number o f large 
neurons.40 Whether these patients also had better educa­
tion or higher pre-morbid ability is unknown.
Prevention T hrough Risk Factor Modification
Of the possible risk factors for Alzheimer’s disease 
reviewed above, only head trauma, depression, hypo­
thyroidism, and exposure to aluminium are modifiable. 
The first three are serious health problems in their own 
right and considerable efforts already go into preventing 
or alleviating them. However, the available evidence, 
while far from definitive, encourages further efforts 
towards these goals. Aluminium exposure is very wide­
spread through food and water, but the link with 
Alzheimer’s disease is far from established. Given the 
current state o f the evidence, a reduction in exposure is 
not justifiable as a public health goal.
The three possible protection factors for Alzheimer’s 
disease are all modifiable. However, in all cases the pre­
sent evidence is weak. In the case of smoking, any gains 
in reduction o f incidence of Alzheimer’s disease would 
be offset by other major health problems caused by
smoking, including vascular dcmcnlia. I lie ease lot 
anti inflammatory drugs rests on indirect evidence. 
However, controlled trials of the preventive cfleets of 
these drugs would be worth pursuing. A major anti­
inflammatory drug is aspirin, which also has anti- 
platelet effects. As discussed below, anti-platelet drugs 
have value in the secondary prevention of vascular 
dementia. The beneficial effects of mental and physical 
activity are also far from established. However, increas­
ed activity may have intrinsic rewards and is unlikely to 
do any harm.
Of the risk factors for vascular dementia, hyper­
tension, smoking, diabetes, and cholesterol are poten­
tially modifiable. Community-wide health education 
programmes have been shown to successfully lower 
blood pressure and cholesterol and reduce smoking.41 
Control of hypertension has the greatest potential for 
preventive effects. Several clinical trials have shown that 
anti-hypertensive medications reduce stroke incidence.42 
There is also evidence that weight control, reduced salt 
and alcohol intake, and a potassium-rich diet are useful 
in controlling hypertension.43 It is likely that control of 
smoking would also help prevent vascular dementia, 
although there is no direct evidence on the matter. As 
for diabetes and cholesterol, the benefits of controlling 
these on stroke incidence are unclear.44
Level of education is a possible prevention factor for 
dementia generally, and is potentially modifiable. 
Education levels are increasing across generations, so 
that the elderly of the future will be better educated than 
the elderly of today. Furthermore, performance on in­
telligence tests is rising over time,45 so that the elderly of 
the future will have higher performance of the sort of 
cognitive tests used in the assessment of dementia. If 
these changes have any benefits for dementia incidence 
they will only be seen in the longer term.
Secondary Prevention or Vascular Dementia
The evidence reviewed above is relevant to the 
primary prevention of dementia. However, another goal 
is to prevent further progression of dementia once it has 
developed. There is evidence that prevention of progres­
sion is feasible with vascular dementia. Because platelet 
aggregation plays a role in thrombosis, anti-platelet 
drugs have been tried as a prevention for stroke. The 
value of anti-p eatment for the primary preven­
tion of stroke has not been established. However, it has 
been found that anti-platelet drugs can prevent stroke in 
patients who already have a history of transient 
ischaemic attack, stroke, angina, or myocardial infarc­
tion. A meta-analysis of 25 randomized trials of anti- 
platelet treatment found a reduction by a quarter in the 
incidence of non-fatal strokes.46 Since there was little 
difference between treatments, the authors of the meta- 
analysis recommended a daily dose of 300-325 mg of 
aspirin as the cheapest and most convenient treatment. 
Anti-platelet treatment has also been shown to be of 
specific value in vascular dementia. Controlled trials 
have found that aspirin can prevent further vascular in­
cidents47 and improve cognitive performance and 
cerebral blood (low.48 While the evidence supports the 
effectiveness of anti-platelet treatment in slowing pro­
gression of vascular dementia, the effect on disability 
and survival needs to be evaluated. If this type of treat­
ment were to increase years of disabled life, rather than 
disability-free life, then its value could be questioned.
Risk factor modification has also been evaluated for 
secondary prevention.49 It was found that treatment of 
hypertension can improve cognitive function, provided 
that blood pressure does not become too low. There 
may be an optimal window for blood pressure, above 
and below which there are deleterious effects. Giving up 
smoking vWe also found to be beneficial for cognitive cv 
function in vascular dementia, at least in normotensive 
cases.
The Threshold Model and Prevention
The threshold model of dementia provides a useful 
framework for integrating knowledge about risk factors 
and prevention.50-51 This is illustrated in Figure 1(b). 
The number of nerve cells in regions of the brain con­
trolling cognitive function diminishes with age, making 
age the major risk factor for dementia. However, the 
rate of loss varies between individuals. Those with a 
family history of dementia or with Down’s syndrome 
have a greater loss (line A) than those without (line C). 
Events such as stroke and head trauma can also cause a 
loss of neuronal function (line B) and bring a person 
closer to the threshold for dementia. A final factor 
influencing onset of dementia is the position of the 
threshold. Some individuals, such as those with more 
education or greater pre-morbid ability, may be better 
able to compensate for neuronal loss. They could be 
said to have a higher threshold for dementia.
In terms of prevention, the threshold model suggests 
three basic strategies. The first is to interfere with the 
rate of neuronal loss with age. This strategy implies an 
alteration in brain ageing processes and is not possible 
at the present time. However, if anti-inflammatory 
drugs, exposure to nicotine, or mental activity were
established to be preventative, they could work by alter­
ing processes of brain ageing, l lie second strategy is to 
prevent the traumatic events which lead to loss of 
neuronal function. This strategy is currently viable and 
would include, for example, prevention of head trauma, 
stroke, and perhaps depression. The third strategy is to 
alter the threshold for dementia. This could be achieved 
by greater education and pre-morbid ability. Another 
possible way of altering thresholds is to change the 
demands of the environment, so that less is required for 
the affected individual to function adequately. This 
possibility brings us into the realms of rehabilitation.
Rehabilitation of dementia
Because dementia will generally be due to a pro­
gressive and presently unbeatable disease, a return to 
normal functioning is not a realistic goal. Nevertheless, 
it is possible to carry out limited retraining of skills and 
to maximize the use of those skills which remain. Since 
dementia involves disabilities due to cognitive impair­
ment and disturbed behaviour, these two domains form 
the major foci of rehabilitative efforts.
Cognitive Rehabilitation
Impairment of memory and other cognitive abilities is 
the major cause of disability in dementia. Attempts to 
train memory in dementia patients have generally had 
limited success, although there are some exceptions. 
Backman52 has distinguished four features of memory 
training approaches which have been effective in 
Alzheimer’s disease.
The training is based on skills which are relatively 
preserved
Research into the cognitive processes of Alzheimer’s 
disease patients has shown that not all processes are 
equally impaired. Major impairments are found in 
episodic memory (a record of specific events which are 
associated with a particular place and time) and seman­
tic memory (knowledge not associated with a particular 
time and place, in effect, a mental dictionary and en­
cyclopaedia).53 Both episodic and semantic memory re­
quire the conscious involvement of the learner, but there 
is another type of memory, called implicit memory, 
which takes place without conscious involvement or 
effort. This unconscious implicit memory is less im­
paired in Alzheimer’s disease than are the conscious 
forms of memory.54 Another type of memory which is
relatively well preserved in Alzheimer's disease is motor 
memory.55 Manors training is therefore more likely to 
be successful if n is based on moloi memory or implicit 
memory.
An approach which appears to be based on implicit 
memory is spaced retrieval. 56 This simple technique in­
volves the patient repeatedly recalling information at in­
creasingly longer intervals of time. If a longer interval 
leads to failure, there is a return to a shorter interval 
before further exposure. Spaced retrieval has been used, 
for example, to teach day-care attenders the names and 
faces of staff at the day-care centre. Demented patients 
trained by spaced retrieval report that it occurs 
effortlessly, and often give a correct answer without be­
ing sure that they are correct. These features indicate the 
involvement of implicit memory.
The relative preservation of motor learning has been 
used as a basis for an ADL training programme for 
Alzheimer’s patients.52 In this work, patients are trained 
on tasks such as setting the table and brushing their 
teeth. The training concentrates on motor aspects of the 
activity and, to reduce demands on other forms of 
memory, signs are used in the environment to inform 
patients about the components of the activity. Gains 
have been found in some patients, but not in others, 
with more severely impaired patients less likely to 
benefit.
The training programmes are fairly prolonged
Where training has been successful, it is extensive, 
lasting weeks or months. For example, a successful 
cognitive stimulation programme involved training 
family care givers to administer the programme to 
Alzheimer’s patients 6 hours a week over 8 months.57 
The programme involved incorporating activities in the 
daily schedule of the family to stimulate and challenge 
the demented patient. The patients in the programme 
were found to maintain their skills over the 8 months, 
while a comparison group deteriorated, as would be ex­
pected with a progressive dementia. The greater success 
of extensive programmes is consistent with experimental 
evidence that Alzheimer’s patients can profit from more 
study time.
Care givers are involved in the training
There are several advantages of care-giver involve­
ment. Care givers are able to provide more training time 
than a professional therapist and their involvement 
should help to maintain gains after professional contact
ceases 1 he involvement of a familiar person will also 
reduce anxiety in the demented patient in learning situa­
tions which may be stressful.
The retrieval process is strongly supported
Alzheimer’s patients have trouble not only encoding 
new information, but also in retrieving it from memory 
afterwards. To be successful, training needs to support 
the patient at both encoding and retrieval. Help with the 
encoding phase alone is not sufficient. Retrieval can be 
supported by providing cues or reminders at the time the 
new skills have to be used.
These four principles apply to interventions with 
Alzheimer’s disease, and some of them apply to other 
dementias as well. With vascular dementia it is more 
difficult to arrive at general principles because the pat­
tern of neuropsychological deficit will vary depending 
on the site of the lesions.
Environmental Design
Cognitive training programmes attempt to overcome 
disabilities by changing the patient. However, the effects 
of training are necessarily limited with a progressive 
disease. An alternative approach is to design the en­
vironment so that it supports and elicits the demented 
patients’ remaining skills without attempting to change 
the patient.
Environmental design is most appropriate in residen­
tial care facilities for demented people. In such en­
vironments, many design features have been proposed 
to accommodate the cognitive limitations of demented 
residents.58 For example, a major problem for 
demented people moving from their own homes to a 
residential care facility is learning the way around the 
new environment. Choosing the correct door to a 
bedroom can be facilitated by using a special bright col­
our for each resident, a name on the door in large let­
ters, and a photograph. Doors for use by staff only, or 
for exit from the facility, can be camouflaged into the 
wall of a corridor or hidden by a curtain. At night, 
residents who wander can be guided in their choices by 
use of lighting, with dim lights in corridors and brighter 
lights in destinations such as toilets. In one innovative 
residential care unit, the problem of spatial disorient­
ation was overcome by using an open-plan design in 
which residents can see all important areas from 
wherever they may be standing.59 Residents can always 
see the dining room, lounge, kitchen, bathroom, door
to their own room, and exit to the outside garden. Only 
when they are in their own room do tesidcnis lack sight 
of these choices.
Since demented people have trouble adjusting to 
change, a shift to a new residential care environment 
could result in a loss of skills such as knowing how to 
get to the toilet, or where clothing is kept. This can be 
minimized by carrying over as much as possible the 
features of the earlier environment. For example, fur­
niture can be brought from home and arranged in the 
familiar way. Other furniture, appliances, and fittings 
should be of an older style familiar to residents rather 
than of a modern type.
Managing Disturbed Behaviour
Despite the importance of disturbed behaviour as a 
component of disability in dementia, its management 
has attracted little research attention. A recent review of 
knowledge about management of common behavioural 
disturbances in Alzheimer’s disease (agitation, aggres­
sion, screaming, wandering, and depression/apathy) 
found a dearth of controlled evaluations of either 
behavioural or pharmacological methods of manage­
ment.60 There are, however, several examples of the suc­
cessful application of behaviour modification techni­
ques to such problems. One such programme attempted 
to manage depression in Alzheimer’s patients by train­
ing care givers to increase the rate of activities which the 
demented person found pleasant.61 The programme 
brought about improvements in depressed mood in 
several patients. A behavioural approach has also been 
used to modify the verbal interactions of patients with 
vascular dementia.62 Spouses were trained to reinforce 
desirable responses and ignore undesirable responses. In 
one case the reinforcement programme reduced the fre­
quency of accusing and suspicious statements, while in 
another it increased the frequency of spontaneous talk. 
Another behaviour modification programme has suc­
ceeded in restoring and maintaining continence in 
demented nursing-home residents.63 The success of 
these programmes should encourage the development of 
programmes to manage other aspects of disturbed 
behaviour.
Some behavioural disturbances may also be managed 
through appropriate environmental design. For exam­
ple, in some residential care units wandering is channell­
ed by creating corridors and outside paths with circular 
routes rather than dead ends. Points of interest and ac­
tivities can be located along the circular routes to attract 
the wanderer’s attention. Such environments attempt to
place minimal rest riet ions on the wanderer, and so 
avoid frustration, while still providing safety and 
sec in ily.
PHARMACOLOGICAL TREATMENTS
A decade ago it appeared that Alzheimer’s disease 
might be amenable to treatment by neurotransmitter 
enhancement therapies analogous to those developed 
for Parkinson’s disease. There was particular interest in 
the cholinergic system, which is particularly deficient in 
Alzheimer’s disease and has major involvement in 
cognitive function. However, cholinergic enhancement 
therapies have not lived up to their early promise and 
have, at best, only small effects.64 It is now generally ac­
cepted that Alzheimer’s disease affects multiple 
transmitter systems. Research interest has shifted to 
other treatment possibilities such as nerve growth fac­
tor. As in so many other areas of dementia research, 
most attention has gone to the pharmacological treat­
ment of cognitive impairment, with the development of 
treatments for disturbed behaviour relatively neglected.
Conclusion
There is an ageing of the population in both the 
developed and developing countries of the world. 
Because the prevalence of dementia rises steeply in old 
age, the number of dementia cases is also likely to in­
crease, and this would produce a consequent increase in 
disability. The best solution to this problem would be to 
prevent the onset of dementia. With vascular dementia 
this is currently possible, and is likely to be occurring at 
the present time. However, too little is known about 
environmental risk factors for Alzheimer’s disease to 
allow the development of preventive programmes. This 
is obviously a priority area for research.
Primary prevention provides a potential for action in 
the long term, but any effects would take decades to be 
seen. If, for example, certain industrial exposures or 
dietary items were established to be risk factors for 
Alzheimer’s disease, and the public was advised to avoid 
these exposures, the benefits might not be seen until peo­
ple who are presently young or middle-aged reach old 
age. A shorter-term approach would be to use an 
understanding of the mechanisms of dementing diseases 
to interfere with the disease process. Such an approach 
is presently possible with vascular dementia using anti­
platelet drugs. Greater understanding of the molecular
biology of Alzheimer’s disease could potentially lead to 
a similar intervention for this disease.
Tor the present, rehabilitative efforts involving the 
design of supportive environments and the management 
of disturbed behaviour provide the best possibility for 
reducing disability in dementia. Unfortunately, these 
approaches lack the glamour of basic biomedical 
research with its promise of future cures, and have not 
received the attention from researchers they deserve.
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Abstract
An investigation was carried out of psychiatric and behavioural symptoms in 
non-demented and demented subjects derived from a population study of the 
very elderly. Information on psychiatric and behavioural symptoms came 
from two independent sources; a physician's examination and an interview 
with an informant. The symptoms were grouped into clusters using principal- 
components analysis. Little agreement was found between the two sources of 
information on symptoms of anxiety, depression and psychosis. However, 
there was agreement about an increase in inactivity symptoms as the severity 
of dementia increased.
Introduction
Dementia is a complex syndrome involving both cog­
nitive dysfunction and psychiatric symptoms. Thus, there 
exists the opportunity to correlate psychiatric distur­
bances with cognitive function. The cognitive dysfunc­
tion seen in dementia is slowly progressive in its course, 
while the pattern of psychiatric symptoms is more com­
plex. The heterogeneity of the symptoms makes them d if­
ficult to classify according to diagnostic criteria [1], and 
no consensus exists concerning the prevalence, phenome­
nology and implications of these symptoms. Most interest 
has been focussed on depresssion, for differential diagno­
sis and as a coexistent disorder. Several studies have 
shown a lower frequency of depression in more advanced
stages of dementia, but there is still no consensus regard­
ing depressive symptoms in different stages of dementia 
[2-6], A major problem is the definition of depression 
and the symptoms which are to be included.
Studies of anxiety symptoms in dementia are scanter. 
A recent study involving only mild dementia showed a 
slight increase as cognitive functions declines [7],
Studies of the relationship between paranoid ideation, 
hallucinations and dementia have shown variable results. 
A major unresolved question is whether such symptoms 
should be considered as reflecting a psychotic disorder or 
as part of the process of cognitive failure [8].
Earlier studies of depression and psychosis have been 
recently reviewed by Wragg and D ilip [9]. Their conclu­
sion was that the selection of the study material as well as
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the methods of assessing psychiatric symptoms will have 
a major influence on the results obtained. In the studies 
reviewed, samples were drawn from the entire spectrum 
of psychiatric and medical settings on the basis of various 
inclusion criteria. What has been lacking is a study based 
on a representative sample of the elderly population. Fur­
thermore, the sample size has often been rather small, 
with a median of 33 cases.
Another reason for variable results may be the source 
of information about the psychiatric symptoms. Studies 
have been based on data from either the demented sub­
ject, an informant or a combination of both sources. 
Mackenzie et al. [10] have suggested that differences in 
results are partially due to different policies in the collec­
tion and integration of informant data in the diagnostic 
process.
The present study is based on the Kungsholmen pro­
ject, an ongoing longitudinal population based study in 
Stockholm, Sweden [11]. Since this study is based on a 
total population, it overcomes the problem of subject 
selection faced in previous studies. Furthermore, infor­
mation on psychiatric symptoms has been collected both 
directly from physicians' examinations of the subjects 
and from independent interviews of informants.
The aim of this paper is to report on psychiatric symp­
toms in the different stages of severity of dementia and to 
compare the information from informants with the data 
from the direct clinical examination.
Methods
Data from the Kungsholmen study were used. This study is based 
on a population aged 3*75 years, and includes all inhabitants living 
in a part of Stockholm, Sweden. The methodology for this stud} has 
been fully described elsewhere [11]. Briefly, the study involved a two- 
phase design. In the screening phase, the Mini Mental State Exami­
nation was used and all subjects who scored <23(314 persons) and a 
comparable random sample with 5^24 (354 persons) were selected 
for further examination. The second phase included an extensive 
clinical examination by physicians and nurses, cognitive tests and a 
structured family interview. The diagnosis of dementia and of types 
of dementing disease was made using DSM-I1I-R with some moditi- 
cations. A category of'questionable dementia' was added for subjects 
who fulfilled all the criteria of dementia except for evidence of loss of 
social functioning. In addition, a category of 'uncertain type of 
dementia' was added for cases w'here information about the onset 
and the course of the disease was missing or insufficient. Staging of 
disease severity was made using the Clinical Dementia Rating (CDR) 
scale [12]. The outcome of the diagnostic procedure was that 225 
persons were identified with dementia and 443 were considered to be 
non-demented. The non-demented and demented came from both 
groups that had been selected from the total population.
The necessary information about the psychiatric symptoms was 
deriv ed from two sources. (1) Physicians who made a psychiatric 
examination using the Comprehensive Psvchopathological Rating 
scale (CPRS). The examination was carried out either by geriatri­
cians or a psychiatrist w ho had regular meetings to ensure rating con­
sis tent.  Reported symptoms and observed signs were rated on a 
6-point scale as described by Äsberg et al. [ 1 3] with a score of 3* 1.0 
being regarded as pathological. In addition to these CPRS items 
there were observed signs concerning depressiv e mood, and the pres­
ence of hallucinations and paranoid symptoms. Information was also 
collected about previous psychiatric disorders, both from subjects' 
self-reports and clinical records. (2) A nurse interv iewed the rela­
tives. or another close person, using questions covering the same 
areas as the physicians' examination. The responses to each question 
were recorded as yes. seldom or no. The informants were also asked 
about previous psychiatric history, although specific diagnoses were 
not recorded.
In order to reduce the large number of symptoms down to a 
smaller set of independent clusters, principal-components analysis 
was used.
Results
In order to compare the information derived from the 
physicians’ examination and the relatives' inten iew. only 
those subjects with data from both sources constituted the 
study base. There were 339 subjects who had complete 
data from the physicians' examination of psychiatric- 
symptoms and 291 who had complete informants' data 
on psychiatric symptoms. Of the 142 who had received 
the diagnosis of dementia. 84 had Alzheimer’s disease. 32 
vascular dementia and 26 other dementias. The mean age 
was 82 years.
Separate principal-components analyses were made 
with the information from the physicians and from the 
relatives. In the analysis of the physicians' data, a scree 
plot was used to determine the number of components 
that should be retained for \ arimax rotation. The first ten 
components accounted for 17.1,9.3. 7.4. 6.2.4.8. 4.3. 4.2. 
4.0. 3.7 and 3.6% of the variance, respectively. It was 
decided to retain only the first four for rotation.
An examination of the signs and symptoms with load­
ings of 5*0.4 on these four components showed the fol­
lowing: (1)A component of inactivity sy mptoms. The 
svmptoms were inability to feel, indecision, lassitude 
concentration difficulties, reduced speech, slowness o: 
movement and loss of affective reactivity . (2) A compo­
nent of depressive sy mptoms. The symptoms were de­
pressed mood, inability to feel, suicidal thoughts, ob­
served apparent sadness and slowness of movement. (3) 4 
component of anxiety symptoms. The sv mptoms w ere t 
feeling of anxiety, worrying over trifles, complaints abou
Table 1. I he correlation coefficients between components do­
m ed Irom the physicians' and the informants' data
Physicians' Informants’ factors
1 actors inactivity sleep anxiety psychotic
InaciiN it\ 0.39* -0.07 0.08 -0.02
(0.55**) (0.08) (0.06) (-0.08)
Depressive 0.06 0.19** 0.09 0.04
(-0.01) (0.06) (0.18) (0.10)
Anxiety 0.04 0.18** 0.25** 0.08
(0.13) (0.26**) (0.21**) (0.06)
Psychotic 0.08 0.18** -0.05 0.35**
(0.11) (0.03) (0.13) (0.13)
Values in parentheses relate to data from close relatives only. 
* p <  0.05: **p <  0.01 (2-tailed).
failing memory, reduced sleep and complaining of aches 
and pain. (4) A component of psychotic symptoms. The 
symptoms were suspiciousness, paranoia and hallucina­
tions.
In order to compare component scores across the 
course of dementia, one-way analyses of variance were 
carried out between the stages of severity. The differences 
across stages were evaluated using planned contrasts for 
linear and quadratic trends. Figure l shows the mean 
component scores in the different stages of dementia 
severity. For the inactivity component, there was a strong 
linear trend across stages [F(l. 334) = 185.45, p < 0.001 ]. 
reflecting the increase in inactivity scores across stages. 
There was also a smaller quadratic trend [F( 1,334) = 9.69, 
p <  0.01 ], due to the upward bowing of the curve. For the 
anxiety factor, there was a small linear trend due to a gen­
eral decrease in anxiety scores across stages [F(l, 334) = 
5.15, p <  0.05], and a stronger quadratic trend due to 
greater anxiety in the early stages of dementia than in 
either non-demented or severely demented subjects 
[F(l. 334) = 9.37. p <  0.01]. For the depressive and psy­
chotic components there were no significant differences 
across stages.
In the analysis of the informants' data, a scree plot was 
again used to determine the number of components that 
should be retained for varimax rotation. The first ten 
components accounted for 24.9, 9.6. 8.2. 7.2, 5.5. 4.9. 4.2. 
3.9. 3.6 and 3.4% of the variance, respectively. It was 
decided to retain only the first four components for rota­
tion. An examination of the signs and symptoms with 
loadings of ^0.4 on these four components showed the
following: (1) A component largely consisting of inactivit 
symptoms similar to those found in the physicians’ data 
The symptoms were less talkative, apathy, caring less fo 
others, indecision, lacking in initiative, physical aggre  ^
sion and depressed mood. (2) A component of sleepin 
disturbance symptoms such as difficulty in falling asleep 
insufficient sleep and early wakening. (3) A component c 
anxiety symptoms: feeling afraid, anxiety, and being wot 
ried. (4) A broad component of psychotic sy mptoms wit 
high loadings for suspiciousness, hallucinations, paranoi- 
symptoms, physical aggression, depressed mood and su 
cidal thoughts.
Figure 2 shows the mean component scores from th 
informants' data across the different stages of dementi 
severity. For the inactivity component, the results were a 
for the physicians' data, with a strong linear increase i 
inactivity across stages [F(l. 286) = 247.53. p <  0.001 
and a smaller quadratic trend reflecting a bowing in th 
curve [F(l. 286) = 11.90. p < 0.001]. For the psychoti 
component, there was a linear increase [F( 1. 286) = 7.4( 
p <  0.01 ]. and a quadratic trend because psychotic symp 
toms were reported to be higher in early dementi 
[F( 1. 286) = 5.62. p <  0.05], For the anxiety componen 
there was a linear increase with severity [F( 1.286) = 4.8.' 
p <  0.05], while for the sleep component there were n 
significant differences across stages.
The four components from the physicians' data an 
from the informants' data are correlated in table 1. It ca 
be seen that the correlations are small, although many ai 
statistically significant. The best agreement was betwee 
the two inactivity components and the two psychot 
components. When only data from close relatives (leg. 
and de facto spouses and children) were considered, tr 
agreement was better for the inactivity component 
However, it was poorer for the psychotic component 
mainly because subjects with psychotic symptoms tende 
not.to have close relatives.
When the correlations were examined in the demenu 
persons separately , the physicians' inactivity componei 
was found to correlate 0.35 with the relatives' inactivi 
component, while the correlation between the physiciar 
and relatives was higher (0.65) for the psychotic comp 
nent. The relatives' sleep component correlated signit 
cantly with the physicians' anxiety and psy chotic comp' 
nents (correlations of 0.40 and 0.31. respectively).
There was also a weak correspondence between th 
physicians' and informants' reports of a previous histor 
of psy chiatric disorder. According to the physicians, 
subjects had a previous history of psychiatric disorde 
but 59 of these had a negative history from the info
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Non- Question- Mild Moderate Severe 
demented able
Fig. 1. The variation of psychiatric and behavioural s> mptoms in 
different stages of dementia. Data from the physicians" ratings. 
•  = Inactivity; ■ = depressive; o = anxiety; □ = psychotic.
mants. According to the informants. 53 had a previous 
history of psychiatric disorder, but 26 of these were nega­
tive according to the physicians.
Discussion
When looking at the results obtained from the physi­
cians. the symptoms were related to each other as in gen­
erally accepted clinical syndromes. These were a typical 
inactivity syndrome as seen in dementia, a depressive 
syndrome, an anxiety syndrome and a syndrome of psy­
chotic symptoms. It is notable that the symptoms that 
loaded on the inactivity component would generally be 
considered as indicating depression in a younger person. 
However, these symptoms showed an increase with sever­
ity of dementia, unlike the symptoms on the pure depres­
sion factor. These findings are consistent with the obser­
vations of Burke et al. [ 14] and Mackenzie et al. [10] who 
concluded that these symptoms reflected dementia rather 
than a separate depression.
The symptom clusters derived from the informants' 
data corresponded in some respects to those of the physi­
cians. but there were also some important differences. 
The depressive component did not exist for the infor­
mants. Rather, it was divided up and the symptoms 
loaded on a specific sleep component as well as on the 
inactivity and psychotic components. Despite the broad 
similarity between the components derived from the phy­
sicians' and informants’ data, the correlation between the
Non- Question- Mild Moderate Severe 
demented able
Fig. 2. The variation of psychiatric and behavioural sy mptoms in 
different stages of dementia. Data from the informants" ratings 
•  = Inactivity; ■ = sleep; o = anxiety: □ = psychotic.
two sets o f components was small. The correlations were 
small both for the whole sample and the demented sam­
ple. The best agreement was on inactivity and on psy­
chotic symptoms. Similarly, for previous history of psy­
chiatric disorder, the agreement between the physicians 
and the informants was weak. These results imply that 
different sources of information cannot be regarded as 
equivalent. Nevertheless, there was a consistent finding of 
increased inactivity with severity of dementia with both 
the physicians' and the informants' data. However, these 
data are cross-sectional and there is a need for longitudi­
nal follow-up in order to see the development of the symp­
toms in the same individuals.
The present study also shows the need for a clearer def­
inition o f the symptoms of depression in old age. When 
the physicians’ ratings were considered, some depressive 
symptoms were found to load on an inactivity component 
which was related to severity of dementia, while others 
loaded on a separate pure depression component. Further 
work is needed to determine symptoms which are linked 
to dementing diseases, to depression per se. and to the 
group with a combined disorder.
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We report here the results of a studs of the 
family history of subjects who took part in a 
case control study of AD between 19X6 and 
1989 (Broe et al. 1990; Henderson et al. 1992) 
Results from the original study indicated that a 
family history of AD in first-degree relatives was 
a significant risk factor for developing AD (odds 
ratio = 3 9). There were no differences in the 
odds ratios for early and late onset cases. In 
1990, informants of 207 subjects from the 
original study were re-interviewed. The purpose 
was to obtain detailed information on the dates 
of birth and death of the subject's parents and 
siblings, to establish whether any had suffered 
dementia or AD and. if so, the age at onset of 
the disorder. This provided the information 
necessary to analyse the cumulative incidence of 
AD and total lifetime risk among first-degree 
relatives and to compare different groups of 
relatives. Questions of the reliability and bias of 
the family history method originally used were 
also addressed. We present here the results of 
the analysis of the re-interview' data and the 
comparison with the initial study.
METHOD
A case-control study of AD was undertaken in 
two Sydney hospitals (Broe et al. 1990). One 
hundred and seventy persons were clinically 
diagnosed by either of two neurologists (H.C. 
and E. McC.) as cases of AD. 83 being ‘ probable" 
and 87 being ‘possible’ by the NINCDS- 
ADRDA criteria (McKhann et al. 1984). An 
equal number of controls was recruited at 
random from the same or neighbouring general 
practice as each case, and were matched for age 
and gender. The controls were examined in their 
homes by one of the neurologists and excluded 
if they had a Mini-Mental State Examination 
(MMSE) (Folstein et al. 1975) score of less than 
26. could not be interviewed in English, or had 
no suitable informant for risk factor assessment 
Informants were mostly spouses, siblings or 
offspring.
As part of the risk factor assessment, the 
informants of both cases and controls were 
asked to identify all first-degree relatives of the 
subjects and then to report whether each relative 
had a history of ‘severe memory loss, mental 
confusion or dementia, even in the last year or
two of life'. Informants were asked about a 
number of disorders in the relatives (heart 
disease. Down's syndrome, blood cancers, thv- 
roid disorders) as well as memory loss. To keep 
cases, controls and their informants blind to the 
purposes of the study, they w'ere asked to 
participate in a Health Study of the Elderly '. 
From the descriptions given of relatives with 
memory loss, each was classified as most likelv 
having AD. multi-infarct dementia (MID), 
mixed AD and MID. other dementia or no 
dementia. Where there w-as at least one first- 
degree relative with likely AD or mixed AD and 
MID. an index case was regarded as 'familial', 
otherwise as ‘sporadic'.
The second interview was limited to a study of 
the dementia status of parents and siblings only. 
The original informants w'ere sent a letter 
explaining that this study w'as concerned with 
memory disorder and dementia in the elderly 
and requesting their cooperation in a forth­
coming telephone interview. A family history 
form, similar to that used in the original study, 
w'as sent with the letter and they were requested 
to complete it with the years of birth and death 
of the subject's parents and siblings. They were 
told that the interviewer would be asking about 
relatives' problems with memory or daily 
functioning and were invited to consult with 
other family members or friends to obtain the 
information being sought. The respondent was 
then telephoned and an interview form com­
pleted. Questions covered were; whether any 
relative had ever had Down's syndrome, a stroke 
with or without paralysis. AD. dementia, or any 
symptoms such as mental confusion. se\ere 
memory loss, loss of the ability to read or write, 
difficulty finding words, speaking nonsense, loss 
of self-care or marked personality change. Where 
there was some doubt about any issue, in­
formants were asked to provide the name of 
another potential informant who was subse­
quently contacted. From the descriptions pro­
vided on both the initial interview and the 
telephone follow-up. a consensus rating was 
then made by six of us. as to the dementia status 
of each relative: no dementia, AD. AD plus 
other dementia such as MID. MID. or other 
dementia. The raters were blind to the case 
control status of the subject. Because of resource 
limitations we were unable to re-interview the 
complete sample In order to ensure a good
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coverage for the purposes of the cumulative 
incidence analysis, we therefore concentrated 
on those whose initial interview's had had the 
fewest information gaps.
We were particularly concerned to obtain 
accurate estimates of onset ages among de­
mented relatives. Onset was defined to be the age 
when informants first noticed cognitive or 
behavioural changes, which is difficult to es­
tablish in individuals who may have been dead 
for many years. We have used the 1 best ’ estimate 
of onset age provided by an informant. For 
cases with doubtful onset ages, we also defined a 
‘youngest probable age at onset' and an ‘oldest 
probable age at onset’, as well as a ‘best’ 
estimate, and compared estimates of the cumu­
lative incidence using these different onset age 
estimates or simply using age at death or current 
age as the onset age.
Statistical analysis
All statistical analyses were made using SAS- 
6.06. Matched-pair odds ratios were estimated 
using PROC LOGIST, and exact confidence 
limits w'ere calculated using the equations given 
in Breslow & Day (1980). Cumulative incidence 
curves w'ere calculated using Kaplan-Meier 
estimation (PROC LIFETEST); differences be­
tween curves were tested using the log-rank 
tests; and differences between risk estimates 
w'ere tested using large sample Z-tests.
RESULTS
There were 91 case and 116 control informants 
who completed the telephone re-interview. Con­
tact was attempted with a further 5 controls and 
10 cases, w'ho either refused, could not be 
contacted or for whom no suitable respondent 
could be found. Every attempt was made to 
reach the same informant as at the initial 
interview. However, five of the case informants 
had since died, dementia was suggested in at 
least two, and illness, unavailability or un­
willingness meant that in all, 16 case informants 
(18%) were different at second interview. 
Among the controls, at least 10 of the original 
informants had died and some controls only 
agreed to participate if they could answer the 
questions themselves. In all, 38 control 
informants (33%) were different from initial 
assessment. For half of the interviews, 44 cases
and 58 controls, two or more respondents were 
consulted.
Comparison of data recorded at initial interview 
and re-interview
The total number of parents and siblings 
identified at the second interview was 1216. of 
w'hom 1055 had lived to at least age 50. There 
were very few differences between the tw'o 
assessments: seven extra siblings were identified, 
six of whom had died in infancy and the other 
had died, non-demented, aged 53; an adopted 
sibling, a step-sibling and a step-parent had been 
wrongly labelled, and two males had been 
wrongly called female. The method used to 
identify the relatives would therefore seem to 
have been quite comprehensive and reliable.
The years of birth and death were obtained 
for each relative on each occasion. At re­
interview. dates were obtained for 17 of the 20 
relatives with unknown dates initially. For 109 
relatives (9%) there was a change of more than 
one year in the dates given. The mean age at 
death, however, did not change.
The telephone interview used questions which 
were more probing than in the initial interview', 
and additional informants were also contacted 
in an effort to identify every relative who may 
have demented Comparisons between ratings 
made on the two occasions for individual 
relatives are showm in Table 1. In all. 15 
additional control relatives were classed as
Table 1. Dementia status allocated at initial 
interview compared to that given a! re-interview 
for all relatives identified on each occasion
Initial interview
Re-interview None
A D /
mixed
MID/
other
Don't
know Total
a. Relatives of controls 
None 602* 3 0 45 650
AD or mixed 9 8 0 "> 19
M ID  or other 4 1 3 0 '
Total 615 12 3 47 6 "
b Relatives of cases
None 433+ •) 1 24 460
AD or mixed 17 40 5 5
M ID or other 10 0 2 0 12
Total 460 42 8 29 5?°
* Includes four relatives who developed AD and three -vho
developed MID between interviews
t  Includes six relatives w ho developed AD and tw o w ho developed 
MID between interviews
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Table 2. Comparison o f family history status o f 
subjects at initial interview and re-interview
Initial interview
Re-interview
Family
history
No known 
family history Total
a Controls*
Family history 5 6 1 1
No known 4 101 105
family history
Not assessed 8 46 54
Total 17 153 170
b. Casest
Family history 31 17 48
No known 0 43 43
family history
Not assessed 21 58 79
Total 52 118 170
* Kappa among those assessed on both occasions = 0 45; 
McNemar's ,y2 among those assessed on both occasions = 01.
+ Kappa among those assessed on each occasion = 0-63; 
McNemar's among those assessed on both occasions =151
demented (11 AD and 4 MID) and 3 who had 
been called AD initially were classed as having 
no dementia. Among the case relatives, an 
additional 32 were classed as demented (22 AD 
and 10 MID), while 2 who had AD according
Table 3. Family history of AD among first- 
degree relatives. Matched-pair odds ratio and 
95% confidence limits for initial interview and re­
interview
Initial interview Re-interview'
All subjects*
Parents and 
siblings
All subjects
3 4 (1 3 8 7) 15 0 (5 1-43-8)
Parents only 2-2 (0 8-6 2) 13 0 (4 3-39 4)
Siblings only 
Onset!
7/0(1 4 -oc) 7/0 (2-0-x )
< 75 (26 pairs) 16 (0 5—4 8) 8 0(2 3-7-5)
> 75 (26 pairs) 9/0 (2 0-oc) 14/0 (0-3-co)
Apraxic cases 
(31 pairs)tt
2 0 (0-6-6 5) 7 0 (2-0-25 0)
Non-apraxic 
cases (27 pairs)tt
9 0(1 6-49 4) 15/0 (3 6-oc)
* Based on the 62 matched pairs who were re-inierviewed. 
t Family history based on AD in both parents and siblings.
I Apraxia defined as the inability to write a sentence in the 
MMSE. Four pairs excluded because MMSE item not attempted.
to the initial interview were classed as non- 
demented.
Among the 59 relatives identified as having 
dementia on both occasions, age at onset was 
initially unknown for 9. At the second interview,
Fig 1 Cumulative incidence and approximate 95% confidence limits for first-degree relatives of cases (*) and controls (O )
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Age at onset
Fig 2 Cumulative incidence for first-degree relatives of earlier-onset cases (*. < 75 years) versus later-onset cases
( 0 . 2  75 years).
however, an estimate was made for 8 of these 9 
relatives. Ages at onset as reported on each 
occasion were similar, the intra-class correlation 
coefficient being 078.
Subjects were regarded as familial if one or 
more of their parents and siblings had AD or 
mixed AD. Table 2 compares their ratings at 
each interview. At re-interview, there were 11 
controls with a family history of dementia 
compared with 9 initially. Four controls changed 
their classification between interviews from 
familial to non-familial, while 6 others changed 
from being non-familial to familial. There were 
17 additional cases identified as familial at re­
interview, so that 53% of the sample of cases 
had at least one first-degree relative with AD. 
No cases originally identified as familial were re­
classified at follow-up.
Estimates of risk at initial interview and re­
interview
Table 3 provides a summary of the matched-pair 
odds ratios for a family history of AD or mixed 
AD, based on the 62 case-control pairs assessed 
at both interviews. The odds ratios at re­
interview are considerably higher than at the 
initial interview reflecting the fact that extra
relatives suffering from AD were discovered 
among the case families more than among the 
control families.
There were no significant differences between 
the odds ratios for parents versus siblings of 
cases, early versus late onset cases, or for apraxic 
versus non-apraxic cases, at either initial or 
second interviews.
Cumulative incidence
The cumulative incidence of Alzheimer's disease 
among relatives of the cases and controls is 
reported for data collected on the 207 families 
assessed at the telephone re-interview.
Fig. 1 shows the cumulative incidence curves 
for relatives of cases and controls. The cumu­
lative incidence for case relatives is significantly 
higher than that for control relatives. At age 88 
years, the risk to control relatives was 0 13 
(s.E. = 004). while for relatives of cases it 
was 0-32 (s.E. = 0-04) at age 88. reaching 0 81 
(s.E. = 015) by age 99.
The comparison of later-onset with earlier- 
onset cases is shown in Fig. 2. where earlier- 
onset is defined as onset before age 75. There 
were no significant differences, either in the 
shape of the curve or for differences in the total
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lifetime risk at age 88, the highest age for which 
there were AD relatives in both earlier and later 
onset categories. For relatives of earlier-onset 
cases, risk was 045 (s.F. = 0 10) and for the 
relatives of later-onset cases it was 0 27 (s.r. =
0 05). Age at onset for AD in affected relatives 
was correlated with that of the proband 
(/ = 0 25, P = 0 03), explaining the paucity of 
older onset relatives of earlier onset cases.
There was no difference between the cumula­
tive incidence curves for relatives of apraxic 
versus non-apraxic cases, contradicting the 
original findings of Breitner & Polstern (1984) 
and Breitner el al. 1986). Following these 
authors, cases who attempted but were unable 
to write a sentence in the MMSE were regarded 
as apraxic, and only cases with illness duration 
of at least 4 years were considered. The 
examining neurologist had also coded each case 
for the presence or absence of apraxia or 
aphasia based on observation during the clinical 
examination. Taking these ratings'instead of the 
MMSE ratings, there were again no significant 
differences between the cumulative incidence 
estimates for the aphasic/apraxic group versus 
others.
There were no significant differences between 
the cumulative incidence curves for male 
relatives versus female relatives; for relatives of 
male cases versus relatives of female cases; for 
parents of cases versus the siblings of cases; or 
for relatives of ‘probable' AD cases versus 
‘possible' AD cases.
Cumulative incidence curves for all cases 
using different onset age estimates were also 
compared. The curves using the three different 
estimates of onset age are very close, while the 
curve using age at death or current age is shifted 
only slightly to the right until age 83, reflecting 
the survival of AD relatives after onset. Final 
lifetime risk estimates range from 074 to 0 91 at 
age 99. but are not significantlv different.
DISCISSION
Reliability of family history data
The family history method adopted in the 
case-control study has been shown to be a 
reliable method for identifying first-degree 
relatives and for determining their dates of birth 
and death.
The initial method of assessing the dementia
status of relatives, however, would seem to have 
under-estimated the number of AD relatives 
quite significantly. Out of 1216 relatives 
identified on the two occasions, there were only 
about 5 out of 54 who were classed as AD 
initially and judged non-AD at re-interview, 
while an extra 33 were classed as AD only at re- 
mterview.
The choice of subjects with minimum in­
formation gaps for re-interview was made so as 
to maximize the amount of information available 
for the calculation of cumulative incidence 
curves. Agreement, therefore, is for subjects w'ho 
can typically be included in family history 
studies since families with large information 
gaps would not be used, although it is possible 
that agreement is higher than w'ould have 
been obtained had the full sample been re­
interviewed. There were no significant differences 
between the subjects who were followed up and 
those who were not with respect to family 
history at initial interview. Among the cases 
followed up. 34% (31/91) had a positive family 
history, w'hile among those not followed up. 
there were 27 % (21/79). Among the controls. 
8% of those followed up (9/116) had had a 
positive family history recorded at initial in­
terview, compared with 15% (8/54) among 
those not followed up. It is also likely that any 
bias would be the same for cases and controls, 
since they were selected on the same basis. 
However, informants at second interview were 
more likely to be different from those at first 
interview for the controls rather than for the 
cases. This could explain lower agreement for 
the controls on familial status.
There are several possible explanations for the 
increased number of AD relatives. In the initial 
risk factor interview', questions about family 
history came at the end of a two-hour ques­
tionnaire given to informants who were often 
elderly themselves. Especially as there has been 
no indication that dementia was a principal 
focus of the study, a "don’t know'" or "no" 
response could have been an easy way to hasten 
the end of a tiring interview. In the re-interview, 
the focus of the study w'as explained to all 
respondents. This could have resulted in more 
complete information but may also have led to 
some undesirable bias: case informants couid 
perhaps find a family history a conventional 
and convenient way to "explain' the illness and
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so over-report the number of affected relatives. 
Control informants, on the other hand, may 
under-report because of lack of awareness, 
although an increased awareness of AD in the 
community could explain the extra control 
relatives identified as AD at re-interview. Ad­
ditional AD relatives were possibly identified 
because the more detailed questions on the 
symptoms helped informants differentiate de­
mentia from frailty among the very old. For the 
re-interview other family members were con­
sulted. In this way it was hoped to avoid a 
problem found at the initial assessment when 
spouses and siblings provided more complete 
family history information than did offspring. 
Silverman el al. (1986) reported an improvement 
in the reliability of family histories when using 
multiple informants in this way. A number of 
informants also indicated that since the time of 
the first interview they had been engaged in 
investigating their family tree and were quite 
adamant as to the superiority of the new data.
While every effort was taken to obtain 
accurate diagnosis, it is certain that some errors 
exist for both the probands and their relatives. 
The resulting bias could either increase or 
decrease the final risk estimates.
Family history as a risk factor for AD
A family history of AD was confirmed as a risk 
factor at re-interview: the matched pairs odds 
ratio for a family history of AD was significant 
at 15 0. Although a total of 116 controls and 91 
cases were assessed at re-interview, there were 
only 62 complete pairs of the original 170 which 
could be used to calculate the matched pair 
odds-ratios. In order to take advantage of all 
data collected at re-interview, we also calculated 
the odds ratios ignoring matching for all 207 
subjects. The resulting odds ratios were similar 
in magnitude to the values for the matched 
pairs. Although confidence limits were narrower, 
the lower confidence limits were very similar.
Cumulative incidence and lifetime risk
The familial nature of AD was also confirmed in 
the significantly higher values of cumulative risk 
among first-degree relatives of cases compared 
with first-degree relatives of controls, for all ages 
at risk.
The values for lifetime risk by age 90. 
estimated for both the initial assessment and the
follow-up, are within the ranges found by other 
investigators (Larsson et al. 1963; Breitner. 
1984; Breitner el al. 1986; Martin et al. 1988; 
Farrer et al. 1989, 1990; Sadovnick et al. 1989; 
Mayeux et al. 1991). If most cases of AD were 
due to the actions of an autosomal dominant 
gene, then cumulative incidence would tend 
asymptoticalK to 0 55 with age (Breitner et al. 
1986: Huff et al. 1987; Mohs et al. 1987; Farrer 
et al. 1990; Mayeux et al. 1991). There is no 
evidence from our data of an asymptote, and the 
estimates increase dramatically for the oldest 
ages to well above 0 55. The small numbers of 
the very elderly, however, mean that lifetime risk 
estimates have very large confidence limits. The 
estimate of total lifetime risk of 0 81 (s .e. = 0.15) 
is not significantly different from 055 (r = 
1-733) Point estimates of total lifetime risk for 
the very elderly are unstable, being sensitive to 
small changes in sample composition and they 
can change considerably with the inclusion or 
exclusion of only one or two cases of AD, or 
with the use of a different onset age estimate. 
Because of large standard errors, however, these 
differences are usually not significant. Unless 
larger samples of those surviving to extreme old 
age can be studied, estimates of total lifetime 
risk are of doubtful value. Models can be 
extended to include other factors, but those 
which estimate the proportion of cases which 
are autosomal dominant and the proportion due 
to other factors such as shared environments or 
polygenes (Breitner et al. 1986; Farrer et al. 
1989) must remain highly speculative without 
improved estimates of tola) lifetime risk, gene 
frequencies and penetrance.
We were unable to replicate the finding that 
familial aggregation was more common among 
earlier-onset cases than among later-onset cases. 
Our cases had a mean onset age of 74-2. and so 
w'ere of later onset than other samples which 
have been studied. Farrer et al. (1990) studied a 
series of kindreds with familial AD. Among 
early-onset cases, defined as having onset before 
age 58. familial aggregation was greater at 
younger ages, but cumulative incidence showed 
evidence of an asymptote and reached 0 53 b\ 
age 80. which is consistent with a model of 
autosomal dominance. Among relatives of their 
later-onset cases, however, cumulative incidence 
showed no asymptote and reached a value ot 
86% b\ age 87. which was significant!} higher
u P i  w
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than the value of 0 53 for early-onset cases. 
Their ‘later-onset’ case series is comparable 
with our whole case series, which showed a 
similar cumulative curve, reaching 0 81 by age 
99. Farrer el al. suggested that although some of 
the late-onset cases may be due to an autosomal 
dominant trait, some may be caused by other 
genetic or shared environmental factors.
We identified those cases which showed 
prominent clinical features of aphasia and 
apraxia, and whose dementia had lasted at least 
four years. Breitner el al. (1986) have suggested 
that these features should be used to identify 
cases arising from the action of an autosomal 
dominant gene. There was. however, no excess 
of AD among the relatives of these cases, thus 
providing no support for their hypothesis.
There were no significance differences between 
the lifetime risks among relatives of female cases 
compared with those of male cases, nor any 
differences between risks to female relatives 
compared to male relatives as would occur if a 
sex-linked gene were implicated. There were also 
no differences between the risks to parents and 
siblings of cases, as would occur if there were 
systematic under-reporting of AD parents due 
to lack of knowledge.
A problem with the analysis of cumulative 
incidence of AD in relatives of probands is the 
difficulty in specifying an age at onset (Breitner 
& Magruber-Habib, 1989). Various suggestions 
have been made as to how to deal with this 
situation: analysis could be limited to those 
relatives who could be examined in person or 
for whom medical records were available 
(Sadovnick el al. 1989); age at onset could be 
ignored altogether and current age or age at 
death taken (Mayeux et al. 1991); or adjustments 
could be made to the estimation process to allow 
for the degree of uncertainty in the age estimates, 
or the degree of uncertainty in the classification 
of the relative as AD or not (Farrer et al. 1989). 
We have used a ‘best’ estimate of onset age, 
which is sometimes little more than an informed 
guess on the part of an informant or the 
interviewer and based on rather scanty in­
formation. The age at onset was sometimes 
presented in the form o f ' 5 to 10 years before she 
died \  o r ' w hen he w;as in his early nineties' o r ' 1 
suppose he would have been about 80'. The 
distribution of age at onset show s some charac­
teristic bunching at 5- and 10-year intervals.
which is reflected in the cumulative incidence 
curv es where jumps in the incidence at 80 and 90 
years of age are obvious (see Fig. 1). However, 
estimates of the cumulative incidence using 
different onset age estimates are very similar 
The curve using age at death or current age is 
shifted slightly , but not significantly, to the right 
of the others up until about age 83. Estimates of 
risk above age 90 are more variable, but standard 
errors are large due to the small number of 
survivors among the very old.
In studies to date, the very few surviving 
relatives among the very old have meant that 
standard errors in the estimates of total risk are 
large. Problems associated with the diagnosis of 
AD in the very old relatives will be exacerbated 
by the presence of other disorders or general 
frailty, and could lead to greater bias in the 
estimates of risk compared to those for younger 
ages. For studies involving younger AD cases, 
many relatives will not have lived through the 
period of risk and so numbers will be small 
among the very elderly. Studies involving much 
larger samples are needed before conclusions 
can be drawm on total lifetime risk and levels of 
risk to the very old, and on the roles of genetic 
and environmental factors in the aetiology of 
AD.
We extend our thanks to Mrs Jill Groth. of the 
Department of Geriatric Medicine. University of 
Sy dney, who contacted the informants and conducted 
all the telephone re-interviews.
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Dementia is a major psychiatric disorder in the elderly, with the prevalence rate rising steeply 
with age. A meta-analysis of dementia prevalence studies found an average prevalence of less than 
1% in the 60-64 age group, rising to 39% in the 90-94 year age group (Jorm et al., 1987). Similarly, a 
pooling of data from recent European prevalence studies found a rate of 1% in the 60-64 age group, 
rising to 32% in the 90-94 age group (Hofman et al., 1991). Less is known about the incidence of 
dementia, but this also appears to rise steeply with age (Jorm, 1990). Because of the ageing of the 
populations of developed countries, the number of dementia cases in these countries is expected to 
increase at a very fast rate, far exceeding the rate of total population growth (Jorm et al., 1988). 
Dementia is also one of the major causes of disability in the elderly (Akhtar et al., 1973; Kay et al., 
1991) and a major reason for needing institutional care (Manton & Stallard, 1991). The disorder not 
only causes disability in its victims, but also distress in carers and it is a major financial burden for the 
whole community. These facts make it clear that the development of preventive strategies is a matter 
of urgency.
Dementia is a syndrome which is associated with many different diseases. However, by far the 
most common diseases responsible for dementia are Alzheimer's disease and cerebrovascular disease. 
Whether Alzheimer's disease or vascular dementia has the greatest prevalence varies from country to 
country. In Caucasian populations, Alzheimer’s disease is more common than vascular dementia, 
whereas in China and Japan the pattern is reversed (Jorm, 1991). The present chapter begins with an 
examination of the possibilities for preventing these two common dementing diseases and then 
considers the prevention of the rarer dementing diseases.
APPROACHES TO PREVENTION
The best guide to prevention is an understanding of the cause and pathological mechanism of a 
disease. It may then be possible to remove the cause or interfere with the pathological processes 
leading to the disease. However, even when the causes are not understood, it may be possible to 
identify risk factors for a disease and base prevention around the modification of these risk factors. Of 
course, this strategy has its limitations. Not all risk factors are modifiable (eg. family history of 
disease) and even those that are modifiable may not exert any causal influence on the disease, because 
not all risk factors are aetiological agents. With dementing diseases, the degree of scientific
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understanding of their aetiology varies. For some of the rarer dementing diseases, the causal 
mechanisms are fairly well understood, whereas for the common dementing diseases, present 
understanding is far more rudimentary.
In discussing prevention of dementia, it is necessary to be clear about what goals are achievable. 
For many diseases, successful prevention implies the elimination of disease over the life-span of an 
individual. This is clearly the case with infectious diseases. Up until recent times, infectious diseases 
were a major cause of death. A reduction in the incidence of fliese diseases has led to an increased life 
span and an increasing prevalence of chronic diseases of ageing, including the dementias. The 
common dementing diseases show a sharp increase with age in both prevalence and incidence. They 
appear to be closely linked to ageing processes and would be difficult to eliminate. For the 
foreseeable future, the most reasonable goal is the postponement of these diseases to later in the life 
span. Prevention can be said to have occurred if dementia can be postponed so that it does not occur 
over the individual's life span. Even if dementia occurs at a later age, the individual benefits by 
having additional years free of disability.
PREVENTION OF ALZHEIMER’S DISEASE
Over the past decade, research on Alzheimer's disease has expanded considerably. There have 
been important advances in understanding the causes and pathological mechanisms of the disease, as 
well as a growth in knowledge about risk factors. The implications of both these areas of research for 
prevention is discussed below.
Progress in Understanding of Disease Mechanisms
The classic neuropathological hallmarks of Alzheimer's disease are the senile plaque and 
neurofibrillary tangle. Recent biomedical research on the disease has focussed on understanding die 
origin of the senile plaque (Selkoe, 1991). The senile plaque consists of altered axons and dendrites 
surrounding deposits of amyloid protein. The chemical structure of this amyloid protein has been 
determined and it has been found to be a fragment of a larger precursor protein. The amyloid 
precursor protein is imbedded in the cell membrane and must play an important role in cell
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functioning. The gene for the amyloid precursor protein has been located on chromosome 21. In a 
small proportion of cases of early-onset Alzheimer's disease, there is an autosomal dominant pattem of 
inheritance. In some of these families, a mutation of the amyloid precursor protein gene has been 
found. Thus, one of the causes of Alzheimer's disease has been discovered. However, the cause of the 
vast majority of cases still remains unknown. It has been estimated that mutations of the amyloid 
precursor protein gene account for only 0.5% of Alzheimer's disease cases and, even with early-onset 
familial Alzheimer's disease, only 10% of cases (Hardy, 1992).
Research into the second neuropathological hallmark of Alzheimer's disease, the neurofibrillary 
tangle, has been less prolific. Neurofibrillary tangles occur within neurons and appear to be 
composed, at least in past, of cytoskeletal proteins (Anderton, 1988). The protein called lau, which is 
involved in microtubule assembly, has been found to be an important constituent. While tangles have 
received less attention than plaques, their accumulation in the brain more closely parallels the 
progression of dementia than does the deposition of plaques (Arriagada et al., 1992).
What are the implications of this research for prevention? The small percentage of cases due to a 
mutation of the amyloid precursor gene could be prevented through genetic testing and fertility 
control. For the majority of cases, however, this research presently provides no preventive strategy. 
Nevertheless, there has been speculation that it might eventually be possible to prevent Alzheimer's 
disease by interfering with the deposition of amyloid or removing the earliest para-amyloid aggregates 
from the brain (Masters, 1992). Such a strategy would be difficult to implement because the 
deposition of amyloid takes place over a period of decades and would require a long-term intervention. 
Even if amyloid deposition could be prevented, it is not certain that this would be beneficial. Regland 
and Gottfries (1992) have hypothesized that deposition of amyloid is not the central event in 
Alzheimer's disease, but a secondary process. They argue that the amyloid precursor protein could 
have a critical role in facilitating cell growth and repair. According to this view, the accumulation of 
amyloid occurs as part of a protective mechanism in response to neuronal injury. Mutations of the 
amyloid precursor gene could thus cause Alzheimer's disease by reducing the chances of cell survival. 
If this hypothesis is correct, then attempts to alter the deposition of amyloid could have unfortunate 
effects.
Risk Factors for Alzheimer's Disease
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A large number of potential risk factors for Alzheimer's disease have been investigated, but the 
evidence on many of these has been inconclusive. A landmark in the investigation of risk factors was 
the EURODEM collaborative re-analysis of case-control studies in which data were pooled from nine 
studies with comparable methodology (Van Duijn & Hofman, 1991). This data pooling allowed a 
more powerful evaluation of potential risk factors than had previously been possible. Here the 
evidence is reviewed concerning those factors which are either confirmed or possible risk factors.
Old age. Old age is by far the most important risk factor for Alzheimer's disease. The prevalence of 
Alzheimer's disease rises exponentially with age, at least up to age 90 (Jorm et al., 1987). Beyond age 
90, little information is available. The incidence of Alzheimer's disease has been less extensively 
investigated than prevalence, but also appears to support an exponential rise with age (Jorm, 1990).
Family history of dementia. There is consistent evidence that this is a risk factor for Alzheimer’s 
disease. In the EURODEM data pooling (van Duijn et al„ 1991), individuals with a first-degree 
relative who had dementia had 3.5 times the risk of Alzheimer's disease (95% confidence interval 2.6- 
4.6). However, the risk varied according to the age of onset of Alzheimer's disease, with early-onset 
cases (aged under 70) more likely to have a family history of dementia than later-onset cases. The risk 
of Alzheimer’s disease was also found to increase with the number of affected relatives. Individuals 
with one affected first-degree relative were found to have 2.6 times the risk (95% confidence interval 
2.0-3.5), while those with two or more affected relatives had 7.5 times the risk (95% confidence 
interval 3.3-16.7).
Down's syndrome. It is now accepted that nearly all individuals with Down's syndrome develop senile 
plaques and neurofibrillary tangles by the age of 40 (Wisniewski et al., 1985). The early appearance 
of Alzheimer neuropathology appears to be due to a gene dosage affect, because Down's syndrome 
involves an extra copy of the amyloid precursor protein gene found on chromosome 21. Given the 
near universal presence of Alzheimer pathology in Down's syndrome, it would be expected that such 
individuals would develop dementia at an early age. However, dementia does not develop until a 
much later age. Studies of large samples of Down's cases spanning a wide age range have found that
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cognitive decline does not generally begin until after age 60 (Silverstein et al., 1988; Zigman et al., 
1987).
Family history of Down's syndrome. In the EURODEM data pooling, an association was found 
between Alzheimer's disease and family history of Down's syndrome. Individuals having a first- 
degree relative with Down's syndrome were found to have 2.7 times the risk of Alzheimer’s disease 
(95% confidence interval 1.2-5.7) (van Duijn et al., 1991). This association is not understood, but one 
possibility is that Alzheimer's disease can be due to mosaicism for trisomy 21, leading to both 
overproduction of amyloid precursor protein and an increased risk of familial Down's syndrome 
(Potter, 1991).
Maternal age. Since advanced maternal age is the major risk factor for Down's syndrome, it has also 
been investigated as a potential risk factor for Alzheimer's disease. Most of the evidence has been 
negative, but a number of positive associations have been reported (Jonn, 1990). In the EURODEM 
analysis, data were pooled from four studies which examined maternal age and a small association was 
found (Rocca et al. 1991). If there is a true association with maternal age, it must be a small effect, 
not comparable with the strong association observed in Down's syndrome.
Fingerprint patterns. Down's syndrome cases are known to have a higher frequency of the ulnar loop 
fingerprint pattern. Researchers have sought to determine whether this difference also occurs in 
Alzheimer’s disease. The evidence is rather inconsistent, with some studies showing a strong link, 
others a link in certain subgroups of cases, and others no association at all (Jorm, 1990). If an 
association does exist, then it could be due to mosaicism for trisomy 21 in some Alzheimer cases.
History of head trauma. In the EURODEM pooled analysis, individuals with a history of head trauma 
involving loss of consciousness were found to have 1.82 times the risk of developing Alzheimer's 
disease (95% confidence interval 1.26-2.67) (Mortimer et al., 1991). Head trauma occurring in the 
decade before onset conferred much greater risk than head trauma earlier in life (relative risks of 5.33 
and 1.63 respectively). While the pooled analysis showed a clear association, in all but one of the
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studies, history of head trauma was assessed by reports of relatives rather than by medical records. It 
is possible that relatives of cases may recall more head trauma in an effort to explain the dementia. A 
large cohort study of patients with medically documented head trauma has found no increased risk for 
Alzheimer's disease (Williams et al. 1991). By contrast, a 30-year longitudinal study of head trauma 
patients has shown that they have greater cognitive decline in later years, although not to such an 
extent as to be diagnosed as demented (Corkin et al. 1989). It has recently been found that an incident 
of major head trauma can lead to extensive deposition of amyloid protein in the cortex, giving greater 
theoretical plausibility to a link between head trauma and Alzheimer's disease (Roberts et al., 1991).
Boxing may also be a risk factor for Alzheimer's disease. Boxing has traditionally been thought to 
be a cause of dementia pugilistica a separate dementing disease characterised pathologically by 
numerous neurofibrillary tangles but absence of plaques. However, recent research has shown that 
dementia pugilistica cases also have diffuse amyloid plaques. This finding suggests a common 
pathogenic mechanism between Alzhiemer's disease and dementia pugilistica (Roberts et al., 1990).
History of depression. The EURODEM data pooling showed that individuals with a history of 
depression had 1.82 times the risk of developing Alzheimer's disease (95% confidence interval 1.16- 
2.86) (Jorm et al., 1991). This association held both for episodes of depression in the decade before 
onset of Alzheimer's disease as well as for episodes earlier in life. Most of the studies included in the 
EURODEM data pooling used reports of relatives to ascertain history of depression. However, one 
study used medical records and this study found an association in its own right. Nevertheless, the 
association needs to be confirmed in prospective studies of cohorts with a documented history of 
depression. If the association is real, then it could be due to an overlap in the neurotransmitter systems 
disrupted by Alzheimer's disease and by depression. Alternatively, depression is known to produce a 
subtle cognitive deficit, so that individuals with a history of depression may more quickly reach the 
threshold for appearance of dementia in old age. A third possibility, supported by considerable animal 
research (Sapolsky et al., 1986), is that depression affects the secretion of glucocorticoids and 
hypersecretion of glucocorticoids can cause hippocampal degeneration. Loss of hippocampal cells is a
characteristic feature of Alzheimer’s disease.
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Aluminium exposure. Aluminium has excited considerable interest as a potential risk factor, based on 
the observation that it is present in senile plaques. It is also known that exposure of the brain to 
aluminium, in both animals in humans, produces a toxic effect. However, the resulting 
encephalopathy is different from Alzheimer's disease, both clinically and neuropathologically 
(Hughes, 1989). Despite these differences, interest in aluminium as a risk factor has continued.
Because aluminium is one of the most abundant elements in the earth's crust, some exposure is 
inevitable. Average daily intake of aluminium has been estimated at 20.5mg, with 20mg coming from 
food, 0.5mg from fluid intake and .01 mg from inhalation (Lancet, 1992)
A potentially major dietary source is antacids, many of which contain aluminium. Taking such 
antacids might lead to ingestion of several hundred milligrams per day, far greater than any other 
source. However, all of the many studies which have looked for an association between antacid intake 
and Alzheimer’s disease have produced negative results (Jorm, 1990).
Another focus of epidemiological research has been aluminium in drinking water. A number of 
studies have examined whether regions with a high aluminium content in drinking water also have a 
higher incidence of dementia. While some positive associations have been found, these have involved 
rather unsatisfactory measures of incidence, such as dementia listed on death certificates (Flaten,
1987), dementia detected by CT scan units (Martyn et al„ 1989) and hospital discharge diagnoses 
(Neri & Hewitt, 1991). Studies using more adequate methods of case ascertainment have had mixed 
results (Forbes et al. 1991; Michel et al., 1991; Weltstein et al., 1991). The final verdict on the role of 
aluminium in drinking water must await more evidence.
Ingestion of aluminium through inhalation has received little attention because typical intake is so 
small. However, a study of miners who inhaled aluminium powder to prevent the lung disease 
silicosis did find that it led to an increased incidence of cognitive impairment (Rifat et al., 1990). 
However, Alzheimer's disease was not specifically investigated.
Even if aluminium exposure is not a cause of Alzheimer's disease, it could play a secondary role, 
accumulating in the brain as a result of the disease. There is some evidence that individual's with 
Alzheimer's disease have an increased absorption of aluminium (Taylor et al., 1992) and one study has 
found evidence that administration of an aluminium chelator slows progress of the disease (McLachlan
etal., 1991).
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I Ivpothyroidism. In the EURODEM pooled analysis, hypothyroidism was found to be associated with 
Alzheimer's disease, with a relative nsk of 2.3 (95% confidence interval 1.0-5.4) (Breteler et al.,
1991). Although hypothyroidism can itself cause cognitive deficit, misdiagnosis is unlikely because 
the average length of time between onset of hypothyroidism and onset of dementia was 20 years. 
Nevertheless, this finding needs replication in cohort studies of hypothyroidism cases. If the effect is 
real, it could be due to the role of thyroid hormone on nervous system maturation (Breteler et al.,
1991).
Inactivity, it is a common lay belief that keeping active will help slow decline in old age. However, 
because Alzheimer's disease produces increased apathy and inertia it is necessary to distinguish 
reduced activity as a prodromal feature of the disease from its possible role as a risk factor. 
Nevertheless, there is a limited amount of evidence supporting physical and/or mental inactivity 
earlier in life as a risk factor.
Only one case-control study has looked at inactivity as a risk factor for Alzheimer's disease. In 
this study it was found that cases were more likely to have had a physically inactive lifestyle, both in 
the decade preceding the study and earlier in life (Broe et al., 1990). Inactivity in the past decade is 
likely to be a prodromal feature, but earlier inactivity cannot be explained in this way. The association 
could be due to memory bias in informants who were influenced by the cases' current inactivity. The 
finding requires replication.
Further supporting evidence comes from a 20-year longitudinal study of twins (La Rue & Jarvik, 
1987). This study found that twins who became demented were less active 20 years previously in 
physical, household and creative pursuits. However, when the effects of age and education were 
statistically controlled, the only remaining risk factor was greater engagement in passive activities 
such as listening to the radio, watching TV and reading. Because this difference was present 20 years 
earlier, it is unlikely to be a prodromal effect. However, this study examined dementia rather than 
Alzheimer's disease specifically.
In addition to this evidence on dementia, there is research on normal ageing showing that 
participation in leisure activities (Huppert, 1991), and maintenance of an engaged lifestyle (Schaie,
10
AFJ
1984) may be important in maintaining cognitive skills in old age. Swaab (1991) has reviewed 
physiological evidence to support the notion that use of nerve cells leads to their maintenance in 
ageing and Alzheimer's disease. This is in contrast to cells in other organs of the body which tend to 
be damaged through use.
Possible Protection Factors
While some factors may increase risk for Alzheimer's disease, there is evidence that other factors 
are protective.
Arthritis. McGeer et al. (1990) have suggested that rheumatoid arthritis may be protective for 
Alzheimer's disease. They hypothesised that a protective effect could arise because of the use of anti­
inflammatory drugs in rheumatoid arthritis. They found a low prevalence of Alzheimer's disease in 
cases of rheumatoid arthritis and, conversely, a low prevalence of rheumatoid arthritis in cases of 
Alzheimer’s disease. However, the samples they studied lacked control groups. The EURODEM data 
pooling found no association between rheumatoid arthritis and Alzheimer's disease, but osteoarthritis 
was protective (relative risk = 0.7; 95% confidence interval 0.5-1.0) (Breteler et al., 1991). The 
EURODEM analysis also found a protective effect for headaches (relative risk = 0.7; 95% confidence 
interval 0.5 - 1.0). Since both osteoarthritis and headaches are commonly treated with anti­
inflammatory drugs, these findings support McGeer et al.'s (1990) hypothesis. However, cohort 
studies of anti-inflammatory drug users are needed to confirm this effect.
Smoking. The EURODEM analysis found a 22% reduction in risk for Alzheimer's disease in 
individuals who had ever been smokers (95% confidence interval for relative risk 0.62-0.98) (Graves 
et al. 1991). A dose-response relationship was also observed. A protective effect of smoking is 
theoretically plausible, because Alzheimer's disease involves a reduction in nicotinic receptors and the 
use of nicotine can increase the number of these receptors. However, a subject selection artefact in 
case-control studies also provides a plausible explanation. The clinical diagnosis of Alzheimer's 
disease requires the exclusion of cerebrovascular disease. Since smoking is a risk factor for 
cerebrovascular disease, Alzheimer's cases who are smokers will tend to be excluded from case-
control studies.
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Prevention Through Risk Factor Modification
On the evidence available to date, only three risk factors for Alzheimer's disease can be regarded 
as confirmed: old age, family history of dementia and Down's syndrome. These risk factors do not 
provide great scope for preventive action. In principle, familial Alzheimer's disease could be 
prevented through genetic counselling and fertility control, but in the vast majority of cases this would 
not be justifiable. Because Alzheimer’s disease generally begins only late in life, individuals with a 
genetic risk can expect to live most of their lives free of disability and may die from other causes 
before onset of dementia. For individuals with an affected first-degree relative, the risk of developing 
Alzheimer’s disease by age 90 is only around 50% (Mayeux el al., 1991). The exception might be the 
rare families with an autosomal dominant pattern of inheritance and onset in middle age. These 
families present similar issues to families with a history of Huntington's disease and genetic 
counselling would be an option to consider. Similarly, Down's syndrome births are preventable 
through chromosomal testing and abortion of affected foetuses, although the ethical issues involved 
are not simple. Because Down's syndrome involves major disability at all stages of life, the possibility 
of additional dementia late in life is not likely to be a major factor influencing parents’ decisions on 
whether to accept having a Down's child.
The other risk factors reviewed above require further evidence before they can be accepted, but it 
is instructive to consider the potential they offer for prevention. The four "possible" risk factors with 
potential for modification are head trauma, depression, hypothyroidism and aluminium exposure.
In considering the preventive impact of modifying a risk factor we need to consider the 
aeliological fraction, which is the proportion of cases in a population attributable to the exposure. 
Assuming the risk factor has a direct causative effect on Alzheimer's disease, the aetiological fraction 
tells the proportion of cases which would be prevented by removing the risk factor from the 
population. The aetiologic fraction can be calculated from the relative risk and an estimate of the 
proportion of the population exposed to the risk factor (Schlesselman, 1982). The benefit of removing 
a risk factor is greater when it has a strong association with the disease (a large relative risk) and it is a 
common exposure in the population. Estimates of these two quantities are provided by the
EURODEM pooled data.
12
AFJ
I:or head trauma, it can be estimated that around 4% of cases of Alzheimer's disease could be 
attributable to this exposure. The public health impact of eliminating head trauma would therefore be 
small, but definitely of value for such a common disease as Alzheimer's. However, reduction of the 
incidence of head trauma is a worthy public health goal in its own right and many countries have 
introduced laws to achieve this (eg. drink driving laws, compulsory seat belts). The possibility that 
reducing the incidence of head trauma might also reduce the incidence of Alzheimer's disease provides 
further support for these measures. Furthermore, the possibility that boxing is a risk factor for 
Alzheimer's disease bolsters the case for further control of this practice.
For history of medically-treated depression, the estimated aetiologic fraction is 3%. Thus, 
eliminating severe depression, if this were ever feasible, could have an impact on Alzheimer's disease 
similar to eliminating head trauma. However, depression is also a disorder which merits treatment in 
its own right and is already the focus of considerable attention. It is doubtful that establishing a 
definite link between history of depression and Alzheimer's disease would lead to any changes in 
current efforts, but an understanding of the mechanism behind the link might suggest further 
possibilities.
From the EURODEM data, it can be estimated that hypothyroidism might account for around 1 % 
of Alzheimer's disease cases. The effect of eliminating hypothyroidism on the incidence of 
Alzheimer’s disease would therefore be small, but nevertheless of some public health significance. 
However, the elimination of hypothyroidism is again a worthy goal in its own right which is already 
being pursued.
The potential contribution of eliminating aluminium exposure is difficult to estimate without 
specifying the source of exposure. If drinking water is the source, then exposure to aluminium is very 
common and even a small relative risk would be of public health significance. However, it is not 
possible to estimate an aetiologic fraction because the available evidence is based on differences 
between geographical districts rather than individual exposure. If inhalation of aluminium powder 
were the source of exposure, then exposure in the population would be rare and its elimination would 
have only a minuscule impact on disease incidence.
Aluminium could be involved in Alzheimer's disease as a secondary accumulation rather than as a 
cause. Nevertheless, this accumulation might exacerbate the disease and a reduction of exposure
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would consequently be of benefit to individuals who are already affected. One study has suggested 
that use of tin aluminium chelator may retard progress of Alzheimer's disease and so be of use in 
secondary prevention (McLachlan et al., 1991). Ilais finding needs replication, but even so, the 
treatment is rather demanding, involving twice-daily intramuscular injections over a period of two 
years. Moreover, the value of secondary prevention with dementia could be questioned if it led to an 
extension of life in a state of disability.
Although there is currently only weak support for mental and physical inactivity as risk factors, 
they potentially allow considerable scope for preventive action. This possibility is embodied in the old 
adage "Use it or lose it". Increasing the level of physical and mental activity in the population will 
certainly do no harm and may have intrinsic benefits in its own right, even if it proves ineffective in 
fending off dementia.
In addition to these possible risk factors, there is some evidence to support two protection factors: 
smoking and arthritis. Looked at another way, not smoking and not having arthritis can be viewed as 
possible risk factors and their potential for modification examined.
From the EURODEM data, not smoking is only a weak nsk factor, but it is a very common 
exposure. It can be estimated that around 10% of cases of Alzheimer’s disease might be eliminated if 
the whole population smoked. This is a fairly large public health impact, but it is of no practical 
importance. Because smoking is a cause of several other diseases and has a major impact on 
morbidity and mortality, any benefit which might accrue to incidence of Alzheimer's disease could not 
be justified. Furthermore, as discussed below, smoking may be a risk factor for vascular dementia, 
thus promoting dementia in another form. Nevertheless, there has been some benefit claimed for 
nicotine as a treatment for Alzheimer's disease (Sahakian et al., 1989) and this merits further research.
Although there is some evidence that a history of arthritis or severe headaches is protective, 
neither are readily modifiable and so provide no direct opportunity for prevention. If, however, the 
protective effects are due to use of anti-inflammatory drugs such as aspirin, this would have preventive 
implications. Even if these drugs had only a modest protective effect, widespread use across die 
whole elderly population could have an important public health impact. Of course, any benefit would 
have to be weighed against potential side effects. There is also some evidence, reviewed below, that 
aspirin can play a therapeutic role in vascular dementia through its anti-platelet action.
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PREVENTION OF VASCULAR DEMENTIA 
ITogress in Understanding of Disease Mechanisms
Vascular dementia is a generic term covering all dementias attributable to cerebrovascular 
disease. The taxonomy of vascular dementia is in a state of confusion, with several separate diseases 
having been proposed over recent years, but no general agreement on the usefulness of diese 
classifications.
A major step in understanding of vascular dementia was the abandonment of the notion that 
cerebrovascular disease caused dementia through a slow strangulation of the brain's blood supply. In 
1974, Hachinski and colleagues reviewed the evidence that strokes rather than chronic ischaemia are 
the cause of dementia. They coined the term multi-infarct dementia which has come into widespread 
use. Hachinski and his colleagoues also systematized the clinical diagnosis of multi-infarct dementia 
by devising a scale for the scoring of signs and symptoms.
More recendy, the advent of CT and MRI scans has provided a direct window on cerebrovascular 
disease and has had a major impact. These scans allowed the observation of small lacunar infarcts 
which were not previously detectable and led to a disdncdon between muld-infarct dementia (due to 
large infarcts) and lacunar dementia. However, there has been dispute about whether multiple lacunes 
do cause demenüa (Scheinberg, 1988).
Brain imaging has also led to an upsurge in the diagnosis of Binswanger's disease, a dementing 
disorder caused by ischaemic white matter changes. A review of pathologically confirmed cases of 
Binswanger's disease revealed only 47 cases in the world's literature (Babikian & Ropper, 1987). 
However, brain imaging has shown periventricular white-matter changes which have been interpreted
the Binswanger type and suggested that it was the most common dementing disease after Alzheimer’s 
disease. However, the validity of radiologically-diagnosed Binswanger’s disease has been disputed. 
Morris et al. (1990) were able to do a post-mortem examination of white matter changes identified by 
MRI. They found no evidence of ischaemic damage and attributed the changes to an accumulation of 
water in certain white-matter regions.
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Another type of vascular dementia has been proposed by Sulkava and Erkinjuntti (1987). They 
hypothesized that this dementia is due to cardiac arrhythmias and hypotension leading to cerebral 
hypoperfusion. One incident of hypoperfusion is thought to be capable of producing dementia.
Sulkava and Erkinjuntti called this proposed dementia vascular dementia of the haemodynamic type.
Given this state of taxonomic confusion, it is hardly surprising that an understanding of disease 
mechanisms does not suggest much for preventive action. A major exception is the realisation two 
decades ago that stroke rather than chronic ischaemia is the major cause of vascular dementia. This 
revolution in understanding suggested that successful preventions for stroke will also generally be 
effective for vascular dementia.
Preventive Effects of Anti-Platelet Treatment
A notable area where knowledge of disease mechanisms has been used to guide prevention is in 
the use of anti-platelet treatments. Platelet aggregation plays an important role in thrombosis, so anti- 
platelet drugs have been used to inhibit this process.
Two major trials have been carried out to assess whether anti-platelet treatment can help in the 
primary prevention of stroke. In Britain, a randomized trial of prophylactic daily aspirin has been 
carried out with over 5000 healthy male physicians (Peto et al., 1988). Over a six-year period, no 
beneficial effect was found in the prevention of vascular diseases. In fact, stroke incidence was 
marginally higher in the group receiving treatment. In the United States, a preventive study has been 
carried out with over 20,000 male physicians (Steering Committee of the Physicians' Health Study 
Research Group, 1989). This study used a randomized double-blind placebo-controlled design. Over 
a five-year period, some reduction was found in the incidence of heart attack, but the incidence of 
stroke was marginally higher. The results of these two large trials clearly show that aspirin is not 
useful in the primary prevention of stroke in individuals who are at low risk.
However, anti-platelet treatment does seem to be of value in the secondary prevention of stroke in 
patients with a history of vascular disease. A meta-analysis has been carried out on 25 randomized 
trials of anti-platelet treatments used on patients with a history of transient ischaemic attacks, stroke, 
angina or myocardial infarction (Antiplatelet Trialists' Collaboration, 1988). This analysis showed a 
reduction by a quarter in the incidence of non-fatal strokes. Several different anti-platelet agents have
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been studied, but the meta-analysis found no difference in their effectiveness. Studies of aspirin also 
used different doses, but this had no effect on outcome, 'rhe authors of the meta-analysis therefore 
concluded that aspirin in a dose of not more than 300-325 mg/day is the cheapest and most convenient 
treatment.
The overall conclusion from these studies appears to be that anti-platelet treatment is useful for 
the secondary prevention, but not the primary prevention, of stroke. However, the majority of 
participants in the primary prevention trials were middle-aged rather than elderly. Given that the 
elderly are at high risk of stroke, it is possible that anti-platelet treatment might be effective in primary 
prevention for their age group (MacMahon & Sharpe, 1991).
If anti-platelet treatment is effective for the secondary prevention of stroke, it is reasonable to 
expect it to be also useful for secondary prevention of vascular dementia. Two small trials have 
shown such an effect. Kellett (1988) earned out a trial comparing aspirin (600mg twice weekly), 
cyclandelate (a peripheral vasodilator) and placebo in 31 elderly subjects with vascular dementia 
living in the community. Subjects received 6 months on each treatment. Both treatments were found 
to be superior to placebo in preventing further vascular incidents. The effect of the treatment on 
cognitive performance was not evaluated. Meyer et al. (1989) randomly assigned 70 vascular 
dementia patients to receive either aspirin (325mg/day) or no treatment. Duration of participation in 
the trial varied, with an average of 16 months for the aspirin group and 15 months for the controls. 
Treatment was found to produce improved cognitive performance and cerebral blood flow. These two 
small trials give grounds for optimism, but it is important that future trials evaluate the quality of the 
patients' lives. If secondary prevention were to add further years of disabled and dependent living, 
then there may be litde gain in slowing down the progression of vascular dementia.
Risk Factors for Vascular Dementia
Risk factors for vascular dementia have not been researched as much as those for Alzheimer's 
disease. However, risk factors for stroke have been more thoroughly researched and it can be 
presumed that these will also generally be risk factors for dementia. Nevertheless, there could be 
differences. Risk factors for strokes which result in dementia could conceivably differ from risk 
factors for strokes which do not. Furthermore, there could be different risk factors for different types
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of vascular dementia. Epidemiological studies have generally not distinguished types of vascular 
dementia, so this possibility cannot be evaluated.
The Stroke Council of the American Heart Association has classified the following as well- 
documented risk factors for stroke: age, gender, familial factors, race, diabetes mellitus, prior stroke, 
asymptomatic carotid bruits, hypertension, cardiac disease, transient ischaemic attacks, elevated 
haemocrit and sickle cell disease (Dyken et al„ 1984). The Council regarded only the last five of 
diese as being modifiable risk factors. In a more recent review, Marmot and Poulter (1992) have 
proposed the following as risk factors for stroke: ethnic group, social class, blood pressure, serum 
cholesterol, smoking, overweight, plasma fibrinogen, diabetes, ventilatory function, oral 
contraceptives, diet (high sodium, low potassium) and alcohol. Some of these factors have also been 
investigated in relation to vascular dementia. Stroke risk factors which also have some evidence to 
support them as risk factors for vascular demenda are reviewed below.
Old age. Old age is by far the most important risk factor for vascular dementia. The prevalence of 
vascular dementia rises exponentially with age, at least up to age 90 (Jorm et al., 1987). Less is 
known about the incidence of vascular demenda, but it also rises steeply with age (Äkesson, 1969; 
Hagnell et al., 1983; Mölsä et al., 1982).
Family history. There is evidence that both family history of vascular dementia (Äkesson, 1969) and 
family history of stroke (Jarvik & Matsuyama, 1983) are risk factors for vascular dementia.
Race. The incidence of vascular demenda is probably greater in Japan and China than in countries 
with predominantly Caucasian populadons (Jorm, 1991). The high incidence of stroke in Japan 
appears to be due to environmental factors, in pardcular diet (Omura et al., 1987).
Hypertension. Hypertension is a strong risk factor for vascular demenda (Ladumer et al., 1982; St 
Clair & Whalley, 1983). It plays a particularly strong role in Binswanger's disease. A review of 
pathologically confirmed cases found that 98% were hypertensive (Babikian & Ropper, 1987). There 
is also much evidence dial hypertension is associated with poor cognidve function, independent of its
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role in stroke. Deficits in hypertensives have been found most clearly with tests of memory, abstract 
reasoning and attention (Waldstein et al., 1991).
Diabetes. Diabetes mellitus has been found more commonly in vascular dementia cases than in 
normals (Meyer et al., 1988).
Blood cholesterol. The association between cholesterol and vascular dementia is not clearcut. Overall 
cholesterol levels do not appear to be related to vascular dementia (Meyer et al., 1988), but levels of 
high-density lipoprotein cholesterol have been found to be lower in several studies (Frkinjuntti et al., 
1985; Muckle & Roy, 1985; Zanetti et al., 1985).
Smoking. Smoking has been found to be more common in vascular dementia cases compared to 
normals (Meyer et al., 1988; Pinessi et al., 1983).
Prevention Through Risk Factor Modification
Vascular dementia gives much greater scope for preventive action than Alzheimer's disease. 
Hachinski (1992) has recently called for concerted action in the prevention of vascular dementia, 
claiming that it is the "only major cause of dementia that is preventable" (p.645). The potential for 
prevention is underlined by historical trends in stroke mortality and incidence which show substantial 
declines (Bonita, 1992). While declining stroke incidence would be expected to produce a 
corresponding decline in vascular dementia, there is little evidence on the issue. The only study on 
historical changes found no difference in incidence of vascular dementia between 1947-57 and 1957- 
72 (Rorsman et al., 1986), but this study has methodological limitations.
Of the risk factors reviewed above, the ones with potential for modification are hypertension, 
cholesterol, diabetes and smoking. It has been shown that health education programmes aimed at a 
whole community can successfully lower blood pressure and cholesterol and reduce smoking 
(Farquhar et al., 1990).
Control of hypertension gives the greatest scope for intervention. Several long-term clinical trials 
have found that anti-hypertensive medications produce a reduction in stroke incidence (Gifford, 1989).
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The benefits of lowering blood pressure are seen in elderly patients as well as younger ones. A 
potential limitation of anti-hypertensive drugs is that some of them have harmful effects on cognitive 
function (Starr & Whalley, 1992). Such effects will be more serious in patients who already have 
some cognitive impairment. In mildly hypertensive individuals non-drug treatments are more 
appropriate. There is evidence supporting the usefulness of weight control, physical exercise, reduced 
salt and alcohol intake and a potassium-rich diet in control of hypertension (Phillips & Whisnant, 
1992). Although there is evidence that blood pressure can be lowered and that this is beneficial to 
stroke incidence, no studies have specifically looked for effects on incidence of vascular dementia. 
Only a small study of secondary prevention has examined the benefits of risk factor modification in 
vascular dementia patients (Meyer et af, 1986). This study found a variable outcome in those patients 
treated for hypertension, with some showing improved cognitive functioning and others declining.
The patients who declined were found to have a lower systolic blood pressure after treatment than 
those who improved. The authors of this study concluded that there is an optimal window for systolic 
blood pressure and that patients whose treatment takes them lower than this could deteriorate.
The benefits of controlling blood cholesterol and diabetes are unclear. There is controversy about 
reducing cholesterol in order to reduce stroke incidence (Donnan, 1991) and there is presently no 
evidence on the issue of whether reducing cholesterol, or altering the ratio of high-density to low- 
density cholesterol, would affect vascular dementia. Similarly with diabetes, it is uncertain whether 
control of blood sugar levels reduces the vascular complications of the disease (Donnan, 1991).
It is likely that control of smoking would be beneficial for the incidence of vascular dementia. 
However, the only direct evidence on the matter comes from Meyer et al.'s (1986) study of secondary 
prevention. They found that normotensive patients who gave up smoking showed significantly 
improved cognitive performance compared to those who continued.
PREVENTION OF OTHER DEMENTIAS
There are a large number of other diseases which can result in dementia. Considered here are 
some of the more prominent.
Alcoholic Dementia
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Alcoholic dementia differs from most other dementias in that it is defined in terms of an 
environmental aetiological factor rather than a brain pathology. A major contribution to alcoholic 
dementia is the Wemicke-Korsakoff syndrome which involves memory impairment. This syndrome is 
known to be caused by thiamine deficiency due to inadequate diet in alcoholics. In addition, alcohol 
may have a direct neurotoxic effect, possibly being the cause of loss of neurones from the frontal 
cortex and other changes seen in the alcoholic brain (Harper, 1988).
By definition, alcoholic dementia can be totally prevented by abstaining from alcohol. Since 
alcohol use differs considerably among cultures, the prevalence of alcoholic dementia is also likely to 
differ. The consumption of alcohol within a population can also vary over time. In Australia, for 
example, consumption of alcohol rose from 1960 to the 1970s and then began to decline. Mortality 
from alcohol-related causes paralleled the change in consumption (Department of Community 
Services and Health, 1988). It is not known whether such historical changes are due to health 
education or other factors, but they do show that consumption patterns are modifiable.
Preventive efforts can also be aimed at the component of alcoholic dementia due to thiamine 
deficiency. One solution which has been proposed is the supplementation of flour or bread with 
thiamine. In some countries, bread is supplemented with thiamine (e.g. USA and Britain), but in 
others it is not (e.g. Australia). However, Price et al. (1987) have found that problem drinkers 
consume too little flour or bread for this to be effective. By contrast, they calculated that 
supplementation of alcoholic beverages such as beer would provide the required intake. Even without 
supplementation of food, Wemicke-Korsakoff syndrome could be prevented by encouraging problem 
drinkers to take thiamine supplements. Price et al. (1987) have suggested that public education may 
be effective in getting problem drinkers to take these supplements. They studied use of thiamine 
supplements by problem drinkers in Australia following media publicity about the possibility of 
supplementing beer. Australian drinkers were found to be taking the supplements much more 
commonly than those in Britain where there was no publicity. However, use of the supplements was 
found to decline subsequently, suggesting the need for continuing public education if supplements are 
to be an effective preventive measure.
Dementia in Parkinson's Disease
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Individuals with Parkinson's disease can develop a dementia. There is little agreement about how 
common this is. An American population based survey found that 41% of Parkinson's disease cases 
were demented (Mayeux et al., 1992) whereas a similar Japanese survey found only 17% (Okada et ah, 
1990). Clinic-based studies of dementia in Parkinson's disease have shown similarly variable findings. 
The mechanism of dementia in Parkinson's disease is controversial, with some believing that it is due 
to coexistent Alzheimer's disease (e.g. Boiler et ah, 1980) and others seeing it as a subcortical 
dementia quite different from Alzheimer's disease (eg. Cummings & Benson, 1983).
Nothing is known about risk factors for dementia in Parkinson's disease. However, dementia 
occurs more often in later-onset cases of Parkinson's disease (Mayeux et ah, 1992; Reid, 1989), which 
appears to support the view that coexistent Alzheimer's disease is a factor. By contrast, risk factors for 
Parkinson's disease in general have been extensively investigated (Tanner, 1991). Genetic factors 
appear to be of minor importance in Parkinson's disease, as concordance in twins is low and close 
relatives are not at increased risk. Various environmental factors have been investigated. There is 
some evidence to support a role for industrial chemicals such as pesticides and herbicides, but this link 
is not established. If a specific environmental exposure could be linked to Parkinson's disease, this 
would have important implications for prevention.
Senile Dementia of the Lewv Body Type
This type of dementia has only recently been identified in neuropathological series. It is 
characterized by Lewy body formation in the brain stem and cerebral cortex (Perry et al., 1990). 
Clinically, the syndrome is characterized by fluctuating cognitive impairment, often accompanied by 
hallucinations and delusions and repeated falls (McKeith et al., in press). Extrapyramidal features are 
not prominent. It may be part of a spectrum of Lewy body disease, with predominantly subcortical 
Lewy bodies leading to Parkinson's disease and predominantly cortical Lewy bodies to senile 
dementia. Nothing is known about the epidemiology of this syndrome, although it may be relatively 
common, constituting up to 20% of a neuropathological series (Perry et al., 1990). Consideration of 
possible preventive strategies must await risk factor studies.
Huntington's Disease
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Huntington's disease is known to be a genetic disorder with autosomal dominant inheritance. In 
recent years, a method of preclinical diagnosis has become available based on genetic markers closely 
linked to the gene for Huntington's disease. The test has a 5% inaccuracy and is only applicable where 
an affected family member is alive and willing to participate. The availability of this test has 
preventive potential because it allows at-risk individuals to make more informed decisions about 
reproduction. Shaw (1987) has stated that "Armed with today's technology, it is now possible to begin 
to eradicate the Huntington gene from our species" (p.243). Before testing became routinely available, 
a number of surveys were carried out with individuals at 50% risk for Huntington’s disease (Kessler et 
al., 1987; Market et al., 1987). These surveys showed that most wished to take the predictive test and 
a positive result would influence the decision to have children. Fewer said they would use prenatal 
diagnosis or terminate a pregnancy if the foetus was found to carry the gene. However, actual 
experience with the test found that demand was much less than expected, with females more likely to 
take the lest than males (Tyler et al., 1992).
Pick's Disease and Dementia ot Frontal Lobe Type
Pick’s disease involves atrophy of the frontotemporal areas and the presence of Pick's bodies in 
neurones. The only risk factor for which there is evidence is family history (Heston et al., 1987). In 
recent years, another dementing disease involving the frontal lobes has been described. This disease 
has been called dementia of the frontal lobe type and is more common than Pick's disease. Orrell and 
Sahakian (1991) have recently reviewed the available evidence. Dementia of the frontal lobe type is 
clinically similar to Pick's disease but does not involve Pick's bodies. It may be a variant of Pick's 
disease. As for Pick's, the only known risk factor is family history. There are presently no 
possibilities for prevention of these dementias other than genetic counselling.
Creutzfeldt -Jakob Disease
Creutzfeldt-Jakob disease is a rare dementing disease with an estimated incidence of 1-2 per 
million people per year. The disease involves an abnormal form of a cell protein called prion protein 
(Weissmann, 1991). There has been experimental transmission to animals, with the prion protein 
apparently the infectious agent. Brown et al. (1987) have reviewed the epidemiological evidence.
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I-iimilial cases make up only 5-10% of cases, with the rest being sporadic. The origin of die disease in 
most sporadic cases is unknown. There is little evidence to support case-to-case contact and people in 
close contact with cases are not at increased risk. However, infection has occurred through surgical 
procedures involving contaminated tissues or in patients inoculated with growth hormone derived from 
human pituitaries. Creutzfeldt-Jakob disease is closely related to the animal disease scrapie, but there 
is no evidence for transmission from animals to humans.
The only implication for prevention in current knowledge is avoiding iatrogenic infection.
POSSIBILITIES FOR UNPLANNED PREVENTION OF DEMENTIA
There has been a considerable improvement in life expectancy in developed countries over the 
past 200 years due to a reduction in mortality from infectious diseases. Although this improvement is 
often attributed to medical advances, McKeown (1979) has shown that these played only a minor role. 
Mortality from infectious diseases was decreasing long before the introduction of medical 
interventions like immunization and antibiotics. Although these interventions were often effective, 
they simply accelerated already existing trends. The major part of the improvement must be 
attributable to improved living standards which were not deliberately planned for the prevention of 
diseases.
Given the role of unplanned prevention in infectious diseases, we must ask whether a similar 
effect could occur with chronic diseases of ageing. That this is a possibility is shown by historical 
trends in mortality from stroke. Stroke mortality has been declining in many developed countries over 
recent decades (Bonita, 1992). In the USA, for example, this decline began at the turn of the century, 
well before the introduction of medical interventions like anti-hypertensive therapy.
Could such an unplanned effect occur with dementing diseases? The limited historical evidence 
suggests that the age-specific incidence of dementia has not changed, but the studies cover only a 
limited period (Kokmen el al., 1988; Rorsman et al., 1986). One social factor which could affect 
future dementia incidence is rising education and intelligence in successive cohorts of the elderly. Not 
only are successive cohorts receiving more years of formal education, they may be becoming more 
intelligent. Flynn (1987) has reviewed data from 14 countries on norms for performance on 
intelligence tests. He found evidence of consistent gains in IQ scores over more than half of century.
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The reason for this rise is unknown, but improvements in education could be a factor (Teasdale &
Owen, 1987). Although the evidence for rising IQ scores comes from studies of children and young 
adults, these cohorts are ageing so that rises in intelligence test performance can be expected for the 
elderly. Rising intelligence could affect the incidence of dementia by providing greater cognitive 
reserves. Dementia involves the loss of memory and other cognitive functions sufficient to interfere 
with social and occupational functioning. An individual with high pre-morbid intelligence may be 
able to sustain greater cognitive loss before reaching the threshold for interference with everyday 
functioning. There is some evidence to support this possibility. In a 20-year longitudinal study of the 
ageing twins, La Rue and Jarvik (1987) found that subjects who had dementia tended to have lower 
cognitive lest scores 20 years previously. In a neuropathological study, Katzman et al. (1988) found a 
group of patients with brain changes indicative of mild Alzheimer's disease but no cognitive 
impairment. These patients were found to have larger brains and a greater number of large neurons, 
showing that the context in which Alzheimer neuropathology occurs can affect the manifestation of 
dementia. More recently. Stem et al. (1992) examined regional cerebral blood flow in Alzheimer's 
disease patients who varied in level of education. They found that when patients were matched for 
clinical severity, better educated patients had a greater parietotemporal perfusion deficit. This finding 
shows that better education can provide a reserve which compensates for the brain changes of 
Alzheimer's disease.
If education and pre-morbid intelligence affect the threshold for manifestation of dementia, then 
there should be an education gradient in prevalence and incidence. The existence of such a gradient is 
controversial. A study of dementia prevalence in China has found higher prevalence in those with no 
formal education (Zhang et al., 1990). However, in developed countries, where educational levels are 
higher, such a strong gradient is not found (Brayne & Calloway, 1990). One of the problems in 
establishing an education gradient is that dementia screening tests are known to be influenced by 
education, but there is disagreement as to whether this is due to test bias or a real education effect
(Berkman, 1986; Kittner et al., 1986).
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CONCLUSION
Because of ils great public health impact, Alzheimer's disease has been llie major focus of 
dementia research. However, neither research into disease mechanisms nor research into risk factors 
has yet given a firm basis for preventive action. By contrast, there are good prospects for prevention 
of some of the other dementias, in particular vascular dementia and alcoholic dementia. As well as the 
planned preventive interventions which are possible for these dementias, there may be unplanned 
benefits of increased education in successive cohorts of the elderly. The potential benefits of 
increased education apply to all dementias by providing a greater cognitive reserve.
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A survey of dementia in the Canberra population: 
experience with ICD-10 and DSM-III-R criteria
A S HE N D E R S ON .1 *A. F JORM.  A MACKI NNON.  H CHRI STENSEN L R SCOTT.
A. E. KORTEN a n d  C DOYLE
From the NH & MRC Social Psychiatry Research Unit. The Australian National iniversitv.
Canberra, ACT. Australia
s y n o p s i s  A community survey of 1045 persons aged 70 years and over was conducted to identify 
cases of dementia in the cities of Canberra and Queanbeyan. Cases were identified using the 
Canberra Interview for the Elderly, administered by lay interviewers. When diagnostic criteria were 
rigidly applied, the point prevalence of dementia in the combined sample of community and 
institutional residents was considerably low'er by ICD-10 than by DSM-III-R. Both criteria showed 
a similar rise in prevalence with age. and no gender difference. Agreement between the two systems 
had a kappa of only 0 48. 4 Probable' cases by either criteria were identified solely from respondent- 
provided information in order to include persons for whom no informant was available The point 
prevalence of such 'probable' cases was more similar for the two systems, and the kappa coefficient 
of agreement rose to 0 80. Analysis of the various components required for a diagnosis of dementia 
showed that The prevalence of all increased wath age. Components involving cognitive assessment 
were correlated with education, but other components were not. The results of the study point to 
important differences between ICD-10 and DSM-III-R diagnoses of dementia
INTRODUCTION
Estimates of the prevalence of dementia have 
now been reported in at least 90 studies in 
various parts of the w'orld (Jorm. 1990; Hender­
son. 1994). The scientific value of these is at best 
only modest, due to great diversity in the 
composition of the samples and the methods 
used for case-finding and case-definition The 
quantitative review by Jorm el al. (1987), based 
on 41 studies where a diagnosis of dementia had 
been made, concluded that prevalence rates vary 
depending on the methods employed, that the 
prevalence doubles every 5-1 years between age 
60 and 90 years, that there is no overall gender 
difference in the prevalence of the dementia 
syndrome, and that true differences in prevalence 
may possibly exist between communities. Hof- 
man et al. (1991) analysed 12 surveys in Europe 
published between 1980 and 1990. From these 
integrated data, they reported that prevalence
1 Address for correspondence: Professor A S Henderson.
National Health and Medical Research Council. Social Psvchiairy
Research Unit. The Australian National University. GPO Bos 4
Canberra, ACT 0200. Australia
rates for dementia rose from 1 % at age 60-64 
years to 32% at age 90-94 years. Ritchie et al 
(1992) have since presented evidence from their 
meta-analysis that prevalence estimates in 
studies conducted since 1980. and claiming to 
have used internationally known diagnostic 
criteria such as DSM-KI or DSM-III-R. gue 
considerably lower age-specific rates for demen­
tia than were previously claimed
While many prevalence studies have used 
standard diagnostic criteria in an efiort to 
increase their comparability, these criteria mav 
not necessarily be implemented in the same wav 
(Copeland et al 1991). There is to date very little 
known about the comparability of results 
obtained by different sets of criteria DSM-III-R 
criteria for dementia are being increasingly used 
in prevalence studies, but ICD-10 should provide 
a truly international alternative. Therefore, it is 
important that the relationship between the two 
should be understood. This paper reports the 
application of both the Draft ICD-10 and DSM- 
III-R diagnostic criteria (American Psychiatric 
Association. 1987; World Health Organization. 
1990) in a survey of dementia in the elderly It
47?
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attempts to provide comparative information on 
the performance of these diagnostic criteria 
when they are applied in a community survey. 
The prevalence estimates reported here were 
obtained as part of the base-line measures in a 
longitudinal survey of cognitive decline and 
depressive disorder in the elderly A previous 
paper reported the findings for depression 
(Henderson et al. 1993)
The first wave of the survey was designed to 
contribute new information in a number of 
areas. First, the estimates of prevalence are 
based on the application of both ICD-10 and 
DSM-III-R diagnostic criteria to the same 
population sample. Secondly, the methods used 
allow an investigation of the clinical components 
specified in ICD-10 and DSM-III-R for a 
diagnosis of dementia, and their association 
with age, gender and educational level. Thirdly, 
both sets of criteria have been applied in the 
closest possible standardized way, using a field 
instrument expressly designed to tap them. 
Fourthly, the sample of elderly persons included 
both community and institutional residents. 
Because of the likelihood of differential move­
ment into institutional care, populations may 
vary in the proportion of dementia cases still in 
the community as compared to those in institu­
tions. The rates from surveys that have not 
included both groups, therefore, are difficult to 
interpret. The methods used in the present study 
may provide a basis for future comparisons with 
others that use the same diagnostic criteria.
METHOD
A description of the general methods in the 
survey has been given in a previous paper 
(Henderson et al. 1993). From the Electoral Roll 
for Canberra (population 284000) and the 
neighbouring town of Queanbeyan (population 
26000), separate samples of men and women 
aged 70 years and over were drawn to yield 
approximately equal numbers. Men and women 
were sampled at rates proportional to the 
numbers in the community aged 70-74 years, 
75-79 years, and 80 years or over. The Electoral 
Roll lists all persons who have the right to vote. 
Voting in Australia is compulsory. As elderly 
persons w'ho are infirm, or their family, may 
request that their name be removed from the 
Roll, it is possible that the Roll under-represents
persons with cognitive decline or dementia. 
Separate from the Electoral Roll sample, a 
sample of residents aged 70 years and over was 
also obtained from all nursing homes and 
sheltered- accommodation (or the elderly within 
the same community The size of the target 
samples was 1377 and 143 respectively, chosen 
to yield approximately 1000 and 100 completed 
interviews for the community and institutional 
residents in the population
The instrument
Cognitive function w-as assessed by lay inter­
viewers trained by us in the administration of 
the Canberra Interview' for the Elderly (CIE). 
This is a fully scripted interview with two 
components: an assessment of the elderly per­
son's current mood and cognitive function 
including a neuropsychological examination; 
and an interview with an informant to obtain 
information on current functioning and be­
haviour. including reports of deterioration where 
this has occurred.' Informants were persons 
whom the respondents declared knew' them well. 
The great majority were spouses or first-degree 
relatives. The development of the CIE and its 
reliability have been reported previously (Social 
Psychiatry Research Unit. 1992) and its validity 
demonstrated (Mackinnon et al 1993). The CIE 
was designed specifically to measure each of the 
elements required for the diagnosis of dementia 
or depressive disorder according to the Draft 
ICD-10 and DSM-lll-R criteria. Algorithms 
have been written in SPSS (Norusis, \990) to 
identify individuals who meet these criteria. The 
CIE also includes all the items necessary for the 
Mini-Mental State Examination (Folstein et al. 
1975). For the purposes of this survey, an 
extension to the CIE was developed to assess 
other areas, such as current health, performance 
in the activities of daily living, and recent use of 
services. The average duration of the interview 
w'ith the respondent w'as 117 min (s .d . 29 min) in 
the community, and 90 min (s.d . 45 min) in 
nursing homes and hostels. With the informant, 
it was 40 min (s.d . 15 min) and 46 min (s.d . 
16 mm) respectively.
Application of the ICD-10 Diagnostic Criteria 
for Research under survey conditions
In the ICD-10 Diagnostic Criteria for Research 
an appraisal from an informant is specified
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though not made essential, for establishing both 
memory decline (Criterion G 1 (1)) and intel­
lectual decline (Gl(2)). It is also implicitly 
required for establishing deterioration in emo­
tional control, social behaviour or motivation 
(G3) But under the conditions of an epidemi­
ological field survey, application of these criteria 
may present difficulty because some respondents 
do not have an available informant. Where the 
data are incomplete in this way, it might bias the 
results to exclude those with incomplete data. 
Where an informant interview could not be 
obtained and certain criteria therefore were 
not determined, but all the other ICD-10 cri­
teria were fulfilled, we defined a diagnosis of 
‘probable’ ICD-10 dementia. However, rather 
than mix two definitions of ICD-10 dementia, 
one for respondents with complete data and one 
for those lacking an informant, our results are 
presented in two ways. The first involves 
respondents for whom data were sufficient for a 
diagnosis of ICD-10 dementia, while the second 
considered the diagnosis ‘probable dementia' in 
everybody with a respondent interview regard­
less of whether an informant interview was 
also available. Thus, we present results with a 
strict definition of ICD-10 dementia in the 
subsample of respondents with complete inform­
ation. as w'ell as results with a looser definition 
in a broader sample.
In the DSM-III-R criteria for dementia. 
Criterion B(2) requires information about im­
paired judgement, and B(4) about personality 
change. Criterion C requires evidence that the 
cognitive disturbance ‘significantly interferes 
with work or usual social activities or relation­
ships with others’. In the belief that satisfactory 
information about each of these is best obtained 
from an informant, we constructed the DSM- 
III-R algorithm to have these criteria based only 
on such information, although this requirement 
is not specified in DSM-III-R to be essential 
Where informant data were unavailable or left 
aside, but all the other criteria were fulfilled, the 
individual has been termed a ‘probable’ case of 
DSM-III-R dementia.
Survey procedure
Twelve professional interviewers were selected 
on the basis of their advanced experience and 
personal attributes for undertaking a survey of 
elderly persons. They were trained in the Unit in
the administration of the GTE This included 
detailed instruction on the examination of 
elderly persons, and the administration of 
cognitive tests At least two offisample interviews 
were carried out. followed by their critical 
appraisal. Close contact with the interviewers 
was maintained throughout the fieldwork, 
which lasted from October 1990 to June 1991
RESULTS
Interviews were completed on the community 
and institutional samples as shown in Table 1. 
This shows that in 69% of the former, an 
interview was obtained with either the respon­
dent, or an informant, or both In the institu-
Table 1. Response rates, completeness of 
interviews and applicability oj diagnostic 
algorithms for community and nursing home 
residents
R e s p o n s e  r a l e s N 0 0
T a r g e t  s a m p l e  o f  c o m m u n i t s  r e s i d e n t s 1 7 7 7
R e f u s a l s 4  72 71 4
C o m m u n i t y  r e s i d e n t s  p a r t i c i p a t i n g  i n  s u r s e s 9 4 5 6 8  6
i n t e r v i e w  w i t h  r e s p o n d e n t  o n l s 2 0 0 21 1
I n t e r v i e w  w i t h  i n f o r m a n t  o n l s 4 8 5 1
I n t e r v i e w  w i t h  b o t h 6 9 7 7 7  8
P e r s o n s  w i t h  e n o u g h  d a t a  t o  a l l o w  l o r  a d e f i n i t e 8 8 8 9 4  0
d i a g n o s i s  o f  I C D - 1 0  d e m e n t i a  b s  t h e  C I E  
a l g o n t h m
P e r s o n s  w i t h  e n o u g h  d a t a  t o  a l l o w  t o r  a  d e t i n u e 8 0 6 8 5  7
d i a g n o s i s  o f  D S M - I I I - R  d e m e n t i a  b s  t h e  C I E  
a l g o n t h m
P e r s o n s  w i t h  e n o u g h  d a t a  t o  a l l o w  l o r  a  d i a g n o s i s 8 9 7 9 4  9
o f  ‘ p r o b a b l e ’ I C D - 1 0  d e m e n t i a  b> t h e  C I E
a l g o n t h m
P e r s o n s  w i t h  e n o u g h  d a t a  t o  a l l o w  f o r  a  d i a g n o s i s 8 2 4 8 * :
o f ' p r o b a b l e '  D S M - I U - R  d e m e n t i a  b s  i h e  C I E
a l g o r i t h m
T a r g e t  s a m p l e  o f  i n s t i t u t i o n a l  r e s i d e n t s 1 4 7
7 0  1R e f u s a l s 4  7
I n s t i t u t i o n a l  r e s i d e n t s  p a r t i c i p a t i n g  i n  s u r s e s 1 0 0 6 9  9
I n t e r v i e w  w i t h  r e s p o n d e n t  o n l s 2 2  0
I n t e r v i e w  w i t h  i n f o r m a n t  o n l s 16 16 0
I n t e r s i e s s '  s s i t h  b o t h 6 2 6 2  0
P e r s o n s  w i t h  e n o u g h  d a t a  t o  a l lo s s  l o r  a  d e t i n u e 81 81 0
d i a g n o s i s  o f  I C D - 1 0  d e m e n t i a  b s  t h e  C I E  
a l g o n t h m
P e r s o n s  w i t h  e n o u g h  d a t a  t o  a l lo s s  t o r  a  d e f i n i t e 6 4 6 4  u
d i a g n o s i s  o f  D S M - I I I - R  d e m e n t i a  b s  t h e  C I E  
a l g o n t h m
P e r s o n s  w i t h  e n o u g h  d a t a  t o  a l l o w  l o r  a  d i a g n o s i s 8 4 8 4  o
o f  '  p r o b a b l e ' I C D - 1 0  d e m e n t i a  b y  t h e  C I E  
a l g o r i t h m
P e r s o n s  w i t h  e n o u g h  d a t a  t o  a l l o s s  l o r  a  d i a g n o s i > 6 9 ( w  n
o f  '  p r o b a b l e ' D S M  - 111- R  d e m e n t i a  b s  t h e  C l  E 
a l g o n t h m
------------------------------------------------------------------ —-------- —
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Table 2 Point prevalence estimates ( per cent) Jor  /CD-10 and D S M - l l l - R  dementia
( S t a n d a r d e r r o r s i n  p a r e n t h e s e s  )
Community Institutional 1 otjl population " " "
residents residents
Age group Men Women Total Men Women Total Men 'A omen Total
ICD 10
70 74 1 0 0ft 0 8 2 5 0 13 3 10 1 : 4 1 4 1 4
(0 7) ( O f t ) ( 0 4 ) <13 71 (27 2) (17 5) (0 ' ) (09) (0 9)
7S 79 2 7 0 7 1 3 0 0 0 0 0 0 2 l 0 7 1 2
(1 2) (0 7) ( 0 6 ) (1 2t ( 0 f t ) ( 0 6 )
80 84 2 4 1 7 3 2 16 7 22 2 2 0 9 1 9 7 2 S 2
( 1 6 ) (2 0) (1 4) (10 3) ( 1 1 1 ) ( 8 8 ) (1 8i ( 2 6 ) (1 4)
5 85 2 9 7 5 6 0 12 5 2 0 0 186 5 1 12 3 10 3
( 2 7 ) (3 9) ( 2 8 ) ( 7 6 ) (8 2) (6 8) (2 ’ 1 ( 4 0 ) ( 2 9 )
D S M - l l l - R
70 74 4 3 0 7 2 3 37 5 50 0 45 2 4 9 1 8 3 2
( 1 4 ) ( 0 6 ) (0 7) (15 3) (28 9) (18 7) (1 41 ( 0 9 ) (0 8)
75 79 6 1 50 5 5 16 7 0 0 6 4 ft ft 4 9 5 5
(2 0) (1 2) (1 3) (II 2) ( 3 8 ) ( 2 0 ) (1 6) (1 3)
80- 84 3 9 10 4 7 9 5 0 0 40 0 42 4 8 7 16 0 124
(2 1) (3 2) (2 1) ( 1 3 9 ) (13 1) (10 5) (2 3i ( 1 6 ) ( 2 0 )
J  85 13 3 10 5 11 5 41 7 38 9 19 4 19  ' 21 5 2 1 0
(5 5) (4 6) (3 6) ( I I  3| ( I 0 O ) (8 1) 1 5  O i ( 4 8 ) <3 7)
Table 3 Point prevalence estimates (per cent) for /C D -10 and D S M -lll-R  dementia and probable
dementia {cases and 'probable' cases)
(Standard errors in parentheses )
Community
residents
Institutional
residents
Total population 
aged ^ 70
Age group Men Women Total Men Women Total Men Women Total
ICD-10 
70-74 136 15 3 14 5 50 0 66 7 60 2 14 3 16 5 15 5
(24) (2 7) (1 8) (158) (27 2) (178) (2 3) (2 7) (18)
7S-79 21 2 25 3 23 6 37 5 0-0 14 5 220 24 7 229
(3 4) (3 5i (2 5) (14 6) — (4 9) (3 3) (3 2) (2 l)
80-84 300 34 1 32 5 50 0 58 3 56 3 .'2 0 18 7 35 6
(49) (5 0) (3 6) (13 9) (13 2) (10 5) (4 ftl (4 8) (10)
5 85 42 4 359 38 1 750 66 7 68 2 49 S 47 8 48 3
(80) (72) (5 5) (99) (9 61 (8 0) (6 ftl (58) (4 5)
DSM-lll-R
70-74 1 1 9 158 14 0 500 500 50 0 12 6 16 6 14 8
(22) (2 8i (18) (158) (289) (18 7) (2 2i (2 8) (1 8)
75- 79 210 20-ft 20 7 33 3 00 64 21 ' 20 1 20 1
(34) (32) (24) (14 2) — (38) l3 3) (30) (22)
80-84 17 8 29 2 24 7 63 6 400 42 4 22 5 18 7 31 6
(4 1) (4 8) (3 3) (13 3) (13 1) (10 5) (3 91 (4 4) (2 7)
2 85 23 3 35 1 3! 2 61 5 389 394 31 9 48 1 43 5
(69) (7 1) (5 3) (112) (10 0) (8 3) (5 9i (57) (4 4)
tional sample, 70% were examined in one or 
both of these ways. In applying the diagnostic 
algorithms, we found that missing data pre­
vented application o f the algorithms in 76 
persons for IC D -10 (57 in the community and 19 
in institutions); and in 175 for DSM -III-R  (139
in the community and 36 in institutions). In the 
majority o f cases with either a missing re­
spondent or a missing informant interview, a 
virtually certain judgement o f ' no dementia can 
be made. But because both sets o f criteria 
require information trom an informant for the
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Table 4 I r c q u c n c x  o f  cases, non-eases a n i l  the  n u n ihe i  o f  lespondents  w i th  insu l in  tent in / a n n a t ia i i  
to m ake  a d iagnos is  f o r  each s t ra tu m  u i t l u n  the sam p l ing  design
Detinue dem entia Proh.ih ie  J c m c n iu
( om m um lv  
residents
In \ in u i i i 'D . i I  ( o m m u n ih
reside n i n le M i ie n is
•See  c r o u p M e n W o m e n M e n W  o m e n M e n W o m e n Men \K  - t v : :
K  D - I O
7 0  74 (  ascs 2 1 i i 28 2 6 4
N o n -c a s e s 1 9 9 1 67 6 2 1 7 8 1 44 4 1
I n c o m p le te 10 6 2 i t S 4 : 0
7 5  7 9 C a ses t 1 0 ft 29 IX * II
N o n -c a s e s 1 3 0 1 47 9 4 1 0 8 1 1 2 > 4
In c o m p le te 9 9 2 2 5 7
8 0 - 8 4 C a ses 2 1 2 2 2 4 28 6
N o n -c a s e s X I 78 10 7 5 6 54 6
In c o m p le te 5 9 1 s 8 X i
5  8 5 C a ses 1 1 s 4 14 14 i : 14
N o n -c a s e s 13 17 14 16 19 3S 4 ~
In c o m p le te 4 5 1 4 5 6 ; '
T o ta l C a ses 8 X 6 ' >JS 1 0 6 '  >
N o n -c a s e s 4 4  1 4 2 9 19 24 161 ' 1 5 i *
In c o m p le te 2 8 2 9 X 11 21 2S ~
D S M - l l l - R
7 0 - 7 4 C a ses X 1 1 1 2 1 2S 4 1
N o n -c a s e s 1X 0 1 5 2 5 1 1 7 | 1 1 3 4 !
I n c o m p le te 2 1 21 2 1 1 ■> 16 2 1
7 5 - 7 9 C a ses 7 7 1 II 2s 2 9 2 i t
N o n -c a s e s 10 X 1 12 s 9 4 1 1 2 4
In c o m p le te 2 7 18 S 2 1 16 S
8 0 - 8 4 C a ses .1 7 X 11 51 7 \
N o n -c a s e s 7 3 6 0 5 \ 6 0 21 4
I n c o m p le te 12 2 3 1 15 18 4
2 85 C a ses 4 4 5 ? 7 1 1 8 ! !
N o n -c a s e s 2 6 14 7 I 1 2 ; 2 4 s >
I n c o m p le te 8 7 7 ft X 8 6 V
T o t a l C a se s s s 19 14 m 6X 8 8 21 2 ()
N o n -c a s e s 18 7 17X 22 I S 1 48 1 2 0 1 7 : !
I n c o m p le te 7 0 6 9 17 6 1 5 8 l < 1 A
:  - - r . ■- ~ — . -  . ‘ —
certain diagnosis of dementia, the absence of 
such an interview accounted for a proportion of 
these losses. In the remaining respondents, other 
data essential for the two algorithms could not 
be obtained from the elderly person
Point prevalence of dementia
The point prevalence of dementia, as determined 
by strict application of the two sets of criteria, is 
shown in Table 2, set out by gender and age- 
group. The rate for persons living in the 
community was obtained by weighting the data 
for men and for women by their proportion in 
the age group in the Canberra and Queanbeyan 
population. For the total population, an estimate 
was made by weighting the institutional case- 
rates according to the proportion of the total 
population living in such settings. It can be seen
from the Table that age-specific pre\alence rates 
by 1CD-10 criteria are considerably lower than 
by D S M -lll-R  criteria
As defined above, ‘ probable' cases are those 
who meet all criteria for either I CD - 10 or DSM- 
III-R  except those components that rely on 
informant-provided information These criteria 
were applied to all respondents in the sample, 
whether an informant was available or not. The 
point prevalence for both cases and ‘ probable- 
cases of dementia is shown in Table 3 These 
rates are substantially higher than when in­
formant data were used to derive a confident 
diagnosis for persons for whom this information 
was available. For 'probable cases, the two 
diagnostic systems yield overall rates that are 
essentially similar. Table 4 shows the numbers of 
cases, non-cases, and those on whom mlor-
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Table 5 Agreement between the diagnostic 
systems
(Combined community and institutional 
samples )
D S M 111 R
( a s c s  o f  d e m e n t i a
N o Y e s T o t  a  1
I C D - 1 0  I N o 7 9 6 41 X37
C a s e s  o f  d e m e n t i a  ( Y e s 5 23 2X
T o t a l
( k a p p a  = 0  4 S |
K O I 64 X65
O S M  111 R 
C a s e s  a n d
p r o b a b l e ’ c a s e s  o f
d e m e n t i a
N o Y e s T o t a l
I C D - 10 C a s e s  a n d  / 
p r o b a b l e  c a s e s  s 
o f  d e m e n t i a  '
N o
N e s
6 4 2
52
13
1X4
6 5 5
2 3 6
T o t a l
( k a p p a  -  0  SO )
6 9 4 197 8 91
z . -_TTT .
mation for the algorithms was incomplete. It 
should be emphasized that the rates in Tables 2 
and 3 are not derived directly from the raw 
strata frequencies, because weighting by sex and 
by institutional residency is required to report 
rates for the total population
Comparison of ICD-10 and DSM-III-R 
dementia
The cases identified by the two systems are 
cross-tabulated in Table 3. This is shown first 
for cases of dementia meeting the full criteria, 
then for the total sample diagnosed according to 
the 'probable' dementia criteria which do not 
require informant information, as described 
above. For the former, the denominator included 
those who were lacking an informant interviewe 
For cases of dementia, the level of agreement 
was only modest (kappa = 0 48). but very good 
for cases and ' probable' cases combined (kappa 
= 0-80).
Analysis of components in the criteria
ICD-10 dement in
The diagnostic criteria for ICD-10 dementia 
have four components that are assessed sep­
arately: a decline in memory (Criterion Gl( 1)); 
a decline in intellectual abilities (Criterion
01(2)). deterioration in emotional control and 
motivation (Criterion G3). and the presence of 
Cj I for at least 6 months (Criterion G4). The 
prevalence of these b\ age-group for the total 
population is shown m Fig 1 Since some 
respondents fulfilled individual criteria but were 
not cases, the prevalence rates of the components 
arc considerably higher than the age-specific 
case-rates All the components increase in 
prevalence with age The first three have very 
similar rales, while the fourth is distinctly lower.
DSM-III-R dementia
The equivalent data for the DSM-III-R criteria 
are shown in Fig 2. These are: impaired short- 
and long-term memory (Criterion A); impair­
ment in abstract thinking (Criterion Bl); 
impaired judgement (Criterion B2); other dis­
turbance of higher cortical function (Criterion 
B3). personality changes (Criterion B4); im­
pairment in the above significantly interfering 
with w-ork or usual social activities or relation­
ships with others (Criterion C) While not so 
closely aligned as the first three criteria in ICD- 
10. these also show an increasing prevalence 
with age
Criteria components and educational le\el
To investigate the efleet of education on the 
probability of fulfilling each component in the 
diagnostic criteria, the mean number of years of 
education was compared for person who fu• 
filled, versus those who did not fulfil, each 
component In the community sample, signifi­
cant education effects were found for DSM-llI 
R components A. B. Bl. and B3; and for ICD- 
10 components Gl ( l ) andGl ( 2) ( a l l R< 0 001) 
For all of these components, respondents 
who fulfilled them had had less education There 
was also a significant education effect on the 
diagnosis of DSM-III-R dementia (P < 005). 
but not on the diagnosis of ICD-10 dementia. In 
the institutional sample, the only significant 
education effect was on ICD-10 component 
G 1 (2) (a decline in intellectual abilities)
(P < 0 05). but in this case respondents fulfilling 
the component had better average education. 
The general finding is that the lev el of education 
was consistently lower in persons w'ho had 
impairment of memors. abstract thinking, and 
higher cortical function. By contrast, the edu­
cational level was not different for those with
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80 8470 74
Age group
F ig I Prevalence o f  IC D -1 0  com ponents b> age group co m m u n ity  and nursing home residents ■  ■  C r ite r io n  G l t l l
m em ory decline. □  c r ite rio n  G  1(2) in tellectual dec line . ♦  ♦  . crite rion  G 1 em otiona l c o n t ro l. c r ite rion  G4
present i  b m onths
70 74 75-79
Age group
F ir. 2 Prevalence o f  D S M - l l l- R  co m p o n e n t' bv age group co m m u n ity  and nur>ing home residents ■  ■  C rite r io n  \
□  r )  c r ite rio n  B •  •  c r ite rio n  C  ♦  ♦  c r ite rio n  B l O  cruenon B2 A  ▲ c r ite r io n  Bs ' Js
«.morion B4
impairmeni in judgement, personality, or per­
formance in work, social activities or relation­
ships with others.
DISCUSSION
Because of the refusals and the fact that the 
diagnostic algorithms could not be applied to all 
o f the achieved community and institutional 
samples (Table 1). the prevalence estimates 
obtained in this survey cannot be claimed to be 
representative for the population studied As 
shown in Table 1. refusals led to some in­
formation being obtained for only 69°n. exactly 
the same as that obtained in the Paquid study in
France (Dartigues ei al.. 1991; Führer ei al 
1992). and b\ Folstein ei al. (1991) in the second 
stage of their Baltimore survey of the elderly. A 
separate problem is that rigorous application ot 
the algorithms by a computer program, as 
required b\ the diagnostic criteria, does not 
allow clinical inferences to be made where 
information is missing in the examination
Prevalence estimates
For the ICD-10 diagnostic criteria for research 
there are so far no other studies with which to 
compare the present findings. However, the age- 
specific prevalence rates are substantially le^ 
than those obtained with D S M -Ill-R  Fig '
4 SO A S H enderson <nui others
90 9485 8970 74 80 8475 79
Age group
F ig t Com parison o f age-specific prevalence ol  dem entia in the present study and three previous studies O  Q .J o r m e io /  (1987). 
V  O .H o fm a n  ei at (1441) Q  f j .  R uch ic  ei ul ( 1442) A "  * 1 A  th is  studs D S M - l l l - R ; A “ “ “ A  this study 1C D -I0
shows our prevalence rales compared lo stat­
istical summaries of rates from earlier surveys 
The ICD-10 criteria, as applied in this survey, 
lead to strikingly lower estimates of prevalence 
Three interpretations are offered. First, it is 
possible that a higher response rate, including 
greatei availability of informants, would have 
led to prevalence rates for ICD-10 closer to the 
expected values, and to somewhat higher rates 
by DSM-III-R criteria. A second interpretation 
is that the ICD-10 criteria for dementia, or our 
algorithm which applies each component, are 
set at a considerably higher threshold than 
DSM-IIl-R. This is a hypothesis that we are 
investigating further The ICD-10 criteria differ 
from DSM-III-R in the following respects 
(/) There has to be memory decline that is 
objectively verifiable', with evidence 'from an 
informant supplemented, if possible, by neuro­
psychological tests or quantified cognitive as­
sessment'. By contrast. DSM-III-R requires 
evidence only of impairment, indicated by simple 
cognitive questions.
(//) ICD-10 requires evidence of a decline in 
cognitive ability from a previously higher level 
of performance. DSM-Ill-R requires evidence 
only of impairment in abstract thinking or 
judgement, or disturbances in higher cortical 
function, or personality change
(///) ICD-10 requires, as a separate criterion, 
a decline in emotional control or motivation, or 
a change in social behaviour. This is not an 
obligatory criterion in DSM-III-R
( t v )  ICD-10 requires that the cognitive decline
be present for at least 6 months for a confident 
diagnosis to be made DSM-III-R has no such 
requirement
In the light of these differences, it may not be 
surprising that the prevalence estimates by ICD- 
10 are considerably lower than by DSM-III-R. 
The ICD-10 criteria for dementia are more 
demanding In particular, they are more de­
pendent on information from an informant. 
When the criteria are relaxed to use only 
the information provided by respondents 
( probable' cases), many more individuals meet 
the criteria, and the kappa coefficient of agree­
ment becomes highly satisfactory at 0 80. The 
additional informant information required for a 
diagnosis of dementia according to ICD-10 
therefore appears to raise the threshold to a 
higher level
A third interpretation is that there is some 
attribute of the Canberra population which 
leads to a lower number of persons who perform 
poorly on cognitive testing The latter is more 
heavily represented in the ICD-10 algorithm. 
Educational skew might be one such attribute, 
and it is known to apply to Canberra. But since 
the diagnosis of dementia by ICD-10 has been 
shown not to be influenced by education, this 
attribute of the Canberra population cannot be 
invoked as an adequate explanation.
The much higher prevalence of probable 
compared to 'confident' dementia in the total 
sample indicates that the former diagnosis 
cannot be simply regarded as an estimate ol the 
diagnostic status of respondents tor whom no
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informant information was available Rather. n 
includes definite eases o f dementia together with 
a larger number of respondents who meet only a 
subset of the criteria The classification is 
import-ant in a community survey setting Our 
inability to obtain an informant interview for 
over 20% of respondents is probably typical in 
such surveys To exclude these persons from an 
attempt at diagnosis runs the risk o f considerably 
biasing prevalence estimates. In addition, the 
high level of concordance between the diagnoses 
o f ‘ probable' dementia under DSM-III-R and 
ICD-10 indicates the existence of a common 
kernel within the two diagnostic systems
Components of the ICD-10 and DSM-III-R 
criteria for dementia
The age-specific prevalence of the separate 
components for the two diagnoses, as shown in 
Figs. 1 and 2. suggests that these have some face 
validity in both systems: the prevalence does 
increase with age Furthermore, in ICD-10 there 
is remarkable coherence between a decline in 
memory, a decline in thinking, and deterioration 
in emotional control. For DSM -III-R . there is 
somewhat more dispersal in the prevalence of 
the components
Components of the criteria and education
A differentia! association has been found be­
tween education and the various components of 
the diagnostic criteria in both systems This 
might suggest that poor education is a risk 
factor for a decline in memory, abstract thinking 
or higher cortical function in late life, but not for 
impairment in judgement, personality attributes, 
or performance in work or social relationships 
(Berkman. 1986). Such an interpretation would 
be compatible with the proposal by Katzman 
(1993) that education may postpone the clinical 
manifestations of a dementing process Alterna­
tively, it could be that the methods currently 
used to measure decline in cognitive performance 
are educationally biased (Kittner. 1986) That is, 
for impairment in these domains, the present 
methods may generate more false positive 'cases' 
among people with poor education than among 
those with good education. Despite the edu­
cational differences in the cognitive components 
of the criteria, it is notable that the influence of 
education on the overall diagnosis is small for 
DSM -III-R  and non-existent for ICD-10
CONCLUSION
This study provides the first estimate ol the 
prevalence of dementia using the new ICD-10 
research criteria 1 he estimate by D S M -III-R  is 
very similar to the rates reported in European 
and North American populations In our hands, 
the ICD-10 criteria prove to be demanding to 
apply in a community survey, and identify 
considerably fewer cases than DSM -III-R . It is 
therefore important that the ICD-10 criteria be 
assessed against DSM-III-R, and DSM -IV when 
it is published, using both lay interviewers 
with algorithms and clinicians directly apply ing 
these diagnostic criteria to community and 
clinical samples This would go some way to 
determining if ICD-10 is set at too high a 
threshold of sev erity In addition, there is clearly 
a need to explain the association between poor 
education and fulfilling some of the diagnostic 
criteria for dementia, but not others, in both 
systems.
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SUMMARY
Personality changes are included in the DSM-III-R and ICD-10 criteria for diagnosis of dementia. However, until 
quite recently, dementia research has emphasized cognitive decline, with little interest being shown in personality 
change. Recent studies looking at personality changes in dementia have usually used small clinical samples. In 
the study reported here, such changes have been assessed in a community sample of persons over 70 years. Information 
was obtained from a close relative or friend. A single dimension of personality change was found. There was 
a moderate but significant correlation between personality change and cognitive change. Reports of personality 
change were also correlated to neurotic symptoms in the informant. Personality change was unrelated to the gender 
of the informant, the relationship of the informant to their relative or whether they lived with their relative Also, 
there was no association between personality change and the elderly subject’s age, gender or level of education. 
Through logistic regression, the neurotic symptom score of the informant was found to be the best predictor 
of reported personality change. This suggests that caution may be needed in interpreting information about persona­
lity change obtained from informants.
key w o r d s — Personality change, cognitive impairment, dementia, community survey
Dementia is characterized by a range of cognitive 
and behavioural changes. Although impairment of 
memory and abstract thinking is central to its diag­
nosis (Lishman, 1987), personality change is also 
considered to be a frequently occurring characteris­
tic (Roth and Myers, 1969). Both the Tenth 
Revision of the International Classification of Dis­
eases (WHO, 1990) and the Diagnostic and Statisti­
cal Manual. DSM-III-R (American Psychiatric 
Association. 1987) include personality changes as 
part of the diagnostic criteria for dementia. Until 
quite recently, personality change has been a neg­
lected area of investigation, with most research 
looking at cognitive decline in dementia. Know­
ledge of personality changes was based on clinical 
reports, but in the last few years there have been
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a number of quantitative studies reporting changes 
in many areas of personality including an increase 
in apathy, withdrawal, irritability and emotional 
lability and a decrease in conscientiousness (Rubin 
el al., 1987; Petry ei al., 1988; Siegler ei al., 1991; 
Chatterjee et al.. 1992).
All of these studies have been based on persons 
who have reached hospitals or clinics and have been 
diagnosed as suffering from dementia or probable 
dementia. It is possible that the patients referred 
to such clinics are not representative of all people 
in the population who suffer from dementia, but 
rather are a subsample suffering more socially dis­
ruptive symptoms. Furthermore, such studies have 
not always compared the demented sample to a 
normal group.
Assessment of personality changes in dementia 
is usually based on information from a spouse or 
other close relative who is often caring for the 
demented person. The use of informant ratings 
introduces the possibility that the information pro-
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vided by these people may be contaminated by such 
factors as their relationship to the subject, whether 
they live with the subject, or their own well-being 
Gilley and Wilson (1991) found no association 
between reports of apathy, agitation and irritability 
and either the gender of the informant or the 
informant’s relationship to the subject. Thompson 
and Orvaschel (1982), however, found that reports 
of psychiatric symptomatology varied with the 
informant’s relationship to the subject.
Anxiety or depression in the informant may also 
influence their reports of personality change. 
Carers of people suffering from dementia report 
high levels of psychological distress (Haley ei al., 
1987; Anderson, 1987; Brodaty and Hadzi-Pavlo- 
vic, 1990). Some studies looking at a range of 
behaviour and personality changes have reported 
a correlation with carer stress (Gilleard el al., 1982, 
1984; Zarit el al., 1986). It is reasonable to expect 
that changes in the personality of a close relative 
may cause anxiety or depression in a carer. Another 
possible explanation is that such symptoms in the 
carer may cause them to perceive higher levels of 
personality change. Such an effect is suggested by 
research on mothers’ reports of children’s behav­
iour. Studies by Schaughency and Lahey (1985) and 
Webster-Stratton and Hammond (1988) have 
shown that depression in the mother is associated 
with a negative perception of the child’s behaviour.
The aim of this study was to investigate persona­
lity changes associated with cognitive impairment 
and to look at the relationship between characteris­
tics of the informants and their reports of persona­
lity change.
METHOD
This study has used data collected as part of an 
epidemiological study examining dementia and 
depression in a community sample. This sample 
covered a range of cognitive levels, from those who 
were cognitively normal through to those who were 
significantly cognitively impaired. The strength of 
a community sample is that it does not have the 
possible biases found in clinical studies. Although 
dementia was diagnosed in this sample, it was not 
possible to examine the relationship between 
dementia and personality change, as the personality 
change items had been used in the algorithms for 
the diagnosis of dementia according to DSM-III-R 
and ICD-10 criteria. An association would 
obviously be found between the occurrence of per­
sonality change and the diagnosis of dementia, 
largely due to the inclusion of personality change 
in the dementia diagnosis. The present study there­
fore examined personality change in relation to 
cognitive impairment rather than dementia.
The sample
The subjects were a sample of elderly, community 
dwelling persons from the Australian city of Can­
berra and the nearby town of Queanbeyan. These 
persons were sampled from the electoral roll, which 
is a register of eligible voters. Registration on this 
roll is compulsory for ali Australian citizens aged 
18 or over, although individuals can be removed 
from the roll in circumstances such as severe illness 
or disability. The sample was selected to give equal 
numbers of males and females. For each sex, there 
were three age strata (70-74 years, 75-79 years and 
80+ years), with each stratum sampled to give an 
achieved sample which was proportional to the 
number of individuals in the census population in 
that age group.
Following the interview, subjects were asked if 
they would be willing to provide the name of 
someone who knew them well and might be willing 
to answer some questions about them. The relative 
or friend was later contacted and a separate inter­
view was arranged. Only one member of a house­
hold was chosen as a subject in this study. Every 
effort was made to interview the subject alone; how­
ever, in some cases the informant was present dur­
ing the subject’s interview. The final informant 
sample included a total of 745 persons, 361 of 
whom answered questions about female subjects 
and 384 answered questions about male subjects. 
From this sample, 740 persons completed the perso­
nality questions, 358 about females and 382 about 
males. For some analyses, sample size was lower 
than 740 due to incomplete information from the 
informant. In the case of 46 of the informant inter­
views, there was no corresponding subject inter­
view. This was because the subject either was 
unwilling to be interviewed or was too physically 
or cognitively impaired to do so.
Content o f the interview
The information collected from the subject and 
informant interview's provided data for the diag­
nosis of dementia or depression (Social Psychiatry 
Research Unit, 1992; Mack in non et al., 1993) Data 
were also collected on social background, physical
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health, personality, social support, mental activity, 
self-reported cognitive function and use of services. 
With the exception of the Mini-Mental State Exam­
ination (MMSE), all data used in this article came 
from the informant interview.
Personality change questions. The questions were 
asked in two steps. First, the informant was asked 
if the subject showed a specific personality charac­
teristic. If they answered ‘yes’, they were asked if 
the subject had changed from earlier in life. Those 
who indicated ‘no change’ were classified with 
those indicating that the subject did not show the 
characteristic. Personality characteristics included 
in the scale are shown in Table 1. The questions
Table 1. Per cent of informants reporting change over 
last 10 years on each personality andjudgement item
h e m s  i n  s c a l e P e r  c e n t
P e r s o n a l i t y  i t e m s
1. i r r i t a b l e 9 . 1
2  D e m a n d i n g  a n d  a t t e n t i o n  s e e k i n g 6 . 4
3 L a c k i n g  i n i t i a t i v e 6  3
4 .  S a d  o r  d e p r e s s e d 6 . 3
5 .  D o e s n ' t  l i k e  m i x i n g  w i t h  o t h e r s 4  9
6 .  O v e r l y  e m o t i o n a l 4 6
7 .  A p a t h e t i c  a n d  w i t h d r a w n 4 . 6
8 .  i n f l e x i b l e 4 . 3
9 .  I m p a t i e n t 4 . 2
1 0 .  S u s p i c i o u s 3 . 7
11 C a n t a n k e r o u s 2 5
1 2  N o t  e a s y  t o  g e t  o n  w i t h 2 . 0
J u d g e m e n t  i t e m s
1 3  D o e s n  i  k e e p  c l e a n  a n d  r e s p e c t a b l e 3 . 9
1 4  E m b a r r a s s i n g  b e h a v i o u r 3 8
1 5 .  D o e s n ' t  c o n s i d e r  o t h e r s ’ f e e l i n g s 3 . 3
1 6 .  D o e s n ' t  t h i n k  t h r o u g h  c o n s e q u e n c e s 3 . 0
17 H a n d l e s  m o n e y  f o o l i s h l y 2 4
were derived from the ‘personality change’ and the 
‘impaired judgement and impulse control’ compo­
nents in the DSM-III-R description of dementia 
and the ICD-10 description of dementia
Informant Questionnaire on Cognitive Decline in 
the Elderly ( IQCODE). This 26-item informant 
questionnaire was developed by Jorm and Korten
(1988) to measure changes in memory and intelli­
gence which have taken place in the previous 10 
years. It has been found to correlate highly with 
the MMSE and also to be uninfluenced by premor- 
bid ability as estimated by the National Adult 
Reading Test (Jorm et a l , 1991). The IQCODE 
has also been found to have high internal reliability 
in a general population sample (alpha 0.95) and 
reasonably high test-retest reliability over 1 year 
in a dementing sample (p = 0.15) (Jorm and 
Jacomb, 1989).
Mini-Mental Slate Examination (MMSE) .  This 
test, developed by Folstein et al. (1975), provides 
a means of grading a person's cognitive state.
Global rating o f memory decline. Informants were
asked: ‘In your opinion, d o e s ----- remember
things as well as she used to0'. Those who answered 
‘no’ or ‘depends’ to this were then asked: ‘Does 
this interfere with herTiis day-to-day life?’.
Global rating of intellectual decline. Informants 
were asked the questions: ‘In your opinion, can
-----think and reason as clearly as earlier in life0'
and ‘Does this interfere with her/his day-to-day 
life0’
Anxiety and depression symptoms. Informants 
were asked to complete the scale measuring anxiety 
and depression described by Goldberg et al. (1988). 
These items can be combined to give a scale of 
neurotic symptoms.
Statistical analysis
The statistical package SPSS-X was used for ana­
lysing the data. Principal components analysis with 
orthogonal rotation was used to develop a person­
ality change scale. The distribution of reported per­
sonality changes was found to be quite skewed, 
with 71% (523) reporting no changes and 29% (217) 
reporting one to 16 changes Therefore non-para- 
metric statistics were used in all analyses involving 
the personality change scale. For comparison of 
means, the Mann-Whitney U test was used, while 
Spearman correlation coefficients were computed 
to examine the correlation between the personality- 
score and a range of continuous variables. Statisti­
cal significance was evaluated at the 0.01 level.
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RESULTS
Personality change scale
The 17 questions covering personality and judge­
ment change (Table 1) were entered into a principal 
components analysis. The first factor accounted for 
26% of the variance, the next three accounting for 
9%, 7% and 7% respectively. This analysis suggests 
that a single-factor solution is appropriate. Internal 
consistency was evaluated by calculating Cron- 
bach’s coefficient a which was found to be 0.81. 
Item-total correlations indicated that the a could 
not be improved by dropping any items. Therefore, 
all items were retained in the personality change 
scale and a score was obtained by adding the perso­
nality items for which change was reported. Using 
data from another informant sample of 76 elderly 
patients attending a hospital clinic (Social Psy­
chiatry Research Unit, 1992), the test-retest reliabi­
lity of this personality scale was 0.82. Interviews 
were on average 3.2 days apart.
Relationship between personality change and 
sociodemographic characteristics o f subject
The Spearman correlation coefficient between the 
reported number of personality changes and the 
age of the subject was 0.18 (p < 0.001). The correla­
tion between the number of reported personality 
changes and years of education of the subject was 
not statistically significant. There was also no signi­
ficant difference between the mean personality 
changes for males and females. Males had a mean 
score of 0.78 (SD = 1.75), while females had a mean 
score of 0.70 (SD = 1.60).
Relationship to MMSE and measures o f cognitive 
decline
The correlations between reported number of per­
sonality changes and five measures of cognitive 
decline as well as a measure of current cognitive 
function (MMSE) are shown in Table 2. For all 
measures of cognitive decline, a high score means 
more decline, whereas a high score on the MMSE 
indicate good performance. All correlations were 
found to be significant at the p < 0.01 level. The 
lowest correlation was found with the MMSE. Cor­
relations of personality change with global reports 
of memory and intellectual decline are higher when 
this decline was seen as interfering with the sub­
Table 2. Correlations between measures of cognitive 
decline and reports of personality changes
Correlation with 
personality change score 
Measures of cognitive decline (AO (Spearman coefficients)
MMSE (686) -0.19*
IQCODE (695) 0.37*
Global report of memory decline (738) 0.28*
Memory decline interferes (412) 0.37*
Global report on intellectual 0.35*
decline (738)
Intellectual decline interferes (231) 0.46*
* p  <  0.01
ject’s day-to-day life. The highest correlation was 
with the report of intellectual decline interfering 
with day-to-day life
Relationship to characteristics o f the informant
There was no significant difference in the mean 
number of reported personality changes between 
male (0.64, SD = 1.53) and female (0.78, SD = 1.73) 
informants. There was also no significant differ­
ences between the mean number of personality 
changes reported by those informants who lived 
with the subject (0.83, SD=1.82) compared to 
those who did not (0.66, SD = 1.54). The mean 
number of personality changes reported by spouses 
(0.73, SD = 1.76) was not significantly different to 
the mean number of changes reported by child 
informants (0.85, SD = 1.56). To further investigate 
the possible effect of relationship, principal compo­
nents analysis was carried out on the responses to 
the personality questions given by the spouses and 
the children separately. In this sample, 40% of the 
informants were spouses and 37% were either sons 
or daughters. This showed that for spouses the first 
principal component accounted for 32% of the vari­
ance while for children the first principal compo­
nent accounted for only 18%. The loadings on this 
first component were compared by the coefficient 
of congruence (Reynolds, 1982) to see if they were 
the same. The coefficient had a value of 0.89, which 
suggests that the principal component being mea­
sured was very similar in the two groups.
In this study, there were not enough informants 
w'ho considered themselves ‘carers’ of dependent 
elderly to examine anxiety and depression in this 
specific group. Therefore, we have examined the 
informants in general. 49% of whom lived with the 
subject and a further 43% of whom saw' the subjec 
at least once a week Correlations between the
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number of reported personality changes and mea 
sures of anxiety and depression in the informant 
were both significant at 0.24 and 0.23 respectively 
There was found to be no difference in this correla­
tion between those who lived with the subject and 
those who did not. To investigate the effect of cog­
nitive impairment in the subject on this relation­
ship, a two by two analysis of variance was 
performed using the MMSE scores of the subjects 
dichotomized at a score of 23/24 and the personality 
change score dichotomized on no change’ or 'any 
change as independent variables and anxiety and 
depression as dependent variables. There was 
found to be no interaction effect o f  cognitive 
impairment and personality change on either 
anx.ety or depression, indicating that the relation­
ship between stress in the informant and reports 
of personality change was the same regardless of 
cognitive impairment.
Multivariate analysis
Of the variables examined in this study, the only 
ones showing a significant relationship to person-
tom. T  Werr age °f tHe SUbjeCt’ e r o t i c  symp­toms in the informant and all of the cognitive
measures. To determine the relationship of each 
variable to personality change independently of the
on l T f leS’ l0glStlC regression was performed 
i n r n n r h0l0miZed Personality change score. The 
Q CO O E was used as an indicator o f  cognitive 
change. The results are shown in Table 3 These
m>bchangLe°8iS“C regreSS,0n anal>’sis Pred.cnng persona-
Predictor variable Beta
IQCODE 2 11*
Age of subject o 05
Neurotic symptoms 0 15*
of informant
* P < 0.01.
SE
0.33
0.02
0.03
Interquartile 
odds ratio
1.63
1.38
2.09
on the im yS1S‘ f  imerquarl,le odda ratio is based 
D r e d t . l  qUT lle range ° f a “ ntinuously scaled 
f  . - or t r i a b l e ,  so full power of this predictor 
me . It can be seen that the interquartile odds
ratio was higher for neurotic symptoms m the 
informant than for cognitive decline measured by 
the IQCODE. This suggests that a lthough cognitive 
decline is a significant predictor of reported perso­
nality change, neurotic symptoms in the informant 
have stronger predictive pow'er. The correlation 
with age, independent of other predictors, became 
non-significant.
DISCUSSION
Principal components analysis of the personality 
items included in this study revealed one single 
major factor of personality change in the elderly 
community sample. Studies which have examined 
similar changes in a diagnosed dem entia  sample 
have found that principal com ponents analysis 
revealed more than one factor. In his study o f  60 
subjects with questionable or mild senile dementia 
Rubin et al. (1987a) found seven factors using the 
personality items on the Blessed Dementia Scale 
plus open-ended questions. These were then 
grouped into four clinically meaningful groups: 
passive, agitated, self-centred and suspicious In a 
study by Greene et al. (1982) of  38 people diagnosed 
as suffering from senile dementia, factor analysis 
of 34 questions covering mood and behaviour 
revealed three major factors: apathetic-w ithdraw n, 
active-disturbed and mood disturbance. It is not 
unusual to find differing results between general 
population samples and selected clinical samples. 
In clinical samples, most of the subjects will show 
some level of personality change and factor analysis 
of such change may reveal differences in the types 
of changes. In the community sample examined 
here, however, there was a very low occurrence of 
personality change, 71% of subjects showing no 
change at all. Analysis of these data  reveals one 
major factor which differentiates between those 
showing no change and those showing some 
c ange. Any differences in types o f  personality 
change would have been too small to be detected 
■ n this sample. One limitation of this scale is the 
narrow base for selection of personality items, all 
having come from either the DSM -III-R  or ICD -I0  
criteria for dementia. The changes assessed here 
are largely those which are viewed as problem 
behaviours and do not cover all aspects o f  persona­
lity change which may occur in dementia o r  in nor­
mal ageing. Some of the items are expressed as 
behaviour changes while some ask more directly 
about personality. However, all the characteristics
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assessed by this scale can be found in personality 
inventories designed to measure the five-factor 
model of personality, for example the NEO-PI 
(Costa and McCrae, 1985).
This study has two advantages over studies based 
on small, clinical groups. First, we have data from 
a large sample, making principal components 
analysis of the personality variables more stable 
and more representative of the general population. 
Secondly, our sample would not suffer from the 
biases which may occur in a sample of people who 
have presented to physicians for diagnosis.
A number of studies have looked at the relation­
ship of personality changes to cognitive change. 
The results have not been consistent. Some studies 
report no association between cognitive change and 
personality change in dementia samples (Teri et al., 
1989; Petry et al., 1989), while others report an 
increase in a number of personality changes with 
decrease in cognitive scores (Cooper et al., 1990; 
Rubin et al., 1987b). All of these studies have used 
people who have been diagnosed as suffering from 
dementia or probable dementia. In the present 
study, there was a significant correlation between 
reported personality change and each of the mea­
sures of cognitive change. Controlling for other 
predictor variables by logistic regression indicated 
that cognitive change was a significant predictor 
of personality change. Possible reasons for this 
association are
1 Personality changes may be, in part, a reaction 
to the disease process itself, particularly in the 
early stages when the person is more aware of 
their condition.
2 Damage to areas of the brain concerned with 
cognitive function may also influence persona­
lity.
3 Some of the items in the personality scale used 
in this study may be indicative of cognitive 
change, particularly some of the items on judge­
ment. This is a possible weakness of the scale.
The correlation, however, was found only to be 
moderate. There may therefore be processes 
involved in personality change that are unrelated 
to cognitive decline.
Information about behaviour and personality 
changes in people suffering from dementia is fre­
quently obtained from carers or close, relatives. It 
is possible that the responses to the questions may 
be influenced by characteristics of the informant. 
In this study, no correlation was found between 
reported personality changes and gender of inform­
ant, relationship of subject to informant or whether 
the informant lived with the subject. Principal com­
ponents analysis of the responses to the personality- 
items for spouse informants and child informants 
separately showed that for the spouses’ responses 
the first factor accounted for a greater percentage 
of the variance than the children’s responses. This 
suggests that the spouses were most likely to see 
a more global personality change in their partners, 
while their children were more likely to report spe­
cific changes. Calculation of the coefficient of 
congruence, however, indicated that the principal 
component being measured was very similar for 
both groups.
Symptoms of anxiety and depression in the 
informant, were significantly correlated with the 
number of reported personality changes. This cor­
relation was about the same for those informants 
who lived with the subject as it was for those who 
did not live with the subject. The relationship was 
also found to be the same for different levels of 
cognitive impairment. Logistic regression showed 
neurotic symptoms in the informant to be a better 
predictor of reported personality change than cog­
nitive change or the age of the subject. In this study 
it is not possible to draw any conclusions about 
the direction of the relationship between reported 
personality change and informant stress. It is inter­
esting that Jorm et a!, (in press) using the same 
survey data found a similar relationship between 
informant stress and informant reports of cognitive 
change (although not the IQCODE score). A fol­
low-up of this sample is planned during 1994 and 
it will then be possible to look at this association 
longitudinally.
As it is possible that information obtained from 
informants is influenced by their level of stress, then 
the reliability of such information may be thrown 
into doubt. Studies using the DSM-III (Spitzer et 
al., 1979) and the DSM-III-R (Arntz et al., 1992) 
diagnostic criteria for personality disorders have 
found interrater reliability to be poor. Other studies 
which have investigated the interrater reliability of 
inventories designed to assess personality in 
healthy individuals have found that items which 
are easily observable have better reliability than 
those items which have to be inferred (Funder and 
Dobroth, 1987; Funder and Colvin, 1988). This 
needs to be considered in interpreting results based 
on informant reports.
Personality changes were not found to be corre­
lated with gender or years of education of the sub­
jects. Also, the correlation with age of the subject
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disappeared when the effect of other variables was 
controlled by logistic regression. Cooper et al. 
(1990) also found that personality change was not 
significantly correlated with age, gender or edu­
cation. Given that such personality changes are 
included in the diagnostic criteria for dementia, it 
is useful to know that they are not influenced by 
such factors.
Although only a small proportion of the sample 
were diagnosed as demented, 29% of informants 
reported that personality changes had occurred in 
their elderly relatives. These changes were found 
to be moderately correlated to cognitive change. 
It has frequently been reported that personality 
changes occur early in the course of dementia 
(Rubin and Kinscherf, 1989). The 4-year follow-up 
of this sample will make it possible to determine 
the incidence of dementia in currently non- 
demented subjects in whom personality changes 
have been reported. It will also be possible to look 
at further change in personality and whether this 
varies on an item-by-item level.
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SUMMARY
Cognitive impairment was assessed using the Mini-Mental State Examination in community surveys of the elderly 
in Canberra and Hobart. Mean scores on the Mini-Mental were higher in Canberra than in Hobart and the prevalence 
of cognitive impairment was lower. This difference was found to be attributable to the higher level of education 
in the Canberra elderly. When education was statistically controlled, the difference between the cities disappeared. 
These findings may have implications for future cohorts o f the elderly, which wall have a higher level of education 
than the present-day elderly. It is argued that the prevalence of cognitive impairment could drop in the future.
key words—Cognitive impairment, Mini-Mental State Examination, prevalence, dementia, education, ethnicity, 
intelligence, elderly.
Comparisons of the prevalence of dementia across 
studies are difficult because of differences in case 
finding methods. Even where standardized diag­
nostic criteria are used, they may be interpreted 
or applied differently (Burvill, 1990; Henderson, 
1991). Comparisons of communities assessed in dif­
ferent studies only become possible where standard 
case finding instruments such as the Geriatric Men­
tal State Examination (GMS) are used (Copeland 
et al., 1988). Using this approach, Copeland and 
his colleagues (1987) have reported that New York 
has a higher prevalence of dementia than London, 
although the reason for the difference remains 
unknown. However, such comparisons are rarely 
possible because of the great variety of methods 
used for case finding in dementia prevalence 
studies.
Although methods for assessing dementia have
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remained varied, epidemiological studies have 
shown much greater consistency in the assessment 
of cognitive impairment. Cognitive impairment 
refers to a low level of cognitive functioning for 
any reason and may be due to dementia, learning 
disabilities, mental retardation, depression, de­
lirium or cultural disadvantage. The Mini-Mental 
State Examination (MMSE) (Folstein et al., 1975) 
has achieved a pre-eminent position for the assess­
ment of cognitive impairment in English-speaking 
countries (Tombaugh and McIntyre, 1992) and has 
been translated into many other languages. 
Although there are variant forms of the MMSE. 
epidemiological studies have generally used the 
Epidemiologic Catchment Area (ECA) version 
(Holzer et al., 1984), making direct comparisons 
across studies possible.
In this paper, we report MMSE data from a 
recent community survey of the elderly carried out 
in Canberra and compare these to data from an 
earlier survey of the elderly in Hobart. The paper 
reports that cognitive impairment was found to be
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less common in Canberra than in Hobart and 
explores the possible reasons for this difference. 
The strategy for attempting to explain the differ­
ence between the cities is taken from Rutter el al.'s 
(1974) work comparing child behaviour problems 
in inner .London versus the Isle of Wight. They 
explored the social correlates of behaviour prob­
lems within the two communities and showed that 
these variables also differed between the communi­
ties. Here, we examine the socio-demographic cor­
relates of MMSE performance within the Canberra 
and Hobart samples and assess whether these vari­
ables can explain the difference between the cities. 
In a recent review of research with the MMSE, 
Tombaugh and McIntyre (1992) have concluded 
that scores are influenced by educational level, age, 
race/ethnicity and social class, but not by gender. 
We chose age, education and ethnicity as the socio­
demographic variables to explore, these being mea­
sured in the same way in both surveys. Social class 
was not included because it is highly correlated with 
education in Australia and it was not measured 
in the same way in the two surveys.
METHOD
The Communities Studied
Canberra is a city of 284,000 persons and the 
adjacent town of Queanbeyan has a population of 
26,000. Canberra is Australia’s national capital, 
having been built specifically for this purpose. The 
public service is the major employer and there is 
little secondary industry. Canberra has a relatively 
young population compared to the rest of Austra­
lia. Queanbeyan is a rural town which existed 
before the founding of Canberra in 1913. With the 
expansion of Canberra in recent years, the two have 
come to function more as a single city.
Hobart is the capital of the state of Tasmania 
and at the time of the survey had a population 
of 158,000. The city is the second oldest in Australia 
and has a high degree of demographic stability.
The methods for the Canberra survey have been 
described by Henderson et al. (1993) and for the 
Hobart survey by Kay et al. (1985). Only aspects 
of the method important to the assessment of cogni­
tive impairment are described here.
The Samples
Both surveys used the Electoral Roll as the sam­
pling frame because enrollment is compulsory in 
Australia. Persons living in institutions were 
excluded from both samples.
The Canberra survey covered residents of both 
the city of Canberra and the adjacent town of 
Queanbeyan. Separate samples of men and women 
aged 70+ were drawn to yield approximately equal 
numbers in the achieved sample. Both sexes were 
sampled at rates proportional to the numbers in 
the community aged 70-74, 75—79 and 80+ years. 
Interviews with subjects were carried out in 1990- 
91. Of 1377 persons approached, 897 (65%) pro­
vided an interview and 880 (64%) completed the 
MMSE. The response rate was higher in males 
(72%) than in females (59%), but there was little 
difference across age groups. The Canberra study 
also included a separate institutional sample which 
is not reported on here.
The Hobart study attempted to get roughly equal 
achieved samples in the age groups 70-79 and 80 + 
years. Men and women were sampled together so 
as to get a gender breakdown like that in the popu­
lation. Interviews were carried out in 1982-83. Of 
368 persons approached, 274 (74%) provided an 
interview and 269 (73%) completed the MMSE. The 
response rate was higher in the 70-79 year age 
group (80%) than in the 80+ age group (68%), but 
there was not a significant sex difference in response 
rate.
Since only community dwellers are being con­
sidered in both surveys, it is important to determine 
that the institutionalization rate was similar for 
both cities. A census of institutional residents was 
carried out in Canberra and Queanbeyan and a 
similar census was carried out in Hobart by Kay 
et al. (1987), but the methods of each involve suffi­
cient differences to make direct comparison diffi­
cult. However, other available figures suggest that 
institutionalization rates were similar. In 1985, Tas­
mania had 95.5 nursing home and hostel beds per 
1000 aged 70+ , while in 1991 the equivalent rate 
for the Australian Capital Territory was 96.9 (Com­
monwealth Department of Health, Housing and 
Community Services, 1991). It is of course possible 
that there was some difference in policy towards 
institutionalization of the cognitively impaired 
which could affect the prevalence rates in the two 
communities, particularly given that they were 
studied 8 years apart. However, there is no w'ay 
of assessing this possibility.
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Table I. Mean MMSE score by age group for Canberra and Hobart
A g e  g r o u p
C a n b e r r a H o b a r t
M e a n 9 5 %  C l N M e a n 9 5 %  C l N
7 0 - 7 4 2 7 . 9 6 2 7 . 7 7  t o  2 8 . 1 6 371 2 6 . 7 3 2 6 . 1 3  t o  2 7 .3 2 74
7 5 - 7 9 2 7 . 2 5 2 6 . 9 3  l o  2 7 .5 7 2 8 2 2 5 . 8 8 2 4 . 9 4  t o  2 6 .8 3 73
8 0 - 8 4 2 6 . 5 2 2 6 .0 1  t o  2 7 .0 3 1 59 2 4 . 8 4 2 4 . 0 0  t o  2 5 . 6 8 79
8 5  + 2 5 . 7 3 2 4 . 7 0  t o  2 6 . 7 6 6 8 2 4 . 4 4 2 3 .0 4  t o  2 5 .8 3 4 3
The Interviews
The Canberra survey used the Canberra Inter­
view for the Elderly (CIE) (Social Psychiatry 
Research Unit, 1992) supplemented with questions 
to cover additional areas. The CIE incorporates 
the items of the MMSE. All interviews were carried 
out by professional lay interviewers.
The Hobart survey used the GMS supplemented 
with other tests, including the MMSE. All inter­
views were carried out by the same trained lay inter­
viewer.
In both studies, the MMSE was scored out of 
30 using the same method. Subjects were given both 
‘WORLD backwards’ and ‘serial sevens’ and cre­
dited with the best score of these. Refusals to do 
an item were scored as errors. Subjects with missing 
data because of sensory or motor impairments had 
their scores prorated. This scoring procedure maxi­
mizes the amount of usable data and reduces bias 
in the sample.
Socio-Demographic Characteristics
In both surveys, educational attainment was 
measured in terms of years of education and 
included post-school qualifications. Ethnicity was 
measured by country of birth. Subjects born in pre­
dominantly English-speaking countries (Australia, 
New Zealand, United Kingdom, Ireland, Canada, 
USA) were placed in one category and subjects 
born in all other countries in another.
RESULTS
Table 1 shows the mean MMSE score by age group 
for Canberra and Hobart. It can be seen that the 
mean scores are higher in Canberra for all age 
groups. MMSE scores can be used to classify peo­
ple as cognitively impaired. Scores of 24-30 are 
usually taken as indicating no cognitive impair­
ment, 18-23 as mild cognitive impairment and 0-17 
as severe cognitive impairment. Although the 23/24 
cutoff was originally based on findings in clinical 
samples, it has been widely used in community sur­
veys. (Tombaugh and McIntyre, 1992). Figure 1 
shows the proportion of each age group with mild 
or severe cognitive impairment. Again, it is appar­
ent that impairment is less prevalent in Canberra 
than Hobart. Furthermore, the differences between 
the cities is consistent across the four age groups. 
Examining only severe cognitive impairment pro­
duced similar differences between the cities over 
the age groups 70-74 to 85+ : 0%, 1%, 2% and 7% 
for Canberra versus 0%, 7%, 5% and 9% for 
Hobart.
The Canberra and Hobart data can also be com­
pared to those from the American ECA studies 
(George et al., 1991). The American studies have 
grouped the ages differently as 65-74, 75-84 and 
85+ years. Because the Canberra and Hobart 
studies did not include subjects in the 65-69 age 
range, only the latter two groups can be compared 
across all three surveys. In the 75-84 year age 
group, the prevalence of mild or severe cognitive 
impairment was 12% (SE = 2%) in Canberra, 21% 
(SE = 3%) in Hobart and 26%(SE= 1%) in the USA. 
In the 85+ age group, the prevalence was 15% 
(SE=4%) in Canberra. 30% (SE = 7%) in Hobart 
and 45% (SE = 2%) in the USA.
The socio-demographic characteristics of age, 
education and ethnicity were examined as predic­
tors of MMSE score, in the Canberra and Hobart 
samples separately, using multiple linear regres­
sion. Table 2 shows the results. In both cities, age 
and education were predictors of MMSE score, but 
ethnicity was a reliable predictor only in Canberra. 
In Canberra the regression model gave a multiple 
R of 0.37 and in Hobart it was 0.39. It was found 
that square root or logarithmic transformations of 
years of education gave a slightly better prediction 
in Hobart, but made no difference in Canberra. 
These transformations have the effect of placing
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Figure 1. Prevlance of cognitive impairment (and standard errors) across age groups for Hobart and Canberra
Table 2. Regression analyses predicting MMSE score from age, English-speaking ethnicity and years of education: 
Canberra and Hobart
Predictor
Variable
Canberra Hobart
B Beta 95% Cl of Beta B Beta 95% Cl o f Beta
Age -0.13 -0 .24 -0 .1 7  to -0 .30 -0 .14 -0.21 -0 .0 9  to -0 .32
Ethnicity 1.59 0.20 0.14 to 0.26 2.10 0.11 -0 .01  to 0.23
Education 0.21 0.20 0.14 to 0.26 0.42 0.32 0.20 to 0.43
Constant 33.82 — — 31.49 — —
greater weight on differences among the poorly 
educated than on differences among the well edu­
cated. However, because the basic results were the 
same, only the untransformed education variable 
is reported here.
Comparing the socio-demographic characteris­
tics of the two samples, the mean age was found 
to be slightly younger in Canberra (mean = 76.7, 
SD = 5.0) than in Hobart (mean = 78.9, SD = 5.6), 
reflecting the oversampling of the very elderly in 
the Hobart study. Years of education were much 
higher in Canberra (mean= 11.2, SD = 2.6) than in 
Hobart (mean = 7.2, SD = 2.9), while Canberra had
a lower percentage with an English-speaking ethnic 
background than Hobart (85% versus 96%).
To see if the socio-demographic variables could 
account for the difference in MMSE scores between 
the cities, a series of hierarchical linear regressions 
was carried out in which socio-demographic vari­
ables were entered on the first step and city 
(l=Hobart, 2 = Canberra) on the second. The 
results of these are shown in Table 3. In the first 
regression, age was entered on the first step 
(accounting for 8% of the variance in MMSE) and 
city on the second (accounting for a further 3%). 
This analysis showed that the city difference
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remained even when the effect of age was statisti­
cally removed. The second regression analysis 
entered age and ethnicity on the first step (9% of 
the variance) and city on the second (a further 4%). 
Again, removing the effects of age and ethnicity 
did not remove the city difference. The third regres­
sion analysis entered age and education on the first 
step (15% of the variance) and city on the second 
(accounting for no additional variance). This 
analysis showed that there is no city difference once 
educational effects are taken into account.
Table 3. Hierarchical regression analyses predicting 
MMSE score in the combined Canberra-Hobart sample
S te p
P r e d ic to r
v a r ia b le s R R 2 R 2 c h a n g e P
1 A ge 0 .2 8 0 .08 0 .0 8 .000
2 C ity 0 .3 4 0.11 0 .0 3 .000
1 A g e , E th n ic i ty 0.31 0 .09 0 .0 9 .000
2 C ity 0 .3 6 0 .13 0 .0 4 .000
I A g e , E d u c a t io n 0 .3 9 0 .15 0 .1 5 .000
2 C ity 0 .3 9 0 .15 0 .0 0 .098
The confidence intervals and significance tests 
for these regressions are based on the assumption 
of a normal distribution of errors. Examination of 
the distribution of residuals showed substantial 
concordance with the normality assumption with 
the exception of a small number of subjects who 
had MMSE scores consistent with dementia. In 
order to test the robustness of the findings, a case/ 
non-case classification was made using both the 
conventional 23/24 and 17/18 cutpoints for the 
MMSE. Multiple logistic regression analyses were 
then carried out with cognitive impairment as the 
dependent variable and the socio-demographic fac­
tors as the predictors. However, the substance of 
the results was the same as for the linear regres­
sions, so these are not reported here.
DISCUSSION
It has been found that the elderly living in the Can­
berra community have higher mean scores on the 
MMSE and a lower prevalence of cognitive impair­
ment than the elderly of Hobart. Both Australian 
cities have less cognitive impairment than has been
reported for the elderly in the USA. When age, 
ethnicity and education were examined in Canberra 
and Hobart, it was found that the difference in 
MMSE scores disappeared when age and education 
were controlled. Therefore, the higher level of edu­
cation in the Canberra sample seems to account 
for the difference between the cities. This finding 
is consistent with the many studies showing that 
education is an important determinant of MMSE 
scores (e.g. Brayne and Calloway, 1990; Fillen- 
baum et al., 1988; Ganguli et al., 1991; Jagger et 
al., 1992; O ’Connor et al., 1989; Uhlmann and 
Larson, 1991).
Another possible reason for the difference 
between the cities is the higher refusal rate for sub­
jects in Canberra. If persons with cognitive impair­
ment were more likely to refuse an interview, then 
cognitive impairment would appear to be less 
prevalent in Canberra. However, if differential 
refusal rather than education were the real source 
of the difference, the regression analyses would 
have shown that a city difference remained even 
after the effects of education were partialled out. 
No such residual city difference was found, arguing 
against this interpretation. A similar argument can 
be made against other possible explanations o f the 
city difference, such an institutionalization rates or 
policies.
If the difference in prevalence of cognitive 
impairment between Canberra and Hobart is 
attributable to education, then this may have poss­
ible implications for the functioning of future 
cohorts of the elderly. The elderly of Canberra are 
presently atypical of the rest of Australia in terms 
of level of education. However, educational atta in ­
ment in the population is improving, so that the 
elderly of the future will be much better educated 
than the elderly of today. For example, in 1981, 
less than half of the Australian population reaching 
retirement age had formal schooling to at least age 
15. but this is expected to rise to three quarters 
by the year 2001 (Rowland, 1991). If a high level 
of education is protective for cognitive impairment, 
then it is possible that the prevalence of cognitive 
impairment will decline in the future. This possibi­
lity is predicated on the assumption that education 
has a direct influence on cognitive impairment and 
is not simply a proxy for another variable such 
as nutrition which is the real cause. If education 
is a proxy variable, then improvements in education 
may not necessarily influence cognitive im pair­
ment.
However, a case can be made that better edu-
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cation will lead to improvements in cognitive func­
tioning of future cohorts of the elderly. Flynn 
(1984) has reviewed American studies providing 
norms for intelligence tests, spanning a period of 
over 40 years, and found consistent evidence of 
improved performance. The improvement over this 
period was equivalent to almost one standard devi­
ation. Flynn (1987) later confirmed these findings 
with intelligence test data from 14 nations. In an 
attempt to explain this sort of improvement, Teas- 
dale and Owen (1987) analyzed intelligence test 
data for 18 year old Danish conscripts born 
between 1939 and 1958. They found an improve­
ment of 0.4 standard deviations in performance 
which was predicted in a regression model by rises 
in level of education. These intelligence test studies 
all deal with children and young adults, but the 
improvements found must eventually flow on to 
older age groups and are likely to result in better 
performance on cognitive tests like the MMSE.
If changes in educational attainment do affect 
the prevalence of cognitive impairment, it might 
be expected that this would only occur with mild 
cases. However the present data show a city differ­
ence using both the 23/24 and 17/18 cutpoints on 
the MMSE. This finding implies that education 
affects the full range of MMSE scores and the 
prevalence of cognitive impairment at all levels of 
severity.
Improvements in cognitive test performance may 
not, of course, imply improvements in everyday 
functioning. It is possible that future cohorts of 
the elderly will do better on tests such as the MMSE 
without any improvement in levels of disability in 
the population. However, there is evidence that 
MMSE scores are strong predictors of disability 
as measured by activities of daily living, with corre­
lations ranging from 0.40 to 0.75 in various studies 
(Tombaugh and McIntyre, 1992). Furthermore, a 
given MMSE score predicts the same level of disabi­
lity whether a person has a high or low level of 
educational attainment (Fratiglioni et al., 1993; 
Jorm et al., 1988), indicating that MMSE scores 
do not overestimate the functional capacities of the 
well educated or underestimate those of the poorly 
educated. It is therefore plausible that improve­
ments in education will lead to a reduction in dis­
ability due to cognitive impairment, as well as an 
improvement in cognitive test scores. However, 
correlations in the range 0.40 to 0.75 have scope 
for divergence between cognitive impairment and 
disability measures, so that an improvement in cog­
nitive test scores might not necessarily imply an
improvement in daily functioning. This issue can 
only be resolved by comparisons of both cognitive 
impairment and disability across groups contrast­
ing in education. While both the Canberra and 
Hobart surveys collected data on disability, differ­
ent items were used makingcomparison impossible.
A major limitation of the MMSE is that it mea­
sures cognitive impairment without diagnosing the 
source of this impairment. The more interesting 
issue is whether differences in prevalence of cogni­
tive impairment imply differences in the prevalence 
of specific disorders, particularly dementing dis­
eases. Although dementia was assessed in both the 
Canberra and Hobart surveys, quite different case 
ascertainment methods were used, making direct 
comparison of prevalence rates hazardous. It is, 
however, possible that educational differences 
between communities could affect rates of 
dementia. Mortimer (1988) has argued that 
dementia results when neuronal reserves drop 
below a critical threshold. Better educated people 
are postulated to have a greater reserve capacity 
which allows them to sustain more neuronal loss. 
Katzman (1993) has recently reviewed a number 
of studies which support this notion. This reserve 
capacity hypothesis does not imply that the better 
educated have a slower rate of neuronal loss or 
cognitive decline with ageing, only that they can 
sustain greater loss before reaching the threshold 
for dementia. Indeed, there is evidence that edu­
cation does not affect the rate of cognitive decline 
(Christensen and Henderson, 1991).
Cross-community comparisons of dementia 
prevalence will remain difficult until there is greater 
standardization of case-ascertainment methods. 
However, the widespread use of the MMSE in epi­
demiological studies encourages further attempts 
to compare communities in terms of cognitive 
impairment. Comparison would be facilitated 
where studies also use comparable methods for 
measuring education and disability.
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ABSTRACT
Dementia-free life expectancy is a synthetic indicator of an important aspect of mental 
health which may have considerable use in public health decision-making. Dementia 
expectancies were derived from senile dementia prevalence rates in Australia in 
1991-1992 in conjunction with national life-tables using Sullivan’s method. At 70 
years dementia-free life expectancy for Australian women was found to be 14 years 
within a total life expectancy of 1 5 years, and 11 years for men within a total life 
expectancy of 12 years. Between 70 and 85 years there is a constant average 
expectation of about one year of life expectancy with dementia. The largest number of 
persons with dementia in the Australian population is estimated to be around 82 years 
of age. Australians appear to have very similar dementia-free life expectancies to 
those reported in the European studies, with small differences probably due to 
sampling variation or to differences in case-finding methods.
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Introduction
Mortality rates have long been the most commonly used indicator of population 
health. However, awareness that gains in life-expectancy in western countries are 
increasingly occurring at higher ages (1), has led to speculation as to the quality of 
these life years gained. Concern that increasing longevity may be leading to what 
Kramer (2) has referred to as a “ pandemic of mental disorders and associated chronic 
diseases and disabilities” has led researchers in the field of public health to conclude 
that life-expectancy alone may be an insufficient measure of the changing health of 
populations. There has consequently been increasing interest in the concept of “ health 
expectancies” which examine changes in mortality in relation to the prevalence of 
physical disease. The aim of these disability-free life expectancy calculations is to 
examine the quality of gains in life years and thus the burden which increases in age- 
related pathology may place on society.
Health expectancies are composite health indicators, which are a generalisation 
of total life expectancy to include information on health status (3,4). The large 
number of health expectancy calculations which have been made up until now have been 
largely concerned with life expectancy and physical disability (4). Disability-free 
life expectancy has been calculated for Australians (5) and New Zealanders (6) and 
also for many other countries, as has been reviewed elsewhere (4). It is only recently 
that the problem of mental disability has been raised. This is surprising given that 
Kramer’s pandemic theory (2), which has inspired much work in this area, was 
initially based on observations derived from studies of schizophrenia, mental 
retardation and senile dementia. Within the area of mental health expectancies it is 
senile dementia which has been considered the most pressing due to predictions of 
marked increases in the prevalence of this disorder as a result of the ageing of the 
population (7). From a public health point of view dementia poses a special problem 
not only because of the severity of the associated disability, but also because of the 
stress it places on family care-givers who are themselves at increased risk of 
physical and mental ill health (8). Senile dementia not only causes progressive 
physical disability, but also interferes with the individual’s capacity to make decisions 
concerning his or her own care. Carers must therefore not only provide assistance 
with physical needs, but also assume decision-making processes and provide 
supervision. The burden is clearly far greater than for physical disability alone.
A first calculation of dementia-free life expectancy made for a French 
population (9) showed that: at age 65, dementia free life expectancy is 16.9 years 
within a total life expectancy of 17.7 years; women have a higher dementia-free life
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expectancy than men; but this advantage is reduced when expressed as a proportion of 
total life expectancy. The additional years of life expectancy which women experience 
are thus years of both good and bad mental health. This paper also presented 
comparative estimates of dementia-free life expectancy for the United Kingdom, using 
prevalence estimates from three British studies in Liverpool, Cambridge and Melton 
Mowbray. Similar patterns were found, with dementia-free life expectancy from age 
65 appearing to be slightly greater for the French estimates than for the British 
estimates (9). The present communication presents the first dementia-free life 
expectancy calculation made for an Australian population.
Methods and data sources
The most common method for calculating health expectancy is the method 
proposed by Sullivan (3) as it permits the use of cross-sectional data. The method 
involves the estimation of the number of years lived between different ages from a 
fictitious cohort using a period mortality table, then subtracting the number of years 
lived with or without the relevant morbid condition using observed prevalence rates. 
By applying the cumulative number of years to the number of survivors at a given age, 
the life expectancy with and without the relevant morbid condition may be estimated 
for a given age. For example, if 1000 years have been lived between 70 and 75 years 
by a fictitious cohort in the mortality conditions of 1 990, and the observed prevalence 
rate of a given disability in the age-group 70 to 75 is 10% (or 0.1) that year, it is 
estimated that 1000x( 1-0.1 ) = 900 years have been lived without the disability 
between 70 and 75 years. By applying the cumulative number of years to the number 
of survivors at a given age, disability free life expectancy may be estimated at that age.
Although other methods have subsequently been developed which take into 
account the reversibility of disability (for example multi-state and Markovian 
processes), there is less need for this in the case of dementia where the disease is 
progressive in the vast majority of cases. Standard errors of dementia prevalence 
rates (10) were used to compute standard errors for dementia-free life expectancy 
and life expectancy with dementia using the methods developed by Mathers (5).
The dementia prevalence data used in the present study come from a field 
survey conducted in Canberra and the neighbouring town of Queanbeyan in 1990- 
1991. The methods used in this survey have been fully described elsewhere (10). 
Briefly the survey involved 1045 people aged 70 or over and covered both those living 
in the community and those in nursing homes and hostels. Dementia was diagnosed 
according to  both DSM-lll-R (11) and ICD-10 criteria (12) using a structured 
interview administered by trained lay interviewers (13). Only the DSM-lll-R
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prevalence rates were used here, because these diagnostic criteria are similar to those 
used in other studies. The diagnosis of dementia by these criteria requires an interview 
with the informant as well as an assessment of the subject. The required data were 
available for 870 of the 1045 participants in the survey. The age-specific prevalence 
rates of dementia in Canberra-Queanbeyan were found to be very similar to those 
reported in European studies using similar diagnostic criteria (14). Australian life 
tables for males and females in 1990 were obtained from the Australian Bureau of 
Statistics (15).
Results
Table 1 shows dementia-free life expectancy, and life expectancy with 
dementia, for men and women aged 70 to 90.
Table 1 Here
In Australia, life expectancy in 1990 at 70 years of age is 12.0 years for men and 
1 5.1 years for women. Dementia-free life expectancy is 1 1.0 years for men and 1 3.7 
years for women at age 70, going down to 3.9 years for men and 4.7 years for women 
at age 85. The standard errors for these estimates increase from around 0.1 years at 
age 70 up to 0.1 5 years at age 85. As is true for disability-free life expectancy (5), 
women have a higher dementia-free life expectancy at all ages (see Figure 1).
Figures 1 and 2
The average life expectancy with dementia is around 0.9 years for men and 1.5 
years for women, with standard errors of around 0.1 years. From Figures 1 and 2 it 
can be seen that the average number of years expected to be spent with dementia 
remains relatively constant for men and women. This is similar to results found in the 
French study where life expectancy with dementia remains stable at 0.8 years for both 
sexes between 65 and 95 years, in the United Kingdom, where life expectancy over 70 
is slightly less than in both France and Australia, life expectancy with dementia is 
about the same (0.9 years for men and women in the Liverpool study and 1.0 years for 
men and women in the Cambridge study) (9).
The proportion of demented survivors in relation to the total number in the 
initial cohort increases from age 70 for women to reach its highest point at around 80 
years, then decreases steadily due to the dual and contradictory movement of an 
increase in dementia prevalence with age in combination with a dimunition in the
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population due to mortality. As a result of this, the greatest number of women in the 
Australian population with dementia will be found at about 80 years. No such peak is 
observed in men, probably due to the very small numbers in the Australian prevalence 
data at higher ages.
From Figure 3 it can be seen that life expectancy without dementia takes up 
about 92% of total life expectancy at age 71 for men and about 90% for women. At 89 
years life expectancy without dementia still represents around 80% of life expectancy 
for women and slightly more for men. Zero dementia-free life-expectancy (which is 
what we might expect if dementia were an inevitable part of the ageing process) would 
not occur using these projections at an age likely to be reached by anyone in present 
survival conditions.
Figure 3
Figure 4 compares the dementia-free life expectancy estimates for Australia 
with similar calculations made for France and the United Kingdom (9). The proportion 
of dementia-free life for Australian women up to age 85 is slightly lower than 
estimates made from the European studies, but this is unlikely to be statistically 
significant given the estimated standard errors for the Australian data and the likely 
comparable standard errors for the European estimates. For men, the Australian 
estimate is slightly lower than those from the French and Liverpudlian studies, but 
close to the estimates for Cambridge. The biggest differences are seen with very 
elderly males. Flowever, the small numbers observed at this age in all studies except 
France, and the big standard errors seen at higher ages for both sexes, make this latter 
observation very unreliable.
Figure 4
Discussion
The calculation of dementia free life expectancy in an Australian population, 
using prevalence data from a survey of the Canberra and Queanbeyan population and 
national mortality data, shows that at 70 years of age women have a life expectancy of 
1 5 years of which thirteen and a half years will be without dementia. Men at the same 
age have a life expectancy of 1 2 years of which 11 years will be without dementia. As 
has also been observed in relation to physical disability (5), the extra years of life 
which Australian women have gained over men are neither of entirely good or poor 
mental health, but a little of each. The same observation has been made for France and
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the United Kingdom (9). Thus when mortality alone is used as an indicator of 
population health, women have a clear advantage, but when health expectancies are 
used this advantage is somewhat reduced.
Although the prevalence of dementia is known to increase with age, when 
mortality is taken into account it can be seen that the largest number of persons with 
senile dementia in an Australian population is likely to be around 82 years of age. This 
is similar to France where the maximum number is estimated to be 84 years (9). The 
biggest burden in terms of care provision will therefore be for persons in their early 
eighties.
Comparing the estimates obtained for the Australian population with those 
previously reported for the United Kingdom and France, the proportion of life 
expectancy at older ages which is free of dementia appears somewhat lower for the 
Australian estimates than for most of the European estimates, although this difference 
is unlikely to be statistically significant. It is difficult to ascertain, also, to what 
extent the differences in these estimates reflect real differences or differences in the 
methodology used to derive the data used in the calculations. While it may be assumed 
that the national life-tables used are sufficiently accurate, there are a number of 
differences in the case-finding procedures used in the different studies. Although all 
studies used the same diagnostic criteria (DSM-lll-R), they did not use the same 
diagnostic instruments. Furthermore, although all studies have included 
institutionalized elderly, in the United Kingdom they were derived by random sampling 
from the lists of general practitioners which are of unknown reliability. In France and 
Australia the institutionalized sample was sampled separately. It is therefore highly 
likely that the differences observed between Australia and Europe not due to sampling 
variability are artefacts of the measures used to diagnose dementia, and the manner in 
which the populations were sampled.
Further work is clearly required on the development of reliable cross-cultural 
methods for the detection of senile dementia before international comparisons may be 
interpreted with any confidence. Such comparisons will also require prevalence data 
based on reasonably large sample sizes to allow statistically significant differences to 
be detected.
The use of longitudinal dementia prevalence data in future calculations of dementia- 
free life expectancy will provide an indication of any changes in dementia-free life 
expectancy which may accompany therapeutic intervention strategies, and also help to
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answer the question of whether increasing longevity is indeed bringing with it a 
pandemic of mental disorder.
7
Conclusion
The estimation of dementia-free life expectancy in an Austra lian population suggests 
that over the age of 70 Australians have a continual expectation of approximately one 
year of dementia. While women have a higher life expectancy and dementia-free life 
expectancy than men at all ages, it is clear from these calculations that the gains made 
by women in longevity are not entirely years of good mental health, but a mixture of 
good and poor health. As has been observed in France, the highest number of persons 
with dementia in Australia are in their early eighties. While the Australian study gives 
somewhat lower estimates of dementia-free life expectancy than the European studies, 
this difference is most likely due to sampling variability and to the different sampling 
and case-finding methods used in the different countries.
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Table I
Life expectancy, dementia-free life expectancy and life expectancy with dementia as 
estimated by Sullivan’s method (3,5) for an Australian population in 1990. The final column 
gives estimated standard errors for life expectancy with dementia.
Dementia-free Life expectancy SE(Life expectancy 
Age Life expectancy Life expectancy with dementia with dementia)
(years) Males Females Males Females Males Females Males Females
70 11.95 15.12 10.98 13.66
years  —  
0.98 1.46 0 .1 0 0.10
75 9.15 11.62 8 .22 10.08 0.93 1.54 0.1 1 0.10
80 6.80 8.56 5.89 6.95 0.90 1.60 0 .1 3 0.13
85 4.91 6 .0 2 3.94 4.73 0.97 1.29 0 .1 5 0.1 5
90 3.49 4.12 2.80 3.23 0.69 0.89 0.17 0 .2 2
Data sources (1 0,1 5)
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Figure 1
Total life expectancy, dementia-free life expectancy and life expectancy with dementia,
Australian males, 1990.
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Figure Z
Total life expectancy, dementia-free life expectancy and life expectancy with dementia,
Australian females, 1990.
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Figure 3
Dementia-free life expectancy in Australia as a proportion of total life expectancy for men
and women
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Figure 4
Dementia-free life expectancy as a proportion of life expectancy (DemFLE/LE) for men and 
women based on studies in Australia, France, Liverpool and Cambridge.
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Abstract
Objective—To assess the efficacy of tacrine and 
lecithin in treating Alzheimer’s disease over nine 
months.
Design—Double blind randomised controlled 
trial.
Setting—Outpatients clinic of university depart­
ment of geriatric medicine.
Subjects—53 subjects (26 women, 27 men) with 
probable Alzheimer’s disease. 41 completed the 
dose finding phase and were randomised to treat­
ment. 32 (14 tacrine, 18 placebo) completed nine 
months’ treatment.
Interventions—Lecithin and tacrine or lecithin 
and placebo for 36 weeks.
Main outcome measures—Scores on neuro­
psychological tests sensitive to deficits in the 
cholinergic system; m i n i - m e n t a l  state score; 
behaviour change; mood; functional state; and 
stress in carers.
Results—The tacrine and placebo groups were 
similar except that the tacrine group had a longer 
duration of disease (mean S'4 v 2*5 years in placebo 
group; P-0-003). Only 17 of the 32 patients could 
tolerate the maximum dose of tacrine (100 mg). No 
significant difference was found between the groups 
for any of the tests after nine months’ treatment 
except for the digit backwards test, which is 
insensitive to cholinergic deficit. Analysis of 
subjects taking the maximum dose of tacrine 
and of subjects with mild dementia also found no 
differences.
Conclusions—Tacrine produces no clinically 
relevant improvement over 36 weeks at the doses 
tolerated by these patients.
Introduction
One of the most consistently reported bram deficits 
in Alzheimer's disease is in the cholinergic system. 
Consequently many treatment regimens have aimed at 
enhancing cholinergic transmission.1
The acetylcholine precursors (lecithin and choline) 
and cholinergic receptor agonists (for example, 
arecoline and bethanechol) have been shown to have no 
significant effect on the course of Alzheimer’s disease.^ 
A limited effect has been shown, however, with 
physostigmine,*"0 and substantial improvement has 
been reported with tacnne (1,2,3,4-tetrahydroamino- 
acridine)," a less potent but longer acting cholin­
esterase inhibitor. The trial of tacrine has been 
criticised,1213 but at least one better designed trial also 
found improvement on some measures."' Recent trials 
have been criticised for their short treatment penod, 
poor design,"17“ poor patient selection,'''""’ small 
numbers,14 2121 rapid dose titration, and the absence of 
washout during crossover." 14 20 21 Taking these
criticisms into account, we report a randomised double 
blind trial aimed at determining the longer term effects 
of tacnne used with lecithin in treating dementia of the 
Alzheimer type.
Subjects and methods
Fifty three subjects (26 women and 27 men) partici­
pated in the study’. They were recruited from referring 
neurologists, psychiatrists, and other physicians. All 
subjects fulfilled the critena for dementia in the 
Diagnostic and Statistical M anual o f Mental Disorders, 
third edition, revised (DSM-III-R)24 and the criteria 
for probable Alzheimer’s disease of the National 
Institute of Neurological and Communicative Dis­
orders and Stroke.23 All the subjects lived at home 
and had a carer willing to complete questionnaires. 
Exclusion critena were concurrent terminal illness or 
end organ failure, inability to speak English or to 
comprehend the instructions for the verbal selective 
reminding task,2* which was used to assess efficacy. 
Carers and, whenever possible, the patients gave 
informed written consent.
All patients initially underwent a dose finding phase 
with tacrine. Memory performance, liver enzyme 
concentrations, and carers’ assessment of functioning 
were recorded at baseline and after two weeks of 
treatment with lecithin alone (9 x 1200 mg capsules 
daily). Subjects were then given tacrine, starting at 25 
mg daily; doses were increased by 25 mg every’ two 
weeks to a maximum daily dose of 100 mg if there were 
no side effects and liver enzyme concentrations were 
not raised. Doses are expressed in terms of the 
hydrochloride salt of tacrine; an equivalent maximum 
dose of the base of tacnne is 80 mg daily. We defined a 
best dose of tacnne as either the highest tolerated dose 
or the tolerated dose at which performance on memory 
tests was at least 50% better than at baseline.
After a four week wash out penod on lecithin alone, 
41 subjects who could tolerate at least 25 mg tacnne 
daily were randomly assigned to one of two treatment 
groups for the nine month double blind phase: placebo 
plus lecithin or tacnne plus lecithin. Subjects took 
their own best dose and were assessed monthly for drug 
efficacy and safety.
ASSESSMENT
We assessed memory using verbal and visual 
selective reminding tasks consisting of lists of 10 words 
or seven objects respectively.2*27 Subjects were given 
10 attempts to learn the lists. Multiple forms of the 
verbal and visuospaual tests were available so that 
different lists were presented to the patient at each test, 
thus minimising practice effects.
A battery of psychometric tests aimed at the specific 
cholinergic effects of tacnne was completed at baseline 
and after three and six months of treatment. The tests
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were selected on the basis of reported effects in healthy statistical analysis
volunteers given the cholinergic blocking drug p or tfte verbal selective reminding task, total words 
hyoscme. The battery included cholinergic sensitive recalled over 10 trials (maximum 100) were scored as
tests (that is, hyosctne impairs test performance) and outlined by Buschke ei al.2" A similar scoring system
cholinergic insensitive tests. Further details have been was usecj for the visuospatial selective reminding task
reported.28 (maximum 70). The total London psychogeriatnc
A cluneal examination, including a standardised rating score and subscores of mental disorganisation
neurological examination and the mini-mental state (confusion), physical disability, socially irritating
examination,2'1 was repeated every three months. behaviour, and disengagement were calculated accord-
We calculated the extrapyramidal score taking into ing to standard scoring procedures.“ Scores of fatigue
account resting tremor, glabella tap, ngidity of upper (worn out, fatigued, weary), vigour (alert, lively,
or lower limbs, nuchal rigidity, cogwheeling, fine vigorous), depression, (sad, miserable, gloomy), and
finger movement, postural flexion, arm swing, and confusion (confused, forgetful, unable to concentrate)
bradykinesia. Each measure was scored on a scale of 0 were calculated from the modified profile of mood
(normal) to 3 (severe defect), and the scores were states."
summed. For measures performed monthly, we averaged the
Carers rated the patient’s functioning and mood scores over three months to minimise missing data and 
usmg the London psychogeriatnc rating scale“ and a mcrease the reliability of the measurement. The
profile of mood states scale’ modified for use baseline score was the average of scores at the pretnal
by carers. They assessed the patients’ instrumental assessment, the lecithin only assessment in the dose 
activities of daily living’2 and their own symptoms of finding phase, and the assessment after the wash out
stress (using a 30 item general health questionnaire’’) phase. Paired i tests of the verbal memory test score
every three months. before dose finding with the score after the wash out
We used standardised neurological tests to assess phase indicated no significant carry over effect of the
patients before inclusion in the trial and after the nine drug after the wash out phase (P-0-85). We analysed
month double blind phase. Based on the neuropsycho- data for patients completing 36 weeks of treatment
logical approach of Walsh,*4 the tests assessed using repeated measures analysis of variance. Treat-
language, attention, memory and learning, visuo- ment (tacrine v placebo) was the independent groups
spatial and constructional skills, frontal or executive factor and testing occasion (baseline, 1-3 months, 4-6
function, visual agnosia, and apraxia. In addition the months, and 7-9 months) the repeated measures factor,
national adult reading test" and geriatric depression We aiso used repeated measures analysis of variance to
scale were administered.** compare the results of the neurological tests before and
after in the two treatment groups. The i test and \ 2 test
s i d e  e f f e c t s  were used l0 compare other measures as appropriate.
Carers reported side effects by completing a monthly 
checklist of 20 symptoms of cholinergic and liver 
dysfunction. Side effects were regarded as present if 
they were noted at least once by a carer during three 
months and had not been noted at baseline.
We tested liver function monthly. If enzyme 
concentrations were raised, they were measured 
weekly; if the rise continued or worsened the dose of 
tacrine (or placebo) was reduced. Treatment was 
stopped if concentrations reached three times the 
upper limit of normal.
table 1— Baseline characteristics of patients randomised to placebo 
and taenne treatment groups who completed 36 weeks of treatment. 
Figures arc means (ranges)
Taenne
(o -1 4 )
Placebo 
(n -  18)
Sex (M:F) 8:6 9:9
Age (vean) 66-5(52-80) 71 1 (52-84)
Best taenne dose (mg/day) 80 4(25-100) 75 0(25-100)
Duranon of .Alzheimer’s disease (years)’ 5 4(1-11) 2-5 (<  1-7)
Mini mental state scorej 
Carer.
16 6(3-27) 17 3 (4-26)
Spouse 14 13
Children 2
Sister 2
Unrelated 1
* S igmficant difference by i test; p •  0 003 
t  Maximum score 30
table n— Characteristics of patients who withdrew from double blind phase of study
ithdrawal
Sex
•Age
(years)
Weeks of 
treatment
Best dose 
(mg/day)
Reason for 
withdrawal
related to 
taenne
Taenne
M 71 8 75 Aggressive behaviour Possibly
M 65 19 50 Depression Possibh
F 74 4 50 Raised ljver enzymes Probably
M 71 1 25 Raised ljver enzymes Probably
M 69 2 75 Jo ml inflimmanof) Possibly
F 84 12 50 Raised liver enzymes Probably
Placebo
F 71 16 100 Travel intolerable No
F 57 4 50 Refused medscaDon No
F 81 4 75 Carer unavailable No
Results
Twelve of the 53 subjects who began the dose finding 
phase withdrew before randomisation. Six subjects 
had raised liver enzyme concentrations and were not 
rechallenged; two had urticaria; one had partial bowel 
obstruction; one developed nausea and refused re­
challenge; one developed urinary frequency, which 
caused the carer to withdraw consent; and one died of a 
myocardial infarction. Forty one patients were ran­
domly assigned to either placebo (21 patients) or 
tacrine (20 patients) for 36 weeks.
Thirty two patients completed 36 weeks of treat­
ment: 14 in the taenne group and 18 in the placebo 
group. Table I gives a profile of the subjects in each 
treatment group. There was no significant difference 
between the two groups in age (P-0-11), sex (X = 
-0-161; P -0-69), mini-mental state scores (P-O-75), 
or dose of taenne (P-0-60). However, the taenne 
group had a significantly longer duranon of disease 
than the placebo group ( P - 0-003).
The repeated measures analysis of vanance was done 
for only these 32 subjects. The nine subjects who did 
not complete the mal (table II) did not differ from 
subjects who completed the mal with respect to age 
(P-0-36) or mini-mental score (P-0-63). There was, 
however, a significant difference between the doses of 
taenne the groups were taking. The mean daily dose 
was 55-6 (SD 27-3) mg in subjects who dropped out 
and 77-3 (27-9) mg in those who completed the mal. 
When subjects who dropped out are excluded from 
the analysis, the results should favour a posiuve effect 
of tacrine.
Table HI summanses the test scores achieved by each 
treatment group over the 36 weeks of treatment 
The only baseline assessment in which there was a 
significant difference between treatment groups was 
the instrumental activities of daily living (P-0-04). We 
found no interaction between treatment group and 
occasion for any of the measures except the digits
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t a b l e  m— Means (SD ) values for each lest according u> treatment group and time of assessment
Months of treatment
Placebo Tacnne
0 3 6 9 0 3 6 9 P value
Selective reminding tests
Verbal (total words) 35 5 (15-9) 37-0 (15 8) 37 5 (16 0) 34-6 (16 3) 34 9(15 1) 37-8(17 8) 38 7 (16 5) 38 5 (16 3) 0-200
Visual (total objects) 56 8 (21 2) 32 6 (20 3) 32-8 (22 8) 30 8(22-7) 30-7 (13 3) 30-4 (20 2) 314 (18 1) 26 2(16 9) 0 359
Cholinergic insensitive tests
Digit forward 5 9 (2 7) 5 1 (2 6) 5 2(2-6) 6 1 (2-8) 5-5(2 1) 5 9(2-4) 0-723
Digit backwards 4 2 (2-6) 4 7 (2 6) 3-5(2 1) 3-4 (1-9) 3-1 (2 2) 3-2(20) 0 035
Verbal fiuenev 22 4 (1 3 2) 20 5 (13 1) 198(11 8) 23 1 (15-0) 22-6(14 9) 24 3 (14 8) 0 198
Stmt] antics 9-4 (6 8) 8 7 (6-8) 7 5 (6 5) 12 6 (6 9) 12-6(7-9) 12 9 (70 ) 0 197
Word stem completion 2 2 (2 7) 2-3(1 9) 2 0 (1 4 ) 1-7 (18) 1-5(1 7) 2 4(1-9) 0 360
Homophone spelling 1-6(1 7) 1 0 (1 3 ) 1-7(1 7) 14(1-3) 0 9 (1 6 1 3 (1 3 ) 0 889
Cholinergic sensitive tests:
Face recognition 3 8(1 4) 3 -7 (13) 3-4(1 8) 3 9(2-0) 3-4 (11) 3-4(1 2) 0 651
Word recognition 5-3 (2-9) 5-5(4 4) 41 (4-3) 4 4 (3 5) 3-93(4-6) 2-6(4-9) 0 913
Word recall 11(1-0) 1 3(1-0) 1 0 (0  8) 1-4(1 3) 14 (18) 1 3(0-7) 0-932
Symbol digit modalines 10-9(9 7) 117 (10-8) 10-6 (9 6) 8 5 (9 5) 9 1 (10 3) 8-1 (9-1) 0-981
Neurological assessment:
Mini-mental state 17 3 (6 7) 17 2 (6 8) 16 4 (6 8) 15 2(8 0) 16 6 (6 8) 16 8(6-6) 16 1 (6 5) 14 4 (6-7) 0 944
Extra pyramidal score 1 9(3-0) 2-0 (2 8) 2-7 (3-4) 1 9(2  5) 2 7(2-3) 2-9 (2 9) 3 2 (3  1) 2-3(3 3) 0 899
M ean blood pressure
(mm Hg) 104 6(12 7) 104 6(11 8) 105 3 (14 9) 101 8(14-8) 103 1 (13 8) 99 6(17 8) 95 2 (10 4) 97 3(11 0) 0 423
Carer assessments:
London 14 1 (7-7) 14 7 (9-3) 15 7(10-9) 18-9(12 1) 15 2 (6 5) 16 9(6-9) 18 2(9  6) 19-5(10-9) 0 638
Modified profile of mood states
Fatigue 5 5 (2  1) 5 2 (2  1) 5 3 (2 4) 5-7 (2-5) 5 8 (2 0) 5-3(2 1) 5 3 (2 0 ) 5 9 (2  2) 0 951
Vigour 8 7(2-1) 9-0 (2 2) 9-4(2-3) 8-6(1 9) 8 9(1-9) 8 -9 (20) 9 0  (2-4) 8 9 (2 3) 0 571
Depression 4-2 (14) 40(1-4 ) 4-2(1 8) 4 8(2 3) 4 8(2.0) 4-8 (2-4) 4-6(2-2) 4-6(1 7) 0  316
Confusion 8 6(2-4) 8-8(2 2) 9-0 (2 6) 9-4 (2-8) 8-9(1 7) 8-8 (2-6) 8 7 (2  9) 8-6 (2-6) 0-281
Instrumental activities
of daily living 10 3 (2-6) 9-8(2 5) 9 5 (2 6) 9 6(2-7) 8 5(2  5) 8-1 (3-0) 8 3 (2 8) 7 6(3-4) 0 622
Carer stress assessment:
General health
questionnaire 2 4 (4 4) 16 (2 7) 2 6(4  9) 2-2 (3-9) 4-0(6 3) 4-4 (6-9) 20(2-2 ) 3 1 (4 8) 0 397
* Repeated measures analysis of variance.
backwards test. Performance on the digits backwards 
deteriorated m the placebo group but not in the 
tacrine group. This test is cholinergic insensitive so 
tacrine would not be expected to have affected the 
results.
One year after the first neuropsychological assess­
ment—that is, two months in the dose finding phase, 
one month wash out, and nine months of double blind 
treatment—only two out of the 22 tests showed any 
treatment effect: the colour form sorting test (P- 
O-W )^*1 and similarities test (P -0  04).'* The tacnne 
group improved on both tests. The placebo treated 
group improved on the similarities test but to a lesser 
extent.
There was no significant interaction between the 
treatment group and the total number of side effects 
reported. Three subjects withdrew because of raised 
liver enzyme concentrations (more than three times 
normal). Four subjects (two in the tacrine group and 
two in the placebo group) developed raised alanine 
aminotransferase concentrations less than three times 
the upper limit of normal; this resolved without 
reducing the dose in all but one case (placebo group).
To check the possibility that the dose was 
inadequate, 17 subjects with complete data who were 
taking tacnne or placebo at the 100 mg dose (10 
placebo, seven tacnne) were analysed separately. No 
improvement was found in mini-mental state score or 
in the tests in the cholinergic battery compared with 
the placebo group. We also analysed separately data on 
a subgroup of patients with milder disease with mini- 
mental state scores above 20 (eight placebo, six 
tacnne). These subjects might be expected to have a 
purely cholinergic defiat and therefore be more respon­
sive to treatment. No treatment effea of tacnne was 
observed in any of the tests.
examinations, and assessments of carers of patients’ 
functioning. Thirty two of the 41 subjects with mild to 
moderate Alzheimer’s disease who were randomised 
completed 36 weeks of double blind treatment: 14 in 
the tacrine treatment group and 18 in the placebo 
treatment group. Significant treatment effects were 
detected in no more of the efficacy measures than 
would be preditted by chance. Although the number 
of patients completing the trial was not large, neither 
was the difference in response to treatment between 
active and placebo groups. This study had a 90% 
chance of detecting a difference between groups 
in cognitive performance of three mini-mental state 
points or six Buschke words over 36 weeks.”
The trial measured the effects of tacnne on top of 
any effects of lecithin. Lecithin alone could affect 
cholinergic transmission by saturating the metabolic 
enzymes and thus promoting synthesis of acetylcholine 
in the brain. Previous research has found little 
evidence of any effea of leathin on the course of 
Alzheimer’s disease,* but there is theoretical evidence 
that lecithin could prevent damage from tacrine 
by loading the brain with choline. Cholinesterase 
inhibitors have been suggested to cause cell suicide 
by promoting breakdown of membranes containing 
phosphatidylcholine in order to obtain choline.*0
Many of the tests that we used to assess drug efficacy- 
have been used in previous trials of cholinergic 
agonists’4'-0 or to assess the progression of .Alzheimer’s 
disease.“ **** The tests are reproducible and sensiuve 
to change and despite the power of the study to detea 
clinically significant changes we found no effea of 
tacrine. It is unlikely that all the instruments used were 
consistendy insensitive to an effea by tacnne. The 
doses of tacnne administered may, however, have been 
subtherapeuuc or only a subgroup of patients may have 
been responsive to the treatment.
Discussion
This randomised double blind trial was designed to 
determine the longer term effea of treatment with 
tacnne and lecithin on the dementing process of 
Alzheimer’s disease. Measures of efficacy included 
repeated psychometnc testing, neurological
DOSES ADM INISTERED
No studies since that of Summers et al" have 
reported clinically relevant results of treatment with 
tacrine. Chatellier et al, Molloy et aL, and Wilcock et al 
were unable to detea any significant effea of 
tacrine.11-’’*5 Two studies reported that tacrine pro-
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duced significant changes in mini-mental state score 
but not in other measures after 13 and four weeks of 
treatment,“ 46 and Davis ei al noted marginal improve­
ments over six weeks of treatment.20
The most important factor limiting the tolerated 
dose of tacrine was liver toxicity. Raised liver enzyme 
concentrations have often been reported, ranging in 
incidence from 13% to 42%.®22 In this tnal 14 of the 53 
patients (26%) given tacrine in the dose finding phase 
had liver enzyme concentrations three times the upper 
limit of normal. Although there are no reported 
incidents of permanent damage and all our subjects 
had normal concentrations within a month of with­
drawing the drug, biopsies of patients with raised liver 
function test results have reported damage ranging 
from focal inflammatory infiltration to extensive 
hepatocellular necrosis.46^* We therefore decided to 
restrict doses to 100 mg daily. The trials which found 
a noticeable effect of tacrine used doses up to 150 mg 
and 200 mg daily." “
We used a dose finding phase before randomisation 
to determine personal best doses for each subject, 
largely on the basis of the subject’s highest tolerated 
dose. The mean best dose of tacnne was 72-6 (SD 
28-94) mg daily. Therapeutic serum concentrations of 
tacrine four hours after the last dose are suggested to be 
7 to 20 jig/l.46 We did not always collect blood exactly 
four hours after the last dose and the methods did 
not take into account the metabolites of tacrine oF 
differential protem binding. The plasma concentrations 
can therefore be considered only a rough estimate. 
However, in the dose finding phase the mean concen­
tration of tacrine when patients were taking their best 
dose was 13-3 p.g/1 (SE T91; range 0 to 49-64). This is 
potentially a therapeutic dose.
We found a marginally significant correlation 
between memory (selective reminding task scores) and 
blood tacrine concentrations (R-0-33; P-0-04). This 
seems to support the argument that higher doses of 
tacrine are needed for a cognitive effect. Analysis of the 
subgroup of patients whose ‘best dose’ for the trial was 
100 mg daily, however, showed no evidence of a long 
term treatment effect on the mini-mental state score. 
Because of liver toxicity, higher doses could be used 
only in selected patients and would require conserva­
tive titration and frequent monitoring.
Compliance may be a problem in subjects with 
dementia, but all our subjects had a carer who took 
responsibility for ensuring drugs were taken. General 
inquiry by the neurologists at three monthly assess­
ments suggested that compliance was excellent, but 
this was not assessed independently.
RESPONSIVE SU BG R O U PS
Eagger el al suggested that some patients respond 
better than others to tacrine.“ If tacrine is an effective 
centrally acting cholinergic agonist it might be 
expected to be most effective in mild Alzheimer’s 
disease, when the deficits are predominantly 
cholinergic. We carried out a sub analysis on a group 
of patients with mild Alzheimer’s disease who had 
a pattern of cognitive performance consistent with 
a purely cholinergic deficit.“ However, we found 
no difference between the tacrine and placebo treat­
ments.
Although patients were randomly assigned to treat­
ment groups, patients treated with tacrine had a longer 
duration of disease than those treated with placebo. 
Our results could be falsely negative if subjects with a 
short duration of disease respond better to treatment. 
However, within the tacrine treated group there was no 
correlation between response to tacrine (as measured 
by the mini-mental state examination) and duration of 
disease (P-0-50), and analysis of the whole group 
showed no correlation between duration of disease and
Clinical implications
•  Patients with Alzheimer’s disease are thought 
to have deficits in the cholinergic system
•  Patients have been treated with the cholin­
esterase inhibitor tacrine to enhance cholinergic 
transmission
•  In this study no clinically relevant effect 
of tacrine was found over nine months of 
treatment, and nine of the 53 subjects withdrew 
because of liver toxicity
•  Tacnne is not clinically useful for patients 
with Alzheimer’s disease
baseline mini-mental state score (R-0-25) or verbal 
memory (P-0-21).
C O N C L U SIO N
We found no evidence of any effect of treatment with 
tacrine on Alzheimer’s disease. Although the doses 
administered may have been too low to be effective, 
fewer than half our subjects were able to tolerate the 
maximum 100 mg dose, and we believe that trials 
at higher doses would not find clinically relevant 
improvement.
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Abstract
Objective—To characterise clinical, investigative, 
and prognostic features of women referred with 
chest pain who subsequently underwent coronary 
angiography.
Design—Analysis of all women with angina 
referred to one consultant during 1987-91 who 
subsequently underwent coronary angiography, with 
follow up to present day.
Setting—Cardiothoracic centre.
Subjects—Women with normal coronary arteries; 
women with coronary artery disease shown on angio­
graphy; men with coronary artery disease matched 
for age; men referred with chest pain during the same 
period subsequently found to have normal coronary 
arteries.
Main outcome measures—Risk factor analysis; 
results of exercise testing and coronary angiography; 
intervention; morbidity and mortality.
Results—Women comprised 237« (202/886) of 
patients referred with chest pain who subsequently 
underwent angiography. 83/202 women had normal 
coronary angiograms compared with 55/684 men 
(417« v 87«, P <0-001). Diabetes mellitus was the only 
risk factor more frequently encountered in women 
with coronary artery disease (P*=0-001). The specifi­
city and positive predictive value of exercise testing 
before angiography were significantly lower in 
women than men (717. v 937«, P <  0-001 and 767. v 
957«, P<0-001, respectively). Revascularisation pro­
cedures were as common in women with coronary 
artery disease as in men (81 (687.) v 70 (59%)), 
and there was no difference in event rate during 
follow up. Many patients with normal coronary 
arteries, irrespective of sex, had symptoms 
during follow up (61 (737.) women, 36 (657.) men) 
and continued to take antianginal drugs (27 (337.) 
women, 14 (287.) men); 14 (177.) women and six
(11%) men required hospital readmission for severe 
symptoms.
Conclusions—In this series, although women 
comprised the minority of patients referred with 
chest pain, a diagnosis of normal coronary arteries 
was five times more common in women than men. 
Risk factor analysis and exercise testing were of 
limited value in predicting coronary artery disease in 
women. There was no sex bias regarding revascu­
larisation procedures, and outcome was similar. A 
diagnosis of non-cardiac chest pain in patients with 
normal coronary arteries was of little benefit to the 
patient with regard to morbidity.
Introduction
Chest pain in women is a commonly encountered 
condition which accounts for an appreciable number of 
referrals to cardiologists for further evaluation. The 
symptom of chest pam has many causes which may or 
may not be cardiac in origin, and difficulty arises in 
establishing whether or not the patient’s symptoms 
can be ascribed to reversible myocardial ischaemia. 
Coronary angiography is the entenon for establishing a 
diagnosis of coronary artery disease.
The reasons for referral for cardiac invesngauon are 
mulufactorial and generally take into account the 
seventy of the symptoms and the perceived likelihood 
of coronary artery disease. For example, increasing age 
and the presence of several recognised nsk factors for 
coronary artery disease would tend to lower the 
threshold for referral. Patients with positive results on 
an exercise test are more likely to be further investi­
gated, but ST segment shift with exerase is a less 
specific marker of coronary artery disease in women. " 
Many patients referred with chest pam for investi­
gation undergo coronary angiography. However, 
coronary angiography carries a small but well docu-
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Complaints of cognitive decline in the elderly: a 
comparison of reports by subjects and informants in
a community survey
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A J. M A C K I N N O N  a n d  R. SCOTT
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s y n o p s i s  In a community survey, subjects and their informants were asked the same questions 
about memory and intellectual decline in the subjects. Subjects and informants both commonly 
reported cognitive decline, although in most cases the decline was not seen as interfering with daily 
life. However, when responses from subjects and informants were cross-tabulated, agreement was 
found to be poor. For subjects, reports of cognitive decline were correlated with anxiety and 
depression symptoms and with trait neuroticism. Subjects’ reports were uncorrelated with age and 
only weakly correlated with cognitive, test performance, indicating little validity. By contrast, 
informants’ reports were correlated with the subjects’ cognitive test performance and age, but also 
with the informants’ own anxiety and depression symptoms. Although informants' reports have 
validity, they may also be contaminated by the informants' affective state.
INTRODUCTION
Complaints of a decline in memory function are 
relatively common in the elderly (Cutler &
Grams, 1988; Poitrenaud et al. 1989; Bolla et at.
1991), although in most cases this decline is not 
felt to be a handicap in everyday life (Sunderland 
et al. 1986). The evidence on whether such 
complaints increase with age is mixed, with 
some studies finding an increase and others no 
change (Hermann, 1982; Cutler & Grams, 1988;
Bolla et al. 1991).
A surprising finding is that memory com­
plaints are not clearly related to objectively- 
tested memory performance. Many cross-sec­
tional studies have found small or non-existent 
associations between complaints and tested 
memory performance (Hermann, 1982; O’Hara 
et al. 1986; Sunderland et al. 1986; O’Connor el 
al. 1990) and longitudinal studies have also 
failed to find associations between self-rated 
decline and tested decline (Poitrenaud et al.
1 Address for correspondence: Dr A F. Jorm, NH&MRC Social 
Psychiatry Research Unit. The Australian National University.
Canberra. ACT 0200. Australia
1989; O'Brien et al. 1992; Taylor et al. 1992). An 
exception to these general findings is a study by 
Christensen (1991) which found objective per­
formance deficits in a subgroup of complainers 
who rated themselves as having a recently 
acquired memory deficit which was worse than 
their peers. Christensen also found that com­
plainers were impaired when their memory 
performance was evaluated relative to pre- 
morbid intelligence
There appear to be a number of non-memory 
factors which are important determinants of 
memory complaints. Foremost of these is de­
pression, which has emerged as the best correlate 
of memory complaints in several studies (Kahn 
et al. 1975; O’Hara et al. 1986; McGlone et al. 
1990; O’Connor et al. 1990; Bolla et al. 1991). 
One study has found that the personality trait of 
neuroticism is related to memory complaints, 
while the trait of extra version is not (Poitrenaud 
et al. 1989). This finding is consistent with 
studies relating complaints to depression, be­
cause neuroticism and depression are themselves 
highly correlated (Watson & Clark. 1984). 
Another correlate of complaint may be edu­
cation. Cutler & Grams (1988) found that less
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educated people were more likely to complain of 
memory problems, while Bolla et al. (1991) 
found a similar association with low verbal 
intelligence which is itself correlated with poor 
education.
In contrast to the results with subjective 
complaints, informant reports of memory de­
cline arc related to objectively tested perform­
ance (see Jorm, 1992. for a review). Furthermore, 
informant reports have been found to be 
uncorrelated with other characteristics of 
subjects such as depression (McGlone el al. 
1990) and education (Jorm & Korten, 1988).
The present paper reports the results from a 
community survey of elderly people in which 
subjects and informants w'ere asked parallel 
questions about cognitive decline in the subjects. 
The study included a global question about 
memory decline and w-hether this interfered with 
daily life, as well as specific questions dealing 
w'ith particular aspects of everyday memory. 
There was also a global question about decline 
in thinking and reasoning and whether this 
interfered with daily life. While memory com­
plaints have been extensively investigated, it is 
surprising that complaints of intellectual decline 
have been ignored. It is not known whether 
complaints of intellectual decline have any 
greater validity than memory complaints. The 
present paper examines whether these com­
plaints of memory and intellectual decline are 
related to objective measures of memory per­
formance, current intellectual function and an 
estimate of pre-morbid intelligence. The paper 
also examines relationships between cognitive 
complaints and other characteristics of the 
subjects: depression and anxiety symptoms, 
neuroticism and education. While depression in 
the subject has been shown to be related to 
memory complaint, depression in the informant 
has not been investigated in relation to their 
reports. The present study assessed anxiety and 
depression symptoms in informants, making it 
possible to assess w'hether depression in the 
informants affects assessments of the subject. 
Such an effect is suggested by research on 
parents' reports of children’s behaviour which 
has shown that depression in the parent is 
associated with a negative perception of the 
child's behaviour (Schaughency & Lahey. 1985; 
Brody & Forehand, 1986; Webster-Slratton & 
Hammond, 1988).
METHOD 
The sample
The subjects were a sample of elderly persons 
living in the community, from the Australiat 
city of Canberra and adjacent town oi 
Queanbeyan The elderly were sampled from the 
electoral roll which is a register of eligible voters 
To assist the present study, the Australian 
Electoral Commission supplied a computer tape 
of elderly voters giving dates of birth. Regis­
tration on the electoral roll is compulsory for all 
Australian citizens aged 18 or more, although 
individuals can be taken off the roll in certain 
circumstances such as severe illness or disability. 
Individuals who are taken off the roll are mainly 
those residing in nursing homes or other 
sheltered accommodation. A separate sample 
was taken of elderly residents of institutions, but 
only the community sample is used in the 
present paper. The sample was drawn to give an 
equal achieved sample of males and females. For 
each sex, there were three age strata (70-74 
years, 75-79 and ^  80), with each stratum 
sampled to give an achieved sample which was 
proportional to the number of individuals in the 
population in that age group.
The persons sampled were sent a letter inviting 
participation in the survey and then approached 
at home by trained interviewers. The purposes 
of the study and what was asked of the 
participant were explained orally. If a person 
was unable to give informed consent by reason 
of disability, the principal caring relative was 
asked. If an interview was granted, the subject 
was asked at the end to nominate a close relative 
or friend who knew them well and would be able 
to describe their present circumstances. An 
interview was then sought from the informant 
nominated.
Of 745 females selected, both subject and 
informant interviews were obtained from 336, 
only subject interviews from 104 and only 
informant interviews from 25. Of 632 males 
selected, both subject and informant interviews 
were obtained from 361, only subject interviews 
from 96 and only informant interviews from 23. 
The refusal rate (no subject or informant 
interview) was therefore 38% for females and 
24% for males. Across age groups, the refusal 
rate was similar: 30% for 70-74 years. 34% for 
75—79 years, and 30% for ^  80 years However,
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because of missing data, the number of subjects 
used m the present article is smaller than this. 
The sample used in the present paper comprised 
the 431 females and 446 males who answered 
questions about cognitive decline. Informant 
reports on cognitive decline were available on 
362 female and 382 male subjects.
Interview with subjects
The subject interview collected the information 
necessary for a diagnosis of dementia or de­
pression using the Canberra Interview for the 
Elderly (Social Psychiatry Research Unit, 1992), 
as well as information on social background, 
physical health, personality, social support, 
mental activity, self-reported cognitive function 
and use of services. In the present paper, only 
the information on reports of cognitive decline, 
cognitive test performance, anxiety and de­
pression symptoms and personality is used.
A test-retest reliability study has previously 
been carried out on a clinical sample using many 
of the same questions and tests as the present 
study. Where test-retest data are available, the 
relevant reliabilities are reported below.
Global ratings o f memory decline
Subjects were asked: ‘Overall, do you feel you 
can remember things as well as you used to? 
That is, is your memory the same as it was 
earlier in life?’. Responses were recorded as: 3, 
‘N o ';  2, ‘Depends, sometimes’; or 1, ‘Yes'. 
Subjects who responded ‘N o ’ or ‘Depends’ 
were then asked: ‘ Does this interfere in any way 
with your day to day life?' Responses were 
recorded: 1, ‘N o ’; 2, ‘Yes’, or ‘Does not 
know’. Subjects who responded ‘Yes’ or ‘Does 
not know’ to the second question were asked: 
How long ago did this change in your memory 
start?’. For the question on memory decline 
interfering with life, subjects reporting no mem­
ory change were classified with those reporting 
no interference.
Global ratings o f intellectual decline
Subjects were asked: ‘ Do you feel you can think 
and reason as clearly as earlier in life?’ 
Responses were recorded as: 1, ‘Yes’; 2, ‘N o ’ 
or ‘ Don’t know’. Those who responded ‘No' or 
'D o n ’t know' were then asked: ‘Does this 
interfere in anyway with your day to day life0' 
n
(1, ‘ N o ' or 2, ‘ Yes’) and if there was interference:
' How long ago did this change start?'. Again, 
subjects who reported no change on the first 
question were classified with those reporting no 
interference on the second question.
Memory decline scale
Subjects were also asked a series of questions 
about change in specific areas of everyday 
memory. These questions were: ‘Do you have 
more trouble remembering things that have 
happened recently?’; ‘Are you worse at remem­
bering where belongings are kept?’; ‘Do you 
have trouble recalling conversations a few days 
later?’; ‘ Do you have more trouble remembering 
appointments and social arrangements?’. 
Responses to all questions were rated on the 
same scale: 0, ‘No, not much worse’; 1, ‘A bit 
worse'; 2, ‘Yes, a lot worse’. The ratings from 
the four items were summed to give a score from 
0 to 8.
Mini-Mental State Examination (MMSE)
This test was developed by Folstein el al. (1975) 
as a means for clinicians to grade the cognitive 
state of their patients. The present study used a 
version of the MMSE which has been used in 
other community surveys (Holzer et al., 1984). 
The test gives a score from 0 to 30. In the retest 
study, the reliability of the MMSE was 0 80 
(N = 64).
National Adult Reading Test (NART)
This test requires the subject to read aloud 50 
English words which have irregular spellings. 
The test was developed by Nelson & O'Connell 
(1978) to estimate pre-morbid intelligence in 
demented patients. In the retest study, reliability 
was found to be 0-79 {N = 33).
Symbol-Letter Modalities Test 
This test is part of the Canberra Interview for 
the Elderly (Social Psychiatry Research Unit. 
1992). It is similar to the Digit-Symbol subtest 
on the Wechsler Adult Intelligence Scale-Revised 
(Wechsler, 1981) and the Symbol Digit 
Modalities Test (Smith. 1982). The test was 
examined in the present analyses because it is a 
good measure of fluid intelligence and such 
measures are known to be sensitive to age- 
related intellectual decline. In the test, subjects
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had to say out loud the letters that went with 
geometric symbols. The score was the number of 
letters correctly called out in 90 s. The retest 
reliability was 0 81 (/V = 52).
Episodic memory
Subjects were given four brief tests of episodic- 
memory, two verbal and two non-verbal. The 
tests were: three-word recall, name and address 
recall, face recognition and figure reproduction. 
These tests have been described by Jorm (1992). 
Scores from the four tests were added together 
to give an episodic memory score ranging from 
0 to 16. The retest reliability was 0 83 (N = 46).
Anxiety and depression symptoms
Subjects were given the nine anxiety questions 
and the nine depression questions described by 
Goldberg et al. (1988). The questions were asked 
orally. The anxiety and depression symptoms 
were counted to give scores from 0 to 9. The 
validity of these scales in the present sample has 
been reported by Mackinnon et al (1994).
Personality
During the interview, subjects were asked to fill 
out a questionnaire consisting of the neuroticism 
and extraversion scales of the short form of the 
Eysenck Personality Questionnaire Revised 
(Eysenck et al. 1985). There were 12 neuroticism 
items and 12 extraversion items, with the two 
types of item alternated.
Interview with informants
Informants were given the informant section of 
the Canberra Interview’ for the Elderly (Social 
Psychiatry Research Unit, 1992). Information 
was also collected on disability and use of 
services. At the end of the interview, informants 
reported on their own health and on anxiety and 
depression symptoms. Described below' are the 
items of information used in the present paper 
Test-retest reliability is reported where relevant 
data are available.
Global ratings o f memory decline
Informants were asked a set of questions parallel 
to those asked to the subjects: ‘ In vour opinion,
does------------remember things as well as s/he
used to? That is. is her/his memory the same as 
it was earlier in life 7 ;" Does this interfere in any
way w'ith her/his day to day life?’; and 'Ho\y 
long ago did this change in her/his memorv 
start?' Retest reliability of the question qq 
memory decline was 0 71 (A = 70) and for thfc 
question on interference with life it was 0-7j 
(A'= 69)
Global ratings of intellectual decline
Informants w'ere asked a set of questions parallex 
to those asked to the subjects: ' In your opinion
can ----------- think and reason as clearly as
earlier in life9'; ‘Does this interfere in any way 
with her/his day to day life9': and ‘How long 
ago did this change start?’. The retest reliability 
of the intellectual decline question was 0-7] 
(/V = 70) and of the interference question wa< 
0-64 (A = 70).
Memory decline scale
Intormanis were again asked questions par­
alleling those asked to the subjects: ‘Does
----------- have more trouble remembering things
that have happened recently?'; ‘ I s -----------
worse at remembering where belongings are 
kept9'; 'Does s/he have more trouble recalling 
conversations a few days later9'; and ‘Does 
s/he have more trouble remembering appoint­
ments and social arrangements?' Retest re­
liability of the scale was 0 92 (A = 63).
Anxiety and depression symptoms
The informants were asked about these 
symptoms in themselves using the scales of 
Goldberg et al. (1988). The informants filled out 
a questionnaire, in contrast to the subjects who 
had the questions read out to them.
Statistical analysis
The frequency of complaints in the sample was 
calculated in terms of percent prevalence. 
Internal reliability of scales was assessed using 
coefficient alpha. Agreement between subjects 
and informants on the same questions was 
quantified using the kappa coefficient. As 
recommended by Cicchetti & Feinstein (1990), 
proportion of positive and negative agreement 
(Ppoi and Pne?) were calculated along with kappa. 
All other relationships between variables were 
quantified using Pearson correlations. Where 
one of the variables being correlated w;as 
continuous and the other dichotomous, the 
Pearson correlations are poim-biserial co-
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Table 1 Prevalence (and 95% Cf) of cognitive decline according to subjects and informants
S u b j e c t s I n f o r m a n t s
Q u e s t i o n %  ( 9 5 %  C l ) %  ( 9 5 %  C l )
M e m o r y  s a m e  a s  e a r l i e r  i n  l i fe
N o 6 2  0 ( 5 8  7 6 5  2) 4 9  0  ( 4 5  3- S2 6i
D e p e n d s 8 5 (6 6  10 4 ) 6  7 (4 9 8 5)
Y e s 29  2 ( 2 6  2 32 3) 4 4  2 ( 4 0  6  4 7  9 1
D o n ' t  k n o w 0  2 (0 0  0  6) 0  1 ( 0 C 3 )  2)
M e m o r y  d e c l i n e  w h i c h  i n t e r f e r e s  w i t h  l i fe
N o  ( i n c l u d e s  s u b j e c t s  r e s p o n d i n g 9 3  7 ( 92  0 - 9 5  3) 8 6  8 (8 4  4  89  2)
' y e s '  a b o v e )
Y e s 6  3 (4 7 8 0 ) 12 4 ( 1 0  1 - 1 4  8)
D o n ’t  k n o w 0  (0  0  0  0 ) 0  8 ( 0  1-1 4)
D u r a t i o n  o f  m e m o r y  d e c l i n e
N o  d e c l i n e 9 3  8 ( 9 2  2 - 9 5  4) 8 7  3 (8 4  9 - 8 9  7)
0 - 5  y e a r s 4 2 (2 8 -5 5) 8 3 (6  4  10 3)
6 - 1 0  y e a r s 0  5 ( 0  1 - 0  9 ) 2 4  (1 3 - 3  5)
>  10 y e a r s 0  6  (0  1 - 1 1 ) 1 1 ( 0  4 - 1  8)
D o n ' t  k n o w 1 0  (0  3 - 1 6 ) 0  9  ( 0 -2 -1  6)
T h i n k  a n d  r e a s o n  a s  e a r l i e r  i n  l i f e
N o / d e p e n d s 30  0 ( 2 6  9 - 3 3  0 ) 31 4 (2 8  1 - 3 4  8)
Y e s 6 8  8 ( 6 5  7 - 7 1  9 ) 6 8  3 (6 4  9 -  71 6)
D o n ' t  k n o w 1 2 ( 0  5 - 2 0 ) 0  3 (0  0 - 0  7)
I n t e l l e c t u a l  d e c l i n e  w h i c h  i n t e r f e r e s  w i t h  l ife
N o  ( i n c l u d e s  s u b j e c t s  r e s p o n d i n g 9 5  3 (9 3  9 - 9 6  8) 8 9  1 ( 8 6  9 - 9 1  3)
' y e s ' a b o v e )
Y e s 4 7 (3  2 - 6  1) 10 7 ( 8 4 - 1 2  91
D o n ' t  k n o w 0  (0  0 - 0  0 ) 0  2 (0  0 - 0  6)
D u r a t i o n  o f  i n t e l l e c t u a l  d e c l i n e
N o  d e c l i n e 9 5  5 ( 9 4  1 - 9 6  9 ) 8 9  2 (8 7  0 - 9 1  5)
0 - 5  y e a r s 3 0  (1 8 - 4  2) 6  7 (5  0 - 8  5)
6 - 1 0  v e a r s 0  8 (0  2 - 1 3 ) 2 - 4 ( 1  3 - 3  5)
>  10 y e a r s 0  1 ( 0 0 - 0  3) 1 0  (0  3 - 1  7)
D o n ' t  k n o w 0  6  ( 0 1 - 1 - 1 ) 0  6 ( 0 0 - 1  2)
efficients, while where both variables are di­
chotomous, they are phi coefficients. Because of 
the large number of correlations examined, the 
more conservative P <  0 01 level was chosen for 
statistical significance. However, with the present 
large sample size, statistically significant corre­
lations are often quite small, so the magnitude of 
the coefficients was the primary guide to in­
terpretation. Relationships between complaints 
and sets of other variables were examined using 
multiple linear regression.
RESULTS
Global questions on cognitive decline
Table 1 shows data on the prevalence of cognitive 
decline according to subjects and informants. 
To allow for the over-weighting of males in the 
sample, the prevalence rates have been weighted 
back to the age and sex breakdown of the 
population. It can be seen that memory decline
was commonly reported by both subjects and 
informants. Intellectual decline was reported 
less frequently than memory decline. However, 
in only a minority of cases was the memory or 
intellectual decline reported to interfere with 
daily living. Interference was reported more by 
informants than by subjects. Where cognitive 
decline was reported by the subject or informant 
to interfere with daily life, it was most often seen 
as beginning within the previous five years. 
These prevalence rates for reports of decline can 
be compared to the prevalence of cognitive 
impairment according to the MMSE (scores of 0 
to 23), which in this population was 7-2% 
(95% Cl: 5 6—8-9).
For both subjects and informants, ratings of 
memory decline were found to be correlated 
with ratings of intellectual decline. For the 
subjects, the memory decline rating correlated 
0 33 with the rating of intellectual decline. When 
decline which interfered with life was considered,
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Table 2. Correlations betw een cognitive test scores and reports o f cognitive decline
Cognitive test
Symbol-letter Episodic
Measure of decline MMSE NART modalities memory
Subject reports
Memory decline 004 008 0 06 0 01
Memory decline interferes - 0  09* 005 - 0  04 - 0  15*
Intellectual decline - 0  09 - 0  09 - 0  12* - 0  12*
Intellectual decline interferes — 013* - 0  01 - 0  10* - 0  13*
Memory decline scale - 0 1 3 * 0 01 - 0  06 -  0 14*
Informant reports
Memory decline - 0  12* - 0  02 - O i l * - 0  12*
Memory decline interferes - 0 2 7 * - 0 0 5 - 0  19* - 0  28*
Intellectual decline - 0 3 0 * - 0  14* - 0 2 5 * - 0  29*
Intellectual decline interferes -0-28* - O i l * - 0 2 0 * - 0  27*
Memory decline scale - 0  39* - 0  12* - 0  27* - 0  38*
• P < 0 0 l
Note: A/s for subject reports were 808-868 and Ns  for informant reports were 623-687
the correlation rose to 051. Similarly for 
informants, the correlation between the ratings 
of memory and intellectual decline was 0 39, but 
for decline which interfered with life it rose to 
0-60.
Subject and informant scales of memory decline
The four subject items on specific areas of 
memory decline were found to have a coefficient 
alpha of 0-71. The corresponding informant 
items had an alpha of 0 80. The distribution of 
both scales was found to be skewed. Of the 863 
subjects who had data on all items, 37-4 % 
reported no change on any item. For the 704 
informants with complete data, 46 9% reported 
no change on any item.
Subject/informant agreement
When the responses from subjects and 
informants on the global questions were cross- 
tabulated, little agreement was found. For the 
memory decline question, kappa was 0-18 (agree­
ment on decline Ppos = 0 63; agreement on non­
decline P neg = 0-53), and for the question about 
memory interfering with life it was 0 24 (Ppos = 
0 31; P neg = 0 93). Similarly, for the question on 
intellectual decline kappa was 017 (agreement 
on decline Ppos = 0-40; agreement on non-decline 
n^eg = 0-77) and for the question on intellectual 
decline interfering it was 021 (P =0-26; 
P n e g  = 0 94).
When the subject and informant memory 
scales were correlated, agreement was also found 
to be low, with a correlation of 0 36 (N = 646).
Relationship to sociodemographic 
characteristics
Correlations were calculated between reports of 
decline and the subjects' age, sex and years of 
education. Informants tended to report more 
cognitive decline with advancing age of the 
subject (correlations ranging from 0 11 to 0-20), 
but the subjects themselves did not (range —0 04 
to 0 09). There was also a weak trend for males 
to report more cognitive decline (range of 
correlations 002 to 010). Education was not 
correlated with either subjects' or informants’ 
reports of cognitive decline (ranges of —0 04 to 
0 07 and —0 08 to 0 01, respectively).
Correlations were also calculated between 
informants' reports of cognitive decline and 
their age and sex. All correlations were small 
and non-significant.
Relationship to cognitive tests
Correlations were calculated between the 
measures of cognitive decline and the cognitive 
tests. The correlations are shown in Table 2. For 
all the cognitive tests, a high score indicates 
good performance. For subject reports of cog­
nitive decline, there were a number of significant 
correlations, but the magnitude of the associa­
tions was small. For informant reports, most 
correlations were significant and the correlations 
were uniformly higher than for subject reports.
Because correlation coefficients measure only 
linear association, it is possible that the corre­
lations with subject reports are small because
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T a b ic  3. Correlations between affective characteristics o f subjects and informants and reports o f
cognitive decline
Subject characteristics
Informant
characteristics
Measure o f decline Anxiety Depression Neuroticism Anxiety Depression
Subject reports 
Memory decline 0 12* 0 22* 0 13* - 0  02 000
Memory decline interferes 0 14* 0 18* 0 16* 003 007
Intellectual decline 0 14* 0 26* 0 20* - 0  02 004
Intellectual decline interferes 0 12* 0 16* 0 17* 001 009
Memory decline scale 0 21* 0 .71* 0 24* 009 0 15*
Informant reports 
Memory decline 007 009 0 10 O il* 007
Memory decline interferes 007 0 13* 006 0 10» 009
Intellectual decline 007 009 0 14* 0 16* 009
Intellectual decline interferes 008 0 10 0 12* 0 14* Oi l *
Memory decline scale 009 008 0 12* 0 16* 0 18*
* P < 0 01
N ote: Ns for subject reports were 617-846 and Ns for informant reports were 527-710
there are curvilinear associations with cognitive 
performance. Such associations could arise, for 
example, if subjects with very good or very poor 
performance were less likely to complain of 
cognitive decline than those with intermediate 
performance. To check this possibility, all the 
associations were plotted and inspected for non­
linear trends, but none were found.
Most of the cognitive tests used in the study 
measure current cognitive function, whereas the 
subjects and informants reported on cognitive 
decline. Following Christensen (1991). cognitive 
decline can be estimated by using the N A R T as 
an indicator o f  pre-morbid intelligence. Ac­
cordingly, all cognitive test scores were converted 
to standardized form and N A R T  scores were 
subtracted from each of the other cognitive test 
scores. The resulting difference scores were then 
correlated with the subject and informant 
reports. This procedure did not produce an 
overall increase in the size o f  the correlations. 
While some individual correlations increased 
slightly, others became smaller.
Relationship to affective characteristics of 
subjects
Subject and informant reports were correlated 
with anxiety, depression and neuroticism score 
in the subjects. These correlations are shown in 
the left half of Table 3. Subject reports of 
cognitive decline were consistently found to be 
correlated with these variables. There was also a 
tendency for informants to report more decline
in subjects with high neuroticism scores, but the 
association was weaker than for the subject’s 
own reports. Correlations were also calculated 
between reports of decline and the subject’s 
extraversion score (not shown in Table 3). The 
correlations were all small. The only significant 
correlation was between extraversion and subject 
reports of memory decline interfering with life 
(r =  - O  i l ,  A =  674).
As would be expected, the affective variables 
were themselves highly intercorrelated. Anxiety 
correlated 0 55 with depression (A = 674), neu­
roticism 0 43 with depression (A = 696), and 
neuroticism 048 with anxiety (A = 691).
Relationship to affective characteristics of 
informants
The right-hand side of Table 3 shows the 
correlations between cognitive decline ratings 
and anxiety and depression in the informants. It 
can be seen that anxiety and depression in the 
informants are correlated with their ratings of 
the subjects. By contrast, informant anxiety and 
depression scores are not consistently correlated 
with the subjects’ ratings of their own decline.
The informants’ anxiety and depression scores 
were found to be correlated 0 61 (A = 663).
Multiple regression analysis
Inspection of the pattern of correlations in 
Tables 2 and 3 reveals a fairly consistent pattern : 
subjects' ratings of decline are correlated most 
highly with their affective characteristics and
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I able 4 Multiple regression analyses predicting 
subject and informant scales of memory decline
Subject scale Informant scale
of memory ol mentors
decline decline
Predictor variable Beta / Beta ;
Subject's age - 0  02 0 45 0 04 0 06
Subject's MMSE score -  0 08 -  1 70 -0  15 1 14*
Subject's depression 0 26 X 46* 00 6 1 15
score
Informant's depression 0 1 1 2 4X 0 16 .1 5 7 *
score
• P < 0 01
only weakly with cognitive test performance. By 
contrast, informants’ ratings are correlated with 
age of the subjects, with cognitive test per­
formance and with the informants' affective 
state.
To confirm these associations in a multivariate 
analysis, variables having the best univariate 
correlations were selected. The subject and 
informant scales of memory decline were selected 
as the dependent variables and subject's age. 
MMSE score, subject’s depression score and 
informant s depression score as the predictor 
variables. Multiple linear regression analyses 
were carried out using these variables. Beta 
weights for the predictors are shown in Table 4 
For the subjects’ scale of memory decline, only 
the depression score emerged as a significant 
predictor. The adjusted R2 for the regression 
was 015. For the informant’s scale of memory 
decline. MMSE score and the informant's 
depression score had significant beta weights 
The adjusted R2 was 0 05
DISCUSSION
Consistent with previous research, the present 
study has found that complaints of cognitive 
decline are common in the elderly. Informants 
were also found to report that cognitive decline 
is common and both subjects and informants 
reported memory decline more frequently than 
intellectual decline. However, as found by 
Sunderland et al. (1986). in only a small 
proportion of cases did subjects or informants 
believe that the cognitive decline interfered with 
everyday life.
Although subjects and informants appear to
give the same general picture about cognitive 
decline, there was little agreement when their 
reports were cross-tabulated, indicating a lack 
of validity in one or both sources of information 
When the subjects' and informants’ reports were 
correlated with cognitive tests, the subjects’ 
reports were found to have only weak corre­
lations. indicating a lack of validity. Validity 
was poor irrespective of whether subjects made 
global assessments of memory or intellectual 
decline, whether they were assessing interference 
with daily life, or whether they made ratings of 
decline in specific aspects of everyday memory 
By contrast, informants’ reports were found to 
have consistently higher correlations with cog­
nitive tests, supporting their validity. Even so, 
the correlations were smaller than has been 
reported in some previous studies (Jorm. 1992). 
A possible reason is that the sample came from 
the community and most subjects were 
functioning well. The relatively high refusal rate 
in the present study (38% for females and 24% 
for males) could also have biased the sample if 
cognitively impaired persons were more likely 
to refuse. We have no information on whether 
either cognitive or affective state influenced 
refusal. Nevertheless, correlations with infor­
mants' reports may be higher in clinical samples 
where cognitive decline is more prevalent.
Another factor which could potentially have 
reduced the size of the correlations is that the 
subjects and informants rated cognitive decline, 
whereas the cognitive tests measured function at 
only one point in time. The measurement of 
cognitive decline requires at least two assess­
ments. However, an indirect assessment of 
decline can be made by comparing a test w'hich 
holds up well in ageing and dementia with one 
w'hich does not. When this approach was used, 
the size of correlations did not increase for either 
subjects or informants. This finding does not 
support Christensen's (1991) study which found 
that self-reports of memory decline w'ere related 
to estimates of decline using ‘hold’ and 'don’t 
hold tests. Nevertheless, the cognitive tests used 
in the present study may be relatively blunt 
instruments for detecting early decline which 
may be noticeable to the individuals affected. 
The present data came from the first wave of a 
longitudinal study, so that it wall eventually be 
possible to assess whether complaints have 
predictive validity
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Memory Complaints of Elderly People m a 
Population Survey: Variation According to 
Dementia Stage and Depression
Michaela Grut, MD,* Anthony F. form, PhD,*] Laura Fratiglioni, MD,* Yvonne Forsell, MD,*
Math Viitanen, PhD,* and Bengl Winblad, PhD*
Objective: To study the relationship between subjective 
memory complaints, cognitive functioning, and clinical di­
agnosis of dementia.
Design: Cross-sectional, total-population survey. 
Measurements: A two-phase study was done. All 2368 were 
screened by Mini-Mental State Examination (MMSE). Then 
the 314 who screened positive and a sample of 354 who 
screened negative were examined clinically (by examining 
the subject and interviewing an informant) for DMS-11I-R 
entena for dementia, Clinical Dementia Rating (CDR) scale 
for severity of dementia and the presence of memory com­
plaints or depressed mood.
Setting: An area in Stockholm, Sweden
Participants: All inhabitants of the area (2368) bom in 1912
or before, living at home or in institutions.
Results: A greater percentage of informants reported marked 
memory impairment than did the subjects themselves. Nei­
ther the informants' nor the subject' reports differed accord­
IV  / T emory complaints are common in elderly peo-
\ / |  pie. This has been reported in many clinical 
-L ▼ and volunteer samples as well as in com m u­
nity-based studies.1“4 For example, in a clinical sample, 
75% were found to complain about memory problems,1 
while in a community survey it has been reported that 
30% of normal subjects complain about memory.5
Several studies have shown that there is little rela­
tionship between memory complaints and objective 
memory' performance.1- 2-5~7 Normal elderly subjects 
who complain about memory disturbance seem to per­
form much better on objective tests of memory function 
than would be predicted from their memory com­
plaints.3 However, in clinical and population-based 
studies, demented subjects seem to report more m em ­
ory complaints than normal elderly persons. In a pop­
ulation-based study, subjects with mild and moderate 
dementia complained more about their memory than 
normais, but it is notable that 40% of the dementia 
cases did not complain.5
Most studies show a relationship between subjective
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ing to the type of dementia, but they differed clearly accord­
ing to the stage of dementia. Informants reported memory 
impairment more frequently as dementia severity increased, 
while the subjects' complaints of marked memory impair­
ment were most common in mild-moderate dementia. Fur­
thermore, non-demented subjects with marked complaints 
performed more poorly on the MMSE. Subjects with de­
pressed mood were also more likely to complain about their 
memory, both in the demented and non-demented groups. 
Conclusion: Our data show the validity of the informants' 
reports about the subjects' memory deficits. Moreover, the 
study confirmed the clinical impression that the patient's 
own complaints should not be ignored, as subjects in the 
mild stage of dementia often have some insight into their 
own memory deficit. However, depressed individuals mav 
underestimate their own memory, and individuals with mod­
erate-severe dementia may overestimate theirs. } Am Geriatr 
Soc 41:1295-1300, 1993
memory complaints and depression,1,6' 8 9 but there are 
some exceptions.3 Depressed people have more com ­
plaints of memory deficit than normal elderly people 
This tendency also applies in demented patients, with 
those who are also depressed being more likely to 
complain.1 5
Most of the studies of memory complaint are based 
on clinical series and are not ideal because patients 
who self-refer may be a biased group. There has been 
a recent epidemiological study on this topic,5 but this 
involved a restricted range of subjects in that it ex­
cluded those with good cognitive performance
The issue of staging of dementia is also important. 
Grouping all dem ented cases together may be m islead­
ing. Mild cases may have more insight than the m od­
erately or severely demented. It has been reported that 
demented patients who needed nursing care had a l­
most no complaints, in contrast to dem ented patients 
who could take care of themselves.10
In conclusion, the review of the literature suggests 
the need for a total population-based study on subjec 
tive memory complaints, which takes into account the 
staging of dem entia as well as other variables that 
could influence memory complaints.
In contrast to w hat has been found with subjects 
complaints, the literature on inform ants' reports o r 
poor memory indicates that they have greater validity 
The findings from inform ant instruments are consistent 
in showing that these can disenmmate various clinical 
groups from normals, including cases of dementia, 
head injury, and amnesia Informants' reports also
I ACS 41 1295-1300.1993
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correlate with cognitive tests and discriminate between 
different levels of dementia."
The present study is based on a community survey 
involving all inhabitants of an area in Stockholm born 
in 1912 or before The subjects were evaluated for the 
diagnosis of dementia and staged according to level of 
seventy. The aim of the paper is to study the relation 
ship between memory complaints, cognitive function­
ing, and clinical diagnosis of dementia The subjective 
memory complaints were examined as a function of 
dementia diagnosis, stage of dementia, and presence 
or absence of depressed mood. A similar analysis was 
performed on the data concerning the informants' re­
ports of subjects' memory problems
MATERIALS AND METHODS
The present study is based on the Kungsholmen 
Project, the design of which has been descnbed in 
detail elsewhere.12 In summary, the project is based on 
all the inhabitants of the Kungsholmen area of Stock­
holm in October 1987 who were born in 1912 or before. 
There were 2368 individuals, 1800 females and 568 
males, living at home or in an institution, who met 
these criteria In order to find suspected dementia cases, 
a two-phase study design was used. During Phase I, 
the Mini-Mental State Examination (MMSE)’3 was used 
as a screening test. It was translated into Swedish, and 
the total possible score was 30." A cut-off point of 23/ 
24 was used to detect suspected demented subjects. 
Dunng Phase II, 668 subjects were extensively inves­
tigated in order to reach a final diagnosis of dementia 
and to differentiate types of dementia. They were the 
314 subjects who screened positive (MMSE score < 23; 
suspected demented) and a sample of 354 of the sub­
jects who screened negative (MMSE > 24; suspected 
non-demented). The sample of screened negatives was 
selected from all the screened negatives but matched 
by gender and age (± 5 years) with the screened 
positives. The investigation consisted of a comprehen­
sive clinical examination earned out by a physician, 
laboratory tests, and an informant interview performed 
by a nurse.
The informant was named by the subject as the 
pnmary caregiver. When the subject was unable to 
nominate an informant, the nurse from the home-care 
service or from the institution was asked for the name 
of the closest relative. The informants were spouses 
(16%), children (40%), siblings (26%), and other rela­
tives (19%).
The diagnosis of dementia and different types of 
dementia was reached by means of a diagnostic pro­
cedure according to DSM-III-R criteria.15 The number 
of subjects who were diagnosed as demented was 225, 
116 of the screened positives and nine of the screened 
negatives. Of these, 52% had Alzheimer's disease, 23% 
had vascular dementia, and the rest had other types of 
dementia.16
Staging of the seventy of dementia was made using 
the Clinical Dementia Rating scale (CDR), which clas­
sified cases as Questionable, Mild, Moderate, or Se­
vere.17 Among the dementia cases, the staging showed 
that 23 were Questionable, 60 were Mild, 99 were
iacs-decemblr J W - rol  41. \'o
Moderate, and 42 were Severe, one case was not Das 
sified as the data were not sufficient
The medical examination included a scale for rating 
psychiatric symptoms and signs, a subset of the Conv 
prehensive Psychopathological Rating Scale (CPRS)
In order to find subjects with memory complaints, we 
used one item from this scale in which the subject was 
asked about his/her memory The answer was recorded 
on a three-point scale: (1) no memory complaints, (2) 
occasional memory disturbances, and (3) the disturb 
ance was embarrassing or the subject complained of 
almost total memory loss. This item has previously 
been shown to have high inter-rater reliability.20
In the informant interview, the informant was asked 
if he/she found the memory of the subject to be 
impaired. The informant had three alternatives to 
choose from in answering this question: unchanged, 
some impairment, or considerable impairment. For ease 
of reference, we hereafter use the terms none, sl ight ,  
and marked  to describe the three levels of memory 
impairment as distinguished by both the subjects and 
the informants.
'Depression' was assessed as current depressed 
mood using two items from the CPRS. One item con­
cerned self-reported depressed mood, and the second 
concerned depressed mood as observed by the physi­
cian. These two items were rated on a four-point scale 
ranging from normal mood to extreme sadness and 
depression. A score of 0 indicated no depressed mood,
1 and 2 slight depressed mood, and 3 marked de­
pressed mood. These items have previously been 
shown to have high inter-rater reliability ‘u The inform­
ant interview also contained one question on current 
depression. This question asked whether the subject 
was noted to be depressed often, somet imes ,  or never.
The data analysis compared subjects in various 
groups by using means for continuous measures (age, 
MMSE) and proportions for categoncal measures (stage 
and type of dementia, depressed mood, education, and 
sex). The relationships between different vanables 
were tested using the Pearson correlation coefficient. 
When the influence of a third variable needed to be 
controlled, partial correlation analysis was used." Fi­
nally, percent agreement and the Kappa statistic were 
used to quantify the agreement between the subjects 
and the informants' reports 22
RESULTS
Among the 668 subjects who underwent the medical 
examination, data on subjective memory complaints 
were missing in 54 cases and data from the informant 
interview about the subject's memory were missing in 
162 cases. The number of subjects in the various CDR 
stages who had data on memory complains was 436 
Non-demented, 21 Questionable, 57 Mild, 79 Moder­
ate, and 21 Severe. The number of informants who 
reported on memory problems according to different 
CDR stages was 332 Non-demented, 13 Questionable, 
47 Mild, 82 Moderate, and 32 Severe.
When socio-demographic vanables such as age, sex, 
and education were examined separately for the de­
mented and non-demented subjects, similar distnbu-
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C0n r0 t ° r T ? reSSed m° 0d r3ted bv the Physician
made little  difference in the results
Qc l able 2 shows the mean value of the MMSE and 
95 7o confidence intervals according to subjective mem 
ory complaints and the informant's judgment of the 
ubject s memory. It also shows the percentages of
I h Z  l  ad ? T ntS rep0rtm8 nü memorv d fneits-Ig n t, and marked memory disturbances These ner 
centages d.ffered greatly for the subjects and th /m -  
fomrams Äeeordang 10 the sublets, there were only 
, ‘ l r o d  8r ° uP w,lh marked complaints, compared
Fo b o d iC "  lheKcomParable for the informants 
For both the subjects and the inform ants’ tudgments
e group w ith  marked memory problems was found
C  s i , e h , T  if, l0 W r MMSE SCOres ,han eitherthe slight or no-problems groups.
a r d r d r,h 7  T « ySIS ° r 5ub|‘-'c" VP memorv com pla ins
m Fteure8 P  Ph 51001,5 MMSE scores 15 shown
30) a8nd mThe gr0Up5 Wlth h,oh MMSE sc°res (26- ) and vMth very' poor scores (0-5) had the hiebest
percentage of subjects w ithout memorv com pla ins
teefs haCd T P d 'n,S Were m0SI frePueni w hen the sub- 
[  d moderate cognitive impairment (16-25) The
m th ^ c n 'r ^ ^ n T o ^ !  mCOumP l! In!S Were rnost frequent
could
I ’M i l l  2 1 R[ g u i  NIC Y Ol  M l ’M O I h  I M I ’A I K M j  \  1 
Kl [’OK I 1.0 B'l SUBJI C IS A N D  I N F O R M A N T S  \V1 | j |  
CORRLSPONDING MMSI i  SCORES (Ml  ANS ANT)  
957« C O N F ID I  NCI  INT I  RVAI  S)
M e m o r v  D e f i a t  
R e po r t ed  bv
Kuh|t\ I
flight
Marked
Informant
None
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21 8-23 T
5-1 8 8 18 5 16.5-20 4
124 23 5 26 0 25 2-27 0
200 3 79 249 244 -2S 5
204 38 6 13 7 12A-15Q
also be found in the group w ith  very poor cognition 
0 - - )  and in the group w ith  very' good perform ance 
(26-30) on the MMSE Bv contrast, inform ants reported 
marked impairment more frequently as the MMSE 
score decreased, whereas slight im pairm ent was re ­
ported more frequently as the scores increased
The informants were more likely than the subjects 
to report marked memory im pairm ent and less like ly  
to report no memorv impairment (Figure 2) From both 
the subjects and the inform ants' perspectives, d e ­
mented subjects were more like ly to be rated as having  
marked memory impairment than the non-dem ented ' 
However, the informants' reports more clearly d isc rim ­
inated between the demented and non-demented sub ­
jects The iniormants rated 85% of the demented sub ­
jects as having marked memory impairm ent, compared 
u ith only 15 /c of the non-demented Conversely, less 
than 1 % ot the demented subjects were rated by the 
inform ants as having no memory im pairm ent, co m ­
pared w ith  35 /c of the non-demem d W hen the rat- 
mgs of the subjects themselves wer«- ;onsidered, 19% 
of the demented and 5% of the normals saw :hem - 
selves as having marked memorv im pairm ent, whereas 
5 0 /c of the demented and 65% of the normals saw 
themselves as having no memory im pairm ent
Memory complaints had the same frequency in d i f ­
ferent types of dementia. 20% of 101 cases ot A lz ­
heim ers disease and 21% of 38 cases o f vascular
Tvni. A ll Subiects ____~Type of 
Informant
All informants
Spouses
Children
Siblings
Others
* P < 0 01 
P < 0 05
Demented Non-Demented
r r
0 23“  
(« = 506) 
0 32“
(n = 79) 
0.29“
(n = 202) 
0 . 21“
(n =  131) 
- 0  01 
('» = 94)
0 2D 
0.32* 
0 27* 
0 20 *  
- 0  01
-0  23“
(n = 174) 
- 0  29 
(h = 23) 
- 0  18 
(n = 69) 
- 0  10 
('! = 51) 
- 0  50*
(" = 31)
rp
-0  23* 
-0  24 
— 0 1 6 
-0  09 
-0  51 *
0 2 1 “
(n = 332) 
0 28*
(n =  5b)
0 23“
(» = 133) 
0.25*
('i = 80)
0 14
(" = 63)
P«rasn Correia,,,,, « « T u r o v s a l a  enroll,,,g m r d „p .
r r
0 20"  
c 2 S *
L 2 1 "  
0 22 * 
0 16
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FIGURE 1. The distribution of reported memory impairment according to MMSE score subjects' reports and informants' reports
dementia had complaints of marked memory problems. 
The informant's judgment of the subject's memory also 
did not d iffer greatly between Alzheimer's disease and 
vascular dementia (87% vs 78% reporting marked im ­
pairment).
Although neither informants' nor subject' reports 
differed according to type of dementia, the stage of 
dementia made a clear difference. In Figure 3, the 
percentage of subjects w ith marked memory im pair­
ment is shown according to the subjects' and the 
informants' reports. The subjects' complaints of mem­
ory impairment were most frequent in m ild and mod­
erate dementia (30% and 18%, respectively). When the 
subject suffered from severe dementia, only 5% had 
marked complaints. By contrast, the percentage of in ­
formants reporting marked memory impairment in ­
creased as severity of dementia increased.
In order to quantify the relationships shown in Fig­
ures 1-3, Table 3 presents Pearson correlation coeffi­
cient between subjects' and informants' reports and 
the MMSE and CDR. Table 3 also reports partial cor­
relation coefficients controlling for depression. It can 
be seen that informants' reports are correlated w ith  the 
MMSE and CDR scores, both for the sample as a whole 
and for the demented and non-demented subjects con­
sidered separately. Subjects' reports have a lower cor­
relation w ith  MMSE and CDR in the sample as a whole. 
The reason for this can be seen when the demented 
and non-demented subjects are considered separately
SUBJECTS' REPORTS
100 1
%
80-
■  Not Dc mcnied 
O  Dcmaiicd
none slight m arked 
Degree of Memory Impairment 
According to Subjects
INFORMANTS' REPORTS
■  Noi demented 
□  Dcmemed
Degree of Memory Impairment 
according to Informants
FIGURE 2. The distribution of reported memory impairment in 
demented and non-demented subjects ( %  in the two groups, sepa­
rately): subjects' reports and informants' reports
For the non-demented subjects, memory complaints 
are related to greater cognitive impairment, while for 
the demented subjects, complaints are related to lesser 
cognitive impairment.
Table 4 shows correlations between subjects' and 
informants' reports on memory deficit and measures 
of depressed mood in the subjects. Subjects' reports of 
memory deficit were correlated with depressed mood, 
both in the whole sample and in the demented and 
non-demented groups considered separately. The pat­
tem of correlations was more complex for informants' 
reports of memory deficit. For the whole sample, in ­
formants' reports of memory deficit were correlated 
with depressed mood as reported by the informants 
and rated by the physicians, but not w ith the subjects' 
own reports of depressed mood. When the sample was 
divided into demented and non-demented groups 
these results held for the non-demented group, but 
there were no correlations between depressed mood 
and informants' reports of memory deficit for the de­
mented group.
DISCUSSION
The findings of this study show interesting discrep­
ancies between subjective memory complaints and per­
formance on the MMSE. The frequency of marked 
memory complaints generally increased as perform­
ance on the MMSE got poorer, but complaints became 
less common w ith  severe cognitive impairment When 
we examined memory complaints according to staging 
of dementia, we found a similar pattem of results as 
w ith the MMSE. In the severe stage of dementia the 
subjects had almost no complaints, while in the mild 
and moderate stages, complaints increased in fre­
quency. However, we did not find that the type of 
dementia had a significant relationship to frequency of 
complaints. Previous studies that have reported on 
memory complaints in demented subjects did not take 
the type and the stage of dementia into considera­
tion . 1- 2 In agreement with other studies, depressed 
mood was found to have a positive correlation with 
memory com plaint.1' 5' 6 8 This finding held irrespective 
of whether depressed mood was assessed by subject 
report, physician's rating, or informant report.
The informants were found to be more likely to
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TABLE 3. CORRELATION BETWEEN SUBJECTS' AND 
INFORMANTS' REPORTS ON MEMORY DEFICIT 
AND THE MMSE AND CDR
MMSE CDR
r r e r Tr
Whole Sample 
Subjects' reports -0.12** -0 .10“ 0.08* 0.0 7*
Informants' re- -0.60** -0.60** 0.60“ 0.60"
ports
Demented
Subjects' reports 0.30** 0.32“ -0 .31“ -0.31“
Informants' re- -0.25** -0.33** 0.20“ 0.28“
ports
Non-Demented 
Subjects' reports 
Informants' re­
ports
-0.25**
-0 .35“
-0.24**
-0.33“
** P  <  0 .0 1  
* P  <  0 .0 5 .
P e a r s o n  c o r r e l a t i o n  c o e f f i c i e n t s  (r) a n d  p a r t ia l  co r r e la t i o n  c o e f f ic ien ts  
c o n t r o l l i n g  fo r  d e p r e s s i o n  r a t e d  b y  th e  p h y s i c i a n  ( r j .
report memory deficits than the subjects. Furthermore, 
the reports of memory problems from the informants 
were closely related to the subjects' performance on 
the MMSE. As cognitive impairment increased, the 
informants reported a greater frequency of marked 
memory problems in the subjects. The same pattern 
was found when we correlated the informant reports 
to staging of dementia. The informants reported 
marked memory deficit with a higher frequency as the 
severity of dementia increased.
Consistent with previous research, 10- 23 agreement 
between subjects and informants about memory im­
pairments was poor. However, there was better agree­
ment when the subjects were non-demented than 
when they were demented. Although some research 
has suggested that elderly informants may provide less 
valid information, 23 agreement did not differ depend­
ing on the relationship of the informant to the subject, 
with spouses and siblings agreeing to the same extent 
as children.
The important issue for clinical practice emerging 
from this study is the presence of a discrepancy be­
TABLE 4. CORRELATIONS BETWEEN MEASURES OF 
MEMORY DEFICIT (SUBJECTS' AND INFORMANTS, 
REPORTS) AND MEASURES OF DEPRESSED 
MOOD (SUBJECTS', INFORMANTS' AND 
PHYSICIANS' REPORTS)
Measure of Depressed Mood
Measure of 
Memory Deficit
Subjects'
Reports
Informants'
Reports
Physicians'
Ratings
Whole Sample 
Subjects' reports 0.24** 0.24** 0.12**
Informants' re- 0.09 0.28“ 0.14**
ports 
Demented 
Subjects' reports 0.24** 0.27“ 0.10
Informants' re- 0.01 0.02 -0 .04
ports
Non-Demented 
Subjects' reports 0.22“ 0.11* 0.11*
Informants' re- 0.01 0 25“ 0.12*
ports
• •  P  <  0 .0 1  
* P <  0 .0 5
tween the subject's and the informant's reports about 
memory disturbances. As we have shown, the inform­
ant's report about cognitive functioning is valid, espe­
cially when judging severely impaired subjects. There­
fore, it is of great importance to take the informant's 
opinion senously. When investigating a case of possible 
memory impairment, the patient's own complaints 
must be treated with caution, as depressed patient's 
may underestimate their memory and, conversely, de­
mented patients may overestimate theirs. However, 
subjects in the early stage of dementia did have some 
insight into their memory deficit, and even non-de­
mented subjects who had marked complaints were 
found to perform more poorly on the MMSE. There­
fore, the patient's own complaints should not be ig­
nored. Nevertheless, we found that there were both 
non-demented subjects and demented subjects who 
did not complain about their memory. Absence of 
memory complaints could indicate either that a person 
is demented or non-demented and needs to be viewed 
with caution.
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I he present study has a number of methodological 
strengths not shared by previous studies. It is based on 
a survey of a very e lderly population, and tbe drop 
outs were few It invo lved the full range of function ing  
from  high cognitive performance through to severe 
dementia
7 he study also has some weaknesses. The assessment 
of memory complaints was based only on single items, 
in contrast to some earlier studies that used detailed 
questionnaires, often measuring several dimensions of 
com plaint However, the simpler measures used here 
were appropriate because we were interested in the 
va lid ity  of the sort o f memory complaints typ ica lly 
encountered in clinical practice.
A second lim ita tion  o f the present study is that the 
data are cross-sectional and, so far, not fo llow ed over 
time. However, the present paper is based on the first 
phase of a long itud ina l study, and it w ill become 
possible to relate complaints to cognitive change. It 
w ill be interesting to fo llow  non-demented subjects 
over time to see if  memory complaints are an earlv 
symptom of dementia and if complaints are related to 
objective deficits that increase over time. It is also of 
interest to see if  subjects w ith  depressed mood and 
memory complaints have a d ifferent development 
compared to subjects w ith  depressed mood and no 
memory complaints.
As a clinician, one often meets elderly patients who 
complain of poor memory, and it is im portant to judge 
if  this is a symptom o f dementia, depression, or a 
normal complaint o f o ld age This study reveals that 
memory complaints could be an early sign o f dementia 
or of depressed mood so one should always do a fu rther 
examination to assess the va lid ity of this com pla int
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Cognitive functioning and neuroticism in an elderly community sample
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Summary—The relationship between neuroticism and cognitive functioning was investigated using data 
from a community survey of the elderly. Contrary to Pearson (1993, Personality and Individual Differences, 
4, 265-266), neuroticism was related to poorer performance on a number of cognitive measures, but the 
pattern of correlations differed between men and women. For men there were correlations with a dementia 
screening test and with tests of episodic memory and fluid intelligence, while for women there were 
corrdations with reaction time measures. It is hypothesized that correlations with neuroticism reflect the 
effect of chronic stress on cognitive ageing.
INTRODUCTION
Pearson (i993) recently reported data on a group of 94 elderly female psychiatric patients showing that neuroticism 
correlated 0.24 and 0.04 with scores on two brief cognitive tests. This finding was contrary to his prediction that neuroticism 
would be negatively related to cognitive performance. Pearson called for the investigation of the relationship in normal 
elderly groups. Here we report relevant data from an Australian community survey of the elderly which used a range of
METHOD
A survey was carried out on people aged 70+ years living in the city of Canberra or the adjacent town of Queanbeyan. 
i s  were sampled from the compulsory electoral roll. The sample was drawn to given equal numbers of men and women, 
i s  were interviewed in their own homes by trained interviewers. The interview covered mental and physical health use 
of services social support personality and cognitive function. Where available, an informant who knew the 5 well was 
in erviewed to get an independent view of their health. S  interviews were obtained from 440 women and 457 men 
representing acceptance rates of 59 and 72%, respectively. Informant interviews were also obtained for 336 of the women 
and 361 or the men. The sample reported on here comprised the 344 women and 367 men who were able to complete the 
datatIOnnaire meaSUnng neurotlclsm- Sample sizes in analyses reported below are often less than this because of missing
Personality was measured using the extraversion and neuroticism scales of the short form of the Eysenck Personality 
S nnair!  Revised (Eysenck, Eysenck & Barrett, 1985). 5s were also assessed for symptoms of anxiety and depression 
using the scales of Goldberg, Bridges, Duncan-Jones and Grayson (1988).
Cognitive functioning was measured using the following tests: the Mini-Mental State Examination (MMSE) (Folstein,
m C,HU8^’a! 7i5 ^ hl?  Was SCOred 0Ut of 35 following Ray. Henderson, Scott, Wilson, Rickwood and Grayson 
( 85), the National Adult Reading Test (NART) (Nelson & O’Connell, 1978); the Symbol Letter Modalities Test (SLMT)
Morr!! ^ qq- T  ,  the Symbol Digit Modalities Test (Smith, 1973); scales of episodic and semantic memory
r and tCStS of simPle taction time (10 trials with each hand) and choice reaction time (20 trials with choice
,, an /  lnformants were asked to fil1 out the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) 
(Jorm & Jacomb, 1989) to measure change in the 5s’ everyday cognitive functioning.
RESULTS
Table 1 shows the correlations between personality and scores on the cognitive tests. It should be noted that high scores 
represent good performance for all tests except the IQCODE. Because of the large number of correlations, all effects were
hm !ll ^  ' ' T u  Slgmficance at the P < 0 '01 level 11 ^ n  be seen that there are a number of significant correlations, 
in all cases high neuroticism is associated with worse cognitive performance. The correlations are higher for men on 
some variables, but higher for women on others.
These correlations could reflect either cognitive functioning across the life span or age-related cognitive decline The 
correlations with IQCODE scores would support a relationship with cognitive decline. To evaluate this possibility further 
partial correlations were calculated controlling for indicators of ability earlier in life (NART score and years of education)
I hese partial correlations revealed essentially the same results, indicating that the relationship is with recent decline It is 
possible that the correlations with neuroticism are due to the effects of state anxiety or depression Partial correlations
*To whom correspondence should be addressed
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Table I. Correlations between personality and cognitive tests
Cognitive lest
Neuroticism Extraversion
Men Women Men Women
MMSE -0 .2 6 “ -0 .0 5 - 0  03 0.09
NART - 0  12 -0 .0 8 - 0  15* 0.04
SLMT - 0  19“ -0 .08 - 0 0 4 009
Episodic memory -0 .2 5 “ - 0  07 0 03 005
Semantic memory -0 .12 - 0  03 - 0  02 0 10
1 /Simple reaction time - 0  08 -0 .2 0 “ 0 05 0.11
1/Choice reaction time - 0  10 -0 .2 1 “ 0.08 0.12
IQCODE 0.14 0 16* - 0  04 - 0  12
N s  for correlation range from 300- 367, except for IQCODE ( N  = 243-284). 
• P  < 0 0 1 ; * * P  <0.001.
controlling for anxiety and depression also did not alter the basic findings for men, but the correlations for women became 
smaller (partial rs of —0.09 and -0.13 for reaction time, and 0.10 for IQCODE). The correlations might also be due to 
the inclusion of 5s with dementia. However, excluding 5s with a MMSE score of <24/30 which is indicative of dementia 
(Folstein et al., 1975) reduced the size of the correlations, but did not eliminate them.
The differing results from Pearson (1993) could be due to differences in the sample. Pearson used female psychiatric 
patients with a high average neuroticism score (mean = 7.00), while the present study used a community sample with lower 
scores (means of 2.59 for men and 3.43 for women). To simulate Pearson’s sample in the present data, the correlations 
were calculated excluding 5s with neuroticism scores below 4. However, this procedure did not change the substance of 
the results.
DISCUSSION
The present findings are in conflict with those of Pearson (1993). Correlations were in the opposite direction, with 
neuroticism being associated with poor cognitive functioning. For males, neuroticism correlated with a short cognitive test 
used to screen for dementia (the MMSE), a measure of fluid intelligence (the SLMT) and a test of episodic memory. These 
are all tests which tend to decline in old age. By contrast, correlations with neuroticism were small for tests which tend 
to hold up well in old age (the NART and semantic memory). For women, neuroticism was correlated with slower reaction 
time and greater cognitive decline as rated by informants (the IQCODE). For both sexes, the correlations did not change 
greatly when indicators of ability earlier in life (NART and education) were controlled, suggesting that neuroticism is related 
to recent cognitive decline rather than life-long cognitive functioning.
One interpretation is that anxiety or depression mediate the correlations. However, for males the correlation persisted 
when anxiety and depression were partialled out, suggesting that the correlation between neuroticism and cognitive 
performance is associated with the personality trait rather than with neurotic state effects. By contrast, the correlations were 
lower for females, indicating that neurotic state effects are important.
The correlation between neuroticism and poorer cognitive function could arise in a number of ways. The association could 
be due to response bias, with the cognitively impaired more likely to endorse neuroticism items. However, if response bias 
was responsible, then tests estimating ability earlier in life might be expected to correlate with neuroticism, but this was 
not observed. Another possibility is that awareness of failing cognition increases neuroticism. However, reaction to cognitive 
decline would be expected to manifest more as state effects than as trait effects. Furthermore, while cognitive deficit tends 
to increase in old age, neuroticism tends to decrease. A final possibility is that neuroticism is associated with greater cognitive 
decline in old age. High neuroticism predisposes to stress and there is considerable evidence from animal research that 
prolonged stress can lead to loss of hippocampal neurons in old age (Sapolsky, Krey & McEwen, 1986). Based on such 
research, Kerr, Campbell, Applegate, Brodish and Landfield (1991) have raised the possibility that "(1) chronic stress in 
young and midaged humans could alter neurophysiologic mechanisms important for normal memory and other cognitive 
functions, and (2) aged individuals could be more sensitive than young to neurodegenerative (and perhaps other) actions 
of chronic stress” (p. 1323). Whatever the mechanism behind the association between neuroticism and cognitive function, 
the sex difference in pattern of correlations is puzzling. This issue merits further investigation in surveys of the elderly, 
particularly in longitudinal studies.
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I n t r o d u c t i o n
It has been c l a imed  that  man y  age-associated declines in 
intel lectual  fu nc t i on in g  are due  not  so muc h  to anv 
matu r a t ion a l  or  biological  ageing process as to the 
effects of ill hea l th .  T h i s  possibil i ty has some  plausibil i ty 
g u e n  that  hea l th p ro b le m s  become  more  prevalent  with 
aye [1 ]. W hile m a n y  researchers  have a rgued that  health 
factors are ot g rea t  impor tance  [2, 3], others,  most  
notably Sa l thou se  [4], have c l aimed  the opposite.  After 
r eviewing the avai lable l i terature,  Sal thouse [4] stated 
s t rongly that  ‘co n t ra ry  to intui t ion and popula r  opinion,  
the re  is little ev i den ce  that  decl ines  in cogni t ive per fo r ­
mance  associa ted wi th  increased age are mediated bv 
decl ines  in hea l th  s t a t u s ’ (p. 66).
It is i m p o r ta n t  to clarify the na tu re  of  the differing 
views I he issue is not  w he the r  very poor  health can 
di rect ly c o n t r i b u t e  to cogni t ive deter iorat ion.  It is clear 
t at cond i t ions  such as hypoxia ,  anaemia,  t ransient  
infect ion or hy po th y r o id i s m  mav cause d ramat i c 
changes  in cogn i t ive  pe r fo r ma nce  [5], W ha t  ,s at issue is 
wh e t he r  the ob se rve d  deter iorat ion  in cogni t ive per fo r ­
mance  in old age is p r imar i ly  med ia ted  bv the effects of  
! khea !\h - T h e  o f  this issue is wh e th e r  account ing for 
ill heal th r educes  or  e l iminates  de ter iora t ion  in cognit ive 
per fo rmance .
A n u m b e r  of methodological  issues need to be ov er ­
come  in o rde r  to evaluate the issue. Accoun t m u s t  be 
taken ot a mul t i tude  of variables such as sex, educa t ion  
soc io-economic status, and psychiat ric  status that  migh t  
indep end en t ly  affect cognit ive per fo rmance  [6], Clar i f i ­
cation and definition of what const i tut es  heal th or  illness 
is also required  Investigators have used physic ian 
rat ings ot health,  objectively measured  indices of  heal th  
s tatus [7, 8], self-ratings of global heal th [1 3. 9. ](J], 
sel f - repor ts  ot specific previous or cu r ren t  i l lnesses 
d isorder s  and  complaints  [ 1 1 ] and repor ts  of  med ica t ion  
use [ 1 ]. I he measurement  of  cogni t ive p e r f o rm anc e  has 
also v ar ied greatly.  Manv cognitiv e tests hav e been used,  
only some  which have been associated with heal th 
status [6], Mor e  significantly, the sample ex am ine d  is 
par t i cular ly relevant to whe the r  a r ela t ionsh ip  is 
observed.  In volunteer  studies [2. 12], there mav  b -  a 
restr icted range of health status,  because largely heal thy  
subjects  are more likely to part icipate.  Finally,  the age of 
the sample  mav be crucial in med ia t ing  anv effects.
I he present  research study,  as part  of  a larger  
research project ,  a t tempted to examine  the r ela t ionship 
be tween heal th and cognit ive funct ion taking into 
account  a n u m b e r  ot these research difficulties.  A var iety 
of object ive and subject ive indices of  heal th s ta tus  a nd  a
cogn i t ive test hat t erv  covering a range ot funct ions were 
used.  I’his  a l lowed us to examine intercorrelat ions 
between m e as u r es  of health and repor t  on possible 
different ial  associa t ions of these indices w ith cognit ive 
pe r f o rm anc e .  T h e  functions covered by the test bat tery 
al lowed us to der ive stable measures  of  cognit ive 
p e r f o r m an ce  us ing factor analysis.  YVe were also able to 
cont rol  for the effects of variables such as sex, educat ion 
and psych ia t r i c  s tatus using regression analysis.
We e x a m i n e d  five indices of health:  (i) se l f- repor ted 
global r a t ings  o f  overall  health; (ti) r epor ts  of previous 
and c u r r e n t  medica l  complaints  ( these r epor ts  were 
p r ov ided  by bo th  the par ticipant  and an informant) ;  (iii) 
object ively m e as u r ed  diastolic and systolic blood p res ­
sure;  (iv) r e po r t s  of  cur rent  and past smoking;  and (v) 
me asures  o f  activi t ies ot daily living ( A D L )  prov ided by 
bo th  the pa r t i c ip an t  and an informant .
T h e  cogn i t ive  bat tery consisted of a n u m b e r  of  tests ot 
crystal l ized intel l igence,  fluid intel l igence and memory.  
T h e  M i n i - M e n t a l  State Examinat ion ( M M S E )  [13] was 
also inc lud ed  as a brief global measure  of  cognit ive 
funct ion.  Crysta l l i zed  intelligence,  fluid intelligence,  
and  m e m o r y  per fo rmance  are known to have different 
de ve lop me nta l  trajectories across the l ife-span.  Crys ta l ­
lized inte l l igence remains stable or improves  while fluid 
intel l igence decl ines  steadily. T h e  rate of decline of 
m e m o r y  p e r f o r m an ce  is dep enden t  on the type of 
m e m o r y  task [14], a l though me m or y  per formance 
general ly  dec l ines  moderately over  the life span,  e spe ­
cially w he n  me as u re d  by tasks r equi r ing recall r athe r  
than recogn i t ion .
A n u m b e r  o f  ou tcomes migh t  be expected if the 
hypo thes i s  is sustainable that poor  heal th account s  for 
decl ines  in cogni t ive  per formance in old age. First ly,  in a 
cross- sect ional  s tudy ,  it would be expected that  signifi­
cant  cor re l a t ions  would be found be tween health s tatus 
and  intel lectual  funct ioning.  Moreover ,  when  health 
s ta tus  was stat ist ically control led,  or  subjects  with 
heal th  p r o b l e m s  were r emoved  f rom the sample,  the 
c ross - sect ional  age differences in cogni t ive pe r formance  
would  be exp ec ted  to weaken.  Secondly,  the association 
be t ween  hea l th  and cognit ive pe r fo rmance  would be 
greater  for fluid and memory  tasks (i.e. those sensit ive to 
age decl ine)  than  for crystallized intel l igence tasks. If it 
is a s su m ed  tha t  poor  health mediates  cognitiv e change,  
this o u t c o m e  would be expected since associations 
be t ween  hea l th  and cognit ive pe r fo rmance should be 
g rea ter  in a spec t s  of cognit ion which are known to show 
the g rea tes t  age-associated decl ine [6], F inally, it migh t  
also be ex pe c t ed  that  the association between  cogni t ive 
funct ion  a n d  heal th would be greater  in older  age 
g roups .  T h e  lat ter  outcome would  be expected if min or  
p h a n g e s  in hea l th  status had more  devasta t ing co n se ­
quences  for  o lde r  subjects.  Such  an ou tc ome  has also 
been sugge s te d  by Pe r lmut te r  and Nyq u i s t  [3] who 
wrote that  ' t he  mediat ing  effects of heal th accumulate  
over  t ime,  an d  because of the greater  possible t ime for 
ac cu m ul a t io n  of  health effects in older  than younger  
subject s ,  we expected that  the re  may be s t ronger  
r e l a t ionsh ips  be tween  sel f- repor ted heal th and intel l i ­
gence in older  compared  to younger  adul ts '  (p. 146) 
These hypotheses  were examin ed  in the present  studv
Methods
Subjects
The sub jec ts  were a sam ple  of e lder ly  people living in the 
c o m m u n i ty  in the Austra l ian  city of C a n b e r ra  and the  adjacent 
town ot Q u ean b e y a n .  The su b jec ts  were sam pled  t ro m  the 
electoral roll which  is a regis te r  ot eligible  voters Y'oting is 
co m p u lso ry  in A ustra l ia  T h e  sa m p le  was d raw n  to give equal 
n u m b e rs  ot m en  and w om en.  There were tour  age stra ta  (70 
74, 75 -79, 80 84 and 85 89 years),  with each s t ra tu m  (70 74, 
75 -79  and 8 0 -l- years)  sam p le d  to give an achieved sam ple  
p ropor t iona l  to the n u m b e r  of in d iv idua ls  in that  age g roup.  
T h i r ty - o n e  p e r  cent of those  a p p ro a c h e d  refused to p a r t ic i ­
pate . 'This refusal rate is s im ila r  to those  recentlv o b ta ined  m 
o th e r  c o m m u n i ty  sam ples  [15]. Six ty-five  p e r c e n t  ot refusers 
were w om en ,  b u t  the age range of the  re tusers  d id  not differ 
from  that  of  the pa r t ic ipan ts .  The reasons s ta ted tor refusal 
were physical illness (1 6 IJ0 ), m en ta l  illness (less th an  T,,>. 
d i rec t  unw il l ingness  ( 7 8 " 0) and  language  p ro b lem s  ( 6 ). 'The 
sam ple  used in the p re sen t  p a p e r  co m p r ise d  708 m en  and 
w om en  w ho prov ided co m p le te  d a ta  on all cognit ive  tests .  'This 
excluded  173 sub jec ts  who were  able to answ er  ques t ions  
a bou t  them se lves ,  b u t  w ho failed to co m ple te  all cognitive  
tests. 'This la t te r  g ro u p  was later  e x am in ed  in a su p p le m e n ta ry  
analysis. T h e  n u m b e r  and  sex d is t r ib u t io n  ot the  tou r  age 
stra ta  are sh o w n  in 'Table I.
General procedure
S ub jec ts  were  in te rv iew ed  in th e i r  own hom es by tra ined  
in te rv iewers.  In fo rm a t io n  necessa ry  for the d iagnos is  of 
d e m e n t ia  and  dep ress io n  [16, 17] was collected , as well as 
in fo rm at ion  on  social b a ck g ro u n d ,  personali ty ,  social support ,  
m enta l  activ ity ,  s e l f - rep o r ted  cogn it ive  func tion  and  use of 
services. P reva lence  rates for d e p re ss io n  and  d e m e n t ia  have 
been r ep o r ted  e lsew here  [18, 19], Su b jec ts  were asked to 
n o m in a te  a close rela tive or f r iend  w ho knew  th em  well, and  an 
in fo rm an t  interview was th en  so u g h t  f rom  that person .
Measures o f  health
Five b ro ad  areas ot heal th  were  ex am in ed :
Self-reported measures of global health status Su b jec ts  were 
asked w h e th e r  they ra ted  the ir  overall  health  n o w adays  as 
excellent,  good, fair or poor.  Their re sponse  was scored 
1 =  excellent.  2 = good, 3 = fair, 4 =  p o o r  Thev also ra ted their 
heal th  c o m p a re d  with m ost  p eop le  of the ir  age on a 5-point 
scale (1 =  be t te r .  2 = a bou t  the  sam e ,  3 = worse) and  the extent 
to which  their  heal th  p ro b lem s  s tood  in the  wav ot the ir  doing 
th ings  (1 =  no t  at all. 2 =  little, 3 =  a great d e a l ).
Reports of previous and current medical conditions Subjects  
were asked w h e th e r  thev had  ever  had a heart  attack which 
req u ired  h osp i ta l iza t ion ,  suffered  f rom  high b lood pressure ,  
had  a s troke ,  a m in i - s t ro k e ,  t r an s ien t  ischaemic attack, a 
weakness in one  side that got  b e t te r ,  su d d e n  and severe 
difficulty w ith  speak ing ,  v ision or m em o ry ,  h y p o m an ia .  manic 
ep isode,  sc h izo p h re n ia ,  P a rk in so n 's  disease, or  anv ot the 
fo l lowing c ond it ions :  a r th r i t is ,  ca ta rac t ,  a s thm a ,  diabetes,  
intest inal  d iso rd e rs ,  liver or k id n ey  disease, cancer,  anaemia, 
th y ro id  c o n d i t io n ,  skin d iso rd e r  o r  b ro k en  bones.  Thev were 
also asked a b o u t  the  sy m p to m s  l is ted  in 'Table I I I  In fo rm an ts  
were  asked w h e th e r  the  sub jec t  ever  had had a stroke, mini- 
s troke o r  t ran s ie n t  ischaem ic  a ttack ,  P a rk in so n ’s disease,  a 
weakness on  one  side, s u d d e n  and  severe difficulty  with 
speak ing ,  vision or m em o ry ,  h y p o m a n ia ,  m anic  episode  or
sch izo p h re n ia .  A g re em e n t  be tw een  in fo rm an t  and sub jec t  was 
sa t is fac to ry  for m a jo r  illnesses [s troke  ( r -- 0.74),  m in i-s t ro k e  
( r = 0.55), t r a n s ie n t  ischaemic a ttack  ( r =  0.38), P a rk in so n ’s 
disease (r =  0 .79)] ,  b u t  less sa t is fac to ry  (or sy m p to m s  (w eak ­
ness, r =  0 .21)  o r  less v\e 11 defined co n d it io n s  (h y p o m an ia ,  
r — 0.21)
D ep res s io n  w as  m easured  in th ree  ways: (a) Su b jec ts  were 
asked w h e th e r  they  had ever been  m ark ed ly  depressed ,  (b) A 
scale was c o n s t r u c t e d  based on replies to 28 q u es t io n s  asking 
ab o u t  c u r r e n t  d ep ress iv e  s y m p to m s  [19], (c) A d iagnos is  of 
d e p ress io n  was m a d e  based on q u e s t io n s  f rom  the  C a n b e r ra  
In terv iew for the  F.lderly T h is  is a fully sc r ip ted  in te rv iew  
f rom  which  D S M  - 111-R and IC 'D  - 10 d iagnoses of dep ress ion  
can be m ad e .  T w e n ty - s ix  of the  p re sen t  sam ple  m et one  of 
these  d iag n o ses  for depress ion ,  o f  w h o m  20 p rov ided  da ta  on 
all p sy c h o m e t r i c  tests .
Blood pressure measurements: B lood p re ssu re  w as taken 
twice over  a 5 - m in u te  period us ing  an O M R O N  au to m a tic  
digital  b lo o d - p r e s s u r e  m onito r ,  m o d e l  H E M - 7 0 3 C .  C o r r e la ­
t ions b e tw e e n  th e  two diastolic a n d  systolic m easu re s  were 
0.71 and  0 .82 ,  respectively,  and  an average o f  the  two 
reco rd in g s  was u se d  to estim ate  systolic  and  diastolic  p ressu re .  
T h e  average  o f  tw o  readings is o f ten  rep o r te d  as an es t im a te  of 
b lood  p re s su re  in research  s tud ies  [e.g. 8], a lth o u g h  re liability  
can be im p r o v e d  by  using m o re  m e a su re m e n t  occasions [7], 
S ub jec ts  w i th  d iag n o s t ic  read ings  above  90 were classified as 
hav ing  h ig h  d ias to l ic  p ressure  while  those with systolic 
read ings  o v e r  160 were classified as hav ing  h igh  systolic  
p re ssu re  [6].
S m o k in g :  S u b je c t s  were asked w h e th e r  they  had  ever 
sm oked  to b acco  regu lar ly  and w h e th e r  they  now sm oked .
Measures o f  activit ies of daily  l iv ing:  Both in fo rm an ts  and 
sub jects  w ere  ask ed  about  the su b je c t ’s capacity  to get ab o u t  
when  t rav e ll in g  w as requ ired ,  to walk abou t  400 m e tre s  
w ithou t  pa in  o r  difficulty, to get in and  ou t  of  bed ,  to get 
d ressed  b a th e d  a n d  show ered ,  to get in and  ou t  of  an a rm ch a i r ,  
to d ress  c o m p le te ly  w ithou t  difficulty , to take care o f  feet and 
toe nails a n d  to  get to the toilet.  T h e  e ight  i tem s were 
c o m b in e d  to fo rm  a scale. Each i tem  was ra ted on a scale with 
f rom  3 to 5 p o in ts .  T h e  items were  su m m e d  separa te ly  for 
sub jects  a n d  in f o r m a n ts  to give scores  rang ing  from  0 to 22, 
w ith h igh  sco res  ind ica t in g  d isab il i ty .  T h e  co rre la t ion  b e tw ee n  
in fo rm an t  an d  su b je c t  for the e igh t  i tem s was 0.88 ind ica t in g  
excellent a g re e m e n t .
Measures o f  cognitive  performance
T h e  cogn it ive  b a t t e ry  consis ted  o f  tes ts  of  crystal l ized  and 
fluid in te l l igence ,  speed, as well as the  M M S E .  T h e  tests ot 
crystal l ized  in te l l igence  included  the  N a tiona l  A d u l t  R ead ing  
T es t  ( N A R T )  [20], th ree  i tems f ro m  the  V ocabu la ry  su b te s t  of  
the W e c h s le r  A d u l t  Intell igence Sc a le -R ev ise d  ( W A I S - R )  
[21] th ree  i tem s  f ro m  the S im ila r it ies  su b te s t  of the  W A I S - R ,  
four genera l  k n o w le d g e  items and  a verbal  f luency item.
Flu id  in te l l ig en ce  was m easu red  us ing  the  S y m b o l  L e t t e r  
M odalit ies  T e s t .  T h i s  test re sem b le s  the D ig it  S y m b o l  
S u b s t i tu t io n  s u b te s t  of the W A I S  and  the S y m b o l  D ig it  
M odalit ies  T e s t  [22]. Subjects  were  p ro v id ed  with a key which  
linked 10 sy m b o ls  w ith  letters of the  a lp h ab e t  (A to I). T h e i r  
task w as to  call o u t  the  correc t  le t te r  for a series o f  sym bols .  
Scores w ere  b ase d  on  the  n u m b e r  of co rrec t  let ter  sym bol  pairs  
made in 90 se c o n d s .  As a second m ea su re  of fluid in te lligence, 
subjects w ere  r e q u i r e d  to d raw a cube .  Both choice  a n d  s im ple  
reaction t im e  ( R T )  w ere  also m e a su re d .  In  the  sim ple  R T  task, 
the su b je c t ’s t im e  (in mil l iseconds) to re sp o n d  to e i th e r  a r ight 
(R) or  left (L )  l igh t  was m easured .  T w o  l ights were  loca ted  to 
the r igh t  a n d  left  on  a small box, su b jec ts  placed the ir  h a n d s
over  b u t to n s  posi t ioned d irec tly  u n d e r  the  lights,  a ‘re ad v ’ 
signal was given and the right o r  left light was n o m in a te d  as the 
light to be i l luminated . Su b jec ts  r e sp o n d ed  as qu ick ly  as 
poss ib le .  T h e  delay interval b e tw een  the ‘re a d y ’ signal and the 
l ight be ing  il lum inated  v aried f ro m  0.5 to 0.2 seconds .  T h e r e  
were  10 1. and 10 R trials. C ho ice  R T  was m ea su re d  over  20 
trials.  E ithe r  the R or I. l ight was act ivated ,  and  sub jects  
r e sp o n d e d  to the R light with a R b u t to n  press  and the  L light 
w ith  a I. b u t to n  press.
M e m o r y  pe rfo rm ance  was m e a su re d  using  the  fo llowing: (1) 
the  recall of a name and address  (sub jec ts  were  g iven  a nam e 
a n d  ad d ress  and requ ired  to recall it a few m in u te s  later); (2) 
the  recall of three  co m m o n  ob jec ts  ( th ree  ob jec ts  were  learnt 
a n d  sub jec ts  were requ ired  to repea t  th e m  a few m in u te s  later); 
(3) an  in ten tiona l  face recognition  task, s im ila r  to tha t  used  in 
the  R iv erm ead  Behavioural M e m o ry  T e s t  [23]; and  (4) I tem  1 
f ro m  the  W echsler  M e m o ry  S ca le -V isu a l  R e p ro d u c t io n  su b ­
test  [24], T h e y  were also given; (5) an inc iden ta l  word  
re cogn i t ion  task where they were  asked to an sw e r  q u es t io n s  
and  later  asked to identify  w h e th e r  they  had  h eard  p a r t icu la r  
w o rd s  f rom  these questions.
R e su lt s
D ata  are presented first on ch an g es  in health status and 
co g n it iv e  perform ance with age. N e x t ,  correlations  
b etw een  health factors and co g n it iv e  per form an ce  are 
ex a m in ed .  Regression analyses ex a m in in g  the effects ot 
age o n  cognit ive  perform ance after acco u n tin g  for health  
factors were undertaken, and age x health  interaction  
effects  are presented for the total sam p le .  F inally ,  the 
relat ionsh ip  between health and co g n it iv e  perform ance  
is ex a m in ed  for subjects w ho failed to prov id e  data on all 
p sy ch o m etr ic  tests.
M easures  of health and age
S e lf - rep o r ted  measures of health:  T a b le  I d isp lays  the 
m ean  ratings as a function o f  age on the three self-  
reported  health scales. O lder subjects  were m o re  likely 
to rate their health as better than their con tem p o ra r ies  
(^ (3 .671) =  3 37, p < 0 . 0 2 ) .  N o  other age effects  were  
present.
Checklists  of previous and current medica l con d it ion s: 
'Fables II and III display the  percentage  o f  subjects  
w ith in  each age category reporting p rev io u s  (T a b le  II)
Table I  Se lf - rep o r ted  m easu re s  of  global h ea l th  (m eans,  
s t a n d a rd  deviations) as a func tion  of age
Age (in years) 
7 0 -74  7 5 -7 9 8 0 -8 4 85-89
N u m b e r 324 225 115 44
P e rc en tag e  male 54 47 51 52
O vera l l  health : m ean (SD ) 2.11 2.12 2.10 2.21
(0.73) (0.76) (0.84) (0.77)
H e a l th  co m p a red  with others*: 1.43 1.41 1.26 1.30
m ea n  (S D ) (0.54) (0.57) (0.48) (0.52)
H e a l th  ‘s tan d s  in w av’: 1.61 1.63 1.68 1.69
m e a n  (S D ) (0.73) (0.71) (0.72) (0.71)
* p <  0.02. Low scores denote  b e t t e r  health .
Table I T  P e rc en tag e  of subjects  and in form ants  report ing  past 
m edical  c o n d i t io n s  as a function  of age
Age (in 
70 74
years) 
75 79 SO 84 85 89
H ear t  a ttack 16 17 21 14
High b lo o d  p re ssu re* 46 39 45 28
Stroke 7 7 8 12
S tro k e  ( in fo rm a n t) 8 5 9 12
M in i - s t ro k es 2 3 4
M in i - s t ro k e s  ( in fo rm a n t) 2 4 5 —
T r a n s ie n t  ischaem ic  attacks 4 2 4 5
T r a n s ie n t  IA ( in fo rm a n t) 4 2 3 9
W eak n ess  on  one  side 7 5 6 —
W eak n ess  ( in fo rm a n t)* 4 2 1 1 15
S u d d e n  diff iculty  speak ing 5 4 7 5
S u d d e n  sp e a k in g  ( in fo rm an t) 3 5 1 9
S u d d e n  diff iculty  vision 10 7 10 5
S u d d e n  v is ion  ( in fo rm an t) 6 8 8 2
S u d d e n  diff iculty  m e m o ry 5 2 3 7
S u d d e n  m e m o r y  ( in fo rm an t) 4 4 1 —
H y p o m a m a 2 — — —
H y p o m a m a  ( in fo rm a n t) 4 — —
M anic  ep iso d e 2 1 — —
S c h iz o p h re n ia 1 — — 2
- 'ch izo p h ren ia  ( in fo rm a n t) 1 — — —
P a r k in s o n ’s d isease — 1 — —
P a r k in s o n ’s ( in fo rm a n t) 1 1 3 3
M ark ed ly  d e p re ssed 21 19 20 7
A r th r i t i s  o r  rh e u m a t i s m 65 63 61 59
C a ta rac t  o r  eye disease* 24 27 47 47
A s th m a  o r  re sp i ra to ry  disease 18 18 21 16
D iab e tes 7 5 / 2
In tes t ina l  d iso rd e r s 19 26 20 18
L iver  disease 1 1 2 —
K id n e y  disease 4 4 4 —
O th e r  u r in a ry  trac t  disease 16 23 17 16
C a n ce r 13 10 10 9
A naem ia 5 4 5 2
T h y r o i d  c o n d i t io n s 8 6 4
Skin  d iso rd e r s 9 13 17 16
B roken  bones 9 8 4 9
Para lysed  l im b s 1 1 1 —
* p < 0.05.
and  c ur re n t  (T a b l e  I I I )  medical  health problems.  Only  
the prevalence  of  cataract  or o the r  eye disease, c ramps  in 
legs, weakness  in a rms  or legs (both informant -  and 
sub jec t - r a t ed )  and unsteadiness  on legs increased as a 
funct ion  of  age. Self -r epor t  of high blood pressure 
decl ined significant ly with age. T h e  depression scale 
cor rel a ted  significant ly with fluid intel l igence 
(r = —0.18) bu t  not  with crystallized intel l igence or 
me m or y .  T h o s e  with depression per formed signifi­
cant ly worse than those wi thout  on fluid intelligence 
tasks bu t  not  on the M M S E ,  crystallized intel l igence or 
m e m o r y  tests.
Blood pressure measurements: T ab le  IV displays the 
me an  systolic and  diastolic blood pressu re  of  subjects in 
each age g roup .  Also repor ted are the percentages of 
subject s p r ov id i ng  systolic and diastolic readings wi thin
Table I I I  Pe rcen tage  of sub jec ts  rep o r t in g  c u r re n t  (last 
m o n th )  medical sv m p to m s  as a func tion  of age
Age (in years)
7 0-74 75-7 9 80 84 8 5 -8 9
C r a m p s  in legs* 26 3 2 32 48
Pain in hear t 13 15 13 14
T r o u b le  b rea th in g 23 23 29 27
Sw ollen  ankles 22 21 30 30
Back pain 40 36 34 27
S to m ac h  pains 7 7 6 5
I nd iges tion 24 28 24 23
f  re q u e n t  headaches 10 9 10 2
C o n s ta n t  cough ing l 1 12 14 18
C o n s ta n t  heavy colds 2 2 2 2
Influenza 3 3 3 —
Stiffness in jo in ts 33 29 30 23
W eakness  in a rm s legs* 15 15 24 36
U n s te a d y  on legs* 20 26 42 46
Falls 8 8 9 14
Allergies 18 22 18 9
Dizziness 15 14 20 21
Palp i ta t ions 9 12 4 9
D ia r rh o e a 8 8 10 9
C o n s t ip a t io n 15 11 19 23
Infec t ion 5 3 2 2
* p < 0.05.
Table I V . Blood p re ssu re  an d  h y p e r te n s io n  as a fu n c tio n  o f  age
Age (in years)
Blood p re ssu re 7 0 -7 4 7 5 -7 9 8 0 -8 4 8 5 -8 9
Systolic
M ean* 143 145 148 150
S D 19 21 23 24
M i n i m u m 84 \ 0 \ 98 102
M a x im u m 201 207 207 198
Percen tag e  > 160 m m H g * 54 56 57 59
Diasto lic
M e a n 82 82 83 81
S D 12 12 14 15
M i n i m u m 50 55 52 57
M a x im u m 115 118 153 137
Percen tag e  > 90 m m H g 22 26 18 18
* p < 0.05.
the hyper t ens ive  range.  T h e  percen tage  of  subject s  with 
high systolic blood p ressu re (greater  than 160) increased 
with age while the pe rcen tage of  those with high 
diastolic did not [/■ (4) =  17.62, p < 0.002],
Sm oking:  T h e  pe rcentage  of  subject s  w ho  repor ted  
never  smoking was 57, 53, 57 and 54 for each of the age 
s t rata 70-74.  75-79,  80-84,  and  85 -89,  respectix ely. T h e  
n u m b e r  cur rent ly smoking  was 15,8 ,  5 and 1 1, r e spe c t ­
ively. T h e r e  were no significant  age effects.
A D L  measures: T a b l e  V shows the average score for 
subject s  on the A D L  measures .  Both in fo rman t  and
T able V . M e a n  se l f - reported  and i nfor mant -ra t ed  A D I .
Age  (in years)
A 1)1. 70 74 75 79 80 84 85 89
S e l f - r e p o r t e d * 1.00 1.67 2.33 3.41
1 n  f o rma nt -  reported* 1 20 1 96 2.52 3.76
* p < 0.001
Table Tl.  M e a n  factor scores  and M M S E scores  as a funct ion
o f  age
A g e  (in years)
7 0 - 7 4 7 5 - 7 9 8 0 - 8 4 8 5 - 8 9
F actor  1 (Crys t a l l i zed  IQ); 0 .03 - 0 . 0 3 0 . 09 - 0 . 2 7
m e a n  ( S D ) ( 0 . % ) (1 .03) ( 1.03) (1 .07)
Fa c t or  2 ( F l u id  IQ): 0 . 28 - 0 . 0 7 - 0 . 3 8 - 0 . 5 5
m e a n  ( S D ) ( 0.84) ( 0.98) (1 04) ( 1 3 9 )
Fa c t or  3 ( M e m o r y ) : 0 . 1 9 - 0 . 0 5 - 0 . 2 6 - 0 . 3 7
m e a n  ( S D ) (0 .86) (0 .99) ( 1 1 9 ) (1 .20)
M M S E : 28 .17 27.73 27 . 44 26 .74
m e an  ( S D ) (1 . 52) ( 1 9 9 ) ( 1.94) (2 .53)
subject  scores increased with age ( F  =  16.42, p <  0.001; 
F=  19.62, p <  0.001).
Correlations among health measures
Sel f- r at ings of  global  health cor rela ted (above 0.20) with 
r epor t s  of  ar thr i t i s  (r = 0.23),  a s thma  (r = 0.24),  t i gh t ­
ness in the chest  (r =  0.20),  t roub le  b rea th ing  (r = 0.33), 
se l f- rated A D L  (r = 0.34) and in fo rman t - ra t ed  A D L  
(r =  0.3 1). Sel f -r at ings  of heal th  in compar i son  to o n e ’s 
pee r s  correlated 0.20 with self- rated A D L  and 0.22 wi th 
in f o rm an t - r a t e d  A D L .  S ta t ing  that  heal th problems 
inte rfe red with o n e ’s life co rrela ted (above 0.20) with 
t r oub le  b rea th ing  (r = 0.29),  self-rated A D L  (r = 0.42) 
and  in fo rm an t - r a t e d  A D L  (r = 0.38).  No o the r  rela t ion­
sh ips  cor rela ted above 0.20.
Measures o f  cognitive performance
Because of  high cor rela t ions  am ong  ou tc ome  measures ,  
data f rom the psychomet r i c  tasks were subjected to a 
pr incipal  c o m p o n e n t s  analysis with var imax rotat ion.  
Three factors which emerged  with eigenvalues greater  
than 1.00 were retained in the factor solut ion.  F rom 
thei r  factor loadings,  these factors were labelled Crys ta l ­
lized Intel l igence,  Fluid Intel l igence and Me mor y ,  and 
the factor  scores were used in the A N O Y A s ,  thereby 
reduc ing  the n u m b e r  of ou tc ome  measures .  Mean  scores 
on these factors for each age g roup  are shown in T ab le  
VI.  T ab le  VI also displays the mean M M S E  scores for 
each age g roup .  T h e r e  were significant  declines in 
cognitiv e pe r fo rm ance  across the age g roups  for Factor  2 
(F lu id  Intel l igence)  ( F ( 3 7()4 ) =  20.21,  p < 0.0001),  Factor  
3 ( M e m o r y )  (F(i 7(M) = 9.09, p <  0.0001) and for the
Table i ' l l .  Signi f i cant  corre la t i ons  b e t w e e n  heal th and c o g n i ­
t ive variables
Factor  1
H ea l t h  me asur e  (Crys t a l l i zed  IQ)
Factor  2 
( F l u id  IQ)
1 actor 3 
( M e m o r y )
Self-reported measures
Overal l  heal th —0 . 1 0 * * -  0 17**
H ea l t h  c o mp a re d
wi th  o t he rs  0 . 0 9 * 0 .08*
He a l t h  s tands  in w a v ’ - 0 . 0 8 *
Previous medical conditions 
W e a k n e s s  on one
s i de  ( i nf ormant )  —0 . 0 9 *  
S u d d e n  di ff icul ty  
wi t h  speaki ng  
( i nf or ma n t ) -  0 14**
Arthr i t i s  - 0 . 1 1 * * - 0 . 0 8 *
U r i n a ry  tract
i n f ec t i o n s  0 . 1 4 * *
C ataracts - 0 . 1 4 * *
A s t h m a - 0 . 0 8 *
' Thyroid  di sorder - 0 . 0 8 * 0 . 11*
Current medical conditions 
C r a m p s - 0 . 1 1 * *
B re a t h i ng  di ff icul t ies — 0 . 1 1 **
S w o l l e n  ankles - 0 . 0 9 *
W e a k n e s s  in 
a r m s  legs - 0 . 1 5 * *
U n s t e a d y  on legs - 0 . 1 9 * * - 0 . 1 0 *
D i z z i n e s s - 0 . 1 4 * *
T i g h t n e s s  in heart - 0 . 0 8 *
A D L  (subject ) - 0 . 2 8 * *
A D L  ( i nf or ma nt ) - 0 . 3 1 * *
N o  o t he r  re la t ionships  we r e  s igni f i cant .  
* p < 0 . 05 ;  ** p < 0 .01 .
M M S E  ( F, v-i)4 , =  10.93,  p  < 0.0001),  b u t  not  for Fac tor  
1 (Crysta l l ized Intel l igence)  ( F , 3 .7«h» =  1-53. p = 0.20).
Relationship between health measures, cognitive per for­
mance and age fo r  the total sample
Correlations betzceen health measures and cognitive perpor- 
mance and differences betzceen hypertensive and smoking 
groups:  Signif icant  cor re la t ions  be t ween  sel l - repor t ed 
measures ,  previous  medical  condi t ions  and cur rent  
medica l  sy m p t o m s  and  cogni t ive pe r f o rmance  are p r o ­
vided in T a b l e  YU .  Mos t  cor re la t ions  were weak and the 
n u m b e r  of health var iables which correla ted signifi- 
cant lv wi th cogni t ive p e r f o rm anc e  was low. 1 hus,  only 
seven of  a possible 38 past  medical  condi t ions ,  and only 
seven of  a possible 21 cu r r en t  s y m p t o m s  were signifi­
cant ly  associated wi th cogni t ive per formance .  Both 
in fo rm an t -  and sub jec t - r a t ed  A D L  measures  correlated 
negat ively with fluid intel l igence scores.  T h e r e  were no 
significant  differences in cogni t ive per formance 
be t wee n  subject s wi th and  wi thout  high systolic or 
diastol ic blood pressure.  Subjec ts  were divided into 
those  cu r r en t l y  smoking,  those who  never  smoked  and 
ex- smokers .  C u r r en t  smokers  pe r f o rm ed  significantly
Cr ys t a l l i z ed  i n t e l l i g en ceTable l I I I  S u m m a r y  of h ierarch ical  regress ions  pred ic ting  
fluid in te l l igence ,  c rysta l l ized  in te lligence and  m em o ry
C rysta ll ized
inte lligence
Fluid
in te lligence M em o ry
0>
o
0 5 -
P re d ic to r R W R R : R R-
o
CO
fsj
-0.5 -
•  - --------£
-----Q----  All subiects
Sex and  e d u ca t io n  
1 lealth
0.39
0.40
0.15*
0.16
0.26 0.07* 
0.35 0.12*
0 16 
0.20
0.02*
0.04 0
■---- ♦----  After adjustment
Age 0.40 0.16 0.38 0.15* 0.27 0.07* 60 70 80 90
C h r o n o l o g i c a l  age
* p < 0.05.
lower  than did the o the r  g rou ps  on Factor  1 (crystallized 
intel l igence)  and Factor  2 (fluid intelligence).
M ultip le  regression analyses:  If heal th is impor tant  in 
med ia t ing  cogni t ive  pe r fo rmance  in old age, age-related 
changes  in intel l igence should  weaken if account  were 
taken of hea l th  factors.  T h i s  was examined using 
hierarchical  r egression analysis.  Because sex, educat ion 
and  psychiat r ic  sta tus  of ten confound  interpretat ion of 
heal th  and its inf luence on cogni t ive per formance ,  these 
var iables were inc luded in the analysis.  T h u s ,  on step 1, 
sex and educ a t ion  were en tered ;  on step 2, A D L ,  scores 
on the depress ion scale, total n u m b e r  of  cu r r en t  and past  
com pla in t s ,  average systolic and  diastolic blood p r es ­
sure,  and global  rat ings of  heal th s tatus were entered.  
Final ly,  on s tep 3, age was en tered.  T h e  results are 
disp layed  in T a b l e  VI I I .  Educa t ion  and sex were related 
to scores on  all three factors,  but  most  strongly for 
crystal l ized intel l igence,  wh ich is d ep en den t  on educ a­
t ion level. Hea l th  factors accoun ted  for significant 
var iance for fluid intel l igence bu t  not  for e i ther  crysta l ­
lized intel l igence or  memo ry .  Wi th  demograph ic  and 
heal th  factors entered ,  age accounted for significant 
var iance for bo th  fluid intel l igence and me mo ry  factors. 
T h i s  analysis  clearly shows  that  accoun t ing  for the 
effects of hea l th  and soc io -demographic  factors did not 
e l imina te  the  influence of age on cogni t ive per formance.  
The effect tha t  accoun t ing for heal th factors has on the 
r e l a t ionship  be tween  age and cogni t ion can best be seen 
g raphical ly ( Figure) .  T w o  regression lines are shown for 
each of the th ree  factors.  T h e  first represents  the 
r e l a t ionship  be tween  age and cogni t ive per formance 
w hen  no ac coun t  was made  of  heal th factors T h e  second 
is a regression analysis where the influence of health 
factors is stat ist ically cont rol led.  T h u s ,  health factors 
co n t r i bu t e  little to the level of  crystal l ized intelligence 
and m e m o r y ,  a l though  they do account  for some 
var iance in the fluid intel l igence factor scores.  However ,  
accoun t ing  for such var iance does not el iminate the 
effects of  age.
Age, health and  cognitive performance interactions
W h e t h e r  the  associat ion between cogni t ive funct ioning 
and heal th  s t a tus  was greater  for subjects  in the older  age 
g r o up s  was also examined.  Age x heal th variable in t er ­
act ions were exa min ed  by A N O V A  using the M M S E ,  
and  Factors  1,2 and  3. T h e r e  were no age x global health
Fluid int e l l i gence
All subiects 
After adjustment
-0 5 -
C h r o n o l o g i c a l  a g e
Figure.  R egression  lines re la ting age to cognit ive  p e r fo rm a n ce  
tor  (i) all research  pa r t ic ipan ts ,  a n d  (ii) all research  p a r t ic ip a n ts  
a fte r  ad ju s t in g  for health
rat ing interact ions (F : 3 ;<«,i =  1.82, N S; Fy„.»9i =  1.72, N S  
and F (7 nuQi ~ 0.48,  NS,  for fluid, crystal l ized and  
m e m o r y  factors,  respect ively)  indicat ing that  r epor ts  of  
poor  heal th were not associated wi th  mor e  impa i red  
cogni t ive per formance in older  age groups.  Significant 
age x health effects were noted  for t roub le  b rea th ing  and 
f  actor  1 (crystal l ized intel l igence)  ( F (- m:, =  6.82,  
p <  0.0001),  recent  heart  pain and Factor  3 (m em ory )  
(Fi? rix» =  5.502, p <  0.001) and  headaches  and M M S E  
score ( F ,7 707) =  4.30,  p < 0 . 0 0 5 ) .  These effects indicated 
that  the association between t rouble  b r ea th ing  and 
Factor  1 scores was s t ronger  in yo unger  age groups.  The 
associat ion between recent hea r t  pain or t ightness  in the 
chest  and  lower  Factor  3 scores was s t ronger  in o lde r  age 
groups .  T h e  significant  interact ion with headache for 
M M S E  scores arose because a few subjects  r epor t ing 
headaches  (n =  1 2) in the two olde r  age g rou ps  also did
par t i cu la r ly  poor ly  on the M M S E .  Significant  age
X hea lth  effects were observed for in formant  repor t  of 
s t roke and fluid intelligence; for weakness on one side 
and M M S E  scores,  fluid intel l igence and memory;  and 
sud de n  difficulty with speaking and me mo ry  pe r for ­
mance .  However ,  the nature  of  these interact ion effects 
was not  such that  they indicated that  deter iorat ion was 
g rea te r  for o lder  age groups.  On the contrary,  ma in  of 
the in te ract ion effects indicated that less well elderly 
sub ject s  pe r f o rm ed  bet ter  than younger  subjects.  Th er e  
were also no age x high diastolic blood pressu re  interac­
tion effects for the M M S E ,  Factor  1, Factor  2. or Factor  
3 and  no age x high systolic interact ion effects for 
h actors 1 to 3. N o  age x smoking s tatus interact ion 
effects were present .
A nalysts  o f  excluded subjects: By exc luding subjects 
who  failed to p rov ide data on all psychological  tests, we 
ma y  have inadver t en t ly  excluded subjects  with severe 
illness. T h i s  possibi l i ty was invest igated by examining 
heal th and cogni t ive pe rfo rmance  in subjects  excluded 
f rom the original  analysis using pe r fo rmance  on those 
tests co m ple te d  by this sample.  We  selected subjects 
f rom the exc luded  g roup  whose data were available on 
the S ym bol  Le t t e r  Modali t ies T e s t  ( n - 1 3 9 )  and the 
M M S E  (n — 165). C orrelat ions between health variables 
and cogni t ive pe r fo rmance  in this g rou p  were slightly 
s t ronger  ( cor re lat ions approaching  0.20) but  were p res ­
ent  for f ewer  variables (cataracts,  uns teadiness  on legs, 
being  depressed  and  ulcers). The correla t ion between 
u rina ry  and  o the r  infections and per fo rmance  on the 
Sy mb ol  Le t t er  Modal i t i es  T es t  was reasonably high 
( r =  - 0 . 3 0 ) .  It t hus  remains a possibil i ty that  s t ronger  
r e la t ionships  would  have been detected if sicker subjects 
had fo rmed  the major i ty  of the sample  s tudied.
D i s c u s s i o n
I he s tud y  a imed  to investigate the r ela t ionship between 
a variety of object ive and subject ive indices of  health 
sta tus  and pe r f o rm anc e  on a cogni t ive test bat tery.  T h e  
p r i ma ry  aim was to investigate whe the r  at least some of 
the age differences in cognit ive funct ion ing could be 
a t t r ibu tab le  to heal th factors. We expected that  health 
would dete r iora te  across the age g roups  (i.e. f rom 70 to 
90 years),  that  ,11-health would be associated with poor 
pe r fo rm ances  in fluid intelligence and me mo ry ,  and that 
accoun t ing  for the effects of health would substant ial ly 
r educe age differences.  We also invest igated correlat ions 
betw een heal th s t a tus  and cognit ive pe r f o rmance  in s u b ­
samples  of our  populat ion.
The findings were complex,  but  on the whole they did 
not su pp o r t  the hypothesi s  that health med iates  declines 
in cogni t ive p rocess ing with age. First ly,  it migh t  have 
been expec ted  that  measures  of physical heal th would 
decl ine with age in a sample which showed  robust  
decl ines  in m e m o r y  and intelligence with age. We  did 
not find that  all measures  of physical  heal th worsened 
with age. T h u s ,  a l though measures  of A D L  showed 
consis tent  age effects,  global rat ings of  heal th status 
blood p ressure  and  reports of specific il lnesses and
s y m p t o m s  did not consis tent ly increase with age. T h es e  
findings p robab ly  indicate that ,  in our  cross-sect ional  
s tudy,  o lde r  survivors,  a l though  more  physical ly d is­
abled,  were systemical lv as hea l thy as younger  subjects.  
Im po r tan t ly ,  however,  this f inding does not invalidate 
our  a t t em p t  to establ ish a r el a t ionship  between heal th 
and cogni t ive  per formance .  S u ch  relat ionships  would be 
expec ted to be observed wi th in each age g roup  if health 
con t r i bu tes  to poor  cogni t ive pe rfo rmance .
A mor e  serious difficulty was that ,  despi te cons ide r ­
able de ter iora t ion  across age on fluid and memory- 
factors,  we found only weak associations between 
repor ts  of  physical  heal th m e asu res  and cogni t ive p e r ­
fo rmance  (most  correla t ions were below 0.15), a l though 
cor rela t ions between  sel f - repor t  and  in formant -based  
A D L  m e asu res  were mu ch  s t ro ng er  (greater  than 0.30). 
Mos t  of  the correla t ions were found for those aspects of
cogni t ion w hich are sensit ive to age-associated decl ine__
a l though  this was not invar i ably the case (see Tab le  
VII ) .  Im po r t an t ly ,  the results o f  the regression analyses 
showed  tha t  age effects were p r esen t  even when  account  
was taken of  heal th factors,  sex,  educa t ion  and de pr e s ­
sive status.  Signif icant  age x hea l th  variable interact ion 
effects were found,  but  it is p r ob ab l e  that  these signifi­
cant  int eract ions  occur red by chance.  T h e r e  were 59 
heal th var iables ,  each exa min ed  in relat ion to four 
d ep e n d en t  variables ( M M S E ,  Fac to r s  1 to 3). U nd er  
these cond i t ions ,  at least two o r  th r ee  significant int erac­
t ions mi g h t  have been expected to occur  by chance.  
Overal l ,  the results f rom the total sample  did not 
su p p or t  the hypothesi s  tha t  hea l th factors mediate 
changes  in intel l igence wi th  age. Al though A D L  
measures  show ed  significant de ter iora t ion  with age, 
account ing  tor  changes  in A D L  using regression ana ly ­
sis did not  reverse d rops in fluid intel l igence and 
m e m o r y  wi th  age.
Because we failed to find significant  health de t e r io r a ­
t ion wi th  age for mos t  measures ,  and  to find a rela t ion­
ship be tw een  heal th and cogni t ion  in our  full sample,  we 
mus t  cons ider  why  our  r esults differ f rom o the r  studies.  
One  possible  reason for the fai lure to show st rong health 
and age effects in the total sample  concerns  the measures  
of heal th used,  which may  have been insensit ive or 
con t ami na te d ,  for example ,  by educa t ion.  However ,  this 
possibi l i ty is unlikely,  given that  such scales have often 
been used successful ly in p rev ious  research.  For  e x a m ­
ple, s e l f - r epor t ed health has been shown to predict  
mor tal i ty  [25-27] ,  Moreover ,  t he fai lure to find rela t ion­
ships occur red  consis tent ly  over  a large n u m b e r  of  the 
measures  used.
A n ot he r  possibi l i ty is that  mul t ip le  r a the r  than iso­
lated heal th  compla in t s  are associated with poorer  
cogni t ive pe r fo rmance .  T h i s  is the idea that  heal th onlv 
significant ly affects cogni t ive s ta tus  when it is seriouslv 
impa ired .  W e  deve loped  two com pos i t e  heal th scores 
( n u m b e r  of  past  complaints ,  n u m b e r  o f  cu r r en t  health 
compla int s)  and examined  the ir  con t r ibu t ion  to pe r f o r ­
mance  in the mul t ip le  r egression analyses.  T h e  amo unt  
of var iance p redic ted  by these co m po s i t e  scales was very 
small and  significant  only for cu r r en t  heal th complaint s
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Abstract
The cognitive test performance of 897 community dwelling elderly subjects, 
aged 70 years and over, was examined for age trends and inter-individual 
variation. Data were subjected to factor analysis and three factors emerged 
(Crystallized intelligence, Fluid intelligence and Memory). Over the age span 
sam pled, C rystallized intelligence, Fluid intelligence and M emory all 
decreased with the decrease being greatest for Fluid intelligence and least for 
Crystallized intelligence. In ter-individual variation increased for Fluid 
intelligence and M emory, but not for C rystallized intelligence. These 
findings give support to the view that crystallized intelligence is lower in the 
very old, and that there is a greater degree of variability in test performance 
with advancing age.
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Age Differences and Inter-individual Variation 
in Community-dwelling Elderly
Much recent research in aging has concentrated on determining the 
basis of age-associated deficits in memory and intelligence. Yet, rather 
surprisingly, there is still no agreement about the nature and extent of 
changes in cognitive functioning across the life span. Rabbitt (1990) claimed 
that continuous decline occurs after the fourth decade of life and rapidly 
accelerates after the sixth decade. Others have argued that the tendency to 
decline begins in the seventh or eighth decade, with a more pronounced 
decline in the ninth decade (Hochanadel & Kaplan, 1984). The type of ability 
or task is said to determine the timing and extent of deterioration, with 
crystallized intelligence declining later than fluid abilities (e.g., Horn, 1987). 
However, according to Hultsch, Hertzog, Small, McDonald-Miszczak and 
Dixon (1992) even this claim may not adequately represent the process of 
change in abilities over time. Hertzog and Schaie (1988, p.128) have suggested 
that "most individuals make a transition from a stability to a decline pattern 
of g development at some point between age 55 and age 70". During this time 
many abilities will begin to decline. Even tasks which can be seen to reflect 
crystallized intelligence, such as verbal meaning tasks, may show steep age 
gradients similar to those of spatial orientation.
Description of intellectual and memory performance changes across 
the life span has been particularly limited for elderly subjects over the age of 
70 years. Although information is now available (Johansson, Zarit & Berg, 
1992; Poon et al., 1992; Schaie, 1985), it is almost always based on volunteer 
samples (Schaie & Willis, 1993) or restricted to a few tests of cognitive 
functioning (eg., Colsher & Wallace, 1991; Scherr et al., 1988). For example, 
Colsher and Wallace examined recall and recognition performance over 6
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years in a sample of 1,768 community dwelling adults. Significant declines 
on these measures of memory were observed over the 6-year period.
A second area where inform ation is lacking is that of in ter­
individual variation. Older subjects, as a group, are often said to produce a 
greater range of responses to psychometric (and other) tests than do younger 
subjects (see Morse, 1993). This increased variation has been taken to reflect a 
greater range of individual responses to aging, with some subjects remaining 
unchanged, and other deteriorating dramatically. According to Salthouse, 
(1991) there is still little convincing evidence that inter-individual variability 
is greater with increased age. Contradictory reports have recently emerged. 
Horn and Hofer (1992), in an analysis of WAIS data, reported inter-individual 
variation increased w ith  age in groups up to 75 years for crystallized 
intelligence, but not for fluid intelligence. They attributed the increase in 
individual differences in crystallized ability to the "fact that some individuals 
continue to devote considerable effort to enhancing their cognitive capability 
after formal schooling ceases, whereas others do less of such work" (p.92). By 
contrast, individual differences in fluid intelligence were not found to 
increase with age, leading Horn and Hofer (1992) to conclude that this "seems 
to indicate that these abilities reach an asymptote of development in early 
adulthood" (p.92). However, the opposite finding has been reported in a 
m eta-analysis of the literature. Morse (1993) examined the coefficient of 
variability (a measure of dispersion which takes into account differences in 
mean scores) for four classes of task— reaction time, memory, crystallized and 
fluid intelligence — sam pling papers from the Journal of Gerontology and 
Psychology and Aging for the years 1986-1990. Reaction time measures 
showed increased variability for older age groups of healthy elderly subjects 
compared to younger groups w hen all experimental comparisons were used 
(although different results were seen w hen the study, rather than the 
comparison, form ed the basis of the analysis). Memory m easures were
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associated w ith increased variability in older sam ples, as were fluid 
intelligence measures. However, crystallized intelligence measures (mostly 
WAIS verbal tests) failed to show a mean difference in variability between 
older and younger subject groups. An explanation for these opposing 
findings is not immediately apparent. There are, however, substantial 
differences in the samples used by the two studies. Morse used a variety of 
individual studies of healthy volunteer samples while Horn's analyses were 
based on WAIS data, which comes from a stratified and representative 
sample of subjects which reflect census data.
Data are presented in this paper on memory and intelligence for a 
sample of 897 community dwellers aged 70 years or over. Using regression 
analysis, two issues were investigated. First, we asked whether there were 
age-associated changes in intelligence and memory in the com m unity 
sample. Thirteen cognitive tasks and the Mini-Mental State Examination— a 
brief screening test for dementia (Folstein, Folstein & McHugh, 1974)— were 
used to measure a variety of aspects of cognition. Since data were derived 
from a population based sample and covered a range of cognitive functions, 
valid estim ates of age differences could be obtained for many cognitive 
abilities. In particular, the issue of whether crystallized intelligence shows 
less age-related change than fluid intelligence and memory in subjects over 
70 could be examined. Secondly, we examined w hether inter-individual 
variation increased with age, and whether this variation was greatest for tasks 
claimed to be sensitive to age decline, such as speeded or fluid tasks.
Method
Subjects
The sample consisted of 897 community dwelling Australians aged 
70 years or more living in Canberra and the adjacent town of Queanbeyan. 
The elderly were sampled from a compulsory register of voters. Their mean
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age was 76.5 (SD 4.94) (range 70-97). The sample was drawn to give equal 
numbers of males and females. Three strata (70-74 years, 75-79 years and 80+ 
years) were used to give an achieved sample which was in proportion to the 
number of individuals in that age group. Thus 42% were aged 70-74 
inclusive, 32% were aged 75-79 inclusive, and 26% were 80 or over. Subjects 
had an average of 11.3 years of education. Eighty-six percent of the sample 
were native English speakers. The distribution of age, education and English 
speaking background of the sample was commensurate with the 
characteristics of people living in the region (Australian Bureau of Statistics, 
1989). Self-ratings of health, measures of blood pressure, self and informant 
based reports of current and past illnesses indicated that the participants were 
generally healthy (see Christensen et al., in press). Older subjects reported 
greater disability than did younger subjects as measured by Activities of Daily 
Living scales administered to both participants and informants (Jorm et ah, 
1993).
Sixty nine percent of those approached agreed to participate, a 
response rate similar to those recently obtained in other community samples 
(e.g., Führer et ah, 1992). Sixty five percent of refusers were women, but the 
age range of refusers did not differ from that of the participants.
Procedure
Subjects were interviewed in their homes by trained interviewers. 
Information necessary for the diagnosis of dementia and depression was 
collected (Mackinnon et ah, 1993; Social Psychiatry Research Unit, 1992), as 
well as information on social background, personality and social support. 
The diagnoses of dementia and depression were made using the Canberra 
Interview for the Elderly (CIE). This is a structured interview, incorporating 
the report of an informant, the respondent and psychometric testing. The CIE 
incorporates a variety of cognitive tests, many of which have been shortened
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for use in epidemiological settings. It is the results from these tests which 
form the basis of the present study. The prevalence of depression and 
dementia in the sample are reported elsewhere (Henderson et al., 1993; 
Henderson et al., in press). The entire interview took, on average, 117 
minutes (SD=29 minutes) and was usually conducted in one session. Because 
of the epidemiological nature of the study, intellectually demanding 
cognitive or experimental tasks which were likely to be received 
unfavourably by our sample were precluded. With the exception of the flag 
and cube drawing tasks, the reaction time task, and some items from the 
Mini-Mental State Examination, the responses required were oral. Thus, 
although subjects were required to read, examine pictures, and respond to a 
printed key, only oral responses were required. The reaction time tasks were 
presented along with other tests such as hand dynamometer and blood 
pressure, which were designed to measure physical health.
Cognitive tasks
The cognitive test battery consisted of 14 tasks including standard tests.
The National Adult Reading Test (NARTk This test (Nelson, 1982) 
relies on the reading of words which are not pronounceable phonetically to 
yield an estimate of premorbid intelligence. Testing was discontinued 
whenever there were 14 failures out of 15 items.
Symbol Letter Modalities Test fSLMTT This test is a modified version 
of the (oral) Symbol Digit Modalities Test (SDMT) (Smith, 1973). During the 
test, subjects tell the interviewer the letters of the alphabet which correspond 
to patterns in a key. Scores are based on the number of correct letter-symbol 
pairs made in 90 seconds. Instructions are equivalent to those printed in the 
manual to the SDMT and subjects are allowed 10 practice items.
Choice and simple reaction time. Each was measured over 20 trials. 
The simple reaction time (SRT) task measured the time (in milliseconds) to
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respond to a signalled right (R) or left (L) light with a R or L button press was 
measured. In the choice reaction time task (CRT) either the R or L light was 
illuminated and subjects responded with either a R or L button press. 
Individual's mean times for the trials were used in analyses. The following 
instructions were given "I now want to measure your speed to respond to a 
light. This will take about five minutes or so to do. Please take this box. As 
you can see it has two buttons on it. I want you to place your fingers over 
these buttons. Your left index finger goes over the left button and your right 
index finger goes over the right button. Now I am going to turn the left light 
on and as soon as you can see the left light come on I want you to press the 
left button as fast as you can". The instructor then says 'ready' and turns on 
the left light. (Inter stimulus intervals range from .5 to 2.0 seconds). The 
subject is given 5 practice trials. The instructor then says "Now I am going to 
take the measurements proper. The light coming on will be the left light 
only." Ten trials are then completed. The experimenter then says "This time 
the light coming on will be the right one and I want you to press the button 
with your right finger as soon as it comes on. Are you ready?" Four practice 
trials are then given. For the complex reaction time task, the following 
instruction are given. "This time I'm not going to tell you which light will 
come on. If the right one comes on I want you to press the right button. If 
the left one comes on, I want you to press the left button. I'll give you a few 
practices" (four are given).
V o cab u la ry . This consisted of 3 items; 'Repair', 'Terminate', 
'Compassion' from the Wechsler Adult Intelligence Scale -Revised (WAIS- 
R). Items were scored 0, 1 or 2 to give a total out of 6.
Sim ilarities. This consisted on 3 items (apple/banana, boat/car, 
seed/egg) from the WAIS-R. Items were scored 0, 1 or 2 to give a total out of
6 .
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Information. This consisted of four items developed for an Australian 
sample. Subjects were asked to identify four historical figures (Captain Cook, 
Charlie Chaplin, Joseph Stalin, Adolf Hitler). Scores ranged from 0 to 4.
Cube Drawing. Subjects were required to produce a copy of a cube from 
a drawn 2-D figure. Scores ranged from 0 to 12 on the basis of a pretested 
scoring system. In an earlier study of 64 elderly subjects (see below) seen at a 
geriatric clinic, the inter-rater reliability for the task using scoring criteria 
below (with scored examples) was 0.89. One point was given for each line of 
the front face, top and side which was vertical or horizontal (lines were not to 
depart the plane by more than 15 degrees). Further points were given for 
correct orientation, proportion, and coherence. Points were deducted if the 
finished drawing was elongated or non-cube like. Exact scoring criteria are 
available on request.
Memory for a figure. Item 1 (Flags) from the Visual Reproduction 
Subtest of the Wechsler Memory Scale was used. Scores ranged from 0 to 3 
points.
Recall of words. Subjects were required to recall 3 words which had 
been learnt to criterion about 1 to 2 minutes earlier. The following 
instructions were used: "I am going to name three objects. After I have said 
them I want you to repeat them. Remember what they are because I am 
going to ask you to name them again in a few minutes" The objects are 
repeated for a maximum of five trials until the subject has learnt all three. A 
few minutes later, subjects are asked "Now what were the 3 objects I asked 
you to remember?" Subjects unable to repeat the items after the learning trial 
are scored 0 for the memory task.
Address recall. Subjects were required to recall a name and address (5 
items) learnt to criterion 1 to 2 minutes earlier. Instructions for the address 
were as follows: "Please listen carefully to the following name and address, 
then repeat it: John Brown, 42 West Street, Kensington." The address is
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repeated for a maximum of five trials until it is learned. "Please go on 
remembering this name and address and I will ask you about it later." A few 
minutes later, the subject is asked "What is the name and address I asked you 
to remember a short time ago?" Subjects unable to repeat the phrase are 
scored 0 on the memory component.
Face recognition. This was an intentional face recognition task, similar 
to that used in the Rivermead Behavioural Memory Test (Wilson, Cockburn 
& Baddeley, 1985). Participants were shown five faces of men and women 
and then, after an interval of a few minutes, were required to select the faces 
they had previously seen from a set of 15 (5 targets and 10 distractors). 
Subjects were given 2 points for 'hits' and 1 point for correct recognitions. 
'Don't know' responses were given half points to be comparable with subjects 
who may have guessed.
Word recognition. Subjects were asked to answer 13 questions 
(including 1 buffer item), each of which contained key words. They were later 
asked to identify which key words could be remembered from 24 items (12 
targets and 12 distractors). For example, participants were asked "Is a table a 
piece of furniture?" "Are flowers a type of floor covering?" and so on, and 
later told "Now I want you to listen as I read through a list of words. Do you 
remember that a few minutes ago I asked you some questions like Ts a table a 
piece of furniture?' Now try to remember if I asked you a question about any 
of the following words. Church? (No/Yes/Don't know). Flowers?" etc. Half 
of the 'Don't know' responses were scored correct to be comparable to subjects 
who may have guessed.
Verbal fluency. Subjects were asked to say aloud as many animals as 
they could within 30 seconds.
Mini-Mental State Examination (MMSE). This brief screening test for 
dementia was included to provide comparability with other epidemiological
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studies and to provide a measure of clinically significant cognitive 
impairment.
Tests for the study were chosen to measure decline in cognitive 
functioning as specifically outlined by the DSM-III-R and ICD-10 Criteria for 
dementia. There were a small number of other items measuring aspects of 
cognitive functioning which were included in the interview but not reported 
here. Examples of such items were those measuring orientation in time and 
place, long term memory, and those requiring the subject to identify pictures 
of ordinary objects taken from unusual angles, or perform a sequence of 
actions in response to a command- for example, pointing to the window and 
then to the door. These items were answered incorrectly by only a small 
percentage of respondents.
Reliability of measures. Because many of the tests used in this study 
were developed for the study, or were shortened versions of longer tests, we 
report data on the test-retest reliability measured after an average interval of 3 
days for 13 of the 14 measures. (Reaction time re-test reliability was not 
available). These data were collected from a sample of 64 elderly people 
attending a geriatric clinic (see Social Psychiatry Research Unit, 1992). Since 
these attenders presented with physical, psychological or neurological 
problems, the reliability of measures is likely to be underestimated for a 
community sample. Re-test reliability was very good for most measures: 
NART (.79), SLMT (.81), Information (.86), Verbal fluency (.87), Word 
recognition (.71) and MMSE (.80), and adequate for most of the remainder: 
Vocabulary (.69), Cube (.56), Visual Reproduction (.61), Face Recognition (.58), 
Word recall (.65), and Address recall (.52). Retest reliability for Similarities 
was less satisfactory (.49) but this may reflect individual's learning following 
first test administration, since the mean level of performance increased on re­
test. Inter-rater reliability for item scoring was very high: Cube drawing (.89),
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Memory for Figure (.92). In the present study, Cronbach alpha for choice 
reaction time was very satisfactory (.84).
Results
Factor analysis of measures of cognitive performance
Usable responses were obtained from 884 of the 897 subjects. Because of 
high correlations among outcome m easures, data from the psychometric 
tasks were subjected to a principal components analysis. Choice but not 
Simple Reaction Time was used in this analysis because of the very high 
correlation between these two measures. Three factors which emerged with 
eigenvalues greater than 1.00 w ere reta ined  in the factor solution. 
O rthogonal (varimax) and oblique (oblimin) rotations were examined. 
A lthough the factors in the oblique rotation were m oderately correlated 
(maximum interfactor r=0..39) both solutions yielded a substantially similar 
interpretation. Because data com pression w as the principal aim of this 
analysis, the orthogonal solution was adopted (see Table 1).
Insert Table 1 about here
From their factor loadings, the factors were labelled Crystallized 
intelligence, Fluid intelligence and Memory, and composite scores were used 
in the regression analysis, thereby reducing the num ber of outcome 
measures. The first two factors could have been labelled knowledge and 
speed/spatial but we chose to label them using H orn's (1987) terms to allow 
easy comparability to the research literature. Only 715 subjects provided 
complete data and could be included in the factor analysis. The loss of the
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other 169 cases might have serious consequences if subjects with partially 
missing data differed in important respects from those with full data sets. In 
order to minimise this problem in subsequent analyses, composite scores 
were constructed by standardising all variables and calculating, for each 
subject, the mean of the variables comprising each factor. To determine 
which tests were included in the calculation of composite scores, tests which 
loaded less than .4 on the three factors were elim inated and rem aining 
variables were assigned to the highest factor. Composite scores were 
calculated so long as the subject completed at least one test for the factor. As 
well as perm itting the inclusion of more subjects, this procedure effectively 
assigns unit weights to the variables in each factor. Horn and McArdle (1992) 
have suggested that this approach produces more stable results than when 
weights derived from factor analysis are used. It should be noted that analysis 
of subjects with complete data only (n=715) produced identical results to that 
of the main analysis. Intercorrelations among the composite scores were .54 
for flu id  and crystallized intelligence, .52 betw een memory and fluid 
intelligence, and .48 between memory and crystallized intelligence.
Analysis of mean composite scores and individual tests with age
The means of the composite scores for the three factors as a 
function of age are shown in Figure 1. Linear and quadratic age trends for the 
com posite scores and individual tests across age were examined using 
regression analysis. Table 2 provides beta coefficients, multiple R and R2 
change statistics. Crystallized, Fluid intelligence and Memory show ed 
significant linear decreases with age. The strongest trend was present for 
Fluid intelligence (R2 = .11), although a relatively small amount of variance 
was accounted for. Scores for the Memory factor were not distributed 
symmetrically about the mean, which indicated a ceiling effect was present. 
All individual tests showed a linear trend with age except for Vocabulary.
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The strongest trend was present for SLMT. Quadratic trends were present for 
Word recognition and the MMSE. The age trends for Crystallized, Fluid and 
Memory scores were significantly different from one another (ßCrystallized 
(-.17) vs. ßFluid('-33): t = 5.11, p<.01; ßCrystallized(--17) vs■ ßMemory(--24): 
t = 2.04, p=.04; ßFluid(--33) vs. ßMemory(--24): t = 2.84, pc.01). This indicates 
differences in the rate of changes in these ability clusters with age. Age 
differences were greater for Fluid intelligence than for Memory and greater 
for Memory than for Crystallized intelligence. The relatively small age range 
in this study meant that higher-order polynomials could not be fitted to the 
data.
Insert Figure 1 and Table 2 about here
Analysis of residuals of composite scores and individual tests
Differences in inter-individual variability as a function of age were 
examined using regression analyses of the absolute value of residuals from 
the polynomial regressions on age. If there is a increase in the dispersion of 
performance scores as a function of age, a significant positive slope should be 
observed in the regression of the m agnitude of the residuals of the earlier 
analyses against age. Residuals were calculated w ith only the significant 
polynomial trends included in the equations. Figure 2 shows the absolute 
value of the residuals as a function of age for each of the three factors. 
Results from the regression analyses for the composite scores and individual 
tests are shown in Table 3. Linear and quadratic trends were tested across age 
for each factor and each test. Residuals for Fluid intelligence and Memory 
increased linearly w ith  age, w hile C rystallized  intelligence did not. 
Approximately 4 percent of the variance was accounted for by the linear trend
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for the Memory factor. The linear trend for Memory factor was essentially 
unchanged when the largest residual which happened to belong to the oldest 
subject was taken out. Residuals increased linearly for the following 
individual tests: NART, Similarities, Information, Cube drawing, Visual 
Reproduction, Face recognition, Word recall, Address recall and the MMSE. 
The magnitude of the residuals did not increase with age for SLMT, CRT, 
Vocabulary or Verbal fluency.
Insert Figure 2 and Table 3 about here
The age trends for residuals of the composite scores were compared 
by testing for differences between the significant linear beta-coefficients in the 
regressions of the residuals. There was a significant difference between 
Memory and both Crystallized and Fluid intelligence (ßCrystallized(-04) vs. 
ßMemory(-19): t = 3.71, pc.01; ßFluid(09) vs. ßMemory(d.9): t = 2.66, pc.01), 
but not between Crystallized and Fluid intelligence (ßCrystallized(-04) vs. 
ßFluid(-09): t = 1.22, p=.22). Increase in inter-individual variation as a 
function of age was greater for Memory compared to intelligence.
Possible artifacts
There is a possibility that the age-related changes in variability for 
some of the tests was a scaling artifact due to ceiling effects. Ceiling effects 
occur when individuals have higher levels of ability than a test is able to 
measure and have their score restricted to the maximum achievable on the 
test. Because younger subjects have been shown to have higher ability in this 
study, it is possible that the increase in variability of scores observed in the 
analysis of residuals could be due to the underestimation of the ability of 
younger subjects rather than to larger natural variability in older persons. To 
examine this possibility, subjects were divided according to age into four
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groups: 70-74 years, 75 to 79 years, 80-84 years and 85 years plus. Across age 
groups the proportion with maximum scores decreased for 3 of the 13 tests: 
Cube draw ing (34% with maximum scores in youngest group to 14% with 
maximum scores in the oldest group), Word recognition (52% to 31%), and 
W ord recall (70% to 50%). The proportion decreased somewhat for three 
others: Visual Reproduction (36% to 24%), Address recall (50 to 38%) and 
Vocabulary (40 to 28%). However, it is clear that tests with "ceiling effects" in 
the younger cohorts did not correspond closely to tests showing increased 
variation w ith age, making it unlikely that increased variability was an 
artifact of the scaling characteristics of the tests. For example, inter-individual 
variation increased for the NART, Similarities and Information, and ceiling 
effects were not present for these tests and, conversely, inter-individual 
variation did not increase for Vocabulary, despite the presence of 'ceiling 
effects' in younger participants.
It was also unlikely that increased variability was a function of the 
unreliability of the tests. There was no direct link between test reliability and 
the presence of increased in ter-individual variation. Thus, increased 
variability was observed on tasks w ith  both high (NART, Information, 
MMSE) and low reliability (Similarities, Address recall), and was not 
observed on tasks with both high (Verbal fluency) and moderate reliability 
(Vocabulary).
In addition, increased variability was not likely to be a function of 
m ean age differences. Variability increased in tasks where the mean score 
decreased w ith age. Moreover, factor scores, which are more stable than 
individual tests, also increased in variability across age, making it unlikely 
that scaling artifacts were a complete explanation for increased in ter­
individual variation.
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Analysis excluding subjects with low MMSE scores
Subjects with MMSE scores below 24 were excluded in a re-analysis 
of the data. This allowed an examination of whether the same relationships 
between age and the ability composite scores were present when subjects with 
very low scores, consistent with dementia, were excluded. The conventional 
cutoff for a suspected case of clinical dementia is usually below 24. Although 
the MMSE is a crude screening test for dementia, it nevertheless serves to 
exclude cases with very low levels of cognitive functioning. After exclusion, 
807 subjects remained in the analysis. Forty five percent of those included 
were aged 70-74, 31% aged 75-79, 17% were aged 80-84, and 7% were aged over 
85. These proportions did not differ from those for the total sample (see 
Subjects). The mean standardised NART score for the sample of 807 subjects 
was .10 (SD=.92) while that for the entire sample was .00 (SD=1.0). The mean 
standardised score for SLMT was .12 (SD=.91). Linear trends for the three 
composite scores and the residuals of the composite scores were examined. 
Crystallized intelligence decreased linearly (Multiple R=.12; R2 = .01), as did 
Fluid intelligence (Multiple R =. 31, R2 = .09), and Memory (Multiple R = .21; 
R2 = .05). Variation did not increase for Crystallized intelligence (Multiple R 
= .01, R2 = .00, n = 807) but did for Fluid intelligence (Multiple R = .08, R2 = 
.01) and Memory (Multiple R = .18, R2 = .03).
A more direct test of the influence of the MMSE on the pattern of age 
gradients and inter-individual variation is to use regression analysis and 
enter MMSE along with age as a predictor variable. By examining the cross- 
product interaction term (MMSE x Age), an examination can be made of 
whether MMSE level moderates age effects. However, because both MMSE 
and age are highly correlated with their cross-product, straightforward 
interpretation of the regression analyses may not be possible. In the 
regression analyses reported here, MMSE score was entered first, followed by 
age expressed as a linear trend, and then their cross product. Beta coefficients,
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R2, R2 change, and number of participants for these analyses are shown in 
Table 4. For all three weighted composite scores (Crystallized, Fluid and 
Memory), MMSE accounted for a significant proportion of the variance. Age 
contributed additional variance to fluid and memory scores, but not to 
crystallized intelligence. The MMSE x Age interaction was significant for 
C rystallized intelligence, although only a small am ount of additional 
variance was explained. This interaction indicated that age was not a useful 
predictor of Crystallized intelligence scores for younger subjects with very low 
MMSE scores. However, only a small num ber of subjects scored low on 
MMSE in the younger age groups.
For the residuals, both MMSE and age accounted for significant 
variance for all three scores. The MMSE x Age interaction accounted for 
additional variance for crystallized intelligence, but not for the other two 
factors. This latter interaction indicated that very young people with low 
MMSE scores had proportionately greater residual scores.
Discussion
The findings of the present are based on data from a large community 
sam ple, and hence they provide valuable data on the topography of age 
differences in intelligence in elderly subjects over the age of 70 years. The 
study aim ed to examine both the m ean differences in intelligence and 
m em ory across age and to determ ine w hether inter-individual variation 
increased.
Mean changes in memory and intelligence
C rystallized intelligence, Fluid intelligence and Memory decreased 
linearly across age in our sample. All individual tests of functioning showed 
age differences, w ith the exception of Vocabulary. The greatest difference was 
associated w ith SLMT followed by Verbal fluency, W ord recognition, Visual
Age differences 18
Reproduction and Choice reaction time. The smallest difference was 
associated with tests of Vocabulary and the NART. Overall, the amount of 
variance accounted for by the linear trends was small (the range was from 
11% to less than 1%). These results suggest that Crystallized intelligence does 
not remain stable in late old age although it shows a smaller age difference 
than other ability clusters. The age differences were not determined by a 
subgroup of subjects with very low scores.
The data from this study are consistent with both cross-sectional and 
longitudinal data based largely on volunteer samples. For example, cross- 
sectional data from the fifth wave of the Seattle Longitudinal Study (Schaie 
and Willis, 1993), which were based on 1,628 community dwelling 
individuals aged 25 to 88 drawn from a health maintenance organisation, 
showed significant age effects for all of the examined ability clusters- 
inductive reasoning, spatial orientation, numeric ability, verbal ability, verbal 
memory and perceptual speed. The magnitude of the age difference between 
the youngest and oldest age groups varied from about .75 of a standard 
deviation for the verbal ability measure to over 2.5 standard deviations for 
perceptual speed. Verbal ability and numerical ability showed age differences 
by the late 60s. Divergence in trajectories for different abilities became 
marked by the 70s, with verbal ability being the best preserved and perceptual 
speed the most reduced.
Other studies, again using volunteer or highly selected samples, have 
confirmed age-associated decline in many ability clusters (see Arbuckle, Gold 
& Andres, 1986; Luszcz, 1992; Moehle & Long, 1989; Poon et al., 1992; 
Salthouse, Kausler & Saults, 1990). With the exception of a few studies (e.g., 
Van Gorp, Satz & Mitrushina, 1990), consistent age differences have been 
observed in most abilities, including verbal ones, and particularly in samples 
over the age of 70 years (Poon et al., 1992). This evidence of the existence of 
age-associated differences in most abilities is substantial considering that
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volunteer sam ples are likely to be healthier and less d isabled than 
representative sam ples. Two studies, which have used representative 
samples, (Colsher & Wallace, 1991; Scherr et al., 1988) have also found age 
differences in groups of subjects from 65 years up. Unfortunately, these 
studies have been limited in the number of outcome measures used, w ith 
tests of memory predominating. A more recent study (Lindenberger, Mayr & 
Kleigl, 1993) using a sam ple w hich included  both com m unity  and 
institu tionalised individuals, found correlations w ith age of -.45 for a 
reasoning factor, -.39 for a memory factor and -.40 for a knowledge factor. The 
corresponding correlations for our study were -.33 for the Fluid factor, -.24 for 
the M emory factor and -.17 for the C rystallized factor. The fact that 
L indenberger used fuller versions of sim ilar tests, sam pled  from  
institutionalised populations as well as the com m unity, and used only a 
small proportion of the original sample (i.e., 29% of those approached 
com pared to 69% for our sample) may provide an explanation for the 
differences between the studies in the m agnitude of correlations betw een the 
factors and age. The advantage of the present study is that a broad range of 
abilities were measured using a large population sample. In sum, it is clear 
that the age differences observed in the present study are in accord with most 
other research based on largely volunteer samples.
Inter-individual variation
The second issue of interest in the present study was the examination 
of inter-individual variation across age. Inter-individual variation increased 
for Fluid intelligence and Memory, but not for Crystallized intelligence. 
G reatest ind iv idua l varia tion  w as observed  for W ord recognition , 
Information, Visual Reproduction, Face recognition, and the least am ount 
for SLMT and Verbal fluency. Memory perform ance showed significantly 
greater inter-individual variation w ith age than did fluid or crystallized
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intelligence. This pattern of results did not change when very low scorers 
were excluded or when MMSE score was entered as an additional predictor in 
the regression analyses. The increased variability for memory measures may 
have been partly due to a restriction in the range of possible scores for 
younger participants (i.e., less than 75 years), since the proportion w ith 
maximum scores in younger cohorts compared to older cohorts was higher by 
20% for W ord recognition and W ord recall. However, it is unlikely to be 
fully, or even largely, responsible for the increased variability. For instance, 
face recognition (which was associated w ith one of the higher in ter­
individual variation results) had a greater percentage of old compared to 
young subjects achieving maximum scores.
Very little attention has been directed to investigating inter-individual 
variation, a lthough it is often rem arked that in ter-indiv idual variation 
increases with age. Salthouse (1991) used two methods to examine the issue; 
(a) an analysis of inter-individual variation using a num ber of secondary data 
sets containing subjects aged betw een about 20 and 60 years and (b) an 
exam ination of the relative stability  of perform ance across years in 
longitudinal studies. He concluded that the evidence did not support 
increased individual variation because the extent of variation  did not 
increase w ith age and the high correlations betw een perform ance at two 
occasions was consistent w ith great stability. Since the data used in these 
analyses were based, at least in some cases, on nationally representative 
sam ples, the major reason for differences betw een our study and these 
analyses may have been due to differences in the age ranges represented. The 
present findings are more in accord w ith those recently published by Morse 
(1993) of a meta-analysis of selected literature from 1986. M emory and 
reasoning m easures increased in variability w ith  age, while crystallized 
intelligence did not. Morse found that reaction time tasks also increased in 
variability if all comparisons across the sam pled studies were included,
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although if the study served as the unit of analysis, variability was not found 
to increase. Morse explained the discrepancy by noting that increases in 
variability in reaction time tasks were dependent on task type. These findings 
with respect to reaction-time are, in any case, not appropriately compared to 
our choice reaction time measure. Morse's reaction time measures consisted 
of time to perform various complex tasks such as word association, the search 
of patterns, and decision time for recognition. There were no simple or 
choice reaction time measures like those used in the present study included 
in the meta-analytic study.
Accepting that the present results are not artifactual, a number of 
issues concerning the cause and pattern of inter-individual variation need to 
be further examined. One explanation for mean increases in inter-individual 
variation with age is that certain individuals deteriorate dramatically while 
others remain the same. However, in the present study the pattern of inter­
individual variation did not change markedly when very low scorers were 
excluded. Thus, it is more likely that there is a general increase in the 
proportion of elderly subjects who show age-associated decline in older age 
groups. The pattern of inter-individual variation was not uniform across 
tests or composite scores, with both Crystallized and Fluid intelligence 
showing less variation than Memory. One interpretation of this finding is 
that the scaling properties of tests which contributed to the three composite 
scores were different. As noted above, there was some support for this 
suggestion in that memory tasks were associated with restriction of scores in 
younger cohorts because of scaling artifacts. The spread of scores achievable 
may have decreased with age. However, as argued above, artifacts are 
unlikely to provide a total explanation. It should be noted that the strength 
of age differences was not directly proportional to the extent of variation. A 
larger age difference was observed for the Fluid composite score but 
significantly greater variation was observed for the Memory score. An
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alternative explanation may be that memory is more sensitive than other 
functions to change at older ages. Evidence from studies of patients with 
severe cognitive im pairm en t is consisten t w ith  th is exp lanation  
(Christensen, Hadzi-Pavlovic & Jacomb, 1991). Memory changes are more 
vulnerable to deterioration than other abilities in early dementia. It is also 
known that complaints of memory are frequent in elderly people, although 
w hether they increase w ith age is controversial. Com plaints of loss of 
intellectual function are not as com m on (Jorm et al., in press). This 
difference may reflect the relative vulnerability of memory compared to 
other intellectual functions.
It should be noted that the range of ages over which we examined for 
polynomial trends was small (70-97 years). Many cross-sectional studies 
examine trajectories across the life span (see for example, Schaie and Willis, 
1993). Within the age range of this study, the nature of age differences may be 
difficult to determ ine because differences that are significantly non-linear 
over the course of the life-span may be well approxim ated by a linear 
function.
It is likely that the proportion of community dwellers decreases as a 
function  of age, w ith  a greater p ro p o rtio n  of older people being 
accommodated in nursing homes or sheltered accommodation rather than in 
their own homes. Older subjects rem aining in our sample were likely to be 
physically healthier and perhaps educationally more advantaged than their 
peers. The change in the composition of age groups in cross-sectional studies 
(the equivalent of the survivor effect in longitudinal studies) is likely to 
result in proportionately higher mean performances on most cognitive tests 
for older groups of subjects. The result will be an under-estimate of the age 
difference across the span of years studied. This bias is also likely to result in 
an under-estimate of inter-individual variation in older samples.
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Another problem with cross-sectional studies is that variables other 
than age can contribute to mean differences and individual variation (see 
Schaie and Willis, 1993). Such variables include education and life-style 
experiences. Longitudinal analyses, where change in each individual's level 
of performance is m easured, will provide information on age differences in 
subjects from the same cohorts. We intend to conduct a four year follow-up 
of our subjects in 1994/95.
A nother lim itation of the present study is that many tests were 
shortened versions of longer ones, or developed for oral reply to an 
epidemiological interview. The nature of an epidemiological study is such 
that it precludes subjecting participants to rigorous psychological testing. 
However, the validity of our measures seems to be reasonable despite their 
length, given that the factor analysis solution is similar to others found in 
elderly samples. Despite these limitations, the results of the present study 
provide data on the nature of age differences from a large sam ple of 
com m unity dwelling elderly on a variety of cognitive tests. The findings 
support those from samples of volunteers. They also suggest that in ter­
indiv idual variation increases across age, and that episodic m em ory is 
associated with greater inter-individual variation than fluid or crystallized 
intelligence.
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Table 1
Factor analysis of psychom etric m easures
Factor 1 
(Crystallized
IQ)
Factor 2 
(Fluid IQ)
Factor 3 
(M em ory)
C o m m u n a lity
N A R T .80 .19 .20 .72
SLM T .43 .55 .33 .60
V ocabulary .74 -.03 .19 .58
S im ila ritie s .72 .24 .13 .59
In fo rm a tio n .34 .35 -.02 .24
C ube d raw ing .46 .56 -.02 .52
CRT -.01 -.70 -.14 .50
V isual R ep ro d u ctio n .31 .64 .09 .51
Face recogn ition -.29 .46 .39 .44
V erbal fluency .45 .22 .23 .30
W ord  reco g n itio n .21 .20 .66 .52
W ord  recall .08 .07 .70 .51
A ddress recall .26 .02 .67 .51
E ig en v a lu e 4.16 1.28 1.10
Note: NART=National Adult Reading Test, SLMT=Symbol Letter Modalities Test 
CRT= Choice Reaction Time.
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Table 2
Summary of predictors of composite scores and psychometric tests
Predictor Beta R R^change Number
Crystallized intelligence
Linear age effects -.17 .17 .03* 882
Quadratic age effects -.04 .17 .00
Fluid intelligence
Linear age effects -.33 .33 .11* 880
Quadratic age effects -.52 .33 .00
Memory
Linear age effects -.24 .24 .06* 880
Quadratic age effects -1.09 .25 .00
NART
Linear age effects -.07 .07 .01* 834
Quadratic age effects .52 .08 .00
SLMT
Linear age effects -.33 .33 .11* 852
Quadratic age effects .21 .33 .00
Vocabulary
Linear age effects -.06 .06 .00 874
Quadratic age effects -.37 .07 .00
S im ilarities
Linear age effects -.16 .16 .02* 872
Quadratic age effects -.33 .16 .00
Information
Linear age effects -.10 .10 .01* 879
Quadratic age effects -.03 .10 .00
Cube
Linear age effects -.09 .09 .01* 865
Quadratic age effects .89 .10 .00
CRT
Linear age effects -.20 .20 .04* 826
Quadratic age effects 1.02 .21 .00
Visual Reproduction
Linear age effects -.20 .20 .04* 852
Quadratic age effects .38 .20 .00
Face recognition
Linear age effects -.19 .19 .04* 872
Quadratic age effects -1.55 .20 .00
Verbal fluency
Linear age effects -.25 .25 .06* 875
Quadratic age effects .49 .25 .00
Word recognition
Linear age effects -.21 .21 .04* 866
Quadratic age effects -1.78 .23 .01*
Word recall
Linear age effects -.17 .17 .03* 864
Quadratic age effects .54 .17 .00
Address recall
Linear age effects -.15 .15 .02* 825
Quadratic age effects .14 .16 .00
MMSE
Linear age effects -.24 .24 .06* 878
Quadratic age effects -1.71 .25 .01*
* p<.05
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Table 3
Summary of predictors of residuals for composites and psychometric tests
Predictor Beta R R^ change N
Crystallized intelligence
Linear age effects .04 .04 .00 882
Quadratic age effects -.91 .05 .00
Fluid intelligence
Linear age effects .09 .09 .01* 878
Quadratic age effects -.77 .09 .00
Memory
Linear age effects .19 .19 .04* 880
Quadratic age effects .82 .19 .00
NART
Linear age effects .02 .02 .00 834
Quadratic age effects -2.32 .09 .01*
SLMT
Linear age effects .01 .01 .00 852
Quadratic age effects -1.05 .04 .00
Vocabulary
Linear age effects .05 .05 .00 874
Quadratic age effects -1.36 .07 .00
S im ilarities
Linear age effects .09 .09 .01* 872
Quadratic age effects .37 .09 .00
Information
Linear age effects .18 .18 .03* 879
Quadratic age effects -.51 .18 .00
Cube
Linear age effects .07 .07 .01* 865
Quadratic age effects -1.22 .08 .00
CRT
Linear age effects .07 .07 .00 826
Quadratic age effects -.81 .07 .00
Visual Reproduction
Linear age effects .17 .17 .03* 852
Quadratic age effects -.38 .17 .00
Face recognition
Linear age effects .15 .15 .02* 872
Quadratic age effects .21 .15 .00
Verbal fluency
Linear age effects -.04 .03 .00 875
Quadratic age effects 1.09 .05 .00
Word recognition
Linear age effects .20 .20 .04* 866
Quadratic age effects .87 .20 .00
Word recall
Linear age effects .12 .12 .01* 864
Quadratic age effects .87 .20 .00
Address recall
Linear age effects .13 .13 .02* 825
Quadratic age effects -.99 .14 .00
MMSE
Linear age effects .21 .21 .04* 878
Quadratic age effects .71 .21 .00
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Table 4
Summary of predictors of raw scores and residuals for with MMSE as a 
predictor variable
Predictor Beta R change N
Crystallized intelligence
MMSE .60 .36 .36*
Age Linear -.03 .36 .00 877
MMSE X Age -1.10 .37 .01*
Fluid intelligence
MMSE .56 .31 .31*
Age Linear -.21 .36 .04* 875
MMSE X Age -.19 .36 .00
Memory
MMSE .68 .46 .46*
Age Linear -.08 .47 .01* 876
MMSE X Age -.07 .47 .00
Crystallized residuals
MMSE .57 .32 .32*
Age Linear .15 .34 .02* 877
MMSE X Age -1.12 .35 .01*
Fluid residuals
MMSE .51 .26 .26*
Age Linear .12 .27 .01* 875
MMSE X Age -.21 .27 .00
Memory residuals
MMSE .64 .41 .41*
Age Linear .16 .44 .02* 876
MMSE X Age -.07 .44 .00
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Figure Caption
Figure 1. Scatterplot and regression line for composite scores as a 
function of age.
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Figure Caption
Figure 2. Scatterplot and regression line for absolute value of residuals 
of factors as a function of age. The residuals are derived from the regression 
of each composite score against age.
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2Synopsis
Criteria for the diagnosis of ICD-10 Mild Cognitive Disorder (MCD) were 
applied to a sample of 897 community dwelling elderly participants. Criterion 
A (the presence of a physical disorder) was met by 44%, Criterion B (report of a 
cognitive disorder) by 17%, Criterion C (an abnorm ality in quantified 
cognitive assessments) by 60%, and Criterion D (exclusion on basis of 
dementia and other conditions) by 74%. A total of 36 cases (4%) met all four 
criteria. Correlations between Criteria A and B, and B and C were weak 
(R=.18), and the correlation between Criteria A and C was almost zero (R=.02). 
This suggests that no syndrome exists. Membership of MCD was predicted by 
a report that memory or intelligence interfered with daily life but not by 
performance on cognitive tests or by a report of physical illness. Cases of 
MCD had higher anxiety, depression and neuroticism scores than normal 
elderly, but did not differ substantially on tests of cognitive functioning 
These findings cail into question the validity of the ICD-10 diagnosis of MCD.
3Mild Cognitive Disorder (MCD) (F06.7) has been introduced as a new 
entity in the Tenth Revision of the International Classification of Mental and 
Behavioural Disorders (ICD-10) (World Health Organization, 1992, 1993). The 
aim is to accommodate a range of conditions in which memory, thinking and 
information processing have declined from a previous level, but not to an 
extent warranting the diagnosis of dementia. The Clinical Descriptions and 
Diagnostic Guidelines (World Health Organization, 1992, pages 64-65), which 
com plem ent the Diagnostic Criteria for Research (World H ealth  
Organization, 1993) state that "This disorder may precede, accompany, or 
follow a wide variety of infectious and physical disorders.../' While not 
specifically intended for use in the elderly, MCD will clearly have some 
application to this age group. The concept is noted in the Diagnostic Criteria 
for Research to be experimental. These criteria are prefaced by the following 
statement: 'The status of this construct is being examined. Specific research 
criteria must be viewed as tentative. One of the principal reasons for its 
inclusion is to obtain further evidence allowing its differentiation from 
disorders such as dementia (F90-F03), organic amnesic syndrome (F04), 
delirium (F05.-) and several disorders in F07.- '(pp. 42-43). In this paper, we 
critically assess this new entity, and report our findings when an attempt is 
made to apply these criteria to a community sample of persons aged 70 years 
and older.
In the Diagnostic Criteria for Research, MCD requires the presence of 
the features shown in Table 1. MCD can be distinguished from many other 
schemes which describe memory impairment in older individuals. These 
include "benign senescent forgetfulness" (Krai, 1962), Age Associated Memory 
Impairment (AAMI) (Crook et al., 1986), Age Consistent Memory Impairment 
(ACMI), Late-Life Forgetfulness (LLF) (Blackford and La Rue, 1989) and Mild 
Cognitive Impairment (Zaudig. 1992). MCD includes a broader range of 
cognitive functions than memory (cf. AAMI, ACMI, LLF), it requires objective 
evidence of cerebral disease, damage or dysfunction, or of systemic physical 
disorder known to cause cerebral dysfunction, and is applicable to all ages not 
just the elderly (cf. benign senescent forgetfulness, AAMI, ACMI, LLF).
Table 1 about here
4The methods that have been used to validate psychiatric diagnoses 
have been reviewed by Kendall (1989). Building on the earlier work of 
Robins and Guze (1970), he noted that two essential validators for a 
psychiatric condition were, firstly, the identification of a clinical syndrome 
either by 'clinical intuition' or cluster analysis. A clinical syndrome "consists 
of a cluster of related symptoms with a characteristic time course" (p.47). The 
second validator was the demonstration of the boundaries or 'points of rarity' 
between related syndromes by discriminant function analysis, or latent class 
analysis. In this paper, these two validators are examined as they apply to 
MCD, using data from an epidemiological study of nearly 900 elderly subjects 
aged over 70 years. The first of Kendall's validators was examined by noting 
the occurrence of each of the four criteria which comprise MCD, the co­
occurrence of these criteria and the correlations among them. The 
identification of a syndrome requires that its constituent sym ptoms are 
correlated. The second validator was examined by searching for differences 
on measures of cognitive function and affective state between subjects 
meeting MCD criteria and two other conditions: (a) normality (consisting of 
those not attracting diagnoses) and (b) those meeting the criteria for ICD-10 
Dementia. Differences between MCD cases and those not attracting diagnoses, 
and those with diagnoses of Dementia were examined by ANOVA. Predictors 
of classification into the category of MCD were also investigated by logistic 
regression analysis.
METHOD
Subjects
The subjects were a sample of elderly persons living in the 
community, from the Australian city of Canberra and the adjacent town of 
Queanbeyan. The elderly were sampled from the electoral roll which is a 
register of eligible voters. Voting is compulsory in Australia. The sample 
was drawn to give equal numbers of males and females. There were three age 
strata (70-74 years, 75-79 years and 80+ years) which gave an achieved sample 
that was proportional to the number of individuals in each age group. Sixty 
nine percent of those approached agreed to participate. The sample used in 
the present paper consisted of 897 subjects (456 were male) who either
5provided data on themselves (with no informant), or subjects on whom both 
informant and subject data were obtained.
Procedure
R espondents were interview ed in their ow n homes by trained 
interview ers.
Identification of cases of MCD. Responses to appropriate items in the 
interview were used to identify the presence of MCD, as set out in the 
Appendix. Criterion A (physical disease) was met by those who reported, or 
whose inform ant reported, that the respondent had suffered any of the 
following conditions: stroke, mini-stroke, transient ischaemic attack, sudden 
severe difficulty w ith speaking vision or memory, Parkinson's disease, 
diabetes, kidney disease, liver disease, cancer, leukemia, malignancy or 
tum our, thyroid or other glandular disorders. The relationship between the 
onset of the disorder and mental deterioration (Criterion A, G2), subsequent 
recovery (G3) or evidence of family history as an alternative causation (G4) 
could not be obtained.
To satisfy Criterion B (report of a disorder in cognitive function), one of 
the following had to be met: either the subject or an informant reported that 
the respondent had difficulty rem embering (or thinking and reasoning) 
relative to earlier in life, which interfered with his or her everyday life, or the 
informant reported consistent deterioration over the previous 10 years on the 
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) (Jorm 
and Korten, 1988), gaining an average score of 4 or greater. The IQCODE is an 
inform ant-rated instrum ent designed to detect changes in intelligence and 
memory in the previous 10 years. It has established validity and reliability 
(]orm and Jacomb, 1989; Jorm et al., 1991).
To satisfy Criterion C (abnormality or decline on quantified cognitive 
assessments), we determined that one of the following three entry conditions 
had to be met.
(1) Respondents had to score more than one and half standard  
deviations below their age group's performance level on two or more of 12 
tests. Individuals were com pared to norms derived from the present 
population sample for three age groups: 70-79 years, 80-89 years; 90+ years. 
The following tests were used: (a) The Symbol Letter Modalities Test (SLMT), 
similar to the Symbol Digit Modalities Test (Smith, 1982), (b)Verbal Fluency,
6(c) The M in i-M en ta l State Exam ination (MMSE) (Folstein et al., 1975), (d) 
three item s from  the S im ilarities subtest of the W AIS-R (Wechsler, 1981), (e) 
a sentence verification task, (f) three items of Vocabulary from  the W AIS-R, 
(g) In fo rm a tion  questions s im ilar to those in the W AIS and developed fo r an 
A ustra lian  sample, (h) Cube d raw ing , (i) Face recognition (s im ila r to that o f 
the R iverm ead Behavioural M em ory Test, (W ilson  et ah, 1985), (j) a w o rd  
recognition  memory task, (k) recall of name and address and three in d iv id u a l 
w ords and (1) Visual Reproduction (one item  from  the W echsler M em ory  
Scale) (W echsler, 1945). The sentence ve rifica tio n  task invo lved  subjects 
responding to questions w hich were either true or false. Examples o f such 
questions were "Is a table a piece of fu rn itu re? " "A re  flowers a type o f floo r 
covering?" These tests are described in detail elsewhere (Christensen et ah, in  
press). G iven a normal d is tr ib u tio n  of scores, seven percent of cases can be 
expected to fa ll under 1.5 standard deviations below the mean on each test. 
Subjects w ho  d id  not attempt at least five o f the 12 tests were considered to 
have scored zero on two or more o f the tests and to have met C rite rion  C.
(2) C ognitive im pa irm en t was also id e n tif ie d  i f  subjects showed 
evidence o f a decline in  in te llec tua l perform ance from  earlier in  life . A n  
estim ate o f pre-m orb id  in te lligence was made using the N a tiona l A d u lt  
Reading Test (NART) (Nelson, 1982). This score was compared w ith  an 
estimate o f the ind iv idua l's  curren t level o f fu n c tio n in g  based on h is /h e r  
perform ance on the SLMT, a test w h ich  is sensitive to cognitive change w ith  
age. Tests very sim ilar to SLMT (such as the D ig it Symbol Substitu tion o f the 
W echsler A d u lt Intelligence Scale (DSS), or the Sym bol D ig it M odalities  Test, 
(SDMT) (Sm ith, 1982)) have been found to be more sensitive than most other 
measures to age-related changes in  cognitive func tion ing  (see Brom ley, 1974; 
W echsler, 1981), and to bra in  damage (Lezak, 1976), and to correlate s trong ly  
w ith  fu ll-sca le  intelligence scores in  young (r=0.61) and o ld  subjects (r=0.58) 
(W echsler, 1981). The SLMT preserves the subs titu tion  form at o f the D ig it 
Symbol Substitu tion but reverses the material so that symbols are p rin ted  and 
letters o f the alphabet (rather than numbers) are called out. This a llow s an 
oral ra th e r than w ritte n  response from  the subject, w h ich  may be more 
appropria te  in  an elderly population. The test is timed. In  the present sample, 
the N A R T  and SLMT scores correlated 0.52. A  standardized SLMT score for 
each in d iv id u a l was subtracted from  his o r her N A R T  score. A  negative
7difference of more than one standard deviation between scores on these tests 
was accepted as evidence of decline in cognitive performance.
(3) Finally, subjects met Criterion C if they exhibited 'severe memory 
impairment7. Subjects who could not provide their age, the place and year of 
their birth, or who had a discrepancy between their stated year of their birth 
and their stated current age, or who were unable to state the date of New 
Year's Day or to identify three of four famous figures from the past, also met 
Criterion C. These subjects often had missing data on the other tests.
Criterion D consisted of exclusion criteria. Exclusion criteria were 
applied if subjects met ICD-10 criteria for ICD-10 Dementia, Probable 
Dementia (defined below), DSM-III-R criteria for Delirium, or Amnestic 
syndrome (American Psychiatric Association, 1987). Persons likely to have 
had drinking problems, as assessed by informant report, were also excluded. 
Persons with post-encephalitic or post-concussional syndromes were unable 
to be identified because questions concerning these disorders were not 
contained in our survey.
Other Diagnoses. Information necessary for the diagnosis of ICD-10 
MCD, ICD-10 Dementia, ICD-10 Depressive Episode, DSM-III-R Delirium and 
DSM-III-R Amnestic Disorder was collected using the Canberra Interview for 
the Elderly (CIE) (Social Psychiatry Research Unit, 1992; Mackinnon et al., 
1993). This is a fully scripted interview with two components: an assessment 
of the elderly person's current mood and cognitive function including a 
neuropsychological examination, and an interview  with an inform ant to 
obtain information on current functioning and behaviour, including reports 
of deterioration where this has occurred. The CIE was designed specifically to 
measure each of the elements required for the diagnosis of dem entia or 
depressive disorder according to the Draft ICD-10 and DSM-III-R criteria. 
Algorithms were w ritten in SPSS to identify individuals who m et these 
criteria. In the ICD-10 Research Diagnostic Criteria for Dementia an appraisal 
from an informant is implicitly required in order to establish deterioration in 
emotional control, social behaviour or m otivation (Criterion G3). Because 
we did not have informants available for some respondents, the diagnosis of 
"Probable Dementia" was given to those persons who fulfilled all the other 
ICD-10 criteria. Specifically, the criteria for Probable Dementia were met if 
subjects satisfied criteria for memory and intellectual decline (Dementia 
Criteria G l(l) and Gl(2)) but where data for G3 or G4 were not considered.
8The category "Probable Dementia" is not an ICD-Diagnosis. It contains cases 
where ICD-10 dementia cannot be identified because of lack of informant data 
as well as subjects who have informant data available but whose responses 
and test performance meet all non-informant based criteria for the diagnosis.
Activities of Daily Living (ADLh Both informants and subjects were 
asked about the subjects' capacity to get about when travelling was required, to 
walk about 400 metres w ithout pain or difficulty, to get in and out of bed, to 
get dressed bathed and showered, to get in and out of an armchair, to dress 
oneself completely, to take care of feet and toe nails and to get to the toilet. 
The eight items were combined to form a scale. Each item was rated on a 
scale which had from 3 to 5 points. The items were summed separately for 
subjects and informants to give scores ranging from 0 to 22, with high scores 
indicating disability. The correlation between the two scales was 0.88.
Sensory deficits. Subjects were required to rate their eyesight in 
response to the question "W ould you say your eyesight (with glasses) is 
generally good, fair or poor?" Responses were scored 1 to 4 with lower scores 
indicating better vision. Subjects were also asked to rate their ability to read 
letters and mail, under the best conditions, on a scale of 1 to 3 with 1 
representing no difficulty and 3 representing difficulty Hearing was assessed 
by self report in response to the question "Would you say your hearing (with 
a hearing aid) is generally good, fair, or poor?". Responses were scored from 1 
to 3 with lower scores indicating better hearing.
N euroticism . The neuroticism /stability scale of the 12-item short form 
of the Eysenck Personality Questionnaire-Revised (Eysenck et al., 1985) was 
used. High scores indicate greater neuroticism.
Depression and anxiety. An 18 item inventory designed by Goldberg et 
ah, (1988) measured anxiety and depression. Higher scores indicated greater 
anxiety and depression.
RESULTS
For the analysis of cognitive performance in the sample, scores on the 
psychometric tests were reduced to three factors, using principal components 
factor analysis. The factors identified were labelled Crystallized Intelligence, 
Fluid Intelligence and Memory (Christensen et ah, in press). The advantage 
in using factor analysis is that the number of tests can be reduced and the
9stability of the scores is increased. The mean score for a factor becomes zero 
and the standard deviation is 1. Tests loading highest on the Crystallized 
Intelligence factor were the NART, Vocabulary and Similarities. Tests 
loading highest on the Fluid factor were SLMT, Cube drawing and Visual 
Reproduction and tests loading highest on the Memory factor were Word 
recognition and Recall. Of the 897 subjects, factor scores were available for the 
714 subjects who completed every cognitive task. Because subjects not 
contributing full data sets may have differed substantially from those 
providing partial sets, data for the individual tests are also reported. The 
numbers contributing to each of these tests were greater than the number 
included in the factor analysis. Eight hundred and eighty four subjects 
provided at least some data on the tests.
Frequency with which, subjects met the four criteria
Criterion A (physical disorder) was met by 391 of the 897 subjects (44%). 
This rate was similar to that reported by other investigators who report high 
prevalence of diseases which could produce neurological impairment in a 
sample of elderly subjects (Smith et al., 1991). Criterion B (report of a disorder 
in cognition) was met by 149 respondents (17%), and Criterion C (abnormality 
on quantified cognitive assessments) was met by 541 respondents (60%). Two 
hundred and twenty nine respondents (26%) were excluded because they 
failed to meet Criterion D (no other psychiatric or neurological disease). A 
total of 36 subjects (4%) met all four of the criteria for MCD.
How Criterion C (abnormality in quantified cognitive assessments) was met.
Over 60% of the sample met Criterion C (abnormality on quantified 
cognitive assessments). The rate is consistent with other studies showing that 
up to 98% of elderly subjects meet criterion for memory impairment (e.g., 
Smith et al., 1991). Rates for inclusion varied for each of the three entry 
conditions (see above). (1) Twenty seven percent of the sample performed 1.5 
standard deviations below the mean on two tests. (2) Forty seven percent 
showed an estimate of change in intelligence of at least one standard 
deviation, and (3) 16% demonstrated "severe memory impairment". Some 
subjects met two or three of the entry conditions. With respect to (1) above, 
between 5 and 10% or the population scored more than 1.5 standard 
deviations below the mean for all tests except Cube drawing and Visual
10
Reproduction. The latter test had 22% of subjects scoring more than 1.5 
standard deviations below the mean. This occurred because all those scoring 
0 (possible scores were 0, 1, 2, or 3) fell below this level. Of the 27% meeting 
the criteria for the individual tests, 45% failed 2 tests, 18% failed 3 tests, 15% 
failed 4 tests, 7% failed 5 tests and 15% failed one of 6,7,8,9 or 10 tests.
Characteristics of subjects meeting Criterion A, Criterion B, and Criterion C.
To examine w hat characteristics of the sample are selected by the 
individual criteria, a comparison was made of those who met or did not meet 
each of the individual criteria (see Table 2).
Criterion A (physical disease). The 44% of subjects meeting Criterion A 
were compared to all those not meeting Criterion A (see Table 2, columns 1 
and 2). These respondents had higher anxiety, depression, neuroticism 
scores, and greater disability, as measured by subject and informant-rated ADL 
scales. They had lower Fluid intelligence scores but did not differ on 
Crystallized intelligence, Memory, or MMSE scores. These findings suggest 
that persons m eeting C riterion A (physical disease) had no greater 
abnorm ality on quantified cognitive assessments than those not meeting 
Criterion A. (Although they differed on Fluid Intelligence, the difference was 
less than 0.2 of a standard deviation). These findings are consistent with 
observations on elderly people showing that physical illness in late life is not 
closely linked to having cognitive impairment (see Salthouse, 1991).
Insert Table 2 about here
Criterion B: (Report of a disorder in cognition). A comparison was
made between those who reported, or whose informant reported, a disorder 
in cognition and those where such a report was not given (see Table 2, 
columns 3 and 4). Those who noted a disorder (met Criterion B) had higher 
anxiety, depression, neuroticism and disability scores. They also had lower 
Memory and MMSE scores. These results indicate that, although those who 
reported the presence of a cognitive disorder were more depressed, anxious 
and disabled than those not reporting a cognitive disorder, they also had, on 
average, more m em ory impairm ent. These findings held when ICD-10
Dementia and ICD-10 Probable Dementia cases were excluded from the 
analysis, thereby ruling out the possibility that the lower level of cognitive 
performance in those meeting Criterion B may have been due to the specific 
influence of the low-scoring dementia cases.
Criterion C: (abnormality on quantified cognitive assessm ents). 
Subjects meeting Criterion C were older and less well educated than subjects 
not meeting the Criterion (see Table 2, columns 5 and 6). Subjects also had 
higher depression scores although did not differ on anxiety and neuroticism. 
As expected, subjects meeting the criterion differed from those not meeting 
the criterion on tests of cognitive functioning and activities of daily living. 
Mean scores on each of the 12 cognitive tests were significantly lower for 
subjects meeting the criteria compared to those not meeting it.
Relationships among Criteria A, B, C and D.
Insert Table 3 about here
Phi correlations among the four MCD criteria are presented in Table 3. 
Most correlations were weak but significant. The correlation between 
Criterion A (the presence of a physical disease) and Criterion C (abnormality 
on quantified cognitive assessments) was almost zero (r=0.02). Moreover, 
there was only a weak correlation between a report of a cognitive disorder 
(Criterion B) and an abnormality as measured by cognitive assessments 
(Criterion C) (r=0.18). The strongest correlation was between Criteria C and D 
(r=-0.43), which indicated that there was a moderate-to-strong association 
between the level of abnormality on cognitive assessments, and the presence 
of a diagnosis of Dementia, Probable Dementia, Amnestic Syndrome or 
Delirium. These relationships were also present when analysed using 
tetrachoric correlations.
Insert Table 4 about here
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Overall, the weak correlations among the components did not suggest 
the underlying presence of a syndrome. However, given the positive 
association found between the report of cognitive disorder (Criterion B) and 
an abnormality on cognitive assessments (Criterion C), the relationship 
between these two components was examined further. The agreement 
between Criteria C and B is shown in Table 4. One hundred and twenty 
respondents (13%) met both Criterion A and Criterion B, while 327 (36%) met 
neither criterion. Four hundred and twenty one (47%) met criterion for an 
abnormality on quantified cognitive assessments (Criterion C) but did not 
report a cognitive disorder (Criterion B). Overall, many more subjects had an 
abnormality on cognitive assessment than reported a cognitive disorder. 
Conversely, very few subjects reported a cognitive disorder in the absence of 
an abnormality on objective tests. Only 29 subjects (3%) of those without an 
abnormality on cognitive assessments reported a cognitive disorder. The 
percentage of the sample who complained of a cognitive disorder when there 
was no objective evidence for the complaint was lower than those who 
complained when objective evidence was present. One interpretation of 
these findings is that at least one of the determinants of the report of a 
cognitive disorder in elderly subjects is cognitive change that can be 
objectively demonstrated. Nevertheless, the agreement rates also show that 
many subjects have an abnormality or decline measured by cognitive 
assessments but do not report a cognitive disorder.
From the perspective of the MOD diagnosis, these relationships 
suggested that 'complaint' or 'report' of a cognitive disorder was crucial in 
permitting entry of respondents to the MCD category. That is, since many 
subjects met Criteria A and C, and fewer met Criterion B, and because Criteria 
B and C were only weakly correlated, Criterion B formed the crucial 
characteristic for inclusion in the MCD category.
The importance of complaint or report of a cognitive disorder was 
examined formally using logistic regression analysis where membership to 
the MCD category was predicted. Because we did not wish to prejudice which 
variables could serve as predictors, we examined how the items comprising 
MCD functioned empirically, that is, independently of their assignment to 
measure a particular aspect of one criterion (see Appendix). All items which 
went to make up the diagnosis of MCD were entered into a factor analysis.
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Three factors with eigenvalues greater than 2 emerged. They were labelled 
Cognitive Impairment, Stroke and Interference in Memory/Intelligence. The 
main items to load on the Cognitive Impairment factor were MMSE, SLMT, 
Cube Drawing and Similarities. The main items to load on the Stroke factor 
were report of stroke, informant report of stroke, report of a sudden severe 
difficulty with speaking, and informant report of a sudden weakness on one 
side. The four main items to load on Interference in Memory/Intelligence 
were informant report of interference in daily functioning because of change 
in memory, or intelligence, changes on the IQCODE, and subject report of 
interference in performance because of changes in intelligence. These three 
fac to rs  (C o g n i t iv e  Im p a irm e n t ,  S troke and In te rfe ren ce  in 
Memory/Intelligence could be seen to correspond roughly to Criterion C, A 
and B- an abnormality on quantified cognitive assessments, presence of a 
physical disease, and report of a cognitive disorder, respectively. The factors 
were then entered into a logistic regression analysis with membership or 
non-membership of the MCD diagnostic category as the dependent variable. 
Five hundred and twelve cases were included in the analysis, with 385 
rejected for missing data. Factor 1 (Cognitive Impairment) and Factor 2 
(Stroke) failed to improve the prediction of membership to the MCD category 
(R=0.00 and R=0.01, respectively). Factor 3 (Report of Interference in 
M em ory/ Intelligence) contributed significantly (R=0.41, p<.001), accounting 
for approximately a 9% improvement in prediction of cases. These findings 
confirm those reported above and indicate that an abnormality or decline as 
measured by cognitive assessments, or the presence of cerebral or physical 
disease did not predict membership of the MCD category. The most 
important contributor was the subjects' or informants' report of cognitive 
impairment which weakly predicted membership.
Sex differences
In our sample, men were better educated than women (11.78 compared 
to 10.88 years) and had lower anxiety (11.02 compared to 11.83, t=5.30), 
depression (10.68 compared to 11.23, t=4.02) and neuroticism scores (14.51 
compared to 15.26, t=3.74). Approximately the same percentage of men and 
women met Criteria A, C and D, but more men than women met Criterion B 
(20% vs 13%). There was no difference in the proportion of men and women 
who met all four criteria for MCD. When each of the criteria was examined
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separately for male and female samples (as in Table 2), a similar pattern of 
findings to that of the total sample emerged. The only differences were that, 
in men, (a) neuroticism was no higher in those who met Criterion A than in 
those who did not, and (b) the memory factor was no lower for those who 
met Criterion B compared to those who did not. In women, scores on the 
Fluid Intelligence factor were no lower for those meeting Criteria A compared 
to those not meeting it (see footnote Table 2). There were no sex differences 
in the percentage of those scoring 1.5 standard deviations below the mean for 
each of the 12 cognitive tests, or in meeting a change in cognitive functioning 
or meeting the requirement for severe memory impairment. These findings 
suggest that, although more men report a disorder or have an inform ant 
report a disorder in cognition (despite lower overall neuroticism and anxiety), 
the pattern of differences between those meeting or not meeting Criteria A, B 
and C and the diagnosis of MCD is very similar for males and females.
Sensory deficits
Approximately 10% of subjects reported poor sight or blindness, 8% 
reported that they could read mail and letters either with difficulty or not at 
all, and 6% said they had poor hearing. Poorer self-ratings of eyesight 
correlated positively with lower cognitive test performance (particularly for 
SLMT (r=0.19) and Visual Reproduction (r=0.15)). Difficulty reading mail also 
correlated significantly with poorer test performance (particularly for SLMT 
(r=0.25) and MMSE (r=0.13)). Self-ratings of hearing loss did not correlate 
with cognitive performance. Ratings on all three of the above questions 
correlated weakly with meeting Criterion A (presence of a physical disorder), 
and poor eyesight correlated with meeting Criterion B (report of cognitive 
impairm ent) and with a diagnosis of MCD. It could not be ascertained 
whether the latter association arose because poor eyesight was linked to 
physical disorder (Criterion A), self-report of poor eyesight was due to over­
reporting of symptoms in general (including Criterion B) or because poor 
eyesight contributed to poorer cognitive performance (Criterion C). To rule 
out the possibility that MCD was composed only of those w ith sensory 
deficits, an analysis was undertaken of those in the sample who had good or 
fair eyesight (n=819). The frequencies with which Criteria A, B, C, and D were 
met were almost identical to that of the total sample (42%, 16%, 58%, 25%). 
MCD diagnosis was met by 31 (4%) of the sub-sample.
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Differentiation from other conditions
Comparisons of the performance of those who met the criteria for 
MCD with the performance of those who met the criteria for ICD-10 
Dementia, ICD-10 Probable Dementia (defined above), and persons without 
diagnoses (normals) were examined next. Table 5 shows differences between 
the groups on demographic, affective, ADL and cognitive factor scores. Table 
6 shows data from each of the neuropsychological tests. Scores on these tests 
have been standardized with a mean of zero and standard deviation of 1. 
Because there were too few cases to compare to the other categories, subjects 
with diagnoses of Amnestic Syndrome or Delirium were excluded from the 
analyses. Planned contrasts were carried out for differences between MCD 
and normality, MCD and Probable Dementia, and MCD and ICD-10 Dementia.
Insert Table 5 about here
Compared to respondents without diagnoses, MCD cases had higher 
anxiety, depression, and neuroticism scores. They had lower Fluid 
Intelligence, and greater disability as measured by informant-rated ADL. They 
did not differ on age, education, Crystallized Intelligence, Memory, or ADL 
subjective report. At the level of neuropsychological test performance, they 
differed very little from normals (see Table 6). On only two of the 14 tests did 
they perform more poorly (SLMT and Verbal Fluency). Two of these 
individual tests (NART and Choice Reaction Time (CRT)) were not used as 
inclusion measures for Criterion C, and no differences were found on them. 
Overall, the findings suggest that (1) MCD cases had greater anxiety and 
depression  than normals; (2) they were som ewhat more physically 
incapacitated than normals; and (3), despite the fact that they were selected 
into the category MCD on the basis of an abnormality on cognitive 
assessments, they did not differ greatly from normals on objective tests of 
cognitive function. The failure to find substantially significant differences 
between normals and MCD cases on cognitive tests was largely due to the 
large number of normals who also met the criterion for an abnormality on 
cognitive assessments.
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Insert Table 6 about here
Compared to persons meeting the criteria for Probable Dementia, MCD 
cases were younger, better educated, more anxious and more depressed. They 
had higher Crystallized Intelligence, Fluid Intelligence and M emory scores 
(Table 5). There were no differences on subject or informant- based ADL 
scores, which indicated that Probable Dementia cases, like MCD cases, had 
some degree of physical disability. Except for Verbal Fluency, subjects w ith 
MCD performed better on all neuropsychological tests than did subjects with 
Probable Dementia.
ICD-10 Dementia cases were older, with lower memory and MMSE 
scores than MCD cases. At the level of individual neuropsychological test 
performance, ICD-10 Dementia cases perform ed more poorly than subjects 
with MCD on all tests except Cube drawing.
Probable Dementia cases qualify for inclusion in the MCD category.
Probable Dementia was a classification introduced by us for use in 
epidemiological surveys to make a diagnosis of Dementia when inform ation 
on behavioural change and duration of im pairm ent were not available 
(Flenderson et al., in press). The category of Probable Dementia includes both 
cases w ith an informant and cases without an informant, as long as the case 
meets those criteria not needing an inform ant's report. In our sam ple 201 
subjects met these conditions of which 16 also had a diagnosis of Dementia 
and one a diagnosis of Delirium. One hundred and forty seven subjects of the 
201 subjects had informant data while 54 did not. On the basis of these figures 
approxim ately 11% of the Probable dementia cases (i.e. 20) might meet a 
diagnosis of ICD-Dementia if an informant had been available. It could be 
argued that our use of the category Probable Dementia unjustifiably reduces 
the num ber of cases eligible for inclusion in the MCD category. Analysis 
w ithout this restriction showed that the num ber of subjects meeting criteria 
for MCD increased from 36 to 54. In contrast to our earlier group of MCD 
subjects, these subjects could be differentiated from normals on the basis of 
their cognitive test performance but not on the basis of their anxiety,
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depression and neuroticism scores. They had lower Memory, SLMT and 
MMSE test scores.
DISCUSSION
The purpose of the present paper was to test the validity of the entity 
MCD using two of Kendall's validators: (1) the presence of a syndrome; and 
(2) differentiation from other associated conditions. There were a number of 
main findings. First, the prevalence of MCD was low, although many of the 
individual criteria were met by respondents. Thus, 44% of the sample met 
Criterion A, 17% met Criterion B, 60% met Criterion C and 74% met Criterion 
D. The value of 17% with a subjective memory complaint is of the same 
order as Livingstone et ah, (1990) found in a London community sample 
(23%). Secondly, weak or non-existent correlations among the four criteria 
were found. Most particularly, no correlation was found betw een the 
presence of a physical disease and an abnorm ality on quantified cognitive 
assessments. This lack of association has also been noted by others who have 
reported that cognitive im pairm ent is present in elderly individuals who 
have no health problem s (see Salthouse, 1991), and that greater age 
differences in cognitive ability in older cohorts are not m ediated by poor 
health. Thirdly, it was found that, although MCD subjects differed from 
normals, these differences were on measures of affective state and physical 
disability and not, as expected, on measures of cognitive functioning. Subjects 
with MCD performed as well as normals on 10 of the 12 neuropsychological 
tests, including the MMSE. Fourthly, MCD cases perform ed better on 
neuropsychological tests than persons with ICD-10 Dementia or ICD-10 
Probable Dementia. They were also more anxious, depressed and younger.
These results call into question the validity of the diagnostic category 
MCD. First, when using our m ethod of im plem enting the criteria, the 
components failed to correlate. This finding suggests that the syndrome lacks 
validity and that the syndrome fails to meet the conditions of Kendall's first 
validator. Even if the symptoms of a particular condition were rare (which 
they were not in the present case), some correlation between symptoms 
would be needed for a syndrome to be identified.
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Second, subjects meeting the criteria for MCD did not differ 
substantially in intellectual or memory abilities from normal elderly. This 
was largely because many 'normal'  subjects (approximately 60%) met the 
criteria for an abnormality or decline in cognitive performance. Additionally, 
many more respondents had an abnormal performance on quantified 
cognitive assessment than reported a cognitive disorder. Thus, inclusion into 
the category MCD was determined by the presence of either subjective or 
informant-based "complaint",  which served a powerful "gate-keeper" 
function. Because complaint was important in MCD membership, it was not 
unexpected that cases of MCD were more anxious and depressed than non­
cases, given the association found between memory complaint and affective 
state (Kahn et al., 1975; O ’Connor et al., 1990, Jorm et al., in press). Informant 
reports have been shown to have greater validity in predicting objective test 
performance, but even these are influenced by the informant's own anxiety 
and depression (jorm et al., in press). The importance of informant and 
subject based report of a disorder for membership to the MCD category was 
confirmed by the logistic regression analysis, where abnormality on cognitive 
assessments and the presence of a physical disorder did not significantly 
predict group membership while report of interference in memory or 
intelligence did.
The importance of subjective complaint of memory difficulty has also 
been found to be crucial in the membership of other conditions such as Age 
Associated Memory Impairment. As noted by Smith et al. (1991) "a subjective 
complaint of memory difficulty in and of itself virtually guarantees the 
diagnosis of AAMI"(p 556). Importantly, memory complaint, as opposed to 
an abnormality in performance level established objectively, has not been 
found to be prognostic of further decline (see Reisberg et al., 1986; O'Brien et 
al., 1992). In a series of 68 patients presenting with such a complaint at a 
memory clinic, O'Brien et al. (1992), found that only 6 had developed a 
dementia 3 years later.
Although little evidence for the validity of MCD was found in this 
study, conclusions about the validity of MCD are dependent on the extent to 
which Criterion A to Criterion D of the ICD-10 diagnosis were satisfied by our 
methods. As we noted earlier, Criterion A has only been partially satisfied 
since we could not meet the sub-criterion G2 (a presumed relationship 
between the disease and cognitive impairment), G3 (recovery following
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improvement in mental disorder) and G4 (absence of sufficient or suggestive 
evidence of alternative causation of the mental disorder). This difficulty with 
partial implementation of Criterion A may not be serious. There was only a 
small num ber of cases reported  that met all four criteria, and our 
implementation of the criteria would probable have led to an over-estimate 
of the number of cases available in the sample. This implies that the disorder 
is rare and that, had more stringent criteria been applied, the disorder may fail 
to yield any cases, and perhaps even less strong associations. Moreover, it is 
arguable that a clinician applying the MCD criteria will rarely be able to 
attribute decline in cognitive functioning to some specific health event (G2), 
and to observe im provem ent following recovery (G3) or obtain reliable 
inform ation  about other possible causes (G4). C onsequently , our 
implem entation of Criterion A may closely approximate what is common 
clinical practice: a relationship between disease and cognitive functioning is 
presumed if cognitive impairment is known to be associated with the illness 
the patient reports.
A lthough there was arbitrariness in the selection of cut-offs for 
meeting Criterion C, these cut-offs can be justified and are consistent with 
levels used by other investigators. Inclusion was based on a level more than 
1.5 standard deviations below the mean on two or more tests of cognitive 
functioning, a discrepancy of more than one standard  deviation  in 
intellectual functioning, or severe memory impairment. The levels selected 
here were in the range used by others for conditions such as AAMI (Crook et 
al., 1986) and late-life forgetfulness (Blackford and La Rue, 1989). AAMI uses 
the criterion of less than one standard deviation below the mean compared to 
young adults ' performance level, while late-life forgetfulness suggests a 
decline on 50% of tests (usually 4) of more than one standard deviation of the 
mean established for the subject's age. The use of an individual estimate of 
decline in intellectual functioning for each subject in our study is an 
im provem ent over standard m ethods for assessing memory or cognitive 
impairment because it takes into account the subject's pre-morbid ability (see 
Barker and Jones, 1993). Nonetheless, the validity of the MCD diagnosis 
does depend on how cognitive impairment (Criterion C) is measured.
It could also be argued that, had the concept of MCD been tested on a 
clinical sample, greater association between each of the criteria might be 
observed, and the point prevalence of the diagnosis might have been greater.
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Data on the prevalence of MCD in a sample of nursing home or sheltered 
accom m odation residents were available to examine this possibility 
(Christensen and Henderson, 1993). In a nursing home sample of 84 patients, 
a total of 64% met Criterion A, 43% met Criterion B, and 92% met Criterion 
C. A total of 62% were excluded because of other diagnoses. Only 4 (5%) of 
the 84 subjects met all four criteria. Thus, although nursing home residents 
had a greater percentage of subjects meeting Criterion C, reported more 
physical illness, and had a higher rate of reports of cognitive disorder, no 
greater percentage of cases were identified compared to the community 
sample.
It should also be acknowledged that the MCD category is not intended 
only for the old. Very different results might have been obtained in younger 
samples and this possibility should be investigated. Inclusion of age limits on 
the category (below 65 years) may be one way of increasing the potential 
validity of the disorder, although its usefulness in a younger population 
remains to be tested.
Sex differences were not substantial in the frequency with which 
subjects met the criteria or in the pattern of differences in those who met or 
did not meet each of the criteria. Although neuroticism was higher in 
females than males, more males than females reported cognitive decline or 
had cognitive decline reported about them by an informant. The significance 
of the latter finding is difficult to judge since self-report of memory 
performance has not been found to differ for men and women (Hultsch et al., 
1987; Crook and Larrabee, 1990) or to be greater in women than men (Cutler 
and Grams, 1988). It may be that informants are more likely to report that 
men com pared  to women show memory or cognitive impairment that 
interferes with their life. Our data are consistent with this possibility because 
informants tended to report more cognitive impairment for men compared 
to wom en (t=1.75, p<0.10), while no sex differences were present for 
respondents' own ratings.
We found that MCD could be differentiated from normality when cases 
with Probable Dementia were included. The 54 identified cases of MCD were 
more impaired than normals on most tests of cognitive function, while our 
original 36 cases were not. This presents a difficulty for the MCD classification 
in that it demonstrates that basic results cannot be replicated with a change in 
the definition of MCD and that, in this case, the reliability of MCD is
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contingent on how the criteria used to identify Dementia have been 
operationalised.
A decision about the fate of MCD as a construct must await further 
research. We intend following up identified cases of MCD after four years. 
But, even at the present stage of evaluation, it seems to us unlikely that the 
construct can be supported, at least using our methods for implementing the 
criteria. From a research perspective, a more useful strategy would be to 
abandon the use of a categorical system altogether in favour of a m ulti­
dimensional approach, in which individuals are rated along various relevant 
parameters. Physical disease and psychiatric morbidity such as affective state, 
for example, could then be assessed as predictors of cognitive impairment. 
The use of a multi-dimensional approach is not new to psychiatry (Faust and 
Miner, 1986). It seems to be particularly applicable to research on cognitive 
im pairm ent in the elderly, where cognitive decline is common, if not 
universal, and where dementia itself has been argued to be best studied as a 
continuum  with normality (Brayne, 1993). Certainly, on the basis of the 
present data, there is little justification in imposing a categorical system on 
what seems to be a continuous dimension.
The adm inistrative consequences of proposing a new category of 
disease in ICD-10 are not trivial. Considerable pressure to make a treatment 
available is one of these. We consider that this would be prem ature, since 
there is so far little evidence that this syndrome exists, let alone what may be 
the natural course in those meeting all its criteria. This situation is the same 
as O'Brien and Levy (1992) reported for AAMI. Kendler (1993) describes major 
problems in the recent enthusiasm for an "empirical nosology in psychiatry", 
claiming that there are dangers that the process will degenerate into "pseudo­
science, in which we pretend to be "objective" and "em pirical" when in 
reality, we are making informed value judgem ents"(p. 972). W ithin this 
context, the creation of new categories of disorder, such as that of MCD, 
without good reason, may not be justified.
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Table 1
ICD-10 Diagnostic Criteria for Research (WHO, 1993)
Mild Cognitive Disorder
A. The general criteria for F06 must be met.
Gl. There is objective evidence (from physical and neurological 
examination and laboratory tests) and/or history of cerebral disease, 
damage, or dysfunction, or of systemic physical disorder known to 
cause cerebral dysfunction, including hormonal disturbances (other 
than alcohol- or other psychoactive substance-related) and non­
psychoactive drug effects.
G2. There is a presumed relationship between the development (or 
marked exacerbation) of the underlying disease, damage, or 
dysfunction, and the mental disorder, the symptoms of which may 
have immediate onset or may be delayed.
G3. There is recovery from or significant improvement in the mental 
disorder following removal or improvement of the underlying 
presumed cause.
G4. There is insufficient evidence for an alternative causation of the 
mental disorder, e.g. a strong family history of a clinically similar or 
related disorder.
If criteria Gl, G2, and G4 are met, a provisional diagnosis is justified; 
if, in addition, there is evidence of G3, the diagnosis can be regarded 
as certain.
B. There is a disorder in cognitive function for most of the time over 
a period of at least 2 weeks, as reported by the individual or a reliable 
informant. The disorder is exemplified by difficulties in any of the 
following areas:
(1) memory (particularly recall) or new learning;
(2) attention or concentration;
(3) thinking (e.g. slowing in problem-solving or abstraction);
(4) language (e.g. comprehension, word-finding);
(5) visual-spatial functioning.
C. There is an abnormality or decline in performance in quantified 
cognitive assessments (e.g. neuropsychological tests or mental status 
examination).
D. None of the difficulties listed in criterion B (l)-(5) is such that a 
diagnosis can be made of dementia (F00-F03), organic amnesic 
syndrome (F04), delirium (F05.-), postencephalitic syndrome (F07.1), 
postconcussional syndrome (F07.2), or other persisting cognitive 
impairment due to psychoactive substance use (Fix.74).
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Table 2
Mean scores of those who met or did not meet the individual criteria A, B,
and C.
Criterion A Criterion B Criterion C
Not Met 
(n=506)
Met
(n=389)
Not Met 
(n=747)
Met
(n=148)
Not Met 
(n=356)
Met
(n=539)
Age 76.49 76.61 76.41 77.21 75.08 77.51*
Education 11.34 11.36 11.31 11.48 11.86 11.00*
Anxiety 11.09 11.83* 11.28 12.11* 11.28 11.51
Depression 10.74 11.21* 10.81 11.68* 10.59 11.20*
N euroticism 14.65 15.18*A 14.72 15.76* 14.67 15.02
Crystallized
Intelligence -0.03 -0.04 -0.03 0.16 0.22 -0.17*
Fluid 0.08 -0.11*# 0.03 -0.21 0.52 -0.41*
Memory -0.04 -0.05 0.05 -0.34*A 0.26 -0.20
ADL 1.51 2.29* 1.75 2.37* 1.26 2.26*
ADL-I 1.66 2.81* 1.98 3.09* 1.48 2.72*
MMSE 27.33 27.25 27.55 26.04* 28.27 26.64*
*p<0.05. Numbers in cells vary. ADL-I is the Informant rated ADL scale. 
# This difference not found in females.
A These differences were not found in males.
Table 3
Correlations between the Criteria for MCD
Criterion B Criterion C Criterion D
Criterion A 0.18** 0.02 -0.01
Criterion B 0.18** -0.21**
Criterion C -0.43**
**p<.01. Correlations for Criteria A-D are based on all codeable responses 
from the total sample. Criterion A=physical disease; Criterion B=report of 
disorder in cognition; Criterion C-abnorm ality on quantified cognitive 
assessments; Criterion D=Exclusion Criteria.
Table 4
The level of agreement between those who met Criterion B (report of 
disorder) and those who met Criterion C (abnormality on quantified
cognitive assessments).
Abnormality or decline on cognitive 
assessments (Criterion C)
Reported YES NO
Cognitive YES 120 29
Disorder NO 421 327
(Criterion B) 541 356
149
748
897
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Table 5
M eans, s tan d a rd  deviations and p lanned  con trasts for M ild C ognitive  
D isorder com pared to o ther diagnoses.
1 2 3 4 P lanned con trasts
N o r m a l s ICD I C D I C D
(n=640) MCD
(n=36)
P r o b a b le
d e m e n t i a
(n=184)
D e m e n t i a
(n=16)
1 vs 2 2 vs 3 2 vs 4
A g e
M 76.0 76.0 78.0 80.8
S D 4.7 4.1 5.2 7.6 ns 0.02 0.001
E d u c a t io n
M 11.6 11.3 10.4 11.4
S D 2.6 2.8 2.3 2.1 ns 0.04 ns
A n x i e t y
M 11.3 12.6 11.6 11.7
S D 2.3 2.3 2.4 2.0 0.001 0.02 ns
D e p r e s s i o n
M 10.8 12.3 11.1 11.7
S D 1.9 2.4 2.4 2.2 0.0001 0.002 ns
N e u r o t i c i s m
M 14.7 16.0 15.3 16.5
S D 2.7 2.8 3.4 1.7 0.01 ns ns
C r y s t a l l i z e d
I n t e l l i g e n c e
M 0.13 0.00 -0.70 -0.10
S D 0.90 1.11 1.20 1.29 ns 0.001 ns
F l u i d
I n t e l l i g e n c e
M 0.20 -0.21 -0.89 -0.75
S D 0.82 1.02 1.22 1.27 0.02 0.0001 n s
M e m o r y
M 0.12 0.07 -0.50 -2.08
S D 0.84 0.79 1.49 0.69 ns 0.004 0.0001
A D L - S u b j e c t
M 1.6 2.8 2.3 3.1
S D 2.3 2.5 3.1 2.6 0.005 ns n s
A D L -
I n f o r m a n t
M
1.8 3.8 2.8 5.2
SD 2.6 4.1 3.6 4.6 0.0001 ns ns
Numbers in cells vary. Factor scores are based on 714 cases. Subjects with a diagnosis of 
Delirium or Amnestic Syndrome are excluded. Age and education details are based on 875- 
871 cases. Affect scales are based on between 852 and 782 cases. P values for planned 
contrasts are based on the pooled variance estimate.
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Table 6
Comparison between groups on neuropsychological tests of memory and
intelligence.
1 2 3 4 Planned contrasts
N o r m a l s
(n=640)
I C D
M C D
(n=36)
IC D
P r o b a b l e
d e m e n t i a
(n=184)
I C D
D e m e n t i a
(n=16)
1 vs 2 2 vs 3 2 vs 4
SLMT 0.29 -0.20 -0.87 -1.16 0.002 0.0001 0.0001
Vocabulary 0.19 0.11 -0.66 -0.77 ns 0.0001 0.002
Sim ilarities
Sentence
0.23 -0.07 -0.69 -1.31 ns 0.0001 0.0001
Verification 0.14 0.14 -0.44 -1.08 ns 0.002 0.0001
Inform ation 0.34 0.34 -1.15 -1.47 ns 0.0001 0.0001
Cube
V isual
0.21 -0.05 -0.68 -0.49 ns 0.0001 ns
R eproduction 0.18 -008 -0.62 -1.03 ns 0.002 0.002
Recall 0.21 0.15 -0.71 -1.85 ns 0.0001 0.0001
Face 0.18 0.04 -0.46 -1.66 ns 0.004 0.0001
M M S E
Verbal
0.27 0.21 -0.78 -2.15 ns 0.0001 0.0001
Fluency
W ord
0.17 -0.23 -0.44 -1.17 0.02 ns 0.001
Recognition 0.21 0.32 -0.61 -2.68 ns 0.0001 0.0001
N A R T * 0.20 0.12 -0.78 -0.62 ns 0.0001 0.01
C R T * -0.15 0.02 0.39 1.97 ns 0.04 0.0001
Numbers in cells vary. MMSE is based on 859 cases and SLMT on 834 cases. 
Cases of Amnestic Syndrome and Delirium are excluded. Scores are 
standardized with a mean of 0 and a standard deviation of 1. *Not used in 
assessment of abnormality on cognitive assessments.
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Appendix
Operational criteria for ICD-10 F06.7 Mild Cognitive Disorder
A. The general criteria for F06 must be met.
G 1 .There is objective evidence (from physical and neurological examination and 
laboratory tests) and/or history of cerebral disease, damage, or dysfunction, or of systemic 
physical disorder known to cause cerebral dysfunction, including hormonal disturbances (other 
than alcohol- or other psychoactive substance-related) and non-psychoactive drug effects.
This criterion is met if any o f the following are met 
Ever been told has had a stroke 
Ever been told has had series o f mini-strokes 
Ever been told has had transient ischaemic attacks 
Ever had a weakness on one side that got better 
Ever had a sudden severe difficulty with speaking 
Ever had a sudden severe dijficulty with vision 
Ever had a sudden severe difficulty with memory 
Evet been diagnosed as having Alzheimer’s disease or dementia 
Ever been diagnosed as having Parkinson ’s disease 
Do you have trouble with diabetes 
Do you have trouble with kidney disease 
Do you have trouble with liver disease
Do you have trouble with cancer, leukemia, malignancy or tumour o f any 
type
Do you have trouble with thyroid or other glandular disorders 
Has s/he ever had or been told that s/he had a stroke 
Has s/he ever been told that s/he has had a series o f mini-strokes 
Has s/he ever had transient ischaemic attacks
Has s/he ever been diagnosed as suffering from Parkinson ’s disease 
Has s/he ever been diagnosed as having Alzheimer’s disease or dementia 
Has s/he ever had a sudden weakness on one side which got better 
Has s/he ever had a sudden severe difficulty with speaking 
Has s/he ever had a sudden severe difficulty with vision 
Has s/he ever had a sudden severe dijficulty with memory
This criterion is likely to miss cases who have other forms o f cerebral insult such as head 
injury, AIDS etc.
G2.There is a presumed relationship between the 
development (or marked exacerbation) of the underlying disease, 
damage, or dysfunction, and the mental disorder, the symptoms of 
which may have immediate onset or may be delayed.
Cannot be measured in our survey.
G3. There is recovery from or significant improvement in the mental 
disorder following removal or improvement of the underlying 
presumed cause.
Cannot be measured in our survey.
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G4. There is insufficient evidence for an alternative causation of the 
mental disorder, e.g. a strong family history of a clinically similar or 
related disorder.
Cannot be measured in our survey.
If criteria Gl, G2, and G4 are met, a provisional diagnosis is justified; if, in addition, there is 
evidence of G3, the diagnosis can be regarded as certain.
B. There is a disorder in cognitive function for most of the time over 
a period of at least 2 weeks, as reported by the individual or a reliable 
informant. The disorder is exemplified by difficulties in any of the 
following areas:
(1) memory (particularly recall) or new learning;
(2) attention or concentration;
(3) thinking (e.g. slowing in problem-solving or abstraction);
(4) language (e.g. comprehension, word-finding);
(5) visual spatial functioning.
EITHER
A score o f more than 4 on the IQCODE
OR a positive response to one o f these four items
Overall, do you feel you can remember things as well as you used to? That is, is 
your memory the same as it was earlier in life ? Does this interfere in any way with 
your day to day life?
Do you feel you can think and reason as clearly as earlier in life? Does this interfere 
in any way with your day to day life?
In your opinion , does_____ remember things as well as she used to? That is , is
her/his memory the same as it was earlier in life? Does this interfere in any way 
with her/his day to day life?
In your opinion can______ think and reason as clearly as earlier in life? Does this
interfere in any way with her/his day to day life?
C. There is an abnormality or decline in performance in quantified 
cognitive assessments (e.g. neuropsychological tests or mental status 
examination).
Entry Condition 1
Those who scored more than 1.5 standard deviations below their age group’s performance 
level (age group considered in 70-79; 80-89;90+) on at least 2 o f the following tests:
SLM T
Verbal Fluency
MMSE
Vocabulary
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Similarities 
Sentence verification 
Information 
Cube drawing 
Face recognition 
Word recognition 
Recall
Visual Reproduction
Entry Condition 2
A score o f greater than 1.0 SD for the following change score is regarded as an estimator o f 
change:
NARTIQ -SLMTIQ
Entry Condition 3 
Criteria are outlined in text.
Note: This area is well covered. Note that age-referenced performance levels and not total 
population levels are used.
D. None of the difficulties listed in criterion B (l)-(5) are such that a diagnosis 
can be made of dementia (F00-F03), organic amnesic syndrome (F04), delirium 
(F05.-), postencephalitic syndrome (F07.1), postconcussional syndrome (F07.2), 
or other persisting cognitive impairment due to psychoactive substance use 
(Flx.74).
Does not satisfy ICD-10 criteria for Dementia or for “Probable Dementia 
Does not satisfy DSM-III-R criteria for Delirium or possible delirium 
Does not satisfy DSM-J1I-R criteria for amnestic syndrome.
Does not have chronic alcohol abuse which has caused problems.
